97. 潰瘍性大腸炎 Disease details / Clinical trials / Drug dev / DR info

0.03% using A foot pump
   The Leeds Teaching Hospitals NHS Trust
      2017   -   NCT03250780   United Kingdom
0.25 MG RPC103
   CELGENE INTERNATIONAL II SàRL
      2015   Phase 3   EUCTR2015-000319-41-IT   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
0.25 MG RPC1063
   CELGENE INTERNATIONAL II SàRL
      2016   Phase 3   EUCTR2015-001600-64-IT   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Germany;Greece;Hungary;Israel;Italy;Korea, Democratic People's Republic of;Korea, Republic of;Latvia;Mexico;Netherlands;New Zealand;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
   Celgene International II Sàrl
      2018   Phase 3   EUCTR2015-001600-64-RO   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2015-001600-64-LV   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2015-001600-64-GR   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2015-001600-64-ES   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2015-001600-64-AT   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2015-001600-64-HR   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-001600-64-NL   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-001600-64-BG   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
      2015   Phase 3   EUCTR2015-001600-64-SK   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Djibouti;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
      2015   Phase 3   EUCTR2015-001600-64-GB   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
      2015   Phase 3   EUCTR2015-001600-64-CZ   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
      2015   Phase 3   EUCTR2015-001600-64-BE   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
   Celgene International II Sàrl (CIS II)
      2018   Phase 3   EUCTR2015-000319-41-GR   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
      2015   Phase 3   EUCTR2015-001600-64-DE   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
      2013   Phase 2   EUCTR2012-003123-38-PL   Belgium;Bulgaria;Czech Republic;Greece;Hungary;Israel;Korea, Republic of;Netherlands;Poland;Russian Federation;Slovakia;Ukraine;United States
      2012   Phase 2   EUCTR2012-003123-38-BE   Belgium;Bulgaria;Greece;Hungary;Israel;Korea, Republic of;Netherlands;Poland;Russian Federation;Slovakia;Ukraine;United States
      -   Phase 3   EUCTR2015-001600-64-PL   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Ukraine;United Kingdom;United States
   Celgene International II Sàrl (CIS II).
      2013   Phase 2   EUCTR2012-003123-38-SK   Belgium;Bulgaria;Greece;Hungary;Israel;Korea, Republic of;Netherlands;Poland;Russian Federation;Slovakia;Ukraine;United States
      2013   Phase 2   EUCTR2012-003123-38-NL   Belgium;Bulgaria;Greece;Hungary;Israel;Korea, Republic of;Netherlands;Poland;Russian Federation;Slovakia;Ukraine;United States
      2013   Phase 2   EUCTR2012-003123-38-HU   Belgium;Bulgaria;Greece;Hungary;Israel;Korea, Republic of;Netherlands;Poland;Russian Federation;Slovakia;Ukraine;United States
      2013   Phase 2   EUCTR2012-003123-38-BG   Belgium;Bulgaria;Greece;Hungary;Israel;Korea, Republic of;Netherlands;Poland;Russian Federation;Slovakia;Ukraine;United States
   Celgene International II Sárl (CIS II)
      2015   Phase 3   EUCTR2015-001600-64-HU   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
   Receptos, Inc.
      2013   Phase 2   EUCTR2012-003123-38-GR   Australia;Belgium;Bulgaria;Canada;Czech Republic;Germany;Greece;Hungary;Israel;Korea, Republic of;Netherlands;New Zealand;Poland;Russian Federation;Slovakia;United States
0.25MG RPC103
   Celgene International II Sàrl
      2015   Phase 3   EUCTR2015-000319-41-GB   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
   Celgene International II Sàrl (CIS II)
      2018   Phase 3   EUCTR2015-000319-41-LV   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2015-000319-41-AT   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2015-000319-41-HR   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000319-41-NL   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
      2015   Phase 3   EUCTR2015-000319-41-SK   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
      2015   Phase 3   EUCTR2015-000319-41-DE   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
      2015   Phase 3   EUCTR2015-000319-41-CZ   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
      2015   Phase 3   EUCTR2015-000319-41-BE   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
      -   Phase 3   EUCTR2015-000319-41-PL   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Ukraine;United Kingdom;United States
      -   Phase 3   EUCTR2015-000319-41-BG   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
   Celgene International II Sárl (CIS II)
      2015   Phase 3   EUCTR2015-000319-41-HU   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Mexico;Netherlands;New Zealand;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
0.25MG RPC1063
   Celgene International II Sàrl (CIS II)
      2018   Phase 3   EUCTR2015-000319-41-ES   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
0.5 MG RPC1063
   Celgene International II Sàrl (CIS II)
      2013   Phase 2   EUCTR2012-003123-38-PL   Belgium;Bulgaria;Czech Republic;Greece;Hungary;Israel;Korea, Republic of;Netherlands;Poland;Russian Federation;Slovakia;Ukraine;United States
      2012   Phase 2   EUCTR2012-003123-38-BE   Belgium;Bulgaria;Greece;Hungary;Israel;Korea, Republic of;Netherlands;Poland;Russian Federation;Slovakia;Ukraine;United States
   Celgene International II Sàrl (CIS II).
      2013   Phase 2   EUCTR2012-003123-38-SK   Belgium;Bulgaria;Greece;Hungary;Israel;Korea, Republic of;Netherlands;Poland;Russian Federation;Slovakia;Ukraine;United States
      2013   Phase 2   EUCTR2012-003123-38-NL   Belgium;Bulgaria;Greece;Hungary;Israel;Korea, Republic of;Netherlands;Poland;Russian Federation;Slovakia;Ukraine;United States
      2013   Phase 2   EUCTR2012-003123-38-HU   Belgium;Bulgaria;Greece;Hungary;Israel;Korea, Republic of;Netherlands;Poland;Russian Federation;Slovakia;Ukraine;United States
      2013   Phase 2   EUCTR2012-003123-38-BG   Belgium;Bulgaria;Greece;Hungary;Israel;Korea, Republic of;Netherlands;Poland;Russian Federation;Slovakia;Ukraine;United States
   Receptos, Inc.
      2013   Phase 2   EUCTR2012-003123-38-GR   Australia;Belgium;Bulgaria;Canada;Czech Republic;Germany;Greece;Hungary;Israel;Korea, Republic of;Netherlands;New Zealand;Poland;Russian Federation;Slovakia;United States
1 MG RPC1063
   Celgene International II Sàrl (CIS II)
      2013   Phase 2   EUCTR2012-003123-38-PL   Belgium;Bulgaria;Czech Republic;Greece;Hungary;Israel;Korea, Republic of;Netherlands;Poland;Russian Federation;Slovakia;Ukraine;United States
      2012   Phase 2   EUCTR2012-003123-38-BE   Belgium;Bulgaria;Greece;Hungary;Israel;Korea, Republic of;Netherlands;Poland;Russian Federation;Slovakia;Ukraine;United States
   Celgene International II Sàrl (CIS II).
      2013   Phase 2   EUCTR2012-003123-38-SK   Belgium;Bulgaria;Greece;Hungary;Israel;Korea, Republic of;Netherlands;Poland;Russian Federation;Slovakia;Ukraine;United States
      2013   Phase 2   EUCTR2012-003123-38-NL   Belgium;Bulgaria;Greece;Hungary;Israel;Korea, Republic of;Netherlands;Poland;Russian Federation;Slovakia;Ukraine;United States
      2013   Phase 2   EUCTR2012-003123-38-HU   Belgium;Bulgaria;Greece;Hungary;Israel;Korea, Republic of;Netherlands;Poland;Russian Federation;Slovakia;Ukraine;United States
      2013   Phase 2   EUCTR2012-003123-38-BG   Belgium;Bulgaria;Greece;Hungary;Israel;Korea, Republic of;Netherlands;Poland;Russian Federation;Slovakia;Ukraine;United States
   Receptos, Inc.
      2013   Phase 2   EUCTR2012-003123-38-GR   Australia;Belgium;Bulgaria;Canada;Czech Republic;Germany;Greece;Hungary;Israel;Korea, Republic of;Netherlands;New Zealand;Poland;Russian Federation;Slovakia;United States
1 serving OF broccoli sprouts
   University of Michigan
      2023   -   NCT05507931   United States
1.0 MG RPC103
   CELGENE INTERNATIONAL II SàRL
      2015   Phase 3   EUCTR2015-000319-41-IT   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
   Celgene International II Sàrl
      2015   Phase 3   EUCTR2015-000319-41-GB   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
   Celgene International II Sàrl (CIS II)
      2018   Phase 3   EUCTR2015-000319-41-LV   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2015-000319-41-AT   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2015-000319-41-HR   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000319-41-NL   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
      2015   Phase 3   EUCTR2015-000319-41-SK   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
      2015   Phase 3   EUCTR2015-000319-41-DE   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
      2015   Phase 3   EUCTR2015-000319-41-CZ   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
      2015   Phase 3   EUCTR2015-000319-41-BE   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
      -   Phase 3   EUCTR2015-000319-41-PL   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Ukraine;United Kingdom;United States
      -   Phase 3   EUCTR2015-000319-41-BG   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
   Celgene International II Sárl (CIS II)
      2015   Phase 3   EUCTR2015-000319-41-HU   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Mexico;Netherlands;New Zealand;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
1.0 MG RPC1063
   CELGENE INTERNATIONAL II SàRL
      2016   Phase 3   EUCTR2015-001600-64-IT   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Germany;Greece;Hungary;Israel;Italy;Korea, Democratic People's Republic of;Korea, Republic of;Latvia;Mexico;Netherlands;New Zealand;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
   Celgene International II Sàrl
      2018   Phase 3   EUCTR2015-001600-64-RO   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2015-001600-64-LV   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2015-001600-64-GR   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2015-001600-64-ES   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2015-001600-64-AT   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2015-001600-64-HR   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-001600-64-NL   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-001600-64-BG   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
      2015   Phase 3   EUCTR2015-001600-64-SK   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Djibouti;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
      2015   Phase 3   EUCTR2015-001600-64-GB   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
      2015   Phase 3   EUCTR2015-001600-64-CZ   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
      2015   Phase 3   EUCTR2015-001600-64-BE   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
   Celgene International II Sàrl (CIS II)
      2018   Phase 3   EUCTR2015-000319-41-GR   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2015-000319-41-ES   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
      2015   Phase 3   EUCTR2015-001600-64-DE   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
      -   Phase 3   EUCTR2015-001600-64-PL   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Ukraine;United Kingdom;United States
   Celgene International II Sárl (CIS II)
      2015   Phase 3   EUCTR2015-001600-64-HU   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
1.remicade
   Helse More og Romsdal Hospital Trust
      2016   Phase 4   EUCTR2016-001409-18-NO   Norway
10 MG natura-alpha capsule
   Natrogen Therapeutics International, Inc
      2010   Phase 2   NCT01216280   United States
100 MG
   Dr August Wolff GmbH & Co KG Arzneimittel
      2012   -   EUCTR2011-002462-20-SK   Czech Republic;Germany;Hungary;Italy;Poland;Slovakia
      2011   -   EUCTR2011-002462-20-PL   Czech Republic;Germany;Hungary;Italy;Poland
      2011   -   EUCTR2011-002462-20-HU   Czech Republic;Germany;Hungary;Italy;Poland
      2011   -   EUCTR2011-002462-20-DE   Czech Republic;Germany;Hungary;Italy;Poland
      2011   -   EUCTR2011-002462-20-CZ   Czech Republic;Germany;Hungary;Italy;Poland
   GETAID
      2008   -   EUCTR2006-005299-42-BE   Belgium;Finland;France;Spain
      2007   -   EUCTR2006-005299-42-FR   Belgium;Finland;France;Spain
   IRCCS ISTITUTO CLINICO HUMANITAS
      2017   Phase 4   EUCTR2016-002707-25-IT   Italy
   Pfizer Inc
      2020   Phase 2   EUCTR2019-002698-74-HU   Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;France;Germany;Hungary;India;Israel;Italy;Japan;Mexico;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United States
   Shikamura Mitsuhiro
      2023   Phase 3   JPRN-jRCT2071230036   China;Greece;Hungary;Italy;Japan;Korea;Poland
      2021   Phase 3   JPRN-jRCT2071210030   Australia;Belgium;Bosnia;Canada;China;Croatia;Czech Republic;Germany;Hungary;Israel;Italy;Japan;Lithuania;New Zealand;Poland;Romania;Russia;Slovakia;Spain;Ukraine;United Kingdom;United States
   UNIVERSITÀ CATTOLICA DEL SACRO CUORE- POLICLINICO A. GEMELLI
      2016   Phase 4   EUCTR2016-002061-54-IT   Italy
100% pomegranate juice
   IRCCS Azienda Ospedaliero-Universitaria di Bologna
      2017   -   NCT03000101   Italy
1500MG mesalazine pellets
   Dr. Falk Pharma GmbH
      2005   Phase 3   EUCTR2004-001218-15-SK   Estonia;Germany;Hungary;Latvia;Lithuania;Slovakia;Slovenia
      2005   -   EUCTR2004-001218-15-SI   Estonia;Germany;Hungary;Latvia;Lithuania;Slovenia
      2005   -   EUCTR2004-001218-15-LV   Estonia;Germany;Hungary;Latvia;Lithuania
      2005   -   EUCTR2004-001218-15-LT   Estonia;Germany;Hungary;Latvia;Lithuania
      2005   -   EUCTR2004-001218-15-HU   Estonia;Germany;Hungary;Latvia;Lithuania
      2005   -   EUCTR2004-001218-15-EE   Estonia;Germany;Hungary;Latvia;Lithuania
      2005   -   EUCTR2004-001218-15-DE   Estonia;Germany;Hungary;Latvia;Lithuania
      2005   Phase 3   EUCTR2004-001216-31-SK   Czech Republic;Estonia;Germany;Hungary;Latvia;Lithuania;Slovakia;Slovenia
      2005   -   EUCTR2004-001216-31-SI   Czech Republic;Estonia;Germany;Hungary;Latvia;Lithuania;Slovenia
      2005   -   EUCTR2004-001216-31-LV   Czech Republic;Estonia;Germany;Hungary;Latvia;Lithuania
      2005   -   EUCTR2004-001216-31-LT   Czech Republic;Estonia;Germany;Hungary;Latvia;Lithuania
      2005   -   EUCTR2004-001216-31-HU   Czech Republic;Estonia;Germany;Hungary;Latvia;Lithuania
      2005   -   EUCTR2004-001216-31-EE   Czech Republic;Estonia;Germany;Hungary;Latvia;Lithuania
      2005   -   EUCTR2004-001216-31-DE   Czech Republic;Estonia;Germany;Hungary;Latvia;Lithuania
      2005   -   EUCTR2004-001216-31-CZ   Czech Republic;Estonia;Germany;Hungary;Latvia;Lithuania
15n2-tofacitinib
   Theravance Biopharma
      2017   Phase 1   NCT03103412   United States
2 X 10 MG natura-alpha capsules
   Natrogen Therapeutics International, Inc
      2010   Phase 2   NCT01216280   United States
2'-fucosyllactose
   Children's Hospital Medical Center, Cincinnati
      2019   Phase 1/Phase 2   NCT03847467   United States
   Royal Berkshire NHS Foundation Trust
      2024   -   NCT06050811   United Kingdom
20 MG
   AbbVie Deutschland GmbH & Co. KG
      2015   Phase 3   EUCTR2015-001346-29-SK   Belgium;Canada;Czech Republic;European Union;Hungary;Israel;Japan;New Zealand;Poland;Slovakia;Spain;Sweden;United Kingdom;United States
      -   Phase 3   EUCTR2015-001346-29-PL   Belgium;Canada;Czech Republic;European Union;Hungary;Israel;Japan;New Zealand;Poland;Slovakia;Spain;Sweden;United Kingdom;United States
   Dr August Wolff GmbH & Co KG Arzneimittel
      2012   -   EUCTR2011-002462-20-SK   Czech Republic;Germany;Hungary;Italy;Poland;Slovakia
      2011   -   EUCTR2011-002462-20-PL   Czech Republic;Germany;Hungary;Italy;Poland
      2011   -   EUCTR2011-002462-20-HU   Czech Republic;Germany;Hungary;Italy;Poland
      2011   -   EUCTR2011-002462-20-DE   Czech Republic;Germany;Hungary;Italy;Poland
      2011   -   EUCTR2011-002462-20-CZ   Czech Republic;Germany;Hungary;Italy;Poland
23-valent polysaccharide pneumococcal vaccine
   Cedars-Sinai Medical Center
      2005   -   NCT00829595   United States
25 MG ontamalimab
   Shire
      2018   Phase 3   NCT03283085   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Colombia;Croatia;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
250MG mesalazine pellets
   Dr. Falk Pharma GmbH
      2005   Phase 3   EUCTR2004-001218-15-SK   Estonia;Germany;Hungary;Latvia;Lithuania;Slovakia;Slovenia
      2005   -   EUCTR2004-001218-15-SI   Estonia;Germany;Hungary;Latvia;Lithuania;Slovenia
      2005   -   EUCTR2004-001218-15-LV   Estonia;Germany;Hungary;Latvia;Lithuania
      2005   -   EUCTR2004-001218-15-LT   Estonia;Germany;Hungary;Latvia;Lithuania
      2005   -   EUCTR2004-001218-15-HU   Estonia;Germany;Hungary;Latvia;Lithuania
      2005   -   EUCTR2004-001218-15-EE   Estonia;Germany;Hungary;Latvia;Lithuania
      2005   -   EUCTR2004-001218-15-DE   Estonia;Germany;Hungary;Latvia;Lithuania
2L polyethylene glycol/ascorbic acid
   American University of Beirut Medical Center
      2018   Phase 4   NCT03581149   Lebanon
2ML peripheral venous blood WAS collected TO detect genetic genes
   Second Affiliated Hospital of Wenzhou Medical University
      2021   -   NCT05071742   China
3 bottles OF lactulose oral solution
   Second Affiliated Hospital of Wenzhou Medical University
      2023   -   NCT05878639   China
3 servings OF broccoli sprouts
   University of Michigan
      2023   -   NCT05507931   United States
331731-18-1
   ABBOTT GMBH & Co. KG
      2012   -   EUCTR2011-002411-29-IT   Austria;Belgium;Canada;Czech Republic;Denmark;Finland;Germany;Greece;Ireland;Israel;Italy;Poland;Portugal;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom
   AbbVie Deutschland GmbH & Co. KG
      2019   Phase 3   EUCTR2013-001682-16-DK   Austria;Canada;Czech Republic;Denmark;Germany;Hungary;Israel;Italy;Japan;Netherlands;Poland;Slovakia;Spain;Switzerland;United States
      2017   Phase 3   EUCTR2015-001346-29-CZ   Belgium;Canada;Czech Republic;European Union;Hungary;Israel;Italy;Japan;New Zealand;Poland;Slovakia;Spain;Sweden;United Kingdom;United States
      2016   Phase 3   EUCTR2015-001346-29-HU   Australia;Belgium;Canada;Czech Republic;Hungary;Israel;Italy;New Zealand;Poland;Slovakia;Spain;Sweden;United Kingdom;United States
      2016   Phase 3   EUCTR2015-001346-29-GB   Belgium;Canada;Czech Republic;European Union;Hungary;Israel;Japan;New Zealand;Spain;Sweden;United Kingdom;United States
      2016   Phase 3   EUCTR2015-001346-29-ES   Australia;Belgium;Canada;Czech Republic;Hungary;Israel;Japan;New Zealand;Poland;Slovakia;Spain;Sweden;United Kingdom;United States
      2016   Phase 3   EUCTR2015-001346-29-BE   Australia;Belgium;Canada;Czech Republic;Hungary;Israel;Japan;New Zealand;Poland;Slovakia;Spain;Sweden;United Kingdom;United States
      2015   Phase 3   EUCTR2015-001346-29-SK   Belgium;Canada;Czech Republic;European Union;Hungary;Israel;Japan;New Zealand;Poland;Slovakia;Spain;Sweden;United Kingdom;United States
      2015   Phase 3   EUCTR2013-001682-16-BE   Belgium;Canada;Germany;Hungary;Israel;Italy;Japan;Netherlands;Poland;Spain;Switzerland;United States
      2014   Phase 3   EUCTR2013-003032-77-IT   Australia;Austria;Belgium;Canada;Czech Republic;France;Hungary;Israel;Italy;New Zealand;Poland;Slovakia;Spain;Switzerland;United Kingdom;United States
      2014   Phase 3   EUCTR2013-003032-77-HU   Australia;Austria;Belgium;Canada;Czech Republic;France;Hungary;Israel;Italy;New Zealand;Poland;Slovakia;Spain;United Kingdom;United States
      2014   Phase 3   EUCTR2013-003032-77-GB   Austria;Belgium;Canada;Czech Republic;France;Hungary;Israel;Italy;New Zealand;Poland;Slovakia;Spain;United Kingdom;United States
      2014   Phase 3   EUCTR2013-001682-16-SK   Austria;Canada;Czech Republic;Denmark;Germany;Hungary;Israel;Italy;Japan;Netherlands;Poland;Slovakia;Spain;Switzerland;United States
      2014   Phase 3   EUCTR2013-001682-16-PL   Austria;Belgium;Canada;Czech Republic;Denmark;Germany;Hungary;Israel;Italy;Japan;Netherlands;Poland;Slovakia;Spain;Switzerland;United States
      2014   Phase 3   EUCTR2013-001682-16-NL   Austria;Belgium;Canada;Czech Republic;Denmark;Germany;Hungary;Israel;Japan;Netherlands;Poland;Slovakia;Spain;Switzerland;United States
      2014   Phase 3   EUCTR2013-001682-16-IT   Austria;Belgium;Canada;Czech Republic;Denmark;Germany;Hungary;Israel;Italy;Japan;Netherlands;Poland;Slovakia;Spain;Switzerland;United States
      2014   Phase 3   EUCTR2013-001682-16-HU   Austria;Belgium;Canada;Czech Republic;Denmark;Germany;Hungary;Israel;Italy;Japan;Netherlands;Poland;Slovakia;Spain;Switzerland;United States
      2014   Phase 3   EUCTR2013-001682-16-ES   Austria;Canada;Czech Republic;Denmark;Germany;Hungary;Israel;Italy;Japan;Netherlands;Poland;Slovakia;Spain;Switzerland;United States
      2014   Phase 3   EUCTR2013-001682-16-DE   Austria;Belgium;Canada;Czech Republic;Denmark;Germany;Hungary;Israel;Italy;Japan;Netherlands;Poland;Slovakia;Spain;Switzerland;United States
      2014   Phase 3   EUCTR2013-001682-16-CZ   Austria;Belgium;Canada;Czech Republic;Denmark;Germany;Hungary;Israel;Italy;Japan;Netherlands;Poland;Slovakia;Spain;Switzerland;United States
      2014   Phase 3   EUCTR2013-001682-16-AT   Austria;Belgium;Canada;Czech Republic;Denmark;Germany;Hungary;Israel;Japan;Netherlands;Poland;Slovakia;Spain;Switzerland;United States
      2013   -   EUCTR2011-002411-29-SK   Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Ireland;Israel;Italy;Norway;Poland;Portugal;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom
      2013   -   EUCTR2011-002411-29-PL   Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Ireland;Israel;Italy;Norway;Poland;Portugal;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom
      2013   -   EUCTR2011-002411-29-CZ   Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Ireland;Israel;Italy;Norway;Poland;Portugal;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom
      2012   -   EUCTR2011-002411-29-SE   Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Ireland;Israel;Italy;Norway;Poland;Portugal;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom
      2012   -   EUCTR2011-002411-29-PT   Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Ireland;Israel;Italy;Netherlands;Norway;Poland;Portugal;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom
      2012   -   EUCTR2011-002411-29-IE   Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Ireland;Israel;Italy;Norway;Poland;Portugal;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom
      2012   -   EUCTR2011-002411-29-FI   Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Ireland;Israel;Italy;Netherlands;Norway;Poland;Portugal;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom
      2012   -   EUCTR2011-002411-29-DK   Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Ireland;Israel;Italy;Norway;Poland;Portugal;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom
      2012   -   EUCTR2011-002411-29-DE   Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Ireland;Israel;Italy;Norway;Poland;Portugal;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom
      2012   -   EUCTR2011-002411-29-BE   Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Ireland;Israel;Italy;Norway;Poland;Portugal;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom
      2012   -   EUCTR2011-002411-29-AT   Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Ireland;Israel;Italy;Norway;Poland;Portugal;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom
      2009   Phase 3   EUCTR2007-004157-28-SE   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Slovakia;Spain;Sweden;Switzerland
      2008   Phase 3   EUCTR2007-004157-28-NL   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Slovakia;Spain;Sweden;Switzerland
      2008   Phase 3   EUCTR2007-004157-28-HU   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Slovakia;Spain;Sweden;Switzerland
      2008   Phase 3   EUCTR2007-004157-28-DE   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Slovakia;Spain;Sweden;Switzerland
      2008   Phase 3   EUCTR2007-004157-28-CZ   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Slovakia;Spain;Sweden;Switzerland
      2008   Phase 3   EUCTR2007-004157-28-BE   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Slovakia;Spain;Sweden;Switzerland
      2008   Phase 3   EUCTR2007-004157-28-AT   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Slovakia;Spain;Sweden;Switzerland
      -   Phase 3   EUCTR2015-001346-29-PL   Belgium;Canada;Czech Republic;European Union;Hungary;Israel;Japan;New Zealand;Poland;Slovakia;Spain;Sweden;United Kingdom;United States
      -   Phase 3   EUCTR2015-001346-29-SE   Belgium;Canada;Czech Republic;European Union;Hungary;Israel;Japan;New Zealand;Spain;Sweden;United Kingdom;United States
      -   Phase 3   EUCTR2015-001346-29-AT   Austria;Belgium;Canada;Czech Republic;European Union;Hungary;Israel;Japan;New Zealand;Spain;Sweden;United Kingdom;United States
   AbbVie Inc.
      -   -   EUCTR2014-004559-29-Outside-EU/EEA   Japan
   Abbott GmbH & Co. KG
      2012   -   EUCTR2011-002411-29-GR   Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Ireland;Israel;Italy;Netherlands;Norway;Poland;Portugal;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom
      2012   -   EUCTR2011-002411-29-ES   Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Ireland;Israel;Italy;Netherlands;Norway;Poland;Portugal;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom
      2009   Phase 3   EUCTR2007-004157-28-PT   Austria;Belgium;Czech Republic;France;Germany;Hungary;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden
      2008   Phase 3   EUCTR2007-004157-28-SK   Austria;Belgium;Czech Republic;France;Germany;Hungary;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden
      2008   Phase 3   EUCTR2007-004157-28-FR   Austria;Belgium;Czech Republic;France;Germany;Hungary;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden
   Abbvie Deutschland GmbH & Co. KG
      2015   Phase 3   EUCTR2013-003032-77-PL   Austria;Belgium;Canada;Czech Republic;France;Hungary;Israel;Italy;New Zealand;Poland;Slovakia;Spain;United Kingdom;United States
      2014   Phase 3   EUCTR2013-003032-77-SK   Austria;Belgium;Canada;Czech Republic;France;Hungary;Israel;Italy;New Zealand;Poland;Slovakia;Spain;United Kingdom;United States
      2014   Phase 3   EUCTR2013-003032-77-ES   Australia;Austria;Belgium;Canada;Czech Republic;France;Hungary;Israel;Italy;New Zealand;Poland;Slovakia;Spain;Switzerland;United Kingdom;United States
      2014   Phase 3   EUCTR2013-003032-77-CZ   Austria;Belgium;Canada;Czech Republic;France;Hungary;Israel;Italy;New Zealand;Poland;Slovakia;Spain;United Kingdom;United States
      2014   Phase 3   EUCTR2013-003032-77-BE   Australia;Austria;Belgium;Canada;Czech Republic;France;Hungary;Israel;Italy;New Zealand;Poland;Slovakia;Spain;Switzerland;United Kingdom;United States
      2014   Phase 3   EUCTR2013-003032-77-AT   Austria;Belgium;Canada;Czech Republic;France;Hungary;Israel;Italy;New Zealand;Poland;Slovakia;Spain;United Kingdom;United States
      2012   -   EUCTR2011-002411-29-GB   Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Ireland;Israel;Italy;Netherlands;Norway;Poland;Portugal;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom
      -   Phase 3   EUCTR2013-003032-77-FR   Australia;Austria;Belgium;Canada;Czech Republic;France;Hungary;Israel;Italy;New Zealand;Poland;Slovakia;Spain;Switzerland;United Kingdom;United States
   Applied Molecular Transport Inc.
      2021   Phase 2   EUCTR2020-002833-13-PL   Georgia;Netherlands;Poland;Ukraine
      2021   Phase 2   EUCTR2020-002833-13-NL   Georgia;Netherlands;Poland;Ukraine
   F. Hoffmann-La Roche Ltd
      2019   Phase 3   EUCTR2013-004279-11-FR   Argentina;Australia;Brazil;Bulgaria;Estonia;France;Hong Kong;Mexico;Poland;Russian Federation;Serbia;Slovakia;Ukraine;United States
      2019   Phase 3   EUCTR2013-004277-27-HU   Argentina;Australia;Brazil;Bulgaria;Colombia;Croatia;Czech Republic;Greece;Hungary;Latvia;Lithuania;Malaysia;New Zealand;Poland;Russian Federation;Turkey;Ukraine;United States
      2019   Phase 3   EUCTR2013-004277-27-CZ   Argentina;Australia;Brazil;Bulgaria;Colombia;Croatia;Czech Republic;Greece;Hungary;Latvia;Lithuania;Malaysia;New Zealand;Poland;Russian Federation;Turkey;Ukraine;United States
      2015   Phase 3   EUCTR2013-004279-11-BG   Argentina;Australia;Brazil;Bulgaria;Estonia;France;Hong Kong;Mexico;Poland;Russian Federation;Serbia;Slovakia;Ukraine;United States
      2015   Phase 3   EUCTR2013-004277-27-BG   Argentina;Australia;Brazil;Bulgaria;Colombia;Croatia;Czech Republic;Greece;Hungary;Latvia;Lithuania;Malaysia;New Zealand;Poland;Russian Federation;Turkey;Ukraine;United States
      2014   Phase 3   EUCTR2013-004279-11-SK   Argentina;Australia;Brazil;Bulgaria;Estonia;France;Hong Kong;Mexico;Poland;Russian Federation;Serbia;Slovakia;Ukraine;United States
      2014   Phase 3   EUCTR2013-004279-11-EE   Argentina;Australia;Brazil;Bulgaria;Estonia;France;Hong Kong;Mexico;Poland;Russian Federation;Serbia;Slovakia;Ukraine;United States
      2014   Phase 3   EUCTR2013-004277-27-LV   Argentina;Australia;Brazil;Bulgaria;Colombia;Croatia;Czech Republic;Greece;Hungary;Latvia;Lithuania;Malaysia;New Zealand;Poland;Russian Federation;Turkey;Ukraine;United States
      2014   Phase 3   EUCTR2013-004277-27-LT   Argentina;Australia;Brazil;Bulgaria;Colombia;Croatia;Czech Republic;Greece;Hungary;Latvia;Lithuania;Malaysia;New Zealand;Poland;Russian Federation;Turkey;Ukraine;United States
      2014   Phase 3   EUCTR2013-004277-27-HR   Argentina;Australia;Brazil;Bulgaria;Colombia;Croatia;Czech Republic;Greece;Hungary;Latvia;Lithuania;Malaysia;New Zealand;Poland;Russian Federation;Turkey;Ukraine;United States
      2014   Phase 3   EUCTR2013-004277-27-GR   Argentina;Australia;Brazil;Bulgaria;Colombia;Croatia;Czech Republic;Greece;Hungary;Latvia;Lithuania;Malaysia;New Zealand;Poland;Russian Federation;Turkey;Ukraine;United States
   Fundación Española de Gastroenterología
      2021   Phase 4   EUCTR2021-002211-65-ES   Spain
   Fundación de Investigación Biomédica Hospital Universitario de la Princesa
      2016   Phase 4   EUCTR2015-001410-10-ES   Spain
   Fundación de Investigación Biomédica del Hospital Universitario de La Princesa
      2018   Phase 4   EUCTR2018-002925-47-ES   Spain
   GETAID
      2019   Phase 4   EUCTR2018-003490-10-FR   France
   Helse More og Romsdal Hospital Trust
      2016   Phase 4   EUCTR2016-001409-18-NO   Norway
   IRCCS ISTITUTO CLINICO HUMANITAS
      2021   Phase 4   EUCTR2020-003420-16-IT   Austria;Belgium;France;Germany;Italy;Portugal;Spain;Sweden;Switzerland;United Kingdom
   Instituto Clinico Humanitas
      2021   Phase 4   EUCTR2020-003420-16-ES   Austria;Belgium;France;Germany;Italy;Portugal;Spain;Sweden;Switzerland;United Kingdom
      2021   Phase 4   EUCTR2020-003420-16-BE   Austria;Belgium;France;Germany;Italy;Portugal;Spain;Sweden;Switzerland;United Kingdom
   PIBD net
      2018   Phase 4   EUCTR2016-000522-18-GB   Belgium;Canada;Czech Republic;France;Germany;Israel;Italy;Netherlands;Poland;Spain;United Kingdom
   Region Örebro län
      2021   Phase 4   EUCTR2019-002942-19-DK   Denmark;Iceland
   Regionalhospital Silkeborg
      2010   Phase 4   EUCTR2009-018085-35-DK   Denmark
   Royal Liverpool University Hospital
      2012   -   EUCTR2011-006084-22-GB   United Kingdom
   Samsung Bioepis Co., Ltd
      2015   -   EUCTR2014-004887-39-PL   Poland
   Samsung Bioepis Co., Ltd.
      2014   -   EUCTR2013-005013-13-PL   Bosnia and Herzegovina;Bulgaria;Czech Republic;Korea, Republic of;Latvia;Lithuania;Mexico;Poland;Russian Federation;Ukraine;United Kingdom
      2014   -   EUCTR2013-005013-13-LT   Bosnia and Herzegovina;Bulgaria;Czech Republic;Korea, Republic of;Lithuania;Mexico;Poland;Russian Federation;Ukraine;United Kingdom
      2014   -   EUCTR2013-005013-13-CZ   Bosnia and Herzegovina;Bulgaria;Czech Republic;Korea, Republic of;Lithuania;Mexico;Poland;Russian Federation;Ukraine;United Kingdom
      2014   Phase 3   EUCTR2013-005013-13-BG   Bosnia and Herzegovina;Bulgaria;Czech Republic;Korea, Republic of;Lithuania;Mexico;Poland;Russian Federation;Ukraine;United Kingdom
   Takeda Development Centre Europe, Ltd.
      2016   Phase 3   EUCTR2015-000939-33-PT   Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000939-33-PL   Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000939-33-NL   Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000939-33-HU   Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000939-33-HR   Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000939-33-ES   Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2015   Phase 3   EUCTR2015-000939-33-SK   Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2015   Phase 3   EUCTR2015-000939-33-LV   Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2015   Phase 3   EUCTR2015-000939-33-LT   Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2015   Phase 3   EUCTR2015-000939-33-GB   Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2015   Phase 3   EUCTR2015-000939-33-EE   Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2015   Phase 3   EUCTR2015-000939-33-DK   Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2015   Phase 3   EUCTR2015-000939-33-DE   Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2015   Phase 3   EUCTR2015-000939-33-CZ   Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2015   Phase 3   EUCTR2015-000939-33-BG   Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2015   Phase 3   EUCTR2015-000939-33-BE   Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
   University Hospital Southampton NHS Foundation Trust
      2019   Phase 4   EUCTR2018-004967-30-GB   United Kingdom
   University Medical Center Groningen
      2021   Phase 4   EUCTR2020-001811-26-BE   Belgium;Netherlands;Spain
      2020   Phase 4   EUCTR2020-001811-26-NL   Belgium;Netherlands;Spain
   Universitätsklinikum Erlangen
      2019   Phase 4   EUCTR2019-003662-40-DE   Germany
3L-polyethylene glycol
   Second Affiliated Hospital of Wenzhou Medical University
      2023   -   NCT05878639   China
40 MG MSB11022
   Fresenius Kabi SwissBioSim GmbH
      2019   Phase 1   NCT04018599   United States
5 ASA, enemas, suppositories, corticosteroids
   Bausch Health Americas, Inc.
      2005   Phase 3   NCT00269438   United States
5-amino salicylic acid
   Shire Pharmaceutical Development Inc
      2004   Phase 3   EUCTR2004-000733-12-CZ   Czech Republic
   Shire Pharmaceutical Development Inc.
      2005   Phase 3   EUCTR2004-000734-36-CZ   Czech Republic
   Shire Pharmaceutical Development Ltd
      2009   -   EUCTR2004-004184-29-DK   Czech Republic;Denmark;Germany;Hungary;Netherlands;Portugal;Spain;Sweden;United Kingdom
      2008   Phase 3   EUCTR2004-004184-29-NL   Czech Republic;Denmark;Germany;Hungary;Netherlands;Portugal;Spain;Sweden;United Kingdom
      2007   -   EUCTR2004-004184-29-SE   Czech Republic;Denmark;Germany;Hungary;Netherlands;Portugal;Spain;Sweden;United Kingdom
      2007   -   EUCTR2004-004184-29-PT   Czech Republic;Denmark;Germany;Hungary;Netherlands;Portugal;Spain;Sweden;United Kingdom
      2005   Phase 3   EUCTR2004-004184-29-HU   Czech Republic;Denmark;Germany;Hungary;Netherlands;Portugal;Spain;Sweden;United Kingdom
      2005   Phase 3   EUCTR2004-004184-29-GB   Czech Republic;Denmark;Germany;Hungary;Netherlands;Portugal;Spain;Sweden;United Kingdom
      2005   -   EUCTR2004-004184-29-ES   Czech Republic;Denmark;Germany;Hungary;Netherlands;Portugal;Spain;Sweden;United Kingdom
      2005   -   EUCTR2004-004184-29-DE   Czech Republic;Denmark;Germany;Hungary;Netherlands;Portugal;Spain;Sweden;United Kingdom
      2005   -   EUCTR2004-004184-29-CZ   Czech Republic;Denmark;Germany;Hungary;Netherlands;Portugal;Spain;Sweden;United Kingdom
5-amino-2-hydroxybenzoic acid
   Otsuka Maryland Research Institute, Inc.
      2004   Phase 3   EUCTR2004-000611-25-IE   Hungary;Ireland
      2004   -   EUCTR2004-000611-25-HU   Hungary;Ireland
5-aminosalicyclic acid
   Asian Institute of Gastroenterology, India
      2016   Phase 3   NCT02683759   India
5-aminosalicylic acid
   Asian Institute of Gastroenterology, India
      2016   Phase 3   NCT02683733   India
   Cardiff and Vale NHS Trust
      2006   Phase 3   EUCTR2005-002784-91-GB   United Kingdom
   Department of Internal medicine, Division of Lower Gastroenterology, Hyogo College of Medicine
      2010   Phase 3   JPRN-UMIN000003785   Japan
   Dr. Falk Pharma GmbH
      2005   Phase 3   EUCTR2004-001218-15-SK   Estonia;Germany;Hungary;Latvia;Lithuania;Slovakia;Slovenia
      2005   -   EUCTR2004-001218-15-SI   Estonia;Germany;Hungary;Latvia;Lithuania;Slovenia
      2005   -   EUCTR2004-001218-15-LV   Estonia;Germany;Hungary;Latvia;Lithuania
      2005   -   EUCTR2004-001218-15-LT   Estonia;Germany;Hungary;Latvia;Lithuania
      2005   -   EUCTR2004-001218-15-HU   Estonia;Germany;Hungary;Latvia;Lithuania
      2005   -   EUCTR2004-001218-15-EE   Estonia;Germany;Hungary;Latvia;Lithuania
      2005   -   EUCTR2004-001218-15-DE   Estonia;Germany;Hungary;Latvia;Lithuania
      2005   Phase 3   EUCTR2004-001216-31-SK   Czech Republic;Estonia;Germany;Hungary;Latvia;Lithuania;Slovakia;Slovenia
      2005   -   EUCTR2004-001216-31-SI   Czech Republic;Estonia;Germany;Hungary;Latvia;Lithuania;Slovenia
      2005   -   EUCTR2004-001216-31-LV   Czech Republic;Estonia;Germany;Hungary;Latvia;Lithuania
      2005   -   EUCTR2004-001216-31-LT   Czech Republic;Estonia;Germany;Hungary;Latvia;Lithuania
      2005   -   EUCTR2004-001216-31-HU   Czech Republic;Estonia;Germany;Hungary;Latvia;Lithuania
      2005   -   EUCTR2004-001216-31-EE   Czech Republic;Estonia;Germany;Hungary;Latvia;Lithuania
      2005   -   EUCTR2004-001216-31-DE   Czech Republic;Estonia;Germany;Hungary;Latvia;Lithuania
      2005   -   EUCTR2004-001216-31-CZ   Czech Republic;Estonia;Germany;Hungary;Latvia;Lithuania
   Essex Pharma GmbH
      2009   -   EUCTR2009-010065-23-DE   Germany
   Ferring BV
      2005   -   EUCTR2004-004565-15-SE   Czech Republic;Denmark;Finland;Germany;Norway;Sweden
      2005   -   EUCTR2004-004565-15-NO   Czech Republic;Denmark;Finland;Germany;Norway;Sweden
      2005   -   EUCTR2004-004565-15-FI   Czech Republic;Denmark;Finland;Germany;Norway;Sweden
      2005   -   EUCTR2004-004565-15-DK   Czech Republic;Denmark;Finland;Germany;Norway;Sweden
      2005   Phase 3   EUCTR2004-004565-15-CZ   Czech Republic;Denmark;Finland;Germany;Norway;Sweden
      -   -   EUCTR2004-004565-15-DE   Czech Republic;Denmark;Finland;Germany;Norway;Sweden
   Ferring International PharmaScience Center U.S., Inc.
      2017   Phase 3   EUCTR2015-002558-11-BG   Belgium;Bulgaria;Canada;Hungary;Latvia;Mexico;Russian Federation;Serbia;Switzerland;Ukraine;United States
      2017   Phase 3   EUCTR2015-002557-35-BG   Belgium;Bulgaria;Canada;Hungary;Latvia;Mexico;Russian Federation;Serbia;Switzerland;Ukraine;United States
      2016   Phase 3   EUCTR2015-002558-11-LV   Belarus;Belgium;Bulgaria;Canada;Hungary;Ireland;Latvia;Lithuania;Mexico;Russian Federation;Serbia;Switzerland;Ukraine;United States
      2016   Phase 3   EUCTR2015-002558-11-HU   Belgium;Bulgaria;Canada;Hungary;Latvia;Mexico;Russian Federation;Serbia;Switzerland;Ukraine;United States
      2016   Phase 3   EUCTR2015-002557-35-LV   Belarus;Belgium;Bulgaria;Canada;Hungary;Ireland;Latvia;Lithuania;Mexico;Russian Federation;Serbia;Switzerland;Ukraine;United States
      2016   Phase 3   EUCTR2015-002557-35-HU   Belgium;Bulgaria;Canada;Hungary;Latvia;Mexico;Russian Federation;Serbia;Switzerland;Ukraine;United States
      2015   Phase 3   EUCTR2015-002558-11-BE   Belgium;Bulgaria;Canada;Czech Republic;Hungary;Israel;Korea, Republic of;Latvia;New Zealand;Poland;Russian Federation;Slovakia;Switzerland;Ukraine;United States
      2015   Phase 3   EUCTR2015-002557-35-BE   Belgium;Bulgaria;Canada;Czech Republic;Hungary;Israel;Latvia;Poland;Russian Federation;Slovakia;Switzerland;Ukraine;United States
   Ferring Pharmaceuticals
      2021   -   NCT04499495   Korea, Republic of
   Medizinische Universität Wien, Universitätsklinik für Innere Medizin 3, Abteilung für Gastroenterologie und Hepatologie
      2012   Phase 2   EUCTR2012-002023-15-AT   Austria
   Merck Sharp & Dohme Corp.
      2009   Phase 3   NCT00984568   Germany
   Procter & Gamble Pharmaceuticals
      2005   Phase 2   EUCTR2004-004077-29-SK   Czech Republic;Germany;Lithuania;Slovakia;United Kingdom
      2005   -   EUCTR2004-004077-29-LT   Czech Republic;Germany;Lithuania;United Kingdom
      2005   -   EUCTR2004-004077-29-DE   Czech Republic;Germany;Lithuania;United Kingdom
      2005   -   EUCTR2004-004077-29-CZ   Czech Republic;Germany;Lithuania;United Kingdom
   Procter & Gamble Technical Centres Limited
      2006   -   EUCTR2006-001310-32-LT   Czech Republic;Estonia;Hungary;Latvia;Lithuania
      2006   -   EUCTR2006-001310-32-HU   Czech Republic;Estonia;Hungary;Latvia;Lithuania
      2006   -   EUCTR2006-001310-32-EE   Czech Republic;Estonia;Hungary;Latvia;Lithuania
      2006   -   EUCTR2006-001310-32-CZ   Czech Republic;Estonia;Hungary;Latvia;Lithuania
   Procter & Gamble Technical Centres Ltd
      2005   -   EUCTR2004-004077-29-GB   Czech Republic;Germany;Lithuania;United Kingdom
   Sheba Medical Center
      2011   Phase 3   NCT01320436   Israel
   Shire Pharmaceutical Development Ltd
      2009   -   EUCTR2004-004184-29-DK   Czech Republic;Denmark;Germany;Hungary;Netherlands;Portugal;Spain;Sweden;United Kingdom
      2008   Phase 3   EUCTR2004-004184-29-NL   Czech Republic;Denmark;Germany;Hungary;Netherlands;Portugal;Spain;Sweden;United Kingdom
      2007   -   EUCTR2004-004184-29-SE   Czech Republic;Denmark;Germany;Hungary;Netherlands;Portugal;Spain;Sweden;United Kingdom
      2007   -   EUCTR2004-004184-29-PT   Czech Republic;Denmark;Germany;Hungary;Netherlands;Portugal;Spain;Sweden;United Kingdom
      2005   Phase 3   EUCTR2004-004184-29-HU   Czech Republic;Denmark;Germany;Hungary;Netherlands;Portugal;Spain;Sweden;United Kingdom
      2005   Phase 3   EUCTR2004-004184-29-GB   Czech Republic;Denmark;Germany;Hungary;Netherlands;Portugal;Spain;Sweden;United Kingdom
      2005   -   EUCTR2004-004184-29-ES   Czech Republic;Denmark;Germany;Hungary;Netherlands;Portugal;Spain;Sweden;United Kingdom
      2005   -   EUCTR2004-004184-29-DE   Czech Republic;Denmark;Germany;Hungary;Netherlands;Portugal;Spain;Sweden;United Kingdom
      2005   -   EUCTR2004-004184-29-CZ   Czech Republic;Denmark;Germany;Hungary;Netherlands;Portugal;Spain;Sweden;United Kingdom
5-aminosalicylic acid(5-ASA) and/or prednisone
   Guangzhou First People's Hospital
      2019   Phase 2/Phase 3   NCT03804931   China
5-ASA
   Bausch Health Americas, Inc.
      2012   Phase 3   NCT01532648   Bulgaria;Canada;Czech Republic;Czechia;Estonia;Hungary;Latvia;Lithuania;Poland;Russian Federation;Ukraine;United States
   Belgian Inflammatory Bowel Disease Research and Development (BIRD) VZW
      2023   Phase 4   NCT05992142   Belgium
   Centre Hospitalier Universitaire de Saint Etienne
      2016   Phase 3   NCT02665845   France;Greece;Israel;Italy;Korea, Republic of;Serbia
   Department of Medicine and Clinical Science, Graduate School of Medical Sciences, Kyushu University
      2017   -   JPRN-UMIN000026175   Japan
   Essex Pharma GmbH
      2009   -   EUCTR2009-010065-23-DE   Germany
   Ferring International PharmaScience Center U.S., Inc.
      2017   Phase 3   EUCTR2015-002558-11-BG   Belgium;Bulgaria;Canada;Hungary;Latvia;Mexico;Russian Federation;Serbia;Switzerland;Ukraine;United States
      2017   Phase 3   EUCTR2015-002557-35-BG   Belgium;Bulgaria;Canada;Hungary;Latvia;Mexico;Russian Federation;Serbia;Switzerland;Ukraine;United States
      2016   Phase 3   EUCTR2015-002558-11-LV   Belarus;Belgium;Bulgaria;Canada;Hungary;Ireland;Latvia;Lithuania;Mexico;Russian Federation;Serbia;Switzerland;Ukraine;United States
      2016   Phase 3   EUCTR2015-002558-11-HU   Belgium;Bulgaria;Canada;Hungary;Latvia;Mexico;Russian Federation;Serbia;Switzerland;Ukraine;United States
      2016   Phase 3   EUCTR2015-002557-35-LV   Belarus;Belgium;Bulgaria;Canada;Hungary;Ireland;Latvia;Lithuania;Mexico;Russian Federation;Serbia;Switzerland;Ukraine;United States
      2016   Phase 3   EUCTR2015-002557-35-HU   Belgium;Bulgaria;Canada;Hungary;Latvia;Mexico;Russian Federation;Serbia;Switzerland;Ukraine;United States
      2015   Phase 3   EUCTR2015-002558-11-BE   Belgium;Bulgaria;Canada;Czech Republic;Hungary;Israel;Korea, Republic of;Latvia;New Zealand;Poland;Russian Federation;Slovakia;Switzerland;Ukraine;United States
      2015   Phase 3   EUCTR2015-002557-35-BE   Belgium;Bulgaria;Canada;Czech Republic;Hungary;Israel;Latvia;Poland;Russian Federation;Slovakia;Switzerland;Ukraine;United States
   Ferring Pharmaceuticals
      2021   -   NCT04499495   Korea, Republic of
      2007   Phase 3   NCT00603733   Canada
   Medizinische Universität Wien, Universitätsklinik für Innere Medizin 3, Abteilung für Gastroenterologie und Hepatologie
      2012   Phase 2   EUCTR2012-002023-15-AT   Austria
   Procter & Gamble Technical Centres Limited
      2006   -   EUCTR2006-001310-32-LT   Czech Republic;Estonia;Hungary;Latvia;Lithuania
      2006   -   EUCTR2006-001310-32-HU   Czech Republic;Estonia;Hungary;Latvia;Lithuania
      2006   -   EUCTR2006-001310-32-EE   Czech Republic;Estonia;Hungary;Latvia;Lithuania
      2006   -   EUCTR2006-001310-32-CZ   Czech Republic;Estonia;Hungary;Latvia;Lithuania
   Shire Pharmaceutical Development Inc
      2004   Phase 3   EUCTR2004-000733-12-CZ   Czech Republic
   Shire Pharmaceutical Development Inc.
      2005   Phase 3   EUCTR2004-000734-36-CZ   Czech Republic
5-ASA MMX
   GIULIANI
      2004   -   EUCTR2004-000916-25-IT   Italy
5-HTP
   University Hospital, Ghent
      2018   Phase 2   NCT03574948   Belgium
50 MG
   Atrium Medical Centre
      2018   Phase 4   EUCTR2012-005644-26-BE   Belgium;Netherlands
   Dr August Wolff GmbH & Co KG Arzneimittel
      2012   -   EUCTR2011-002462-20-SK   Czech Republic;Germany;Hungary;Italy;Poland;Slovakia
      2011   -   EUCTR2011-002462-20-PL   Czech Republic;Germany;Hungary;Italy;Poland
      2011   -   EUCTR2011-002462-20-HU   Czech Republic;Germany;Hungary;Italy;Poland
      2011   -   EUCTR2011-002462-20-DE   Czech Republic;Germany;Hungary;Italy;Poland
      2011   -   EUCTR2011-002462-20-CZ   Czech Republic;Germany;Hungary;Italy;Poland
   IQVIA Services Japan K.K. jRCT Call Center
      2023   Phase 3   JPRN-jRCT2031230081   Argentina;Belgium;Bosnia;Brazil;Bulgaria;Canada;Croatia;Czech Republic;France;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Lithuania;Mexico;New Zealand;Poland;Romania;Serbia;Slovenia;Spain;Taiwan;United Kingdom;United States
   Owada Yasuko
      2021   Phase 1   JPRN-jRCT2051210087   -
500MG mesalazine pellets
   Dr. Falk Pharma GmbH
      2005   Phase 3   EUCTR2004-001216-31-SK   Czech Republic;Estonia;Germany;Hungary;Latvia;Lithuania;Slovakia;Slovenia
      2005   -   EUCTR2004-001216-31-SI   Czech Republic;Estonia;Germany;Hungary;Latvia;Lithuania;Slovenia
      2005   -   EUCTR2004-001216-31-LV   Czech Republic;Estonia;Germany;Hungary;Latvia;Lithuania
      2005   -   EUCTR2004-001216-31-LT   Czech Republic;Estonia;Germany;Hungary;Latvia;Lithuania
      2005   -   EUCTR2004-001216-31-HU   Czech Republic;Estonia;Germany;Hungary;Latvia;Lithuania
      2005   -   EUCTR2004-001216-31-EE   Czech Republic;Estonia;Germany;Hungary;Latvia;Lithuania
      2005   -   EUCTR2004-001216-31-DE   Czech Republic;Estonia;Germany;Hungary;Latvia;Lithuania
      2005   -   EUCTR2004-001216-31-CZ   Czech Republic;Estonia;Germany;Hungary;Latvia;Lithuania
549-0261/F02-01
   F. Hoffmann-La Roche Ltd
      2018   Phase 1   EUCTR2017-003649-10-GB   Belgium;Germany;Poland;Spain;United Kingdom
      2018   Phase 1   EUCTR2017-003649-10-DE   Belgium;Germany;Poland;Spain;United Kingdom;United States
      2018   Phase 1   EUCTR2017-003649-10-BE   Belgium;Germany;Poland;Spain;United Kingdom
      -   Phase 1   EUCTR2017-003649-10-PL   Belgium;Germany;Poland;Spain;United Kingdom
   Roche Farma S.A. (Soc unipersonal) que realiza el ensayo en España y que actúa como represntante de FHoffmann-La Roche
      2018   Phase 1   EUCTR2017-003649-10-ES   Belgium;Germany;Poland;Spain;United Kingdom;United States
6 mercaptopurine
   Indiana University
      2015   -   NCT02413047   United States
6-[2-(3,4-diethoxyphenyl)thiazol-4-YL] pyridine-2-carboxylic acid
   Otsuka Maryland Research Institute, Inc.
      2004   Phase 3   EUCTR2004-000611-25-IE   Hungary;Ireland
      2004   -   EUCTR2004-000611-25-HU   Hungary;Ireland
6-mercaptopurine
   IQVIA Services Japan K.K. jRCT Call Center
      2023   Phase 3   JPRN-jRCT2031230081   Argentina;Belgium;Bosnia;Brazil;Bulgaria;Canada;Croatia;Czech Republic;France;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Lithuania;Mexico;New Zealand;Poland;Romania;Serbia;Slovenia;Spain;Taiwan;United Kingdom;United States
   National Institute of Allergy and Infectious Diseases (NIAID)
      2007   Phase 2   NCT00514982   United States
   PIBD net
      2018   Phase 4   EUCTR2016-000522-18-GB   Belgium;Canada;Czech Republic;France;Germany;Israel;Italy;Netherlands;Poland;Spain;United Kingdom
   ZonMw: The Netherlands Organisation for Health Research and Development
      2007   -   NCT00521950   Netherlands
   jRCT Inquiries IQVIA Contact person
      2023   Phase 3   JPRN-jRCT2031230257   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Czech Republic;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Korea;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Serbia;Slovakia;Slovenia;Spain;Switzerland;Turkey;UK USA
6-MP
   ZonMw: The Netherlands Organisation for Health Research and Development
      2007   -   NCT00521950   Netherlands
68GA-fapi
   Peking Union Medical College Hospital
      2020   Early Phase 1   NCT04507932   China
75 MG ontamalimab
   Shire
      2018   Phase 3   NCT03283085   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Colombia;Croatia;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
750MG mesalazine pellets
   Dr. Falk Pharma GmbH
      2005   Phase 3   EUCTR2004-001218-15-SK   Estonia;Germany;Hungary;Latvia;Lithuania;Slovakia;Slovenia
      2005   -   EUCTR2004-001218-15-SI   Estonia;Germany;Hungary;Latvia;Lithuania;Slovenia
      2005   -   EUCTR2004-001218-15-LV   Estonia;Germany;Hungary;Latvia;Lithuania
      2005   -   EUCTR2004-001218-15-LT   Estonia;Germany;Hungary;Latvia;Lithuania
      2005   -   EUCTR2004-001218-15-HU   Estonia;Germany;Hungary;Latvia;Lithuania
      2005   -   EUCTR2004-001218-15-EE   Estonia;Germany;Hungary;Latvia;Lithuania
      2005   -   EUCTR2004-001218-15-DE   Estonia;Germany;Hungary;Latvia;Lithuania
90 MG hydrocortisone acetate suppository with sephure suppository applicator
   Cristcot HCA LLC
      2023   Phase 3   EUCTR2019-003596-19-BG   Bulgaria;Denmark;Georgia;Germany;Hong Kong;India;Italy;Philippines;Poland;Romania;Russian Federation;Saudi Arabia;South Africa;Spain;Ukraine;United States
      2022   Phase 3   EUCTR2019-003596-19-DK   Bulgaria;Denmark;Georgia;Germany;Hong Kong;India;Italy;Philippines;Poland;Romania;Russian Federation;Saudi Arabia;South Africa;Spain;Ukraine;United States
      2021   Phase 3   EUCTR2019-003596-19-RO   Germany;Hong Kong;India;Italy;Philippines;Poland;Romania;Russian Federation;Spain;Ukraine;United States
      2020   Phase 3   EUCTR2019-003596-19-DE   Antigua and Barbuda;Bulgaria;Denmark;Estonia;Germany;Hong Kong;Hungary;India;Italy;Jamaica;Lebanon;Lithuania;Philippines;Poland;Romania;Saudi Arabia;South Africa;Spain;United States;Virgin Islands, U.S.
90 MG idrocortisone acetato IN supposta CON applicatore PER supposte sephure
   Cristcot HCA LLC
      2020   Phase 3   EUCTR2019-003596-19-IT   Bulgaria;Denmark;Germany;Hong Kong;India;Italy;Philippines;Poland;Romania;Russian Federation;Spain;Ukraine;United States
A plant based high fiber diet that mimics fasting (FMD) plus advanced therapy
   University of Miami
      2020   Phase 3   NCT04505410   United States
A07da03
   Department of surgery, Odense University Hospital
      2014   Phase 4   EUCTR2014-004740-35-DK   Denmark
A: 1 dosis
   AB Biotics, SA
      2018   -   NCT03444311   Spain
Abatacept
   Bristol-Myers Squibb
      2006   Phase 3   NCT00410410   Argentina;Australia;Belgium;Brazil;Canada;Czech Republic;France;Germany;India;Ireland;Italy;Korea, Republic of;Mexico;Netherlands;Poland;Puerto Rico;South Africa;Spain;Switzerland;United Kingdom;United States
   Bristol-Myers Squibb International Corporation
      2008   -   EUCTR2006-003604-19-PL   Belgium;Czech Republic;France;Germany;Ireland;Italy;Poland;United Kingdom
      2007   -   EUCTR2006-003604-19-IT   Belgium;Czech Republic;France;Germany;Ireland;Italy;Poland;United Kingdom
      2007   -   EUCTR2006-003604-19-IE   Belgium;Czech Republic;France;Germany;Ireland;Italy;Poland;United Kingdom
      2007   Phase 3   EUCTR2006-003604-19-GB   Belgium;Czech Republic;France;Germany;Ireland;Italy;Poland;United Kingdom
      2007   Phase 3   EUCTR2006-003604-19-FR   Belgium;Czech Republic;France;Germany;Ireland;Italy;Poland;United Kingdom
      2007   -   EUCTR2006-003604-19-DE   Belgium;Czech Republic;France;Germany;Ireland;Italy;Poland;United Kingdom
      2007   -   EUCTR2006-003604-19-CZ   Belgium;Czech Republic;France;Germany;Ireland;Italy;Poland;United Kingdom
      2007   -   EUCTR2006-003604-19-BE   Belgium;Czech Republic;France;Germany;Ireland;Italy;Poland;United Kingdom
ABBV-006
   ABBVIE DEUTSCHLAND GMBH & CO. KG
      2018   Phase 3   EUCTR2016-004676-22-IT   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czechia;Denmark;Egypt;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
   AbbVie Deutschland GmbH & Co. KG
      2021   Phase 3   EUCTR2016-004676-22-FR   Argentina;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czechia;Denmark;Egypt;France;Germany;Greece;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2016-004676-22-SI   Argentina;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czechia;Denmark;Egypt;France;Germany;Greece;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Türkiye;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2016-004676-22-RO   Argentina;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czechia;Denmark;Egypt;France;Germany;Greece;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Türkiye;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2016-004676-22-HR   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2016-004676-22-DE   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czechia;Denmark;Egypt;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Türkiye;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2016-004676-22-BG   Argentina;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czechia;Denmark;Egypt;France;Germany;Greece;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2016-004676-22-BE   Argentina;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czechia;Denmark;Egypt;France;Germany;Greece;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2016-004676-22-SE   Argentina;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czechia;Denmark;Egypt;France;Germany;Greece;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2016-004676-22-PT   Argentina;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czechia;Denmark;Egypt;France;Germany;Greece;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2016-004676-22-NL   Argentina;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czechia;Denmark;Egypt;France;Germany;Greece;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Türkiye;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2016-004676-22-LV   Argentina;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czechia;Denmark;Egypt;France;Germany;Greece;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2016-004676-22-GR   Argentina;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czechia;Denmark;Egypt;France;Germany;Greece;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2016-004676-22-GB   Argentina;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czechia;Denmark;Egypt;France;Germany;Greece;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2016-004676-22-ES   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2016-004676-22-DK   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2016-004676-22-AT   Argentina;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czechia;Denmark;Egypt;France;Germany;Greece;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Türkiye;Ukraine;United Kingdom;United States
      -   Phase 3   EUCTR2016-004676-22-PL   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czechia;Denmark;Egypt;France;Germany;Greece;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Türkiye;Ukraine;United Kingdom;United States
      -   Phase 3   EUCTR2016-004676-22-CZ   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
ABBV-066
   ABBVIE DEUTSCHLAND GMBH & CO. KG
      2018   Phase 3   EUCTR2016-004676-22-IT   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czechia;Denmark;Egypt;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      -   Phase 2;Phase 3   EUCTR2016-004677-40-IT   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czechia;Denmark;Egypt;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
   AbbVie Deutschland GmbH & Co. KG
      2021   Phase 2;Phase 3   EUCTR2016-004677-40-FR   Argentina;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czechia;Denmark;Egypt;France;Germany;Greece;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2021   Phase 3   EUCTR2016-004676-22-FR   Argentina;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czechia;Denmark;Egypt;France;Germany;Greece;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 2;Phase 3   EUCTR2016-004677-40-SI   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czechia;Denmark;Egypt;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 2;Phase 3   EUCTR2016-004677-40-HR   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 2;Phase 3   EUCTR2016-004677-40-BG   Argentina;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czechia;Denmark;Egypt;France;Germany;Greece;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2016-004676-22-SI   Argentina;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czechia;Denmark;Egypt;France;Germany;Greece;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Türkiye;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2016-004676-22-RO   Argentina;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czechia;Denmark;Egypt;France;Germany;Greece;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Türkiye;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2016-004676-22-HR   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2016-004676-22-DE   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czechia;Denmark;Egypt;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Türkiye;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2016-004676-22-BG   Argentina;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czechia;Denmark;Egypt;France;Germany;Greece;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2016-004676-22-BE   Argentina;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czechia;Denmark;Egypt;France;Germany;Greece;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 2;Phase 3   EUCTR2016-004677-40-SK   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czechia;Denmark;Egypt;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 2;Phase 3   EUCTR2016-004677-40-SE   Argentina;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czechia;Denmark;Egypt;France;Germany;Greece;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 2;Phase 3   EUCTR2016-004677-40-PT   Argentina;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czechia;Denmark;Egypt;France;Germany;Greece;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 2;Phase 3   EUCTR2016-004677-40-NL   Argentina;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;France;Germany;Greece;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 2;Phase 3   EUCTR2016-004677-40-LV   Argentina;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czechia;Denmark;Egypt;France;Germany;Greece;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 2;Phase 3   EUCTR2016-004677-40-LT   Argentina;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czechia;Denmark;Egypt;France;Germany;Greece;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 2;Phase 3   EUCTR2016-004677-40-GR   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 2;Phase 3   EUCTR2016-004677-40-ES   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 2;Phase 3   EUCTR2016-004677-40-DK   Argentina;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czechia;Denmark;Egypt;France;Germany;Greece;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 2;Phase 3   EUCTR2016-004677-40-DE   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czechia;Denmark;Egypt;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 2;Phase 3   EUCTR2016-004677-40-BE   Argentina;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;France;Germany;Greece;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 2;Phase 3   EUCTR2016-004677-40-AT   Argentina;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czechia;Denmark;Egypt;France;Germany;Greece;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2016-004676-22-SK   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czechia;Denmark;Egypt;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Türkiye;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2016-004676-22-SE   Argentina;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czechia;Denmark;Egypt;France;Germany;Greece;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2016-004676-22-PT   Argentina;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czechia;Denmark;Egypt;France;Germany;Greece;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2016-004676-22-NL   Argentina;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czechia;Denmark;Egypt;France;Germany;Greece;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Türkiye;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2016-004676-22-LV   Argentina;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czechia;Denmark;Egypt;France;Germany;Greece;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2016-004676-22-GR   Argentina;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czechia;Denmark;Egypt;France;Germany;Greece;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2016-004676-22-GB   Argentina;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czechia;Denmark;Egypt;France;Germany;Greece;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2016-004676-22-ES   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2016-004676-22-DK   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2016-004676-22-AT   Argentina;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czechia;Denmark;Egypt;France;Germany;Greece;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Türkiye;Ukraine;United Kingdom;United States
      -   Phase 3   EUCTR2016-004676-22-PL   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czechia;Denmark;Egypt;France;Germany;Greece;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Türkiye;Ukraine;United Kingdom;United States
      -   Phase 3   EUCTR2016-004676-22-CZ   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      -   Phase 2;Phase 3   EUCTR2016-004677-40-PL   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      -   Phase 2;Phase 3   EUCTR2016-004677-40-GB   Argentina;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czechia;Denmark;Egypt;France;Germany;Greece;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      -   Phase 2;Phase 3   EUCTR2016-004677-40-CZ   Argentina;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;France;Germany;Greece;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
ABBV-323
   ABBVIE DEUTSCHLAND GMBH & CO. KG
      2019   Phase 2   EUCTR2018-000930-37-IT   Canada;France;Germany;Hungary;Italy;Korea, Republic of;Netherlands;Spain;United Kingdom;United States
   AbbVie Deutschland GmbH & Co. KG
      2020   Phase 2   EUCTR2018-000930-37-HU   Canada;France;Germany;Hungary;Italy;Korea, Republic of;Netherlands;Spain;United Kingdom;United States
      2019   Phase 2   EUCTR2018-000930-37-GB   Canada;France;Germany;Hungary;Italy;Korea, Republic of;Netherlands;Spain;United Kingdom;United States
      2019   Phase 2   EUCTR2018-000930-37-FR   Canada;France;Germany;Hungary;Italy;Netherlands;Spain;United Kingdom;United States
      2019   Phase 2   EUCTR2018-000930-37-ES   Canada;France;Germany;Hungary;Italy;Netherlands;Spain;United Kingdom;United States
      2019   Phase 2   EUCTR2018-000930-37-DE   Canada;France;Germany;Hungary;Italy;Korea, Republic of;Netherlands;Spain;United Kingdom;United States
      2018   Phase 2   EUCTR2018-000930-37-NL   Canada;France;Germany;Hungary;Italy;Korea, Republic of;Netherlands;Spain;United Kingdom;United States
ABBV-323 dose A
   AbbVie
      2019   Phase 2   NCT03695185   Canada;France;Germany;Hungary;Italy;Korea, Republic of;Netherlands;Spain;United Kingdom;United States
ABBV-323 dose B
   AbbVie
      2019   Phase 2   NCT03695185   Canada;France;Germany;Hungary;Italy;Korea, Republic of;Netherlands;Spain;United Kingdom;United States
ABBV-668
   AbbVie
      2023   Phase 2   NCT05570006   Belgium;France;Poland;United States
Abbvie care 2.0
   AbbVie
      2016   -   NCT02750800   Hungary
ABI-M201
   Assembly Biosciences
      2019   Phase 1   NCT03923478   Canada;United States
Abrilumab
   Amgen
      2012   Phase 2   NCT01694485   Australia;Austria;Belgium;Canada;Czech Republic;Czechia;Denmark;Estonia;France;Germany;Greece;Hungary;Italy;Latvia;Netherlands;Norway;Poland;Russian Federation;Switzerland;United Kingdom;United States
ABT-494
   ABBVIE DEUTSCHLAND GMBH & CO. KG
      2019   Phase 3   EUCTR2016-000642-62-IT   Argentina;Australia;Austria;Belarus;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2016-000674-38-IT   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;Finland;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 2;Phase 3   EUCTR2016-000641-31-IT   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Kazakhstan;Korea, Democratic People's Republic of;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
   AbbVie
      2018   Phase 3   NCT03653026   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czechia;Egypt;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2017   Phase 3   NCT03006068   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czechia;Egypt;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   NCT02819635   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czechia;Egypt;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
   AbbVie Deutschland GmbH & Co. KG
      2020   Phase 3   EUCTR2016-000642-62-SE   Argentina;Australia;Austria;Belarus;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2020   Phase 3   EUCTR2016-000642-62-FR   Argentina;Australia;Austria;Belarus;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2016-000642-62-SK   Argentina;Australia;Austria;Belarus;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2016-000642-62-PT   Argentina;Australia;Austria;Belarus;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2016-000642-62-PL   Argentina;Australia;Austria;Belarus;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2016-000642-62-NL   Argentina;Australia;Austria;Belarus;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2016-000642-62-LT   Argentina;Australia;Austria;Belarus;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2016-000642-62-IE   Argentina;Australia;Austria;Belarus;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2016-000642-62-HR   Argentina;Australia;Austria;Belarus;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2016-000642-62-GR   Argentina;Australia;Austria;Belarus;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2016-000642-62-GB   Argentina;Australia;Austria;Belarus;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2016-000642-62-ES   Argentina;Australia;Austria;Belarus;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2016-000642-62-DE   Argentina;Australia;Austria;Belarus;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2016-000642-62-CZ   Argentina;Australia;Austria;Belarus;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2016-000642-62-BE   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2016-000642-62-AT   Argentina;Australia;Austria;Belarus;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2016-000642-62-NO   Argentina;Australia;Austria;Belarus;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2016-000642-62-LV   Argentina;Australia;Austria;Belarus;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2016-000642-62-HU   Argentina;Australia;Austria;Belarus;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2016-000642-62-FI   Argentina;Australia;Austria;Belarus;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 2;Phase 3   EUCTR2016-000641-31-BE   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Japan;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-000674-38-SE   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;Germany;Greece;Hungary;Ireland;Israel;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-000674-38-PT   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-000674-38-LT   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-000674-38-IE   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-000674-38-HR   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-000674-38-FI   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-000674-38-DE   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-000674-38-CZ   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-000674-38-BE   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2017   Phase 2;Phase 3   EUCTR2016-000641-31-SE   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Japan;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2017   Phase 2;Phase 3   EUCTR2016-000641-31-PT   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Japan;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2017   Phase 2;Phase 3   EUCTR2016-000641-31-LT   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Japan;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2017   Phase 2;Phase 3   EUCTR2016-000641-31-HR   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Japan;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2017   Phase 2;Phase 3   EUCTR2016-000641-31-FR   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Japan;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2017   Phase 2;Phase 3   EUCTR2016-000641-31-FI   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Japan;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2017   Phase 2;Phase 3   EUCTR2016-000641-31-CZ   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Japan;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2016-000674-38-SK   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2016-000674-38-PL   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2016-000674-38-NL   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2016-000674-38-LV   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2016-000674-38-HU   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2016-000674-38-GR   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2016-000674-38-GB   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;Germany;Greece;Hungary;Ireland;Israel;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2016-000674-38-ES   Argentina;Australia;Belarus;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Egypt;Estonia;European Union;Greece;Hungary;Israel;Japan;Kazakhstan;Korea, Republic of;Latvia;Malaysia;Mexico;Netherlands;New Zealand;Norway;Puerto Rico;Russian Federation;Saudi Arabia;Serbia;Singapore;South Africa;Spain;Switzerland;Taiwan;Ukraine;United States
      2016   Phase 3   EUCTR2016-000674-38-EE   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2016-000674-38-AT   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 2;Phase 3   EUCTR2016-000641-31-SK   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Japan;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2016   Phase 2;Phase 3   EUCTR2016-000641-31-PL   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Japan;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2016   Phase 2;Phase 3   EUCTR2016-000641-31-NL   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Japan;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2016   Phase 2;Phase 3   EUCTR2016-000641-31-LV   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Japan;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2016   Phase 2;Phase 3   EUCTR2016-000641-31-IE   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Japan;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2016   Phase 2;Phase 3   EUCTR2016-000641-31-HU   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Japan;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2016   Phase 2;Phase 3   EUCTR2016-000641-31-GR   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Japan;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2016   Phase 2;Phase 3   EUCTR2016-000641-31-GB   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Japan;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2016   Phase 2;Phase 3   EUCTR2016-000641-31-ES   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Japan;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2016   Phase 2;Phase 3   EUCTR2016-000641-31-EE   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Japan;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2016   Phase 2;Phase 3   EUCTR2016-000641-31-AT   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Japan;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      -   Phase 3   EUCTR2016-000674-38-NO   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      -   Phase 2;Phase 3   EUCTR2016-000641-31-NO   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Japan;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      -   Phase 2;Phase 3   EUCTR2016-000641-31-DE   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Japan;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
   AbbVie GK
      2018   Phase 3   JPRN-jRCT2080224070   -;Africa;Asia except Japan;Europe;Japan;North America;Oceania;South America
ABT-humira
   AbbVie Deutschland GmbH & Co. KG
      2009   Phase 3   EUCTR2007-004157-28-SE   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Slovakia;Spain;Sweden;Switzerland
      2008   Phase 3   EUCTR2007-004157-28-NL   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Slovakia;Spain;Sweden;Switzerland
      2008   Phase 3   EUCTR2007-004157-28-HU   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Slovakia;Spain;Sweden;Switzerland
      2008   Phase 3   EUCTR2007-004157-28-DE   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Slovakia;Spain;Sweden;Switzerland
      2008   Phase 3   EUCTR2007-004157-28-CZ   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Slovakia;Spain;Sweden;Switzerland
      2008   Phase 3   EUCTR2007-004157-28-BE   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Slovakia;Spain;Sweden;Switzerland
      2008   Phase 3   EUCTR2007-004157-28-AT   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Slovakia;Spain;Sweden;Switzerland
   Abbott GmbH & Co. KG
      2009   Phase 3   EUCTR2007-004157-28-PT   Austria;Belgium;Czech Republic;France;Germany;Hungary;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden
      2008   Phase 3   EUCTR2007-004157-28-SK   Austria;Belgium;Czech Republic;France;Germany;Hungary;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden
      2008   Phase 3   EUCTR2007-004157-28-FR   Austria;Belgium;Czech Republic;France;Germany;Hungary;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden
      2008   -   EUCTR2006-002782-40-DE   Austria;Czech Republic;Denmark;France;Germany;Hungary;Portugal
      2008   -   EUCTR2006-002782-40-AT   Austria;Czech Republic;Denmark;France;Germany;Hungary;Portugal
      2008   -   EUCTR2006-002781-20-SE   Austria;Czech Republic;Germany;Hungary;Italy;Sweden
      2008   -   EUCTR2006-002781-20-AT   Austria;Czech Republic;Germany;Hungary;Italy;Sweden
      2007   -   EUCTR2006-002782-40-PT   Austria;Czech Republic;Denmark;France;Germany;Hungary;Portugal
      2007   -   EUCTR2006-002782-40-HU   Austria;Belgium;Czech Republic;Denmark;France;Germany;Hungary;Portugal;Spain
      2007   Phase 3   EUCTR2006-002782-40-FR   Austria;Belgium;Czech Republic;Denmark;France;Germany;Hungary;Portugal;Spain
      2007   -   EUCTR2006-002782-40-ES   Austria;Belgium;Czech Republic;Denmark;France;Germany;Hungary;Portugal;Spain
      2007   -   EUCTR2006-002782-40-DK   Austria;Czech Republic;Denmark;France;Germany;Hungary;Portugal
      2007   -   EUCTR2006-002782-40-CZ   Austria;Czech Republic;Denmark;France;Germany;Hungary;Portugal
      2007   -   EUCTR2006-002782-40-BE   Austria;Belgium;Czech Republic;Denmark;France;Germany;Hungary;Portugal;Spain
      2007   Phase 3   EUCTR2006-002781-20-SK   Austria;Belgium;Czech Republic;Germany;Hungary;Italy;Slovakia;Sweden
      2007   -   EUCTR2006-002781-20-HU   Austria;Czech Republic;Germany;Hungary;Italy;Sweden
      2007   -   EUCTR2006-002781-20-DE   Austria;Czech Republic;Germany;Hungary;Italy;Sweden
      2007   -   EUCTR2006-002781-20-CZ   Austria;Czech Republic;Germany;Hungary;Italy;Sweden
      2007   -   EUCTR2006-002781-20-BE   Austria;Belgium;Czech Republic;Germany;Hungary;Italy;Sweden
ABX464
   ABIVAX
      2022   Phase 2   EUCTR2021-004398-30-SI   Austria;Belgium;Canada;Czechia;France;Germany;Hungary;Italy;Poland;Serbia;Slovakia;Slovenia;Spain;Ukraine
      2022   Phase 2   EUCTR2021-004398-30-FR   Austria;Belgium;Canada;Czechia;France;Germany;Hungary;Italy;Poland;Serbia;Slovakia;Slovenia;Spain;Ukraine
      2022   Phase 2   EUCTR2021-004398-30-BE   Austria;Belgium;Canada;Czechia;France;Germany;Hungary;Italy;Poland;Serbia;Slovakia;Slovenia;Spain;Ukraine
      2022   Phase 2   EUCTR2021-004398-30-AT   Austria;Belgium;Canada;Czechia;France;Germany;Hungary;Italy;Poland;Serbia;Slovakia;Slovenia;Spain;Ukraine
      2021   Phase 2   EUCTR2021-004398-30-SK   Austria;Belgium;Canada;Czechia;France;Germany;Hungary;Italy;Poland;Serbia;Slovakia;Slovenia;Spain;Ukraine
      2021   Phase 2   EUCTR2021-004398-30-HU   Austria;Belgium;Canada;Czechia;France;Germany;Hungary;Italy;Poland;Serbia;Slovakia;Slovenia;Spain;Ukraine
      2020   Phase 2   EUCTR2019-000733-39-GB   Austria;Belarus;Belgium;Canada;Czech Republic;France;Germany;Hungary;Poland;Serbia;Slovakia;Slovenia;Spain;Ukraine;United Kingdom
      2020   Phase 2   EUCTR2019-000733-39-FR   Austria;Belarus;Belgium;Canada;Czech Republic;France;Germany;Hungary;Ireland;Italy;Netherlands;Poland;Serbia;Slovakia;Slovenia;Spain;Ukraine;United Kingdom
      2020   Phase 2   EUCTR2019-000733-39-DE   Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Poland;Serbia;Slovakia;Slovenia;Spain;Ukraine;United Kingdom
      2020   Phase 2   EUCTR2019-000733-39-AT   Austria;Belarus;Belgium;Canada;Czechia;France;Germany;Hungary;Italy;Poland;Serbia;Slovakia;Slovenia;Spain;Ukraine;United Kingdom
      2020   Phase 2   EUCTR2018-003558-26-GB   Austria;Belarus;Belgium;Canada;Czech Republic;France;Germany;Hungary;Italy;Poland;Serbia;Slovakia;Slovenia;Spain;Ukraine;United Kingdom;United States
      2019   Phase 2   EUCTR2019-000733-39-SK   Austria;Belarus;Belgium;Canada;Czechia;France;Germany;Hungary;Italy;Poland;Serbia;Slovakia;Slovenia;Spain;Ukraine;United Kingdom
      2019   Phase 2   EUCTR2019-000733-39-SI   Austria;Belarus;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Poland;Serbia;Slovakia;Slovenia;Spain;Ukraine;United Kingdom
      2019   Phase 2   EUCTR2019-000733-39-PL   Austria;Belgium;Canada;Czechia;France;Germany;Hungary;Italy;Poland;Serbia;Slovakia;Slovenia;Spain;Ukraine;United Kingdom
      2019   Phase 2   EUCTR2019-000733-39-ES   Austria;Belarus;Belgium;Canada;Czech Republic;France;Germany;Hungary;Ireland;Netherlands;Poland;Serbia;Slovakia;Slovenia;Spain;Ukraine;United Kingdom
      2019   Phase 2   EUCTR2018-003558-26-SK   Austria;Belarus;Belgium;Canada;Czechia;France;Germany;Hungary;Italy;Poland;Serbia;Slovakia;Slovenia;Spain;Ukraine;United Kingdom;United States
      2019   Phase 2   EUCTR2018-003558-26-SI   Austria;Belarus;Belgium;Canada;Czech Republic;France;Germany;Hungary;Italy;Poland;Serbia;Slovakia;Slovenia;Spain;Ukraine;United Kingdom;United States
      2019   Phase 2   EUCTR2018-003558-26-PL   Austria;Belarus;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Poland;Serbia;Slovakia;Slovenia;Spain;Ukraine;United Kingdom;United States
      2019   Phase 2   EUCTR2018-003558-26-HU   Austria;Belarus;Belgium;Canada;Czechia;France;Germany;Hungary;Italy;Poland;Serbia;Slovakia;Slovenia;Spain;Ukraine;United Kingdom;United States
      2019   Phase 2   EUCTR2018-003558-26-FR   Austria;Belarus;Belgium;Canada;Czech Republic;France;Germany;Hungary;Ireland;Italy;Netherlands;Poland;Serbia;Slovakia;Slovenia;Spain;Ukraine;United Kingdom
      2019   Phase 2   EUCTR2018-003558-26-DE   Austria;Belarus;Belgium;Canada;Czechia;France;Germany;Hungary;Ireland;Italy;Netherlands;Poland;Serbia;Slovakia;Slovenia;Spain;Ukraine;United Kingdom
      2019   Phase 2   EUCTR2018-003558-26-CZ   Austria;Belarus;Belgium;Canada;Czech Republic;France;Germany;Hungary;Ireland;Italy;Netherlands;Poland;Serbia;Slovakia;Slovenia;Spain;Ukraine;United Kingdom
      2019   Phase 2   EUCTR2018-003558-26-BE   Austria;Belarus;Belgium;Canada;Czech Republic;France;Germany;Hungary;Italy;Poland;Serbia;Slovakia;Slovenia;Spain;Ukraine;United Kingdom;United States
      2018   Phase 2   EUCTR2017-003284-35-PL   Belgium;Hungary;Poland;Spain
      2018   Phase 2   EUCTR2017-003284-35-HU   Belgium;Hungary;Poland;Spain
      2018   Phase 2   EUCTR2017-003284-35-ES   Hungary;Spain
      2018   Phase 2   EUCTR2017-000937-30-AT   Austria;Belgium;France;Germany;Hungary;Poland;Spain
      2017   Phase 2   EUCTR2017-003284-35-BE   Belgium;Hungary;Poland;Spain
      2017   Phase 2   EUCTR2017-000937-30-PL   Austria;Belgium;France;Germany;Hungary;Poland;Spain
      2017   Phase 2   EUCTR2017-000937-30-FR   Austria;Belgium;France;Germany;Hungary;Poland;Spain
      2017   Phase 2   EUCTR2017-000937-30-ES   Austria;Belgium;France;Germany;Hungary;Poland;Spain
      2017   Phase 2   EUCTR2017-000937-30-DE   Austria;Belgium;France;Germany;Hungary;Poland;Spain
      2017   Phase 2   EUCTR2017-000937-30-BE   Austria;Belgium;France;Germany;Hungary;Poland;Spain
   Abivax
      2021   Phase 2   EUCTR2021-004398-30-IT   Austria;Belgium;Canada;Czechia;France;Germany;Hungary;Italy;Poland;Serbia;Slovakia;Slovenia;Spain;Ukraine
      2020   Phase 2   EUCTR2019-000733-39-IT   Austria;Belarus;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Ireland;Italy;Netherlands;Poland;Serbia;Slovakia;Slovenia;Spain;Ukraine;United Kingdom
      2019   Phase 2   EUCTR2018-003558-26-IT   Austria;Belarus;Belgium;Canada;Czechia;France;Germany;Hungary;Ireland;Italy;Netherlands;Poland;Serbia;Slovakia;Slovenia;Spain;Ukraine;United Kingdom
   Abivax S.A.
      2023   Phase 3   NCT05535946   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;China;Croatia;Czechia;France;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Serbia;Slovakia;Spain;Switzerland;Turkey;United Kingdom;United States
      2022   Phase 3   NCT05507216   Argentina;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czechia;France;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Lithuania;Mexico;New Zealand;Poland;Romania;Serbia;Slovakia;Spain;United Kingdom;United States
      2022   Phase 3   NCT05507203   Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czechia;France;Germany;Greece;Hungary;India;Italy;Korea, Republic of;Netherlands;Poland;Portugal;Spain;Switzerland;Turkey;United Kingdom;United States
      2021   Phase 2   NCT05177835   Belgium;Czechia;Hungary;Poland
      2020   Phase 2   NCT04023396   Austria;Belarus;Belgium;Canada;Czechia;France;Germany;Hungary;Italy;Poland;Serbia;Slovakia;Slovenia;Spain;Ukraine;United Kingdom
      2018   Phase 2   NCT03368118   Belgium
      2017   Phase 2   NCT03093259   Belgium
   IQVIA Services Japan K.K. jRCT Call Center
      2023   Phase 3   JPRN-jRCT2031230081   Argentina;Belgium;Bosnia;Brazil;Bulgaria;Canada;Croatia;Czech Republic;France;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Lithuania;Mexico;New Zealand;Poland;Romania;Serbia;Slovenia;Spain;Taiwan;United Kingdom;United States
   Owada Yasuko
      2021   Phase 1   JPRN-jRCT2051210087   -
ABX464 100MG
   Abivax S.A.
      2019   Phase 2   NCT03760003   Austria;Belarus;Belgium;Canada;Czechia;France;Germany;Hungary;Italy;Poland;Serbia;Slovakia;Slovenia;Spain;Ukraine;United Kingdom;United States
ABX464 25MG
   Abivax S.A.
      2019   Phase 2   NCT03760003   Austria;Belarus;Belgium;Canada;Czechia;France;Germany;Hungary;Italy;Poland;Serbia;Slovakia;Slovenia;Spain;Ukraine;United Kingdom;United States
ABX464 50MG
   Abivax S.A.
      2019   Phase 2   NCT03760003   Austria;Belarus;Belgium;Canada;Czechia;France;Germany;Hungary;Italy;Poland;Serbia;Slovakia;Slovenia;Spain;Ukraine;United Kingdom;United States
   jRCT Inquiries IQVIA Contact person
      2023   Phase 3   JPRN-jRCT2031230257   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Czech Republic;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Korea;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Serbia;Slovakia;Slovenia;Spain;Switzerland;Turkey;UK USA
Acacia GUM
   University of Alberta
      2025   -   NCT06515210   -
Accelerated 1 HOUR-infusion
   Asan Medical Center
      2011   Phase 4   NCT01346826   Korea, Republic of
Accelerated 30 minutes-infusion
   Asan Medical Center
      2011   Phase 4   NCT01346826   Korea, Republic of
Accelerated HBV vaccine
   Assiut University
      2023   -   NCT05967650   -
Acceptance and commitment therapy
   University College Dublin
      2023   -   NCT05906043   Ireland
Acetate
   NIBEC Co., Ltd.
      2024   Phase 1   NCT06681389   Australia
Acetato DI ammonio
   Protagonist Therapeutics, Inc.
      2020   Phase 2   EUCTR2019-004469-41-IT   Austria;Bulgaria;Canada;Georgia;Germany;Hungary;Italy;Korea, Republic of;Netherlands;Poland;Russian Federation;Serbia;Ukraine;United States
Acetic acid
   Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences
      2015   -   JPRN-UMIN000021460   Japan
Acetylcarnitine
   POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI
      2009   -   EUCTR2009-013680-19-IT   Italy
Acetylcysteine
   VU university medical centre
      2009   -   EUCTR2008-005015-17-NL   Netherlands
Acidophilus
   Odense University Hospital
      2003   -   NCT00374725   Denmark
Aclasta
   Novartis Pharma Services AG
      -   -   EUCTR2008-001252-52-Outside-EU/EEA   Australia;Canada;New Zealand
Actavis ferrous sulphate tablets BP 200MG
   GlobiFer International bvba
      2010   Phase 2   EUCTR2008-004277-17-GB   United Kingdom
Actonel once A week 35MG
   United Bristol Healthcare Trust
      2005   -   EUCTR2004-004325-10-GB   United Kingdom
Adalimumab
   ABBOTT GMBH & Co. KG
      2012   -   EUCTR2011-002411-29-IT   Austria;Belgium;Canada;Czech Republic;Denmark;Finland;Germany;Greece;Ireland;Israel;Italy;Poland;Portugal;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom
   AbbVie
      2024   Phase 2   NCT06257875   Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;New Zealand;Norway;Poland;Puerto Rico;Serbia;Slovenia;South Africa;Spain;Switzerland;Taiwan;United Kingdom;United States
      2016   -   NCT02750800   Hungary
      2015   Phase 3   NCT02632175   Japan;Poland;Slovakia;Spain;United Kingdom;United States
      2014   Phase 3   NCT02065622   Austria;Belgium;Canada;Czech Republic;Czechia;Denmark;France;Germany;Hungary;Israel;Italy;Japan;Netherlands;Poland;Romania;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States
      2014   Phase 3   NCT02065557   Australia;Austria;Belgium;Canada;Czech Republic;Czechia;Hungary;Israel;Italy;Japan;New Zealand;Poland;Slovakia;Spain;Sweden;United Kingdom;United States
      2013   -   NCT01768858   Austria
   AbbVie (prior sponsor, Abbott)
      2012   Phase 3   NCT01550965   Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Ireland;Israel;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom
      2009   Phase 3   NCT00853099   Japan
      2007   Phase 3   NCT00573794   Australia;Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Israel;Italy;Netherlands;New Zealand;Poland;Puerto Rico;Slovakia;Spain;Sweden;Switzerland;United States
   AbbVie Deutschland GmbH & Co. KG
      2019   Phase 3   EUCTR2013-001682-16-DK   Austria;Canada;Czech Republic;Denmark;Germany;Hungary;Israel;Italy;Japan;Netherlands;Poland;Slovakia;Spain;Switzerland;United States
      2017   Phase 3   EUCTR2015-001346-29-CZ   Belgium;Canada;Czech Republic;European Union;Hungary;Israel;Italy;Japan;New Zealand;Poland;Slovakia;Spain;Sweden;United Kingdom;United States
      2016   Phase 3   EUCTR2015-001346-29-HU   Australia;Belgium;Canada;Czech Republic;Hungary;Israel;Italy;New Zealand;Poland;Slovakia;Spain;Sweden;United Kingdom;United States
      2016   Phase 3   EUCTR2015-001346-29-GB   Belgium;Canada;Czech Republic;European Union;Hungary;Israel;Japan;New Zealand;Spain;Sweden;United Kingdom;United States
      2016   Phase 3   EUCTR2015-001346-29-ES   Australia;Belgium;Canada;Czech Republic;Hungary;Israel;Japan;New Zealand;Poland;Slovakia;Spain;Sweden;United Kingdom;United States
      2016   Phase 3   EUCTR2015-001346-29-BE   Australia;Belgium;Canada;Czech Republic;Hungary;Israel;Japan;New Zealand;Poland;Slovakia;Spain;Sweden;United Kingdom;United States
      2015   Phase 3   EUCTR2015-001346-29-SK   Belgium;Canada;Czech Republic;European Union;Hungary;Israel;Japan;New Zealand;Poland;Slovakia;Spain;Sweden;United Kingdom;United States
      2015   Phase 3   EUCTR2013-001682-16-BE   Belgium;Canada;Germany;Hungary;Israel;Italy;Japan;Netherlands;Poland;Spain;Switzerland;United States
      2014   Phase 3   EUCTR2013-003032-77-IT   Australia;Austria;Belgium;Canada;Czech Republic;France;Hungary;Israel;Italy;New Zealand;Poland;Slovakia;Spain;Switzerland;United Kingdom;United States
      2014   Phase 3   EUCTR2013-003032-77-HU   Australia;Austria;Belgium;Canada;Czech Republic;France;Hungary;Israel;Italy;New Zealand;Poland;Slovakia;Spain;United Kingdom;United States
      2014   Phase 3   EUCTR2013-003032-77-GB   Austria;Belgium;Canada;Czech Republic;France;Hungary;Israel;Italy;New Zealand;Poland;Slovakia;Spain;United Kingdom;United States
      2014   Phase 3   EUCTR2013-001682-16-SK   Austria;Canada;Czech Republic;Denmark;Germany;Hungary;Israel;Italy;Japan;Netherlands;Poland;Slovakia;Spain;Switzerland;United States
      2014   Phase 3   EUCTR2013-001682-16-PL   Austria;Belgium;Canada;Czech Republic;Denmark;Germany;Hungary;Israel;Italy;Japan;Netherlands;Poland;Slovakia;Spain;Switzerland;United States
      2014   Phase 3   EUCTR2013-001682-16-NL   Austria;Belgium;Canada;Czech Republic;Denmark;Germany;Hungary;Israel;Japan;Netherlands;Poland;Slovakia;Spain;Switzerland;United States
      2014   Phase 3   EUCTR2013-001682-16-IT   Austria;Belgium;Canada;Czech Republic;Denmark;Germany;Hungary;Israel;Italy;Japan;Netherlands;Poland;Slovakia;Spain;Switzerland;United States
      2014   Phase 3   EUCTR2013-001682-16-HU   Austria;Belgium;Canada;Czech Republic;Denmark;Germany;Hungary;Israel;Italy;Japan;Netherlands;Poland;Slovakia;Spain;Switzerland;United States
      2014   Phase 3   EUCTR2013-001682-16-ES   Austria;Canada;Czech Republic;Denmark;Germany;Hungary;Israel;Italy;Japan;Netherlands;Poland;Slovakia;Spain;Switzerland;United States
      2014   Phase 3   EUCTR2013-001682-16-DE   Austria;Belgium;Canada;Czech Republic;Denmark;Germany;Hungary;Israel;Italy;Japan;Netherlands;Poland;Slovakia;Spain;Switzerland;United States
      2014   Phase 3   EUCTR2013-001682-16-CZ   Austria;Belgium;Canada;Czech Republic;Denmark;Germany;Hungary;Israel;Italy;Japan;Netherlands;Poland;Slovakia;Spain;Switzerland;United States
      2014   Phase 3   EUCTR2013-001682-16-AT   Austria;Belgium;Canada;Czech Republic;Denmark;Germany;Hungary;Israel;Japan;Netherlands;Poland;Slovakia;Spain;Switzerland;United States
      2013   -   EUCTR2011-002411-29-SK   Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Ireland;Israel;Italy;Norway;Poland;Portugal;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom
      2013   -   EUCTR2011-002411-29-PL   Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Ireland;Israel;Italy;Norway;Poland;Portugal;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom
      2013   -   EUCTR2011-002411-29-CZ   Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Ireland;Israel;Italy;Norway;Poland;Portugal;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom
      2012   -   EUCTR2011-002411-29-SE   Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Ireland;Israel;Italy;Norway;Poland;Portugal;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom
      2012   -   EUCTR2011-002411-29-PT   Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Ireland;Israel;Italy;Netherlands;Norway;Poland;Portugal;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom
      2012   -   EUCTR2011-002411-29-IE   Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Ireland;Israel;Italy;Norway;Poland;Portugal;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom
      2012   -   EUCTR2011-002411-29-FI   Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Ireland;Israel;Italy;Netherlands;Norway;Poland;Portugal;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom
      2012   -   EUCTR2011-002411-29-DK   Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Ireland;Israel;Italy;Norway;Poland;Portugal;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom
      2012   -   EUCTR2011-002411-29-DE   Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Ireland;Israel;Italy;Norway;Poland;Portugal;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom
      2012   -   EUCTR2011-002411-29-BE   Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Ireland;Israel;Italy;Norway;Poland;Portugal;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom
      2012   -   EUCTR2011-002411-29-AT   Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Ireland;Israel;Italy;Norway;Poland;Portugal;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom
      2009   Phase 3   EUCTR2007-004157-28-SE   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Slovakia;Spain;Sweden;Switzerland
      2008   Phase 3   EUCTR2007-004157-28-NL   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Slovakia;Spain;Sweden;Switzerland
      2008   Phase 3   EUCTR2007-004157-28-HU   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Slovakia;Spain;Sweden;Switzerland
      2008   Phase 3   EUCTR2007-004157-28-DE   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Slovakia;Spain;Sweden;Switzerland
      2008   Phase 3   EUCTR2007-004157-28-CZ   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Slovakia;Spain;Sweden;Switzerland
      2008   Phase 3   EUCTR2007-004157-28-BE   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Slovakia;Spain;Sweden;Switzerland
      2008   Phase 3   EUCTR2007-004157-28-AT   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Slovakia;Spain;Sweden;Switzerland
      -   Phase 3   EUCTR2015-001346-29-SE   Belgium;Canada;Czech Republic;European Union;Hungary;Israel;Japan;New Zealand;Spain;Sweden;United Kingdom;United States
      -   Phase 3   EUCTR2015-001346-29-PL   Belgium;Canada;Czech Republic;European Union;Hungary;Israel;Japan;New Zealand;Poland;Slovakia;Spain;Sweden;United Kingdom;United States
      -   Phase 3   EUCTR2015-001346-29-AT   Austria;Belgium;Canada;Czech Republic;European Union;Hungary;Israel;Japan;New Zealand;Spain;Sweden;United Kingdom;United States
   AbbVie GK
      2014   Phase 3   JPRN-jRCT2080222598   Europe;Japan;North America
      2014   Phase 3   JPRN-jRCT2080222597   Europe;Japan;North America
      2009   Phase 2-3   JPRN-jRCT2080220693   -
   AbbVie Inc.
      -   -   EUCTR2014-004559-29-Outside-EU/EEA   Japan
   Abbott
      2006   Phase 3   NCT00408629   Argentina;Australia;Austria;Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;New Zealand;Norway;Poland;Portugal;Spain;Sweden;Switzerland;United States
      2006   Phase 3   NCT00385736   Austria;Belgium;Canada;Czech Republic;Germany;Hungary;Italy;Netherlands;Poland;Puerto Rico;Slovakia;Sweden;United States
   Abbott GmbH & Co. KG
      2012   -   EUCTR2011-002411-29-GR   Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Ireland;Israel;Italy;Netherlands;Norway;Poland;Portugal;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom
      2012   -   EUCTR2011-002411-29-ES   Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Ireland;Israel;Italy;Netherlands;Norway;Poland;Portugal;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom
      2009   Phase 3   EUCTR2007-004157-28-PT   Austria;Belgium;Czech Republic;France;Germany;Hungary;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden
      2008   Phase 3   EUCTR2007-004157-28-SK   Austria;Belgium;Czech Republic;France;Germany;Hungary;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden
      2008   Phase 3   EUCTR2007-004157-28-IT   Austria;Belgium;Czech Republic;France;Germany;Hungary;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden
      2008   Phase 3   EUCTR2007-004157-28-FR   Austria;Belgium;Czech Republic;France;Germany;Hungary;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden
      2008   -   EUCTR2006-002782-40-DE   Austria;Czech Republic;Denmark;France;Germany;Hungary;Portugal
      2008   -   EUCTR2006-002782-40-AT   Austria;Czech Republic;Denmark;France;Germany;Hungary;Portugal
      2008   -   EUCTR2006-002781-20-SE   Austria;Czech Republic;Germany;Hungary;Italy;Sweden
      2008   -   EUCTR2006-002781-20-AT   Austria;Czech Republic;Germany;Hungary;Italy;Sweden
      2007   -   EUCTR2006-002782-40-PT   Austria;Czech Republic;Denmark;France;Germany;Hungary;Portugal
      2007   -   EUCTR2006-002782-40-HU   Austria;Belgium;Czech Republic;Denmark;France;Germany;Hungary;Portugal;Spain
      2007   Phase 3   EUCTR2006-002782-40-FR   Austria;Belgium;Czech Republic;Denmark;France;Germany;Hungary;Portugal;Spain
      2007   -   EUCTR2006-002782-40-ES   Austria;Belgium;Czech Republic;Denmark;France;Germany;Hungary;Portugal;Spain
      2007   -   EUCTR2006-002782-40-DK   Austria;Czech Republic;Denmark;France;Germany;Hungary;Portugal
      2007   -   EUCTR2006-002782-40-CZ   Austria;Czech Republic;Denmark;France;Germany;Hungary;Portugal
      2007   -   EUCTR2006-002782-40-BE   Austria;Belgium;Czech Republic;Denmark;France;Germany;Hungary;Portugal;Spain
      2007   Phase 3   EUCTR2006-002781-20-SK   Austria;Belgium;Czech Republic;Germany;Hungary;Italy;Slovakia;Sweden
      2007   -   EUCTR2006-002781-20-HU   Austria;Czech Republic;Germany;Hungary;Italy;Sweden
      2007   -   EUCTR2006-002781-20-DE   Austria;Czech Republic;Germany;Hungary;Italy;Sweden
      2007   -   EUCTR2006-002781-20-CZ   Austria;Czech Republic;Germany;Hungary;Italy;Sweden
      2007   -   EUCTR2006-002781-20-BE   Austria;Belgium;Czech Republic;Germany;Hungary;Italy;Sweden
   Abbvie Deutschland GmbH & Co. KG
      2015   Phase 3   EUCTR2013-003032-77-PL   Austria;Belgium;Canada;Czech Republic;France;Hungary;Israel;Italy;New Zealand;Poland;Slovakia;Spain;United Kingdom;United States
      2014   Phase 3   EUCTR2013-003032-77-SK   Austria;Belgium;Canada;Czech Republic;France;Hungary;Israel;Italy;New Zealand;Poland;Slovakia;Spain;United Kingdom;United States
      2014   Phase 3   EUCTR2013-003032-77-ES   Australia;Austria;Belgium;Canada;Czech Republic;France;Hungary;Israel;Italy;New Zealand;Poland;Slovakia;Spain;Switzerland;United Kingdom;United States
      2014   Phase 3   EUCTR2013-003032-77-CZ   Austria;Belgium;Canada;Czech Republic;France;Hungary;Israel;Italy;New Zealand;Poland;Slovakia;Spain;United Kingdom;United States
      2014   Phase 3   EUCTR2013-003032-77-BE   Australia;Austria;Belgium;Canada;Czech Republic;France;Hungary;Israel;Italy;New Zealand;Poland;Slovakia;Spain;Switzerland;United Kingdom;United States
      2014   Phase 3   EUCTR2013-003032-77-AT   Austria;Belgium;Canada;Czech Republic;France;Hungary;Israel;Italy;New Zealand;Poland;Slovakia;Spain;United Kingdom;United States
      2012   -   EUCTR2011-002411-29-GB   Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Ireland;Israel;Italy;Netherlands;Norway;Poland;Portugal;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom
      -   Phase 3   EUCTR2013-003032-77-FR   Australia;Austria;Belgium;Canada;Czech Republic;France;Hungary;Israel;Italy;New Zealand;Poland;Slovakia;Spain;Switzerland;United Kingdom;United States
   Applied Molecular Transport
      2021   Phase 2   NCT05372939   Georgia;Netherlands;Poland;Ukraine
   Applied Molecular Transport Inc.
      2021   Phase 2   EUCTR2020-002833-13-PL   Georgia;Netherlands;Poland;Ukraine
      2021   Phase 2   EUCTR2020-002833-13-NL   Georgia;Netherlands;Poland;Ukraine
   Celltrion HealthCare France
      2022   -   NCT05427942   France
   Clalit Health Services
      2012   Phase 3   NCT01494857   Israel
   Erasmus MC
      2014   -   EUCTR2014-001919-39-NL   Netherlands
   Erasmus Medical Center
      2013   -   NCT01971970   Netherlands
   F. Hoffmann-La Roche Ltd
      2019   Phase 3   EUCTR2013-004279-11-FR   Argentina;Australia;Brazil;Bulgaria;Estonia;France;Hong Kong;Mexico;Poland;Russian Federation;Serbia;Slovakia;Ukraine;United States
      2019   Phase 3   EUCTR2013-004277-27-HU   Argentina;Australia;Brazil;Bulgaria;Colombia;Croatia;Czech Republic;Greece;Hungary;Latvia;Lithuania;Malaysia;New Zealand;Poland;Russian Federation;Turkey;Ukraine;United States
      2019   Phase 3   EUCTR2013-004277-27-CZ   Argentina;Australia;Brazil;Bulgaria;Colombia;Croatia;Czech Republic;Greece;Hungary;Latvia;Lithuania;Malaysia;New Zealand;Poland;Russian Federation;Turkey;Ukraine;United States
      2015   Phase 3   EUCTR2013-004279-11-BG   Argentina;Australia;Brazil;Bulgaria;Estonia;France;Hong Kong;Mexico;Poland;Russian Federation;Serbia;Slovakia;Ukraine;United States
      2015   Phase 3   EUCTR2013-004277-27-BG   Argentina;Australia;Brazil;Bulgaria;Colombia;Croatia;Czech Republic;Greece;Hungary;Latvia;Lithuania;Malaysia;New Zealand;Poland;Russian Federation;Turkey;Ukraine;United States
      2014   Phase 3   EUCTR2013-004279-11-SK   Argentina;Australia;Brazil;Bulgaria;Estonia;France;Hong Kong;Mexico;Poland;Russian Federation;Serbia;Slovakia;Ukraine;United States
      2014   Phase 3   EUCTR2013-004279-11-EE   Argentina;Australia;Brazil;Bulgaria;Estonia;France;Hong Kong;Mexico;Poland;Russian Federation;Serbia;Slovakia;Ukraine;United States
      2014   Phase 3   EUCTR2013-004277-27-LV   Argentina;Australia;Brazil;Bulgaria;Colombia;Croatia;Czech Republic;Greece;Hungary;Latvia;Lithuania;Malaysia;New Zealand;Poland;Russian Federation;Turkey;Ukraine;United States
      2014   Phase 3   EUCTR2013-004277-27-LT   Argentina;Australia;Brazil;Bulgaria;Colombia;Croatia;Czech Republic;Greece;Hungary;Latvia;Lithuania;Malaysia;New Zealand;Poland;Russian Federation;Turkey;Ukraine;United States
      2014   Phase 3   EUCTR2013-004277-27-HR   Argentina;Australia;Brazil;Bulgaria;Colombia;Croatia;Czech Republic;Greece;Hungary;Latvia;Lithuania;Malaysia;New Zealand;Poland;Russian Federation;Turkey;Ukraine;United States
      2014   Phase 3   EUCTR2013-004277-27-GR   Argentina;Australia;Brazil;Bulgaria;Colombia;Croatia;Czech Republic;Greece;Hungary;Latvia;Lithuania;Malaysia;New Zealand;Poland;Russian Federation;Turkey;Ukraine;United States
   Fukuyama Medical Center
      2016   -   JPRN-UMIN000020840   Japan
   Fundación Española de Gastroenterología
      2021   Phase 4   EUCTR2021-002211-65-ES   Spain
   Fundación Publica Andaluza para la Gestión de Salud en Sevilla (FISEVI)
      2019   Phase 4   EUCTR2019-000717-37-ES   Spain
   Fundación de Investigación Biomédica - Hospital Universitario de La Princesa
      2017   Phase 4   NCT02994836   Spain
   Fundación de Investigación Biomédica Hospital Universitario de la Princesa
      2016   Phase 4   EUCTR2015-001410-10-ES   Spain
   Fundación de Investigación Biomédica del Hospital Universitario de La Princesa
      2018   Phase 4   EUCTR2018-002925-47-ES   Spain
   GETAID
      2019   Phase 4   EUCTR2018-003490-10-FR   France
   Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives
      2020   Phase 4   NCT04183608   France
   Helse More og Romsdal Hospital Trust
      2016   Phase 4   EUCTR2016-001409-18-NO   Norway
   Hoffmann-La Roche
      2014   Phase 3   NCT02171429   Argentina;Australia;Brazil;Bulgaria;Colombia;Croatia;Czechia;France;Greece;Hungary;Latvia;Lithuania;Malaysia;New Zealand;Poland;Russian Federation;Turkey;Ukraine;United States
      2014   Phase 3   NCT02163759   Argentina;Australia;Brazil;Bulgaria;Estonia;France;Hong Kong;Mexico;Poland;Russian Federation;Serbia;Slovakia;Ukraine;United States
   IRCCS ISTITUTO CLINICO HUMANITAS
      2021   Phase 4   EUCTR2020-003420-16-IT   Austria;Belgium;France;Germany;Italy;Portugal;Spain;Sweden;Switzerland;United Kingdom
   Instituto Clinico Humanitas
      2021   Phase 4   EUCTR2020-003420-16-ES   Austria;Belgium;France;Germany;Italy;Portugal;Spain;Sweden;Switzerland;United Kingdom
   Iwate Medical University Kochi Medical School Hospital Keio University School of Medicine
      2016   -   JPRN-UMIN000019958   Japan
   Jamp Pharma Corporation
      2023   -   NCT05913817   Canada
   Keio University Gastroenterology and Hepatology
      2016   -   JPRN-UMIN000024936   Japan
   Mayo Clinic
      2006   Phase 1   NCT00421642   United States
   McMaster University
      2018   Phase 4   NCT03059849   -
   Nantes University Hospital
      2017   -   NCT02878083   France
   National Institute of Allergy and Infectious Diseases (NIAID)
      2007   Phase 2   NCT00514982   United States
   Odense University Hospital
      2012   Phase 3   NCT01670240   Denmark
   Osaka Medical College
      2014   -   JPRN-UMIN000015912   Japan
   PIBD net
      2018   Phase 4   EUCTR2016-000522-18-GB   Belgium;Canada;Czech Republic;France;Germany;Israel;Italy;Netherlands;Poland;Spain;United Kingdom
   Region Örebro län
      2021   Phase 4   EUCTR2019-002942-19-NO   Denmark;Iceland;Norway
      2021   Phase 4   EUCTR2019-002942-19-IS   Denmark;Iceland
      2021   Phase 4   EUCTR2019-002942-19-DK   Denmark;Iceland
   Regionalhospital Silkeborg
      2010   Phase 4   EUCTR2009-018085-35-DK   Denmark
   Rehab Werida
      2022   -   NCT05291039   Egypt
   Royal Liverpool University Hospital
      2012   -   EUCTR2011-006084-22-GB   United Kingdom
   Sakura Medical Center, Toho university
      2018   -   JPRN-UMIN000030988   Japan
   Sakura Medical Center,Toho university
      2015   -   JPRN-UMIN000019066   Japan
   Samsung Bioepis Co., Ltd
      2015   -   EUCTR2014-004887-39-PL   Poland
   Samsung Bioepis Co., Ltd.
      2014   -   EUCTR2013-005013-13-PL   Bosnia and Herzegovina;Bulgaria;Czech Republic;Korea, Republic of;Latvia;Lithuania;Mexico;Poland;Russian Federation;Ukraine;United Kingdom
      2014   -   EUCTR2013-005013-13-LT   Bosnia and Herzegovina;Bulgaria;Czech Republic;Korea, Republic of;Lithuania;Mexico;Poland;Russian Federation;Ukraine;United Kingdom
      2014   -   EUCTR2013-005013-13-CZ   Bosnia and Herzegovina;Bulgaria;Czech Republic;Korea, Republic of;Lithuania;Mexico;Poland;Russian Federation;Ukraine;United Kingdom
      2014   Phase 3   EUCTR2013-005013-13-BG   Bosnia and Herzegovina;Bulgaria;Czech Republic;Korea, Republic of;Lithuania;Mexico;Poland;Russian Federation;Ukraine;United Kingdom
   Shandong Qilu Stem Cells Engineering Co., Ltd.
      2021   -   NCT04882683   China
   Takeda
      2015   Phase 3   NCT02497469   Argentina;Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Taiwan;Turkey;Ukraine;United Kingdom;United States
   Takeda Development Centre Europe, Ltd.
      2016   Phase 3   EUCTR2015-000939-33-PT   Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000939-33-PL   Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000939-33-NL   Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000939-33-HU   Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000939-33-HR   Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000939-33-ES   Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2015   Phase 3   EUCTR2015-000939-33-SK   Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2015   Phase 3   EUCTR2015-000939-33-LV   Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2015   Phase 3   EUCTR2015-000939-33-LT   Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2015   Phase 3   EUCTR2015-000939-33-GB   Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2015   Phase 3   EUCTR2015-000939-33-EE   Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2015   Phase 3   EUCTR2015-000939-33-DK   Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2015   Phase 3   EUCTR2015-000939-33-DE   Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2015   Phase 3   EUCTR2015-000939-33-CZ   Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2015   Phase 3   EUCTR2015-000939-33-BG   Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2015   Phase 3   EUCTR2015-000939-33-BE   Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
   The First Affiliated Hospital of Shantou University Medical College
      2022   -   ChiCTR2200058055   China
   The Second Affiliated Hospital of Shandong University of Traditional Chinese Medicine
      2021   Phase 0   ChiCTR2100046284   China
   University Hospital Southampton NHS Foundation Trust
      2019   Phase 4   EUCTR2018-004967-30-GB   United Kingdom
   University Medical Center Groningen
      2021   Phase 4   NCT04646187   Belgium;Netherlands;Spain
      2021   Phase 4   EUCTR2020-001811-26-BE   Belgium;Netherlands;Spain
      2020   Phase 4   EUCTR2020-001811-26-NL   Belgium;Netherlands;Spain
   University of Alberta
      2009   Phase 4   NCT00972218   Canada
   University of Western Ontario, Canada
      2014   Phase 4   NCT01960426   United States
      2013   Phase 4   NCT01716039   -
   Universitätsklinikum Erlangen
      2019   Phase 4   EUCTR2019-003662-40-DE   Germany
   Vastra Gotaland Region
      2024   -   NCT06269185   Sweden
Adalimumab 40MG
   Instituto Clinico Humanitas
      2021   Phase 4   EUCTR2020-003420-16-BE   Austria;Belgium;France;Germany;Italy;Portugal;Spain;Sweden;Switzerland;United Kingdom
Adalimumab-680LT
   University Medical Center Groningen
      2024   Phase 1/Phase 2   NCT06117423   Netherlands
Adalimumab-800CW
   University Medical Center Groningen
      2023   Phase 1   NCT03938701   Netherlands
Additional therapies
   Connecticut Children's Medical Center
      2012   Phase 4   NCT01536535   Canada;United States
Adipose derived, autologous mesenchymal stem cells
   Mayo Clinic
      2020   Phase 1   NCT04312113   United States
Adipose tissue-derived mesenchymal stem cells
   Fundacion para la Investigacion Biomedica Hospital Universitario La Paz
      2012   -   EUCTR2010-023798-20-ES   Spain
Adrenomedullin
   First Department of Internal Medicine, Faculty of Medicine, University of Miyazaki
      2016   Phase 1,2   JPRN-UMIN000021421   Japan
      2010   Phase 2   JPRN-UMIN000003230   Japan
   University of Miyazaki
      2017   Phase 2   JPRN-jRCT2080225159   Japan
Advanced therapy
   Bristol-Myers Squibb
      2024   -   NCT06126835   United States
Advanced therapy only without dietary intervention
   University of Miami
      2020   Phase 3   NCT04505410   United States
AEB071
   Novartis Pharma Services AG
      2007   Phase 2   EUCTR2007-002542-38-DK   Denmark;Germany
   Novartis Pharmaceuticals
      2010   Phase 2   NCT00572585   Denmark;Germany;Poland;United States
AEB071A
   Novartis Pharma Services AG
      2007   -   EUCTR2007-002542-38-DE   Denmark;Germany
AERO-RED 100 MG/ML gotas orales EN solucióN
   Universitary Hospital Príncipe de Asturias
      2021   Phase 4   EUCTR2021-000985-14-ES   Spain
AG011
   ActoGeniX N.V.
      2008   Phase 1/Phase 2   NCT00729872   Belgium;Canada;Netherlands;Sweden
AG011 - capsules
   ActoGeniX N.V
      2008   -   EUCTR2008-000967-40-BE   Belgium;Netherlands;Sweden
   ActoGeniX NV.
      2008   -   EUCTR2008-000967-40-SE   Belgium;Netherlands;Sweden
      2008   -   EUCTR2008-000967-40-NL   Belgium;Netherlands;Sweden
AG011 - enema
   ActoGeniX N.V
      2008   -   EUCTR2008-000967-40-BE   Belgium;Netherlands;Sweden
   ActoGeniX NV.
      2008   -   EUCTR2008-000967-40-SE   Belgium;Netherlands;Sweden
      2008   -   EUCTR2008-000967-40-NL   Belgium;Netherlands;Sweden
AIN457
   Novartis Pharmaceuticals
      2009   Phase 2   NCT01009281   Austria;Canada;Germany;Poland;United States
AIR
   Osaka University, Graduate School of Medicine, Department of Gastroenterology and Hepatology
      2015   -   JPRN-UMIN000018801   Japan
   The Second Affiliated Hospital of Xi'an Jiaotong University
      2018   Phase 0   ChiCTR2200055616   China
AIR insufflation insertion
   Vitkovice Hospital
      2013   -   NCT01933867   Czech Republic
AIRE-2 portable breath analyzer
   McMaster University
      2024   -   NCT06541938   Canada
AJM300
   EA Pharma Co., Ltd.
      2018   Phase 3   NCT03531892   Japan
   Takeuchi Yutaka
      2017   Phase 1   JPRN-jRCT2071230024   -
      2015   Phase 1   JPRN-jRCT2071230023   -
AK101 IV/AK101 SC
   Akeso
      2020   Phase 1   NCT06281704   China
Aldesleukin
   Scott B. Snapper, MD PHD
      2015   Phase 1   NCT02200445   United States
Alequel
   Hadassah Medical Organization
      2008   Phase 1/Phase 2   NCT02185183   -
Algin
   Ishikawa Dai
      2020   -   JPRN-jRCTs031200103   -
Alicaforsen
   Ionis Pharmaceuticals, Inc.
      2003   Phase 2   NCT00063830   United States
      2002   Phase 2   NCT00063414   United States
Alkaline phosphatase
   AM PHARMA B.V.
      2006   -   EUCTR2006-000197-69-IT   Italy
   AM-Pharma
      2006   Phase 2   NCT00727324   Czech Republic;Italy
   AM-Pharma B.V.
      2006   Phase 2   EUCTR2006-000197-69-CZ   Czech Republic;Italy
Allogeneic adipose tissue-derived mesenchymal stem cells
   Instituto de Investigación Hospital Universitario La Paz
      2013   Phase 1/Phase 2   NCT01914887   Spain
Allogeneic bone marrow-derived mesenchymal stromal cells
   Catherine Bollard
      2015   Phase 1   NCT02150551   United States
Allopurinol
   Hvidovre Hospital
      2016   Phase 3   EUCTR2016-002433-30-DK   Denmark
   SOIBD (The Swedish Organisation for the study of Inflammatory Bowel Diseases)
      2018   Phase 4   EUCTR2016-004112-35-SE   Sweden
Allopurinol sodium
   Marianne Kiszka-Kanowitz
      2013   Phase 3   EUCTR2013-001503-37-DK   Denmark
Allorx
   The Foundation for Orthopaedics and Regenerative Medicine
      2022   Phase 1   NCT05003947   Antigua and Barbuda;Argentina;Mexico
Aloasc
   Fundacion para la Investigacion Biomedica Hospital Universitario La Paz
      2012   -   EUCTR2010-023798-20-ES   Spain
Aloe barbadensis miller
   National Institute of Medical Sciences and Nutrition, Salvador Zubiran
      2012   Phase 0   NCT01783119   Mexico
Aloe vera GEL
   Ospedale Sandro Pertini, Roma
      2010   -   NCT04753775   -
Also referred TO AS 'MEDI2070'
   AstraZeneca AB
      2022   Phase 2   EUCTR2021-001644-10-FR   Austria;Canada;Czechia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Poland;Russian Federation;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
Also referred TO AS MEDI2070
   AstraZeneca AB
      2022   Phase 2   EUCTR2018-001605-93-FR   Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2021   Phase 2   EUCTR2018-001605-93-HU   Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Poland;Romania;Russian Federation;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2020   Phase 2   EUCTR2018-001605-93-DE   Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Poland;Romania;Russian Federation;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2020   Phase 2   EUCTR2018-001605-93-AT   Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Poland;Romania;Russian Federation;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2019   Phase 2   EUCTR2018-001605-93-CZ   Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Poland;Romania;Russian Federation;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
ALTB-168
   AltruBio Inc.
      2018   Phase 2   NCT03298022   Puerto Rico;United States
ALTB-268
   AltruBio Inc.
      2023   Phase 2   NCT06109441   Canada;Puerto Rico;United States
ALTH12-1:4
   Altheus Therapeutics, Inc.
      2009   Phase 1   NCT01020708   United States
ALTH12-2:4
   Altheus Therapeutics, Inc.
      2009   Phase 1   NCT01020708   United States
AMG 181
   Amgen
      2011   Phase 1   NCT01290042   Australia;United States
      2010   Phase 1   NCT01164904   Australia;New Zealand;United States
   Amgen Inc
      2014   Phase 2   EUCTR2011-005251-13-LV   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;Italy;Latvia;Netherlands;New Zealand;Norway;Poland;Russian Federation;Switzerland;United Kingdom;United States
      2014   Phase 2   EUCTR2011-005251-13-EE   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;Italy;Latvia;Netherlands;New Zealand;Norway;Poland;Russian Federation;Switzerland;United Kingdom;United States
      2013   Phase 2   EUCTR2011-005251-13-PL   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;Italy;Latvia;Netherlands;Norway;Poland;Switzerland;United Kingdom;United States
      2013   Phase 2   EUCTR2011-005251-13-NL   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;Italy;Latvia;Netherlands;Norway;Poland;Switzerland;United Kingdom;United States
      2012   Phase 2   EUCTR2011-005251-13-HU   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;Italy;Latvia;Netherlands;Norway;Poland;Switzerland;United Kingdom;United States
      2012   Phase 2   EUCTR2011-005251-13-GR   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;Italy;Latvia;Netherlands;Norway;Poland;Switzerland;United Kingdom;United States
      2012   Phase 2   EUCTR2011-005251-13-GB   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;Italy;Latvia;Netherlands;Norway;Poland;Switzerland;United Kingdom;United States
      2012   Phase 2   EUCTR2011-005251-13-DK   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;Italy;Latvia;Netherlands;Norway;Poland;Switzerland;United Kingdom;United States
      2012   Phase 2   EUCTR2011-005251-13-DE   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;Italy;Latvia;Netherlands;Norway;Poland;Switzerland;United Kingdom;United States
      2012   Phase 2   EUCTR2011-005251-13-CZ   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;Italy;Latvia;Netherlands;Norway;Poland;Switzerland;United Kingdom;United States
      2012   Phase 2   EUCTR2011-005251-13-BE   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;Italy;Latvia;Netherlands;Norway;Poland;Switzerland;United Kingdom;United States
      2012   Phase 2   EUCTR2011-005251-13-AT   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;Italy;Latvia;Netherlands;Norway;Poland;Switzerland;United Kingdom;United States
AMG 592
   AMGEN INC.
      2021   Phase 2   EUCTR2021-002537-41-IT   Argentina;Austria;Bulgaria;Canada;Czechia;Denmark;Finland;Germany;Hungary;Italy;Japan;Korea, Democratic People's Republic of;Mexico;Netherlands;Poland;Romania;Russian Federation;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United States
   Amgen Inc.
      2023   Phase 2   EUCTR2022-001686-12-SK   Argentina;Austria;Belgium;Bulgaria;Canada;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;Italy;Japan;Korea, Republic of;Latvia;Mexico;Netherlands;Poland;Romania;Russian Federation;Slovakia;Spain;Switzerland;Taiwan;Türkiye;United States
      2023   Phase 2   EUCTR2022-001686-12-RO   Argentina;Austria;Belgium;Bulgaria;Canada;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;Italy;Japan;Korea, Republic of;Latvia;Mexico;Netherlands;Poland;Romania;Russian Federation;Slovakia;Spain;Switzerland;Taiwan;Türkiye;Ukraine;United States
      2023   Phase 2   EUCTR2022-001686-12-NL   Argentina;Austria;Belgium;Bulgaria;Canada;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;Italy;Japan;Korea, Republic of;Latvia;Mexico;Netherlands;Poland;Romania;Russian Federation;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United States
      2023   Phase 2   EUCTR2022-001686-12-LV   Argentina;Austria;Belgium;Bulgaria;Canada;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;Italy;Japan;Korea, Republic of;Latvia;Mexico;Netherlands;Poland;Romania;Russian Federation;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United States
      2023   Phase 2   EUCTR2022-001686-12-HU   Argentina;Austria;Belgium;Bulgaria;Canada;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;Italy;Japan;Korea, Republic of;Latvia;Mexico;Netherlands;Poland;Romania;Russian Federation;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United States
      2023   Phase 2   EUCTR2022-001686-12-GR   Argentina;Austria;Belgium;Bulgaria;Canada;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;Italy;Japan;Korea, Republic of;Latvia;Mexico;Netherlands;Poland;Romania;Russian Federation;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United States
      2023   Phase 2   EUCTR2022-001686-12-FR   Argentina;Austria;Belgium;Bulgaria;Canada;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;Italy;Japan;Korea, Republic of;Latvia;Mexico;Netherlands;Poland;Romania;Russian Federation;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United States
      2023   Phase 2   EUCTR2022-001686-12-FI   Argentina;Austria;Belgium;Bulgaria;Canada;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;Italy;Japan;Korea, Republic of;Latvia;Mexico;Netherlands;Poland;Romania;Slovakia;Spain;Switzerland;Taiwan;Türkiye;United States
      2023   Phase 2   EUCTR2022-001686-12-DK   Argentina;Austria;Belgium;Bulgaria;Canada;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;Italy;Japan;Korea, Republic of;Latvia;Mexico;Netherlands;Poland;Romania;Russian Federation;Slovakia;Spain;Switzerland;Taiwan;Türkiye;Ukraine;United States
      2023   Phase 2   EUCTR2022-001686-12-DE   Argentina;Austria;Belgium;Bulgaria;Canada;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;Italy;Japan;Korea, Republic of;Latvia;Mexico;Netherlands;Poland;Romania;Russian Federation;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United States
      2023   Phase 2   EUCTR2022-001686-12-BG   Argentina;Austria;Belgium;Bulgaria;Canada;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;Italy;Japan;Korea, Republic of;Latvia;Mexico;Netherlands;Poland;Romania;Slovakia;Spain;Switzerland;Taiwan;Türkiye;United States
      2023   Phase 2   EUCTR2022-001686-12-BE   Argentina;Austria;Belgium;Bulgaria;Canada;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;Italy;Japan;Korea, Republic of;Latvia;Mexico;Netherlands;Poland;Romania;Russian Federation;Slovakia;Spain;Switzerland;Taiwan;Türkiye;Ukraine;United States
      2023   Phase 2   EUCTR2022-001686-12-AT   Argentina;Austria;Belgium;Bulgaria;Canada;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;Italy;Japan;Korea, Republic of;Latvia;Mexico;Netherlands;Poland;Romania;Slovakia;Spain;Switzerland;Taiwan;Türkiye;United States
      2023   Phase 2   EUCTR2021-002537-41-SK   Argentina;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;Italy;Japan;Korea, Republic of;Latvia;Mexico;Netherlands;Poland;Romania;Russian Federation;Slovakia;Spain;Switzerland;Taiwan;Türkiye;United States
      2023   Phase 2   EUCTR2021-002537-41-LV   Argentina;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;Italy;Japan;Korea, Republic of;Latvia;Mexico;Netherlands;Poland;Romania;Russian Federation;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United States
      2022   Phase 2   EUCTR2021-002537-41-RO   Argentina;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;Italy;Japan;Korea, Republic of;Latvia;Mexico;Netherlands;Poland;Romania;Slovakia;Spain;Switzerland;Taiwan;Türkiye;United States
      2022   Phase 2   EUCTR2021-002537-41-GR   Argentina;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;Italy;Japan;Korea, Democratic People's Republic of;Latvia;Mexico;Netherlands;Poland;Romania;Russian Federation;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United States
      2022   Phase 2   EUCTR2021-002537-41-FR   Argentina;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;Italy;Japan;Korea, Republic of;Latvia;Mexico;Netherlands;Poland;Romania;Russian Federation;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United States
      2022   Phase 2   EUCTR2021-002537-41-FI   Argentina;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;Italy;Japan;Korea, Republic of;Latvia;Mexico;Netherlands;Poland;Romania;Slovakia;Spain;Switzerland;Taiwan;Türkiye;United States
      2022   Phase 2   EUCTR2021-002537-41-ES   Argentina;Austria;Belgium;Bulgaria;Canada;Czechia;Denmark;Finland;Germany;Greece;Hungary;Italy;Japan;Korea, Democratic People's Republic of;Mexico;Netherlands;Poland;Romania;Russian Federation;Spain;Switzerland;Taiwan;Turkey;Ukraine;United States
      2022   Phase 2   EUCTR2021-002537-41-DK   Argentina;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;Italy;Japan;Korea, Republic of;Latvia;Mexico;Netherlands;Poland;Romania;Russian Federation;Slovakia;Spain;Switzerland;Taiwan;Türkiye;Ukraine;United States
      2022   Phase 2   EUCTR2021-002537-41-CZ   Argentina;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;Italy;Japan;Korea, Republic of;Latvia;Mexico;Netherlands;Poland;Romania;Russian Federation;Slovakia;Spain;Switzerland;Taiwan;Türkiye;Ukraine;United States
      2022   Phase 2   EUCTR2021-002537-41-BG   Argentina;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;Italy;Japan;Korea, Democratic People's Republic of;Latvia;Mexico;Netherlands;Poland;Romania;Slovakia;Spain;Sweden;Switzerland;Taiwan;Türkiye;United States
      2022   Phase 2   EUCTR2021-002537-41-BE   Argentina;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;Italy;Japan;Korea, Republic of;Latvia;Mexico;Netherlands;Poland;Romania;Russian Federation;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United States
      2021   Phase 2   EUCTR2021-002537-41-NL   Argentina;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;Italy;Japan;Korea, Republic of;Latvia;Mexico;Netherlands;Poland;Romania;Slovakia;Spain;Switzerland;Taiwan;Türkiye;United States
      2021   Phase 2   EUCTR2021-002537-41-HU   Argentina;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;Italy;Japan;Korea, Democratic People's Republic of;Latvia;Mexico;Netherlands;Poland;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United States
      2021   Phase 2   EUCTR2021-002537-41-DE   Argentina;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;Italy;Japan;Korea, Republic of;Latvia;Mexico;Netherlands;Poland;Romania;Slovakia;Spain;Switzerland;Taiwan;Türkiye;United States
   Hama Yoriko
      2022   Phase 2   JPRN-jRCT2041220001   Argentina;Austria;Belgium;Bulgaria;Canada;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;Italy;Japan;Korea;Latvia;Mexico;Netherlands;Poland;Romania;Slovakia;Spain;Switzerland;Taiwan;Turkey;United States
AMG181
   AMGEN INC.
      2012   Phase 2   EUCTR2011-005251-13-IT   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Estonia;Germany;Greece;Hungary;Italy;Latvia;Netherlands;Poland;Switzerland;United Kingdom;United States
Amgevita
   CHU Amiens-Picardie
      2020   Phase 4   EUCTR2020-004391-18-FR   France
   Fundación Publica Andaluza para la Gestión de Salud en Sevilla (FISEVI)
      2019   Phase 4   EUCTR2019-000717-37-ES   Spain
   IRCCS ISTITUTO CLINICO HUMANITAS
      2021   Phase 4   EUCTR2020-003420-16-IT   Austria;Belgium;France;Germany;Italy;Portugal;Spain;Sweden;Switzerland;United Kingdom
   Instituto Clinico Humanitas
      2021   Phase 4   EUCTR2020-003420-16-ES   Austria;Belgium;France;Germany;Italy;Portugal;Spain;Sweden;Switzerland;United Kingdom
      2021   Phase 4   EUCTR2020-003420-16-BE   Austria;Belgium;France;Germany;Italy;Portugal;Spain;Sweden;Switzerland;United Kingdom
   University Medical Center Groningen
      2021   Phase 4   EUCTR2020-001811-26-BE   Belgium;Netherlands;Spain
      2020   Phase 4   EUCTR2020-001811-26-NL   Belgium;Netherlands;Spain
Amgevita 40 MG injektionslösung IM fertigpen
   Universitätsklinikum Erlangen
      2019   Phase 4   EUCTR2019-003662-40-DE   Germany
Amgevita 40 MG injektionslösung IN einer fertigspritze
   Universitätsklinikum Erlangen
      2019   Phase 4   EUCTR2019-003662-40-DE   Germany
Amgevita 40MG solution FOR injection
   Fundación Pública Andaluza para la gestión de la Investigación en Sevilla
      2019   Phase 4   NCT04131322   Spain
Amino acid mixture beverage
   Entrinsic Bioscience Inc.
      2018   -   NCT03451253   United States
Amino salicylic acid
   Tanta University
      2023   Phase 4   NCT05684484   Egypt
Aminosalicylic acid
   National Center for Research Resources (NCRR)
      1996   Phase 2   NCT00004810   -
Amiselimod
   Kagiyama Shoji
      2022   Phase 2   JPRN-jRCT2031210352   Australia;Belarus;Bulgaria;Czech Republic;Estonia;Georgia;Germany;Hungary;Italy;Japan;Moldova;Poland;Russia;S. Korea;Serbia;Slovakia,;Taiwan;USA;Ukraine
   Salix Pharmaceuticals Inc.
      2022   Phase 2   EUCTR2020-005232-30-IT   Australia;Belarus;Bulgaria;Czech Republic;Czechia;Estonia;Georgia;Germany;Hungary;Italy;Japan;Korea, Republic of;Moldova, Republic of;Poland;Russian Federation;Serbia;Slovakia;Taiwan;Ukraine;United States
   Salix Pharmaceuticals, Inc.
      2021   Phase 2   EUCTR2020-005232-30-HU   Australia;Belarus;Belgium;Bulgaria;Czech Republic;Czechia;Estonia;Georgia;Germany;Hungary;Italy;Japan;Korea, Republic of;Moldova, Republic of;Poland;Russian Federation;Serbia;Slovakia;Taiwan;Ukraine;United States
      2021   Phase 2   EUCTR2020-005232-30-EE   Australia;Belarus;Bulgaria;Czech Republic;Czechia;Estonia;Georgia;Germany;Hungary;Italy;Japan;Korea, Republic of;Moldova, Republic of;Poland;Russian Federation;Serbia;Slovakia;Taiwan;Ukraine;United States
      2021   Phase 2   EUCTR2020-005232-30-DE   Australia;Belarus;Bulgaria;Czech Republic;Czechia;Estonia;France;Georgia;Germany;Hungary;Italy;Japan;Korea, Republic of;Moldova, Republic of;New Zealand;Poland;Russian Federation;Serbia;Slovakia;Taiwan;Ukraine;United States
      2021   Phase 2   EUCTR2020-005232-30-CZ   Australia;Belarus;Bulgaria;Czech Republic;Czechia;Estonia;Georgia;Germany;Hungary;Italy;Japan;Korea, Republic of;Moldova, Republic of;Poland;Russian Federation;Serbia;Slovakia;Taiwan;Ukraine;United States
      2021   Phase 2   EUCTR2020-005232-30-BG   Australia;Belarus;Bulgaria;Czech Republic;Czechia;Estonia;Georgia;Germany;Hungary;Italy;Japan;Korea, Republic of;Moldova, Republic of;Poland;Russian Federation;Serbia;Slovakia;Taiwan;Ukraine;United States
Amitriptyline hydrochloride
   University of Leeds
      2020   Phase 2;Phase 3   EUCTR2019-003220-21-GB   United Kingdom
Amoxicillin
   Division of General Medicine, Department of Internal Medicine, Nihon University School of Medicine
      2013   Phase 3   JPRN-UMIN000009811   Japan
   Hokkaido University Hospital
      2016   -   JPRN-UMIN000024520   Japan
   Ishikawa Dai
      2017   -   JPRN-jRCTs031180415   -
   Japan UC Antibiotics-therapy Study Group(JUCASG)
      2003   Phase 2   JPRN-C000000078   Japan
   Juntendo University
      2008   -   JPRN-UMIN000048515   Japan
   Juntendo University Graduate School of Medicine
      2002   -   JPRN-UMIN000053277   Japan
   Juntendo university school of medicine Department of gastroenterology
      2017   -   JPRN-UMIN000025846   Japan
   Juntendo university school of medicine Department of gastroenterology
      2015   -   JPRN-UMIN000018642   Japan
      2014   -   JPRN-UMIN000014152   Japan
   Nagahara Akihito
      2023   Phase 2   JPRN-jRCTs031220542   -
   National Center for Child Health and Development
      2016   -   JPRN-UMIN000026485   Japan
   Shiga University of Medical Science
      2015   -   JPRN-UMIN000017844   Japan
Amoxicillin and doxycyclin
   Wolfson Medical Center
      2019   Phase 2   NCT03986996   Israel
Amoxicillin, metronidazole and doxycycline
   Wolfson Medical Center
      2019   Phase 2   NCT03986996   Israel
AMT-101
   Applied Molecular Transport
      2021   Phase 2   NCT05372939   Georgia;Netherlands;Poland;Ukraine
      2020   Phase 2   NCT04583358   Belarus;Bulgaria;Canada;France;Georgia;Germany;Hungary;Moldova, Republic of;Poland;Russian Federation;Switzerland;Ukraine;United Kingdom;United States
      2019   Phase 1   NCT04224857   Georgia;Germany;Moldova, Republic of;Ukraine
   Applied Molecular Transport Inc.
      2021   Phase 2   EUCTR2020-002833-13-PL   Georgia;Netherlands;Poland;Ukraine
      2021   Phase 2   EUCTR2020-002833-13-NL   Georgia;Netherlands;Poland;Ukraine
      2021   Phase 2   EUCTR2020-000047-31-PL   Belarus;Bulgaria;Canada;France;Georgia;Germany;Hungary;India;Italy;Kazakhstan;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Switzerland;Ukraine;United Kingdom;United States
      2021   Phase 2   EUCTR2020-000047-31-IT   Belarus;Belgium;Bulgaria;Canada;France;Georgia;Germany;Hungary;India;Italy;Kazakhstan;Moldova, Republic of;Netherlands;Poland;Romania;Russian Federation;Serbia;Spain;Switzerland;Ukraine;United Kingdom;United States
      2021   Phase 2   EUCTR2020-000047-31-DE   Belarus;Belgium;Bulgaria;Canada;France;Georgia;Germany;Hungary;India;Italy;Kazakhstan;Moldova, Republic of;Netherlands;Poland;Romania;Russian Federation;Serbia;Switzerland;Ukraine;United Kingdom;United States
      2020   Phase 2   EUCTR2020-000047-31-HU   Belarus;Belgium;Bulgaria;Canada;France;Georgia;Germany;Hungary;India;Italy;Kazakhstan;Moldova, Republic of;Netherlands;Poland;Romania;Russian Federation;Serbia;Spain;Switzerland;Ukraine;United Kingdom;United States
      2020   Phase 2   EUCTR2020-000047-31-GB   Belarus;Bulgaria;Canada;France;Georgia;Germany;Hungary;India;Italy;Kazakhstan;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Spain;Switzerland;Ukraine;United Kingdom;United States
      2020   Phase 2   EUCTR2020-000047-31-FR   Belarus;Belgium;Bulgaria;Canada;Czech Republic;France;Georgia;Germany;Hungary;India;Italy;Kazakhstan;Moldova, Republic of;Netherlands;Poland;Romania;Russian Federation;Serbia;Spain;Switzerland;Ukraine;United Kingdom;United States
      2020   Phase 2   EUCTR2020-000047-31-BG   Belarus;Belgium;Bulgaria;Canada;France;Georgia;Germany;Hungary;India;Italy;Kazakhstan;Moldova, Republic of;Netherlands;Poland;Romania;Russian Federation;Serbia;Switzerland;Ukraine;United Kingdom;United States
Anakinra
   Cambridge University Hospitals NHS Foundation Trust & University of Cambridge
      2017   Phase 2   EUCTR2017-001389-10-GB   United Kingdom
Andecaliximab
   Gilead Sciences
      2015   Phase 2/Phase 3   NCT02520284   Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;France;Germany;Hong Kong;Hungary;Iceland;Ireland;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
Andosan
   Oslo University Hospital
      2011   Phase 2/Phase 3   NCT01496053   Norway
   Ullevaal University Hospital
      2009   Phase 2   NCT01106742   Norway
Andrographis paniculata
   Hutchison MediPharma Enterprises Limited
      2008   -   EUCTR2007-005166-12-DE   Germany
   Nutrition Science Partners Limited
      2014   -   EUCTR2013-003060-31-PL   Bulgaria;Czech Republic;Hungary;Latvia;Lithuania;Poland;Ukraine;United States
      2014   -   EUCTR2013-003060-31-LV   Bulgaria;Czech Republic;Hungary;Latvia;Lithuania;Poland;Ukraine;United States
      2014   -   EUCTR2013-003060-31-LT   Bulgaria;Czech Republic;Hungary;Latvia;Lithuania;Poland;Ukraine;United States
      2014   -   EUCTR2013-003060-31-HU   Bulgaria;Czech Republic;Hungary;Latvia;Lithuania;Poland;Ukraine;United States
      2014   -   EUCTR2013-003060-31-CZ   Bulgaria;Czech Republic;Hungary;Latvia;Lithuania;Poland;Ukraine;United States
      2014   -   EUCTR2013-003060-31-BG   Bulgaria;Czech Republic;Hungary;Latvia;Lithuania;Poland;Ukraine;United States
      2013   -   EUCTR2013-002116-27-LV   Bulgaria;Czech Republic;Hungary;Korea, Republic of;Latvia;Lithuania;Poland;Ukraine;United States
      2013   -   EUCTR2013-002116-27-LT   Bulgaria;Czech Republic;Hungary;Korea, Republic of;Latvia;Lithuania;Poland;Ukraine;United States
      2013   -   EUCTR2013-002116-27-HU   Bulgaria;Czech Republic;Hungary;Korea, Republic of;Latvia;Lithuania;Poland;Ukraine;United States
      2013   Phase 3   EUCTR2013-002116-27-CZ   Bulgaria;Czech Republic;Hungary;Korea, Republic of;Latvia;Lithuania;Poland;Ukraine;United States
      2013   -   EUCTR2013-002116-27-BG   Bulgaria;Czech Republic;Hungary;Latvia;Lithuania;Poland;Ukraine;United States
Andrographolide
   Nutrition Science Partners Limited
      2014   -   EUCTR2013-003060-31-PL   Bulgaria;Czech Republic;Hungary;Latvia;Lithuania;Poland;Ukraine;United States
      2014   -   EUCTR2013-003060-31-LV   Bulgaria;Czech Republic;Hungary;Latvia;Lithuania;Poland;Ukraine;United States
      2014   -   EUCTR2013-003060-31-LT   Bulgaria;Czech Republic;Hungary;Latvia;Lithuania;Poland;Ukraine;United States
      2014   -   EUCTR2013-003060-31-HU   Bulgaria;Czech Republic;Hungary;Latvia;Lithuania;Poland;Ukraine;United States
      2014   -   EUCTR2013-003060-31-CZ   Bulgaria;Czech Republic;Hungary;Latvia;Lithuania;Poland;Ukraine;United States
      2014   -   EUCTR2013-003060-31-BG   Bulgaria;Czech Republic;Hungary;Latvia;Lithuania;Poland;Ukraine;United States
      2013   -   EUCTR2013-002116-27-LV   Bulgaria;Czech Republic;Hungary;Korea, Republic of;Latvia;Lithuania;Poland;Ukraine;United States
      2013   -   EUCTR2013-002116-27-LT   Bulgaria;Czech Republic;Hungary;Korea, Republic of;Latvia;Lithuania;Poland;Ukraine;United States
      2013   -   EUCTR2013-002116-27-HU   Bulgaria;Czech Republic;Hungary;Korea, Republic of;Latvia;Lithuania;Poland;Ukraine;United States
      2013   Phase 3   EUCTR2013-002116-27-CZ   Bulgaria;Czech Republic;Hungary;Korea, Republic of;Latvia;Lithuania;Poland;Ukraine;United States
      2013   -   EUCTR2013-002116-27-BG   Bulgaria;Czech Republic;Hungary;Latvia;Lithuania;Poland;Ukraine;United States
Anhidrous sodium sulfate
   IPSEN PHARMA SAS
      2017   Phase 3   EUCTR2016-002265-60-IT   Czech Republic;Czechia;France;Germany;Italy;Netherlands;Poland
Anhydrous sodium sulfate
   Ipsen Pharma
      2017   Phase 3   EUCTR2016-002265-60-NL   Czech Republic;France;Germany;Italy;Netherlands;Poland
      2017   Phase 3   EUCTR2016-002265-60-DE   Czech Republic;France;Germany;Italy;Netherlands;Poland
      2017   Phase 3   EUCTR2016-002265-60-CZ   Czech Republic;France;Germany;Italy;Netherlands;Poland
      -   Phase 3   EUCTR2016-002265-60-PL   Czech Republic;France;Germany;Italy;Netherlands;Poland
Anrukinzumab
   Pfizer
      2011   Phase 2   NCT01284062   Austria;Belgium;Bulgaria;Canada;France;Germany;Hungary;Netherlands;Poland;Romania;Spain;United States
Anti BETA7
   F. Hoffmann-La Roche Ltd
      2020   Phase 3   EUCTR2019-004652-11-SI   Argentina;Austria;Belgium;Brazil;Canada;Czech Republic;France;Germany;Hungary;Ireland;Israel;Italy;Latvia;Netherlands;Poland;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
   Genentech, Inc.
      2012   Phase 2   EUCTR2011-003409-36-CZ   Australia;Belgium;Canada;Czech Republic;Germany;Hungary;Israel;New Zealand;Spain;United Kingdom;United States
      2011   Phase 2   EUCTR2011-003409-36-GB   Australia;Belgium;Canada;Czech Republic;Germany;Hungary;Israel;New Zealand;Spain;United Kingdom;United States
Anti CD3 monoclonal antibody
   PDL BioPharma, Inc
      2006   -   EUCTR2005-004105-28-NL   France;Germany;Greece;Hungary;Ireland;Netherlands;United Kingdom
   PDL BioPharma, Inc.
      2007   -   EUCTR2005-004105-28-GR   France;Germany;Greece;Hungary;Ireland;Netherlands;United Kingdom
      2007   -   EUCTR2005-004105-28-FR   France;Germany;Greece;Hungary;Ireland;Netherlands;United Kingdom
      2006   Phase 2   EUCTR2005-004105-28-IE   France;Germany;Greece;Hungary;Ireland;Netherlands;United Kingdom
      2006   -   EUCTR2005-004105-28-GB   France;Germany;Greece;Hungary;Ireland;Netherlands;United Kingdom
      2006   -   EUCTR2005-004105-28-DE   France;Germany;Greece;Hungary;Ireland;Netherlands;United Kingdom
Anti TNF therapy including infliximab
   Janssen Biotech, Inc.
      2007   -   NCT00606346   Canada;United States
ANTI-CD3 monoclonal antibody
   PDL BioPharma, Inc
      2007   -   EUCTR2005-003707-37-BE   Austria;Belgium
      2007   -   EUCTR2005-003707-37-AT   Austria;Belgium
      2006   Phase 2   EUCTR2005-003481-42-IE   Austria;Czech Republic;Germany;Greece;Hungary;Ireland;Slovakia;Spain
      2006   -   EUCTR2005-003481-42-ES   Czech Republic;Germany;Greece;Hungary;Ireland;Italy;Slovakia;Spain
      2006   Phase 2;Phase 3   EUCTR2005-002063-87-SK   Austria;Belgium;Czech Republic;Germany;Hungary;Slovakia
      2006   -   EUCTR2005-002063-87-DE   Belgium;Czech Republic;Germany;Hungary
   PDL BioPharma, Inc.
      2007   Phase 2   EUCTR2005-003482-17-GR   Greece;Ireland;Italy;Spain;United Kingdom
      2007   -   EUCTR2005-003482-17-GB   Greece;Ireland;Italy;Spain;United Kingdom
      2007   -   EUCTR2005-003481-42-GR   Czech Republic;Germany;Greece;Hungary;Ireland;Italy;Slovakia;Spain
      2006   Phase 2   EUCTR2005-003482-17-IE   Greece;Ireland;Italy;Spain;United Kingdom
      2006   -   EUCTR2005-003482-17-ES   Greece;Ireland;Italy;Spain;United Kingdom
      2006   -   EUCTR2005-003481-42-HU   Czech Republic;Germany;Greece;Hungary;Ireland;Italy;Slovakia;Spain
      2006   -   EUCTR2005-003481-42-DE   Czech Republic;Germany;Greece;Hungary;Ireland;Italy;Slovakia;Spain
      2006   Phase 2   EUCTR2005-003481-42-CZ   Austria;Czech Republic;Germany;Greece;Hungary;Ireland;Slovakia;Spain
      2006   Phase 2;Phase 3   EUCTR2005-002063-87-CZ   Austria;Belgium;Czech Republic;Germany;Hungary;Slovakia
   Protein Design Labs, Inc
      2006   Phase 2   EUCTR2005-003481-42-SK   Austria;Czech Republic;Germany;Greece;Hungary;Ireland;Slovakia;Spain
      2006   -   EUCTR2005-003481-42-AT   Austria;Czech Republic;Germany;Greece;Hungary;Ireland;Slovakia;Spain
   Protein Design Labs, Inc.
      2006   -   EUCTR2005-002063-87-HU   Belgium;Czech Republic;Germany;Hungary
      2006   -   EUCTR2005-002063-87-BE   Belgium;Czech Republic;Germany;Hungary
      2005   -   EUCTR2005-002063-87-AT   Austria;Belgium;Czech Republic;Germany;Hungary
ANTI-interleukin-23 immunoglobulin G2 (IGG2) human monoclonal antibody
   ALLERGAN LIMITED
      2019   Phase 2   EUCTR2018-001605-93-IT   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Colombia;Czech Republic;Czechia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Poland;Romania;Russian Federation;Singapore;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States
   ASTRAZENECA AB
      2021   Phase 2   EUCTR2021-001644-10-IT   Austria;Canada;Czechia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Poland;Russian Federation;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
   Allergan Ltd.
      2019   Phase 2   EUCTR2018-001605-93-RO   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Colombia;Czech Republic;Czechia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Poland;Romania;Russian Federation;Singapore;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States
      2019   Phase 2   EUCTR2018-001605-93-ES   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Colombia;Czech Republic;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Poland;Romania;Russian Federation;Singapore;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States
      2019   Phase 2   EUCTR2018-001605-93-BG   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Colombia;Czech Republic;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Poland;Romania;Russian Federation;Singapore;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States
   AstraZeneca AB
      2022   Phase 2   EUCTR2021-001644-10-HU   Austria;Canada;Czechia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Poland;Russian Federation;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2022   Phase 2   EUCTR2021-001644-10-FR   Austria;Canada;Czechia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Poland;Russian Federation;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2022   Phase 2   EUCTR2021-001644-10-DE   Austria;Canada;Czechia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Poland;Russian Federation;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2022   Phase 2   EUCTR2018-001605-93-FR   Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2021   Phase 2   EUCTR2021-001644-10-PL   Austria;Canada;Czechia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Poland;Russian Federation;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2021   Phase 2   EUCTR2021-001644-10-ES   Austria;Canada;Czechia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Poland;Russian Federation;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2021   Phase 2   EUCTR2021-001644-10-AT   Austria;Canada;Czechia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Poland;Russian Federation;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2021   Phase 2   EUCTR2018-001605-93-HU   Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Poland;Romania;Russian Federation;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2020   Phase 2   EUCTR2018-001605-93-DE   Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Poland;Romania;Russian Federation;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2020   Phase 2   EUCTR2018-001605-93-AT   Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Poland;Romania;Russian Federation;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2019   Phase 2   EUCTR2018-001605-93-GB   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Colombia;Czech Republic;Czechia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Poland;Romania;Russian Federation;Singapore;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States
      2019   Phase 2   EUCTR2018-001605-93-CZ   Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Poland;Romania;Russian Federation;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2019   Phase 2   EUCTR2018-001605-93-BE   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Colombia;Czech Republic;Czechia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Poland;Romania;Russian Federation;Singapore;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States
ANTI-IP-10 antibody
   Bristol-Myers Squibb
      2011   Phase 2   NCT01294410   Australia;Austria;Belgium;Brazil;Canada;France;Germany;Hungary;Italy;Mexico;Netherlands;Poland;South Africa;United States
ANTI-madcam antibody
   Baxalta Innovations GmbH
      2018   Phase 3   EUCTR2017-000573-37-BE   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Ukraine;United Kingdom;United States
   Pfizer Inc, 235 East 42nd Street, New York, NY10017, United States
      2014   -   EUCTR2012-002030-37-HR   Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Norway;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;United Kingdom;United States
      2013   Phase 2   EUCTR2012-002031-28-SE   Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Norway;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;United Kingdom;United States
      2013   Phase 2   EUCTR2012-002031-28-IT   Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Norway;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;United Kingdom;United States
      2013   Phase 2   EUCTR2012-002031-28-HU   Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Norway;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;United Kingdom;United States
      2013   Phase 2   EUCTR2012-002031-28-ES   Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Norway;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;United Kingdom;United States
      2013   -   EUCTR2012-002030-37-SK   Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Norway;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;United Kingdom;United States
      2013   -   EUCTR2012-002030-37-SE   Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Norway;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;United Kingdom;United States
      2013   -   EUCTR2012-002030-37-PL   Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Norway;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;United Kingdom;United States
      2013   -   EUCTR2012-002030-37-NL   Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Norway;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;United Kingdom;United States
      2013   -   EUCTR2012-002030-37-IT   Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Norway;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;United Kingdom;United States
      2013   -   EUCTR2012-002030-37-HU   Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Norway;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;United Kingdom;United States
      2013   -   EUCTR2012-002030-37-ES   Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Norway;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;United Kingdom;United States
      2013   Phase 2   EUCTR2012-002030-37-DE   Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Norway;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;United Kingdom;United States
      2013   Phase 2   EUCTR2012-002030-37-CZ   Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Norway;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;United Kingdom;United States
      2013   Phase 2   EUCTR2012-002030-37-BG   Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Norway;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;United Kingdom;United States
      2013   Phase 2   EUCTR2012-002030-37-AT   Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Norway;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;United Kingdom;United States
   Pfizer Inc.
      2013   Phase 2   EUCTR2012-002030-37-BE   Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;United Kingdom
   Shire Human Genetic Therapie, Inc.
      2013   Phase 2   EUCTR2012-002031-28-BG   Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Norway;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;United Kingdom;United States
   Shire Human Genetic Therapies, Inc.
      2019   Phase 3   EUCTR2017-000574-11-RO   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2017-000574-11-GR   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-000574-11-ES   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-000573-37-ES   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-000572-28-FR   Argentina;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Colombia;France;Greece;Hungary;Ireland;Japan;Korea, Republic of;Mexico;Portugal;Slovakia;Spain;Switzerland;Ukraine;United States
      2018   Phase 3   EUCTR2017-000572-28-ES   Argentina;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Colombia;France;Greece;Hungary;Ireland;Japan;Korea, Republic of;Mexico;Portugal;Slovakia;Spain;Switzerland;Ukraine;United States
      2017   Phase 3   EUCTR2017-000573-37-GR   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2017-000572-28-GR   Argentina;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Colombia;France;Greece;Hungary;Ireland;Japan;Korea, Republic of;Mexico;Portugal;Slovakia;Spain;Switzerland;Ukraine;United States
      2013   Phase 2   EUCTR2012-002031-28-SK   Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Norway;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;United Kingdom;United States
      2013   Phase 2   EUCTR2012-002031-28-PL   Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Norway;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;United Kingdom;United States
      2013   Phase 2   EUCTR2012-002031-28-NL   Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Norway;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;United Kingdom;United States
      2013   Phase 2   EUCTR2012-002031-28-DE   Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Norway;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;United Kingdom;United States
      2013   Phase 2   EUCTR2012-002031-28-CZ   Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Norway;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;United Kingdom;United States
      2013   Phase 2   EUCTR2012-002031-28-BE   Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Norway;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;United Kingdom;United States
      2013   Phase 2   EUCTR2012-002031-28-AT   Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Norway;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;United Kingdom;United States
ANTI-TL1A
   Pfizer Inc
      2021   Phase 2   EUCTR2019-002698-74-RO   Australia;Austria;Belgium;Bulgaria;Canada;China;France;Germany;Hungary;India;Italy;Japan;Mexico;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Turkey;Ukraine;United Kingdom;United States
      2020   Phase 2   EUCTR2019-002698-74-SK   Australia;Austria;Belgium;Bulgaria;Canada;China;Colombia;France;Germany;Hungary;India;Italy;Japan;Mexico;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Thailand;Turkey;Ukraine;United Kingdom;United States
      2020   Phase 2   EUCTR2019-002698-74-PL   Australia;Austria;Belgium;Bulgaria;Canada;China;Colombia;France;Germany;Hungary;India;Italy;Japan;Mexico;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Thailand;Turkey;Ukraine;United Kingdom;United States
      2020   Phase 2   EUCTR2019-002698-74-HU   Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;France;Germany;Hungary;India;Israel;Italy;Japan;Mexico;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United States
      2020   Phase 2   EUCTR2019-002698-74-GB   Australia;Austria;Belgium;Bulgaria;Canada;China;France;Germany;Hungary;India;Italy;Japan;Mexico;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Turkey;Ukraine;United Kingdom;United States
      2020   Phase 2   EUCTR2019-002698-74-FR   Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;France;Germany;Hungary;India;Israel;Italy;Japan;Mexico;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States
      2020   Phase 2   EUCTR2019-002698-74-ES   Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;France;Germany;Hungary;India;Israel;Italy;Japan;Mexico;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States
      2020   Phase 2   EUCTR2019-002698-74-DE   Australia;Austria;Belgium;Bulgaria;Canada;China;Colombia;France;Germany;Hungary;India;Italy;Japan;Mexico;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Thailand;Turkey;Ukraine;United Kingdom;United States
      2020   Phase 2   EUCTR2019-002698-74-BG   Australia;Austria;Belgium;Bulgaria;Canada;China;France;Germany;Hungary;India;Italy;Japan;Mexico;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Turkey;Ukraine;United Kingdom;United States
      2020   Phase 2   EUCTR2019-002698-74-BE   Australia;Austria;Belgium;Bulgaria;Canada;China;France;Germany;Hungary;India;Italy;Japan;Mexico;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Turkey;Ukraine;United Kingdom;United States
      2020   Phase 2   EUCTR2019-002698-74-AT   Australia;Austria;Belgium;Bulgaria;Canada;China;France;Germany;Hungary;India;Italy;Japan;Mexico;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Turkey;Ukraine;United Kingdom;United States
ANTI-TNF discontinuation: physiological saline solution
   Fundación de Investigación Biomédica - Hospital Universitario de La Princesa
      2017   Phase 4   NCT02994836   Spain
ANTI-TNF drug
   HaEmek Medical Center, Israel
      2009   -   NCT03747068   -
ANTI-TNF therapy
   Takeda
      2017   -   NCT03090139   Argentina;China;Colombia;Korea, Republic of;Mexico;Russian Federation;Saudi Arabia;Singapore;Taiwan;Turkey
ANTI-tumor necrosis factor alpha agents
   El-Hussuna, Alaa, M.D.
      2014   -   NCT01974869   Denmark
Antibiotic cocktail
   Prof. Arie Levine
      2015   Phase 4   NCT02345733   Canada;Israel;United States
      2014   -   NCT02217722   Israel
Antibiotics
   Ishikawa Dai
      2017   -   JPRN-jRCTs031180415   -
   Juntendo university school of medicine Department of gastroenterology
      2017   -   JPRN-UMIN000025846   Japan
   Juntendo university school of medicine Department of gastroenterology
      2015   -   JPRN-UMIN000018642   Japan
      2014   -   JPRN-UMIN000014152   Japan
   Nagahara Akihito
      2023   Phase 2   JPRN-jRCTs031220542   -
   Shaare Zedek Medical Center
      2014   -   NCT02033408   Canada;Finland;Israel;Italy;Poland;Spain
Antibodies TO golimumab
   Hospital San Carlos, Madrid
      2019   -   NCT03773445   Spain
Antigeno superficie hepatitis B
   Hospital Universitario La Princesa
      2011   Phase 3   EUCTR2010-023947-14-ES   Spain
Antioxidant diet
   Università Politecnica delle Marche
      2019   -   NCT04513015   Italy
Anxiety/depression questionnaires
   Connecticut Children's Medical Center
      2015   -   NCT02984059   United States
APD334
   Arena Pharmaceuticals
      2017   Phase 2   NCT03139032   Belgium;Germany;Serbia
   Arena Pharmaceuticals Inc.
      2020   Phase 3   EUCTR2018-003987-29-FR   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
   Arena Pharmaceuticals, Inc.
      2017   Phase 2   EUCTR2016-003797-40-DE   Belgium;Germany;United States
      2017   Phase 2   EUCTR2016-003797-40-BE   Belgium;Germany;United States
      2017   Phase 2   EUCTR2015-001942-28-FR   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;France;Germany;Hungary;Israel;Latvia;Lithuania;New Zealand;Poland;Romania;Russian Federation;Spain;Ukraine;United Kingdom;United States
      2017   Phase 2   EUCTR2015-001942-28-DE   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;France;Germany;Hungary;Israel;Latvia;Lithuania;New Zealand;Poland;Romania;Spain;Ukraine;United Kingdom;United States
      2016   Phase 2   EUCTR2015-002109-12-LV   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;France;Germany;Hungary;Israel;Latvia;Lithuania;New Zealand;Poland;Romania;Russian Federation;Spain;Ukraine;United Kingdom;United States
      2016   Phase 2   EUCTR2015-002109-12-LT   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;France;Germany;Hungary;Israel;Latvia;Lithuania;New Zealand;Poland;Romania;Russian Federation;Spain;Ukraine;United Kingdom;United States
      2016   Phase 2   EUCTR2015-002109-12-HU   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;France;Germany;Hungary;Israel;Latvia;Lithuania;New Zealand;Poland;Romania;Spain;Ukraine;United Kingdom;United States
      2016   Phase 2   EUCTR2015-002109-12-GB   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;France;Germany;Hungary;Israel;Latvia;Lithuania;New Zealand;Poland;Romania;Russian Federation;Spain;Ukraine;United Kingdom;United States
      2016   Phase 2   EUCTR2015-002109-12-ES   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;France;Germany;Hungary;Israel;Latvia;Lithuania;New Zealand;Poland;Romania;Russian Federation;Spain;Ukraine;United Kingdom;United States
      2016   Phase 2   EUCTR2015-002109-12-CZ   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;France;Germany;Hungary;Israel;Latvia;Lithuania;New Zealand;Poland;Romania;Russian Federation;Spain;Ukraine;United Kingdom;United States
      2016   Phase 2   EUCTR2015-002109-12-BG   Austria;Belgium;Bulgaria;Canada;Czech Republic;Germany;Hungary;Korea, Republic of;Latvia;Lithuania;Poland;Romania;Russian Federation;Spain;Ukraine;United Kingdom;United States
      2016   Phase 2   EUCTR2015-002109-12-BE   Austria;Belgium;Bulgaria;Canada;Czech Republic;Germany;Hungary;Latvia;Lithuania;Poland;Romania;Russian Federation;Spain;Ukraine;United Kingdom;United States
      2016   Phase 2   EUCTR2015-002109-12-AT   Austria;Belgium;Bulgaria;Canada;Czech Republic;Germany;Hungary;Latvia;Lithuania;Poland;Romania;Russian Federation;Spain;Ukraine;United Kingdom;United States
      2016   Phase 2   EUCTR2015-001942-28-PL   Austria;Belgium;Bulgaria;Canada;Czech Republic;France;Germany;Hungary;Korea, Republic of;Latvia;Lithuania;Poland;Romania;Russian Federation;Spain;Ukraine;United Kingdom;United States
      2016   Phase 2   EUCTR2015-001942-28-GB   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;France;Germany;Hungary;Israel;Latvia;Lithuania;New Zealand;Poland;Romania;Russian Federation;Spain;Ukraine;United Kingdom;United States
      2016   Phase 2   EUCTR2015-001942-28-BE   Austria;Belgium;Bulgaria;Canada;Czech Republic;France;Germany;Hungary;Latvia;Lithuania;Poland;Romania;Russian Federation;Spain;Ukraine;United Kingdom;United States
      2016   Phase 2   EUCTR2015-001942-28-AT   Austria;Belgium;Bulgaria;Canada;Czech Republic;France;Germany;Hungary;Latvia;Lithuania;Poland;Romania;Russian Federation;Spain;Ukraine;United Kingdom;United States
      2015   Phase 2   EUCTR2015-001942-28-LT   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;France;Germany;Hungary;Israel;Korea, Republic of;Latvia;Lithuania;New Zealand;Poland;Romania;Russian Federation;Spain;Ukraine;United Kingdom;United States
      2015   Phase 2   EUCTR2015-001942-28-ES   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;France;Germany;Hungary;Israel;Latvia;Lithuania;New Zealand;Poland;Romania;Russian Federation;Spain;Ukraine;United Kingdom;United States
      2015   Phase 2   EUCTR2015-001942-28-CZ   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;France;Germany;Hungary;Israel;Latvia;Lithuania;New Zealand;Poland;Romania;Spain;Ukraine;United Kingdom;United States
   IQVIA Services Japan K.K. ICCC:
      2020   Phase 3   JPRN-jRCT2071200080   -
   Kawai Norisuke
      2024   Phase 2   JPRN-jRCT2031230586   Austria;Japan;Poland;Spain;United States
APD334 L-arginine
   ARENA PHARMACEUTICALS, INC.
      2021   Phase 2   EUCTR2020-003507-34-IT   Australia;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Moldova, Republic of;Netherlands;Poland;Portugal;Russian Federation;South Africa;Spain;United States
      2019   Phase 3   EUCTR2018-003987-29-IT   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2018-003986-33-IT   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Korea, Democratic People's Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2018-003985-15-IT   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
   Arena Pharmaceuticals Inc.
      2021   Phase 3   EUCTR2018-003987-29-RO   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
      2020   Phase 3   EUCTR2018-003987-29-AT   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
      2020   Phase 3   EUCTR2018-003985-15-FR   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
      2020   Phase 3   EUCTR2018-003985-15-AT   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2018-003987-29-NL   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2018-003987-29-LV   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2018-003987-29-HU   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Thailand;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2018-003987-29-HR   Australia;Austria;Belarus;Belgium;Bulgaria;Canada;China;Croatia;Czech Republic;Denmark;Estonia;France;Georgia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2018-003987-29-ES   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2018-003987-29-DK   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2018-003986-33-SK   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2018-003985-15-SK   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2018-003985-15-RO   Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Georgia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2018-003985-15-PT   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2018-003985-15-NL   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2018-003985-15-LV   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2018-003985-15-LT   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2018-003985-15-HU   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2018-003985-15-HR   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2018-003985-15-ES   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2018-003985-15-EE   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2018-003985-15-DK   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2018-003985-15-CZ   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2018-003985-15-BG   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
      -   Phase 3   EUCTR2018-003987-29-PL   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
      -   Phase 3   EUCTR2018-003985-15-PL   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
      -   Phase 3   EUCTR2018-003985-15-DE   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
      -   Phase 3   EUCTR2018-003985-15-BE   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
   Arena Pharmaceuticals Inc. a wholly owned subsidiary of Pfizer Inc.
      2019   Phase 3   EUCTR2018-003987-29-CZ   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Thailand;Türkiye;Ukraine;United Kingdom;United States
   Arena Pharmaceuticals Inc. a wholly owned subsidiary of Pfizer Inc.
      2020   Phase 3   EUCTR2018-003987-29-PT   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Thailand;Türkiye;Ukraine;United Kingdom;United States
   Arena Pharmaceuticals Inc. a wholly owned subsidiary of Pfizer Inc.
      2020   Phase 3   EUCTR2018-003987-29-DE   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Thailand;Türkiye;Ukraine;United Kingdom;United States
      2020   Phase 3   EUCTR2018-003987-29-BG   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Thailand;Türkiye;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2018-003987-29-SK   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Thailand;Türkiye;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2018-003987-29-LT   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Thailand;Türkiye;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2018-003987-29-BE   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Thailand;Türkiye;Ukraine;United Kingdom;United States
      -   Phase 3   EUCTR2018-003987-29-EE   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Thailand;Turkey;Ukraine;United Kingdom;United States
   Arena Pharmaceuticals, Inc.
      2021   Phase 2   EUCTR2020-003507-34-PT   Australia;Belarus;Belgium;Bulgaria;Czech Republic;Czechia;France;Georgia;Germany;Hungary;Israel;Italy;Korea, Republic of;Poland;Portugal;Russian Federation;Spain;United States
      2021   Phase 2   EUCTR2020-003507-34-HU   Australia;Belarus;Belgium;Bulgaria;Czech Republic;Czechia;France;Georgia;Germany;Hungary;Israel;Italy;Korea, Republic of;Poland;Portugal;Russian Federation;Spain;United States
      2021   Phase 2   EUCTR2020-003507-34-FR   Australia;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Moldova, Republic of;Netherlands;Poland;Portugal;Russian Federation;South Africa;Spain;United States
      2021   Phase 2   EUCTR2020-003507-34-CZ   Australia;Belarus;Belgium;Bulgaria;Czech Republic;Czechia;France;Georgia;Germany;Hungary;Israel;Italy;Korea, Republic of;Poland;Portugal;Russian Federation;Spain;United States
      2021   Phase 2   EUCTR2020-003507-34-BG   Australia;Belarus;Belgium;Bulgaria;Czech Republic;Czechia;France;Georgia;Germany;Hungary;Israel;Italy;Korea, Republic of;Poland;Portugal;Russian Federation;Spain;Ukraine;United States
      2021   Phase 2   EUCTR2020-003507-34-BE   Australia;Belarus;Belgium;Bulgaria;Czech Republic;Czechia;France;Georgia;Germany;Hungary;Israel;Italy;Korea, Republic of;Poland;Portugal;Russian Federation;Spain;Ukraine;United States
      2020   Phase 3   EUCTR2018-003986-33-PT   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Thailand;Turkey;Ukraine;United Kingdom;United States
      2020   Phase 3   EUCTR2018-003986-33-LV   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
      2020   Phase 3   EUCTR2018-003986-33-GB   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
      2020   Phase 3   EUCTR2018-003986-33-FR   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
      2020   Phase 3   EUCTR2018-003986-33-ES   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
      2020   Phase 3   EUCTR2018-003986-33-DK   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Thailand;Turkey;Ukraine;United Kingdom;United States
      2020   Phase 3   EUCTR2018-003986-33-BG   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
      2020   Phase 3   EUCTR2018-003986-33-AT   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Thailand;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2018-003986-33-NL   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Thailand;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2018-003986-33-LT   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Thailand;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2018-003986-33-HU   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2018-003986-33-HR   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2018-003986-33-BE   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
      -   Phase 3   EUCTR2018-003986-33-PL   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
      -   Phase 3   EUCTR2018-003986-33-EE   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
      -   Phase 3   EUCTR2018-003986-33-DE   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Thailand;Turkey;Ukraine;United Kingdom;United States
      -   Phase 3   EUCTR2018-003986-33-CZ   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Thailand;Turkey;Ukraine;United Kingdom;United States
Apigenin
   Nutrition Science Partners Limited
      2014   -   EUCTR2013-003060-31-PL   Bulgaria;Czech Republic;Hungary;Latvia;Lithuania;Poland;Ukraine;United States
      2014   -   EUCTR2013-003060-31-LV   Bulgaria;Czech Republic;Hungary;Latvia;Lithuania;Poland;Ukraine;United States
      2014   -   EUCTR2013-003060-31-LT   Bulgaria;Czech Republic;Hungary;Latvia;Lithuania;Poland;Ukraine;United States
      2014   -   EUCTR2013-003060-31-HU   Bulgaria;Czech Republic;Hungary;Latvia;Lithuania;Poland;Ukraine;United States
      2014   -   EUCTR2013-003060-31-CZ   Bulgaria;Czech Republic;Hungary;Latvia;Lithuania;Poland;Ukraine;United States
      2014   -   EUCTR2013-003060-31-BG   Bulgaria;Czech Republic;Hungary;Latvia;Lithuania;Poland;Ukraine;United States
      2013   -   EUCTR2013-002116-27-LV   Bulgaria;Czech Republic;Hungary;Korea, Republic of;Latvia;Lithuania;Poland;Ukraine;United States
      2013   -   EUCTR2013-002116-27-LT   Bulgaria;Czech Republic;Hungary;Korea, Republic of;Latvia;Lithuania;Poland;Ukraine;United States
      2013   -   EUCTR2013-002116-27-HU   Bulgaria;Czech Republic;Hungary;Korea, Republic of;Latvia;Lithuania;Poland;Ukraine;United States
      2013   Phase 3   EUCTR2013-002116-27-CZ   Bulgaria;Czech Republic;Hungary;Korea, Republic of;Latvia;Lithuania;Poland;Ukraine;United States
      2013   -   EUCTR2013-002116-27-BG   Bulgaria;Czech Republic;Hungary;Latvia;Lithuania;Poland;Ukraine;United States
Apixaban 2.5 milligram
   McMaster University
      2021   Early Phase 1   NCT03935451   Canada
APL-1401
   Jiangsu Yahong Meditech Co., Ltd aka Asieris
      2023   Phase 1   NCT05743010   United States
Appendectomy
   Federico II University
      2023   -   NCT05931458   -
Apremilast
   Amgen
      2015   Phase 2   NCT02289417   Australia;Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Netherlands;New Zealand;Poland;Russian Federation;Ukraine;United States
   CELGENE CORPORATION
      2015   Phase 2   EUCTR2014-002981-64-IT   Australia;Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Netherlands;New Zealand;Poland;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States
   Celgene Corporation
      2016   Phase 2   EUCTR2014-002981-64-BG   Australia;Bulgaria;Canada;Czech Republic;France;Germany;Hungary;Italy;Netherlands;New Zealand;Poland;Russian Federation;Slovakia;Ukraine;United States
      2015   Phase 2   EUCTR2014-002981-64-NL   Australia;Bulgaria;Canada;Czech Republic;France;Germany;Hungary;Italy;Netherlands;New Zealand;Poland;United Kingdom;United States
      2015   -   EUCTR2014-002981-64-HU   Australia;Bulgaria;Canada;Czech Republic;France;Germany;Hungary;Italy;Netherlands;New Zealand;Poland;Slovakia;Turkey;Ukraine;United Kingdom;United States
      2015   Phase 2   EUCTR2014-002981-64-DE   Australia;Bulgaria;Canada;Czech Republic;France;Germany;Hungary;Italy;Netherlands;New Zealand;Poland;Russian Federation;Slovakia;Ukraine;United States
      2015   Phase 2   EUCTR2014-002981-64-CZ   Australia;Bulgaria;Canada;Czech Republic;France;Germany;Hungary;Italy;Netherlands;New Zealand;Poland;Russian Federation;Slovakia;Ukraine;United States
Apriso 0.375G ER CAP
   Bausch Health Americas, Inc.
      2017   Phase 1   NCT03327558   United States
Apriso 375 MG extended-release capsules
   Bausch Health Americas, Inc.
      2017   Phase 1   NCT03327558   United States
APVO210
   Aptevo Therapeutics
      2019   Phase 1   NCT03768219   Australia
Aquamin
   James Varani
      2021   Phase 2   NCT04855799   United States
      2019   Phase 2   NCT03869905   United States
AR401959 L-arginine
   Arena Pharmaceuticals Inc.
      2021   Phase 3   EUCTR2018-003987-29-RO   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
      2020   Phase 3   EUCTR2018-003987-29-AT   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
      2020   Phase 3   EUCTR2018-003985-15-FR   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
      2020   Phase 3   EUCTR2018-003985-15-AT   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2018-003987-29-NL   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2018-003987-29-LV   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2018-003987-29-HR   Australia;Austria;Belarus;Belgium;Bulgaria;Canada;China;Croatia;Czech Republic;Denmark;Estonia;France;Georgia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2018-003987-29-ES   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2018-003987-29-DK   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2018-003986-33-SK   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2018-003985-15-SK   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2018-003985-15-RO   Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Georgia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2018-003985-15-PT   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2018-003985-15-NL   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2018-003985-15-LV   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2018-003985-15-LT   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2018-003985-15-HU   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2018-003985-15-HR   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2018-003985-15-ES   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2018-003985-15-EE   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2018-003985-15-DK   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2018-003985-15-CZ   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2018-003985-15-BG   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
      -   Phase 3   EUCTR2018-003987-29-PL   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
      -   Phase 3   EUCTR2018-003985-15-PL   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
      -   Phase 3   EUCTR2018-003985-15-DE   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
      -   Phase 3   EUCTR2018-003985-15-BE   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
   Arena Pharmaceuticals Inc. a wholly owned subsidiary of Pfizer Inc.
      2019   Phase 3   EUCTR2018-003987-29-CZ   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Thailand;Türkiye;Ukraine;United Kingdom;United States
   Arena Pharmaceuticals Inc. a wholly owned subsidiary of Pfizer Inc.
      2020   Phase 3   EUCTR2018-003987-29-DE   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Thailand;Türkiye;Ukraine;United Kingdom;United States
      2020   Phase 3   EUCTR2018-003987-29-BG   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Thailand;Türkiye;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2018-003987-29-LT   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Thailand;Türkiye;Ukraine;United Kingdom;United States
      -   Phase 3   EUCTR2018-003987-29-EE   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Thailand;Turkey;Ukraine;United Kingdom;United States
   Arena Pharmaceuticals, Inc.
      2021   Phase 2   EUCTR2020-003507-34-PT   Australia;Belarus;Belgium;Bulgaria;Czech Republic;Czechia;France;Georgia;Germany;Hungary;Israel;Italy;Korea, Republic of;Poland;Portugal;Russian Federation;Spain;United States
      2021   Phase 2   EUCTR2020-003507-34-HU   Australia;Belarus;Belgium;Bulgaria;Czech Republic;Czechia;France;Georgia;Germany;Hungary;Israel;Italy;Korea, Republic of;Poland;Portugal;Russian Federation;Spain;United States
      2021   Phase 2   EUCTR2020-003507-34-FR   Australia;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Moldova, Republic of;Netherlands;Poland;Portugal;Russian Federation;South Africa;Spain;United States
      2021   Phase 2   EUCTR2020-003507-34-CZ   Australia;Belarus;Belgium;Bulgaria;Czech Republic;Czechia;France;Georgia;Germany;Hungary;Israel;Italy;Korea, Republic of;Poland;Portugal;Russian Federation;Spain;United States
      2021   Phase 2   EUCTR2020-003507-34-BG   Australia;Belarus;Belgium;Bulgaria;Czech Republic;Czechia;France;Georgia;Germany;Hungary;Israel;Italy;Korea, Republic of;Poland;Portugal;Russian Federation;Spain;Ukraine;United States
      2021   Phase 2   EUCTR2020-003507-34-BE   Australia;Belarus;Belgium;Bulgaria;Czech Republic;Czechia;France;Georgia;Germany;Hungary;Israel;Italy;Korea, Republic of;Poland;Portugal;Russian Federation;Spain;Ukraine;United States
      2020   Phase 3   EUCTR2018-003986-33-PT   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Thailand;Turkey;Ukraine;United Kingdom;United States
      2020   Phase 3   EUCTR2018-003986-33-LV   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
      2020   Phase 3   EUCTR2018-003986-33-GB   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
      2020   Phase 3   EUCTR2018-003986-33-FR   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
      2020   Phase 3   EUCTR2018-003986-33-ES   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
      2020   Phase 3   EUCTR2018-003986-33-DK   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Thailand;Turkey;Ukraine;United Kingdom;United States
      2020   Phase 3   EUCTR2018-003986-33-BG   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
      2020   Phase 3   EUCTR2018-003986-33-AT   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Thailand;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2018-003986-33-NL   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Thailand;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2018-003986-33-LT   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Thailand;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2018-003986-33-HU   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2018-003986-33-HR   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2018-003986-33-BE   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
      -   Phase 3   EUCTR2018-003986-33-PL   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
      -   Phase 3   EUCTR2018-003986-33-EE   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
      -   Phase 3   EUCTR2018-003986-33-DE   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Thailand;Turkey;Ukraine;United Kingdom;United States
      -   Phase 3   EUCTR2018-003986-33-CZ   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Thailand;Turkey;Ukraine;United Kingdom;United States
ARM 2
   Zydus Lifesciences Limited
      2024   Phase 2   NCT06398808   India
ARM B- standard OF care
   University of Alabama at Birmingham
      2020   Early Phase 1   NCT03333148   -
ARM1
   Zydus Lifesciences Limited
      2024   Phase 2   NCT06398808   India
Asacol
   Annette Langseder
      2006   -   NCT00349388   United States
   Cardiff and Vale University Health Board
      2006   Phase 3   NCT00708656   United Kingdom
   Chiba University Hospital
      2013   Phase 2   JPRN-UMIN000010906   Japan
   Copenhagen University Hospital Hvidovre
      2019   Phase 4   EUCTR2019-002070-31-DK   Denmark
   GIULIANI
      2009   -   EUCTR2008-007292-25-IT   Italy
   GlaxoSmithKline Research and Development Ltd
      2009   -   EUCTR2009-011608-51-SE   Germany;Sweden
      2009   Phase 2   EUCTR2009-011608-51-BE   Belgium;Germany;Sweden
   GlaxoSmithKline Research and Development Ltd.
      2009   -   EUCTR2009-011608-51-DE   Germany;Sweden
   MOCHIDA PHARMACEUTICAL CO., LTD.
      2014   Phase 3   JPRN-jRCT2080222425   -
   Otsuka Pharmaceutical Development & Commercialization, Inc.
      2004   Phase 3   NCT00092508   United States
   Procter & Gamble Pharmaceuticals
      -   Phase 3   EUCTR2007-005702-49-PL   Poland
   Shire
      2005   Phase 3   NCT00151892   Argentina;Australia;Belgium;Brazil;Canada;Chile;Czech Republic;Czechia;Denmark;France;Germany;Hungary;India;Korea, Republic of;Mexico;Netherlands;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Singapore;South Africa;Spain;Sweden;Taiwan;United Kingdom;United States
   Tillotts Pharma AG
      2015   Phase 3   EUCTR2013-000366-11-RO   Belarus;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Hungary;Ireland;Latvia;Lithuania;Norway;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Ukraine;United Kingdom
      2014   Phase 3   EUCTR2013-000366-11-SK   Belarus;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;Hungary;Ireland;Latvia;Lithuania;Poland;Romania;Russian Federation;Slovakia;Spain;Sweden;Ukraine
      2014   Phase 3   EUCTR2013-000366-11-LV   Belarus;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Hungary;Ireland;Latvia;Lithuania;Norway;Poland;Romania;Russian Federation;Slovakia;Spain;Sweden;Ukraine;United Kingdom
      2014   Phase 3   EUCTR2013-000366-11-LT   Belarus;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Hungary;Ireland;Latvia;Lithuania;Norway;Poland;Romania;Russian Federation;Slovakia;Spain;Sweden;Ukraine;United Kingdom
      2014   Phase 3   EUCTR2013-000366-11-HU   Belarus;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Hungary;Ireland;Latvia;Lithuania;Norway;Poland;Romania;Russian Federation;Slovakia;Spain;Sweden;Ukraine;United Kingdom
      2014   Phase 3   EUCTR2013-000366-11-BG   Belarus;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Hungary;Ireland;Latvia;Lithuania;Norway;Poland;Romania;Russian Federation;Slovakia;Spain;Sweden;Ukraine;United Kingdom
      2013   Phase 3   EUCTR2013-000366-11-SE   Belarus;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Hungary;Ireland;Latvia;Lithuania;Norway;Poland;Romania;Russian Federation;Slovakia;Spain;Sweden;Ukraine;United Kingdom
      2013   Phase 3   EUCTR2013-000366-11-PL   Belarus;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;Hungary;Ireland;Latvia;Lithuania;Poland;Romania;Russian Federation;Spain;Sweden;Ukraine
      2013   Phase 3   EUCTR2013-000366-11-IE   Belarus;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Hungary;Ireland;Latvia;Lithuania;Norway;Poland;Romania;Russian Federation;Slovakia;Spain;Sweden;Ukraine;United Kingdom
      2013   Phase 3   EUCTR2013-000366-11-GB   Belarus;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Hungary;Ireland;Latvia;Lithuania;Norway;Poland;Romania;Russian Federation;Slovakia;Spain;Sweden;Ukraine;United Kingdom
      2013   Phase 3   EUCTR2013-000366-11-FI   Belarus;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Hungary;Ireland;Latvia;Lithuania;Norway;Poland;Romania;Russian Federation;Slovakia;Spain;Sweden;Ukraine;United Kingdom
      2013   -   EUCTR2013-000366-11-ES   Belarus;Belgium;Bulgaria;Canada;Denmark;Finland;Hungary;Ireland;Latvia;Lithuania;Poland;Russian Federation;Spain;Sweden;Ukraine
      2013   Phase 3   EUCTR2013-000366-11-DK   Belarus;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Hungary;Ireland;Latvia;Lithuania;Norway;Poland;Romania;Russian Federation;Slovakia;Spain;Sweden;Ukraine;United Kingdom
      2013   Phase 3   EUCTR2013-000366-11-CZ   Belarus;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Hungary;Ireland;Latvia;Lithuania;Norway;Poland;Romania;Russian Federation;Slovakia;Spain;Sweden;Ukraine;United Kingdom
      2013   Phase 3   EUCTR2013-000366-11-BE   Belarus;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Hungary;Ireland;Latvia;Lithuania;Norway;Poland;Romania;Russian Federation;Slovakia;Spain;Sweden;Ukraine;United Kingdom
      2010   Phase 3   NCT01257399   China
      2010   Phase 3   NCT01257386   China
   University of Chicago
      2006   Phase 3   NCT00343850   United States
   University of Washington
      2003   Phase 4   NCT00194818   United States
Asacol (mesalamine) delayed-release tablets
   Otsuka Maryland Research Institute, Inc.
      2004   Phase 3   EUCTR2004-000611-25-IE   Hungary;Ireland
      2004   -   EUCTR2004-000611-25-HU   Hungary;Ireland
Asacol 400 MG
   Tillotts Pharma AG
      2013   Phase 3   NCT01903252   Netherlands;Switzerland
   Warner Chilcott
      2009   Phase 3   NCT01004185   Canada;Croatia;Poland;Romania;Russian Federation;United States
      2008   Phase 3   NCT00713310   Canada;Croatia;Poland;Romania;United States
      2000   Phase 3   NCT00073021   Canada;Puerto Rico;United States
Asacol 400 MG tablet
   Procter & Gamble Technical Centres Limited
      2006   -   EUCTR2006-001310-32-LT   Czech Republic;Estonia;Hungary;Latvia;Lithuania
      2006   -   EUCTR2006-001310-32-HU   Czech Republic;Estonia;Hungary;Latvia;Lithuania
      2006   -   EUCTR2006-001310-32-EE   Czech Republic;Estonia;Hungary;Latvia;Lithuania
      2006   -   EUCTR2006-001310-32-CZ   Czech Republic;Estonia;Hungary;Latvia;Lithuania
Asacol 400MG tablet
   Procter & Gamble Technical Centres Limited
      2006   -   EUCTR2006-001310-32-LV   Czech Republic;Estonia;Hungary;Latvia;Lithuania
Asacol 800 MG tablet
   Procter & Gamble Technical Centres Limited
      2006   -   EUCTR2006-001310-32-LT   Czech Republic;Estonia;Hungary;Latvia;Lithuania
      2006   -   EUCTR2006-001310-32-HU   Czech Republic;Estonia;Hungary;Latvia;Lithuania
      2006   -   EUCTR2006-001310-32-EE   Czech Republic;Estonia;Hungary;Latvia;Lithuania
      2006   -   EUCTR2006-001310-32-CZ   Czech Republic;Estonia;Hungary;Latvia;Lithuania
Asacol 800MG tablet
   Procter & Gamble Technical Centres Limited
      2006   -   EUCTR2006-001310-32-LV   Czech Republic;Estonia;Hungary;Latvia;Lithuania
Asacol delayed release tablets
   Shire Pharmaceutical Development Ltd
      2009   -   EUCTR2004-004184-29-DK   Czech Republic;Denmark;Germany;Hungary;Netherlands;Portugal;Spain;Sweden;United Kingdom
      2008   Phase 3   EUCTR2004-004184-29-NL   Czech Republic;Denmark;Germany;Hungary;Netherlands;Portugal;Spain;Sweden;United Kingdom
      2007   -   EUCTR2004-004184-29-SE   Czech Republic;Denmark;Germany;Hungary;Netherlands;Portugal;Spain;Sweden;United Kingdom
      2007   -   EUCTR2004-004184-29-PT   Czech Republic;Denmark;Germany;Hungary;Netherlands;Portugal;Spain;Sweden;United Kingdom
      2005   Phase 3   EUCTR2004-004184-29-HU   Czech Republic;Denmark;Germany;Hungary;Netherlands;Portugal;Spain;Sweden;United Kingdom
      2005   Phase 3   EUCTR2004-004184-29-GB   Czech Republic;Denmark;Germany;Hungary;Netherlands;Portugal;Spain;Sweden;United Kingdom
      2005   -   EUCTR2004-004184-29-ES   Czech Republic;Denmark;Germany;Hungary;Netherlands;Portugal;Spain;Sweden;United Kingdom
      2005   -   EUCTR2004-004184-29-DE   Czech Republic;Denmark;Germany;Hungary;Netherlands;Portugal;Spain;Sweden;United Kingdom
      2005   -   EUCTR2004-004184-29-CZ   Czech Republic;Denmark;Germany;Hungary;Netherlands;Portugal;Spain;Sweden;United Kingdom
Asacol delayed-release tablets
   EMET Pharmaceuticals LLC
      2008   -   EUCTR2007-004732-23-LV   Estonia;Latvia;Poland
      2007   -   EUCTR2007-004732-23-EE   Estonia;Latvia;Poland
   EMET Pharmaceuticals, LLC
      2008   -   EUCTR2007-004732-23-PL   Estonia;Latvia;Poland
Asacol® 400 MG
   Bausch Health Americas, Inc.
      2008   Phase 3   NCT00679432   Canada;India;Mexico;United States
ASC
   Fundacion para la Investigacion Biomedica Hospital Universitario La Paz
      2012   -   EUCTR2010-023798-20-ES   Spain
   Fundación para la Investigación Biomédica del Hospital Universitario La Paz
      2012   Phase 3   EUCTR2012-001178-28-ES   Spain
Ascorbic acid
   Hospital Universitario La Paz
      2019   Phase 4   EUCTR2018-001402-28-ES   Spain
   Kyungpook National University
      2013   -   NCT01929668   Korea, Republic of
Ascs
   Tigenix S.A.U.
      2007   Phase 3   NCT00475410   Germany;Spain;United Kingdom
Ascs:adipose derived stem cells
   CELLERIX, S.L.
      2008   -   EUCTR2006-003370-95-NL   Germany;Netherlands;Spain
      2008   -   EUCTR2006-003370-95-DE   Germany;Netherlands;Spain
      2007   Phase 3   EUCTR2006-003370-95-ES   Germany;Netherlands;Spain
ASP015K
   Janssen-Cilag International NV
      2014   Phase 2   EUCTR2013-000263-88-RO   Belgium;Bulgaria;Canada;France;Germany;Hungary;Netherlands;Poland;Romania;Russian Federation;Ukraine;United States
      2014   -   EUCTR2013-000263-88-PL   Belgium;Bulgaria;Canada;France;Germany;Hungary;Netherlands;Poland;Romania;Russian Federation;Ukraine;United States
      2014   -   EUCTR2013-000263-88-NL   Belgium;Bulgaria;Canada;France;Germany;Hungary;Netherlands;Poland;Romania;Russian Federation;Ukraine;United States
      2014   -   EUCTR2013-000263-88-HU   Belgium;Bulgaria;Canada;France;Germany;Hungary;Netherlands;Poland;Romania;Russian Federation;Ukraine;United States
      2014   Phase 2   EUCTR2013-000263-88-DE   Belgium;Bulgaria;Canada;France;Germany;Hungary;Netherlands;Poland;Romania;Russian Federation;Ukraine;United States
      2014   Phase 2   EUCTR2013-000263-88-BG   Belgium;Bulgaria;Canada;France;Germany;Hungary;Netherlands;Poland;Romania;Russian Federation;Ukraine;United States
      2014   -   EUCTR2013-000263-88-BE   Australia;Belgium;Bulgaria;Canada;France;Germany;Hungary;Israel;Netherlands;Poland;Romania;Russian Federation;Ukraine;United States
ASP3291
   Telsar Pharma Inc.
      2012   Phase 2   NCT01612039   United States
      2010   Phase 1   NCT01320332   United States
Aspergillus oryzae
   Graduate School of Medical Science, Kyoto Prefectural University of Medicine
      2012   Phase 2   JPRN-UMIN000009364   Japan
Aspirin 81MG EC TAB
   Stefan Holubar MD MS FACS, FASCRS
      2024   Phase 3   NCT05104229   United States
Assessment OF biological factors
   Queen Mary University of London
      2021   -   NCT04995224   United Kingdom
Assessment OF genetics
   Queen Mary University of London
      2021   -   NCT04995224   United Kingdom
Assessment OF psychophysiological factors
   Queen Mary University of London
      2021   -   NCT04995224   United Kingdom
Assessment OF quality OF life
   Queen Mary University of London
      2021   -   NCT04995224   United Kingdom
AST-120
   Ocera Therapeutics
      2006   Phase 3   NCT00321412   Austria;Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Netherlands;Poland;United Kingdom;United States
   Ocera Therapeutics, Inc.
      2007   -   EUCTR2005-005363-28-HU   Austria;Belgium;Czech Republic;Germany;Hungary;United Kingdom
      2007   -   EUCTR2005-005363-28-AT   Austria;Belgium;Czech Republic;Germany;Hungary;United Kingdom
      2006   Phase 3   EUCTR2005-005363-28-GB   Austria;Belgium;Czech Republic;Germany;Hungary;United Kingdom
      2006   -   EUCTR2005-005363-28-DE   Austria;Belgium;Czech Republic;Germany;Hungary;United Kingdom
      2006   -   EUCTR2005-005363-28-CZ   Austria;Belgium;Czech Republic;Germany;Hungary;United Kingdom
      2006   -   EUCTR2005-005363-28-BE   Austria;Belgium;Czech Republic;Germany;Hungary;United Kingdom
ATH-063
   Athos Therapeutics Inc
      2023   Phase 1   NCT05807971   Australia
ATL-2502
   ALIZYME
      2006   -   EUCTR2004-005032-35-IT   Belgium;Czech Republic;Denmark;Hungary;Italy;Spain;Sweden;United Kingdom
   Alizyme Therapeutics Limited
      2007   -   EUCTR2004-005032-35-BE   Belgium;Czech Republic;Denmark;Hungary;Italy;Spain;Sweden;United Kingdom
      2005   -   EUCTR2004-005032-35-SE   Belgium;Czech Republic;Denmark;Hungary;Italy;Spain;Sweden;United Kingdom
      2005   -   EUCTR2004-005032-35-HU   Belgium;Czech Republic;Denmark;Hungary;Italy;Spain;Sweden;United Kingdom
      2005   Phase 3   EUCTR2004-005032-35-GB   Belgium;Czech Republic;Denmark;Hungary;Italy;Spain;Sweden;United Kingdom
      2005   -   EUCTR2004-005032-35-DK   Belgium;Czech Republic;Denmark;Hungary;Italy;Spain;Sweden;United Kingdom
      2005   -   EUCTR2004-005032-35-CZ   Belgium;Czech Republic;Denmark;Hungary;Italy;Spain;Sweden;United Kingdom
Atorvastatin
   Region Skåne
      2006   -   EUCTR2005-000496-17-SE   Sweden
   Takeuchi Yutaka
      2015   Phase 1   JPRN-jRCT2071230023   -
Atorvastatin 80MG
   Tanta University
      2023   Phase 2   NCT05567068   Egypt
      2022   Phase 2   NCT05561062   Egypt
Atorvastatin calcium
   Northwestern University
      2021   Phase 2   NCT04767984   United States
Autologous platelet-poor plasma (PPP) and thrombin coagulum treatment
   Xijing Hospital of Digestive Diseases
      2023   Phase 1   NCT05912712   China
Autologous platelet-rich plasma (PRP) and thrombin coagulum treatment
   Xijing Hospital of Digestive Diseases
      2023   Phase 1   NCT05912712   China
Avonex
   Biogen Idec Ltd
      2009   Phase 2   EUCTR2007-004867-22-SK   Czech Republic;Hungary;Slovakia
      2008   -   EUCTR2007-004867-22-HU   Czech Republic;Hungary
      2008   -   EUCTR2007-004867-22-CZ   Czech Republic;Hungary
   National Institute of Allergy and Infectious Diseases (NIAID)
      2002   Phase 2   NCT00048347   United States
AVT16
   Alvotech Swiss AG
      2024   Phase 3   NCT06570772   Argentina;Bulgaria;Croatia;Georgia;Latvia;Poland;Romania;Serbia;Slovakia;Sri Lanka;Ukraine
AVX 470
   Avaxia Biologics, Incorporated
      2013   Phase 1   NCT01759056   Belgium;Canada;Hungary;United States
AZA
   Dipartimento di Pediatria Università Federico II di Napoli
      2013   -   EUCTR2012-001653-13-IT   Italy
   Merck Sharp & Dohme Corp.
      2007   Phase 3   NCT00537316   Argentina;Belgium;Canada;Colombia;Czech Republic;France;Germany;Hungary;Italy;Poland;Portugal;Russian Federation;Spain;Sweden;Switzerland;Ukraine;United Kingdom
   ZonMw: The Netherlands Organisation for Health Research and Development
      2007   -   NCT00521950   Netherlands
Azafor - 50 MG compresse rivestite CON film 50 compresse IN blister PVC/pvdc/AL
   IRCCS ISTITUTO CLINICO HUMANITAS
      2017   Phase 4   EUCTR2016-002707-25-IT   Italy
Azafor 50MG
   Dipartimento di Pediatria Università Federico II di Napoli
      2013   -   EUCTR2012-001653-13-IT   Italy
Azathioprine
   Affiliated Hospital of Nanjing University of Chinese Medicine
      2015   Phase 1 study   ChiCTR-IPR-15005760   China
   Dipartimento di Pediatria Università Federico II di Napoli
      2013   -   EUCTR2012-001653-13-IT   Italy
   Essex Pharma GmbH
      2009   -   EUCTR2009-010065-23-DE   Germany
   Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives
      2016   Phase 4   NCT02425852   France
   Hvidovre Hospital
      2016   Phase 3   EUCTR2016-002433-30-DK   Denmark
   IQVIA Services Japan K.K. jRCT Call Center
      2023   Phase 3   JPRN-jRCT2031230081   Argentina;Belgium;Bosnia;Brazil;Bulgaria;Canada;Croatia;Czech Republic;France;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Lithuania;Mexico;New Zealand;Poland;Romania;Serbia;Slovenia;Spain;Taiwan;United Kingdom;United States
   Indiana University
      2015   -   NCT02413047   United States
   Istituto Clinico Humanitas
      2017   Phase 4   NCT03151525   Italy
   Kyungpook National University Hospital
      2016   Phase 4   NCT02579733   Korea, Republic of
   Marianne Kiszka-Kanowitz
      2013   Phase 3   EUCTR2013-001503-37-DK   Denmark
   Merck Sharp & Dohme Corp.
      2009   Phase 3   NCT00984568   Germany
      2007   Phase 3   NCT00537316   Argentina;Belgium;Canada;Colombia;Czech Republic;France;Germany;Hungary;Italy;Poland;Portugal;Russian Federation;Spain;Sweden;Switzerland;Ukraine;United Kingdom
   PIBD net
      2018   Phase 4   EUCTR2016-000522-18-GB   Belgium;Canada;Czech Republic;France;Germany;Israel;Italy;Netherlands;Poland;Spain;United Kingdom
   Region Örebro län
      2021   Phase 4   EUCTR2019-002942-19-DK   Denmark;Iceland
   SCHERING-PLOUGH
      2007   -   EUCTR2006-002670-22-IT   Belgium;Czech Republic;France;Germany;Hungary;Italy;Portugal;Spain;United Kingdom
   SOIBD (The Swedish Organisation for the study of Inflammatory Bowel Diseases)
      2018   Phase 4   EUCTR2016-004112-35-SE   Sweden
   Sakura Medical Center, Toho university
      2018   -   JPRN-UMIN000030988   Japan
   Shandong Qilu Stem Cells Engineering Co., Ltd.
      2021   -   NCT04882683   China
   Tanta University
      2025   Phase 2   NCT06213857   Egypt
   The Second Affiliated Hospital of Shandong University of Traditional Chinese Medicine
      2021   Phase 0   ChiCTR2100046284   China
   Xiangya Hospital, Central South University
      2017   -   ChiCTR-OOC-17010617   China
   ZonMw: The Netherlands Organisation for Health Research and Development
      2007   -   NCT00521950   Netherlands
   jRCT Inquiries IQVIA Contact person
      2023   Phase 3   JPRN-jRCT2031230257   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Czech Republic;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Korea;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Serbia;Slovakia;Slovenia;Spain;Switzerland;Turkey;UK USA
Azathioprine (imuran) 50 MG overencapsulated tablet
   Schering-Plough Research Institute, a division of Schering Corporation
      2007   Phase 3   EUCTR2006-002670-22-FR   Belgium;Czech Republic;France;Germany;Hungary;Italy;Portugal;Slovakia;Spain;United Kingdom
Azathioprine / allopurinol
   University of Zurich
      2009   Phase 1   NCT00849368   Switzerland
Azathioprine and allopurinol
   Hvidovre University Hospital
      2016   Phase 3   NCT03101800   Denmark
Azathioprine BP
   Instituto Clinico Humanitas
      2021   Phase 4   EUCTR2020-003420-16-BE   Austria;Belgium;France;Germany;Italy;Portugal;Spain;Sweden;Switzerland;United Kingdom
Azatioprina
   Dipartimento di Pediatria Università Federico II di Napoli
      2013   -   EUCTR2012-001653-13-IT   Italy
   IRCCS ISTITUTO CLINICO HUMANITAS
      2021   Phase 4   EUCTR2020-003420-16-IT   Austria;Belgium;France;Germany;Italy;Portugal;Spain;Sweden;Switzerland;United Kingdom
      2017   Phase 4   EUCTR2016-002707-25-IT   Italy
B03A A07
   Pharmacosmos A/S
      2011   -   EUCTR2009-012544-16-HU   Austria;Denmark;Hungary;United Kingdom
      2011   -   EUCTR2009-012544-16-AT   Austria;Denmark;Hungary;United Kingdom
B03ac06
   Pharmacosmos A/S
      2012   Phase 3   EUCTR2011-001593-25-HU   Austria;Hungary
      2011   -   EUCTR2011-001593-25-AT   Austria;Hungary
      2011   -   EUCTR2009-012544-16-HU   Austria;Denmark;Hungary;United Kingdom
      2011   -   EUCTR2009-012544-16-AT   Austria;Denmark;Hungary;United Kingdom
      2009   -   EUCTR2009-012544-16-DK   Austria;Denmark;Hungary;United Kingdom
B2-asmedic
   Novartis Pharma Services AG
      2007   -   EUCTR2007-002542-38-DE   Denmark;Germany
B: 2 dosis
   AB Biotics, SA
      2018   -   NCT03444311   Spain
Bacteriotherapy
   David Suskind
      2012   Phase 1   NCT01757964   United States
Baitouweng tang
   The Second Hospital of Nanjing Medical University
      2024   Phase 2   NCT06421818   China
Balsalazide
   Roxane Laboratories
      2005   -   NCT00618202   United States
      2004   -   NCT00618228   United States
Balsalazide disodium
   Bausch Health Americas, Inc.
      2006   Phase 3   NCT00486031   United States
      2006   Phase 3   NCT00408174   United States
Baminercept
   Biogen Idec Ltd.
      2011   Phase 2   EUCTR2010-019558-42-SK   Belgium;Czech Republic;Hungary;Slovakia
      2011   -   EUCTR2010-019558-42-HU   Belgium;Czech Republic;Hungary
      2011   -   EUCTR2010-019558-42-CZ   Belgium;Czech Republic;Hungary
      2010   -   EUCTR2010-019558-42-BE   Belgium;Czech Republic;Hungary
Bascial prescription plus or minus herbs depend ON symptoms
   Shanghai University of Traditional Chinese Medicine
      2009   -   NCT00963287   China
Basiliximab
   Cerimon Pharmaceuticals
      2007   Phase 2   NCT01061996   United Kingdom
      2007   Phase 2   NCT00430898   Belgium;Czech Republic;India;Poland;Russian Federation;Slovakia;Ukraine;United Kingdom;United States
   Cerimon Pharmaceuticals, Inc.
      2007   Phase 2   EUCTR2006-006319-54-SK   Belgium;Czech Republic;Slovakia;United Kingdom
      2007   Phase 2   EUCTR2006-006319-54-GB   Belgium;Czech Republic;Slovakia;United Kingdom
      2007   Phase 2   EUCTR2006-006319-54-CZ   Belgium;Czech Republic;United Kingdom
      2007   -   EUCTR2006-006319-54-BE   Belgium;United Kingdom
      2007   Phase 2   EUCTR2006-004303-19-SK   Belgium;Czech Republic;Slovakia;United Kingdom
      2007   Phase 2   EUCTR2006-004303-19-GB   Belgium;Czech Republic;Slovakia;United Kingdom
      2007   -   EUCTR2006-004303-19-CZ   Belgium;Czech Republic;United Kingdom
      2007   -   EUCTR2006-004303-19-BE   Belgium;Czech Republic;United Kingdom
BBT-401-1S
   Bridge Biotherapeutics, Inc.
      2021   Phase 2   NCT04596293   Korea, Republic of;New Zealand;Poland;Ukraine;United States
      2021   Phase 1   NCT04478825   New Zealand
      2021   Phase 2   EUCTR2020-003556-33-PL   Korea, Republic of;New Zealand;Poland;Ukraine;United States
      2019   Phase 2   NCT03800420   United States
BBT-401-1S, multiple doses
   Bridge Biotherapeutics, Inc.
      2018   Phase 1   NCT03482648   United States
BBT-401-1S, single dose
   Bridge Biotherapeutics, Inc.
      2018   Phase 1   NCT03482648   United States
Beclometasone
   CHIESI
      2007   -   EUCTR2006-004230-32-IT   Belgium;Italy;Poland;Spain
Beclometasone dipropionate
   CHIESI ESPAÑA S.A.U.
      2017   Phase 3   EUCTR2017-000330-61-ES   Spain
   CHIESI Farmaceutici S.p.A.
      2007   -   EUCTR2006-004230-32-BE   Belgium;Italy;Poland;Spain
   Chiesi Farmaceutici SpA
      2007   Phase 3   EUCTR2006-004230-32-ES   Belgium;Italy;Poland;Spain
Beclomethasone dipropionate IN addition TO MC-evoo
   Casa Sollievo della Sofferenza IRCCS
      2017   -   NCT03408847   Italy
Beclomethasone dipropionate IN addition TO refined OIL
   Casa Sollievo della Sofferenza IRCCS
      2017   -   NCT03408847   Italy
Beclomethasone diproprionate
   Chiesi Farmaceutici SpA
      2007   Phase 3   EUCTR2006-004230-32-PL   Belgium;Italy;Poland;Spain
Behavioral counseling
   Eva Szigethy
      2013   Phase 4   NCT02162862   United States
Berberine
   Peking University Third Hospital
      2024   Phase 0   ChiCTR2400083224   China
   Xijing Hospital of Digestive Diseases
      2016   Phase 4   NCT02962245   -
Berberine chloride
   National Cancer Institute (NCI)
      2016   Phase 1   NCT02365480   China;United States
Bertilimumab
   Immune Pharmaceuticals
      2015   Phase 2   NCT01671956   Israel
Best medical therapy
   Royal College of Surgeons, Ireland
      2022   -   NCT05174754   Ireland
BETA-1,3/1,6-D-glucan
   Fakultas Kedokteran Universitas Indonesia
      2019   Phase 2/Phase 3   NCT04029649   Indonesia
Bezlotoxumab
   Brigham and Women's Hospital
      2020   Phase 2   NCT03829475   United States
   David Binion, MD
      2021   Phase 4   NCT04626947   United States
BG9924
   Biogen Idec Ltd.
      2011   Phase 2   EUCTR2010-019558-42-SK   Belgium;Czech Republic;Hungary;Slovakia
      2011   -   EUCTR2010-019558-42-HU   Belgium;Czech Republic;Hungary
      2011   -   EUCTR2010-019558-42-CZ   Belgium;Czech Republic;Hungary
      2010   -   EUCTR2010-019558-42-BE   Belgium;Czech Republic;Hungary
BGP-014
   BioGaia Pharma AB
      2022   Phase 1/Phase 2   NCT05118919   Sweden
BGP-014 capsules
   BioGaia Pharma AB
      2021   Phase 1;Phase 2   EUCTR2019-004578-25-SE   Sweden
BI 655130
   BOEHRINGER-INGELHEIM ITALIA S.P.A.
      2018   Phase 2   EUCTR2018-000334-35-IT   Australia;Austria;Belgium;Canada;Germany;Hungary;Italy;Japan;Korea, Republic of;Netherlands;Norway;Poland;Russian Federation;Spain;United Kingdom;United States
      2018   Phase 2;Phase 3   EUCTR2017-004230-28-IT   Austria;Belgium;Canada;Czech Republic;Denmark;Germany;Greece;Hungary;Italy;Japan;Korea, Republic of;Netherlands;Poland;Russian Federation;Spain;Taiwan;United Kingdom;United States
   Boehringer Ingelheim
      2018   Phase 2   JPRN-jRCT2080224139   Asia except Japan;Europe;Japan;North America;Oceania
      2018   Phase 2-3   JPRN-jRCT2080223993   Asia except Japan;Europe;Japan;North America;Oceania
   Boehringer Ingelheim BV Netherlands
      2017   Phase 2   EUCTR2016-004572-21-NL   Denmark;Germany;Netherlands;Norway;Spain;United Kingdom
   Boehringer Ingelheim Denmark A/S
      2019   Phase 2;Phase 3   EUCTR2017-004230-28-DK   Argentina;Australia;Austria;Belgium;Canada;China;Czech Republic;Denmark;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Norway;Poland;Russian Federation;Spain;Taiwan;United Kingdom;United States
   Boehringer Ingelheim España, S.A.
      2018   Phase 2   EUCTR2018-000334-35-ES   Austria;Belgium;Canada;Germany;Italy;Japan;Korea, Republic of;Netherlands;Poland;Russian Federation;Spain;United Kingdom;United States
      2018   Phase 2;Phase 3   EUCTR2017-004230-28-ES   Austria;Belgium;Canada;Czech Republic;Denmark;Germany;Greece;Hungary;Italy;Japan;Korea, Republic of;Netherlands;Poland;Russian Federation;Spain;Taiwan;United Kingdom;United States
      2017   Phase 2   EUCTR2016-004572-21-ES   Denmark;Germany;Netherlands;Norway;Spain;United Kingdom
   Boehringer Ingelheim International GmbH
      2019   Phase 2;Phase 3   EUCTR2017-004230-28-HU   Argentina;Australia;Austria;Belgium;Canada;China;Czech Republic;Denmark;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Norway;Poland;Russian Federation;Spain;Taiwan;United Kingdom;United States
      2019   Phase 2;Phase 3   EUCTR2017-004230-28-GR   Argentina;Australia;Austria;Belgium;Canada;China;Czech Republic;Denmark;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Norway;Poland;Russian Federation;Spain;Taiwan;United Kingdom;United States
      2019   Phase 2;Phase 3   EUCTR2017-004230-28-CZ   Argentina;Australia;Austria;Belgium;Canada;China;Czech Republic;Denmark;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Norway;Poland;Russian Federation;Spain;Taiwan;United Kingdom;United States
   Boehringer Ingelheim LImited
      2018   Phase 2   EUCTR2018-000334-35-GB   Austria;Belgium;Canada;Germany;Hungary;Italy;Japan;Korea, Republic of;Netherlands;Norway;Poland;Russian Federation;Spain;United Kingdom;United States
   Boehringer Ingelheim Limited
      2018   Phase 2;Phase 3   EUCTR2017-004230-28-GB   Argentina;Australia;Austria;Belgium;Canada;China;Czech Republic;Denmark;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Norway;Poland;Russian Federation;Spain;Taiwan;United Kingdom;United States
      2017   Phase 2   EUCTR2017-000100-20-GB   Belgium;Germany;United Kingdom
      2017   Phase 2   EUCTR2016-004572-21-GB   Denmark;Germany;Netherlands;Norway;Spain;United Kingdom
   Boehringer Ingelheim Norway KS
      2019   Phase 2   EUCTR2018-000334-35-NO   Austria;Belgium;Canada;Germany;Hungary;Italy;Japan;Korea, Republic of;Netherlands;Norway;Poland;Russian Federation;Spain;United Kingdom;United States
      2017   Phase 2   EUCTR2016-004572-21-NO   Denmark;Germany;Netherlands;Norway;Spain;United Kingdom
   Boehringer Ingelheim Pharma GmbH & Co. KG
      2018   Phase 2   EUCTR2018-000334-35-DE   Australia;Austria;Belgium;Canada;Czechia;Denmark;Germany;Greece;Hungary;Italy;Japan;Korea, Republic of;Netherlands;Norway;Poland;Russian Federation;Spain;United Kingdom;United States
      2018   Phase 2;Phase 3   EUCTR2017-004230-28-DE   Argentina;Australia;Austria;Belgium;Canada;China;Czech Republic;Denmark;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Norway;Poland;Russian Federation;Spain;Taiwan;United Kingdom;United States
      2017   Phase 2   EUCTR2017-000100-20-DE   Belgium;Germany;United Kingdom
      2017   Phase 2   EUCTR2016-004572-21-DK   Denmark;Germany;Netherlands;Norway;Spain;United Kingdom
      2017   Phase 2   EUCTR2016-004572-21-DE   Denmark;Germany;Netherlands;Norway;Spain;United Kingdom
   Boehringer Ingelheim RCV GmbH & Co KG
      2018   Phase 2;Phase 3   EUCTR2017-004230-28-AT   Argentina;Australia;Austria;Belgium;Canada;China;Czech Republic;Denmark;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Norway;Poland;Russian Federation;Spain;Taiwan;United Kingdom;United States
   Boehringer Ingelheim RCV GmbH&Co. KG
      2019   Phase 2   EUCTR2018-000334-35-PL   Australia;Austria;Belgium;Canada;Czechia;Denmark;Germany;Greece;Hungary;Italy;Japan;Korea, Republic of;Netherlands;Norway;Poland;Russian Federation;Spain;United Kingdom;United States
      2019   Phase 2   EUCTR2018-000334-35-HU   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Germany;Greece;Hungary;Italy;Japan;Korea, Republic of;Netherlands;Norway;Poland;Russian Federation;Spain;United Kingdom;United States
      2018   Phase 2   EUCTR2018-000334-35-AT   Austria;Belgium;Canada;Germany;Hungary;Italy;Japan;Korea, Republic of;Netherlands;Norway;Poland;Russian Federation;Spain;United Kingdom;United States
   Boehringer Ingelheim bv
      2018   Phase 2;Phase 3   EUCTR2017-004230-28-NL   Austria;Belgium;Canada;Czech Republic;Denmark;Germany;Greece;Hungary;Italy;Japan;Korea, Republic of;Netherlands;Poland;Russian Federation;Spain;Taiwan;United Kingdom;United States
   Boehringer Ingelheim bv Netherlands
      2019   Phase 2   EUCTR2018-000334-35-NL   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Germany;Greece;Hungary;Italy;Japan;Korea, Republic of;Netherlands;Norway;Poland;Russian Federation;Spain;United Kingdom;United States
   SCS Boehringer Ingelheim Comm. V
      2018   Phase 2   EUCTR2018-000334-35-BE   Austria;Belgium;Canada;Germany;Hungary;Italy;Japan;Korea, Republic of;Netherlands;Norway;Poland;Russian Federation;Spain;United Kingdom;United States
      2018   Phase 2;Phase 3   EUCTR2017-004230-28-BE   Argentina;Australia;Austria;Belgium;Canada;China;Czech Republic;Denmark;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Poland;Russian Federation;Spain;Taiwan;United Kingdom;United States
      2017   Phase 2   EUCTR2017-000100-20-BE   Belgium;Germany;United Kingdom
BI-peglyte
   University of Manitoba
      2024   Phase 4   NCT06298461   Canada
Biap
   AM PHARMA B.V.
      2006   -   EUCTR2006-000197-69-IT   Italy
   AM-Pharma
      2006   Phase 2   NCT00727324   Czech Republic;Italy
   AM-Pharma B.V.
      2006   Phase 2   EUCTR2006-000197-69-CZ   Czech Republic;Italy
Bicarbonato DI sodio
   IPSEN PHARMA SAS
      2017   Phase 3   EUCTR2016-002265-60-IT   Czech Republic;Czechia;France;Germany;Italy;Netherlands;Poland
Bifidobacterium
   Affiliated Hospital of Jiangnan University
      2021   -   ChiCTR2100046446   China
Bifidobacterium breve
   Public Health Research foundation
      2012   -   JPRN-UMIN000007593   Japan
   The Peoples' Hospital of Tinghu District of Yancheng City
      2022   -   ChiCTR2200065108   China
Bifidobacterium infantis 35624
   University College Cork
      2002   Phase 2/Phase 3   NCT00510978   Ireland
Bifidobacterium longum
   The Peoples' Hospital of Tinghu District of Yancheng City
      2022   -   ChiCTR2200065108   China
Bimekizumab
   UCB Biopharma SPRL
      2017   Phase 2   EUCTR2016-000420-26-PL   Bulgaria;Czech Republic;France;Georgia;Italy;Moldova, Republic of;Poland;Romania;South Africa;Spain;United Kingdom
      2017   Phase 2   EUCTR2016-000420-26-BG   Bulgaria;Czech Republic;Georgia;Italy;Moldova, Republic of;Poland;Romania;South Africa;Spain;United Kingdom
      2016   Phase 2   EUCTR2016-000420-26-ES   Bulgaria;Czech Republic;France;Georgia;Italy;Moldova, Republic of;Poland;Romania;South Africa;Spain;United Kingdom
      2016   Phase 2   EUCTR2016-000420-26-CZ   Bulgaria;Czech Republic;France;Georgia;Italy;Moldova, Republic of;Poland;Romania;South Africa;Spain;United Kingdom
BIO-enhanced curcumin soft gelatin capsule
   Asian Institute of Gastroenterology, India
      2016   Phase 3   NCT02683759   India
      2016   Phase 3   NCT02683733   India
Biological drug
   Assiut University
      2021   -   NCT04818788   -
Biological sampling
   Imagine Institute
      2015   -   NCT02909244   France
Biologically active human fecal material, openbiome
   University of California, San Francisco
      2015   Early Phase 1   NCT02460705   United States
Biologically active human fecal microbiota
   Virginia O. Shaffer
      2014   Phase 2   NCT02049502   United States
Biologics
   IQVIA Services Japan K.K. jRCT Call Center
      2023   Phase 3   JPRN-jRCT2031230081   Argentina;Belgium;Bosnia;Brazil;Bulgaria;Canada;Croatia;Czech Republic;France;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Lithuania;Mexico;New Zealand;Poland;Romania;Serbia;Slovenia;Spain;Taiwan;United Kingdom;United States
   Janssen Biotech, Inc.
      2007   -   NCT00606346   Canada;United States
   Sixth Affiliated Hospital, Sun Yat-sen University
      2020   -   NCT05542459   China
   jRCT Inquiries IQVIA Contact person
      2023   Phase 3   JPRN-jRCT2031230257   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Czech Republic;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Korea;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Serbia;Slovakia;Slovenia;Spain;Switzerland;Turkey;UK USA
Biopsy OF colon
   Northwestern University
      2021   Phase 2   NCT04767984   United States
Biosimilar
   Fukuoka University Chikushi Hospital
      2021   -   JPRN-UMIN000043165   Japan
   Fundación Publica Andaluza para la Gestión de Salud en Sevilla (FISEVI)
      2019   Phase 4   EUCTR2019-000717-37-ES   Spain
   Jamp Pharma Corporation
      2023   -   NCT05913817   Canada
   McGill University Health Centre/Research Institute of the McGill University Health Centre
      2018   -   NCT03729674   Canada
   Pfizer
      2019   -   NCT03884439   Japan
Biosimilar infliximab
   Diakonhjemmet Hospital
      2014   Phase 4   NCT02148640   Norway
   University of Toyama
      2017   -   JPRN-UMIN000027465   Japan
Biospecimen collection
   National Cancer Institute (NCI)
      2019   Phase 1   NCT03816345   Canada;United States
   Northwestern University
      2021   Phase 2   NCT04767984   United States
Bisacodyl
   AZIENDA OSPEDALIERA L. SACCO (A.O. DI RILIEVO NAZIONALE)
      2012   -   EUCTR2012-004214-34-IT   Italy
Bitter candytuft fresh plant extract
   Steigerwald Arzneimittelwerk GmbH
      2014   -   EUCTR2013-000891-13-DE   Germany
Bitterschleifenblume-ganzpflanze 1,5ML/10ML
   Steigerwald Arzneimittelwerk GmbH
      2014   -   EUCTR2013-000891-13-DE   Germany
BL-7040
   BioLineRx, Ltd.
      2012   Phase 2   NCT01506362   Israel
Blood and fecal samples
   Centre Hospitalier Régional d'Orléans
      2023   -   NCT05916274   France
Blood or saliva sample collection
   Mount Sinai Hospital, Canada
      2022   -   NCT06042387   Canada
Blood sample
   Centre Hospitalier Universitaire de Saint Etienne
      2017   -   NCT03172195   France
Blood samples
   Centre Hospitalier Universitaire de Saint Etienne
      2019   -   NCT04030676   France
      2017   Phase 2   NCT03182166   France
   University Hospital, Bordeaux
      2020   -   NCT04272307   France
Blood sampling, endoscopy
   Bausch Health Americas, Inc.
      2008   Phase 3   NCT00679432   Canada;India;Mexico;United States
      2008   Phase 3   NCT00679380   Australia;Belgium;Estonia;France;Israel;Italy;Latvia;Lithuania;Poland;Romania;Russian Federation;Slovakia;Sweden;Ukraine;United Kingdom
Blood test 4 edta tubes
   University Hospital, Grenoble
      2025   -   NCT06944873   France
Blueberry-rich diet
   Universität Duisburg-Essen
      2024   -   NCT06698601   Germany
BMS-188667
   Bristol-Myers Squibb International Corporation
      2008   -   EUCTR2006-003604-19-PL   Belgium;Czech Republic;France;Germany;Ireland;Italy;Poland;United Kingdom
      2007   -   EUCTR2006-003604-19-IT   Belgium;Czech Republic;France;Germany;Ireland;Italy;Poland;United Kingdom
      2007   -   EUCTR2006-003604-19-IE   Belgium;Czech Republic;France;Germany;Ireland;Italy;Poland;United Kingdom
      2007   Phase 3   EUCTR2006-003604-19-GB   Belgium;Czech Republic;France;Germany;Ireland;Italy;Poland;United Kingdom
      2007   Phase 3   EUCTR2006-003604-19-FR   Belgium;Czech Republic;France;Germany;Ireland;Italy;Poland;United Kingdom
      2007   -   EUCTR2006-003604-19-DE   Belgium;Czech Republic;France;Germany;Ireland;Italy;Poland;United Kingdom
      2007   -   EUCTR2006-003604-19-CZ   Belgium;Czech Republic;France;Germany;Ireland;Italy;Poland;United Kingdom
      2007   -   EUCTR2006-003604-19-BE   Belgium;Czech Republic;France;Germany;Ireland;Italy;Poland;United Kingdom
BMS-936557
   Bristol-Myers Squibb International Corporation
      2011   -   EUCTR2010-022506-41-PL   Australia;Austria;Belgium;Brazil;Canada;France;Germany;Hungary;Italy;Mexico;Netherlands;Poland;South Africa;United States
      2011   -   EUCTR2010-022506-41-IT   Australia;Austria;Brazil;Canada;Germany;Hungary;Italy;Mexico;Poland;South Africa;United States
      2011   -   EUCTR2010-022506-41-HU   Australia;Austria;Belgium;Brazil;Canada;France;Germany;Hungary;Italy;Mexico;Netherlands;Poland;South Africa;United States
      2011   -   EUCTR2010-022506-41-DE   Australia;Austria;Belgium;Brazil;Canada;France;Germany;Hungary;Italy;Mexico;Netherlands;Poland;South Africa;United States
      2011   Phase 2   EUCTR2010-022506-41-BE   Australia;Austria;Belgium;Brazil;Canada;France;Germany;Hungary;Italy;Mexico;Netherlands;Poland;South Africa;United States
      2011   -   EUCTR2010-022506-41-AT   Australia;Austria;Belgium;Brazil;Canada;France;Germany;Hungary;Italy;Mexico;Netherlands;Poland;South Africa;United States
BMS-986165
   BRISTOL-MYERS SQUIBB INTERNATIONAL CORPORATION
      2021   Phase 2   EUCTR2020-004461-40-IT   Australia;Belgium;Brazil;Canada;China;Czechia;Denmark;France;Germany;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Spain;Switzerland;Taiwan;United Kingdom;United States
      2019   Phase 2   EUCTR2018-004694-27-IT   Australia;Belgium;Czech Republic;Czechia;France;Germany;Hungary;Italy;Japan;Korea, Republic of;Poland;Russian Federation;United Kingdom;United States
   Bristol-Myers Squibb
      2021   Phase 2   NCT04613518   Australia;Canada;Germany;Netherlands;Poland;Puerto Rico;United Kingdom;United States
      2019   Phase 2   NCT03934216   Australia;Belgium;Canada;Czechia;France;Germany;Hungary;Italy;Japan;Korea, Republic of;Poland;Russian Federation;United Kingdom;United States
   Bristol-Myers Squibb International Corporation
      2022   Phase 2   EUCTR2020-004461-40-PT   Australia;Belgium;Brazil;Canada;China;Czechia;Denmark;France;Germany;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Spain;Switzerland;Taiwan;United Kingdom;United States
      2022   Phase 2   EUCTR2020-004461-40-NL   Australia;Belgium;Brazil;Canada;China;Czechia;Denmark;France;Germany;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Spain;Switzerland;Taiwan;United Kingdom;United States
      2022   Phase 2   EUCTR2019-004878-26-PL   Australia;Canada;Germany;Netherlands;Poland;United Kingdom;United States
      2021   Phase 2   EUCTR2020-004461-40-DE   Australia;Belgium;Brazil;Canada;China;Czechia;Denmark;France;Germany;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Spain;Switzerland;Taiwan;United Kingdom;United States
      2021   Phase 2   EUCTR2019-004878-26-NL   Australia;Canada;Germany;Netherlands;Poland;United Kingdom;United States
      2021   Phase 2   EUCTR2019-004878-26-DE   Australia;Canada;Germany;Netherlands;Poland;United Kingdom;United States
      2020   Phase 2   EUCTR2018-004694-27-FR   Australia;Belgium;Czech Republic;France;Germany;Hungary;Italy;Japan;Korea, Republic of;Poland;Russian Federation;United Kingdom;United States
      2019   Phase 2   EUCTR2018-004694-27-PL   Australia;Belgium;Czech Republic;France;Germany;Hungary;Italy;Japan;Korea, Republic of;Poland;Russian Federation;United Kingdom;United States
      2019   Phase 2   EUCTR2018-004694-27-HU   Belgium;Canada;Czech Republic;Germany;Hungary;Italy;Japan;Korea, Republic of;Poland;Russian Federation;Spain;Switzerland;United Kingdom;United States
      2019   Phase 2   EUCTR2018-004694-27-GB   Australia;Belgium;Czech Republic;France;Germany;Hungary;Italy;Japan;Korea, Republic of;Poland;Russian Federation;United Kingdom;United States
      2019   Phase 2   EUCTR2018-004694-27-DE   Australia;Belgium;Czech Republic;Czechia;France;Germany;Hungary;Italy;Japan;Korea, Republic of;Poland;Russian Federation;United Kingdom;United States
      2019   Phase 2   EUCTR2018-004694-27-CZ   Australia;Belgium;Czech Republic;France;Germany;Hungary;Italy;Japan;Korea, Republic of;Poland;Russian Federation;United Kingdom;United States
   Walid Elsharkawi
      2022   Phase 2   JPRN-jRCT2031210637   Australia;Belgium;Brazil;Canada;China;Czech Republic;Denmark;France;Germany;Hungary;Ireland;Israel;Italy;Japan;Mexico;Netherlands;Poland;Portugal;Romania;Russia;South Korea;Spain;Switzerland;Taiwan;UK;US
BMS-986166
   Bristol-Myers Squibb
      2017   Phase 1   NCT03038711   United States
BMS-986184
   Bristol-Myers Squibb
      2016   Phase 1   NCT02864264   Australia;Georgia;Moldova, Republic of;Romania
BMS986165
   Bristol-Myers Squibb International Corporation
      2022   Phase 2   EUCTR2020-004461-40-PT   Australia;Belgium;Brazil;Canada;China;Czechia;Denmark;France;Germany;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Spain;Switzerland;Taiwan;United Kingdom;United States
      2022   Phase 2   EUCTR2020-004461-40-NL   Australia;Belgium;Brazil;Canada;China;Czechia;Denmark;France;Germany;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Spain;Switzerland;Taiwan;United Kingdom;United States
      2022   Phase 2   EUCTR2019-004878-26-PL   Australia;Canada;Germany;Netherlands;Poland;United Kingdom;United States
      2021   Phase 2   EUCTR2020-004461-40-DE   Australia;Belgium;Brazil;Canada;China;Czechia;Denmark;France;Germany;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Spain;Switzerland;Taiwan;United Kingdom;United States
      2021   Phase 2   EUCTR2019-004878-26-NL   Australia;Canada;Germany;Netherlands;Poland;United Kingdom;United States
      2021   Phase 2   EUCTR2019-004878-26-DE   Australia;Canada;Germany;Netherlands;Poland;United Kingdom;United States
      2020   Phase 2   EUCTR2018-004694-27-FR   Australia;Belgium;Czech Republic;France;Germany;Hungary;Italy;Japan;Korea, Republic of;Poland;Russian Federation;United Kingdom;United States
      2019   Phase 2   EUCTR2018-004694-27-PL   Australia;Belgium;Czech Republic;France;Germany;Hungary;Italy;Japan;Korea, Republic of;Poland;Russian Federation;United Kingdom;United States
      2019   Phase 2   EUCTR2018-004694-27-HU   Belgium;Canada;Czech Republic;Germany;Hungary;Italy;Japan;Korea, Republic of;Poland;Russian Federation;Spain;Switzerland;United Kingdom;United States
      2019   Phase 2   EUCTR2018-004694-27-GB   Australia;Belgium;Czech Republic;France;Germany;Hungary;Italy;Japan;Korea, Republic of;Poland;Russian Federation;United Kingdom;United States
      2019   Phase 2   EUCTR2018-004694-27-DE   Australia;Belgium;Czech Republic;Czechia;France;Germany;Hungary;Italy;Japan;Korea, Republic of;Poland;Russian Federation;United Kingdom;United States
      2019   Phase 2   EUCTR2018-004694-27-CZ   Australia;Belgium;Czech Republic;France;Germany;Hungary;Italy;Japan;Korea, Republic of;Poland;Russian Federation;United Kingdom;United States
Boulardii
   University Clinic Dr Dragisa Misovic-Dedinje
      2019   -   NCT03941418   -
Brazikumab
   ALLERGAN LIMITED
      2019   Phase 2   EUCTR2018-001605-93-IT   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Colombia;Czech Republic;Czechia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Poland;Romania;Russian Federation;Singapore;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States
   ASTRAZENECA AB
      2021   Phase 2   EUCTR2021-001644-10-IT   Austria;Canada;Czechia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Poland;Russian Federation;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
   Ageishi Yuji
      2022   Phase 2   JPRN-jRCT2011210047   Austria;Canada;Czech Republic;France;Germany;Hungary;India;Israel;Italy;Japan;Poland;Russia;South Africa;South Korea;Spain;Taiwan;Ukraine;United Kingdom;United States
      2022   Phase 2   JPRN-jRCT2011210030   Australia;Austria;Belgium;Bulgaria;Canada;Czechia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Poland;Puerto Rico;Romania;Russian Federation;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
   Allergan Ltd.
      2019   Phase 2   EUCTR2018-001605-93-RO   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Colombia;Czech Republic;Czechia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Poland;Romania;Russian Federation;Singapore;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States
      2019   Phase 2   EUCTR2018-001605-93-ES   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Colombia;Czech Republic;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Poland;Romania;Russian Federation;Singapore;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States
      2019   Phase 2   EUCTR2018-001605-93-BG   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Colombia;Czech Republic;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Poland;Romania;Russian Federation;Singapore;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States
   AstraZeneca
      2018   Phase 2   NCT04718818   Canada;India;Korea, Republic of;Puerto Rico;Romania;Taiwan;United States
      2018   Phase 2   NCT03616821   Australia;Austria;Belgium;Bulgaria;Canada;Czechia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Poland;Puerto Rico;Romania;Russian Federation;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
   AstraZeneca AB
      2022   Phase 2   EUCTR2021-001644-10-HU   Austria;Canada;Czechia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Poland;Russian Federation;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2022   Phase 2   EUCTR2021-001644-10-DE   Austria;Canada;Czechia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Poland;Russian Federation;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2022   Phase 2   EUCTR2018-001605-93-FR   Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2021   Phase 2   EUCTR2021-001644-10-PL   Austria;Canada;Czechia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Poland;Russian Federation;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2021   Phase 2   EUCTR2021-001644-10-ES   Austria;Canada;Czechia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Poland;Russian Federation;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2021   Phase 2   EUCTR2021-001644-10-AT   Austria;Canada;Czechia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Poland;Russian Federation;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2021   Phase 2   EUCTR2018-001605-93-HU   Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Poland;Romania;Russian Federation;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2020   Phase 2   EUCTR2018-001605-93-DE   Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Poland;Romania;Russian Federation;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2020   Phase 2   EUCTR2018-001605-93-AT   Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Poland;Romania;Russian Federation;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2019   Phase 2   EUCTR2018-001605-93-GB   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Colombia;Czech Republic;Czechia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Poland;Romania;Russian Federation;Singapore;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States
      2019   Phase 2   EUCTR2018-001605-93-CZ   Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Poland;Romania;Russian Federation;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2019   Phase 2   EUCTR2018-001605-93-BE   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Colombia;Czech Republic;Czechia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Poland;Romania;Russian Federation;Singapore;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States
Brazikumab induction dose
   AstraZeneca
      2020   Phase 2   NCT04277546   Austria;Belgium;Bulgaria;Canada;Czechia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Poland;Puerto Rico;Romania;Russian Federation;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
Brazikumab maintenance dose
   AstraZeneca
      2020   Phase 2   NCT04277546   Austria;Belgium;Bulgaria;Canada;Czechia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Poland;Puerto Rico;Romania;Russian Federation;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
Breast milk sampling
   AbbVie
      2024   Phase 4   NCT06346288   Israel;United States
Brepocitinib 25 MG
   Pfizer Inc.
      2017   Phase 2   EUCTR2016-003708-29-SK   Austria;Bulgaria;Canada;Denmark;Georgia;Germany;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United States
   Pfizer Inc., 235 East 42nd Street, New York, NY 10017
      2018   Phase 2   EUCTR2016-003708-29-BG   Austria;Bulgaria;Canada;Czechia;Denmark;Georgia;Germany;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United States
      2017   Phase 2   EUCTR2016-003708-29-PL   Austria;Bulgaria;Canada;Czechia;Denmark;Georgia;Germany;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United States
      2017   Phase 2   EUCTR2016-003708-29-DK   Austria;Bulgaria;Canada;Czechia;Denmark;Georgia;Germany;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United States
      2017   Phase 2   EUCTR2016-003708-29-DE   Austria;Bulgaria;Canada;Czechia;Denmark;Georgia;Germany;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United States
Brepocitinib 5 MG
   Pfizer Inc.
      2017   Phase 2   EUCTR2016-003708-29-SK   Austria;Bulgaria;Canada;Denmark;Georgia;Germany;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United States
   Pfizer Inc., 235 East 42nd Street, New York, NY 10017
      2017   Phase 2   EUCTR2016-003708-29-PL   Austria;Bulgaria;Canada;Czechia;Denmark;Georgia;Germany;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United States
      2017   Phase 2   EUCTR2016-003708-29-DK   Austria;Bulgaria;Canada;Czechia;Denmark;Georgia;Germany;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United States
      2017   Phase 2   EUCTR2016-003708-29-DE   Austria;Bulgaria;Canada;Czechia;Denmark;Georgia;Germany;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United States
Broccoli
   University of Tsukuba
      2020   -   JPRN-UMIN000041972   Japan
Bromlein
   National Nutrition and Food Technology Institute
      2024   -   NCT06351696   Iran, Islamic Republic of
BRS201
   Brigham and Women's Hospital
      2025   Phase 2   NCT06420492   United States
      2025   Phase 2   NCT06420375   United States
BT-11
   Landos Biopharma Inc.
      2019   Phase 2   EUCTR2018-005086-39-HU   Belarus;Bosnia and Herzegovina;Bulgaria;Croatia;Georgia;Hungary;Moldova, Republic of;Poland;Russian Federation;Serbia;Ukraine;United States
   NImmune Biopharma
      2019   Phase 2   NCT03861143   Belarus;Bosnia and Herzegovina;Croatia;Georgia;Hungary;Moldova, Republic of;Poland;Russian Federation;Serbia;Ukraine;United States
BT-11 1000MG
   Landos Biopharma Inc.
      2020   Phase 2   EUCTR2018-005086-39-BG   Belarus;Bosnia and Herzegovina;Bulgaria;Croatia;Georgia;Hungary;Moldova, Republic of;Poland;Russian Federation;Serbia;Ukraine;United States
      2019   Phase 2   EUCTR2018-005086-39-PL   Belarus;Bosnia and Herzegovina;Bulgaria;Croatia;Georgia;Hungary;Moldova, Republic of;Poland;Russian Federation;Serbia;Ukraine;United States
      2019   Phase 2   EUCTR2018-005086-39-HR   Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Georgia;Hungary;Moldova, Republic of;Poland;Russian Federation;Serbia;Ukraine;United States
BT-11 500 MG
   Landos Biopharma Inc.
      2020   Phase 2   EUCTR2018-005086-39-BG   Belarus;Bosnia and Herzegovina;Bulgaria;Croatia;Georgia;Hungary;Moldova, Republic of;Poland;Russian Federation;Serbia;Ukraine;United States
      2019   Phase 2   EUCTR2018-005086-39-PL   Belarus;Bosnia and Herzegovina;Bulgaria;Croatia;Georgia;Hungary;Moldova, Republic of;Poland;Russian Federation;Serbia;Ukraine;United States
      2019   Phase 2   EUCTR2018-005086-39-HR   Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Georgia;Hungary;Moldova, Republic of;Poland;Russian Federation;Serbia;Ukraine;United States
BT051 200 MG
   Adiso Therapeutics
      2021   Phase 1   NCT05084261   Georgia;Moldova, Republic of;Poland;Ukraine;United States
BT051 3200 MG
   Adiso Therapeutics
      2021   Phase 1   NCT05084261   Georgia;Moldova, Republic of;Poland;Ukraine;United States
BT051 800 MG
   Adiso Therapeutics
      2021   Phase 1   NCT05084261   Georgia;Moldova, Republic of;Poland;Ukraine;United States
Budenofalk 2MG rectal foam
   University Hospital Birmingham NHS Foundation Trust
      2009   Phase 4   EUCTR2009-015077-12-GB   United Kingdom
Budenofalk 3MG
   Dr. Falk Pharma GmbH
      2007   Phase 3   EUCTR2006-005377-22-SK   Czech Republic;Germany;Latvia;Lithuania;Poland;Slovakia;Spain
      2007   -   EUCTR2006-005377-22-LV   Czech Republic;Germany;Latvia;Lithuania;Poland;Spain
      2007   -   EUCTR2006-005377-22-LT   Czech Republic;Germany;Latvia;Lithuania;Poland;Spain
      2007   Phase 3   EUCTR2006-005377-22-ES   Czech Republic;Germany;Latvia;Lithuania;Poland;Slovakia;Spain
      2007   -   EUCTR2006-005377-22-DE   Czech Republic;Germany;Latvia;Lithuania;Poland;Spain
      2007   -   EUCTR2006-005377-22-CZ   Czech Republic;Germany;Latvia;Lithuania;Poland;Spain
      -   Phase 3   EUCTR2006-005377-22-PL   Czech Republic;Germany;Latvia;Lithuania;Poland;Slovakia;Spain
Budenofalk rectal foam
   University Hospital Birmingham NHS Foundation Trust
      2009   Phase 4   EUCTR2009-015077-12-GB   United Kingdom
Budenofalk® suppositories
   Dr. Falk Pharma GmbH
      2021   Phase 3   EUCTR2019-003334-16-LV   Belarus;Bulgaria;Germany;Latvia;Poland;Russian Federation;Ukraine
      2021   Phase 3   EUCTR2019-003334-16-BG   Belarus;Bulgaria;Germany;Latvia;Poland;Russian Federation;Ukraine
      2020   Phase 3   EUCTR2019-003334-16-DE   Belarus;Bulgaria;Germany;Latvia;Poland;Russian Federation;Ukraine
Budesonide
   Ajinomoto Pharmaceuticals Co., Ltd.
      2013   Phase 2   JPRN-jRCT2080222245   -
   Bausch Health Americas, Inc.
      2010   Phase 3   NCT01100112   India
   Dr. Falk Pharma GmbH
      2021   Phase 3   EUCTR2019-003334-16-LV   Belarus;Bulgaria;Germany;Latvia;Poland;Russian Federation;Ukraine
      2021   Phase 3   EUCTR2019-003334-16-BG   Belarus;Bulgaria;Germany;Latvia;Poland;Russian Federation;Ukraine
      2020   Phase 3   EUCTR2019-003334-16-DE   Belarus;Bulgaria;Germany;Latvia;Poland;Russian Federation;Ukraine
      2019   Phase 3   EUCTR2017-004576-57-SK   Czech Republic;Czechia;Germany;Hungary;Latvia;Lithuania;Poland;Russian Federation;Serbia;Slovakia;Ukraine
      2019   Phase 3   EUCTR2017-004576-57-PL   Czech Republic;Czechia;Germany;Hungary;Latvia;Lithuania;Poland;Russian Federation;Serbia;Slovakia;Ukraine
      2019   Phase 3   EUCTR2017-004576-57-LV   Czech Republic;Czechia;Germany;Hungary;Latvia;Lithuania;Poland;Russian Federation;Serbia;Slovakia;Ukraine
      2019   Phase 3   EUCTR2017-004576-57-LT   Czech Republic;Czechia;Germany;Hungary;Latvia;Lithuania;Poland;Russian Federation;Serbia;Slovakia;Ukraine
      2019   Phase 3   EUCTR2017-004576-57-HU   Czech Republic;Germany;Hungary;Latvia;Lithuania;Poland;Russian Federation;Slovakia;Ukraine
      2019   Phase 3   EUCTR2017-004576-57-DE   Czech Republic;Czechia;Germany;Hungary;Latvia;Lithuania;Poland;Russian Federation;Serbia;Slovakia;Ukraine
      2019   Phase 3   EUCTR2017-004576-57-CZ   Czech Republic;Czechia;Germany;Hungary;Latvia;Lithuania;Poland;Russian Federation;Serbia;Slovakia;Turkey;Ukraine
      2015   Phase 2   NCT02550418   Germany
      2015   Phase 2   EUCTR2014-005635-14-LV   Hungary;Latvia;Lithuania
      2015   Phase 2   EUCTR2014-005635-14-LT   Hungary;Latvia;Lithuania
      2015   Phase 2   EUCTR2014-005635-14-HU   Hungary;Latvia;Lithuania
      2015   Phase 2   EUCTR2014-005635-14-DE   Germany;Hungary;Latvia;Lithuania
      2007   Phase 3   NCT00747110   Germany
      2007   Phase 3   EUCTR2006-005377-22-SK   Czech Republic;Germany;Latvia;Lithuania;Poland;Slovakia;Spain
      2007   -   EUCTR2006-005377-22-LV   Czech Republic;Germany;Latvia;Lithuania;Poland;Spain
      2007   -   EUCTR2006-005377-22-LT   Czech Republic;Germany;Latvia;Lithuania;Poland;Spain
      2007   Phase 3   EUCTR2006-005377-22-ES   Czech Republic;Germany;Latvia;Lithuania;Poland;Slovakia;Spain
      2007   -   EUCTR2006-005377-22-DE   Czech Republic;Germany;Latvia;Lithuania;Poland;Spain
      2007   -   EUCTR2006-005377-22-CZ   Czech Republic;Germany;Latvia;Lithuania;Poland;Spain
      -   Phase 3   EUCTR2006-005377-22-PL   Czech Republic;Germany;Latvia;Lithuania;Poland;Slovakia;Spain
   EA Pharma Co.,Ltd.
      2018   -   JPRN-jRCT1080223802   Japan
      2014   Phase 3   JPRN-jRCT2080222653   -
   Ferring Pharmaceuticals
      2018   Phase 3   NCT03412682   Japan
   Hyogo College of Medicine
      2018   -   JPRN-UMIN000034016   Japan
   Matsuoka Katsuyoshi
      2022   -   JPRN-jRCTs031210326   -
Budesonide MMX
   Assiut University
      2022   Phase 2/Phase 3   NCT05341401   -
   Bausch Health Americas, Inc.
      2012   Phase 3   NCT01532648   Bulgaria;Canada;Czech Republic;Czechia;Estonia;Hungary;Latvia;Lithuania;Poland;Russian Federation;Ukraine;United States
   COSMO TECHNOLOGIES LTD
      2008   -   EUCTR2006-004776-12-IT   Belgium;Estonia;France;Italy;Latvia;Lithuania;Sweden;United Kingdom
   Ferring Pharmaceuticals
      2015   -   NCT02586259   Canada;Germany;Ireland;Israel;Italy;Netherlands;Poland;Sweden;Switzerland;United Kingdom
Budesonide MMX 6 MG tablet
   Bausch Health Americas, Inc.
      2008   Phase 3   NCT00801723   Canada;United States
Budesonide MMX® 6 MG
   Bausch Health Americas, Inc.
      2008   Phase 3   NCT00679380   Australia;Belgium;Estonia;France;Israel;Italy;Latvia;Lithuania;Poland;Romania;Russian Federation;Slovakia;Sweden;Ukraine;United Kingdom
Budesonide MMX® 9 MG
   Bausch Health Americas, Inc.
      2008   Phase 3   NCT00679380   Australia;Belgium;Estonia;France;Israel;Italy;Latvia;Lithuania;Poland;Romania;Russian Federation;Slovakia;Sweden;Ukraine;United Kingdom
Budesonide-MMX
   COSMO TECHNOLOGIES LTD
      2009   -   EUCTR2008-003913-28-IT   Italy
      2008   -   EUCTR2006-004776-12-IT   Belgium;Estonia;France;Italy;Latvia;Lithuania;Sweden;United Kingdom
   COSMO Technologies Ltd
      2008   Phase 3   EUCTR2006-004776-12-SK   Belgium;Estonia;France;Italy;Latvia;Lithuania;Slovakia;Sweden;United Kingdom
      2008   -   EUCTR2006-004776-12-SE   Belgium;Estonia;France;Italy;Latvia;Lithuania;Sweden;United Kingdom
      2008   -   EUCTR2006-004776-12-LV   Belgium;Estonia;France;Italy;Latvia;Lithuania;Sweden;United Kingdom
      2008   -   EUCTR2006-004776-12-LT   Belgium;Estonia;France;Italy;Latvia;Lithuania;Sweden;United Kingdom
      2008   Phase 3   EUCTR2006-004776-12-GB   Belgium;Estonia;France;Italy;Latvia;Lithuania;Slovakia;Sweden;United Kingdom
      2008   -   EUCTR2006-004776-12-FR   Belgium;Estonia;France;Italy;Latvia;Lithuania;Sweden;United Kingdom
      2008   -   EUCTR2006-004776-12-EE   Belgium;Estonia;France;Italy;Latvia;Lithuania;Sweden;United Kingdom
      2008   -   EUCTR2006-004776-12-BE   Belgium;Estonia;France;Italy;Latvia;Lithuania;Sweden;United Kingdom
   Santarus, Inc.
      2012   -   EUCTR2011-005115-82-PL   Bulgaria;Canada;Czech Republic;Estonia;Hungary;Latvia;Lithuania;Poland;Ukraine;United States
      2012   -   EUCTR2011-005115-82-LV   Bulgaria;Canada;Czech Republic;Estonia;Hungary;Latvia;Lithuania;Poland;Ukraine;United States
      2012   -   EUCTR2011-005115-82-LT   Bulgaria;Canada;Czech Republic;Estonia;Hungary;Latvia;Lithuania;Poland;Ukraine;United States
      2012   -   EUCTR2011-005115-82-HU   Bulgaria;Canada;Czech Republic;Estonia;Hungary;Latvia;Lithuania;Poland;Ukraine;United States
      2012   -   EUCTR2011-005115-82-EE   Bulgaria;Canada;Czech Republic;Estonia;Hungary;Latvia;Lithuania;Poland;Ukraine;United States
      2012   -   EUCTR2011-005115-82-CZ   Bulgaria;Canada;Czech Republic;Estonia;Hungary;Latvia;Lithuania;Poland;Ukraine;United States
      2012   -   EUCTR2011-005115-82-BG   Bulgaria;Canada;Czech Republic;Estonia;Hungary;Latvia;Lithuania;Poland;Ukraine;United States
Budesonide-MMX® 6 MG
   Bausch Health Americas, Inc.
      2008   Phase 3   NCT00679432   Canada;India;Mexico;United States
Budesonide-MMX® 9 MG
   Bausch Health Americas, Inc.
      2008   Phase 3   NCT00679432   Canada;India;Mexico;United States
Bupropion-SR
   Eva Szigethy
      2013   Phase 4   NCT02162862   United States
Butanoic acid
   SIGMA-TAU
      2012   -   EUCTR2011-004765-32-IT   Belgium;Czech Republic;Italy;Netherlands
   Sigma-Tau Industrie Farmaceutiche Riunite S.p.A.
      2012   -   EUCTR2011-004770-28-PL   Austria;France;Germany;Hungary;Latvia;Lithuania;Poland;Spain
      2012   -   EUCTR2011-004770-28-LV   Austria;France;Germany;Hungary;Latvia;Lithuania;Poland;Spain
      2012   -   EUCTR2011-004770-28-LT   Austria;France;Germany;Hungary;Latvia;Lithuania;Poland;Spain
      2012   -   EUCTR2011-004770-28-HU   Austria;Germany;Hungary;Latvia;Lithuania;Poland;Spain
      2012   Phase 3   EUCTR2011-004770-28-ES   Austria;France;Germany;Hungary;Latvia;Lithuania;Poland;Spain
      2012   -   EUCTR2011-004770-28-DE   Austria;Germany;Hungary;Latvia;Lithuania;Poland;Spain
      2012   -   EUCTR2011-004770-28-AT   Austria;Germany;Hungary;Latvia;Lithuania;Poland;Spain
      2012   Phase 3   EUCTR2011-004765-32-SK   Belgium;Czech Republic;Italy;Netherlands;Slovakia
      2012   Phase 3   EUCTR2011-004765-32-NL   Belgium;Czech Republic;Israel;Italy;Netherlands;Russian Federation;Slovakia
      2012   -   EUCTR2011-004765-32-CZ   Belgium;Czech Republic;Italy;Netherlands
      2012   Phase 3   EUCTR2011-004765-32-BE   Belgium;Czech Republic;Italy;Netherlands;Slovakia
Butyrate
   Children's Hospital Los Angeles
      2022   Phase 1   NCT05218850   United States
   University of Padova
      2020   -   NCT04879914   Italy
BY demand
   Hospital Galdakao-Usansolo
      2020   -   NCT04188990   Spain
Cacit D3 effervescent granules, 500 MG/440 IU
   United Bristol Healthcare Trust
      2005   -   EUCTR2004-004325-10-GB   United Kingdom
Caffeine
   Takeda
      2016   Phase 4   NCT02760615   United States
Caffeine 100 MG
   Janssen Research & Development, LLC
      2018   Phase 1   NCT03358706   Austria;Belgium;Denmark;Germany;Sweden;United Kingdom;United States
Calcio
   ASTRAZENECA AB
      2021   Phase 2   EUCTR2021-001644-10-IT   Austria;Canada;Czechia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Poland;Russian Federation;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
Calcium
   Nagahara Akihito
      2023   Phase 2   JPRN-jRCTs031220542   -
Calcium carbonate 600 MG once daily
   Sheba Medical Center
      2015   -   NCT02470663   -
Calprotectin
   Beijing Friendship Hospital, Capital Medical University
      2019   -   ChiCTR1900021229   China
   Connecticut Children's Medical Center
      2015   -   NCT02984059   United States
   Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives
      2020   Phase 4   NCT04183608   France
Caltrate
   Second Affiliated Hospital of Wenzhou Medical University
      2015   -   NCT04276649   China
Cannabidiol
   GW Pharma Ltd.
      2013   Phase 2   EUCTR2011-003208-19-CZ   Czech Republic;United Kingdom
      2011   Phase 2   EUCTR2011-003208-19-GB   Czech Republic;United Kingdom
   Meir Medical Center
      2010   Phase 1/Phase 2   NCT01037322   Israel
Cannabis, medical
   OMNI Medical Services, LLC
      2018   Phase 2   NCT03944447   United States
Carbon
   Hyogo College of Medicine, Department of Internal medicine, Division of Lower GI disease
      2007   Phase 2,3   JPRN-UMIN000004401   Japan
Carbon dioxide insufflation
   Osaka University, Graduate School of Medicine, Department of Gastroenterology and Hepatology
      2015   -   JPRN-UMIN000018801   Japan
   Vitkovice Hospital
      2015   -   NCT02563132   Czech Republic
Carbon dioxide insufflation during colonoscopy
   University Hospital Muenster
      2017   -   NCT03282786   Germany
Carbossimaltosio ferrico
   FONDAZIONE I.R.C.C.S. POLICLINICO SAN MATTEO
      2017   Phase 3   EUCTR2016-001772-30-IT   Italy
Carotegrast methyl
   Takayuki Yamamoto
      2022   Phase 4   NCT06897150   Japan
Carvi extractum fluidum
   Steigerwald Arzneimittelwerk GmbH
      2014   -   EUCTR2013-000891-13-DE   Germany
Casein
   University of Aarhus
      2016   -   NCT02825914   Denmark
CAT-354
   ASTRAZENECA
      2011   -   EUCTR2011-004812-40-IT   Czech Republic;Germany;Italy;Netherlands;United Kingdom
   AstraZeneca AB
      2012   -   EUCTR2011-004812-40-NL   Czech Republic;Italy;Netherlands;United Kingdom
      2012   Phase 2   EUCTR2011-004812-40-GB   Czech Republic;Germany;Italy;Netherlands;United Kingdom
      2012   -   EUCTR2011-004812-40-DE   Czech Republic;Germany;Italy;Netherlands;United Kingdom
      2012   -   EUCTR2011-004812-40-CZ   Czech Republic;Italy;Netherlands;United Kingdom
Catridecacog
   Novo Nordisk A/S
      2013   -   EUCTR2011-001568-22-HU   Bulgaria;Croatia;Denmark;European Union;Hungary;Russian Federation;Ukraine
      2012   Phase 2   NCT01706159   Bulgaria;Croatia;Denmark;Hungary;Poland;Russian Federation;Ukraine
      2012   -   EUCTR2011-001568-22-DK   Bulgaria;Croatia;Denmark;European Union;Hungary;Russian Federation;Ukraine
      2012   -   EUCTR2011-001568-22-BG   Bulgaria;Croatia;Denmark;European Union;Hungary;Russian Federation;Ukraine
CB-01-02
   COSMO TECHNOLOGIES LTD
      2009   -   EUCTR2008-003913-28-IT   Italy
      2008   -   EUCTR2006-004776-12-IT   Belgium;Estonia;France;Italy;Latvia;Lithuania;Sweden;United Kingdom
   COSMO Technologies Ltd
      2008   Phase 3   EUCTR2006-004776-12-SK   Belgium;Estonia;France;Italy;Latvia;Lithuania;Slovakia;Sweden;United Kingdom
      2008   -   EUCTR2006-004776-12-SE   Belgium;Estonia;France;Italy;Latvia;Lithuania;Sweden;United Kingdom
      2008   -   EUCTR2006-004776-12-LV   Belgium;Estonia;France;Italy;Latvia;Lithuania;Sweden;United Kingdom
      2008   -   EUCTR2006-004776-12-LT   Belgium;Estonia;France;Italy;Latvia;Lithuania;Sweden;United Kingdom
      2008   Phase 3   EUCTR2006-004776-12-GB   Belgium;Estonia;France;Italy;Latvia;Lithuania;Slovakia;Sweden;United Kingdom
      2008   -   EUCTR2006-004776-12-FR   Belgium;Estonia;France;Italy;Latvia;Lithuania;Sweden;United Kingdom
      2008   -   EUCTR2006-004776-12-EE   Belgium;Estonia;France;Italy;Latvia;Lithuania;Sweden;United Kingdom
      2008   -   EUCTR2006-004776-12-BE   Belgium;Estonia;France;Italy;Latvia;Lithuania;Sweden;United Kingdom
CB-01-05-MMX
   COSMO TECHNOLOGIES LTD
      2006   -   EUCTR2006-001782-42-IT   Hungary;Italy;United Kingdom
   Cosmo Technologies Ltd
      2006   -   EUCTR2006-001782-42-HU   Hungary;Italy;United Kingdom
      2006   Phase 2   EUCTR2006-001782-42-GB   Hungary;Italy;United Kingdom
CBD, synthetic form
   CannaMore Biotechs
      2023   Phase 2   NCT06353828   Israel
CBP-307
   Suzhou Connect Biopharmaceuticals, Ltd.
      2019   Phase 2   NCT04700449   China;Pakistan;Ukraine;United States
CC-10004
   CELGENE CORPORATION
      2015   Phase 2   EUCTR2014-002981-64-IT   Australia;Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Netherlands;New Zealand;Poland;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States
   Celgene Corporation
      2016   Phase 2   EUCTR2014-002981-64-BG   Australia;Bulgaria;Canada;Czech Republic;France;Germany;Hungary;Italy;Netherlands;New Zealand;Poland;Russian Federation;Slovakia;Ukraine;United States
      2015   Phase 2   EUCTR2014-002981-64-NL   Australia;Bulgaria;Canada;Czech Republic;France;Germany;Hungary;Italy;Netherlands;New Zealand;Poland;United Kingdom;United States
      2015   -   EUCTR2014-002981-64-HU   Australia;Bulgaria;Canada;Czech Republic;France;Germany;Hungary;Italy;Netherlands;New Zealand;Poland;Slovakia;Turkey;Ukraine;United Kingdom;United States
      2015   Phase 2   EUCTR2014-002981-64-DE   Australia;Bulgaria;Canada;Czech Republic;France;Germany;Hungary;Italy;Netherlands;New Zealand;Poland;Russian Federation;Slovakia;Ukraine;United States
      2015   Phase 2   EUCTR2014-002981-64-CZ   Australia;Bulgaria;Canada;Czech Republic;France;Germany;Hungary;Italy;Netherlands;New Zealand;Poland;Russian Federation;Slovakia;Ukraine;United States
CD7 CAR T-cells
   Zhejiang University
      2022   Early Phase 1   NCT05239702   China
Cded (crohn'S disease exclusion diet) IN addition TO ANTI-TNF therapy
   IRCCS Ospedale San Raffaele
      2025   -   NCT06896305   Italy
Ceftriaxone
   Postgraduate Institute of Medical Education and Research
      2019   Phase 2   NCT03794765   India
Cefuroxime
   University of Dundee
      2006   -   NCT00355602   United Kingdom
Celecoxib
   Southwest Hospital, China
      2024   -   NCT05960864   -
Cgmp protein
   University of Aarhus
      2012   -   NCT01534312   Denmark
Chloride
   SIGMA-TAU
      2012   -   EUCTR2011-004765-32-IT   Belgium;Czech Republic;Italy;Netherlands
   Sigma-Tau Industrie Farmaceutiche Riunite S.p.A.
      2012   -   EUCTR2011-004770-28-PL   Austria;France;Germany;Hungary;Latvia;Lithuania;Poland;Spain
      2012   -   EUCTR2011-004770-28-LV   Austria;France;Germany;Hungary;Latvia;Lithuania;Poland;Spain
      2012   -   EUCTR2011-004770-28-LT   Austria;France;Germany;Hungary;Latvia;Lithuania;Poland;Spain
      2012   -   EUCTR2011-004770-28-HU   Austria;Germany;Hungary;Latvia;Lithuania;Poland;Spain
      2012   Phase 3   EUCTR2011-004770-28-ES   Austria;France;Germany;Hungary;Latvia;Lithuania;Poland;Spain
      2012   -   EUCTR2011-004770-28-DE   Austria;Germany;Hungary;Latvia;Lithuania;Poland;Spain
      2012   -   EUCTR2011-004770-28-AT   Austria;Germany;Hungary;Latvia;Lithuania;Poland;Spain
      2012   Phase 3   EUCTR2011-004765-32-SK   Belgium;Czech Republic;Italy;Netherlands;Slovakia
      2012   Phase 3   EUCTR2011-004765-32-NL   Belgium;Czech Republic;Israel;Italy;Netherlands;Russian Federation;Slovakia
      2012   -   EUCTR2011-004765-32-CZ   Belgium;Czech Republic;Italy;Netherlands
      2012   Phase 3   EUCTR2011-004765-32-BE   Belgium;Czech Republic;Italy;Netherlands;Slovakia
Chlorogenic acid
   Nutrition Science Partners Limited
      2014   -   EUCTR2013-003060-31-PL   Bulgaria;Czech Republic;Hungary;Latvia;Lithuania;Poland;Ukraine;United States
      2014   -   EUCTR2013-003060-31-LV   Bulgaria;Czech Republic;Hungary;Latvia;Lithuania;Poland;Ukraine;United States
      2014   -   EUCTR2013-003060-31-LT   Bulgaria;Czech Republic;Hungary;Latvia;Lithuania;Poland;Ukraine;United States
      2014   -   EUCTR2013-003060-31-HU   Bulgaria;Czech Republic;Hungary;Latvia;Lithuania;Poland;Ukraine;United States
      2014   -   EUCTR2013-003060-31-CZ   Bulgaria;Czech Republic;Hungary;Latvia;Lithuania;Poland;Ukraine;United States
      2014   -   EUCTR2013-003060-31-BG   Bulgaria;Czech Republic;Hungary;Latvia;Lithuania;Poland;Ukraine;United States
      2013   -   EUCTR2013-002116-27-LV   Bulgaria;Czech Republic;Hungary;Korea, Republic of;Latvia;Lithuania;Poland;Ukraine;United States
      2013   -   EUCTR2013-002116-27-LT   Bulgaria;Czech Republic;Hungary;Korea, Republic of;Latvia;Lithuania;Poland;Ukraine;United States
      2013   -   EUCTR2013-002116-27-HU   Bulgaria;Czech Republic;Hungary;Korea, Republic of;Latvia;Lithuania;Poland;Ukraine;United States
      2013   Phase 3   EUCTR2013-002116-27-CZ   Bulgaria;Czech Republic;Hungary;Korea, Republic of;Latvia;Lithuania;Poland;Ukraine;United States
      2013   -   EUCTR2013-002116-27-BG   Bulgaria;Czech Republic;Hungary;Latvia;Lithuania;Poland;Ukraine;United States
Cholecalciferol
   Boston Children’s Hospital
      2008   -   NCT00621257   United States
   Emory University
      2013   Phase 1/Phase 2   NCT02076750   United States
   Medical clinic, University Hospital of North Norway
      2009   Phase 4   EUCTR2009-015649-21-NO   Norway
Chronic- PF-06480605 150 MG SC Q4W
   Hoffmann-La Roche
      2019   Phase 2   NCT04090411   Australia;Austria;Belgium;Bulgaria;Canada;Colombia;France;Germany;Hungary;India;Italy;Japan;Mexico;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Thailand;Turkey;Ukraine;United Kingdom;United States
Chronic- PF-06480605 450 MG SC Q4W
   Hoffmann-La Roche
      2019   Phase 2   NCT04090411   Australia;Austria;Belgium;Bulgaria;Canada;Colombia;France;Germany;Hungary;India;Italy;Japan;Mexico;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Thailand;Turkey;Ukraine;United Kingdom;United States
Chronic- PF-06480605 50 MG SC Q4W
   Hoffmann-La Roche
      2019   Phase 2   NCT04090411   Australia;Austria;Belgium;Bulgaria;Canada;Colombia;France;Germany;Hungary;India;Italy;Japan;Mexico;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Thailand;Turkey;Ukraine;United Kingdom;United States
Ciclosporin
   GETAID
      2008   -   EUCTR2006-005299-42-BE   Belgium;Finland;France;Spain
      2007   -   EUCTR2006-005299-42-FR   Belgium;Finland;France;Spain
   Groupe d'Etude Thérapeutique des Affections Inflammatoires Digestives (G.E.T.A.I.D.)
      2008   -   EUCTR2006-005299-42-FI   Belgium;Finland;France;Spain
   Sigmoid Pharma Ltd
      2010   Phase 2   EUCTR2008-003169-19-GB   Ireland;United Kingdom
      2009   -   EUCTR2008-003169-19-IE   Ireland;United Kingdom
   Sublimity Therapeutics (Hold Co) Ltd.
      2019   Phase 2   EUCTR2018-003349-41-RO   Belarus;Bulgaria;Canada;France;Germany;Hungary;Israel;Italy;Poland;Romania;Russian Federation;Serbia;Ukraine;United Kingdom;United States
      2019   Phase 2   EUCTR2018-003349-41-PL   Belarus;Bulgaria;Canada;France;Germany;Hungary;Israel;Italy;Poland;Russian Federation;Serbia;Ukraine;United Kingdom;United States
      2019   Phase 2   EUCTR2018-003349-41-HU   Belarus;Belgium;Bulgaria;Canada;France;Germany;Hungary;Ireland;Israel;Poland;Romania;Russian Federation;Serbia;Spain;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 2   EUCTR2018-003349-41-GB   Belarus;Bulgaria;Canada;France;Germany;Hungary;Ireland;Israel;Italy;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
      2019   Phase 2   EUCTR2018-003349-41-FR   Belarus;Bulgaria;Canada;France;Germany;Hungary;Ireland;Israel;Italy;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
      2019   Phase 2   EUCTR2018-003349-41-DE   Belarus;Bulgaria;Canada;France;Germany;Hungary;Israel;Poland;Russian Federation;Serbia;Ukraine;United Kingdom;United States
      2019   Phase 2   EUCTR2018-003349-41-BG   Belarus;Bulgaria;Canada;France;Germany;Hungary;Ireland;Israel;Italy;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
   Sublimity Therapeutics HoldCo Limited
      2019   Phase 2   EUCTR2018-003349-41-IT   Belarus;Bulgaria;Canada;France;Germany;Hungary;Ireland;Israel;Italy;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
Ciclosporina
   GETECCU (Grupo Español para el estudio de la enfermedad de Crohn y la colitis ulcerosa)
      2008   -   EUCTR2006-005299-42-ES   Belgium;Finland;France;Spain
Cimzia
   University of Washington
      2010   Phase 2   NCT01090154   United States
Ciprofloxacin
   Hvidovre University Hospital
      2011   Phase 4   NCT01772615   Denmark
   University of Dundee
      2006   -   NCT00355602   United Kingdom
CLA
   Nutrition Science Partners Limited
      2014   -   EUCTR2013-003060-31-PL   Bulgaria;Czech Republic;Hungary;Latvia;Lithuania;Poland;Ukraine;United States
      2014   -   EUCTR2013-003060-31-LV   Bulgaria;Czech Republic;Hungary;Latvia;Lithuania;Poland;Ukraine;United States
      2014   -   EUCTR2013-003060-31-LT   Bulgaria;Czech Republic;Hungary;Latvia;Lithuania;Poland;Ukraine;United States
      2014   -   EUCTR2013-003060-31-HU   Bulgaria;Czech Republic;Hungary;Latvia;Lithuania;Poland;Ukraine;United States
      2014   -   EUCTR2013-003060-31-CZ   Bulgaria;Czech Republic;Hungary;Latvia;Lithuania;Poland;Ukraine;United States
      2014   -   EUCTR2013-003060-31-BG   Bulgaria;Czech Republic;Hungary;Latvia;Lithuania;Poland;Ukraine;United States
      2013   -   EUCTR2013-002116-27-LV   Bulgaria;Czech Republic;Hungary;Korea, Republic of;Latvia;Lithuania;Poland;Ukraine;United States
      2013   -   EUCTR2013-002116-27-LT   Bulgaria;Czech Republic;Hungary;Korea, Republic of;Latvia;Lithuania;Poland;Ukraine;United States
      2013   -   EUCTR2013-002116-27-HU   Bulgaria;Czech Republic;Hungary;Korea, Republic of;Latvia;Lithuania;Poland;Ukraine;United States
      2013   Phase 3   EUCTR2013-002116-27-CZ   Bulgaria;Czech Republic;Hungary;Korea, Republic of;Latvia;Lithuania;Poland;Ukraine;United States
      2013   -   EUCTR2013-002116-27-BG   Bulgaria;Czech Republic;Hungary;Latvia;Lithuania;Poland;Ukraine;United States
Clarithromycin
   University of Dundee
      2006   -   NCT00355602   United Kingdom
Clipper
   CHIESI
      2007   -   EUCTR2006-004230-32-IT   Belgium;Italy;Poland;Spain
   CHIESI ESPAÑA S.A.U.
      2017   Phase 3   EUCTR2017-000330-61-ES   Spain
   CHIESI Farmaceutici S.p.A.
      2007   -   EUCTR2006-004230-32-BE   Belgium;Italy;Poland;Spain
   Chiesi Farmaceutici SpA
      2007   Phase 3   EUCTR2006-004230-32-PL   Belgium;Italy;Poland;Spain
      2007   Phase 3   EUCTR2006-004230-32-ES   Belgium;Italy;Poland;Spain
Cloruro DI potassio
   IPSEN PHARMA SAS
      2017   Phase 3   EUCTR2016-002265-60-IT   Czech Republic;Czechia;France;Germany;Italy;Netherlands;Poland
Cloruro DI sodio
   IPSEN PHARMA SAS
      2017   Phase 3   EUCTR2016-002265-60-IT   Czech Republic;Czechia;France;Germany;Italy;Netherlands;Poland
Clotrimazole
   Web
      2002   Phase 1/Phase 2   NCT00061282   United States
CMTS0929
   The Second Hospital of Nanjing Medical University
      2025   Early Phase 1   NCT06844708   China
Cnto 148
   Centocor BV
      2010   -   EUCTR2006-003398-28-CZ   Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden
      2008   -   EUCTR2006-003399-37-LT   Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden
      2008   -   EUCTR2006-003398-28-SE   Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden
      2008   -   EUCTR2006-003398-28-NL   Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden
      2008   -   EUCTR2006-003398-28-LT   Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden
      2008   -   EUCTR2006-003398-28-DK   Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden
      2008   -   EUCTR2006-003398-28-BG   Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden
      2008   -   EUCTR2006-003397-94-SE   Austria;Belgium;Bulgaria;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden
      2008   -   EUCTR2006-003397-94-NL   Austria;Belgium;Bulgaria;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden
      2008   -   EUCTR2006-003397-94-LT   Austria;Belgium;Bulgaria;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden
      2008   -   EUCTR2006-003397-94-BG   Austria;Belgium;Bulgaria;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden
      2007   Phase 3   EUCTR2006-003399-37-FR   Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Slovakia;Sweden
      2007   Phase 2;Phase 3   EUCTR2006-003398-28-SK   Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Slovakia;Sweden
      2007   -   EUCTR2006-003398-28-LV   Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden
      2007   -   EUCTR2006-003398-28-HU   Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden
      2007   Phase 2;Phase 3   EUCTR2006-003398-28-FR   Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Slovakia;Sweden
      2007   -   EUCTR2006-003398-28-DE   Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden
      2007   -   EUCTR2006-003398-28-BE   Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden
      2007   -   EUCTR2006-003398-28-AT   Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden
      2007   Phase 2;Phase 3   EUCTR2006-003397-94-SK   Austria;Belgium;Bulgaria;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Slovakia;Sweden
      2007   -   EUCTR2006-003397-94-LV   Austria;Belgium;Bulgaria;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden
      2007   Phase 2;Phase 3   EUCTR2006-003397-94-HU   Austria;Belgium;Bulgaria;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Slovakia;Sweden
      2007   Phase 2;Phase 3   EUCTR2006-003397-94-FR   Austria;Belgium;Bulgaria;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Slovakia;Sweden
      2007   -   EUCTR2006-003397-94-DE   Austria;Belgium;Bulgaria;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden
      2007   -   EUCTR2006-003397-94-BE   Austria;Belgium;Bulgaria;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden
      2007   -   EUCTR2006-003397-94-AT   Austria;Belgium;Bulgaria;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden
   Janssen Biologics B.V.
      2010   -   EUCTR2006-003399-37-CZ   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;India;Israel;Japan;Latvia;Lithuania;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Sweden;Ukraine;United States
      2008   -   EUCTR2006-003399-37-SE   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;India;Israel;Japan;Latvia;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Sweden;Ukraine;United States
      2008   -   EUCTR2006-003399-37-DK   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;India;Israel;Japan;Latvia;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Sweden;Ukraine;United States
      2008   -   EUCTR2006-003399-37-BG   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;India;Israel;Japan;Latvia;Lithuania;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Sweden;Ukraine;United States
      2007   -   EUCTR2006-003399-37-LV   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;India;Israel;Japan;Latvia;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Sweden;Ukraine;United States
      2007   -   EUCTR2006-003399-37-HU   Australia;Austria;Belgium;Bulgaria;Czech Republic;Denmark;Finland;France;Germany;Hungary;India;Israel;Latvia;Lithuania;Netherlands;New Zealand;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Sweden;Ukraine
      2007   -   EUCTR2006-003399-37-DE   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;India;Israel;Japan;Latvia;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Sweden;Ukraine;United States
      2007   -   EUCTR2006-003399-37-BE   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;India;Israel;Japan;Latvia;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Sweden;Ukraine;United States
      2007   -   EUCTR2006-003399-37-AT   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;India;Israel;Japan;Latvia;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Sweden;Ukraine;United States
   Janssen Biologics BV
      2008   -   EUCTR2006-003399-37-NL   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;India;Israel;Japan;Latvia;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Sweden;Ukraine;United States
      2007   Phase 3   EUCTR2006-003399-37-SK   Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Slovakia;Sweden
CNTO-148
   University Medical Centre Ljubljana, Department of gastroenterology
      2020   Phase 4   EUCTR2019-003987-37-SI   Slovenia
CNTO1275
   JANSSEN CILAG INTERNATIONAL NV
      2019   Phase 3   EUCTR2018-002629-51-IT   Austria;Czech Republic;France;Germany;Italy;Netherlands;Spain;Sweden;United Kingdom;United States
      2015   Phase 3   EUCTR2014-005606-38-IT   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;United Kingdom;United States
   Janssen-Cilag International N.V.
      2020   Phase 3   EUCTR2018-002629-51-GB   Austria;France;Germany;Italy;Netherlands;Spain;Sweden;United Kingdom;United States
      2019   Phase 3   EUCTR2018-002629-51-SE   Austria;Czech Republic;Czechia;France;Germany;Italy;Korea, Republic of;Netherlands;Russian Federation;Spain;Sweden;United Kingdom;United States
      2019   Phase 3   EUCTR2018-002629-51-FR   Austria;Czech Republic;France;Germany;Italy;Netherlands;Spain;Sweden;United Kingdom;United States
      2018   Phase 3   EUCTR2018-002629-51-ES   France;Germany;Netherlands;Spain;Sweden;United States
   Janssen-Cilag International NV
      2022   Phase 3   EUCTR2020-004457-76-HU   Argentina;Belgium;France;Germany;Hungary;Italy;Japan;Poland;Russian Federation;Spain;Turkey;United Kingdom;United States
      2022   Phase 3   EUCTR2020-004457-76-DE   Argentina;Belgium;France;Germany;Hungary;Italy;Japan;Poland;Russian Federation;Spain;Turkey;United Kingdom;United States
      2022   Phase 3   EUCTR2020-004457-76-BE   Argentina;Belgium;France;Germany;Hungary;Italy;Japan;Poland;Russian Federation;Spain;Turkey;United Kingdom;United States
      2021   Phase 3   EUCTR2020-004457-76-PL   Argentina;Belgium;France;Germany;Hungary;Japan;Poland;Russian Federation;Turkey;United States
      2021   Phase 3   EUCTR2019-004224-38-DE   Belgium;Germany;Hungary;Japan;Poland;United Kingdom;United States
      2021   Phase 3   EUCTR2019-004224-38-BE   Belgium;Germany;Hungary;Japan;Poland;Russian Federation;United Kingdom;United States
      2021   Phase 3   EUCTR2018-002629-51-CZ   Austria;Czech Republic;Czechia;France;Germany;Italy;Korea, Republic of;Netherlands;Russian Federation;Spain;Sweden;United Kingdom;United States
      2020   Phase 3   EUCTR2019-004224-38-HU   Belgium;Germany;Hungary;Japan;Poland;Russian Federation;United Kingdom;United States
      2019   Phase 3   EUCTR2018-002629-51-NL   Austria;Czech Republic;Czechia;France;Germany;Italy;Korea, Republic of;Netherlands;Russian Federation;Spain;Sweden;United Kingdom;United States
      2019   Phase 3   EUCTR2018-002629-51-AT   Austria;Czech Republic;Czechia;France;Germany;Italy;Korea, Republic of;Netherlands;Russian Federation;Spain;Sweden;United Kingdom;United States
      2016   Phase 3   EUCTR2014-005606-38-PL   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;United Kingdom;United States
      2015   Phase 3   EUCTR2014-005606-38-SK   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;United Kingdom;United States
      2015   Phase 3   EUCTR2014-005606-38-NL   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;United Kingdom;United States
      2015   Phase 3   EUCTR2014-005606-38-HU   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;United Kingdom;United States
      2015   Phase 3   EUCTR2014-005606-38-DK   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;United Kingdom;United States
      2015   Phase 3   EUCTR2014-005606-38-DE   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;United Kingdom;United States
      2015   Phase 3   EUCTR2014-005606-38-CZ   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;United Kingdom;United States
      2015   Phase 3   EUCTR2014-005606-38-BG   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;United Kingdom;United States
      2015   Phase 3   EUCTR2014-005606-38-BE   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;United Kingdom;United States
      2015   Phase 3   EUCTR2014-005606-38-AT   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;United Kingdom;United States
      -   Phase 3   EUCTR2019-004224-38-PL   Belgium;Germany;Hungary;Japan;Poland;Russian Federation;United Kingdom;United States
      -   Phase 3   EUCTR2019-004224-38-Outside-EU/EEA   Belgium;Germany;Hungary;Japan;Poland;Russian Federation;United Kingdom;United States
      -   Phase 3   EUCTR2019-004224-38-GB   Belgium;Germany;Hungary;Japan;Poland;Russian Federation;United Kingdom;United States
CNTO148
   Centocor BV
      2010   -   EUCTR2006-003398-28-CZ   Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden
      2008   -   EUCTR2006-003398-28-SE   Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden
      2008   -   EUCTR2006-003398-28-NL   Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden
      2008   -   EUCTR2006-003398-28-LT   Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden
      2008   -   EUCTR2006-003398-28-DK   Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden
      2008   -   EUCTR2006-003398-28-BG   Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden
      2008   -   EUCTR2006-003397-94-SE   Austria;Belgium;Bulgaria;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden
      2008   -   EUCTR2006-003397-94-NL   Austria;Belgium;Bulgaria;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden
      2008   -   EUCTR2006-003397-94-LT   Austria;Belgium;Bulgaria;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden
      2008   -   EUCTR2006-003397-94-BG   Austria;Belgium;Bulgaria;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden
      2007   Phase 2;Phase 3   EUCTR2006-003398-28-SK   Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Slovakia;Sweden
      2007   -   EUCTR2006-003398-28-LV   Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden
      2007   -   EUCTR2006-003398-28-HU   Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden
      2007   Phase 2;Phase 3   EUCTR2006-003398-28-FR   Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Slovakia;Sweden
      2007   -   EUCTR2006-003398-28-DE   Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden
      2007   -   EUCTR2006-003398-28-BE   Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden
      2007   -   EUCTR2006-003398-28-AT   Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden
      2007   Phase 2;Phase 3   EUCTR2006-003397-94-SK   Austria;Belgium;Bulgaria;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Slovakia;Sweden
      2007   -   EUCTR2006-003397-94-LV   Austria;Belgium;Bulgaria;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden
      2007   Phase 2;Phase 3   EUCTR2006-003397-94-HU   Austria;Belgium;Bulgaria;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Slovakia;Sweden
      2007   Phase 2;Phase 3   EUCTR2006-003397-94-FR   Austria;Belgium;Bulgaria;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Slovakia;Sweden
      2007   -   EUCTR2006-003397-94-DE   Austria;Belgium;Bulgaria;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden
      2007   -   EUCTR2006-003397-94-BE   Austria;Belgium;Bulgaria;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden
      2007   -   EUCTR2006-003397-94-AT   Austria;Belgium;Bulgaria;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden
   JANSSEN CILAG INTERNATIONAL NV
      2022   Phase 2   EUCTR2021-005528-39-IT   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;Finland;France;Georgia;Germany;Greece;Hong Kong;Hungary;India;Ireland;Israel;Italy;Japan;Jordan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
   Janssen Biologics B.V.
      2019   Phase 3   EUCTR2017-004496-31-IT   Belgium;Brazil;France;Israel;Italy;Korea, Republic of;Netherlands;Poland;Spain;Taiwan;United States
      2015   Phase 2   EUCTR2013-002042-36-FR   Belgium;Bulgaria;Canada;Czech Republic;France;Germany;Hungary;Israel;Netherlands;Poland;Russian Federation;Ukraine;United States
      2014   Phase 2   EUCTR2013-002042-36-PL   Belgium;Bulgaria;Canada;Czech Republic;France;Germany;Hungary;Israel;Netherlands;Poland;Russian Federation;Ukraine;United States
      2014   -   EUCTR2013-002042-36-NL   Belgium;Bulgaria;Canada;Czech Republic;France;Germany;Hungary;Israel;Netherlands;Poland;Russian Federation;Ukraine;United States
      2014   -   EUCTR2013-002042-36-HU   Belgium;Bulgaria;Canada;Czech Republic;France;Germany;Hungary;Israel;Netherlands;Poland;Russian Federation;Ukraine;United States
      2014   -   EUCTR2013-002042-36-DE   Belgium;Bulgaria;Canada;Czech Republic;France;Germany;Hungary;Israel;Netherlands;Poland;Russian Federation;Ukraine;United States
      2014   -   EUCTR2013-002042-36-CZ   Belgium;Bulgaria;Canada;Czech Republic;France;Germany;Hungary;Israel;Netherlands;Poland;Russian Federation;Ukraine;United States
      2014   Phase 2   EUCTR2013-002042-36-BG   Belgium;Bulgaria;Canada;Czech Republic;France;Germany;Hungary;Israel;Netherlands;Poland;Russian Federation;Ukraine;United States
      2014   -   EUCTR2013-002042-36-BE   Belgium;Bulgaria;Canada;Czech Republic;France;Germany;Hungary;Israel;Netherlands;Poland;Russian Federation;Ukraine;United States
      2014   Phase 1   EUCTR2012-004366-18-BE   Austria;Belgium;Canada;Denmark;France;Germany;Israel;Netherlands;Poland;United States
      2013   -   EUCTR2012-004366-18-NL   Austria;Belgium;Canada;Denmark;France;Germany;Israel;Netherlands;Poland;United States
      2013   Phase 1   EUCTR2012-004366-18-DK   Austria;Belgium;Canada;Denmark;France;Germany;Israel;Netherlands;Poland;United States
      2013   Phase 1   EUCTR2012-004366-18-DE   Austria;Belgium;Canada;Denmark;France;Germany;Israel;Netherlands;Poland;United States
      2013   Phase 1   EUCTR2012-004366-18-AT   Austria;Belgium;Canada;Denmark;France;Germany;Israel;Netherlands;Poland;United States
      2008   -   EUCTR2006-003399-37-SE   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;India;Israel;Japan;Latvia;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Sweden;Ukraine;United States
      2008   -   EUCTR2006-003399-37-DK   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;India;Israel;Japan;Latvia;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Sweden;Ukraine;United States
      2007   -   EUCTR2006-003399-37-LV   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;India;Israel;Japan;Latvia;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Sweden;Ukraine;United States
      2007   -   EUCTR2006-003399-37-DE   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;India;Israel;Japan;Latvia;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Sweden;Ukraine;United States
      2007   -   EUCTR2006-003399-37-BE   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;India;Israel;Japan;Latvia;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Sweden;Ukraine;United States
      2007   -   EUCTR2006-003399-37-AT   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;India;Israel;Japan;Latvia;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Sweden;Ukraine;United States
      -   Phase 1   EUCTR2012-004366-18-FR   Austria;Belgium;Canada;Denmark;France;Germany;Israel;Netherlands;Poland;United States
   Janssen Biologics BV
      2019   Phase 3   EUCTR2017-004496-31-PL   Belgium;Brazil;France;Israel;Italy;Korea, Republic of;Netherlands;Poland;Spain;Taiwan;United States
      2019   Phase 3   EUCTR2017-004496-31-NL   Belgium;Brazil;France;Israel;Italy;Korea, Republic of;Netherlands;Poland;Spain;Taiwan;United States
      2018   Phase 3   EUCTR2017-004496-31-FR   Belgium;Brazil;France;Israel;Italy;Korea, Republic of;Netherlands;Poland;Spain;Taiwan;United States
      2018   Phase 3   EUCTR2017-004496-31-ES   Belgium;Brazil;France;Israel;Italy;Korea, Republic of;Netherlands;Poland;Spain;Taiwan;United States
      2018   Phase 3   EUCTR2017-004496-31-BE   Belgium;Brazil;France;Israel;Italy;Korea, Republic of;Netherlands;Poland;Spain;Taiwan;United States
      2008   -   EUCTR2006-003399-37-NL   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;India;Israel;Japan;Latvia;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Sweden;Ukraine;United States
   Janssen-Cilag International NV
      2023   Phase 2   EUCTR2021-005528-39-SK   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Jordan;Korea, Republic of;Lithuania;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Switzerland;Taiwan;Türkiye;Ukraine;United Kingdom;United States
      2023   Phase 2   EUCTR2021-005528-39-SI   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Jordan;Korea, Republic of;Lithuania;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2023   Phase 2   EUCTR2021-005528-39-SE   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Jordan;Korea, Republic of;Lithuania;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2023   Phase 2   EUCTR2021-005528-39-PT   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;Finland;France;Georgia;Germany;Greece;Hong Kong;Hungary;India;Ireland;Israel;Italy;Japan;Jordan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2023   Phase 2   EUCTR2021-005528-39-NO   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Jordan;Korea, Republic of;Lithuania;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2023   Phase 2   EUCTR2021-005528-39-HR   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;Finland;France;Georgia;Germany;Greece;Hong Kong;Hungary;India;Ireland;Israel;Italy;Japan;Jordan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2023   Phase 2   EUCTR2021-005528-39-FR   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Jordan;Korea, Republic of;Lithuania;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2023   Phase 2   EUCTR2021-005528-39-DK   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Jordan;Korea, Republic of;Lithuania;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2023   Phase 2   EUCTR2021-005528-39-DE   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Jordan;Korea, Republic of;Lithuania;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2023   Phase 2   EUCTR2021-005528-39-BG   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Jordan;Korea, Republic of;Lithuania;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2023   Phase 2   EUCTR2021-005528-39-AT   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2022   Phase 2   EUCTR2021-005528-39-NL   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Jordan;Korea, Republic of;Lithuania;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2022   Phase 2   EUCTR2021-005528-39-HU   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Jordan;Korea, Republic of;Lithuania;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2022   Phase 2   EUCTR2021-005528-39-CZ   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Jordan;Korea, Republic of;Lithuania;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 2   EUCTR2018-001510-15-PL   Argentina;Australia;Brazil;Germany;Mexico;Poland;Russian Federation;Ukraine;United States
      2019   Phase 2   EUCTR2018-001510-15-DE   Argentina;Australia;Brazil;Germany;Mexico;Poland;Russian Federation;Ukraine;United States
CNTO1959
   JANSSEN CILAG INTERNATIONAL NV
      2022   Phase 2   EUCTR2021-005528-39-IT   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;Finland;France;Georgia;Germany;Greece;Hong Kong;Hungary;India;Ireland;Israel;Italy;Japan;Jordan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2018-004002-25-IT   Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czechia;France;Germany;Hong Kong;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Malaysia;Netherlands;Poland;Portugal;Russian Federation;Slovakia;Spain;Sweden;Taiwan;Turkey;Ukraine;United Kingdom;United States
   Janssen-Cilag International NV
      2023   Phase 3   EUCTR2022-000365-41-PL   Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;China;Czech Republic;Czechia;France;Germany;Hungary;India;Israel;Italy;Japan;Jordan;Korea, Republic of;Malaysia;Mexico;New Zealand;Poland;Portugal;Serbia;Slovakia;Spain;Sweden;Taiwan;Türkiye;United States
      2023   Phase 3   EUCTR2022-000365-41-HU   Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;China;Czech Republic;Czechia;France;Germany;Hungary;India;Israel;Italy;Japan;Jordan;Korea, Republic of;Malaysia;Mexico;New Zealand;Poland;Portugal;Serbia;Slovakia;Spain;Sweden;Taiwan;Turkey;United States
      2023   Phase 3   EUCTR2022-000365-41-FR   Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;China;Czech Republic;Czechia;France;Germany;Hungary;India;Israel;Italy;Japan;Jordan;Korea, Republic of;Malaysia;Mexico;New Zealand;Poland;Portugal;Serbia;Slovakia;Spain;Sweden;Taiwan;Turkey;United States
      2023   Phase 3   EUCTR2022-000365-41-DE   Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;China;Czech Republic;Czechia;France;Germany;Hungary;India;Israel;Italy;Japan;Jordan;Korea, Republic of;Malaysia;Mexico;New Zealand;Poland;Portugal;Serbia;Slovakia;Spain;Sweden;Taiwan;Turkey;United States
      2023   Phase 3   EUCTR2022-000365-41-CZ   Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;China;Czech Republic;Czechia;France;Germany;Hungary;India;Israel;Italy;Japan;Jordan;Korea, Republic of;Malaysia;Mexico;New Zealand;Poland;Portugal;Serbia;Slovakia;Spain;Sweden;Taiwan;Turkey;United States
      2023   Phase 3   EUCTR2022-000365-41-BG   Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;China;Czech Republic;Czechia;France;Germany;Hungary;India;Israel;Italy;Japan;Jordan;Korea, Republic of;Malaysia;Mexico;New Zealand;Poland;Portugal;Serbia;Slovakia;Spain;Sweden;Taiwan;Türkiye;United States
      2023   Phase 2   EUCTR2021-005528-39-SK   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Jordan;Korea, Republic of;Lithuania;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Switzerland;Taiwan;Türkiye;Ukraine;United Kingdom;United States
      2023   Phase 2   EUCTR2021-005528-39-SI   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Jordan;Korea, Republic of;Lithuania;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2023   Phase 2   EUCTR2021-005528-39-SE   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Jordan;Korea, Republic of;Lithuania;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2023   Phase 2   EUCTR2021-005528-39-PT   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;Finland;France;Georgia;Germany;Greece;Hong Kong;Hungary;India;Ireland;Israel;Italy;Japan;Jordan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2023   Phase 2   EUCTR2021-005528-39-NO   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Jordan;Korea, Republic of;Lithuania;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2023   Phase 2   EUCTR2021-005528-39-HR   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;Finland;France;Georgia;Germany;Greece;Hong Kong;Hungary;India;Ireland;Israel;Italy;Japan;Jordan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2023   Phase 2   EUCTR2021-005528-39-FR   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Jordan;Korea, Republic of;Lithuania;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2023   Phase 2   EUCTR2021-005528-39-DK   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Jordan;Korea, Republic of;Lithuania;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2023   Phase 2   EUCTR2021-005528-39-DE   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Jordan;Korea, Republic of;Lithuania;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2023   Phase 2   EUCTR2021-005528-39-BG   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Jordan;Korea, Republic of;Lithuania;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2023   Phase 2   EUCTR2021-005528-39-AT   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2022   Phase 2   EUCTR2021-005528-39-NL   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Jordan;Korea, Republic of;Lithuania;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2022   Phase 2   EUCTR2021-005528-39-HU   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Jordan;Korea, Republic of;Lithuania;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2022   Phase 2   EUCTR2021-005528-39-CZ   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Jordan;Korea, Republic of;Lithuania;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2021   Phase 2;Phase 3   EUCTR2018-004002-25-SK   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Czechia;France;Germany;Hungary;Ireland;Israel;Italy;Japan;Jordan;Korea, Republic of;Latvia;Malaysia;Netherlands;New Zealand;Poland;Portugal;Russian Federation;Serbia;Slovakia;Spain;Sweden;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2021   Phase 2;Phase 3   EUCTR2018-004002-25-LV   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Czechia;France;Germany;Hungary;Ireland;Israel;Italy;Japan;Jordan;Korea, Republic of;Latvia;Netherlands;Poland;Portugal;Russian Federation;Serbia;Slovakia;Spain;Sweden;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2021   Phase 2;Phase 3   EUCTR2018-004002-25-AT   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Czechia;France;Germany;Hungary;Ireland;Israel;Italy;Japan;Jordan;Korea, Republic of;Latvia;Malaysia;Netherlands;New Zealand;Poland;Portugal;Russian Federation;Serbia;Slovakia;Spain;Sweden;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2020   Phase 2;Phase 3   EUCTR2018-004002-25-PT   Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czechia;France;Germany;Hong Kong;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Malaysia;Netherlands;Poland;Portugal;Russian Federation;Slovakia;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
      2020   Phase 2;Phase 3   EUCTR2018-004002-25-NL   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Czechia;France;Germany;Hungary;Ireland;Israel;Italy;Japan;Jordan;Korea, Republic of;Latvia;Malaysia;Netherlands;New Zealand;Poland;Portugal;Russian Federation;Serbia;Slovakia;Spain;Sweden;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2020   Phase 2;Phase 3   EUCTR2018-004002-25-ES   Argentina;Australia;Belgium;Bulgaria;Canada;China;Czech Republic;France;Germany;Hong Kong;Hungary;Israel;Italy;Japan;Korea, Republic of;Malaysia;Netherlands;Poland;Portugal;Russian Federation;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
      2020   Phase 2;Phase 3   EUCTR2018-004002-25-DE   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Czechia;France;Germany;Hong Kong;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Malaysia;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2020   Phase 2;Phase 3   EUCTR2018-004002-25-BG   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Czechia;France;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Malaysia;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Taiwan;Türkiye;Ukraine;United Kingdom;United States
      2019   Phase 2;Phase 3   EUCTR2018-004002-25-SE   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Czechia;France;Germany;Hong Kong;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Malaysia;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 2;Phase 3   EUCTR2018-004002-25-PL   Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czechia;France;Germany;Hong Kong;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Malaysia;Netherlands;Poland;Portugal;Russian Federation;Slovakia;Spain;Sweden;Taiwan;Thailand;Türkiye;Ukraine;United Kingdom;United States
      2019   Phase 2;Phase 3   EUCTR2018-004002-25-HU   Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;France;Germany;Hong Kong;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Malaysia;Netherlands;Poland;Portugal;Russian Federation;Slovakia;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 2;Phase 3   EUCTR2018-004002-25-GB   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Czech Republic;France;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 2;Phase 3   EUCTR2018-004002-25-FR   Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;France;Germany;Hong Kong;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Malaysia;Netherlands;Poland;Portugal;Russian Federation;Slovakia;Spain;Sweden;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 2;Phase 3   EUCTR2018-004002-25-BE   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Czechia;France;Germany;Hungary;Ireland;Israel;Italy;Japan;Jordan;Korea, Republic of;Latvia;Malaysia;Netherlands;New Zealand;Poland;Portugal;Russian Federation;Serbia;Slovakia;Spain;Sweden;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 2   EUCTR2018-001510-15-PL   Argentina;Australia;Brazil;Germany;Mexico;Poland;Russian Federation;Ukraine;United States
      2019   Phase 2   EUCTR2018-001510-15-DE   Argentina;Australia;Brazil;Germany;Mexico;Poland;Russian Federation;Ukraine;United States
CNTO312
   Janssen Biologics B.V.
      2019   Phase 3   EUCTR2017-004496-31-IT   Belgium;Brazil;France;Israel;Italy;Korea, Republic of;Netherlands;Poland;Spain;Taiwan;United States
   Janssen Biologics BV
      2019   Phase 3   EUCTR2017-004496-31-PL   Belgium;Brazil;France;Israel;Italy;Korea, Republic of;Netherlands;Poland;Spain;Taiwan;United States
      2019   Phase 3   EUCTR2017-004496-31-NL   Belgium;Brazil;France;Israel;Italy;Korea, Republic of;Netherlands;Poland;Spain;Taiwan;United States
      2018   Phase 3   EUCTR2017-004496-31-BE   Belgium;Brazil;France;Israel;Italy;Korea, Republic of;Netherlands;Poland;Spain;Taiwan;United States
CO-transplantation OF FMT and pectin
   Jinling Hospital, China
      2013   -   NCT02016469   China
Coamoxiclav
   University of Dundee
      2006   -   NCT00355602   United Kingdom
Cobitolimod
   INDEX PHARMACEUTICALS AB
      2021   Phase 3   EUCTR2021-002549-13-IT   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czechia;Denmark;France;Georgia;Germany;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 2   EUCTR2016-004217-26-IT   Czech Republic;France;Germany;Hungary;Italy;Montenegro;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Ukraine
   InDex Pharmaceuticals
      2023   Phase 3   EUCTR2021-002549-13-BG   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czechia;Denmark;France;Georgia;Germany;Hungary;Israel;Italy;Korea, Democratic People's Republic of;Lithuania;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Taiwan;Türkiye;Ukraine;United Kingdom;United States
      2022   Phase 3   EUCTR2021-002549-13-NO   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czechia;Denmark;France;Georgia;Germany;Hungary;Israel;Italy;Korea, Democratic People's Republic of;Lithuania;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2022   Phase 3   EUCTR2021-002549-13-NL   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czechia;Denmark;France;Georgia;Germany;Hungary;Israel;Italy;Korea, Democratic People's Republic of;Lithuania;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2022   Phase 3   EUCTR2021-002549-13-HR   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czechia;Denmark;France;Georgia;Germany;Hungary;Israel;Italy;Korea, Democratic People's Republic of;Lithuania;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2022   Phase 3   EUCTR2021-002549-13-DK   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czechia;Denmark;France;Georgia;Germany;Hungary;Israel;Italy;Korea, Democratic People's Republic of;Lithuania;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Taiwan;Türkiye;Ukraine;United Kingdom;United States
      2022   Phase 3   EUCTR2021-002549-13-BE   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czechia;Denmark;France;Georgia;Germany;Hungary;Israel;Italy;Korea, Democratic People's Republic of;Lithuania;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2022   Phase 3   EUCTR2021-002549-13-AT   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czechia;Denmark;France;Georgia;Germany;Hungary;Israel;Italy;Korea, Democratic People's Republic of;Lithuania;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2021   Phase 3   EUCTR2021-002549-13-SE   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czechia;Denmark;France;Georgia;Germany;Hungary;Israel;Italy;Korea, Democratic People's Republic of;Lithuania;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2021   Phase 3   EUCTR2021-002549-13-LT   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czechia;Denmark;France;Georgia;Germany;Hungary;Israel;Italy;Korea, Democratic People's Republic of;Lithuania;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2021   Phase 3   EUCTR2021-002549-13-HU   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czechia;Denmark;France;Georgia;Germany;Hungary;Israel;Italy;Korea, Democratic People's Republic of;Lithuania;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2021   Phase 3   EUCTR2021-002549-13-FR   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czechia;Denmark;France;Georgia;Germany;Hungary;Israel;Italy;Korea, Democratic People's Republic of;Lithuania;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2021   Phase 3   EUCTR2021-002549-13-DE   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czechia;Denmark;France;Georgia;Germany;Hungary;Israel;Italy;Korea, Democratic People's Republic of;Lithuania;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2017   Phase 2   NCT03178669   Czechia;France;Germany;Hungary;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine
   InDex Pharmaceuticals AB
      2022   Phase 3   EUCTR2021-002549-13-PT   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czechia;Denmark;France;Georgia;Germany;Hungary;Israel;Italy;Korea, Democratic People's Republic of;Lithuania;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2021   Phase 1;Phase 2   EUCTR2021-003023-14-SE   Sweden
      2021   Phase 3   EUCTR2021-002549-13-SK   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czechia;Denmark;France;Georgia;Germany;Hungary;Israel;Italy;Korea, Democratic People's Republic of;Lithuania;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Taiwan;Türkiye;Ukraine;United Kingdom;United States
      2017   Phase 2   EUCTR2016-004217-26-SE   Czech Republic;France;Germany;Hungary;Italy;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Ukraine
      2017   Phase 2   EUCTR2016-004217-26-HU   Czech Republic;France;Germany;Hungary;Italy;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Ukraine
      2017   Phase 2   EUCTR2016-004217-26-FR   Czech Republic;France;Germany;Hungary;Italy;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Ukraine
      2017   Phase 2   EUCTR2016-004217-26-ES   Czech Republic;France;Germany;Hungary;Italy;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Ukraine
      2017   Phase 2   EUCTR2016-004217-26-DE   Czech Republic;France;Germany;Hungary;Italy;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Ukraine
      2017   Phase 2   EUCTR2016-004217-26-CZ   Czech Republic;France;Germany;Hungary;Italy;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Ukraine
Cobitolimod 250 MG
   InDex Pharmaceuticals
      2021   Phase 3   NCT04985968   Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Canada;Croatia;Denmark;France;Georgia;Germany;Hungary;Israel;Italy;Korea, Democratic People's Republic of;Korea, Republic of;Lithuania;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Serbia;Slovakia;Sweden;Turkey;United Kingdom;United States
Cobitolimod 500 MG
   InDex Pharmaceuticals
      2021   Phase 3   NCT04985968   Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Canada;Croatia;Denmark;France;Georgia;Germany;Hungary;Israel;Italy;Korea, Democratic People's Republic of;Korea, Republic of;Lithuania;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Serbia;Slovakia;Sweden;Turkey;United Kingdom;United States
Cobitolimod 500MG
   InDex Pharmaceuticals
      2021   Phase 1   NCT05404074   Sweden
Coffee coal
   REPHA GmbH
      2008   -   EUCTR2007-007928-18-DE   Germany
Colal pred
   ALIZYME
      2006   -   EUCTR2004-005032-35-IT   Belgium;Czech Republic;Denmark;Hungary;Italy;Spain;Sweden;United Kingdom
Colal-pred
   Alizyme
      2006   Phase 3   NCT00299013   Australia;Belgium;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Poland;Russian Federation;South Africa;Spain;Sweden;United Kingdom
   Alizyme Therapeutics Limited
      2007   -   EUCTR2004-005032-35-BE   Belgium;Czech Republic;Denmark;Hungary;Italy;Spain;Sweden;United Kingdom
      2005   -   EUCTR2004-005032-35-SE   Belgium;Czech Republic;Denmark;Hungary;Italy;Spain;Sweden;United Kingdom
      2005   -   EUCTR2004-005032-35-HU   Belgium;Czech Republic;Denmark;Hungary;Italy;Spain;Sweden;United Kingdom
      2005   Phase 3   EUCTR2004-005032-35-GB   Belgium;Czech Republic;Denmark;Hungary;Italy;Spain;Sweden;United Kingdom
      2005   -   EUCTR2004-005032-35-DK   Belgium;Czech Republic;Denmark;Hungary;Italy;Spain;Sweden;United Kingdom
      2005   -   EUCTR2004-005032-35-CZ   Belgium;Czech Republic;Denmark;Hungary;Italy;Spain;Sweden;United Kingdom
   Prometheus Laboratories
      2008   Phase 2   NCT00676832   United States
Colchicine
   Nakase Hiroshi
      2024   Phase 1   JPRN-jRCTs061240020   -
   Sapporo Medical University
      2024   -   JPRN-UMIN000054655   Japan
Colecalciferol
   Imperial College London
      2008   Phase 4   NCT00672763   United Kingdom
Colectomy
   Connecticut Children's Medical Center
      2012   Phase 4   NCT01536535   Canada;United States
Colon KCC heptapeptide
   Danielle Kim Turgeon
      2014   Phase 1   NCT02156557   United States
Colon preparation FOR colonoscopy
   Luigi Sacco University Hospital
      2013   Phase 4   NCT02248337   Italy
Colonoscopy
   Department of Gastroenterology, Kanazawa University Hospital
      2016   -   JPRN-UMIN000020954   Japan
   Hospital San Carlos, Madrid
      2019   -   NCT03773445   Spain
   Ishikawa Dai
      2020   -   JPRN-jRCTs031200103   -
      2017   -   JPRN-jRCTs031180415   -
   Nagahara Akihito
      2023   Phase 2   JPRN-jRCTs031220542   -
   Shenzhen Second People's Hospital
      2020   Phase 0   ChiCTR2000039920   China
   Tel-Aviv Sourasky Medical Center
      2015   Phase 2   NCT04434872   Israel
   The Second Affiliated Hospital of Xi'an Jiaotong University
      2018   Phase 0   ChiCTR2200055616   China
Colonoscopy with indigo-carmine chromoendoscopy
   Karolinska University Hospital
      2011   -   NCT01505842   Sweden
Colorectal biopsies
   University Hospital, Bordeaux
      2020   -   NCT04272307   France
Colored water
   Turku University Hospital
      2021   -   NCT04687150   Finland
Coltect
   Tel-Aviv Sourasky Medical Center
      2008   -   NCT00793130   Israel
Combination oral budesonide and rectal hydrocortisone
   University of Maryland, Baltimore
      2008   Phase 2   NCT00805285   United States
Companion diagnostic (CDX) testing
   Prometheus Biosciences, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
      2021   Phase 2   NCT04996797   Australia;Belgium;Canada;Czechia;France;Georgia;Hungary;Israel;Italy;Poland;United Kingdom;United States
Compressed oxygen
   Amsterdam UMC
      2022   Phase 4   EUCTR2021-003913-21-NL   Netherlands
Control diet
   Universität Duisburg-Essen
      2024   -   NCT06698601   Germany
Control group: mesalazine enema treatment
   Beijing Hospital of Traditional Chinese Medicine
      2023   -   NCT05780723   China
Conventional drugs
   Liaocheng People's Hospital
      2018   Phase 1/Phase 2   NCT03609905   China
Conventional IBD medical treatment
   Mohamed Nasr
      2024   -   NCT06601595   -
Conventional therapy
   Bristol-Myers Squibb
      2024   -   NCT06126835   United States
   The First Affiliated Hospital of Nanjing Medical University
      2023   -   ChiCTR2300071576   China
Conventional treatment
   Peking Union Medical College Hospital
      2020   -   NCT05386290   China
   Tanta University
      2022   Early Phase 1   NCT05610956   -
   The First Affiliated Hospital of Nanjing Medical University
      2023   -   ChiCTR2300071576   China
Conventional white-light colonoscopy
   Karolinska University Hospital
      2011   -   NCT01505842   Sweden
Coolonic biopsies
   Centre Hospitalier Régional d'Orléans
      2023   -   NCT05916274   France
Corn starch
   The First Affiliated Hospital, College of Medicine, Zhejiang University
      2024   Phase 0   ChiCTR2400094060   China
Corticosteroid
   Department of Gastroenterology, Jinan Central Hospital
      2018   -   ChiCTR2100043797   China
   Sixth Affiliated Hospital, Sun Yat-sen University
      2021   -   NCT04879966   China
   Tampere University Hospital
      2015   -   NCT04564638   -
   Yale University
      2015   Phase 4   NCT02392286   United States
Corticosteroids
   Centre Hospitalier Universitaire de Saint Etienne
      2016   Phase 3   NCT02665845   France;Greece;Israel;Italy;Korea, Republic of;Serbia
   Children's Hospital of Fudan University
      2021   Phase 4   NCT04999228   China
   IQVIA Services Japan K.K. jRCT Call Center
      2023   Phase 3   JPRN-jRCT2031230081   Argentina;Belgium;Bosnia;Brazil;Bulgaria;Canada;Croatia;Czech Republic;France;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Lithuania;Mexico;New Zealand;Poland;Romania;Serbia;Slovenia;Spain;Taiwan;United Kingdom;United States
   Jinling Hospital, China
      2013   Phase 1/Phase 2   NCT02922374   China
   National Institute of Allergy and Infectious Diseases (NIAID)
      2007   Phase 2   NCT00514982   United States
   jRCT Inquiries IQVIA Contact person
      2023   Phase 3   JPRN-jRCT2031230257   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Czech Republic;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Korea;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Serbia;Slovakia;Slovenia;Spain;Switzerland;Turkey;UK USA
Corticosteroids only
   Sheba Medical Center
      2013   Phase 4   NCT01941589   China;France;Greece;Israel;Italy;Korea, Republic of;Serbia
Cortimentmmx 9 MG
   Dr. Falk Pharma GmbH
      2019   Phase 3   EUCTR2017-004576-57-SK   Czech Republic;Czechia;Germany;Hungary;Latvia;Lithuania;Poland;Russian Federation;Serbia;Slovakia;Ukraine
      2019   Phase 3   EUCTR2017-004576-57-PL   Czech Republic;Czechia;Germany;Hungary;Latvia;Lithuania;Poland;Russian Federation;Serbia;Slovakia;Ukraine
      2019   Phase 3   EUCTR2017-004576-57-LV   Czech Republic;Czechia;Germany;Hungary;Latvia;Lithuania;Poland;Russian Federation;Serbia;Slovakia;Ukraine
      2019   Phase 3   EUCTR2017-004576-57-LT   Czech Republic;Czechia;Germany;Hungary;Latvia;Lithuania;Poland;Russian Federation;Serbia;Slovakia;Ukraine
      2019   Phase 3   EUCTR2017-004576-57-HU   Czech Republic;Germany;Hungary;Latvia;Lithuania;Poland;Russian Federation;Slovakia;Ukraine
      2019   Phase 3   EUCTR2017-004576-57-DE   Czech Republic;Czechia;Germany;Hungary;Latvia;Lithuania;Poland;Russian Federation;Serbia;Slovakia;Ukraine
      2019   Phase 3   EUCTR2017-004576-57-CZ   Czech Republic;Czechia;Germany;Hungary;Latvia;Lithuania;Poland;Russian Federation;Serbia;Slovakia;Turkey;Ukraine
Cosmofer
   Leiden University Medical Center
      2022   Phase 4   EUCTR2022-000894-16-NL   Netherlands
Cosmofer 50MG/ML solution FOR infusion or injection
   Barts Health NHS Trust
      2011   Phase 4   EUCTR2010-023797-39-GB   United Kingdom
Cotrimoxazole
   University of Dundee
      2006   -   NCT00355602   United Kingdom
Covid-19 vaccine
   GI Alliance
      2023   -   NCT05014555   United States
   University of Wisconsin, Madison
      2023   -   NCT05584735   United States
Covid-19 vaccines AT A 3-month interval
   McGill University Health Centre/Research Institute of the McGill University Health Centre
      2024   Phase 2   NCT06599658   Canada
Covid-19 vaccines AT A 6-month interval
   McGill University Health Centre/Research Institute of the McGill University Health Centre
      2024   Phase 2   NCT06599658   Canada
CP- 690 550
   Pfizer
      2008   Phase 2   NCT00787202   Belgium;Brazil;Chile;Czech Republic;Denmark;France;Hungary;Israel;Italy;Mexico;Netherlands;Poland;Slovakia;South Africa;Spain;Sweden;Turkey;United Kingdom
CP-101
   Brigham and Women's Hospital
      2023   Phase 1   NCT05852574   United States
CP-690,500 5 MG
   Pfizer
      2017   Phase 4   NCT03281304   Belgium;Canada;Czechia;France;Germany;Hungary;Italy;Japan;Korea, Republic of;Netherlands;New Zealand;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
CP-690,550
   PFIZER
      2009   -   EUCTR2008-004564-40-IT   Belgium;Czech Republic;France;Hungary;Italy;Netherlands;Slovakia;Spain;Sweden;United Kingdom
   PFIZER INC
      2022   Phase 3   EUCTR2018-002378-30-IT   Australia;Belgium;Canada;Finland;France;Germany;Hungary;Israel;Italy;Japan;Netherlands;Poland;Slovakia;Spain;Sweden;United Kingdom;United States
   Pfizer
      2012   Phase 3   NCT01470612   Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2012   Phase 3   NCT01458574   Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
   Pfizer S.A
      2008   Phase 2   EUCTR2008-004564-40-ES   Belgium;Czech Republic;France;Hungary;Italy;Netherlands;Slovakia;Spain;Sweden;United Kingdom
   Pfizer limited, Ramsgate Road, Sandwich, Kent, CT13 9NJ, UK
      2009   -   EUCTR2008-004564-40-SE   Belgium;Czech Republic;France;Hungary;Italy;Netherlands;Slovakia;Spain;Sweden;United Kingdom
      2009   Phase 2   EUCTR2008-004564-40-NL   Belgium;Czech Republic;France;Hungary;Italy;Netherlands;Slovakia;Spain;Sweden;United Kingdom
      2009   -   EUCTR2008-004564-40-GB   Belgium;Czech Republic;France;Hungary;Italy;Netherlands;Slovakia;Spain;Sweden;United Kingdom
      2009   Phase 2   EUCTR2008-004564-40-FR   Belgium;Czech Republic;France;Hungary;Italy;Netherlands;Slovakia;Spain;Sweden;United Kingdom
      2009   -   EUCTR2008-004564-40-CZ   Belgium;Czech Republic;France;Hungary;Italy;Netherlands;Slovakia;Spain;Sweden;United Kingdom
      2009   -   EUCTR2008-004564-40-BE   Belgium;Czech Republic;France;Hungary;Italy;Netherlands;Slovakia;Spain;Sweden;United Kingdom
      2008   Phase 2   EUCTR2008-004564-40-SK   Belgium;Czech Republic;France;Hungary;Italy;Netherlands;Slovakia;Spain;Sweden;United Kingdom
      2008   -   EUCTR2008-004564-40-HU   Belgium;Czech Republic;France;Hungary;Italy;Netherlands;Slovakia;Spain;Sweden;United Kingdom
CP-690,550 10 MG
   Pfizer
      2017   Phase 4   NCT03281304   Belgium;Canada;Czechia;France;Germany;Hungary;Italy;Japan;Korea, Republic of;Netherlands;New Zealand;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
CP-690,550-10
   PFIZER INC
      2018   Phase 3;Phase 4   EUCTR2017-002274-39-IT   Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Japan;Korea, Republic of;Netherlands;New Zealand;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
   PFIZER INC.
      2013   -   EUCTR2011-004578-27-IT   Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Democratic People's Republic of;Korea, Republic of;Latvia;Netherlands;Poland;Russian Federation;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
   PFIZER LIMITED
      2013   -   EUCTR2011-004581-14-IT   Australia;Austria;Brazil;Canada;Colombia;Czech Republic;Denmark;Estonia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;Russian Federation;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2013   Phase 3   EUCTR2011-004580-79-IT   Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;New Zealand;Poland;Russian Federation;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
   Pfizer Inc
      2012   Phase 3   EUCTR2011-004580-79-CZ   Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
   Pfizer Inc, 235 East 42nd Street, New York, New York 10017
      2018   Phase 3;Phase 4   EUCTR2017-002274-39-NL   Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Japan;Korea, Republic of;Netherlands;New Zealand;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
      2018   Phase 3;Phase 4   EUCTR2017-002274-39-GB   Austria;Belgium;Canada;Czech Republic;France;Germany;Hungary;Italy;Japan;Korea, Republic of;Netherlands;New Zealand;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
      2018   Phase 3;Phase 4   EUCTR2017-002274-39-CZ   Austria;Belgium;Canada;Czech Republic;Czechia;Germany;Hungary;Italy;Japan;Korea, Republic of;Netherlands;New Zealand;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
      2018   Phase 3;Phase 4   EUCTR2017-002274-39-BE   Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Japan;Korea, Republic of;Netherlands;New Zealand;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-002274-39-AT   Austria;Belgium;Canada;Czech Republic;France;Germany;Hungary;Italy;Japan;Korea, Republic of;Netherlands;New Zealand;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
      2017   Phase 3;Phase 4   EUCTR2017-002274-39-HU   Austria;Belgium;Canada;Czech Republic;France;Germany;Hungary;Italy;Japan;Korea, Republic of;Netherlands;New Zealand;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2017-002274-39-ES   Austria;Belgium;Canada;Czech Republic;France;Germany;Hungary;Italy;Japan;Korea, Republic of;Netherlands;New Zealand;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
      2013   Phase 3   EUCTR2011-004581-14-HR   Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2013   Phase 3   EUCTR2011-004580-79-HR   Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2013   -   EUCTR2011-004579-35-HR   Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2013   -   EUCTR2011-004578-27-NL   Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2013   -   EUCTR2011-004578-27-HR   Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2012   Phase 3   EUCTR2011-004581-14-NL   Australia;Austria;Belgium;Canada;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
      2012   Phase 3   EUCTR2011-004581-14-LV   Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2012   Phase 3   EUCTR2011-004581-14-HU   Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2012   Phase 3   EUCTR2011-004581-14-GB   Australia;Austria;Belgium;Canada;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
      2012   Phase 3   EUCTR2011-004581-14-ES   Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2012   Phase 3   EUCTR2011-004581-14-EE   Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2012   Phase 3   EUCTR2011-004581-14-DK   Australia;Austria;Belgium;Canada;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
      2012   Phase 3   EUCTR2011-004581-14-BE   Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2012   Phase 3   EUCTR2011-004581-14-AT   Australia;Austria;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2012   Phase 3   EUCTR2011-004580-79-SK   Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2012   Phase 3   EUCTR2011-004580-79-PL   Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2012   Phase 3   EUCTR2011-004580-79-LV   Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2012   Phase 3   EUCTR2011-004580-79-HU   Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2012   Phase 3   EUCTR2011-004580-79-GB   Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2012   Phase 3   EUCTR2011-004580-79-ES   Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2012   Phase 3   EUCTR2011-004580-79-EE   Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2012   Phase 3   EUCTR2011-004580-79-DK   Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2012   Phase 3   EUCTR2011-004580-79-BE   Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2012   Phase 3   EUCTR2011-004580-79-AT   Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2012   -   EUCTR2011-004579-35-SK   Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2012   -   EUCTR2011-004579-35-PL   Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2012   -   EUCTR2011-004579-35-NL   Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2012   -   EUCTR2011-004579-35-LV   Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2012   -   EUCTR2011-004579-35-HU   Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2012   -   EUCTR2011-004579-35-GB   Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2012   -   EUCTR2011-004579-35-ES   Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2012   -   EUCTR2011-004579-35-EE   Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2012   Phase 3   EUCTR2011-004579-35-DK   Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2012   -   EUCTR2011-004579-35-BE   Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2012   -   EUCTR2011-004579-35-AT   Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2012   -   EUCTR2011-004578-27-SK   Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2012   -   EUCTR2011-004578-27-PL   Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2012   -   EUCTR2011-004578-27-LV   Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2012   -   EUCTR2011-004578-27-HU   Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2012   -   EUCTR2011-004578-27-GB   Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2012   -   EUCTR2011-004578-27-ES   Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2012   -   EUCTR2011-004578-27-EE   Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2012   Phase 3   EUCTR2011-004578-27-DK   Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2012   -   EUCTR2011-004578-27-BE   Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2012   -   EUCTR2011-004578-27-AT   Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
   Pfizer Inc, 235 East 42nd Street, New York, New York 10017, USA
      2012   Phase 3   EUCTR2011-004581-14-DE   Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2012   Phase 3   EUCTR2011-004580-79-DE   Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2012   Phase 3   EUCTR2011-004579-35-DE   Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2012   Phase 3   EUCTR2011-004578-27-DE   Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
   Pfizer Inc.
      2022   Phase 3   EUCTR2018-002378-30-SK   Australia;Belgium;Canada;Finland;France;Germany;Hungary;Israel;Italy;Japan;Netherlands;Poland;Slovakia;Spain;Sweden;United Kingdom;United States
      2022   Phase 3   EUCTR2018-002378-30-NL   Australia;Belgium;Canada;Finland;France;Germany;Hungary;Israel;Italy;Japan;Netherlands;Poland;Slovakia;Spain;Sweden;United Kingdom;United States
      2022   Phase 3   EUCTR2018-002378-30-HU   Australia;Belgium;Canada;Finland;France;Germany;Hungary;Israel;Italy;Japan;Netherlands;Poland;Slovakia;Spain;Sweden;United Kingdom;United States
      2022   Phase 3   EUCTR2018-002378-30-FR   Australia;Belgium;Canada;Finland;France;Germany;Hungary;Israel;Italy;Japan;Netherlands;Poland;Slovakia;Spain;Sweden;United Kingdom;United States
      2022   Phase 3   EUCTR2018-002378-30-DE   Australia;Belgium;Canada;Finland;France;Germany;Hungary;Israel;Italy;Japan;Netherlands;Poland;Slovakia;Spain;Sweden;United Kingdom;United States
      2021   Phase 3   EUCTR2018-002378-30-FI   Australia;Belgium;Canada;Finland;France;Germany;Hungary;Israel;Italy;Japan;Netherlands;Poland;Slovakia;Spain;Sweden;United Kingdom;United States
      2017   Phase 3;Phase 4   EUCTR2017-002274-39-SK   Austria;Belgium;Canada;Czech Republic;Czechia;Germany;Hungary;Italy;Japan;Korea, Republic of;Netherlands;New Zealand;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
      2012   Phase 3   EUCTR2011-004581-14-SK   Australia;Austria;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2012   Phase 3   EUCTR2011-004581-14-CZ   Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      -   Phase 3   EUCTR2018-002378-30-SE   Australia;Belgium;Canada;Finland;France;Germany;Hungary;Israel;Italy;Japan;Netherlands;Poland;Slovakia;Spain;Sweden;United Kingdom;United States
      -   Phase 3   EUCTR2018-002378-30-PL   Australia;Belgium;Canada;Finland;France;Germany;Hungary;Israel;Italy;Japan;Netherlands;Poland;Slovakia;Spain;Sweden;United Kingdom;United States
      -   Phase 3   EUCTR2018-002378-30-BE   Australia;Belgium;Canada;Finland;France;Germany;Hungary;Israel;Italy;Japan;Netherlands;Poland;Slovakia;Spain;Sweden;United Kingdom;United States
   Pfizer Inc., 235 East 42nd Street, New York, New York 10017, United States
      2012   Phase 3   EUCTR2011-004581-14-PL   Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
CP690,550
   Pfizer
      2012   Phase 3   NCT01458574   Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
Creatine monohydrate
   University of Colorado, Denver
      2022   Early Phase 1   NCT02463305   United States
Crohn'S disease
   The Affiliated Hospital of Qingdao University
      2023   -   ChiCTR2300073620   China
   The Second Affiliated Hospital of the Chinese People's Liberation Army Air Force Medical University
      2025   -   ChiCTR2500095979   China
CS (corticosteroids) only
   Shaare Zedek Medical Center
      2014   -   NCT02033408   Canada;Finland;Israel;Italy;Poland;Spain
CT-P13
   CELLTRION INC.
      2020   Phase 3   EUCTR2019-003849-15-IT   Austria;Belarus;Brazil;Bulgaria;Chile;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Latvia;Mexico;Moldova, Republic of;Peru;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Turkey;Ukraine;United States
   CMC Ambroise Paré
      2024   Phase 3   NCT06274294   France
   Celltrion
      2020   Phase 3   NCT04205643   Poland
      2016   Phase 1   NCT02883452   Korea, Republic of
   Celltrion, Inc.
      2020   Phase 3   EUCTR2019-003849-15-PL   Austria;Belarus;Bulgaria;Croatia;Czech Republic;Czechia;France;Greece;Israel;Italy;Latvia;Mexico;Moldova, Republic of;Peru;Poland;Russian Federation;Serbia;South Africa;Spain;Turkey;Ukraine
      2020   Phase 3   EUCTR2019-003849-15-HR   Austria;Belarus;Brazil;Bulgaria;Chile;Croatia;Czechia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Latvia;Mexico;Moldova, Republic of;Peru;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Turkey;Ukraine;United States
      2020   Phase 3   EUCTR2019-003849-15-GR   Austria;Belarus;Brazil;Bulgaria;Chile;Croatia;Czech Republic;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Latvia;Mexico;Moldova, Republic of;Peru;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Turkey;Ukraine;United States
      2020   Phase 3   EUCTR2019-003849-15-FR   Austria;Belarus;Brazil;Bulgaria;Chile;Croatia;Czech Republic;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Latvia;Mexico;Moldova, Republic of;Peru;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Turkey;Ukraine;United States
      2020   Phase 3   EUCTR2019-003849-15-ES   Austria;Belarus;Brazil;Bulgaria;Chile;Croatia;Czech Republic;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Latvia;Mexico;Moldova, Republic of;Peru;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Turkey;Ukraine;United States
      2020   Phase 3   EUCTR2019-003849-15-CZ   Austria;Belarus;Bulgaria;Croatia;Czech Republic;Czechia;France;Greece;Israel;Italy;Latvia;Mexico;Moldova, Republic of;Peru;Poland;Russian Federation;Serbia;South Africa;Spain;Turkey;Ukraine
      2020   Phase 3   EUCTR2019-003849-15-BG   Austria;Belarus;Bulgaria;Croatia;Czech Republic;Czechia;France;Greece;Israel;Italy;Latvia;Mexico;Moldova, Republic of;Peru;Poland;Russian Federation;Serbia;South Africa;Spain;Turkey;Ukraine
      2020   Phase 3   EUCTR2019-003849-15-AT   Austria;Belarus;Brazil;Bulgaria;Chile;Croatia;Czech Republic;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Latvia;Mexico;Moldova, Republic of;Peru;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Turkey;Ukraine;United States
   Fukuoka University Chikushi Hospital
      2021   -   JPRN-UMIN000043165   Japan
   Hospira UK Ltd.
      2015   Phase 4   EUCTR2014-005192-89-FI   Belgium;Czech Republic;Finland;France;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovakia;Spain;United Kingdom
   Marta Maia Boscá Watts
      2019   Phase 2   EUCTR2019-000668-27-ES   Spain
   Pfizer
      2015   -   NCT02539368   Belgium;Czech Republic;Czechia;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;United Kingdom
CU104
   Curacle Co., Ltd.
      2024   Phase 2   NCT05907330   -
Curcumin
   Chinese University of Hong Kong
      2017   -   NCT03122613   Hong Kong
   Schneider Children's Medical Center, Israel
      2020   Phase 3   NCT02277223   Israel
   Seattle Children's Hospital
      2009   Phase 1   NCT00889161   United States
   Sheba Medical Center
      2011   Phase 3   NCT01320436   Israel
   Tianjin Medical University General Hospital
      2019   Phase 0   ChiCTR1900022243   China
Curcumin supplementation
   Ardahan University
      2022   -   NCT05761327   Turkey
Cyclosporin
   GETAID
      2008   -   EUCTR2006-005299-42-BE   Belgium;Finland;France;Spain
      2007   -   EUCTR2006-005299-42-FR   Belgium;Finland;France;Spain
Cyclosporine
   Chiba University Hospital
      2013   -   JPRN-UMIN000010776   Japan
   Postgraduate Institute of Medical Education and Research
      2023   -   NCT05112263   -
   Sigmoid Pharma Ltd
      2010   Phase 2   EUCTR2008-003169-19-GB   Ireland;United Kingdom
      2009   -   EUCTR2008-003169-19-IE   Ireland;United Kingdom
   Sublimity Therapeutics (Hold Co) Ltd.
      2019   Phase 2   EUCTR2018-003349-41-RO   Belarus;Bulgaria;Canada;France;Germany;Hungary;Israel;Italy;Poland;Romania;Russian Federation;Serbia;Ukraine;United Kingdom;United States
      2019   Phase 2   EUCTR2018-003349-41-PL   Belarus;Bulgaria;Canada;France;Germany;Hungary;Israel;Italy;Poland;Russian Federation;Serbia;Ukraine;United Kingdom;United States
      2019   Phase 2   EUCTR2018-003349-41-HU   Belarus;Belgium;Bulgaria;Canada;France;Germany;Hungary;Ireland;Israel;Poland;Romania;Russian Federation;Serbia;Spain;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 2   EUCTR2018-003349-41-GB   Belarus;Bulgaria;Canada;France;Germany;Hungary;Ireland;Israel;Italy;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
      2019   Phase 2   EUCTR2018-003349-41-FR   Belarus;Bulgaria;Canada;France;Germany;Hungary;Ireland;Israel;Italy;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
      2019   Phase 2   EUCTR2018-003349-41-DE   Belarus;Bulgaria;Canada;France;Germany;Hungary;Israel;Poland;Russian Federation;Serbia;Ukraine;United Kingdom;United States
      2019   Phase 2   EUCTR2018-003349-41-BG   Belarus;Bulgaria;Canada;France;Germany;Hungary;Ireland;Israel;Italy;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
   Sublimity Therapeutics HoldCo Limited
      2019   Phase 2   EUCTR2018-003349-41-IT   Belarus;Bulgaria;Canada;France;Germany;Hungary;Ireland;Israel;Italy;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
Cyclosporine oral product
   Berinstein, Jeffrey
      2023   Phase 4   NCT05867329   United States
Cyclosporine VS infliximab
   Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives
      2007   Phase 4   NCT00542152   Belgium;Finland;France;Italy;Spain
Cycol
   Sigmoid Pharma
      2010   Phase 2   NCT01033305   Ireland;United Kingdom
   Sigmoid Pharma Ltd
      2010   Phase 2   EUCTR2008-003169-19-GB   Ireland;United Kingdom
      2009   -   EUCTR2008-003169-19-IE   Ireland;United Kingdom
Cytochrome P450 (CYP) substrates
   AbbVie
      2020   Phase 1   NCT04254783   Germany;Israel;United States
D.3.6.2.1 - valore: 45 / 0.45 MG/ML
   Janssen Biologics B.V.
      2019   Phase 3   EUCTR2017-004496-31-IT   Belgium;Brazil;France;Israel;Italy;Korea, Republic of;Netherlands;Poland;Spain;Taiwan;United States
Daclizumab
   Facet Biotech
      2003   Phase 2   NCT00073047   Belgium;Canada;United States
Dacortin
   GETECCU (Grupo Español de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa)
      2009   -   EUCTR2007-003815-30-PT   Portugal;Spain
      2007   -   EUCTR2007-003815-30-ES   Portugal;Spain
Dapagliflozin 10MG TAB
   Mostafa Bahaa
      2023   Phase 2/Phase 3   NCT05986136   Egypt
Decortin H 1 MG
   Essex Pharma GmbH
      2009   -   EUCTR2009-010065-23-DE   Germany
Decortin H 10MG
   Essex Pharma GmbH
      2009   -   EUCTR2009-010065-23-DE   Germany
Decortin H 20MG
   Essex Pharma GmbH
      2009   -   EUCTR2009-010065-23-DE   Germany
Decortin H 50 MG
   Essex Pharma GmbH
      2009   -   EUCTR2009-010065-23-DE   Germany
Decortin H 5MG
   Essex Pharma GmbH
      2009   -   EUCTR2009-010065-23-DE   Germany
Dekavil
   PFIZER INC
      2018   Phase 2   EUCTR2017-002108-28-IT   Australia;Belgium;Germany;Israel;Italy;Korea, Democratic People's Republic of;Saudi Arabia;Serbia;Spain;United States
   Pfizer Inc, 235 East 42nd Street, New York, New York 10017
      2018   Phase 2   EUCTR2017-002108-28-ES   Australia;Belgium;Germany;Israel;Italy;Korea, Republic of;Saudi Arabia;Serbia;Spain;United States
      2018   Phase 2   EUCTR2017-002108-28-DE   Australia;Belgium;Germany;Israel;Italy;Korea, Republic of;Saudi Arabia;Serbia;Spain;United States
      2018   Phase 2   EUCTR2017-002108-28-BE   Australia;Belgium;Germany;Israel;Italy;Korea, Republic of;Saudi Arabia;Serbia;Spain;United States
Dekristol
   Medical clinic, University Hospital of North Norway
      2009   Phase 4   EUCTR2009-015649-21-NO   Norway
Delayed and extended release mesalazine
   Shire
      2003   Phase 3   NCT00503243   United States
Deligoparin
   Incara Pharmaceuticals
      2001   Phase 2/Phase 3   NCT00033943   United States
Delmitide acetate
   Procter & Gamble Pharmaceuticals
      2005   Phase 2   EUCTR2004-004077-29-SK   Czech Republic;Germany;Lithuania;Slovakia;United Kingdom
      2005   -   EUCTR2004-004077-29-LT   Czech Republic;Germany;Lithuania;United Kingdom
      2005   -   EUCTR2004-004077-29-DE   Czech Republic;Germany;Lithuania;United Kingdom
      2005   -   EUCTR2004-004077-29-CZ   Czech Republic;Germany;Lithuania;United Kingdom
   Procter & Gamble Technical Centres Ltd
      2005   -   EUCTR2004-004077-29-GB   Czech Republic;Germany;Lithuania;United Kingdom
Deltacortene
   Chiesi Farmaceutici SpA
      2007   Phase 3   EUCTR2006-004230-32-PL   Belgium;Italy;Poland;Spain
      2007   Phase 3   EUCTR2006-004230-32-ES   Belgium;Italy;Poland;Spain
Deltacortene 10 CPR 25MG
   CHIESI Farmaceutici S.p.A.
      2007   -   EUCTR2006-004230-32-BE   Belgium;Italy;Poland;Spain
Deltacortene 20 CPR 5MG
   CHIESI Farmaceutici S.p.A.
      2007   -   EUCTR2006-004230-32-BE   Belgium;Italy;Poland;Spain
Deltacortene forte*10CPR 25MG
   CHIESI
      2007   -   EUCTR2006-004230-32-IT   Belgium;Italy;Poland;Spain
Deltacortene*20CPR 5MG
   CHIESI
      2007   -   EUCTR2006-004230-32-IT   Belgium;Italy;Poland;Spain
Dersalazina sodica
   Palau Pharma S.A.
      2008   Phase 2   EUCTR2008-004610-27-ES   Belgium;Hungary;Slovakia;Spain
Dersalazine sodium
   Palau Pharma S.A.
      2009   Phase 2   EUCTR2008-004610-27-SK   Belgium;Hungary;Slovakia;Spain
      2009   -   EUCTR2008-004610-27-HU   Belgium;Hungary;Spain
      2008   Phase 2   NCT00808977   Belgium;Hungary;Slovakia;Spain
      2008   Phase 2   EUCTR2008-004610-27-ES   Belgium;Hungary;Slovakia;Spain
      2008   -   EUCTR2008-004610-27-BE   Belgium;Hungary;Spain
Deucravacitinib
   BRISTOL-MYERS SQUIBB INTERNATIONAL CORPORATION
      2021   Phase 2   EUCTR2020-004461-40-IT   Australia;Belgium;Brazil;Canada;China;Czechia;Denmark;France;Germany;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Spain;Switzerland;Taiwan;United Kingdom;United States
   Bristol-Myers Squibb
      2021   Phase 2   NCT04877990   Australia;Brazil;Canada;China;Czechia;Germany;Hungary;Italy;Japan;Netherlands;Poland;Portugal;Romania;Russian Federation;Spain;Taiwan;United Kingdom;United States
   Bristol-Myers Squibb International Corporation
      2022   Phase 2   EUCTR2020-004461-40-PT   Australia;Belgium;Brazil;Canada;China;Czechia;Denmark;France;Germany;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Spain;Switzerland;Taiwan;United Kingdom;United States
      2022   Phase 2   EUCTR2020-004461-40-NL   Australia;Belgium;Brazil;Canada;China;Czechia;Denmark;France;Germany;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Spain;Switzerland;Taiwan;United Kingdom;United States
      2021   Phase 2   EUCTR2020-004461-40-DE   Australia;Belgium;Brazil;Canada;China;Czechia;Denmark;France;Germany;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Spain;Switzerland;Taiwan;United Kingdom;United States
   Walid Elsharkawi
      2022   Phase 2   JPRN-jRCT2031210637   Australia;Belgium;Brazil;Canada;China;Czech Republic;Denmark;France;Germany;Hungary;Ireland;Israel;Italy;Japan;Mexico;Netherlands;Poland;Portugal;Romania;Russia;South Korea;Spain;Switzerland;Taiwan;UK;US
DEX 21-P
   Quince Therapeutics S.p.A.
      2003   Phase 2   NCT01171807   Italy
Dexametasone sodium phosphate
   EryDel S.p.A.
      -   Phase 2   EUCTR2018-004763-31-IT   Italy
Dexamethasone
   University of Chicago
      2004   -   NCT00152620   United States
Dextran 1 FOR injection
   PFIZER LIMITED
      2012   -   EUCTR2010-022766-27-IT   Belgium;Canada;Hungary;Italy;Sweden;United States
   Pfizer Limited, Ramsgate Road, Sandwich, Kent, CT13 9NJ, UK
      2012   -   EUCTR2010-022766-27-SK   Belgium;Canada;Hungary;Italy;Poland;Slovakia;Sweden;United States
      2012   -   EUCTR2010-022766-27-SE   Belgium;Canada;Germany;Hungary;Italy;Poland;Slovakia;Sweden;United States
      2012   -   EUCTR2010-022766-27-HU   Belgium;Canada;Germany;Hungary;Italy;Poland;Slovakia;Sweden;United States
      2012   -   EUCTR2010-022766-27-BE   Belgium;Canada;Germany;Hungary;Italy;Poland;Slovakia;Sweden;United States
Dextromethorphan
   Takeda
      2016   Phase 4   NCT02760615   United States
Dextromethorphan 30 MG
   Janssen Research & Development, LLC
      2018   Phase 1   NCT03358706   Austria;Belgium;Denmark;Germany;Sweden;United Kingdom;United States
Diet 1
   University of Washington
      2017   -   NCT03012542   United States
Diet 2
   University of Washington
      2017   -   NCT03012542   United States
Dietary fiber mixture
   Sahlgrenska University Hospital, Sweden
      2023   -   NCT06504784   Sweden
Dietary intervention with NO-carrageenan diet
   University of Illinois at Chicago
      2010   -   NCT01065571   United States
Dietary therapy
   Rush University Medical Center
      2006   Phase 1/Phase 2   NCT00343642   United States
Dificlir 200 MG compresse rivestite CON film
   ASTELLAS PHARMA EUROPE LIMITED
      2015   Phase 3;Phase 4   EUCTR2014-003002-32-IT   Austria;Czech Republic;Czechia;France;Germany;Greece;Italy;Poland;Russian Federation;United Kingdom
Dificlir 200 MG FILM-coated tablets
   Astellas Pharma Europe Ltd.
      2015   Phase 3;Phase 4   EUCTR2014-003002-32-PL   Austria;Czech Republic;France;Germany;Greece;Italy;Poland;Russian Federation;United Kingdom
      2015   Phase 4   EUCTR2014-003002-32-GR   Austria;Czech Republic;Germany;Greece;Poland
      2015   Phase 4   EUCTR2014-003002-32-DE   Austria;Czech Republic;Germany;Greece;Poland
      2015   Phase 3;Phase 4   EUCTR2014-003002-32-CZ   Austria;Czech Republic;France;Germany;Greece;Italy;Poland;Russian Federation;United Kingdom
      2015   Phase 3;Phase 4   EUCTR2014-003002-32-AT   Austria;Czech Republic;France;Germany;Greece;Italy;Poland;Russian Federation;United Kingdom
DIMS0150
   INDEX PHARMACEUTICALS
      2012   -   EUCTR2011-003130-14-IT   Czech Republic;Germany;Hungary;Italy;Poland;United Kingdom
   INDEX PHARMACEUTICALS AB
      2018   Phase 2   EUCTR2016-004217-26-IT   Czech Republic;France;Germany;Hungary;Italy;Montenegro;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Ukraine
   InDex Pharmaceuticals AB
      2021   Phase 1;Phase 2   EUCTR2021-003023-14-SE   Sweden
      2017   Phase 2   EUCTR2016-004217-26-SE   Czech Republic;France;Germany;Hungary;Italy;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Ukraine
      2017   Phase 2   EUCTR2016-004217-26-HU   Czech Republic;France;Germany;Hungary;Italy;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Ukraine
      2017   Phase 2   EUCTR2016-004217-26-FR   Czech Republic;France;Germany;Hungary;Italy;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Ukraine
      2017   Phase 2   EUCTR2016-004217-26-ES   Czech Republic;France;Germany;Hungary;Italy;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Ukraine
      2017   Phase 2   EUCTR2016-004217-26-DE   Czech Republic;France;Germany;Hungary;Italy;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Ukraine
      2017   Phase 2   EUCTR2016-004217-26-CZ   Czech Republic;France;Germany;Hungary;Italy;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Ukraine
      2012   -   EUCTR2011-003130-14-CZ   Czech Republic;Germany;Hungary;Italy;Poland;United Kingdom
      2011   -   EUCTR2011-003130-14-PL   Czech Republic;Germany;Hungary;Italy;Poland;United Kingdom
      2011   -   EUCTR2011-003130-14-HU   Czech Republic;Germany;Hungary;Italy;Poland;United Kingdom
      2011   Phase 3   EUCTR2011-003130-14-GB   Czech Republic;Germany;Hungary;Italy;Poland;United Kingdom
      2011   -   EUCTR2011-003130-14-DE   Czech Republic;Germany;Hungary;Italy;Poland;United Kingdom
      2006   -   EUCTR2006-001846-15-SE   Sweden
Diosmin
   Tanta University
      2022   Phase 3   NCT05626166   Egypt
Diphtheria booster vaccination
   Medical University of Warsaw
      2012   -   NCT03998215   -
Doxycycline
   Hamilton Health Sciences Corporation
      2016   Phase 2   NCT02606032   Canada
   University of Dundee
      2006   -   NCT00355602   United Kingdom
Dried chicory root
   University Medical Center Groningen
      2023   -   NCT06016322   Netherlands
Dual biological therapy
   Tampere University Hospital
      2015   -   NCT05135221   Finland
Dupilumab
   Sanofi
      2023   Phase 2   NCT05731128   Argentina;Canada;Chile;Japan;Korea, Republic of;Mexico;Puerto Rico;South Africa;Taiwan;Turkey;United States
   Tanaka Tomoyuki
      2023   Phase 2   JPRN-jRCT2031220662   Japan;United States
E-monitoring
   Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives
      2020   Phase 4   NCT04183608   France
E. coli nissle
   Hvidovre University Hospital
      2011   Phase 4   NCT01772615   Denmark
   Kangbuk Samsung Hospital
      2018   Phase 4   NCT04969679   Korea, Republic of
E400 elimination
   Region Skane
      2024   -   NCT05743374   Sweden
E6007
   EA Pharma Co., Ltd.
      2016   Phase 2   NCT03018054   Japan
   Eisai Inc.
      2010   Phase 1   NCT01221818   United States
E6011
   EA Pharma Co., Ltd.
      2019   Phase 2   EUCTR2018-002109-70-HU   Czech Republic;Hungary;Japan;Poland
      2019   Phase 2   EUCTR2018-002109-70-CZ   Czech Republic;Czechia;Hungary;Japan;Poland;Russian Federation
Ebetrex 15 MG = 0,75 ML, oplossing voor injectie IN voorgevulde injectiespuit 20 MG/ML
   Amsterdam UMC location AMC
      2021   Phase 3;Phase 4   EUCTR2021-000469-33-NL   Netherlands
Echinacea extract
   Benha University
      2023   -   NCT06583863   Egypt
Ecologic 825
   Wageningen University
      2014   -   NCT02361957   Netherlands
Efavaleukin alfa
   AMGEN INC.
      2021   Phase 2   EUCTR2021-002537-41-IT   Argentina;Austria;Bulgaria;Canada;Czechia;Denmark;Finland;Germany;Hungary;Italy;Japan;Korea, Democratic People's Republic of;Mexico;Netherlands;Poland;Romania;Russian Federation;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United States
   Amgen
      2023   Phase 2   NCT05672199   Argentina;Bulgaria;Denmark;Germany;Hungary;Japan;Korea, Republic of;Mexico;Poland;Romania;Switzerland;Turkey;United States
      2022   Phase 2   NCT04987307   Argentina;Austria;Belgium;Bulgaria;Canada;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;Italy;Japan;Korea, Republic of;Latvia;Mexico;Netherlands;Poland;Romania;Slovakia;Spain;Switzerland;Taiwan;Turkey;United States
   Amgen Inc.
      2023   Phase 2   EUCTR2022-001686-12-SK   Argentina;Austria;Belgium;Bulgaria;Canada;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;Italy;Japan;Korea, Republic of;Latvia;Mexico;Netherlands;Poland;Romania;Russian Federation;Slovakia;Spain;Switzerland;Taiwan;Türkiye;United States
      2023   Phase 2   EUCTR2022-001686-12-RO   Argentina;Austria;Belgium;Bulgaria;Canada;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;Italy;Japan;Korea, Republic of;Latvia;Mexico;Netherlands;Poland;Romania;Russian Federation;Slovakia;Spain;Switzerland;Taiwan;Türkiye;Ukraine;United States
      2023   Phase 2   EUCTR2022-001686-12-NL   Argentina;Austria;Belgium;Bulgaria;Canada;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;Italy;Japan;Korea, Republic of;Latvia;Mexico;Netherlands;Poland;Romania;Russian Federation;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United States
      2023   Phase 2   EUCTR2022-001686-12-LV   Argentina;Austria;Belgium;Bulgaria;Canada;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;Italy;Japan;Korea, Republic of;Latvia;Mexico;Netherlands;Poland;Romania;Russian Federation;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United States
      2023   Phase 2   EUCTR2022-001686-12-HU   Argentina;Austria;Belgium;Bulgaria;Canada;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;Italy;Japan;Korea, Republic of;Latvia;Mexico;Netherlands;Poland;Romania;Russian Federation;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United States
      2023   Phase 2   EUCTR2022-001686-12-GR   Argentina;Austria;Belgium;Bulgaria;Canada;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;Italy;Japan;Korea, Republic of;Latvia;Mexico;Netherlands;Poland;Romania;Russian Federation;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United States
      2023   Phase 2   EUCTR2022-001686-12-FR   Argentina;Austria;Belgium;Bulgaria;Canada;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;Italy;Japan;Korea, Republic of;Latvia;Mexico;Netherlands;Poland;Romania;Russian Federation;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United States
      2023   Phase 2   EUCTR2022-001686-12-FI   Argentina;Austria;Belgium;Bulgaria;Canada;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;Italy;Japan;Korea, Republic of;Latvia;Mexico;Netherlands;Poland;Romania;Slovakia;Spain;Switzerland;Taiwan;Türkiye;United States
      2023   Phase 2   EUCTR2022-001686-12-DK   Argentina;Austria;Belgium;Bulgaria;Canada;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;Italy;Japan;Korea, Republic of;Latvia;Mexico;Netherlands;Poland;Romania;Russian Federation;Slovakia;Spain;Switzerland;Taiwan;Türkiye;Ukraine;United States
      2023   Phase 2   EUCTR2022-001686-12-DE   Argentina;Austria;Belgium;Bulgaria;Canada;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;Italy;Japan;Korea, Republic of;Latvia;Mexico;Netherlands;Poland;Romania;Russian Federation;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United States
      2023   Phase 2   EUCTR2022-001686-12-BG   Argentina;Austria;Belgium;Bulgaria;Canada;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;Italy;Japan;Korea, Republic of;Latvia;Mexico;Netherlands;Poland;Romania;Slovakia;Spain;Switzerland;Taiwan;Türkiye;United States
      2023   Phase 2   EUCTR2022-001686-12-BE   Argentina;Austria;Belgium;Bulgaria;Canada;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;Italy;Japan;Korea, Republic of;Latvia;Mexico;Netherlands;Poland;Romania;Russian Federation;Slovakia;Spain;Switzerland;Taiwan;Türkiye;Ukraine;United States
      2023   Phase 2   EUCTR2022-001686-12-AT   Argentina;Austria;Belgium;Bulgaria;Canada;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;Italy;Japan;Korea, Republic of;Latvia;Mexico;Netherlands;Poland;Romania;Slovakia;Spain;Switzerland;Taiwan;Türkiye;United States
      2023   Phase 2   EUCTR2021-002537-41-SK   Argentina;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;Italy;Japan;Korea, Republic of;Latvia;Mexico;Netherlands;Poland;Romania;Russian Federation;Slovakia;Spain;Switzerland;Taiwan;Türkiye;United States
      2023   Phase 2   EUCTR2021-002537-41-LV   Argentina;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;Italy;Japan;Korea, Republic of;Latvia;Mexico;Netherlands;Poland;Romania;Russian Federation;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United States
      2022   Phase 2   EUCTR2021-002537-41-RO   Argentina;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;Italy;Japan;Korea, Republic of;Latvia;Mexico;Netherlands;Poland;Romania;Slovakia;Spain;Switzerland;Taiwan;Türkiye;United States
      2022   Phase 2   EUCTR2021-002537-41-GR   Argentina;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;Italy;Japan;Korea, Democratic People's Republic of;Latvia;Mexico;Netherlands;Poland;Romania;Russian Federation;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United States
      2022   Phase 2   EUCTR2021-002537-41-FR   Argentina;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;Italy;Japan;Korea, Republic of;Latvia;Mexico;Netherlands;Poland;Romania;Russian Federation;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United States
      2022   Phase 2   EUCTR2021-002537-41-FI   Argentina;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;Italy;Japan;Korea, Republic of;Latvia;Mexico;Netherlands;Poland;Romania;Slovakia;Spain;Switzerland;Taiwan;Türkiye;United States
      2022   Phase 2   EUCTR2021-002537-41-ES   Argentina;Austria;Belgium;Bulgaria;Canada;Czechia;Denmark;Finland;Germany;Greece;Hungary;Italy;Japan;Korea, Democratic People's Republic of;Mexico;Netherlands;Poland;Romania;Russian Federation;Spain;Switzerland;Taiwan;Turkey;Ukraine;United States
      2022   Phase 2   EUCTR2021-002537-41-DK   Argentina;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;Italy;Japan;Korea, Republic of;Latvia;Mexico;Netherlands;Poland;Romania;Russian Federation;Slovakia;Spain;Switzerland;Taiwan;Türkiye;Ukraine;United States
      2022   Phase 2   EUCTR2021-002537-41-CZ   Argentina;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;Italy;Japan;Korea, Republic of;Latvia;Mexico;Netherlands;Poland;Romania;Russian Federation;Slovakia;Spain;Switzerland;Taiwan;Türkiye;Ukraine;United States
      2022   Phase 2   EUCTR2021-002537-41-BG   Argentina;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;Italy;Japan;Korea, Democratic People's Republic of;Latvia;Mexico;Netherlands;Poland;Romania;Slovakia;Spain;Sweden;Switzerland;Taiwan;Türkiye;United States
      2022   Phase 2   EUCTR2021-002537-41-BE   Argentina;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;Italy;Japan;Korea, Republic of;Latvia;Mexico;Netherlands;Poland;Romania;Russian Federation;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United States
      2021   Phase 2   EUCTR2021-002537-41-NL   Argentina;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;Italy;Japan;Korea, Republic of;Latvia;Mexico;Netherlands;Poland;Romania;Slovakia;Spain;Switzerland;Taiwan;Türkiye;United States
      2021   Phase 2   EUCTR2021-002537-41-HU   Argentina;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;Italy;Japan;Korea, Democratic People's Republic of;Latvia;Mexico;Netherlands;Poland;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United States
      2021   Phase 2   EUCTR2021-002537-41-DE   Argentina;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;Italy;Japan;Korea, Republic of;Latvia;Mexico;Netherlands;Poland;Romania;Slovakia;Spain;Switzerland;Taiwan;Türkiye;United States
   Hama Yoriko
      2023   Phase 2   JPRN-jRCT2071230044   Japan;Romania;Switzerland;United States
      2022   Phase 2   JPRN-jRCT2041220001   Argentina;Austria;Belgium;Bulgaria;Canada;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;Italy;Japan;Korea;Latvia;Mexico;Netherlands;Poland;Romania;Slovakia;Spain;Switzerland;Taiwan;Turkey;United States
Efmarodocokin alfa
   Chugai Pharmaceutical Co., Ltd.
      2019   Phase 1   JPRN-jRCT2080224649   Japan
   Genentech, Inc.
      2018   Phase 2   EUCTR2017-004997-32-IE   Bulgaria;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
EGF enema
   University Hospitals of Leicester NHS Trust
      2006   Phase 3   EUCTR2006-002036-25-GB   United Kingdom
Eicosapentaenoic acid
   Azienda Ospedaliera Universitaria di Bologna Policlinico S. Orsola Malpighi
      2014   -   NCT02179372   Italy
      2014   -   NCT02069561   Italy
Elemental 028 extra
   Nutricia UK Ltd
      2025   -   NCT06877923   -
Eltrekibart
   Eli Lilly and Company
      2024   Phase 2   NCT06598943   Argentina;Belgium;Canada;Croatia;Czechia;Denmark;France;Germany;Greece;Hungary;Ireland;Italy;Japan;Korea, Republic of;Latvia;Poland;Romania;Serbia;Spain;Turkey;United States
Emea/H/C/000240
   Santeon
      2015   Phase 4   EUCTR2015-001954-14-NL   Netherlands
Emea/H/C/000481
   Odense University Hospital
      2011   Phase 3   EUCTR2011-004268-31-DK   Denmark
Emea/H/C/002576
   Amsterdam UMC location AMC
      2021   Phase 3;Phase 4   EUCTR2021-000469-33-NL   Netherlands
Empagliflozin
   Guangdong Provincial People's Hospital
      2022   Phase 4   ChiCTR2400080773   China
   National Institute of Allergy and Infectious Diseases (NIAID)
      2021   Phase 1   NCT05078879   United States
   Tanta University
      2022   Early Phase 1   NCT05610956   -
Empagliflozin 10 MG
   Sadat City University
      2021   Phase 2   NCT05058417   Egypt
Encapsulated faecal microbiota filtrate
   Andreas Stallmach
      2023   Phase 3   NCT03843385   Germany
Enema
   Beijing Anorectal Hospital (Beijing Erlong Road Hospital)
      2024   Phase 0   ChiCTR2400082951   China
   Charité Universitätsmedizin, Campus Charité Mitte
      2007   Phase 2   EUCTR2006-004162-13-DE   Germany
   Chengdu University of Traditional Chinese Medicine
      2020   Phase 0   ChiCTR2000039161   China
      2020   Phase 0   ChiCTR2000038888   China
   Children´s Hospital, University of Helsinki
      2012   Phase 4   EUCTR2012-004851-35-FI   Finland;Israel
   Nagahara Akihito
      2023   Phase 2   JPRN-jRCTs031220542   -
   Nanjing Hospital of Traditional Chinese Medicine
      2023   -   ChiCTR2300076210   China
   Otsuka Pharmaceutical Co., Ltd.
      2007   Phase 2   JPRN-jRCT2080220390   Japan
   Tel-Aviv Sourasky Medical Center
      2015   Phase 2   NCT04434872   Israel
   The Affiliated Hospital of Nanjing University of Traditional Chinese Medicine
      2006   Phase 1 study   ChiCTR-TRC-08000048   China
   The First Affiliated Hospital, College of Medicine, Zhejiang University
      2024   Phase 0   ChiCTR2400092548   China
   The Jikei University School of Medicine Division of Gastroenterology and Hepatology
      2009   -   JPRN-UMIN000008967   Japan
   sterna biologicals GmbH & Co. KG
      2014   Phase 2   EUCTR2013-004599-36-DE   Germany
Engerix-B 20µG / 1ML suspensióN inyectable EN jeringa precargada
   Hospital Universitario La Princesa
      2011   Phase 3   EUCTR2010-023947-14-ES   Spain
Ensure surgery immunonutrition shakes
   NYU Langone Health
      2025   -   NCT06309017   United States
Entecavir
   Saitama Medical University
      2016   -   JPRN-UMIN000020029   Japan
Enteral nutrition
   Department of Colonrectal Disease, Shanghai Tenth people's Hospital
      2020   Phase 0   ChiCTR2000039915   China
   McMaster Children's Hospital
      2015   -   NCT02521064   Canada
   Nagoya University Graduate School of Medicine, Department of Gastroentrology and hepatology
      2015   -   JPRN-UMIN000018745   Japan
Entocort CR
   COSMO TECHNOLOGIES LTD
      2008   -   EUCTR2006-004776-12-IT   Belgium;Estonia;France;Italy;Latvia;Lithuania;Sweden;United Kingdom
Entocort EC® 3 MG
   Bausch Health Americas, Inc.
      2008   Phase 3   NCT00679380   Australia;Belgium;Estonia;France;Israel;Italy;Latvia;Lithuania;Poland;Romania;Russian Federation;Slovakia;Sweden;Ukraine;United Kingdom
Entocort® CR
   COSMO Technologies Ltd
      2008   Phase 3   EUCTR2006-004776-12-SK   Belgium;Estonia;France;Italy;Latvia;Lithuania;Slovakia;Sweden;United Kingdom
      2008   -   EUCTR2006-004776-12-SE   Belgium;Estonia;France;Italy;Latvia;Lithuania;Sweden;United Kingdom
      2008   -   EUCTR2006-004776-12-LV   Belgium;Estonia;France;Italy;Latvia;Lithuania;Sweden;United Kingdom
      2008   -   EUCTR2006-004776-12-LT   Belgium;Estonia;France;Italy;Latvia;Lithuania;Sweden;United Kingdom
      2008   Phase 3   EUCTR2006-004776-12-GB   Belgium;Estonia;France;Italy;Latvia;Lithuania;Slovakia;Sweden;United Kingdom
      2008   -   EUCTR2006-004776-12-FR   Belgium;Estonia;France;Italy;Latvia;Lithuania;Sweden;United Kingdom
      2008   -   EUCTR2006-004776-12-EE   Belgium;Estonia;France;Italy;Latvia;Lithuania;Sweden;United Kingdom
      2008   -   EUCTR2006-004776-12-BE   Belgium;Estonia;France;Italy;Latvia;Lithuania;Sweden;United Kingdom
Entyvio
   ALIMENTIV INC.
      2021   Phase 4   EUCTR2019-002485-12-IT   Belarus;Belgium;Canada;France;Italy;Netherlands;Poland;Russian Federation;Ukraine;United Kingdom;United States
   Academic Medical Center, Gastroenterology
      2017   Phase 4   EUCTR2014-005443-40-HU   Belgium;Hungary;Netherlands
   Academic Medical Center/ Gastroenterology
      2015   Phase 4   EUCTR2014-005443-40-NL   Belgium;Hungary;Netherlands
      2015   Phase 4   EUCTR2014-005443-40-BE   Belgium;Hungary;Netherlands
   Alimentiv
      2021   Phase 4   EUCTR2019-002485-12-PL   Belarus;Belgium;Canada;France;Italy;Netherlands;Poland;Russian Federation;Ukraine;United Kingdom;United States
   Alimentiv Inc.
      2021   Phase 4   EUCTR2019-002485-12-NL   Belarus;Belgium;Canada;France;Italy;Netherlands;Poland;Ukraine;United Kingdom;United States
      2020   Phase 4   EUCTR2019-002485-12-BE   Belarus;Belgium;Canada;France;Italy;Netherlands;Poland;Russian Federation;Ukraine;United Kingdom;United States
   Alimentiv Inc. (formerly Robarts Clinical Trials)
      2020   Phase 4   EUCTR2019-002485-12-GB   Belarus;Belgium;Canada;France;Italy;Netherlands;Poland;Russian Federation;Ukraine;United Kingdom;United States
   Allergan Ltd.
      2019   Phase 2   EUCTR2018-001605-93-RO   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Colombia;Czech Republic;Czechia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Poland;Romania;Russian Federation;Singapore;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States
      2019   Phase 2   EUCTR2018-001605-93-ES   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Colombia;Czech Republic;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Poland;Romania;Russian Federation;Singapore;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States
      2019   Phase 2   EUCTR2018-001605-93-BG   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Colombia;Czech Republic;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Poland;Romania;Russian Federation;Singapore;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States
   AstraZeneca AB
      2019   Phase 2   EUCTR2018-001605-93-GB   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Colombia;Czech Republic;Czechia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Poland;Romania;Russian Federation;Singapore;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States
      2019   Phase 2   EUCTR2018-001605-93-BE   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Colombia;Czech Republic;Czechia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Poland;Romania;Russian Federation;Singapore;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States
   CHU Saint-Etienne
      2018   Phase 4   EUCTR2018-001051-12-FR   France
   Centre Hospitalier Universitaire de Rennes
      2018   Phase 4   EUCTR2018-002673-21-FR   France
   Eli Lilly and Company
      2021   Phase 3   EUCTR2019-001653-99-LV   Argentina;Australia;Austria;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;France;Germany;Hungary;India;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2021   Phase 3   EUCTR2019-001653-99-LT   Argentina;Australia;Austria;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;France;Germany;Hungary;India;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2021   Phase 3   EUCTR2019-001653-99-DE   Argentina;Australia;Austria;Belgium;Brazil;Canada;Croatia;Czech Republic;Czechia;Denmark;France;Germany;Hungary;India;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2021   Phase 3   EUCTR2019-001653-99-BE   Argentina;Australia;Austria;Belgium;Brazil;Canada;Croatia;Czechia;Denmark;France;Germany;Hungary;India;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2021   Phase 3   EUCTR2019-001653-99-AT   Argentina;Australia;Austria;Belgium;Brazil;Canada;Croatia;Czech Republic;Czechia;Denmark;France;Germany;Hungary;India;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2020   Phase 3   EUCTR2019-001653-99-FR   Argentina;Australia;Austria;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;France;Germany;Hungary;India;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
   FONDAZIONE IRCCS CA' GRANDA OSPEDALE MAGGIORE POLICLINICO
      2016   Phase 4   EUCTR2015-003270-32-IT   Italy
   Robarts Clinical Trials Inc.
      2020   Phase 4   EUCTR2019-002485-12-FR   Belarus;Belgium;Canada;France;Italy;Netherlands;Poland;Russian Federation;Ukraine;United Kingdom;United States
   TAKEDA DEVELOPMENT CENTER AMERICAS INC.
      2021   Phase 3   EUCTR2020-004300-34-IT   Australia;Austria;Belgium;Bosnia and Herzegovina;Canada;China;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Japan;Lithuania;New Zealand;Poland;Romania;Russian Federation;Slovakia;Spain;Ukraine;United Kingdom;United States
   TAKEDA DEVELOPMENT CENTRE EUROPE LTD
      2016   Phase 3   EUCTR2015-000480-14-IT   Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2014-003942-28-IT   Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Hungary;Israel;Italy;Japan;Netherlands;Poland;Russian Federation;Spain;Sweden;Switzerland;United Kingdom;United States
      2015   Phase 3   EUCTR2015-000939-33-IT   Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
      -   Phase 4   EUCTR2016-000678-40-IT   Austria;Belgium;Bulgaria;Czech Republic;Czechia;Estonia;Hungary;Iceland;India;Italy;Korea, Democratic People's Republic of;Korea, Republic of;Latvia;Malaysia;New Zealand;Poland;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Taiwan;Turkey;Ukraine
   Takeda Development Center Americas, Inc.
      2023   Phase 3   EUCTR2021-000630-34-SK   Australia;Belgium;Canada;China;Croatia;Czech Republic;Czechia;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Poland;Slovakia;Spain;United Kingdom;United States
      2023   Phase 3   EUCTR2021-000630-34-GR   Australia;Belgium;Canada;China;Croatia;Czech Republic;Czechia;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Poland;Slovakia;Spain;United Kingdom;United States
      2023   Phase 3   EUCTR2021-000630-34-BE   Australia;Belgium;Canada;China;Croatia;Czech Republic;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Poland;Slovakia;Spain;United Kingdom;United States
      2022   Phase 3   EUCTR2021-000630-34-HU   Australia;Belgium;Canada;China;Croatia;Czech Republic;Czechia;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Poland;Russian Federation;Slovakia;Spain;Ukraine;United Kingdom;United States
      2022   Phase 3   EUCTR2021-000630-34-HR   Australia;Belgium;Canada;China;Croatia;Czech Republic;Czechia;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Poland;Russian Federation;Slovakia;Spain;Ukraine;United Kingdom;United States
      2022   Phase 3   EUCTR2020-004300-34-BE   Australia;Belgium;Canada;China;Croatia;Czech Republic;Czechia;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Poland;Slovakia;Spain;United Kingdom;United States
      2021   Phase 3   EUCTR2020-004300-34-SK   Australia;Belgium;Canada;China;Croatia;Czech Republic;Czechia;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Poland;Slovakia;Spain;United Kingdom;United States
      2021   Phase 3   EUCTR2020-004300-34-LT   Australia;Belgium;Canada;China;Croatia;Czech Republic;Czechia;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Poland;Russian Federation;Slovakia;Spain;Ukraine;United Kingdom;United States
      2021   Phase 3   EUCTR2020-004300-34-HU   Australia;Austria;Belgium;Bosnia and Herzegovina;Canada;China;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Japan;Lithuania;New Zealand;Poland;Romania;Russian Federation;Slovakia;Spain;Ukraine;United Kingdom;United States
      2021   Phase 3   EUCTR2020-004300-34-HR   Australia;Austria;Belgium;Bosnia and Herzegovina;Canada;China;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Japan;Lithuania;New Zealand;Poland;Romania;Russian Federation;Slovakia;Spain;Ukraine;United Kingdom;United States
      2021   Phase 3   EUCTR2020-004300-34-GR   Australia;Belgium;Canada;China;Croatia;Czech Republic;Czechia;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Poland;Slovakia;Spain;United Kingdom;United States
      2021   Phase 3   EUCTR2020-004300-34-ES   Australia;Austria;Belgium;Bosnia and Herzegovina;Canada;China;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Japan;Lithuania;New Zealand;Poland;Romania;Russian Federation;Slovakia;Spain;Ukraine;United Kingdom;United States
      -   Phase 3   EUCTR2021-000630-34-PL   Australia;Belgium;Canada;China;Croatia;Czech Republic;Czechia;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Poland;Slovakia;Spain;United Kingdom;United States
      -   Phase 3   EUCTR2021-000630-34-Outside-EU/EEA   Australia;Canada;China;Israel;Japan;Korea, Republic of;United Kingdom;United States
      -   Phase 3   EUCTR2021-000630-34-CZ   Australia;Belgium;Canada;China;Croatia;Czech Republic;Czechia;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Poland;Slovakia;Spain;United Kingdom;United States
      -   Phase 3   EUCTR2020-004300-34-PL   Australia;Belgium;Canada;China;Croatia;Czech Republic;Czechia;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Poland;Slovakia;Spain;United Kingdom;United States
      -   Phase 3   EUCTR2020-004300-34-Outside-EU/EEA   Australia;Belgium;Canada;China;Croatia;Czechia;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Poland;Slovakia;Spain;United Kingdom;United States
      -   Phase 3   EUCTR2020-004300-34-CZ   Australia;Belgium;Canada;China;Croatia;Czech Republic;Czechia;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Poland;Slovakia;Spain;United Kingdom;United States
   Takeda Development Centre Americas Inc.
      2018   Phase 2   EUCTR2017-002182-21-PL   Belgium;Canada;France;Germany;Hungary;Israel;Netherlands;Poland;Ukraine;United Kingdom;United States
   Takeda Development Centre Americas, Ltd.
      2017   Phase 2   EUCTR2017-002182-21-HU   Belgium;Canada;France;Germany;Hungary;Israel;Netherlands;Poland;Ukraine;United Kingdom;United States
   Takeda Development Centre Europe Limited
      2017   Phase 4   EUCTR2016-000678-40-BG   Australia;Bulgaria;Czech Republic;Estonia;Hungary;India;Italy;Korea, Republic of;Latvia;Malaysia;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Taiwan;Turkey;Ukraine
      2016   Phase 4   EUCTR2016-000678-40-LV   Australia;Bulgaria;Czech Republic;Estonia;Hungary;India;Italy;Korea, Republic of;Latvia;Malaysia;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Taiwan;Turkey;Ukraine
      2016   Phase 4   EUCTR2016-000678-40-HU   Australia;Bulgaria;Czech Republic;Czechia;Estonia;Hungary;India;Italy;Korea, Republic of;Latvia;Malaysia;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Taiwan;Turkey;Ukraine
      2016   Phase 4   EUCTR2016-000678-40-EE   Australia;Bulgaria;Czech Republic;Estonia;Hungary;India;Italy;Korea, Republic of;Latvia;Malaysia;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Taiwan;Turkey;Ukraine
      2016   Phase 4   EUCTR2016-000678-40-CZ   Australia;Bulgaria;Czech Republic;Estonia;Hungary;India;Italy;Korea, Republic of;Latvia;Malaysia;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Taiwan;Turkey;Ukraine
   Takeda Development Centre Europe, Ltd.
      2018   Phase 2   EUCTR2017-002231-41-PL   Belgium;Canada;France;Germany;Hungary;Israel;Netherlands;Poland;Ukraine;United Kingdom;United States
      2018   Phase 2   EUCTR2017-002231-41-NL   Belgium;Canada;France;Germany;Hungary;Israel;Netherlands;Poland;Ukraine;United Kingdom;United States
      2018   Phase 2   EUCTR2017-002231-41-BE   Belgium;Canada;France;Germany;Hungary;Israel;Netherlands;Poland;Ukraine;United Kingdom;United States
      2018   Phase 2   EUCTR2017-002182-21-NL   Belgium;Canada;France;Germany;Hungary;Israel;Netherlands;Poland;Ukraine;United Kingdom;United States
      2018   Phase 2   EUCTR2017-002182-21-BE   Belgium;Canada;France;Germany;Hungary;Israel;Netherlands;Poland;Ukraine;United Kingdom;United States
      2017   Phase 2   EUCTR2017-002231-41-HU   Belgium;Canada;France;Germany;Hungary;Israel;Netherlands;Poland;Ukraine;United Kingdom;United States
      2017   Phase 2   EUCTR2017-002231-41-GB   Belgium;Canada;France;Germany;Hungary;Israel;Netherlands;Poland;Ukraine;United Kingdom;United States
      2017   Phase 2   EUCTR2017-002231-41-DE   Belgium;Canada;France;Germany;Hungary;Israel;Netherlands;Poland;Ukraine;United Kingdom;United States
      2017   Phase 2   EUCTR2017-002182-21-GB   Belgium;Canada;France;Germany;Hungary;Israel;Netherlands;Poland;Ukraine;United Kingdom;United States
      2017   Phase 2   EUCTR2017-002182-21-FR   Belgium;Canada;France;Germany;Hungary;Israel;Netherlands;Poland;Ukraine;United Kingdom;United States
      2017   Phase 2   EUCTR2017-002182-21-DE   Belgium;Canada;France;Germany;Hungary;Israel;Netherlands;Poland;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000939-33-PT   Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000939-33-PL   Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000939-33-NL   Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000939-33-HU   Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000939-33-HR   Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000939-33-ES   Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000482-31-NL   Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000482-31-HR   Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000480-14-SK   Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000480-14-SE   Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000480-14-RO   Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000480-14-NL   Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000480-14-LT   Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000480-14-HU   Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000480-14-HR   Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000480-14-GB   Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000480-14-ES   Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000480-14-DK   Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000480-14-DE   Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000480-14-CZ   Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000480-14-BG   Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000480-14-BE   Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2014-003942-28-SE   Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Israel;Italy;Japan;Netherlands;Poland;Russian Federation;Spain;Sweden;Switzerland;United Kingdom;United States
      2016   Phase 3   EUCTR2014-003942-28-PL   Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Israel;Italy;Japan;Netherlands;Poland;Russian Federation;Spain;Sweden;Switzerland;United Kingdom;United States
      2016   Phase 3   EUCTR2014-003942-28-HU   Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Israel;Italy;Japan;Netherlands;Poland;Russian Federation;Spain;Sweden;Switzerland;United Kingdom;United States
      2016   Phase 3   EUCTR2014-003942-28-GB   Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Israel;Italy;Japan;Netherlands;Poland;Russian Federation;Spain;Sweden;Switzerland;United Kingdom;United States
      2016   Phase 3   EUCTR2014-003942-28-FR   Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Israel;Italy;Japan;Netherlands;Poland;Russian Federation;Spain;Sweden;Switzerland;United Kingdom;United States
      2016   Phase 3   EUCTR2014-003942-28-ES   Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Israel;Italy;Japan;Netherlands;Poland;Russian Federation;Spain;Sweden;Switzerland;United Kingdom;United States
      2016   Phase 3   EUCTR2014-003942-28-DE   Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Israel;Italy;Japan;Netherlands;Poland;Russian Federation;Spain;Sweden;Switzerland;United Kingdom;United States
      2016   Phase 3   EUCTR2014-003942-28-CZ   Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Israel;Italy;Japan;Netherlands;Poland;Russian Federation;Spain;Sweden;Switzerland;United Kingdom;United States
      2016   Phase 3   EUCTR2014-003942-28-BE   Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Israel;Italy;Japan;Netherlands;Poland;Russian Federation;Spain;Sweden;Switzerland;United Kingdom;United States
      2016   Phase 3   EUCTR2014-003942-28-AT   Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Israel;Italy;Japan;Netherlands;Poland;Russian Federation;Spain;Sweden;Switzerland;United Kingdom;United States
      2015   Phase 3   EUCTR2015-000939-33-SK   Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2015   Phase 3   EUCTR2015-000939-33-LV   Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2015   Phase 3   EUCTR2015-000939-33-LT   Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2015   Phase 3   EUCTR2015-000939-33-GB   Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2015   Phase 3   EUCTR2015-000939-33-EE   Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2015   Phase 3   EUCTR2015-000939-33-DK   Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2015   Phase 3   EUCTR2015-000939-33-DE   Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2015   Phase 3   EUCTR2015-000939-33-CZ   Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2015   Phase 3   EUCTR2015-000939-33-BG   Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2015   Phase 3   EUCTR2015-000939-33-BE   Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
      -   Phase 2   EUCTR2017-002231-41-FR   Belgium;Canada;France;Germany;Hungary;Israel;Netherlands;Poland;Ukraine;United Kingdom;United States
Entyvio - 300 MG - polvere PE rconcentrato PER soluzione PER infu
   ALLERGAN LIMITED
      2019   Phase 2   EUCTR2018-001605-93-IT   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Colombia;Czech Republic;Czechia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Poland;Romania;Russian Federation;Singapore;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States
Entyvio 300 MG
   CHU Amiens-Picardie
      2020   Phase 4   EUCTR2020-004391-18-FR   France
Entyvio 300MG
   GENENTECH, INC.
      2018   Phase 2   EUCTR2017-002350-36-IT   Bulgaria;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
   Genentech, Inc.
      2018   Phase 2   EUCTR2017-002350-36-NL   Bulgaria;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
      2018   Phase 2   EUCTR2017-002350-36-IE   Bulgaria;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
      2018   Phase 2   EUCTR2017-002350-36-HU   Bulgaria;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
      2018   Phase 2   EUCTR2017-002350-36-GR   Bulgaria;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
      2018   Phase 2   EUCTR2017-002350-36-GB   Bulgaria;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
      2018   Phase 2   EUCTR2017-002350-36-DE   Bulgaria;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
      2018   Phase 2   EUCTR2017-002350-36-BG   Bulgaria;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
   Roche Farma, S.A por delegación de Genentech, Inc.
      2018   Phase 2   EUCTR2017-002350-36-ES   Bulgaria;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
Epidermal growth factor enema
   University Hospitals of Leicester NHS Trust
      2006   Phase 3   EUCTR2006-002036-25-GB   United Kingdom
Ergocalciferol
   Boston Children’s Hospital
      2008   -   NCT00621257   United States
Esketamine
   Jinling Hospital Affiliated to c University
      2020   Phase 4   NCT05506787   China
Ethanol
   Hutchison MediPharma Enterprises Limited
      2008   -   EUCTR2007-005166-12-DE   Germany
Etrasimod
   Arena Pharmaceuticals
      2020   Phase 3   NCT03996369   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czechia;Denmark;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Thailand;Turkey;Ukraine;United Kingdom;United States
      2020   Phase 3   JPRN-jRCT2080225275   Africa;Asia except Japan;Europe;Japan;North America;Oceania;South America
      2019   Phase 3   NCT03945188   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czechia;Denmark;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 2   NCT02536404   Australia;Austria;Belgium;Bulgaria;Canada;Czechia;France;Germany;Hungary;Israel;Korea, Republic of;Latvia;Lithuania;New Zealand;Poland;Romania;Russian Federation;Spain;Ukraine;United Kingdom;United States
      2015   Phase 2   NCT02447302   Australia;Austria;Belgium;Bulgaria;Canada;Czechia;France;Germany;Hungary;Israel;Korea, Republic of;Latvia;Lithuania;New Zealand;Poland;Romania;Russian Federation;Spain;Ukraine;United Kingdom;United States
   Arena Pharmaceuticals Inc.
      2020   Phase 3   EUCTR2018-003987-29-FR   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2018-003987-29-HU   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Thailand;Turkey;Ukraine;United Kingdom;United States
   Arena Pharmaceuticals Inc. a wholly owned subsidiary of Pfizer Inc.
      2020   Phase 3   EUCTR2018-003987-29-PT   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Thailand;Türkiye;Ukraine;United Kingdom;United States
   Arena Pharmaceuticals Inc. a wholly owned subsidiary of Pfizer Inc.
      2019   Phase 3   EUCTR2018-003987-29-SK   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Thailand;Türkiye;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2018-003987-29-BE   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Thailand;Türkiye;Ukraine;United Kingdom;United States
   Everstar Therapeutics Limited
      2019   Phase 3   NCT04176588   China
   IQVIA Services Japan K.K. ICCC:
      2021   Phase 3   JPRN-jRCT2071200081   Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Chile;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea;Lebanon;Mexico;Moldova;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa
      2020   Phase 3   JPRN-jRCT2071200080   -
   Kawai Norisuke
      2024   Phase 2   JPRN-jRCT2031230586   Austria;Japan;Poland;Spain;United States
   Pfizer
      2024   -   NCT06398626   United States
      2024   -   NCT06294925   Germany;United Kingdom
      2022   Phase 2   NCT05287126   Austria;Belgium;Japan;Poland;Slovakia;Spain;United States
      2021   Phase 2   NCT05061446   Japan
      2021   Phase 2   NCT04607837   Australia;Belarus;Belgium;Bulgaria;Canada;Czechia;France;Georgia;Germany;Hungary;Israel;Italy;Korea, Republic of;Poland;Portugal;Russian Federation;Spain;Ukraine;United States
      2019   Phase 3   NCT03950232   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;Croatia;Czechia;Denmark;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Thailand;Turkey;Ukraine;United Kingdom;United States
   Tanabe Masakazu
      2021   Phase 2   JPRN-jRCT2071210052   -
Etrasimod L-arginine
   ARENA PHARMACEUTICALS, INC.
      2021   Phase 2   EUCTR2020-003507-34-IT   Australia;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Moldova, Republic of;Netherlands;Poland;Portugal;Russian Federation;South Africa;Spain;United States
      2019   Phase 3   EUCTR2018-003987-29-IT   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2018-003986-33-IT   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Korea, Democratic People's Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2018-003985-15-IT   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
   Arena Pharmaceuticals Inc.
      2021   Phase 3   EUCTR2018-003987-29-RO   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
      2020   Phase 3   EUCTR2018-003987-29-AT   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
      2020   Phase 3   EUCTR2018-003985-15-FR   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
      2020   Phase 3   EUCTR2018-003985-15-AT   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2018-003987-29-NL   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2018-003987-29-LV   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2018-003987-29-HR   Australia;Austria;Belarus;Belgium;Bulgaria;Canada;China;Croatia;Czech Republic;Denmark;Estonia;France;Georgia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2018-003987-29-ES   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2018-003987-29-DK   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2018-003986-33-SK   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2018-003985-15-SK   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2018-003985-15-RO   Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Georgia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2018-003985-15-PT   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2018-003985-15-NL   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2018-003985-15-LV   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2018-003985-15-LT   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2018-003985-15-HU   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2018-003985-15-HR   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2018-003985-15-ES   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2018-003985-15-EE   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2018-003985-15-DK   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2018-003985-15-CZ   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2018-003985-15-BG   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
      -   Phase 3   EUCTR2018-003987-29-PL   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
      -   Phase 3   EUCTR2018-003985-15-PL   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
      -   Phase 3   EUCTR2018-003985-15-DE   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
      -   Phase 3   EUCTR2018-003985-15-BE   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
   Arena Pharmaceuticals Inc. a wholly owned subsidiary of Pfizer Inc.
      2019   Phase 3   EUCTR2018-003987-29-CZ   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Thailand;Türkiye;Ukraine;United Kingdom;United States
   Arena Pharmaceuticals Inc. a wholly owned subsidiary of Pfizer Inc.
      2020   Phase 3   EUCTR2018-003987-29-DE   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Thailand;Türkiye;Ukraine;United Kingdom;United States
      2020   Phase 3   EUCTR2018-003987-29-BG   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Thailand;Türkiye;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2018-003987-29-LT   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Thailand;Türkiye;Ukraine;United Kingdom;United States
      -   Phase 3   EUCTR2018-003987-29-EE   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Thailand;Turkey;Ukraine;United Kingdom;United States
   Arena Pharmaceuticals, Inc.
      2021   Phase 2   EUCTR2020-003507-34-PT   Australia;Belarus;Belgium;Bulgaria;Czech Republic;Czechia;France;Georgia;Germany;Hungary;Israel;Italy;Korea, Republic of;Poland;Portugal;Russian Federation;Spain;United States
      2021   Phase 2   EUCTR2020-003507-34-HU   Australia;Belarus;Belgium;Bulgaria;Czech Republic;Czechia;France;Georgia;Germany;Hungary;Israel;Italy;Korea, Republic of;Poland;Portugal;Russian Federation;Spain;United States
      2021   Phase 2   EUCTR2020-003507-34-FR   Australia;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Moldova, Republic of;Netherlands;Poland;Portugal;Russian Federation;South Africa;Spain;United States
      2021   Phase 2   EUCTR2020-003507-34-CZ   Australia;Belarus;Belgium;Bulgaria;Czech Republic;Czechia;France;Georgia;Germany;Hungary;Israel;Italy;Korea, Republic of;Poland;Portugal;Russian Federation;Spain;United States
      2021   Phase 2   EUCTR2020-003507-34-BG   Australia;Belarus;Belgium;Bulgaria;Czech Republic;Czechia;France;Georgia;Germany;Hungary;Israel;Italy;Korea, Republic of;Poland;Portugal;Russian Federation;Spain;Ukraine;United States
      2021   Phase 2   EUCTR2020-003507-34-BE   Australia;Belarus;Belgium;Bulgaria;Czech Republic;Czechia;France;Georgia;Germany;Hungary;Israel;Italy;Korea, Republic of;Poland;Portugal;Russian Federation;Spain;Ukraine;United States
      2020   Phase 3   EUCTR2018-003986-33-PT   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Thailand;Turkey;Ukraine;United Kingdom;United States
      2020   Phase 3   EUCTR2018-003986-33-LV   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
      2020   Phase 3   EUCTR2018-003986-33-GB   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
      2020   Phase 3   EUCTR2018-003986-33-FR   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
      2020   Phase 3   EUCTR2018-003986-33-ES   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
      2020   Phase 3   EUCTR2018-003986-33-DK   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Thailand;Turkey;Ukraine;United Kingdom;United States
      2020   Phase 3   EUCTR2018-003986-33-BG   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
      2020   Phase 3   EUCTR2018-003986-33-AT   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Thailand;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2018-003986-33-NL   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Thailand;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2018-003986-33-LT   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Thailand;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2018-003986-33-HU   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2018-003986-33-HR   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2018-003986-33-BE   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
      -   Phase 3   EUCTR2018-003986-33-PL   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
      -   Phase 3   EUCTR2018-003986-33-EE   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
      -   Phase 3   EUCTR2018-003986-33-DE   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Thailand;Turkey;Ukraine;United Kingdom;United States
      -   Phase 3   EUCTR2018-003986-33-CZ   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Thailand;Turkey;Ukraine;United Kingdom;United States
Etrolizumab
   F. Hoffmann-La Roche Ltd
      2019   Phase 3   EUCTR2013-004279-11-FR   Argentina;Australia;Brazil;Bulgaria;Estonia;France;Hong Kong;Mexico;Poland;Russian Federation;Serbia;Slovakia;Ukraine;United States
      2019   Phase 3   EUCTR2013-004277-27-HU   Argentina;Australia;Brazil;Bulgaria;Colombia;Croatia;Czech Republic;Greece;Hungary;Latvia;Lithuania;Malaysia;New Zealand;Poland;Russian Federation;Turkey;Ukraine;United States
      2019   Phase 3   EUCTR2013-004277-27-CZ   Argentina;Australia;Brazil;Bulgaria;Colombia;Croatia;Czech Republic;Greece;Hungary;Latvia;Lithuania;Malaysia;New Zealand;Poland;Russian Federation;Turkey;Ukraine;United States
      2018   Phase 1   EUCTR2017-003649-10-GB   Belgium;Germany;Poland;Spain;United Kingdom
      2018   Phase 1   EUCTR2017-003649-10-DE   Belgium;Germany;Poland;Spain;United Kingdom;United States
      2018   Phase 1   EUCTR2017-003649-10-BE   Belgium;Germany;Poland;Spain;United Kingdom
      2017   Phase 3   EUCTR2013-004278-88-PL   Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Spain;Switzerland;United Kingdom;United States
      2016   Phase 3   EUCTR2013-004280-31-SK   Brazil;Canada;Czech Republic;Denmark;Germany;Hungary;Israel;Italy;Mexico;Poland;Slovakia;South Africa;Ukraine;United States
      2016   Phase 3   EUCTR2013-004280-31-PL   Brazil;Canada;Czech Republic;Denmark;Germany;Hungary;Israel;Italy;Mexico;Poland;Slovakia;South Africa;Ukraine;United States
      2015   Phase 3   EUCTR2013-004435-72-PT   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Philippines;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States;Vietnam
      2015   Phase 3   EUCTR2013-004435-72-NL   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Germany;Greece;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Philippines;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States;Viet Nam
      2015   Phase 3   EUCTR2013-004435-72-IT   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Philippines;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States;Vietnam
      2015   Phase 3   EUCTR2013-004435-72-DE   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Germany;Greece;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Philippines;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States;Viet Nam
      2015   Phase 3   EUCTR2013-004435-72-BG   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Germany;Greece;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Philippines;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States;Vietnam
      2015   Phase 3   EUCTR2013-004282-14-PT   Austria;Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;Norway;Philippines;Portugal;Romania;Singapore;South Africa;Spain;Sweden;Switzerland;United Kingdom;Vietnam
      2015   Phase 3   EUCTR2013-004282-14-NL   Austria;Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;Norway;Philippines;Portugal;Romania;Singapore;South Africa;Spain;Sweden;Switzerland;United Kingdom;Vietnam
      2015   Phase 3   EUCTR2013-004279-11-BG   Argentina;Australia;Brazil;Bulgaria;Estonia;France;Hong Kong;Mexico;Poland;Russian Federation;Serbia;Slovakia;Ukraine;United States
      2015   Phase 3   EUCTR2013-004277-27-BG   Argentina;Australia;Brazil;Bulgaria;Colombia;Croatia;Czech Republic;Greece;Hungary;Latvia;Lithuania;Malaysia;New Zealand;Poland;Russian Federation;Turkey;Ukraine;United States
      2014   Phase 3   EUCTR2013-004435-72-SK   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Germany;Greece;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Philippines;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States;Vietnam
      2014   Phase 3   EUCTR2013-004435-72-SE   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Philippines;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States;Vietnam
      2014   Phase 3   EUCTR2013-004435-72-NO   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Philippines;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States;Vietnam
      2014   Phase 3   EUCTR2013-004435-72-LV   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Philippines;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States;Vietnam
      2014   Phase 3   EUCTR2013-004435-72-LT   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Philippines;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States;Vietnam
      2014   Phase 3   EUCTR2013-004435-72-HU   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Philippines;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States;Vietnam
      2014   Phase 3   EUCTR2013-004435-72-HR   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Philippines;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States;Vietnam
      2014   Phase 3   EUCTR2013-004435-72-GR   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Philippines;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States;Vietnam
      2014   Phase 3   EUCTR2013-004435-72-GB   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Philippines;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States;Vietnam
      2014   Phase 3   EUCTR2013-004435-72-FR   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Philippines;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States;Vietnam
      2014   Phase 3   EUCTR2013-004435-72-EE   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Philippines;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States;Vietnam
      2014   Phase 3   EUCTR2013-004435-72-DK   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Germany;Greece;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Philippines;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States;Vietnam
      2014   Phase 3   EUCTR2013-004435-72-CZ   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Germany;Greece;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Philippines;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States;Viet Nam
      2014   Phase 3   EUCTR2013-004435-72-BE   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Philippines;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States;Vietnam
      2014   Phase 3   EUCTR2013-004435-72-AT   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Philippines;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States;Vietnam
      2014   Phase 3   EUCTR2013-004282-14-NO   Austria;Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;Norway;Philippines;Portugal;Romania;Singapore;South Africa;Spain;Sweden;Switzerland;United Kingdom;Vietnam
      2014   -   EUCTR2013-004282-14-IT   Austria;Belgium;Canada;Czech Republic;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;Norway;Philippines;Portugal;Romania;Singapore;South Africa;Spain;Sweden;Switzerland;United Kingdom;Vietnam
      2014   Phase 3   EUCTR2013-004282-14-HU   Austria;Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;Norway;Portugal;Romania;Singapore;South Africa;Spain;Sweden;Switzerland;United Kingdom
      2014   Phase 3   EUCTR2013-004282-14-GB   Austria;Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;Norway;Portugal;Romania;Singapore;South Africa;Spain;Sweden;Switzerland;United Kingdom
      2014   Phase 3   EUCTR2013-004282-14-FR   Austria;Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;Norway;Philippines;Portugal;Romania;Singapore;South Africa;Spain;Sweden;Switzerland;United Kingdom;Vietnam
      2014   Phase 3   EUCTR2013-004282-14-DE   Austria;Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;Norway;Portugal;Romania;Singapore;South Africa;Spain;Sweden;Switzerland;United Kingdom
      2014   Phase 3   EUCTR2013-004282-14-CZ   Austria;Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;Norway;Portugal;Romania;Singapore;South Africa;Spain;Sweden;Switzerland;United Kingdom
      2014   Phase 3   EUCTR2013-004282-14-BE   Austria;Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;Norway;Portugal;Romania;Singapore;South Africa;Spain;Sweden;Switzerland;United Kingdom
      2014   Phase 3   EUCTR2013-004282-14-AT   Austria;Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;Norway;Portugal;Romania;Singapore;South Africa;Spain;Sweden;Switzerland;United Kingdom
      2014   Phase 3   EUCTR2013-004280-31-HU   Brazil;Canada;Czech Republic;Denmark;Germany;Hungary;Israel;Italy;Mexico;Poland;Slovakia;South Africa;Ukraine;United States
      2014   Phase 3   EUCTR2013-004280-31-DK   Canada;Czech Republic;Denmark;Germany;Hungary;Israel;Poland;Slovakia;South Africa;United States
      2014   Phase 3   EUCTR2013-004280-31-DE   Brazil;Canada;Czech Republic;Denmark;Germany;Hungary;Israel;Italy;Mexico;Poland;Slovakia;South Africa;Ukraine;United States
      2014   Phase 3   EUCTR2013-004280-31-CZ   Brazil;Canada;Czech Republic;Denmark;Germany;Hungary;Israel;Italy;Mexico;Poland;Slovakia;South Africa;Ukraine;United States
      2014   Phase 3   EUCTR2013-004279-11-SK   Argentina;Australia;Brazil;Bulgaria;Estonia;France;Hong Kong;Mexico;Poland;Russian Federation;Serbia;Slovakia;Ukraine;United States
      2014   Phase 3   EUCTR2013-004279-11-EE   Argentina;Australia;Brazil;Bulgaria;Estonia;France;Hong Kong;Mexico;Poland;Russian Federation;Serbia;Slovakia;Ukraine;United States
      2014   Phase 3   EUCTR2013-004278-88-NL   Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Spain;Switzerland;United Kingdom;United States
      2014   Phase 3   EUCTR2013-004278-88-LT   Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Spain;Switzerland;United Kingdom;United States
      2014   Phase 3   EUCTR2013-004278-88-IT   Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Spain;Switzerland;United Kingdom;United States
      2014   Phase 3   EUCTR2013-004278-88-HU   Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Spain;Switzerland;United Kingdom;United States
      2014   Phase 3   EUCTR2013-004278-88-GR   Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Spain;Switzerland;United Kingdom;United States
      2014   Phase 3   EUCTR2013-004278-88-FR   Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Spain;Switzerland;United Kingdom;United States
      2014   Phase 3   EUCTR2013-004278-88-DK   Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Spain;Switzerland;United Kingdom;United States
      2014   Phase 3   EUCTR2013-004278-88-DE   Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Spain;Switzerland;United Kingdom;United States
      2014   Phase 3   EUCTR2013-004278-88-CZ   Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Spain;Switzerland;United Kingdom;United States
      2014   Phase 3   EUCTR2013-004278-88-BE   Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Spain;Switzerland;United Kingdom;United States
      2014   Phase 3   EUCTR2013-004278-88-AT   Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Spain;Switzerland;United Kingdom;United States
      2014   Phase 3   EUCTR2013-004277-27-LV   Argentina;Australia;Brazil;Bulgaria;Colombia;Croatia;Czech Republic;Greece;Hungary;Latvia;Lithuania;Malaysia;New Zealand;Poland;Russian Federation;Turkey;Ukraine;United States
      2014   Phase 3   EUCTR2013-004277-27-LT   Argentina;Australia;Brazil;Bulgaria;Colombia;Croatia;Czech Republic;Greece;Hungary;Latvia;Lithuania;Malaysia;New Zealand;Poland;Russian Federation;Turkey;Ukraine;United States
      2014   Phase 3   EUCTR2013-004277-27-HR   Argentina;Australia;Brazil;Bulgaria;Colombia;Croatia;Czech Republic;Greece;Hungary;Latvia;Lithuania;Malaysia;New Zealand;Poland;Russian Federation;Turkey;Ukraine;United States
      2014   Phase 3   EUCTR2013-004277-27-GR   Argentina;Australia;Brazil;Bulgaria;Colombia;Croatia;Czech Republic;Greece;Hungary;Latvia;Lithuania;Malaysia;New Zealand;Poland;Russian Federation;Turkey;Ukraine;United States
      -   Phase 1   EUCTR2017-003649-10-PL   Belgium;Germany;Poland;Spain;United Kingdom
   Genentech, Inc.
      2012   Phase 2   EUCTR2011-003409-36-CZ   Australia;Belgium;Canada;Czech Republic;Germany;Hungary;Israel;New Zealand;Spain;United Kingdom;United States
      2011   Phase 2   NCT01461317   Australia;Belgium;Canada;Czech Republic;Czechia;Germany;Hungary;Israel;New Zealand;Spain;United Kingdom;United States
      2011   Phase 2   EUCTR2011-003409-36-GB   Australia;Belgium;Canada;Czech Republic;Germany;Hungary;Israel;New Zealand;Spain;United Kingdom;United States
   Hoffmann-La Roche
      2018   Phase 1   NCT03478956   Belgium;Germany;Poland;Spain;United Kingdom;United States
      2014   Phase 3   NCT02171429   Argentina;Australia;Brazil;Bulgaria;Colombia;Croatia;Czechia;France;Greece;Hungary;Latvia;Lithuania;Malaysia;New Zealand;Poland;Russian Federation;Turkey;Ukraine;United States
      2014   Phase 3   NCT02165215   Brazil;Canada;Czech Republic;Czechia;Denmark;Germany;Hungary;India;Israel;Italy;Mexico;Poland;Slovakia;South Africa;Ukraine;United States
      2014   Phase 3   NCT02163759   Argentina;Australia;Brazil;Bulgaria;Estonia;France;Hong Kong;Mexico;Poland;Russian Federation;Serbia;Slovakia;Ukraine;United States
      2014   Phase 3   NCT02136069   Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;Norway;Philippines;Portugal;Romania;Singapore;South Africa;Spain;Sweden;Switzerland;United Kingdom;Vietnam
      2014   Phase 3   NCT02118584   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Germany;Greece;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Philippines;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States;Vietnam
   Roche Farma S.A en nombre de F. Hoffmann-La Roche Ltd
      2014   Phase 3   EUCTR2013-004278-88-ES   Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Spain;Switzerland;United Kingdom;United States
   Roche Farma S.A. (Soc unipersonal) que realiza el ensayo en España y que actúa como represntante de FHoffmann-La Roche
      2018   Phase 1   EUCTR2017-003649-10-ES   Belgium;Germany;Poland;Spain;United Kingdom;United States
   Roche Farma S.A. en nombre de F. Hoffmann-La Roche Ltd
      2014   Phase 3   EUCTR2013-004435-72-ES   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Philippines;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States;Vietnam
      2014   Phase 3   EUCTR2013-004282-14-ES   Austria;Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;Norway;Philippines;Portugal;Romania;Singapore;South Africa;Spain;Sweden;Switzerland;United Kingdom;Vietnam
Etrozulimab
   Hoffmann-La Roche
      2014   Phase 3   NCT02100696   Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Czechia;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Mexico;Netherlands;New Zealand;Poland;Romania;Spain;Switzerland;United Kingdom;United States
Evening group
   Rush University Medical Center
      2016   Phase 4   NCT04304950   United States
EX-vivo stimulation OF cells with infliximab, golimumab, adalimumab, vedolizumab and ustekinumab
   Fundación de Investigación Biomédica - Hospital Universitario de La Princesa
      2016   -   NCT03043677   -
Exercise intervention
   Huadong Hospital Affiliated to Fudan University
      2021   -   ChiCTR2100051843   China
   University College Dublin
      2023   -   NCT05906043   Ireland
Exoflo
   Direct Biologics, LLC
      2022   Phase 1   NCT05176366   United States
Exosomes derived from human umbilical cord mesenchymal stem cells
   Shanghai East Hospital
      2025   Early Phase 1   NCT06853522   China
Exposed TO IBD pharmacotherapy during pregnancy
   CorEvitas
      2025   -   NCT06910553   United States
Exposure TO golimumab
   University of Zurich
      2018   -   NCT05405465   Switzerland
      2018   -   NCT03394586   Switzerland
Eziclen
   Ipsen Pharma
      2017   Phase 3   EUCTR2016-002265-60-NL   Czech Republic;France;Germany;Italy;Netherlands;Poland
      2017   Phase 3   EUCTR2016-002265-60-DE   Czech Republic;France;Germany;Italy;Netherlands;Poland
      2017   Phase 3   EUCTR2016-002265-60-CZ   Czech Republic;France;Germany;Italy;Netherlands;Poland
      -   Phase 3   EUCTR2016-002265-60-PL   Czech Republic;France;Germany;Italy;Netherlands;Poland
F8il10
   Pfizer Inc, 235 East 42nd Street, New York, New York 10017
      2018   Phase 2   EUCTR2017-002108-28-ES   Australia;Belgium;Germany;Israel;Italy;Korea, Republic of;Saudi Arabia;Serbia;Spain;United States
      2018   Phase 2   EUCTR2017-002108-28-DE   Australia;Belgium;Germany;Israel;Italy;Korea, Republic of;Saudi Arabia;Serbia;Spain;United States
      2018   Phase 2   EUCTR2017-002108-28-BE   Australia;Belgium;Germany;Israel;Italy;Korea, Republic of;Saudi Arabia;Serbia;Spain;United States
Factor xiii
   Novo Nordisk A/S
      2013   -   EUCTR2011-001568-22-HU   Bulgaria;Croatia;Denmark;European Union;Hungary;Russian Federation;Ukraine
      2012   -   EUCTR2011-001568-22-DK   Bulgaria;Croatia;Denmark;European Union;Hungary;Russian Federation;Ukraine
      2012   -   EUCTR2011-001568-22-BG   Bulgaria;Croatia;Denmark;European Union;Hungary;Russian Federation;Ukraine
Faecal bacterial transplantation
   Institute for Clinical and Experimental Medicine
      2017   Phase 2   NCT03104036   Czech Republic;Czechia
Faecal matter
   University of Birmingham
      2017   Phase 3   EUCTR2015-005753-12-GB   United Kingdom
Faecal microbiota transplant
   University of Birmingham
      2017   Phase 3   EUCTR2015-005753-12-GB   United Kingdom
Faecal microbiota transplantation
   Odense University Hospital
      2023   Phase 2   NCT04924270   Denmark
   St Vincent's Hospital Melbourne
      2018   -   NCT03477032   Australia
FE 999301
   University Hospital Schleswig-Holstein (UKSH)
      2016   Phase 2   EUCTR2016-000205-36-DE   Germany
Feasibility OF BETA-hydroxybutyrate supplementation TO reduce inflammation IN patients with crohn'S
   University of Texas at Austin
      2024   Phase 1/Phase 2   NCT06351124   United States
Febuxostat
   Tanta University
      2024   Early Phase 1   NCT06525974   -
Fecal microbial L transplantation
   Meir Medical Center
      2015   Phase 1   NCT02391012   Israel
Fecal microbial transplant
   Children's Hospital Los Angeles
      2016   Phase 1   NCT02291523   United States
Fecal microbial transplantation
   Beth Israel Deaconess Medical Center
      2013   Phase 1   NCT01847170   United States
   Stony Brook University
      2013   Early Phase 1   NCT03268213   United States
Fecal microbiota
   Affiliated Wuxi No.2 Hospital of Nanjing Medical University
      2021   Phase 0   ChiCTR2100045035   China
   Ohmiya Naoki
      2019   Phase 2   JPRN-jRCTs041190021   -
   Tel-Aviv Sourasky Medical Center
      2015   Phase 2   NCT04434872   Israel
   University of Alberta
      2022   Phase 2   NCT05327790   Canada
   University of Minnesota
      2019   Phase 1   NCT03948919   United States
Fecal microbiota capsule
   Zhongshan Hospital Xiamen University
      2020   Phase 1   NCT04521205   China
Fecal microbiota enema
   McMaster Children's Hospital
      2015   Phase 1   NCT02487238   Canada
Fecal microbiota transplant
   Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
      2018   Phase 2   NCT05998213   Netherlands
   Baylor College of Medicine
      2014   Phase 1   NCT01947101   United States
   Department of Colonrectal Disease, Shanghai Tenth people's Hospital
      2020   Phase 0   ChiCTR2000039915   China
   Hamilton Health Sciences Corporation
      2022   -   NCT04926103   Canada
   Judith Kelsen
      2015   Phase 1   NCT02636517   United States
   Stacy A. Kahn
      2015   Phase 1/Phase 2   NCT02330653   United States
   University of Alberta
      2014   Phase 1/Phase 2   NCT02227342   Canada
   University of Vermont
      2015   Early Phase 1   NCT02390726   United States
Fecal microbiota transplantation
   Akira Andoh
      2015   -   JPRN-UMIN000016891   Japan
   Ari M Grinspan
      2021   Early Phase 1   NCT04968951   United States
   Army Medical Center(Daping Hospital)
      2023   -   ChiCTR2300078543   China
   Assistance Publique - Hôpitaux de Paris
      2018   Phase 3   NCT03483246   France
   Biao Zou
      2022   -   NCT05679622   China
   Brigham and Women's Hospital
      2020   Phase 2   NCT03829475   United States
      2017   Phase 1/Phase 2   NCT03106844   United States
   Chiba University
      2015   -   JPRN-UMIN000022400   Japan
   Children's Mercy Hospital Kansas City
      2014   Phase 1   NCT02108821   United States
   Chinese PLA General Hosipital
      2016   -   ChiCTR-INR-16010152   China
   Chinese PLA General Hospital
      2016   -   ChiCTR-INR-16010151   China
      2016   -   ChiCTR-INR-16010150   China
      2014   -   ChiCTR-OOC-16007934   China
      2014   -   ChiCTR-ONH-17012572   China
   Chinese University of Hong Kong
      2019   -   NCT04014413   Hong Kong
   Dayanand Medical College and Hospital
      2018   Phase 3   NCT03716388   India
   Department of Gastroenterology, Kanazawa University Hospital
      2016   -   JPRN-UMIN000020954   Japan
   Department of Gastroenterology, the First Affiliated Hospital of Anhui Medical University
      2018   Phase 0   ChiCTR1900022273   China
   Federal Research and Clinical Center of Physical-Chemical Medicine
      2018   -   NCT04011943   Russian Federation
   First Affiliated Hospital of Chengdu Medical College
      2016   Phase 1/Phase 2   NCT03016780   China
   First Affiliated Hospital of Kunming Medical University
      2022   -   NCT06591013   China
   Guangzhou First People's Hospital
      2019   Phase 2/Phase 3   NCT03804931   China
   Gulhane Military Medical Academy
      2015   Phase 3   NCT02575040   Turkey
   Helsinki University Central Hospital
      2018   Phase 2   NCT03378921   Finland
   Joint Authority for Päijät-Häme Social and Health Care
      2016   -   NCT03561532   Finland
   Jun Liu
      2015   Phase 2/Phase 3   NCT02435160   -
   Kinki university
      2016   -   JPRN-UMIN000021399   Japan
   McMaster University
      2021   Phase 4   NCT04231110   Canada
   Nagahara Akihito
      2023   Phase 2   JPRN-jRCTs031220542   -
   National Center for Child Health and Development
      2016   -   JPRN-UMIN000026485   Japan
      2015   -   JPRN-UMIN000019526   Japan
   The Second Hospital of Nanjing Medical University
      2016   Phase 4   NCT02998112   China
   Turku University Hospital
      2021   -   NCT04687150   Finland
      2013   -   NCT01961492   Finland
   University of Chicago
      2013   Phase 1   NCT02058524   United States
   University of Washington
      2012   -   NCT01742754   United States
   Weill Medical College of Cornell University
      2020   Phase 2   NCT03998488   United States
      2016   Phase 1   NCT02516384   United States
Fecal microbiota transplantation (FMT), openbiome
   Najwa Elnachef
      2017   Phase 1   NCT03006809   United States
Fecal microbiota transplantation BY intra-rectal enemas
   Assistance Publique - Hôpitaux de Paris
      2025   Phase 2   NCT05202990   France
Fecal microbiota transplantation BY stool capsules
   Assistance Publique - Hôpitaux de Paris
      2025   Phase 2   NCT05202990   France
Fecal microbiota transplantation capsules
   Alice Højer Christensen
      2017   Phase 1/Phase 2   NCT03711006   Denmark
Fecal transplantation
   Bogomolets National Medical University
      2020   -   NCT05538026   Ukraine
Fendrix, suspensióN inyectable
   Hospital Universitario La Princesa
      2011   Phase 3   EUCTR2010-023947-14-ES   Spain
Fenofibrate
   Tanta University
      2023   Phase 2   NCT05781698   Egypt
Fenofibrate 160MG
   Tanta University
      2023   Phase 2/Phase 3   NCT05753267   Egypt
Fentanyl
   Copenhagen University Hospital at Herlev
      2014   Phase 4   NCT01934088   Denmark
Fentanyl B. braun
   Gastroenheden D, Herlev Hospital
      2013   -   EUCTR2013-002428-17-DK   Denmark
Feraccru
   Leiden University Medical Center
      2022   Phase 4   EUCTR2022-000894-16-NL   Netherlands
   Shield TX (UK) Ltd.
      2017   Phase 3   EUCTR2015-002496-26-HU   Belgium;France;Germany;Hungary;Spain;United States
      2015   Phase 3   EUCTR2015-002496-26-DE   Belgium;France;Germany;Hungary;Spain;United States
Feramyl
   SerumWerk Bernburg AG
      2013   -   EUCTR2013-001123-39-DK   Denmark
Ferinject
   Atrium Medical Centre
      2018   Phase 4   EUCTR2012-005644-26-BE   Belgium;Netherlands
      2014   -   EUCTR2012-005644-26-NL   Netherlands
   Leiden University Medical Center
      2022   Phase 4   EUCTR2022-000894-16-NL   Netherlands
   Medizinische Universität Wien, Klinik für Innere Medizin III, Abteilung für Gastroenterologie und Hepatologie
      2014   Phase 2   EUCTR2011-004561-33-AT   Austria
   Pharmacosmos A/S
      2019   Phase 4   EUCTR2017-002452-87-DE   Austria;Denmark;Germany;Sweden;United Kingdom
      2018   Phase 4   EUCTR2017-002452-87-SE   Austria;Denmark;Germany;Sweden;United Kingdom
      2018   Phase 4   EUCTR2017-002452-87-GB   Austria;Denmark;Germany;Sweden;United Kingdom
      2018   Phase 4   EUCTR2017-002452-87-AT   Austria;Denmark;Germany;Sweden;United Kingdom
      2017   Phase 4   EUCTR2017-002452-87-DK   Austria;Denmark;Germany;Sweden;United Kingdom
   Vifor Inc.
      2009   Phase 3   NCT00810004   Russian Federation
      2006   Phase 2   NCT00882414   Austria
   Vifor Int.
      2006   -   EUCTR2006-003328-12-AT   Austria
Ferinject - 50 MG/ML soluzione iniettabile O PER infusione 1 flaconcino IN vetro DA 10 ML
   FONDAZIONE I.R.C.C.S. POLICLINICO SAN MATTEO
      2017   Phase 3   EUCTR2016-001772-30-IT   Italy
Ferinject 50 MG /ML. solucióN inyectable Y para perfusióN
   Iron Therapeutics (UK) Ltd.
      2016   Phase 3   EUCTR2015-002496-26-ES   Belgium;Germany;Hungary;Spain
Ferinject 50 MG eisen/ML
   Shield TX (UK) Ltd.
      2017   Phase 3   EUCTR2015-002496-26-HU   Belgium;France;Germany;Hungary;Spain;United States
      2015   Phase 3   EUCTR2015-002496-26-DE   Belgium;France;Germany;Hungary;Spain;United States
Ferinject 50 MG iron/ML solution FOR injection and infusion
   Vifor (International) Inc.
      2009   -   EUCTR2008-003591-22-SE   Austria;Denmark;Estonia;Germany;Lithuania;Spain;Sweden;United Kingdom
      2009   -   EUCTR2008-003591-22-LT   Austria;Denmark;Estonia;Germany;Lithuania;Spain;Sweden;United Kingdom
      2009   -   EUCTR2008-003591-22-GB   Austria;Denmark;Estonia;Germany;Lithuania;Spain;Sweden;United Kingdom
      2009   -   EUCTR2008-003591-22-DK   Austria;Denmark;Estonia;Germany;Lithuania;Spain;Sweden;United Kingdom
      2009   -   EUCTR2008-003591-22-AT   Austria;Denmark;Estonia;Germany;Lithuania;Spain;Sweden;United Kingdom
      2009   -   EUCTR2008-002333-75-SE   Austria;Denmark;Estonia;Germany;Lithuania;Spain;Sweden;United Kingdom
      2009   -   EUCTR2008-002333-75-LT   Austria;Denmark;Estonia;Germany;Lithuania;Spain;Sweden;United Kingdom
      2009   Phase 3   EUCTR2008-002333-75-GB   Austria;Denmark;Estonia;Germany;Lithuania;Spain;Sweden;United Kingdom
      2009   -   EUCTR2008-002333-75-DK   Austria;Denmark;Estonia;Germany;Lithuania;Spain;Sweden;United Kingdom
      2009   -   EUCTR2008-002333-75-AT   Austria;Denmark;Estonia;Germany;Lithuania;Spain;Sweden;United Kingdom
      2008   Phase 3   EUCTR2008-003591-22-ES   Austria;Denmark;Estonia;Germany;Lithuania;Spain;Sweden;United Kingdom
      2008   -   EUCTR2008-003591-22-EE   Austria;Denmark;Estonia;Germany;Lithuania;Spain;Sweden;United Kingdom
      2008   -   EUCTR2008-003591-22-DE   Austria;Denmark;Estonia;Germany;Lithuania;Spain;Sweden;United Kingdom
      2008   Phase 3   EUCTR2008-002333-75-ES   Austria;Denmark;Estonia;Germany;Lithuania;Spain;Sweden;United Kingdom
      2008   -   EUCTR2008-002333-75-EE   Austria;Denmark;Estonia;Germany;Lithuania;Spain;Sweden;United Kingdom
      -   -   EUCTR2008-002333-75-DE   Austria;Denmark;Estonia;Germany;Lithuania;Spain;Sweden;United Kingdom
Ferlixit - 62.5 MG/5 ML soluzione PER USO orale E USO endovenoso 5 fiale DA 5 ML
   FONDAZIONE I.R.C.C.S. POLICLINICO SAN MATTEO
      2017   Phase 3   EUCTR2016-001772-30-IT   Italy
Ferracru
   Shield TX (UK) Ltd.
      2017   Phase 3   EUCTR2015-002496-26-HU   Belgium;France;Germany;Hungary;Spain;United States
      2015   Phase 3   EUCTR2015-002496-26-DE   Belgium;France;Germany;Hungary;Spain;United States
Ferric carboxy maltose
   Shield Therapeutics
      2016   Phase 3   NCT02680756   Belgium;France;Germany;Hungary;Spain;United States
Ferric carboxymaltose
   Atrium Medical Centre
      2018   Phase 4   EUCTR2012-005644-26-BE   Belgium;Netherlands
   IRCCS Policlinico S. Matteo
      2020   Phase 3   NCT04587141   Italy
   Iron Therapeutics (UK) Ltd.
      2016   Phase 3   EUCTR2015-002496-26-ES   Belgium;Germany;Hungary;Spain
      2015   Phase 3   EUCTR2015-002496-26-BE   Belgium;Germany;Hungary;Spain
   Istituto Clinico Humanitas
      2014   Phase 2   NCT02517151   Italy
   Leiden University Medical Center
      2022   Phase 4   EUCTR2022-000894-16-NL   Netherlands
   Medizinische Universität Wien, Klinik für Innere Medizin III, Abteilung für Gastroenterologie und Hepatologie
      2014   Phase 2   EUCTR2011-004561-33-AT   Austria
   Pharmacosmos A/S
      2019   Phase 4   EUCTR2017-002452-87-DE   Austria;Denmark;Germany;Sweden;United Kingdom
      2018   Phase 4   NCT03466983   Denmark
      2018   Phase 4   EUCTR2017-002452-87-SE   Austria;Denmark;Germany;Sweden;United Kingdom
      2018   Phase 4   EUCTR2017-002452-87-GB   Austria;Denmark;Germany;Sweden;United Kingdom
      2018   Phase 4   EUCTR2017-002452-87-AT   Austria;Denmark;Germany;Sweden;United Kingdom
      2017   Phase 4   EUCTR2017-002452-87-DK   Austria;Denmark;Germany;Sweden;United Kingdom
   Shield TX (UK) Ltd.
      2017   Phase 3   EUCTR2015-002496-26-HU   Belgium;France;Germany;Hungary;Spain;United States
      2015   Phase 3   EUCTR2015-002496-26-DE   Belgium;France;Germany;Hungary;Spain;United States
   Vifor (International) Inc.
      2009   -   EUCTR2008-003591-22-SE   Austria;Denmark;Estonia;Germany;Lithuania;Spain;Sweden;United Kingdom
      2009   -   EUCTR2008-003591-22-LT   Austria;Denmark;Estonia;Germany;Lithuania;Spain;Sweden;United Kingdom
      2009   -   EUCTR2008-003591-22-GB   Austria;Denmark;Estonia;Germany;Lithuania;Spain;Sweden;United Kingdom
      2009   -   EUCTR2008-003591-22-DK   Austria;Denmark;Estonia;Germany;Lithuania;Spain;Sweden;United Kingdom
      2009   -   EUCTR2008-003591-22-AT   Austria;Denmark;Estonia;Germany;Lithuania;Spain;Sweden;United Kingdom
      2009   -   EUCTR2008-002333-75-SE   Austria;Denmark;Estonia;Germany;Lithuania;Spain;Sweden;United Kingdom
      2009   -   EUCTR2008-002333-75-LT   Austria;Denmark;Estonia;Germany;Lithuania;Spain;Sweden;United Kingdom
      2009   Phase 3   EUCTR2008-002333-75-GB   Austria;Denmark;Estonia;Germany;Lithuania;Spain;Sweden;United Kingdom
      2009   -   EUCTR2008-002333-75-DK   Austria;Denmark;Estonia;Germany;Lithuania;Spain;Sweden;United Kingdom
      2009   -   EUCTR2008-002333-75-AT   Austria;Denmark;Estonia;Germany;Lithuania;Spain;Sweden;United Kingdom
      2008   Phase 3   EUCTR2008-003591-22-ES   Austria;Denmark;Estonia;Germany;Lithuania;Spain;Sweden;United Kingdom
      2008   -   EUCTR2008-003591-22-EE   Austria;Denmark;Estonia;Germany;Lithuania;Spain;Sweden;United Kingdom
      2008   -   EUCTR2008-003591-22-DE   Austria;Denmark;Estonia;Germany;Lithuania;Spain;Sweden;United Kingdom
      2008   Phase 3   EUCTR2008-002333-75-ES   Austria;Denmark;Estonia;Germany;Lithuania;Spain;Sweden;United Kingdom
      2008   -   EUCTR2008-002333-75-EE   Austria;Denmark;Estonia;Germany;Lithuania;Spain;Sweden;United Kingdom
      -   -   EUCTR2008-002333-75-DE   Austria;Denmark;Estonia;Germany;Lithuania;Spain;Sweden;United Kingdom
   Vifor Inc.
      2008   Phase 3   NCT00810030   Austria;Russian Federation
      2006   Phase 2   NCT00882414   Austria
Ferric derisomaltose
   Leiden University Medical Center
      2022   Phase 4   EUCTR2022-000894-16-NL   Netherlands
   Pharmacosmos A/S
      2019   Phase 4   EUCTR2017-002452-87-DE   Austria;Denmark;Germany;Sweden;United Kingdom
      2018   Phase 4   EUCTR2017-002452-87-SE   Austria;Denmark;Germany;Sweden;United Kingdom
      2018   Phase 4   EUCTR2017-002452-87-GB   Austria;Denmark;Germany;Sweden;United Kingdom
      2018   Phase 4   EUCTR2017-002452-87-AT   Austria;Denmark;Germany;Sweden;United Kingdom
      2017   Phase 4   EUCTR2017-002452-87-DK   Austria;Denmark;Germany;Sweden;United Kingdom
Ferric gluconate
   IRCCS Policlinico S. Matteo
      2020   Phase 3   NCT04587141   Italy
Ferric maltol
   Iron Therapeutics (UK) Ltd.
      2016   Phase 3   EUCTR2015-002496-26-ES   Belgium;Germany;Hungary;Spain
      2015   Phase 3   EUCTR2015-002496-26-BE   Belgium;Germany;Hungary;Spain
   Leiden University Medical Center
      2022   Phase 4   NCT05456932   Netherlands
      2022   Phase 4   EUCTR2022-000894-16-NL   Netherlands
   Shield TX (UK) Ltd.
      2017   Phase 3   EUCTR2015-002496-26-HU   Belgium;France;Germany;Hungary;Spain;United States
      2015   Phase 3   EUCTR2015-002496-26-DE   Belgium;France;Germany;Hungary;Spain;United States
   Shield Therapeutics
      2016   Phase 3   NCT02680756   Belgium;France;Germany;Hungary;Spain;United States
Ferric trimaltol
   Iron Therapeutics (UK) Ltd.
      2016   Phase 3   EUCTR2015-002496-26-ES   Belgium;Germany;Hungary;Spain
      2015   Phase 3   EUCTR2015-002496-26-BE   Belgium;Germany;Hungary;Spain
   Shield TX (UK) Ltd.
      2017   Phase 3   EUCTR2015-002496-26-HU   Belgium;France;Germany;Hungary;Spain;United States
      2015   Phase 3   EUCTR2015-002496-26-DE   Belgium;France;Germany;Hungary;Spain;United States
Ferrisat
   Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives
      2011   Phase 3   NCT01428843   France
Ferrisat 50MG/ML
   GETAID
      2010   -   EUCTR2009-011316-38-FR   France
Ferro duretter, prolonged release tablet
   Pharmacosmos A/S
      2011   -   EUCTR2009-012544-16-HU   Austria;Denmark;Hungary;United Kingdom
      2011   -   EUCTR2009-012544-16-AT   Austria;Denmark;Hungary;United Kingdom
      2009   Phase 3   EUCTR2009-012544-16-GB   Austria;Denmark;Hungary;United Kingdom
      2009   -   EUCTR2009-012544-16-DK   Austria;Denmark;Hungary;United Kingdom
Ferro E.V. (come carbossimaltoso ferrico) - ferinject
   FONDAZIONE I.R.C.C.S. POLICLINICO SAN MATTEO
      2017   Phase 3   EUCTR2016-001772-30-IT   Italy
Ferrofumaraat apotex
   Atrium Medical Centre
      2018   Phase 4   EUCTR2012-005644-26-BE   Belgium;Netherlands
Ferrofumaraat teva
   Leiden University Medical Center
      2022   Phase 4   EUCTR2022-000894-16-NL   Netherlands
Ferrous fumarate
   Atrium Medical Centre
      2018   Phase 4   EUCTR2012-005644-26-BE   Belgium;Netherlands
   Leiden University Medical Center
      2022   Phase 4   NCT05456932   Netherlands
      2022   Phase 4   EUCTR2022-000894-16-NL   Netherlands
Ferrous fumarate syrup
   Liverpool University Hospitals NHS Foundation Trust
      2023   Phase 3   NCT06321887   United Kingdom
   Royal Liverpool University Hospital
      2020   Phase 4   EUCTR2018-002982-20-GB   United Kingdom
Ferrous sulfate tablets
   American Regent, Inc.
      2014   Phase 4   NCT02086968   United States
Ferrous sulphate
   Barts Health NHS Trust
      2011   Phase 4   EUCTR2010-023797-39-GB   United Kingdom
   Pharmacosmos A/S
      2011   -   EUCTR2009-012544-16-AT   Austria;Denmark;Hungary;United Kingdom
      2009   -   EUCTR2009-012544-16-DK   Austria;Denmark;Hungary;United Kingdom
   Queen Mary University of London
      2011   Phase 4   NCT01991314   United Kingdom
Ferrous sulphate with 65 MG iron++ PER tablet
   GlobiFer International bvba
      2010   Phase 2   EUCTR2008-004277-17-GB   United Kingdom
Fibrin adhesive
   Tigenix S.A.U.
      2007   Phase 3   NCT00475410   Germany;Spain;United Kingdom
Fidaxomicin
   ASTELLAS PHARMA EUROPE LIMITED
      2015   Phase 3;Phase 4   EUCTR2014-003002-32-IT   Austria;Czech Republic;Czechia;France;Germany;Greece;Italy;Poland;Russian Federation;United Kingdom
   Astellas Pharma Europe Ltd.
      2015   Phase 4   NCT02437591   Austria;Czech Republic;France;Germany;Greece;Italy;Poland;Russian Federation;United Kingdom
      2015   Phase 3;Phase 4   EUCTR2014-003002-32-PL   Austria;Czech Republic;France;Germany;Greece;Italy;Poland;Russian Federation;United Kingdom
      2015   Phase 4   EUCTR2014-003002-32-GR   Austria;Czech Republic;Germany;Greece;Poland
      2015   Phase 4   EUCTR2014-003002-32-DE   Austria;Czech Republic;Germany;Greece;Poland
      2015   Phase 3;Phase 4   EUCTR2014-003002-32-CZ   Austria;Czech Republic;France;Germany;Greece;Italy;Poland;Russian Federation;United Kingdom
      2015   Phase 3;Phase 4   EUCTR2014-003002-32-AT   Austria;Czech Republic;France;Germany;Greece;Italy;Poland;Russian Federation;United Kingdom
   Brigham and Women's Hospital
      2025   Phase 4   NCT06794944   United States
Fidaxomicina
   ASTELLAS PHARMA EUROPE LIMITED
      2015   Phase 3;Phase 4   EUCTR2014-003002-32-IT   Austria;Czech Republic;Czechia;France;Germany;Greece;Italy;Poland;Russian Federation;United Kingdom
Filgotinib
   Alfasigma S.p.A.
      2025   Phase 3   NCT06865417   Belgium;Croatia;France;Germany;Greece;Ireland;Italy;Norway;Poland;Portugal;Romania;Spain
      2023   -   NCT05817942   Austria;Belgium;France;Germany;Ireland;Italy;Netherlands;Norway;Spain;United Kingdom
      2017   Phase 3   NCT02914535   Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
   GALAPAGOS NV
      2022   Phase 3   EUCTR2022-000719-30-IT   Belgium;Czech Republic;Czechia;France;Germany;Hungary;India;Italy;Korea, Republic of;Poland;South Africa;Spain;Switzerland;Taiwan;United Kingdom;United States
   GILEAD SCIENCES INCORPORATED
      2018   Phase 3   EUCTR2016-002765-58-IT   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Czechia;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      -   Phase 3   EUCTR2016-001392-78-IT   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czechia;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
   Galapagos NV
      2022   Phase 3   NCT05479058   Belgium;Czechia;France;Germany;Hungary;Italy;Korea, Republic of;Poland;South Africa;Spain;Taiwan;United Kingdom;United States
      2022   Phase 3   EUCTR2022-000719-30-PL   Belgium;Czech Republic;Czechia;France;Germany;Hungary;India;Italy;Korea, Republic of;Poland;South Africa;Spain;Taiwan;United Kingdom;United States
      2022   Phase 3   EUCTR2022-000719-30-FR   Belgium;Czech Republic;Czechia;France;Germany;Hungary;India;Italy;Korea, Republic of;Poland;South Africa;Spain;Switzerland;Taiwan;United Kingdom;United States
      2022   Phase 3   EUCTR2022-000719-30-ES   Belgium;Czech Republic;Czechia;France;Germany;Hungary;India;Italy;Korea, Republic of;Poland;South Africa;Spain;Switzerland;Taiwan;United Kingdom;United States
      2022   Phase 3   EUCTR2022-000719-30-CZ   Belgium;Czech Republic;Czechia;France;Germany;Hungary;India;Italy;Korea, Republic of;Poland;South Africa;Spain;Taiwan;United Kingdom;United States
      2022   Phase 3   EUCTR2022-000719-30-BE   Belgium;Czech Republic;Czechia;France;Germany;Hungary;India;Italy;Korea, Republic of;Poland;South Africa;Spain;Taiwan;United Kingdom;United States
      2018   Phase 2   EUCTR2017-000402-38-PT   Australia;Austria;Belgium;Canada;Germany;India;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Spain;Sweden;Taiwan;Ukraine;United Kingdom;United States
      2018   Phase 2   EUCTR2017-000402-38-DE   Australia;Austria;Belgium;Canada;Germany;India;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Spain;Sweden;Taiwan;Ukraine;United Kingdom;United States
      2017   Phase 2   NCT03201445   Australia;Austria;Belgium;Canada;Czechia;Germany;India;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Spain;Sweden;Taiwan;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-002765-58-SE   Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-002765-58-NL   Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-002765-58-DE   Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-002765-58-CZ   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Czechia;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sri Lanka;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-002765-58-BE   Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-002765-58-AT   Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sri Lanka;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
   Gilead Sciences
      2018   Phase 1   NCT03417778   Germany;New Zealand;United States
      2016   Phase 3   NCT02914522   Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czechia;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
   Gilead Sciences, Inc
      2017   Phase 3   EUCTR2016-002765-58-SK   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sri Lanka;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
   Gilead Sciences, Inc.
      2018   Phase 2   EUCTR2017-000402-38-SE   Australia;Austria;Belgium;Canada;Czech Republic;Germany;Hungary;India;Italy;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Spain;Sri Lanka;Sweden;Ukraine;United Kingdom;United States
      2018   Phase 2   EUCTR2017-000402-38-RO   Australia;Austria;Belgium;Canada;Czechia;Germany;Hungary;India;Italy;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Spain;Sri Lanka;Sweden;Ukraine;United Kingdom;United States
      2018   Phase 2   EUCTR2017-000402-38-NL   Australia;Austria;Belgium;Canada;France;Germany;India;Italy;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Spain;Sri Lanka;Sweden;Switzerland;Ukraine;United Kingdom;United States
      2018   Phase 2   EUCTR2017-000402-38-GB   Australia;Austria;Belgium;Canada;Germany;India;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Spain;Sweden;Ukraine;United Kingdom;United States
      2018   Phase 2   EUCTR2017-000402-38-ES   Australia;Austria;Belgium;Canada;Czech Republic;France;Germany;Hungary;India;Italy;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Spain;Sri Lanka;Sweden;Ukraine;United Kingdom;United States
      2018   Phase 2   EUCTR2017-000402-38-BE   Australia;Austria;Belgium;Canada;France;Germany;India;Italy;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Spain;Sri Lanka;Sweden;Switzerland;Ukraine;United Kingdom;United States
      2018   Phase 2   EUCTR2017-000402-38-AT   Australia;Austria;Belgium;Canada;Germany;India;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Spain;Sweden;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-002765-58-PT   Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-002765-58-IS   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-002765-58-HU   Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sri Lanka;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-002765-58-HR   Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sri Lanka;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-002765-58-GR   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-002765-58-FR   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-002765-58-ES   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-002765-58-BG   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Czechia;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sri Lanka;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2017   Phase 2;Phase 3   EUCTR2016-001392-78-SK   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sri Lanka;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2017   Phase 2;Phase 3   EUCTR2016-001392-78-SE   Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2017   Phase 2;Phase 3   EUCTR2016-001392-78-PT   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sri Lanka;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2017   Phase 2;Phase 3   EUCTR2016-001392-78-NO   Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2017   Phase 2;Phase 3   EUCTR2016-001392-78-NL   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sri Lanka;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2017   Phase 2;Phase 3   EUCTR2016-001392-78-IS   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sri Lanka;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2017   Phase 2;Phase 3   EUCTR2016-001392-78-HU   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sri Lanka;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2017   Phase 2;Phase 3   EUCTR2016-001392-78-HR   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sri Lanka;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2017   Phase 2;Phase 3   EUCTR2016-001392-78-GR   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2017   Phase 2;Phase 3   EUCTR2016-001392-78-ES   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2017   Phase 2;Phase 3   EUCTR2016-001392-78-DE   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sri Lanka;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2017   Phase 2;Phase 3   EUCTR2016-001392-78-BG   Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2017   Phase 2;Phase 3   EUCTR2016-001392-78-BE   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sri Lanka;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2017   Phase 2;Phase 3   EUCTR2016-001392-78-AT   Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2016-002765-58-GB   Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2016   Phase 2;Phase 3   EUCTR2016-001392-78-GB   Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
Filgotinib maleate
   Eisai Korea Inc.
      2025   Phase 4   NCT06964113   Korea, Republic of
FILM-coated tablet
   4SC AG
      2010   -   EUCTR2008-005903-25-BG   Bulgaria;Germany
      2009   -   EUCTR2008-005903-25-DE   Bulgaria;Germany
   ASTELLAS PHARMA EUROPE LIMITED
      2015   Phase 3;Phase 4   EUCTR2014-003002-32-IT   Austria;Czech Republic;Czechia;France;Germany;Greece;Italy;Poland;Russian Federation;United Kingdom
   AbbVie Deutschland GmbH & Co. KG
      2017   Phase 3   EUCTR2016-000674-38-DE   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
   Alimentiv Inc.
      2020   Phase 4   EUCTR2019-003780-21-NL   Belgium;Canada;Italy;Netherlands;Spain;United States
   Amsterdam UMC, location AMC
      2020   Phase 2   EUCTR2020-002695-12-NL   Netherlands
   Arena Pharmaceuticals, Inc.
      2016   Phase 2   EUCTR2015-002109-12-LV   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;France;Germany;Hungary;Israel;Latvia;Lithuania;New Zealand;Poland;Romania;Russian Federation;Spain;Ukraine;United Kingdom;United States
      2016   Phase 2   EUCTR2015-002109-12-LT   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;France;Germany;Hungary;Israel;Latvia;Lithuania;New Zealand;Poland;Romania;Russian Federation;Spain;Ukraine;United Kingdom;United States
      2016   Phase 2   EUCTR2015-002109-12-HU   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;France;Germany;Hungary;Israel;Latvia;Lithuania;New Zealand;Poland;Romania;Spain;Ukraine;United Kingdom;United States
      2016   Phase 2   EUCTR2015-002109-12-GB   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;France;Germany;Hungary;Israel;Latvia;Lithuania;New Zealand;Poland;Romania;Russian Federation;Spain;Ukraine;United Kingdom;United States
      2016   Phase 2   EUCTR2015-002109-12-ES   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;France;Germany;Hungary;Israel;Latvia;Lithuania;New Zealand;Poland;Romania;Russian Federation;Spain;Ukraine;United Kingdom;United States
      2016   Phase 2   EUCTR2015-002109-12-CZ   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;France;Germany;Hungary;Israel;Latvia;Lithuania;New Zealand;Poland;Romania;Russian Federation;Spain;Ukraine;United Kingdom;United States
      2016   Phase 2   EUCTR2015-002109-12-BG   Austria;Belgium;Bulgaria;Canada;Czech Republic;Germany;Hungary;Korea, Republic of;Latvia;Lithuania;Poland;Romania;Russian Federation;Spain;Ukraine;United Kingdom;United States
      2016   Phase 2   EUCTR2015-002109-12-BE   Austria;Belgium;Bulgaria;Canada;Czech Republic;Germany;Hungary;Latvia;Lithuania;Poland;Romania;Russian Federation;Spain;Ukraine;United Kingdom;United States
      2016   Phase 2   EUCTR2015-002109-12-AT   Austria;Belgium;Bulgaria;Canada;Czech Republic;Germany;Hungary;Latvia;Lithuania;Poland;Romania;Russian Federation;Spain;Ukraine;United Kingdom;United States
   Astellas Pharma Europe Ltd.
      2015   Phase 3;Phase 4   EUCTR2014-003002-32-PL   Austria;Czech Republic;France;Germany;Greece;Italy;Poland;Russian Federation;United Kingdom
      2015   Phase 4   EUCTR2014-003002-32-GR   Austria;Czech Republic;Germany;Greece;Poland
      2015   Phase 4   EUCTR2014-003002-32-DE   Austria;Czech Republic;Germany;Greece;Poland
      2015   Phase 3;Phase 4   EUCTR2014-003002-32-CZ   Austria;Czech Republic;France;Germany;Greece;Italy;Poland;Russian Federation;United Kingdom
      2015   Phase 3;Phase 4   EUCTR2014-003002-32-AT   Austria;Czech Republic;France;Germany;Greece;Italy;Poland;Russian Federation;United Kingdom
   Atrium Medical Centre
      2018   Phase 4   EUCTR2012-005644-26-BE   Belgium;Netherlands
   BRISTOL-MYERS SQUIBB INTERNATIONAL CORPORATION
      2019   Phase 2   EUCTR2018-004694-27-IT   Australia;Belgium;Czech Republic;Czechia;France;Germany;Hungary;Italy;Japan;Korea, Republic of;Poland;Russian Federation;United Kingdom;United States
   Bristol-Myers Squibb International Corporation
      2022   Phase 2   EUCTR2019-004878-26-PL   Australia;Canada;Germany;Netherlands;Poland;United Kingdom;United States
      2021   Phase 2   EUCTR2019-004878-26-NL   Australia;Canada;Germany;Netherlands;Poland;United Kingdom;United States
      2021   Phase 2   EUCTR2019-004878-26-DE   Australia;Canada;Germany;Netherlands;Poland;United Kingdom;United States
      2020   Phase 2   EUCTR2018-004694-27-FR   Australia;Belgium;Czech Republic;France;Germany;Hungary;Italy;Japan;Korea, Republic of;Poland;Russian Federation;United Kingdom;United States
      2019   Phase 2   EUCTR2018-004694-27-PL   Australia;Belgium;Czech Republic;France;Germany;Hungary;Italy;Japan;Korea, Republic of;Poland;Russian Federation;United Kingdom;United States
      2019   Phase 2   EUCTR2018-004694-27-HU   Belgium;Canada;Czech Republic;Germany;Hungary;Italy;Japan;Korea, Republic of;Poland;Russian Federation;Spain;Switzerland;United Kingdom;United States
      2019   Phase 2   EUCTR2018-004694-27-GB   Australia;Belgium;Czech Republic;France;Germany;Hungary;Italy;Japan;Korea, Republic of;Poland;Russian Federation;United Kingdom;United States
      2019   Phase 2   EUCTR2018-004694-27-DE   Australia;Belgium;Czech Republic;Czechia;France;Germany;Hungary;Italy;Japan;Korea, Republic of;Poland;Russian Federation;United Kingdom;United States
      2019   Phase 2   EUCTR2018-004694-27-CZ   Australia;Belgium;Czech Republic;France;Germany;Hungary;Italy;Japan;Korea, Republic of;Poland;Russian Federation;United Kingdom;United States
   Celgene Corporation
      2016   Phase 2   EUCTR2015-003364-36-SK   Bulgaria;Canada;Hungary;Poland;Slovakia;United States
      2016   Phase 2   EUCTR2015-003364-36-HU   Bulgaria;Canada;Hungary;Poland;Slovakia;United States
      2016   Phase 2   EUCTR2015-003364-36-BG   Bulgaria;Canada;Hungary;Poland;Slovakia;United States
   Cosmo Technologies Ltd
      2006   -   EUCTR2006-001782-42-HU   Hungary;Italy;United Kingdom
      2006   Phase 2   EUCTR2006-001782-42-GB   Hungary;Italy;United Kingdom
   DIP. MEDICINA DEI SISTEMI UNIVERSITà DEGLI STUDI DI ROMA TOR VERGATA
      2019   Phase 4   EUCTR2018-004890-28-IT   Italy
   Erasmus Medical Center
      2019   Phase 4   EUCTR2018-004587-61-NL   Netherlands
   GALAPAGOS NV
      2022   Phase 3   EUCTR2022-000719-30-IT   Belgium;Czech Republic;Czechia;France;Germany;Hungary;India;Italy;Korea, Republic of;Poland;South Africa;Spain;Switzerland;Taiwan;United Kingdom;United States
   GB004, Inc.
      2021   Phase 2   EUCTR2020-002306-12-PL   Australia;Belarus;Georgia;Italy;Korea, Republic of;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Ukraine;United States
   GILEAD SCIENCES INCORPORATED
      2020   Phase 2   EUCTR2019-001430-33-IT   Australia;Austria;Belgium;Canada;Czechia;France;Germany;Italy;Poland;Russian Federation;Switzerland;United Kingdom;United States
      2018   Phase 3   EUCTR2016-002765-58-IT   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Czechia;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      -   Phase 3   EUCTR2016-001392-78-IT   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czechia;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
   GIULIANI
      2009   -   EUCTR2008-007292-25-IT   Italy
   Galapagos NV
      2022   Phase 3   EUCTR2022-000719-30-PL   Belgium;Czech Republic;Czechia;France;Germany;Hungary;India;Italy;Korea, Republic of;Poland;South Africa;Spain;Taiwan;United Kingdom;United States
      2022   Phase 3   EUCTR2022-000719-30-FR   Belgium;Czech Republic;Czechia;France;Germany;Hungary;India;Italy;Korea, Republic of;Poland;South Africa;Spain;Switzerland;Taiwan;United Kingdom;United States
      2022   Phase 3   EUCTR2022-000719-30-ES   Belgium;Czech Republic;Czechia;France;Germany;Hungary;India;Italy;Korea, Republic of;Poland;South Africa;Spain;Switzerland;Taiwan;United Kingdom;United States
      2022   Phase 3   EUCTR2022-000719-30-CZ   Belgium;Czech Republic;Czechia;France;Germany;Hungary;India;Italy;Korea, Republic of;Poland;South Africa;Spain;Taiwan;United Kingdom;United States
      2022   Phase 3   EUCTR2022-000719-30-BE   Belgium;Czech Republic;Czechia;France;Germany;Hungary;India;Italy;Korea, Republic of;Poland;South Africa;Spain;Taiwan;United Kingdom;United States
      2018   Phase 2   EUCTR2017-000402-38-PT   Australia;Austria;Belgium;Canada;Germany;India;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Spain;Sweden;Taiwan;Ukraine;United Kingdom;United States
      2018   Phase 2   EUCTR2017-000402-38-DE   Australia;Austria;Belgium;Canada;Germany;India;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Spain;Sweden;Taiwan;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-002765-58-SE   Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-002765-58-NL   Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-002765-58-DE   Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-002765-58-CZ   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Czechia;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sri Lanka;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-002765-58-BE   Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-002765-58-AT   Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sri Lanka;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
   Gilead Sciences, Inc
      2017   Phase 3   EUCTR2016-002765-58-SK   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sri Lanka;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
   Gilead Sciences, Inc.
      2020   Phase 2   EUCTR2019-001430-33-PL   Australia;Austria;Belgium;Canada;Czech Republic;France;Germany;Italy;Poland;Russian Federation;Switzerland;United Kingdom;United States
      2020   Phase 2   EUCTR2019-001430-33-GB   Australia;Austria;Belgium;Canada;Czechia;France;Germany;Italy;Poland;Russian Federation;Switzerland;United Kingdom;United States
      2020   Phase 2   EUCTR2019-001430-33-FR   Australia;Austria;Belgium;Canada;Czech Republic;France;Germany;Italy;Poland;Russian Federation;Switzerland;United Kingdom;United States
      2020   Phase 2   EUCTR2019-001430-33-DE   Australia;Austria;Belgium;Canada;Czech Republic;France;Germany;Italy;Poland;Russian Federation;Switzerland;United Kingdom;United States
      2020   Phase 2   EUCTR2019-001430-33-AT   Australia;Austria;Belgium;Canada;Czech Republic;France;Germany;Italy;Poland;Russian Federation;Switzerland;United Kingdom;United States
      2018   Phase 2   EUCTR2017-000402-38-SE   Australia;Austria;Belgium;Canada;Czech Republic;Germany;Hungary;India;Italy;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Spain;Sri Lanka;Sweden;Ukraine;United Kingdom;United States
      2018   Phase 2   EUCTR2017-000402-38-RO   Australia;Austria;Belgium;Canada;Czechia;Germany;Hungary;India;Italy;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Spain;Sri Lanka;Sweden;Ukraine;United Kingdom;United States
      2018   Phase 2   EUCTR2017-000402-38-NL   Australia;Austria;Belgium;Canada;France;Germany;India;Italy;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Spain;Sri Lanka;Sweden;Switzerland;Ukraine;United Kingdom;United States
      2018   Phase 2   EUCTR2017-000402-38-GB   Australia;Austria;Belgium;Canada;Germany;India;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Spain;Sweden;Ukraine;United Kingdom;United States
      2018   Phase 2   EUCTR2017-000402-38-ES   Australia;Austria;Belgium;Canada;Czech Republic;France;Germany;Hungary;India;Italy;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Spain;Sri Lanka;Sweden;Ukraine;United Kingdom;United States
      2018   Phase 2   EUCTR2017-000402-38-BE   Australia;Austria;Belgium;Canada;France;Germany;India;Italy;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Spain;Sri Lanka;Sweden;Switzerland;Ukraine;United Kingdom;United States
      2018   Phase 2   EUCTR2017-000402-38-AT   Australia;Austria;Belgium;Canada;Germany;India;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Spain;Sweden;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-002765-58-PT   Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-002765-58-IS   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-002765-58-HU   Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sri Lanka;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-002765-58-HR   Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sri Lanka;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-002765-58-GR   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-002765-58-FR   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-002765-58-ES   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-002765-58-BG   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Czechia;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sri Lanka;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2017   Phase 2;Phase 3   EUCTR2016-001392-78-SK   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sri Lanka;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2017   Phase 2;Phase 3   EUCTR2016-001392-78-SE   Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2017   Phase 2;Phase 3   EUCTR2016-001392-78-PT   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sri Lanka;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2017   Phase 2;Phase 3   EUCTR2016-001392-78-NO   Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2017   Phase 2;Phase 3   EUCTR2016-001392-78-NL   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sri Lanka;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2017   Phase 2;Phase 3   EUCTR2016-001392-78-IS   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sri Lanka;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2017   Phase 2;Phase 3   EUCTR2016-001392-78-HU   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sri Lanka;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2017   Phase 2;Phase 3   EUCTR2016-001392-78-HR   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sri Lanka;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2017   Phase 2;Phase 3   EUCTR2016-001392-78-GR   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2017   Phase 2;Phase 3   EUCTR2016-001392-78-ES   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2017   Phase 2;Phase 3   EUCTR2016-001392-78-DE   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sri Lanka;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2017   Phase 2;Phase 3   EUCTR2016-001392-78-BG   Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2017   Phase 2;Phase 3   EUCTR2016-001392-78-BE   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sri Lanka;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2017   Phase 2;Phase 3   EUCTR2016-001392-78-AT   Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2016-002765-58-GB   Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2016   Phase 2;Phase 3   EUCTR2016-001392-78-GB   Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
   GlaxoSmithKline R&D Ltd
      2008   -   EUCTR2007-005520-32-NL   Netherlands
   GlaxoSmithKline Research & Development Ltd
      2017   Phase 2   EUCTR2016-001833-29-PL   Germany;Netherlands;Poland;Sweden;United Kingdom
      2017   Phase 2   EUCTR2016-001833-29-NL   Germany;Netherlands;Poland;Sweden;United Kingdom
      2016   Phase 2   EUCTR2016-001833-29-SE   Germany;Netherlands;Poland;Russian Federation;Sweden;United Kingdom;United States
      2016   Phase 2   EUCTR2016-001833-29-GB   Germany;Netherlands;Poland;Sweden;United Kingdom
   Instituto Clinico Humanitas
      2021   Phase 4   EUCTR2020-003420-16-BE   Austria;Belgium;France;Germany;Italy;Portugal;Spain;Sweden;Switzerland;United Kingdom
   Janssen-Cilag International NV
      2014   Phase 2   EUCTR2013-000263-88-RO   Belgium;Bulgaria;Canada;France;Germany;Hungary;Netherlands;Poland;Romania;Russian Federation;Ukraine;United States
      2014   -   EUCTR2013-000263-88-PL   Belgium;Bulgaria;Canada;France;Germany;Hungary;Netherlands;Poland;Romania;Russian Federation;Ukraine;United States
      2014   -   EUCTR2013-000263-88-NL   Belgium;Bulgaria;Canada;France;Germany;Hungary;Netherlands;Poland;Romania;Russian Federation;Ukraine;United States
      2014   -   EUCTR2013-000263-88-HU   Belgium;Bulgaria;Canada;France;Germany;Hungary;Netherlands;Poland;Romania;Russian Federation;Ukraine;United States
      2014   Phase 2   EUCTR2013-000263-88-DE   Belgium;Bulgaria;Canada;France;Germany;Hungary;Netherlands;Poland;Romania;Russian Federation;Ukraine;United States
      2014   Phase 2   EUCTR2013-000263-88-BG   Belgium;Bulgaria;Canada;France;Germany;Hungary;Netherlands;Poland;Romania;Russian Federation;Ukraine;United States
      2014   -   EUCTR2013-000263-88-BE   Australia;Belgium;Bulgaria;Canada;France;Germany;Hungary;Israel;Netherlands;Poland;Romania;Russian Federation;Ukraine;United States
   LG Chem
      2020   Phase 1   NCT04360343   Korea, Republic of
   Oppilan Pharma Ltd.
      2022   Phase 2   EUCTR2021-003050-23-PL   Belgium;Bulgaria;Czech Republic;Czechia;France;Georgia;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Lithuania;Poland;Serbia;Slovakia;Sweden;Ukraine;United States
   Oppilan Pharma Ltd., wholy owned subsidiary of Ventyx Biosciences Inc.
      2023   Phase 2   EUCTR2021-003050-23-BE   Belgium;Bulgaria;Czech Republic;Czechia;France;Georgia;Germany;Hungary;India;Italy;Korea, Republic of;Lithuania;Poland;Serbia;Slovakia;Sweden;Ukraine;United States
      2022   Phase 2   EUCTR2021-003050-23-SK   Belgium;Bulgaria;Czech Republic;Czechia;France;Georgia;Germany;Hungary;India;Italy;Korea, Republic of;Lithuania;Poland;Serbia;Slovakia;Ukraine;United States
      2022   Phase 2   EUCTR2021-003050-23-LT   Belgium;Bulgaria;Czech Republic;Czechia;France;Georgia;Germany;Hungary;India;Italy;Korea, Republic of;Lithuania;Poland;Serbia;Slovakia;Sweden;Ukraine;United States
      2022   Phase 2   EUCTR2021-003050-23-FR   Australia;Belarus;Belgium;Bulgaria;Czech Republic;Czechia;France;Georgia;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Lithuania;Poland;Russian Federation;Serbia;Slovakia;Sweden;Ukraine;United States
      2021   Phase 2   EUCTR2021-003050-23-CZ   Belgium;Bulgaria;Czech Republic;Czechia;France;Georgia;Germany;Hungary;India;Italy;Korea, Republic of;Lithuania;Poland;Slovakia;Ukraine;United States
   Oppilan Pharma limited
      2022   Phase 2   EUCTR2021-003050-23-IT   Belarus;Belgium;Bulgaria;Czech Republic;Czechia;France;Georgia;Germany;Hungary;Israel;Italy;Lithuania;Poland;Russian Federation;Slovakia;Ukraine;United States
   PFIZER INC
      2022   Phase 3   EUCTR2018-002378-30-IT   Australia;Belgium;Canada;Finland;France;Germany;Hungary;Israel;Italy;Japan;Netherlands;Poland;Slovakia;Spain;Sweden;United Kingdom;United States
      2018   Phase 3;Phase 4   EUCTR2017-002274-39-IT   Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Japan;Korea, Republic of;Netherlands;New Zealand;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
   Pfizer Inc, 235 East 42nd Street, New York, New York 10017
      2018   Phase 3;Phase 4   EUCTR2017-002274-39-NL   Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Japan;Korea, Republic of;Netherlands;New Zealand;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
      2018   Phase 3;Phase 4   EUCTR2017-002274-39-GB   Austria;Belgium;Canada;Czech Republic;France;Germany;Hungary;Italy;Japan;Korea, Republic of;Netherlands;New Zealand;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
      2018   Phase 3;Phase 4   EUCTR2017-002274-39-CZ   Austria;Belgium;Canada;Czech Republic;Czechia;Germany;Hungary;Italy;Japan;Korea, Republic of;Netherlands;New Zealand;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
      2018   Phase 3;Phase 4   EUCTR2017-002274-39-BE   Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Japan;Korea, Republic of;Netherlands;New Zealand;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-002274-39-AT   Austria;Belgium;Canada;Czech Republic;France;Germany;Hungary;Italy;Japan;Korea, Republic of;Netherlands;New Zealand;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
      2017   Phase 3;Phase 4   EUCTR2017-002274-39-HU   Austria;Belgium;Canada;Czech Republic;France;Germany;Hungary;Italy;Japan;Korea, Republic of;Netherlands;New Zealand;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2017-002274-39-ES   Austria;Belgium;Canada;Czech Republic;France;Germany;Hungary;Italy;Japan;Korea, Republic of;Netherlands;New Zealand;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
      2012   Phase 3   EUCTR2011-004581-14-NL   Australia;Austria;Belgium;Canada;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
      2012   Phase 3   EUCTR2011-004581-14-HU   Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2012   Phase 3   EUCTR2011-004581-14-GB   Australia;Austria;Belgium;Canada;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
      2012   Phase 3   EUCTR2011-004581-14-EE   Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2012   Phase 3   EUCTR2011-004581-14-DK   Australia;Austria;Belgium;Canada;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
      2012   Phase 3   EUCTR2011-004581-14-BE   Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2012   Phase 3   EUCTR2011-004581-14-AT   Australia;Austria;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
   Pfizer Inc, 235 East 42nd Street, New York, New York 10017, USA
      2012   Phase 3   EUCTR2011-004581-14-DE   Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2012   Phase 3   EUCTR2011-004580-79-DE   Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2012   Phase 3   EUCTR2011-004579-35-DE   Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2012   Phase 3   EUCTR2011-004578-27-DE   Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
   Pfizer Inc.
      2022   Phase 3   EUCTR2018-002378-30-SK   Australia;Belgium;Canada;Finland;France;Germany;Hungary;Israel;Italy;Japan;Netherlands;Poland;Slovakia;Spain;Sweden;United Kingdom;United States
      2022   Phase 3   EUCTR2018-002378-30-NL   Australia;Belgium;Canada;Finland;France;Germany;Hungary;Israel;Italy;Japan;Netherlands;Poland;Slovakia;Spain;Sweden;United Kingdom;United States
      2022   Phase 3   EUCTR2018-002378-30-HU   Australia;Belgium;Canada;Finland;France;Germany;Hungary;Israel;Italy;Japan;Netherlands;Poland;Slovakia;Spain;Sweden;United Kingdom;United States
      2022   Phase 3   EUCTR2018-002378-30-FR   Australia;Belgium;Canada;Finland;France;Germany;Hungary;Israel;Italy;Japan;Netherlands;Poland;Slovakia;Spain;Sweden;United Kingdom;United States
      2022   Phase 3   EUCTR2018-002378-30-DE   Australia;Belgium;Canada;Finland;France;Germany;Hungary;Israel;Italy;Japan;Netherlands;Poland;Slovakia;Spain;Sweden;United Kingdom;United States
      2021   Phase 3   EUCTR2018-002378-30-FI   Australia;Belgium;Canada;Finland;France;Germany;Hungary;Israel;Italy;Japan;Netherlands;Poland;Slovakia;Spain;Sweden;United Kingdom;United States
      2017   Phase 3;Phase 4   EUCTR2017-002274-39-SK   Austria;Belgium;Canada;Czech Republic;Czechia;Germany;Hungary;Italy;Japan;Korea, Republic of;Netherlands;New Zealand;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
      2012   Phase 3   EUCTR2011-004581-14-SK   Australia;Austria;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2012   Phase 3   EUCTR2011-004581-14-CZ   Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      -   Phase 3   EUCTR2018-002378-30-SE   Australia;Belgium;Canada;Finland;France;Germany;Hungary;Israel;Italy;Japan;Netherlands;Poland;Slovakia;Spain;Sweden;United Kingdom;United States
      -   Phase 3   EUCTR2018-002378-30-PL   Australia;Belgium;Canada;Finland;France;Germany;Hungary;Israel;Italy;Japan;Netherlands;Poland;Slovakia;Spain;Sweden;United Kingdom;United States
      -   Phase 3   EUCTR2018-002378-30-BE   Australia;Belgium;Canada;Finland;France;Germany;Hungary;Israel;Italy;Japan;Netherlands;Poland;Slovakia;Spain;Sweden;United Kingdom;United States
   Pfizer Inc., 235 East 42nd Street, New York, New York 10017, United States
      2012   Phase 3   EUCTR2011-004581-14-PL   Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
   Procter & Gamble Pharmaceuticals
      -   Phase 3   EUCTR2007-005702-49-PL   Poland
   Region Örebro län
      2021   Phase 4   EUCTR2019-002942-19-NO   Denmark;Iceland;Norway
      2021   Phase 4   EUCTR2019-002942-19-IS   Denmark;Iceland
      2021   Phase 4   EUCTR2019-002942-19-DK   Denmark;Iceland
   Reistone Biopharma Company Limited
      2021   Phase 3   EUCTR2021-001940-86-PL   China;Georgia;Poland;Ukraine;United States
      2019   Phase 2   EUCTR2018-003364-31-PL   China;Poland;Ukraine;United States
   Shire Development Inc
      2012   -   EUCTR2011-000164-10-SK   Slovakia;United Kingdom;United States
   Shire Development LLC
      2013   Phase 1   EUCTR2011-000164-10-GB   Australia;Poland;Slovakia;United Kingdom;United States
   University of Leeds
      2020   Phase 2;Phase 3   EUCTR2019-003220-21-GB   United Kingdom
First-line biologic:IFX
   Xijing Hospital of Digestive Diseases
      2025   -   NCT06962020   China
First-line biologic:VDZ
   Xijing Hospital of Digestive Diseases
      2025   -   NCT06962020   China
FITC-adalimumab
   Universitätsklinikum Erlangen
      2017   Phase 1;Phase 2   EUCTR2014-001594-14-DE   Germany
Flagyl
   Benha University
      2023   -   NCT06583863   Egypt
   Division of General Medicine, Department of Internal Medicine, Nihon University School of Medicine
      2013   Phase 3   JPRN-UMIN000009811   Japan
   FORMAC Pharmaceuticals NV
      2009   -   EUCTR2009-015136-14-BE   Belgium
Flixabi
   Centre Hospitalier Universitaire de Rennes
      2018   Phase 4   EUCTR2018-002673-21-FR   France
   UMC Amsterdam location AMC
      2020   Phase 4   EUCTR2018-003524-36-IE   Ireland;Netherlands;Norway
   University Medical Center Groningen
      2021   Phase 4   EUCTR2020-001811-26-BE   Belgium;Netherlands;Spain
      2020   Phase 4   EUCTR2020-001811-26-NL   Belgium;Netherlands;Spain
   University Southampton Hospital NHS Foundation Trust
      2018   Phase 4   EUCTR2018-001546-33-GB   United Kingdom
Fluorescein
   Fujita Health University School of Medicine, Department of Gastroenterology
      2017   -   JPRN-UMIN000032250   Japan
   Ohmiya Naoki
      2017   -   JPRN-jRCTs041180035   -
Fluorescence imaging
   University Medical Center Groningen
      2023   Phase 1   NCT03938701   Netherlands
Fluorescence molecular imaging procedure using vedolizumab-800CW with prior administration OF unlabeled vedolizumab
   University Medical Center Groningen
      2020   Phase 1   NCT04112212   Netherlands
Fluorescence molecular imaging procedure without prior administration OF vedolizumab-800CW
   University Medical Center Groningen
      2020   Phase 1   NCT04112212   Netherlands
Flupentixol
   Guiyang 1st People's Hospital
      2018   -   ChiCTR1800016438   China
FMT
   Assistance Publique - Hôpitaux de Paris
      2018   Phase 3   NCT03483246   France
   Children's Mercy Hospital Kansas City
      2014   Phase 1   NCT02108821   United States
   Chinese PLA General Hospital
      2014   -   ChiCTR-ONH-17012572   China
   Department of Gastroenterology, Jinan Central Hospital
      2018   -   ChiCTR2100043797   China
   Fondazione Policlinico Universitario Agostino Gemelli IRCCS
      2023   Phase 1/Phase 2   NCT05739864   Italy
   Hamilton Health Sciences Corporation
      2022   -   NCT04926103   Canada
   Ishikawa Dai
      2020   -   JPRN-jRCTs031200103   -
      2017   -   JPRN-jRCTs031180415   -
   Joint Authority for Päijät-Häme Social and Health Care
      2016   -   NCT03561532   Finland
   Juntendo university school of medicine Department of gastroenterology
      2015   -   JPRN-UMIN000018642   Japan
   Nagahara Akihito
      2023   Phase 2   JPRN-jRCTs031220542   -
   Stacy A. Kahn
      2015   Phase 1/Phase 2   NCT02330653   United States
   University of Birmingham
      2017   Phase 3   EUCTR2015-005753-12-GB   United Kingdom
   Yanling Wei
      2015   Phase 2   NCT02335281   China
FMT enema
   University of British Columbia
      2022   Phase 2   NCT04202211   Canada
FMT infusions
   The University of New South Wales
      2013   Phase 2   NCT01896635   Australia
FMT oral
   University of British Columbia
      2022   Phase 2   NCT04202211   Canada
FMT protocol
   LanZhou University
      2024   -   NCT06471894   -
Folacin
   Region Örebro län
      2021   Phase 4   EUCTR2019-002942-19-IS   Denmark;Iceland
Folic acid
   Le Bonheur Children's Hospital
      2018   Phase 4   NCT03860012   United States
   Region Örebro län
      2021   Phase 4   EUCTR2019-002942-19-IS   Denmark;Iceland
Fosfomycin
   Center for Surgical Science
      2021   Phase 1;Phase 2   EUCTR2020-000609-10-DK   Denmark
   Division of General Medicine, Department of Internal Medicine, Nihon University School of Medicine
      2013   Phase 3   JPRN-UMIN000009811   Japan
   Ishikawa Dai
      2017   -   JPRN-jRCTs031180415   -
   Nagahara Akihito
      2023   Phase 2   JPRN-jRCTs031220542   -
   National Center for Child Health and Development
      2016   -   JPRN-UMIN000026485   Japan
FP-110
   FORMAC Pharmaceuticals NV
      2009   -   EUCTR2009-015136-14-BE   Belgium
FP-CYA-050
   Sublimity Therapeutics (Hold Co) Ltd.
      2019   Phase 2   EUCTR2018-003349-41-RO   Belarus;Bulgaria;Canada;France;Germany;Hungary;Israel;Italy;Poland;Romania;Russian Federation;Serbia;Ukraine;United Kingdom;United States
      2019   Phase 2   EUCTR2018-003349-41-PL   Belarus;Bulgaria;Canada;France;Germany;Hungary;Israel;Italy;Poland;Russian Federation;Serbia;Ukraine;United Kingdom;United States
      2019   Phase 2   EUCTR2018-003349-41-HU   Belarus;Belgium;Bulgaria;Canada;France;Germany;Hungary;Ireland;Israel;Poland;Romania;Russian Federation;Serbia;Spain;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 2   EUCTR2018-003349-41-GB   Belarus;Bulgaria;Canada;France;Germany;Hungary;Ireland;Israel;Italy;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
      2019   Phase 2   EUCTR2018-003349-41-FR   Belarus;Bulgaria;Canada;France;Germany;Hungary;Ireland;Israel;Italy;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
      2019   Phase 2   EUCTR2018-003349-41-DE   Belarus;Bulgaria;Canada;France;Germany;Hungary;Israel;Poland;Russian Federation;Serbia;Ukraine;United Kingdom;United States
      2019   Phase 2   EUCTR2018-003349-41-BG   Belarus;Bulgaria;Canada;France;Germany;Hungary;Ireland;Israel;Italy;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
   Sublimity Therapeutics HoldCo Limited
      2019   Phase 2   EUCTR2018-003349-41-IT   Belarus;Bulgaria;Canada;France;Germany;Hungary;Ireland;Israel;Italy;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
FP-CYA-053
   Sublimity Therapeutics (Hold Co) Ltd.
      2019   Phase 2   EUCTR2018-003349-41-RO   Belarus;Bulgaria;Canada;France;Germany;Hungary;Israel;Italy;Poland;Romania;Russian Federation;Serbia;Ukraine;United Kingdom;United States
      2019   Phase 2   EUCTR2018-003349-41-PL   Belarus;Bulgaria;Canada;France;Germany;Hungary;Israel;Italy;Poland;Russian Federation;Serbia;Ukraine;United Kingdom;United States
      2019   Phase 2   EUCTR2018-003349-41-FR   Belarus;Bulgaria;Canada;France;Germany;Hungary;Ireland;Israel;Italy;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
   Sublimity Therapeutics HoldCo Limited
      2019   Phase 2   EUCTR2018-003349-41-IT   Belarus;Bulgaria;Canada;France;Germany;Hungary;Ireland;Israel;Italy;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
Free diet
   Wolfson Medical Center
      2023   -   NCT05791487   Israel;Italy;Netherlands;Switzerland
Freeze dried grape powder
   Case Western Reserve University
      2024   -   NCT05972694   United States
Freeze-dried black raspberry powder
   UConn Health
      2013   Phase 1   NCT02267694   United States
Frondanol
   Mohammed Bin Rashid University of Medicine and Health Sciences
      2022   Phase 2/Phase 3   NCT05194007   United Arab Emirates
Fructose sachet
   McMaster University
      2024   -   NCT06541938   Canada
Fully human IGG1 monoclonal antibody specific FOR TL1A
   Teva Branded Pharmaceutical Products R&D, Inc.
      2023   Phase 2   EUCTR2022-002593-89-HU   Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Hungary;Israel;Italy;Norway;Poland;Slovakia;Spain;United Kingdom;United States
      2023   Phase 2   EUCTR2022-002593-89-FR   Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Hungary;Israel;Italy;Norway;Poland;Slovakia;Spain;United Kingdom;United States
      2023   Phase 2   EUCTR2022-002593-89-CZ   Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;France;Georgia;Germany;Hungary;Israel;Italy;Japan;Moldova, Republic of;Norway;Poland;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
      2023   Phase 2   EUCTR2022-002593-89-BG   Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;France;Georgia;Germany;Hungary;Israel;Italy;Japan;Moldova, Republic of;Norway;Poland;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
      2023   Phase 2   EUCTR2022-002593-89-AT   Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;France;Georgia;Germany;Hungary;Israel;Italy;Moldova, Republic of;Norway;Poland;Serbia;Slovakia;South Africa;Spain;United Kingdom;United States
      2023   Phase 2   EUCTR2021-006881-19-PL   Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;France;Georgia;Germany;Hungary;Israel;Italy;Japan;Moldova, Republic of;Norway;Poland;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
      2023   Phase 2   EUCTR2021-006881-19-FR   Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Hungary;Israel;Italy;Japan;Norway;Poland;Slovakia;Spain;United Kingdom;United States
      2023   Phase 2   EUCTR2021-006881-19-CZ   Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;France;Georgia;Germany;Hungary;Israel;Italy;Japan;Moldova, Republic of;Norway;Poland;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
      2023   Phase 2   EUCTR2021-006881-19-BG   Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;France;Georgia;Germany;Hungary;Israel;Italy;Japan;Moldova, Republic of;Norway;Poland;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
      2023   Phase 2   EUCTR2021-006881-19-AT   Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;France;Georgia;Germany;Hungary;Israel;Italy;Japan;Moldova, Republic of;Norway;Poland;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
G1567970
   Galapagos NV
      2020   Phase 2   EUCTR2020-000659-11-PL   Georgia;Moldova, Republic of;Poland;Ukraine
G321605
   Galapagos NV
      2015   -   EUCTR2014-001893-32-PL   Belgium;Czech Republic;Germany;Hungary;Poland;Russian Federation
      2015   Phase 2   EUCTR2014-001893-32-CZ   Belgium;Czech Republic;Germany;Hungary;Poland;Russian Federation
      2014   -   EUCTR2014-001893-32-HU   Belgium;Czech Republic;Germany;Hungary;Poland;Russian Federation
      2014   -   EUCTR2014-001893-32-DE   Belgium;Czech Republic;Germany;Hungary;Poland;Russian Federation
      2014   -   EUCTR2014-001893-32-BE   Belgium;Czech Republic;Germany;Hungary;Poland;Russian Federation
Ganciclovir
   Department of Gastroenterology and Hepatology, Kyoto University Hospital
      2016   -   JPRN-UMIN000022588   Japan
   Graduate School of Medicine, Kyoto University, Gastroenterology and Hepatology
      2007   -   JPRN-UMIN000013925   Japan
Gardasil vaccine
   Boston Children’s Hospital
      2008   -   NCT00727636   United States
Gastro-resistant phosphatidylcholine granules
   Dr. Falk Pharma GmbH
      2016   Phase 3   EUCTR2013-001205-84-HU   Austria;Belgium;Germany;Hungary;Israel;Latvia;Lithuania;Netherlands;Poland;Russian Federation;Slovakia;Switzerland;Ukraine
      2016   Phase 3   EUCTR2013-001205-84-BE   Austria;Belgium;Czech Republic;Germany;Hungary;Israel;Latvia;Lithuania;Netherlands;Poland;Russian Federation;Slovakia;Switzerland;Ukraine
      2015   Phase 3   EUCTR2013-001205-84-SK   Austria;Belgium;Czech Republic;Germany;Hungary;Israel;Latvia;Lithuania;Netherlands;Poland;Russian Federation;Slovakia;Switzerland;Ukraine
      2015   Phase 3   EUCTR2013-001205-84-PL   Austria;Belgium;Czech Republic;Germany;Hungary;Israel;Latvia;Lithuania;Netherlands;Poland;Russian Federation;Slovakia;Switzerland;Ukraine
      2015   Phase 3   EUCTR2013-001205-84-LV   Austria;Belgium;Czech Republic;Germany;Hungary;Israel;Latvia;Lithuania;Netherlands;Poland;Russian Federation;Slovakia;Switzerland;Ukraine
      2015   Phase 3   EUCTR2013-001205-84-DE   Austria;Belgium;Czech Republic;Germany;Hungary;Israel;Latvia;Lithuania;Netherlands;Poland;Russian Federation;Slovakia;Switzerland;Ukraine
      2015   Phase 3   EUCTR2013-001205-84-AT   Austria;Belgium;Czech Republic;Germany;Hungary;Israel;Latvia;Lithuania;Netherlands;Poland;Russian Federation;Slovakia;Switzerland;Ukraine
      2014   Phase 3   EUCTR2012-003702-27-SK   Austria;Belgium;Czech Republic;Germany;Hungary;Israel;Latvia;Lithuania;Netherlands;Poland;Russian Federation;Slovakia;Switzerland;Ukraine
      2014   Phase 3   EUCTR2012-003702-27-PL   Austria;Belgium;Czech Republic;Germany;Hungary;Israel;Latvia;Lithuania;Netherlands;Poland;Russian Federation;Slovakia;Switzerland;Ukraine
      2014   Phase 3   EUCTR2012-003702-27-NL   Austria;Belgium;Czech Republic;Germany;Hungary;Israel;Latvia;Lithuania;Netherlands;Poland;Russian Federation;Slovakia;Switzerland;Ukraine
      2014   Phase 3   EUCTR2012-003702-27-LV   Austria;Belgium;Czech Republic;Germany;Hungary;Israel;Latvia;Lithuania;Netherlands;Poland;Russian Federation;Slovakia;Switzerland;Ukraine
      2014   Phase 3   EUCTR2012-003702-27-LT   Austria;Belgium;Czech Republic;Germany;Hungary;Israel;Latvia;Lithuania;Netherlands;Poland;Russian Federation;Slovakia;Switzerland;Ukraine
      2014   Phase 3   EUCTR2012-003702-27-HU   Austria;Belgium;Czech Republic;Germany;Hungary;Israel;Latvia;Lithuania;Netherlands;Poland;Russian Federation;Slovakia;Switzerland;Ukraine
      2014   Phase 3   EUCTR2012-003702-27-DE   Austria;Belgium;Czech Republic;Germany;Hungary;Israel;Latvia;Lithuania;Netherlands;Poland;Russian Federation;Slovakia;Switzerland;Ukraine
      2014   Phase 3   EUCTR2012-003702-27-CZ   Austria;Belgium;Czech Republic;Germany;Hungary;Israel;Latvia;Lithuania;Netherlands;Poland;Russian Federation;Slovakia;Switzerland;Ukraine
      2014   Phase 3   EUCTR2012-003702-27-BE   Austria;Belgium;Czech Republic;Germany;Hungary;Israel;Latvia;Lithuania;Netherlands;Poland;Russian Federation;Slovakia;Switzerland;Ukraine
      2014   Phase 3   EUCTR2012-003702-27-AT   Austria;Belgium;Czech Republic;Germany;Hungary;Israel;Latvia;Lithuania;Netherlands;Poland;Russian Federation;Slovakia;Switzerland;Ukraine
Gastroscopy
   Tel-Aviv Sourasky Medical Center
      2015   Phase 2   NCT04434872   Israel
GB004
   GB004, Inc.
      2020   Phase 2   NCT04556383   Australia;Georgia;Korea, Republic of;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Ukraine;United States
   GB004, Inc., a wholly owned subsidiary of Gossamer Bio, Inc.
      2019   Phase 1   NCT03860896   Georgia;Moldova, Republic of;United States
GB004-HCL
   GB004, Inc.
      2021   Phase 2   EUCTR2020-002306-12-PL   Australia;Belarus;Georgia;Italy;Korea, Republic of;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Ukraine;United States
GED-0301
   Celgene
      2015   Phase 2   NCT02601300   Bulgaria;Canada;Hungary;Poland;Slovakia;United States
   Celgene Corporation
      2016   Phase 2   EUCTR2015-003364-36-SK   Bulgaria;Canada;Hungary;Poland;Slovakia;United States
      2016   Phase 2   EUCTR2015-003364-36-HU   Bulgaria;Canada;Hungary;Poland;Slovakia;United States
      2016   Phase 2   EUCTR2015-003364-36-BG   Bulgaria;Canada;Hungary;Poland;Slovakia;United States
GED-0507-34-levo
   GIULIANI
      2012   -   EUCTR2011-003283-78-IT   Italy
   PPM SERVICES SA
      2017   Phase 2   EUCTR2016-001684-36-LV   Bulgaria;Canada;France;Hungary;Italy;Latvia;Poland;Slovakia;Spain;Ukraine;United States
      2017   Phase 2   EUCTR2016-001684-36-ES   Bulgaria;Canada;France;Hungary;Italy;Latvia;Poland;Slovakia;Spain;Ukraine;United States
      2016   Phase 2   EUCTR2016-001684-36-SK   Bulgaria;Canada;France;Hungary;Italy;Latvia;Poland;Slovakia;Spain;Ukraine;United Kingdom;United States
      2016   Phase 2   EUCTR2016-001684-36-HU   Bulgaria;Canada;Czech Republic;France;Hungary;Italy;Latvia;Poland;Slovakia;Spain;Ukraine;United Kingdom;United States
      2016   Phase 2   EUCTR2016-001684-36-BG   Bulgaria;Canada;France;Hungary;Italy;Latvia;Poland;Slovakia;Spain;Ukraine;United Kingdom;United States
GED-0507-34-levo 160 MG
   PPM Services S.A.
      2016   Phase 2   NCT02808390   Bulgaria;Canada;France;Hungary;Italy;Latvia;Poland;Slovakia;Ukraine;United States
GED-0507-34-levo 80 MG
   PPM Services S.A.
      2016   Phase 2   NCT02808390   Bulgaria;Canada;France;Hungary;Italy;Latvia;Poland;Slovakia;Ukraine;United States
GED0507
   PPM SERVICES SA
      2017   Phase 2   EUCTR2016-001684-36-LV   Bulgaria;Canada;France;Hungary;Italy;Latvia;Poland;Slovakia;Spain;Ukraine;United States
      2017   Phase 2   EUCTR2016-001684-36-ES   Bulgaria;Canada;France;Hungary;Italy;Latvia;Poland;Slovakia;Spain;Ukraine;United States
      2016   Phase 2   EUCTR2016-001684-36-SK   Bulgaria;Canada;France;Hungary;Italy;Latvia;Poland;Slovakia;Spain;Ukraine;United Kingdom;United States
      2016   Phase 2   EUCTR2016-001684-36-HU   Bulgaria;Canada;Czech Republic;France;Hungary;Italy;Latvia;Poland;Slovakia;Spain;Ukraine;United Kingdom;United States
      2016   Phase 2   EUCTR2016-001684-36-BG   Bulgaria;Canada;France;Hungary;Italy;Latvia;Poland;Slovakia;Spain;Ukraine;United Kingdom;United States
Genomic DNA
   Connecticut Children's Medical Center
      2015   -   NCT02984059   United States
GI-270384
   GlaxoSmithKline
      2004   Phase 1   NCT00457171   Netherlands
Globifer forte
   GlobiFer International bvba
      2010   Phase 2   EUCTR2008-004277-17-GB   United Kingdom
GLPG0634
   GALAPAGOS NV
      2022   Phase 3   EUCTR2022-000719-30-IT   Belgium;Czech Republic;Czechia;France;Germany;Hungary;India;Italy;Korea, Republic of;Poland;South Africa;Spain;Switzerland;Taiwan;United Kingdom;United States
   Galapagos NV
      2022   Phase 3   EUCTR2022-000719-30-PL   Belgium;Czech Republic;Czechia;France;Germany;Hungary;India;Italy;Korea, Republic of;Poland;South Africa;Spain;Taiwan;United Kingdom;United States
      2022   Phase 3   EUCTR2022-000719-30-FR   Belgium;Czech Republic;Czechia;France;Germany;Hungary;India;Italy;Korea, Republic of;Poland;South Africa;Spain;Switzerland;Taiwan;United Kingdom;United States
      2022   Phase 3   EUCTR2022-000719-30-ES   Belgium;Czech Republic;Czechia;France;Germany;Hungary;India;Italy;Korea, Republic of;Poland;South Africa;Spain;Switzerland;Taiwan;United Kingdom;United States
      2022   Phase 3   EUCTR2022-000719-30-CZ   Belgium;Czech Republic;Czechia;France;Germany;Hungary;India;Italy;Korea, Republic of;Poland;South Africa;Spain;Taiwan;United Kingdom;United States
      2022   Phase 3   EUCTR2022-000719-30-BE   Belgium;Czech Republic;Czechia;France;Germany;Hungary;India;Italy;Korea, Republic of;Poland;South Africa;Spain;Taiwan;United Kingdom;United States
GLPG0974
   Galapagos NV
      2013   Phase 2   NCT01829321   Belgium;Czech Republic;Latvia;Slovakia
      2013   -   EUCTR2012-005521-73-LV   Czech Republic;Latvia
      2013   -   EUCTR2012-005521-73-CZ   Belgium;Czech Republic;Latvia
      2013   Phase 2   EUCTR2012-005521-73-BE   Belgium;Czech Republic;Latvia
GLPG1205
   Galapagos NV
      2015   -   EUCTR2014-001893-32-PL   Belgium;Czech Republic;Germany;Hungary;Poland;Russian Federation
      2015   Phase 2   EUCTR2014-001893-32-CZ   Belgium;Czech Republic;Germany;Hungary;Poland;Russian Federation
      2014   Phase 2   NCT02337608   Belgium;Czech Republic;Germany;Hungary;Poland;Russian Federation
      2014   -   EUCTR2014-001893-32-HU   Belgium;Czech Republic;Germany;Hungary;Poland;Russian Federation
      2014   -   EUCTR2014-001893-32-DE   Belgium;Czech Republic;Germany;Hungary;Poland;Russian Federation
      2014   -   EUCTR2014-001893-32-BE   Belgium;Czech Republic;Germany;Hungary;Poland;Russian Federation
GLPG3970
   Galapagos NV
      2020   Phase 2   NCT04577794   Georgia;Moldova, Republic of;Poland;Ukraine
      2020   Phase 2   EUCTR2020-000659-11-PL   Georgia;Moldova, Republic of;Poland;Ukraine
Gluconato ferrico sodico
   FONDAZIONE I.R.C.C.S. POLICLINICO SAN MATTEO
      2017   Phase 3   EUCTR2016-001772-30-IT   Italy
Glucose
   Tanaka Yoshiyuki
      2022   Phase 1   JPRN-jRCT2051210183   -
Glucose-based sports drink
   Entrinsic Bioscience Inc.
      2018   -   NCT03451253   United States
Glutamine
   The Second Hospital of Nanjing Medical University
      2019   -   NCT03917095   China
Gluten free diet
   University of Southern Denmark
      2024   -   NCT06249763   Denmark
Gluten-free diet
   Institute for Clinical and Experimental Medicine
      2023   -   NCT06026449   Czechia
Glycyrrhiza glabra root
   Steigerwald Arzneimittelwerk GmbH
      2014   -   EUCTR2013-000891-13-DE   Germany
GM-CSF, fosfomycin and metronidazole
   Zealand University Hospital
      2021   Phase 1/Phase 2   NCT04979832   Denmark
Golimumab
   Centre Hospitalier Universitaire de Saint Etienne
      2017   Phase 2   NCT03182166   France
   Fundación Española de Gastroenterología
      2021   Phase 4   EUCTR2021-002211-65-ES   Spain
   Fundación de Investigación Biomédica del Hospital Universitario de La Princesa
      2018   Phase 4   EUCTR2018-002925-47-ES   Spain
   GETAID
      2019   Phase 4   EUCTR2016-000152-96-BE   Belgium
   Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives
      2016   Phase 4   NCT02425865   Belgium;France
   Guy's and St Thomas' NHS Foundation Trust
      2017   Phase 4   NCT03124121   United Kingdom
      2017   Phase 4   EUCTR2017-001374-42-GB   United Kingdom
   Helse More og Romsdal Hospital Trust
      2016   Phase 4   EUCTR2016-001409-18-NO   Norway
   Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta
      2016   -   NCT03018925   Spain
   Istituto Clinico Humanitas
      2015   Phase 4   NCT02412085   Italy
      2015   Phase 4   EUCTR2014-002579-27-IT   Italy
   JANSSEN CILAG INTERNATIONAL NV
      2022   Phase 2   EUCTR2021-005528-39-IT   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;Finland;France;Georgia;Germany;Greece;Hong Kong;Hungary;India;Ireland;Israel;Italy;Japan;Jordan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
   JANSSEN PHARMACEUTICAL K.K
      2009   Phase 3   JPRN-jRCT2080220713   -
      2009   Phase 2-3   JPRN-jRCT2080220712   -
   Janssen Biologics B.V.
      2019   Phase 3   EUCTR2017-004496-31-IT   Belgium;Brazil;France;Israel;Italy;Korea, Republic of;Netherlands;Poland;Spain;Taiwan;United States
      2015   Phase 2   EUCTR2013-002042-36-FR   Belgium;Bulgaria;Canada;Czech Republic;France;Germany;Hungary;Israel;Netherlands;Poland;Russian Federation;Ukraine;United States
      2014   Phase 2   EUCTR2013-002042-36-PL   Belgium;Bulgaria;Canada;Czech Republic;France;Germany;Hungary;Israel;Netherlands;Poland;Russian Federation;Ukraine;United States
      2014   -   EUCTR2013-002042-36-NL   Belgium;Bulgaria;Canada;Czech Republic;France;Germany;Hungary;Israel;Netherlands;Poland;Russian Federation;Ukraine;United States
      2014   -   EUCTR2013-002042-36-HU   Belgium;Bulgaria;Canada;Czech Republic;France;Germany;Hungary;Israel;Netherlands;Poland;Russian Federation;Ukraine;United States
      2014   -   EUCTR2013-002042-36-DE   Belgium;Bulgaria;Canada;Czech Republic;France;Germany;Hungary;Israel;Netherlands;Poland;Russian Federation;Ukraine;United States
      2014   -   EUCTR2013-002042-36-CZ   Belgium;Bulgaria;Canada;Czech Republic;France;Germany;Hungary;Israel;Netherlands;Poland;Russian Federation;Ukraine;United States
      2014   Phase 2   EUCTR2013-002042-36-BG   Belgium;Bulgaria;Canada;Czech Republic;France;Germany;Hungary;Israel;Netherlands;Poland;Russian Federation;Ukraine;United States
      2014   -   EUCTR2013-002042-36-BE   Belgium;Bulgaria;Canada;Czech Republic;France;Germany;Hungary;Israel;Netherlands;Poland;Russian Federation;Ukraine;United States
      2014   Phase 1   EUCTR2012-004366-18-BE   Austria;Belgium;Canada;Denmark;France;Germany;Israel;Netherlands;Poland;United States
      2013   -   EUCTR2012-004366-18-NL   Austria;Belgium;Canada;Denmark;France;Germany;Israel;Netherlands;Poland;United States
      2013   Phase 1   EUCTR2012-004366-18-DK   Austria;Belgium;Canada;Denmark;France;Germany;Israel;Netherlands;Poland;United States
      2013   Phase 1   EUCTR2012-004366-18-DE   Austria;Belgium;Canada;Denmark;France;Germany;Israel;Netherlands;Poland;United States
      2013   Phase 1   EUCTR2012-004366-18-AT   Austria;Belgium;Canada;Denmark;France;Germany;Israel;Netherlands;Poland;United States
      -   Phase 1   EUCTR2012-004366-18-FR   Austria;Belgium;Canada;Denmark;France;Germany;Israel;Netherlands;Poland;United States
   Janssen Biologics BV
      2019   Phase 3   EUCTR2017-004496-31-PL   Belgium;Brazil;France;Israel;Italy;Korea, Republic of;Netherlands;Poland;Spain;Taiwan;United States
      2019   Phase 3   EUCTR2017-004496-31-NL   Belgium;Brazil;France;Israel;Italy;Korea, Republic of;Netherlands;Poland;Spain;Taiwan;United States
      2018   Phase 3   EUCTR2017-004496-31-FR   Belgium;Brazil;France;Israel;Italy;Korea, Republic of;Netherlands;Poland;Spain;Taiwan;United States
      2018   Phase 3   EUCTR2017-004496-31-ES   Belgium;Brazil;France;Israel;Italy;Korea, Republic of;Netherlands;Poland;Spain;Taiwan;United States
      2018   Phase 3   EUCTR2017-004496-31-BE   Belgium;Brazil;France;Israel;Italy;Korea, Republic of;Netherlands;Poland;Spain;Taiwan;United States
   Janssen Pharmaceutical K.K.
      2013   Phase 3   NCT01863771   Japan
   Janssen Research & Development, LLC
      2022   Phase 2   NCT05242484   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czechia;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Jordan;Korea, Republic of;Lithuania;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;United Kingdom;United States
      2018   Phase 3   NCT03596645   Belgium;Brazil;France;Israel;Italy;Korea, Republic of;Netherlands;Poland;Spain;Taiwan;United States
      2013   Phase 2   NCT01988961   Belgium;Bulgaria;Canada;Czech Republic;France;Germany;Hungary;Netherlands;Poland;Russian Federation;Ukraine;United States
      2013   Phase 1   NCT01900574   Austria;Belgium;Canada;Denmark;France;Germany;Israel;Netherlands;Poland;United States
   Janssen Scientific Affairs, LLC
      2013   Phase 4   NCT01804166   United States
   Janssen-Cilag International NV
      2023   Phase 2   EUCTR2021-005528-39-SK   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Jordan;Korea, Republic of;Lithuania;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Switzerland;Taiwan;Türkiye;Ukraine;United Kingdom;United States
      2023   Phase 2   EUCTR2021-005528-39-SI   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Jordan;Korea, Republic of;Lithuania;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2023   Phase 2   EUCTR2021-005528-39-SE   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Jordan;Korea, Republic of;Lithuania;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2023   Phase 2   EUCTR2021-005528-39-PT   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;Finland;France;Georgia;Germany;Greece;Hong Kong;Hungary;India;Ireland;Israel;Italy;Japan;Jordan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2023   Phase 2   EUCTR2021-005528-39-NO   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Jordan;Korea, Republic of;Lithuania;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2023   Phase 2   EUCTR2021-005528-39-HR   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;Finland;France;Georgia;Germany;Greece;Hong Kong;Hungary;India;Ireland;Israel;Italy;Japan;Jordan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2023   Phase 2   EUCTR2021-005528-39-FR   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Jordan;Korea, Republic of;Lithuania;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2023   Phase 2   EUCTR2021-005528-39-DK   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Jordan;Korea, Republic of;Lithuania;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2023   Phase 2   EUCTR2021-005528-39-DE   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Jordan;Korea, Republic of;Lithuania;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2023   Phase 2   EUCTR2021-005528-39-BG   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Jordan;Korea, Republic of;Lithuania;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2023   Phase 2   EUCTR2021-005528-39-AT   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2022   Phase 2   EUCTR2021-005528-39-NL   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Jordan;Korea, Republic of;Lithuania;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2022   Phase 2   EUCTR2021-005528-39-HU   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Jordan;Korea, Republic of;Lithuania;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2022   Phase 2   EUCTR2021-005528-39-CZ   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Jordan;Korea, Republic of;Lithuania;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 2   EUCTR2018-001510-15-PL   Argentina;Australia;Brazil;Germany;Mexico;Poland;Russian Federation;Ukraine;United States
      2019   Phase 2   EUCTR2018-001510-15-DE   Argentina;Australia;Brazil;Germany;Mexico;Poland;Russian Federation;Ukraine;United States
   Kliniken im Naturpark Altmuehltal
      2014   Phase 4   NCT02186886   Germany
   MSD
      2014   Phase 4   EUCTR2013-004583-56-GB   United Kingdom
   MSD Belgium BVBA/SPRL
      2014   Phase 4   EUCTR2014-000656-29-BE   Belgium
   Merck Sharp & Dohme Corp.
      2015   Phase 4   NCT02318667   Portugal
      2014   Phase 4   NCT02092285   United Kingdom
   Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc.
      2014   Phase 4   EUCTR2014-003262-25-PT   Portugal
   Nishikawa Kazuko
      2023   Phase 2   JPRN-jRCT2031220308   Argentina;Australia;Austria,;Belgium;Brazil;Bulgaria;Canada;Chile;Czechia;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Korea;Mexico;Netherlands;NewZealand;Norway;Poland;Portugal;Republic Of Lithuania;Serbia;Spain;Switzerland;United Kingdom Of Great Britain
   UCD
      2015   Phase 4   EUCTR2015-004724-62-IE   Ireland
   University College Dublin
      2016   Phase 4   NCT02687724   Ireland
Golimumab 1 MG PER KG
   Janssen Research & Development, LLC
      2007   Phase 2/Phase 3   NCT00488774   Australia;Austria;Belgium;Bulgaria;Canada;Former Serbia and Montenegro;France;Germany;Hungary;India;Israel;Latvia;Lithuania;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;Sweden;Ukraine;United Kingdom;United States
Golimumab 100 MG
   Janssen Research & Development, LLC
      2007   Phase 3   NCT00488631   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Former Serbia and Montenegro;France;Germany;Hungary;India;Israel;Japan;Latvia;Lithuania;Nauru;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Sweden;Ukraine;United Kingdom;United States
      2007   Phase 2/Phase 3   NCT00487539   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;India;Israel;Japan;Latvia;Lithuania;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Sweden;Ukraine;United Kingdom;United States
Golimumab 2 MG PER KG
   Janssen Research & Development, LLC
      2007   Phase 2/Phase 3   NCT00488774   Australia;Austria;Belgium;Bulgaria;Canada;Former Serbia and Montenegro;France;Germany;Hungary;India;Israel;Latvia;Lithuania;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;Sweden;Ukraine;United Kingdom;United States
Golimumab 200 MG
   Janssen Research & Development, LLC
      2007   Phase 3   NCT00488631   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Former Serbia and Montenegro;France;Germany;Hungary;India;Israel;Japan;Latvia;Lithuania;Nauru;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Sweden;Ukraine;United Kingdom;United States
      2007   Phase 2/Phase 3   NCT00487539   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;India;Israel;Japan;Latvia;Lithuania;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Sweden;Ukraine;United Kingdom;United States
Golimumab 4 MG PER KG
   Janssen Research & Development, LLC
      2007   Phase 2/Phase 3   NCT00488774   Australia;Austria;Belgium;Bulgaria;Canada;Former Serbia and Montenegro;France;Germany;Hungary;India;Israel;Latvia;Lithuania;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;Sweden;Ukraine;United Kingdom;United States
Golimumab 400 MG
   Janssen Research & Development, LLC
      2007   Phase 2/Phase 3   NCT00487539   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;India;Israel;Japan;Latvia;Lithuania;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Sweden;Ukraine;United Kingdom;United States
Golimumab 50 MG
   Janssen Research & Development, LLC
      2007   Phase 3   NCT00488631   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Former Serbia and Montenegro;France;Germany;Hungary;India;Israel;Japan;Latvia;Lithuania;Nauru;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Sweden;Ukraine;United Kingdom;United States
      2007   Phase 2/Phase 3   NCT00487539   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;India;Israel;Japan;Latvia;Lithuania;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Sweden;Ukraine;United Kingdom;United States
Golimumab 50 MG IN patients <80 KG and golimumab 100 MG IN patients >80 KG
   Hospital de Manises
      2018   Phase 4   NCT03669029   Spain
Golimumab dose 1
   Janssen Research & Development, LLC
      2018   Phase 2   NCT03662542   Argentina;Australia;Brazil;Germany;Mexico;Poland;Russian Federation;Ukraine;United States
Golimumab dose 2
   Janssen Research & Development, LLC
      2018   Phase 2   NCT03662542   Argentina;Australia;Brazil;Germany;Mexico;Poland;Russian Federation;Ukraine;United States
Golimumab liquid IN prefilled syringe
   Centocor BV
      2010   -   EUCTR2006-003398-28-CZ   Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden
      2008   -   EUCTR2006-003399-37-LT   Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden
      2008   -   EUCTR2006-003398-28-SE   Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden
      2008   -   EUCTR2006-003398-28-NL   Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden
      2008   -   EUCTR2006-003398-28-LT   Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden
      2008   -   EUCTR2006-003398-28-DK   Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden
      2008   -   EUCTR2006-003398-28-BG   Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden
      2007   Phase 3   EUCTR2006-003399-37-FR   Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Slovakia;Sweden
      2007   Phase 2;Phase 3   EUCTR2006-003398-28-SK   Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Slovakia;Sweden
      2007   -   EUCTR2006-003398-28-LV   Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden
      2007   -   EUCTR2006-003398-28-HU   Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden
      2007   Phase 2;Phase 3   EUCTR2006-003398-28-FR   Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Slovakia;Sweden
      2007   -   EUCTR2006-003398-28-DE   Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden
      2007   -   EUCTR2006-003398-28-BE   Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden
      2007   -   EUCTR2006-003398-28-AT   Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden
   Janssen Biologics B.V.
      2010   -   EUCTR2006-003399-37-CZ   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;India;Israel;Japan;Latvia;Lithuania;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Sweden;Ukraine;United States
      2008   -   EUCTR2006-003399-37-SE   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;India;Israel;Japan;Latvia;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Sweden;Ukraine;United States
      2008   -   EUCTR2006-003399-37-DK   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;India;Israel;Japan;Latvia;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Sweden;Ukraine;United States
      2008   -   EUCTR2006-003399-37-BG   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;India;Israel;Japan;Latvia;Lithuania;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Sweden;Ukraine;United States
      2007   -   EUCTR2006-003399-37-LV   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;India;Israel;Japan;Latvia;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Sweden;Ukraine;United States
      2007   -   EUCTR2006-003399-37-HU   Australia;Austria;Belgium;Bulgaria;Czech Republic;Denmark;Finland;France;Germany;Hungary;India;Israel;Latvia;Lithuania;Netherlands;New Zealand;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Sweden;Ukraine
      2007   -   EUCTR2006-003399-37-DE   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;India;Israel;Japan;Latvia;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Sweden;Ukraine;United States
      2007   -   EUCTR2006-003399-37-BE   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;India;Israel;Japan;Latvia;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Sweden;Ukraine;United States
      2007   -   EUCTR2006-003399-37-AT   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;India;Israel;Japan;Latvia;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Sweden;Ukraine;United States
   Janssen Biologics BV
      2008   -   EUCTR2006-003399-37-NL   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;India;Israel;Japan;Latvia;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Sweden;Ukraine;United States
      2007   Phase 3   EUCTR2006-003399-37-SK   Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Slovakia;Sweden
Golimumab liquid IN vial
   Centocor BV
      2008   -   EUCTR2006-003397-94-SE   Austria;Belgium;Bulgaria;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden
      2008   -   EUCTR2006-003397-94-NL   Austria;Belgium;Bulgaria;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden
      2008   -   EUCTR2006-003397-94-LT   Austria;Belgium;Bulgaria;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden
      2008   -   EUCTR2006-003397-94-BG   Austria;Belgium;Bulgaria;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden
      2007   Phase 2;Phase 3   EUCTR2006-003397-94-SK   Austria;Belgium;Bulgaria;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Slovakia;Sweden
      2007   -   EUCTR2006-003397-94-LV   Austria;Belgium;Bulgaria;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden
      2007   Phase 2;Phase 3   EUCTR2006-003397-94-HU   Austria;Belgium;Bulgaria;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Slovakia;Sweden
      2007   Phase 2;Phase 3   EUCTR2006-003397-94-FR   Austria;Belgium;Bulgaria;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Slovakia;Sweden
      2007   -   EUCTR2006-003397-94-DE   Austria;Belgium;Bulgaria;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden
      2007   -   EUCTR2006-003397-94-BE   Austria;Belgium;Bulgaria;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden
      2007   -   EUCTR2006-003397-94-AT   Austria;Belgium;Bulgaria;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden
Golimumab prefilled syringe
   David Drobne
      2021   Phase 4   NCT04156984   Slovenia
Golimumab trough levels
   Hospital San Carlos, Madrid
      2019   -   NCT03773445   Spain
Gralise
   Shirley Ryan AbilityLab
      2012   Phase 4   NCT01678911   United States
Granocyte 34
   POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI
      2009   Phase 2   EUCTR2008-008285-12-IT   Italy
Granulated mesalamine
   Bausch Health Americas, Inc.
      2004   Phase 3   NCT00767728   United States
      2004   Phase 3   NCT00744016   United States
Grape seed extracts
   University of Padova
      2024   -   NCT06576700   Italy
Grapefruit
   Department of Rheumatology and Clinical Immunology, Kyoto University Hospital
      2014   -   JPRN-UMIN000013546   Japan
Group 1 OF patients will receive adalimumab while group 1 will receive ustekinumab
   Ain Shams University
      2025   Early Phase 1   NCT06742606   -
Group 1- control diet
   Prof. Arie Levine
      2020   -   NCT03980405   Israel
Group 2 ustekinumab 130 MG
   Janssen Research & Development, LLC
      2011   Phase 3   NCT01369342   Australia;Belgium;Brazil;Bulgaria;Canada;Croatia;France;Germany;Hungary;Iceland;Ireland;Israel;Japan;Korea, Republic of;Netherlands;New Zealand;Poland;Russian Federation;Serbia;South Africa;Spain;United Kingdom;United States
      2011   Phase 3   NCT01369329   Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;France;Germany;Hungary;Iceland;Ireland;Israel;Japan;Korea, Republic of;Netherlands;New Zealand;Poland;Serbia;South Africa;Spain;United Kingdom;United States
Group 2- UCD diet
   Prof. Arie Levine
      2020   -   NCT03980405   Israel
Group 3: ustekinumab approximately 6 MG/KG
   Janssen Research & Development, LLC
      2011   Phase 3   NCT01369342   Australia;Belgium;Brazil;Bulgaria;Canada;Croatia;France;Germany;Hungary;Iceland;Ireland;Israel;Japan;Korea, Republic of;Netherlands;New Zealand;Poland;Russian Federation;Serbia;South Africa;Spain;United Kingdom;United States
      2011   Phase 3   NCT01369329   Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;France;Germany;Hungary;Iceland;Ireland;Israel;Japan;Korea, Republic of;Netherlands;New Zealand;Poland;Serbia;South Africa;Spain;United Kingdom;United States
Growth hormone
   Royal Hospital For Sick Children, Yorkhill Division
      2004   Phase 4   EUCTR2004-002507-32-GB   United Kingdom
GS-1427
   Gilead Sciences
      2024   Phase 2   NCT06290934   Australia;Austria;Belgium;Canada;Czechia;France;Georgia;Germany;Hong Kong;Hungary;Italy;Korea, Republic of;Malaysia;Moldova, Republic of;Poland;Romania;Spain;Taiwan;United Kingdom;United States
GS-4875
   GILEAD SCIENCES INCORPORATED
      2020   Phase 2   EUCTR2019-001430-33-IT   Australia;Austria;Belgium;Canada;Czechia;France;Germany;Italy;Poland;Russian Federation;Switzerland;United Kingdom;United States
   Gilead Sciences, Inc.
      2020   Phase 2   EUCTR2019-001430-33-PL   Australia;Austria;Belgium;Canada;Czech Republic;France;Germany;Italy;Poland;Russian Federation;Switzerland;United Kingdom;United States
      2020   Phase 2   EUCTR2019-001430-33-GB   Australia;Austria;Belgium;Canada;Czechia;France;Germany;Italy;Poland;Russian Federation;Switzerland;United Kingdom;United States
      2020   Phase 2   EUCTR2019-001430-33-FR   Australia;Austria;Belgium;Canada;Czech Republic;France;Germany;Italy;Poland;Russian Federation;Switzerland;United Kingdom;United States
      2020   Phase 2   EUCTR2019-001430-33-DE   Australia;Austria;Belgium;Canada;Czech Republic;France;Germany;Italy;Poland;Russian Federation;Switzerland;United Kingdom;United States
      2020   Phase 2   EUCTR2019-001430-33-AT   Australia;Austria;Belgium;Canada;Czech Republic;France;Germany;Italy;Poland;Russian Federation;Switzerland;United Kingdom;United States
GS-5745
   Gilead Sciences
      2013   Phase 1   NCT01831427   Belgium;Canada;Hungary;Moldova, Republic of;Netherlands;Romania;United States
   Gilead Sciences, Inc
      2016   Phase 2;Phase 3   EUCTR2014-005217-24-SE   Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Germany;Hong Kong;Hungary;Iceland;India;Iran, Islamic Republic of;Ireland;Israel;Korea, Republic of;Latvia;Malaysia;Mexico;Moldova, Republic of;Netherlands;New Zealand;Philippines;Romania;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;Vietnam
      2016   Phase 2;Phase 3   EUCTR2014-005217-24-IS   Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Germany;Hong Kong;Hungary;Iceland;India;Iran, Islamic Republic of;Ireland;Israel;Korea, Republic of;Latvia;Malaysia;Mexico;Moldova, Republic of;Netherlands;New Zealand;Philippines;Romania;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;Vietnam
      2016   Phase 2;Phase 3   EUCTR2014-005217-24-HR   Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Germany;Hong Kong;Hungary;Iceland;India;Iran, Islamic Republic of;Ireland;Israel;Korea, Republic of;Latvia;Malaysia;Mexico;Moldova, Republic of;Netherlands;New Zealand;Philippines;Romania;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;Vietnam
      2016   Phase 2;Phase 3   EUCTR2014-005217-24-ES   Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Germany;Hong Kong;Hungary;Iceland;India;Iran, Islamic Republic of;Ireland;Israel;Korea, Republic of;Latvia;Malaysia;Mexico;Moldova, Republic of;Netherlands;New Zealand;Philippines;Romania;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;Vietnam
      2016   Phase 2;Phase 3   EUCTR2014-005217-24-DE   Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Germany;Hong Kong;Hungary;Iceland;India;Iran, Islamic Republic of;Ireland;Israel;Korea, Republic of;Latvia;Malaysia;Mexico;Moldova, Republic of;Netherlands;New Zealand;Philippines;Romania;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;Vietnam
      2016   Phase 2;Phase 3   EUCTR2014-005217-24-BG   Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Germany;Hong Kong;Hungary;Iceland;India;Iran, Islamic Republic of;Ireland;Israel;Korea, Republic of;Latvia;Malaysia;Mexico;Moldova, Republic of;Netherlands;New Zealand;Philippines;Romania;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;Vietnam
      2016   Phase 2;Phase 3   EUCTR2014-005217-24-BE   Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Germany;Hong Kong;Hungary;Iceland;India;Iran, Islamic Republic of;Ireland;Israel;Korea, Republic of;Latvia;Malaysia;Mexico;Moldova, Republic of;Netherlands;New Zealand;Philippines;Romania;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;Vietnam
      2015   Phase 2;Phase 3   EUCTR2014-005217-24-SK   Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Germany;Hong Kong;Hungary;Iceland;India;Iran, Islamic Republic of;Ireland;Israel;Korea, Republic of;Latvia;Malaysia;Mexico;Moldova, Republic of;Netherlands;New Zealand;Philippines;Romania;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;Vietnam
      2015   Phase 2;Phase 3   EUCTR2014-005217-24-NL   Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Germany;Hong Kong;Hungary;Iceland;India;Iran, Islamic Republic of;Ireland;Israel;Korea, Republic of;Latvia;Malaysia;Mexico;Moldova, Republic of;Netherlands;New Zealand;Philippines;Romania;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;Vietnam
      2015   Phase 2;Phase 3   EUCTR2014-005217-24-LV   Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Germany;Hong Kong;Hungary;Iceland;India;Iran, Islamic Republic of;Ireland;Israel;Korea, Republic of;Latvia;Malaysia;Mexico;Moldova, Republic of;Netherlands;New Zealand;Philippines;Romania;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;Vietnam
      2015   Phase 2;Phase 3   EUCTR2014-005217-24-IE   Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Germany;Hong Kong;Hungary;Iceland;India;Iran, Islamic Republic of;Ireland;Israel;Korea, Republic of;Latvia;Malaysia;Mexico;Moldova, Republic of;Netherlands;New Zealand;Philippines;Romania;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;Vietnam
      2015   Phase 2;Phase 3   EUCTR2014-005217-24-HU   Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Germany;Hong Kong;Hungary;Iceland;India;Iran, Islamic Republic of;Ireland;Israel;Korea, Republic of;Latvia;Malaysia;Mexico;Moldova, Republic of;Netherlands;New Zealand;Philippines;Romania;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;Vietnam
      2015   Phase 2;Phase 3   EUCTR2014-005217-24-GB   Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Germany;Hong Kong;Hungary;Iceland;India;Iran, Islamic Republic of;Ireland;Israel;Korea, Republic of;Latvia;Malaysia;Mexico;Moldova, Republic of;Netherlands;New Zealand;Philippines;Romania;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;Vietnam
      2015   Phase 2;Phase 3   EUCTR2014-005217-24-CZ   Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Germany;Hong Kong;Hungary;Iceland;India;Iran, Islamic Republic of;Ireland;Israel;Korea, Republic of;Latvia;Malaysia;Mexico;Moldova, Republic of;Netherlands;New Zealand;Philippines;Romania;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;Vietnam
      2015   Phase 2;Phase 3   EUCTR2014-005217-24-AT   Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Germany;Hong Kong;Hungary;Iceland;India;Iran, Islamic Republic of;Ireland;Israel;Korea, Republic of;Latvia;Malaysia;Mexico;Moldova, Republic of;Netherlands;New Zealand;Philippines;Romania;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;Vietnam
GS-5745 IV
   Gilead Sciences
      2014   Phase 1   NCT02209987   New Zealand
GS-5745 SC
   Gilead Sciences
      2014   Phase 1   NCT02209987   New Zealand
GS-6034
   GILEAD SCIENCES INCORPORATED
      2018   Phase 3   EUCTR2016-002765-58-IT   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Czechia;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      -   Phase 3   EUCTR2016-001392-78-IT   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czechia;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
   Galapagos NV
      2018   Phase 2   EUCTR2017-000402-38-PT   Australia;Austria;Belgium;Canada;Germany;India;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Spain;Sweden;Taiwan;Ukraine;United Kingdom;United States
      2018   Phase 2   EUCTR2017-000402-38-DE   Australia;Austria;Belgium;Canada;Germany;India;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Spain;Sweden;Taiwan;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-002765-58-SE   Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-002765-58-NL   Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-002765-58-DE   Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-002765-58-CZ   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Czechia;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sri Lanka;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-002765-58-BE   Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-002765-58-AT   Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sri Lanka;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
   Gilead Sciences, Inc
      2017   Phase 3   EUCTR2016-002765-58-SK   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sri Lanka;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
   Gilead Sciences, Inc.
      2018   Phase 2   EUCTR2017-000402-38-SE   Australia;Austria;Belgium;Canada;Czech Republic;Germany;Hungary;India;Italy;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Spain;Sri Lanka;Sweden;Ukraine;United Kingdom;United States
      2018   Phase 2   EUCTR2017-000402-38-RO   Australia;Austria;Belgium;Canada;Czechia;Germany;Hungary;India;Italy;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Spain;Sri Lanka;Sweden;Ukraine;United Kingdom;United States
      2018   Phase 2   EUCTR2017-000402-38-NL   Australia;Austria;Belgium;Canada;France;Germany;India;Italy;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Spain;Sri Lanka;Sweden;Switzerland;Ukraine;United Kingdom;United States
      2018   Phase 2   EUCTR2017-000402-38-GB   Australia;Austria;Belgium;Canada;Germany;India;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Spain;Sweden;Ukraine;United Kingdom;United States
      2018   Phase 2   EUCTR2017-000402-38-ES   Australia;Austria;Belgium;Canada;Czech Republic;France;Germany;Hungary;India;Italy;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Spain;Sri Lanka;Sweden;Ukraine;United Kingdom;United States
      2018   Phase 2   EUCTR2017-000402-38-BE   Australia;Austria;Belgium;Canada;France;Germany;India;Italy;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Spain;Sri Lanka;Sweden;Switzerland;Ukraine;United Kingdom;United States
      2018   Phase 2   EUCTR2017-000402-38-AT   Australia;Austria;Belgium;Canada;Germany;India;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Spain;Sweden;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-002765-58-PT   Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-002765-58-IS   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-002765-58-HU   Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sri Lanka;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-002765-58-HR   Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sri Lanka;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-002765-58-GR   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-002765-58-FR   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-002765-58-ES   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-002765-58-BG   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Czechia;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sri Lanka;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2017   Phase 2;Phase 3   EUCTR2016-001392-78-SK   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sri Lanka;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2017   Phase 2;Phase 3   EUCTR2016-001392-78-SE   Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2017   Phase 2;Phase 3   EUCTR2016-001392-78-PT   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sri Lanka;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2017   Phase 2;Phase 3   EUCTR2016-001392-78-NO   Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2017   Phase 2;Phase 3   EUCTR2016-001392-78-NL   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sri Lanka;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2017   Phase 2;Phase 3   EUCTR2016-001392-78-IS   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sri Lanka;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2017   Phase 2;Phase 3   EUCTR2016-001392-78-HU   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sri Lanka;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2017   Phase 2;Phase 3   EUCTR2016-001392-78-HR   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sri Lanka;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2017   Phase 2;Phase 3   EUCTR2016-001392-78-GR   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2017   Phase 2;Phase 3   EUCTR2016-001392-78-ES   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2017   Phase 2;Phase 3   EUCTR2016-001392-78-DE   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sri Lanka;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2017   Phase 2;Phase 3   EUCTR2016-001392-78-BG   Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2017   Phase 2;Phase 3   EUCTR2016-001392-78-BE   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sri Lanka;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2017   Phase 2;Phase 3   EUCTR2016-001392-78-AT   Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2016-002765-58-GB   Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2016   Phase 2;Phase 3   EUCTR2016-001392-78-GB   Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
GSK1399686
   GlaxoSmithKline
      2009   Phase 2   NCT01036022   Belgium;Canada;Germany;Norway;Sweden
   GlaxoSmithKline Research and Development Ltd
      2009   -   EUCTR2009-011608-51-SE   Germany;Sweden
      2009   Phase 2   EUCTR2009-011608-51-BE   Belgium;Germany;Sweden
   GlaxoSmithKline Research and Development Ltd.
      2009   -   EUCTR2009-011608-51-DE   Germany;Sweden
GSK1605786
   GlaxoSmithKline
      2013   Phase 2   NCT01658605   Belgium;Netherlands;United Kingdom
GSK1605786A
   GlaxoSmithKline Research & Development Ltd
      2012   -   EUCTR2011-002818-37-NL   Netherlands;United Kingdom
      2012   -   EUCTR2011-002818-37-GB   Netherlands;United Kingdom
      2012   Phase 2   EUCTR2011-002818-37-BE   Belgium;Netherlands;United Kingdom
GSK2586184 400MG
   GlaxoSmithKline
      2013   Phase 1   NCT02000453   Netherlands
GSK2831781
   GlaxoSmithKline Research & Development Limited
      2020   Phase 2   EUCTR2018-003278-28-BG   Bulgaria;Canada;Czech Republic;Czechia;Estonia;France;Hungary;India;Japan;Korea, Republic of;Mexico;Netherlands;Poland;Russian Federation;Serbia;Slovakia;South Africa;Ukraine;United Kingdom;United States
      2019   Phase 2   EUCTR2018-003278-28-PL   Bulgaria;Canada;Czech Republic;Estonia;France;Hungary;India;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Russian Federation;Serbia;Slovakia;South Africa;Ukraine;United Kingdom;United States
      2019   Phase 2   EUCTR2018-003278-28-NL   Belgium;Bulgaria;Canada;Czech Republic;Czechia;Estonia;France;Hungary;India;Korea, Republic of;Mexico;Netherlands;Poland;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Ukraine;United Kingdom;United States
      2019   Phase 2   EUCTR2018-003278-28-HU   Bulgaria;Canada;Czech Republic;Estonia;France;Hungary;India;Korea, Republic of;Lithuania;Netherlands;Poland;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Ukraine;United Kingdom;United States
      2019   Phase 2   EUCTR2018-003278-28-GB   Bulgaria;Canada;Czech Republic;Estonia;France;Hungary;India;Israel;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Ukraine;United Kingdom;United States
      2019   Phase 2   EUCTR2018-003278-28-FR   Bulgaria;Canada;Czech Republic;Estonia;France;Hungary;India;Korea, Republic of;Lithuania;Netherlands;Poland;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Ukraine;United Kingdom;United States
      2019   Phase 2   EUCTR2018-003278-28-CZ   Bulgaria;Canada;Czech Republic;Czechia;Estonia;France;Hungary;India;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Russian Federation;Serbia;Slovenia;South Africa;Ukraine;United Kingdom;United States
GSK2831781 - double blind phase
   GlaxoSmithKline
      2019   Phase 2   NCT03893565   Belgium;Bulgaria;Canada;Czechia;Estonia;France;Hungary;India;Japan;Korea, Republic of;Netherlands;Poland;Russian Federation;Serbia;Slovakia;South Africa;Ukraine;United Kingdom;United States
GSK2831781 - open label phase
   GlaxoSmithKline
      2019   Phase 2   NCT03893565   Belgium;Bulgaria;Canada;Czechia;Estonia;France;Hungary;India;Japan;Korea, Republic of;Netherlands;Poland;Russian Federation;Serbia;Slovakia;South Africa;Ukraine;United Kingdom;United States
GSK2982772
   GlaxoSmithKline
      2016   Phase 2   NCT02903966   Germany;Netherlands;Poland;Russian Federation;Sweden;United Kingdom;United States
   GlaxoSmithKline Research & Development Ltd
      2017   Phase 2   EUCTR2016-001833-29-PL   Germany;Netherlands;Poland;Sweden;United Kingdom
      2017   Phase 2   EUCTR2016-001833-29-NL   Germany;Netherlands;Poland;Sweden;United Kingdom
      2016   Phase 2   EUCTR2016-001833-29-SE   Germany;Netherlands;Poland;Russian Federation;Sweden;United Kingdom;United States
      2016   Phase 2   EUCTR2016-001833-29-GB   Germany;Netherlands;Poland;Sweden;United Kingdom
GSK2982772A, where A denotes THE free base
   GlaxoSmithKline Research & Development Ltd
      2017   Phase 2   EUCTR2016-001833-29-PL   Germany;Netherlands;Poland;Sweden;United Kingdom
      2017   Phase 2   EUCTR2016-001833-29-NL   Germany;Netherlands;Poland;Sweden;United Kingdom
      2016   Phase 2   EUCTR2016-001833-29-SE   Germany;Netherlands;Poland;Russian Federation;Sweden;United Kingdom;United States
      2016   Phase 2   EUCTR2016-001833-29-GB   Germany;Netherlands;Poland;Sweden;United Kingdom
Guaiazulene
   Mie University Graduate School of Medicine, Gastrointestinal and Pediatric Surgery
      2013   -   JPRN-UMIN000013266   Japan
Guselkum
   Janssen-Cilag International NV
      2020   Phase 2;Phase 3   EUCTR2018-004002-25-ES   Argentina;Australia;Belgium;Bulgaria;Canada;China;Czech Republic;France;Germany;Hong Kong;Hungary;Israel;Italy;Japan;Korea, Republic of;Malaysia;Netherlands;Poland;Portugal;Russian Federation;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
Guselkumab
   JANSSEN CILAG INTERNATIONAL NV
      2022   Phase 2   EUCTR2021-005528-39-IT   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;Finland;France;Georgia;Germany;Greece;Hong Kong;Hungary;India;Ireland;Israel;Italy;Japan;Jordan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2018-004002-25-IT   Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czechia;France;Germany;Hong Kong;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Malaysia;Netherlands;Poland;Portugal;Russian Federation;Slovakia;Spain;Sweden;Taiwan;Turkey;Ukraine;United Kingdom;United States
   Janssen Research & Development, LLC
      2024   Phase 3   NCT06663332   China;Japan;Poland;Spain;Turkey;United States
      2022   Phase 2   NCT05242484   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czechia;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Jordan;Korea, Republic of;Lithuania;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;United Kingdom;United States
      2019   Phase 2/Phase 3   NCT04033445   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Czechia;France;Germany;Hungary;Ireland;Israel;Italy;Japan;Jordan;Korea, Republic of;Latvia;Malaysia;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Taiwan;Turkey;Ukraine;United Kingdom;United States
   Janssen-Cilag International NV
      2023   Phase 3   EUCTR2022-000365-41-PL   Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;China;Czech Republic;Czechia;France;Germany;Hungary;India;Israel;Italy;Japan;Jordan;Korea, Republic of;Malaysia;Mexico;New Zealand;Poland;Portugal;Serbia;Slovakia;Spain;Sweden;Taiwan;Türkiye;United States
      2023   Phase 3   EUCTR2022-000365-41-HU   Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;China;Czech Republic;Czechia;France;Germany;Hungary;India;Israel;Italy;Japan;Jordan;Korea, Republic of;Malaysia;Mexico;New Zealand;Poland;Portugal;Serbia;Slovakia;Spain;Sweden;Taiwan;Turkey;United States
      2023   Phase 3   EUCTR2022-000365-41-FR   Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;China;Czech Republic;Czechia;France;Germany;Hungary;India;Israel;Italy;Japan;Jordan;Korea, Republic of;Malaysia;Mexico;New Zealand;Poland;Portugal;Serbia;Slovakia;Spain;Sweden;Taiwan;Turkey;United States
      2023   Phase 3   EUCTR2022-000365-41-DE   Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;China;Czech Republic;Czechia;France;Germany;Hungary;India;Israel;Italy;Japan;Jordan;Korea, Republic of;Malaysia;Mexico;New Zealand;Poland;Portugal;Serbia;Slovakia;Spain;Sweden;Taiwan;Turkey;United States
      2023   Phase 3   EUCTR2022-000365-41-CZ   Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;China;Czech Republic;Czechia;France;Germany;Hungary;India;Israel;Italy;Japan;Jordan;Korea, Republic of;Malaysia;Mexico;New Zealand;Poland;Portugal;Serbia;Slovakia;Spain;Sweden;Taiwan;Turkey;United States
      2023   Phase 3   EUCTR2022-000365-41-BG   Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;China;Czech Republic;Czechia;France;Germany;Hungary;India;Israel;Italy;Japan;Jordan;Korea, Republic of;Malaysia;Mexico;New Zealand;Poland;Portugal;Serbia;Slovakia;Spain;Sweden;Taiwan;Türkiye;United States
      2023   Phase 2   EUCTR2021-005528-39-SK   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Jordan;Korea, Republic of;Lithuania;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Switzerland;Taiwan;Türkiye;Ukraine;United Kingdom;United States
      2023   Phase 2   EUCTR2021-005528-39-SI   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Jordan;Korea, Republic of;Lithuania;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2023   Phase 2   EUCTR2021-005528-39-SE   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Jordan;Korea, Republic of;Lithuania;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2023   Phase 2   EUCTR2021-005528-39-PT   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;Finland;France;Georgia;Germany;Greece;Hong Kong;Hungary;India;Ireland;Israel;Italy;Japan;Jordan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2023   Phase 2   EUCTR2021-005528-39-NO   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Jordan;Korea, Republic of;Lithuania;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2023   Phase 2   EUCTR2021-005528-39-HR   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;Finland;France;Georgia;Germany;Greece;Hong Kong;Hungary;India;Ireland;Israel;Italy;Japan;Jordan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2023   Phase 2   EUCTR2021-005528-39-FR   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Jordan;Korea, Republic of;Lithuania;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2023   Phase 2   EUCTR2021-005528-39-DK   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Jordan;Korea, Republic of;Lithuania;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2023   Phase 2   EUCTR2021-005528-39-DE   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Jordan;Korea, Republic of;Lithuania;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2023   Phase 2   EUCTR2021-005528-39-BG   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Jordan;Korea, Republic of;Lithuania;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2023   Phase 2   EUCTR2021-005528-39-AT   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2022   Phase 2   EUCTR2021-005528-39-NL   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Jordan;Korea, Republic of;Lithuania;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2022   Phase 2   EUCTR2021-005528-39-HU   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Jordan;Korea, Republic of;Lithuania;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2022   Phase 2   EUCTR2021-005528-39-CZ   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Jordan;Korea, Republic of;Lithuania;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2021   Phase 2;Phase 3   EUCTR2018-004002-25-SK   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Czechia;France;Germany;Hungary;Ireland;Israel;Italy;Japan;Jordan;Korea, Republic of;Latvia;Malaysia;Netherlands;New Zealand;Poland;Portugal;Russian Federation;Serbia;Slovakia;Spain;Sweden;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2021   Phase 2;Phase 3   EUCTR2018-004002-25-LV   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Czechia;France;Germany;Hungary;Ireland;Israel;Italy;Japan;Jordan;Korea, Republic of;Latvia;Netherlands;Poland;Portugal;Russian Federation;Serbia;Slovakia;Spain;Sweden;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2021   Phase 2;Phase 3   EUCTR2018-004002-25-AT   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Czechia;France;Germany;Hungary;Ireland;Israel;Italy;Japan;Jordan;Korea, Republic of;Latvia;Malaysia;Netherlands;New Zealand;Poland;Portugal;Russian Federation;Serbia;Slovakia;Spain;Sweden;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2020   Phase 2;Phase 3   EUCTR2018-004002-25-PT   Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czechia;France;Germany;Hong Kong;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Malaysia;Netherlands;Poland;Portugal;Russian Federation;Slovakia;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
      2020   Phase 2;Phase 3   EUCTR2018-004002-25-NL   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Czechia;France;Germany;Hungary;Ireland;Israel;Italy;Japan;Jordan;Korea, Republic of;Latvia;Malaysia;Netherlands;New Zealand;Poland;Portugal;Russian Federation;Serbia;Slovakia;Spain;Sweden;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2020   Phase 2;Phase 3   EUCTR2018-004002-25-ES   Argentina;Australia;Belgium;Bulgaria;Canada;China;Czech Republic;France;Germany;Hong Kong;Hungary;Israel;Italy;Japan;Korea, Republic of;Malaysia;Netherlands;Poland;Portugal;Russian Federation;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
      2020   Phase 2;Phase 3   EUCTR2018-004002-25-DE   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Czechia;France;Germany;Hong Kong;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Malaysia;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2020   Phase 2;Phase 3   EUCTR2018-004002-25-BG   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Czechia;France;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Malaysia;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Taiwan;Türkiye;Ukraine;United Kingdom;United States
      2019   Phase 2;Phase 3   EUCTR2018-004002-25-SE   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Czechia;France;Germany;Hong Kong;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Malaysia;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 2;Phase 3   EUCTR2018-004002-25-PL   Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czechia;France;Germany;Hong Kong;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Malaysia;Netherlands;Poland;Portugal;Russian Federation;Slovakia;Spain;Sweden;Taiwan;Thailand;Türkiye;Ukraine;United Kingdom;United States
      2019   Phase 2;Phase 3   EUCTR2018-004002-25-HU   Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;France;Germany;Hong Kong;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Malaysia;Netherlands;Poland;Portugal;Russian Federation;Slovakia;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 2;Phase 3   EUCTR2018-004002-25-GB   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Czech Republic;France;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 2;Phase 3   EUCTR2018-004002-25-FR   Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;France;Germany;Hong Kong;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Malaysia;Netherlands;Poland;Portugal;Russian Federation;Slovakia;Spain;Sweden;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 2;Phase 3   EUCTR2018-004002-25-BE   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Czechia;France;Germany;Hungary;Ireland;Israel;Italy;Japan;Jordan;Korea, Republic of;Latvia;Malaysia;Netherlands;New Zealand;Poland;Portugal;Russian Federation;Serbia;Slovakia;Spain;Sweden;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 2   EUCTR2018-001510-15-PL   Argentina;Australia;Brazil;Germany;Mexico;Poland;Russian Federation;Ukraine;United States
      2019   Phase 2   EUCTR2018-001510-15-DE   Argentina;Australia;Brazil;Germany;Mexico;Poland;Russian Federation;Ukraine;United States
   Nishikawa Kazuko
      2023   Phase 2   JPRN-jRCT2031220308   Argentina;Australia;Austria,;Belgium;Brazil;Bulgaria;Canada;Chile;Czechia;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Korea;Mexico;Netherlands;NewZealand;Norway;Poland;Portugal;Republic Of Lithuania;Serbia;Spain;Switzerland;United Kingdom Of Great Britain
   Numaguchi Hirotaka
      2024   Phase 3   JPRN-jRCT2071230116   Australia;Belgium;Canada;China;Denmark;Finland;France;Greece;Italy;Japan;Norway;Poland;Portugal;Spain;Sweden;Turkey;United States
Guselkumab dose 1
   Janssen Research & Development, LLC
      2022   Phase 3   NCT05528510   Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;China;Czechia;France;Germany;Hungary;India;Israel;Italy;Japan;Jordan;Korea, Republic of;Malaysia;Mexico;New Zealand;Poland;Portugal;Serbia;Slovakia;Spain;Sweden;Taiwan;Turkey;United States
      2018   Phase 2   NCT03662542   Argentina;Australia;Brazil;Germany;Mexico;Poland;Russian Federation;Ukraine;United States
   Numaguchi Hirotaka
      2022   Phase 3   JPRN-jRCT2031220426   Argentina;Australia;Canada;China;Czechia;France;Germany;Hungary;Israel;Italy;Japan;Malaysia;New Zealand;Poland;Portugal;Republic of Korea;Serbia;Slovakia;Spain;Sweden;Taiwan;Turkey;United States Of America
Guselkumab dose 2
   Janssen Research & Development, LLC
      2022   Phase 3   NCT05528510   Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;China;Czechia;France;Germany;Hungary;India;Israel;Italy;Japan;Jordan;Korea, Republic of;Malaysia;Mexico;New Zealand;Poland;Portugal;Serbia;Slovakia;Spain;Sweden;Taiwan;Turkey;United States
      2018   Phase 2   NCT03662542   Argentina;Australia;Brazil;Germany;Mexico;Poland;Russian Federation;Ukraine;United States
   Numaguchi Hirotaka
      2022   Phase 3   JPRN-jRCT2031220426   Argentina;Australia;Canada;China;Czechia;France;Germany;Hungary;Israel;Italy;Japan;Malaysia;New Zealand;Poland;Portugal;Republic of Korea;Serbia;Slovakia;Spain;Sweden;Taiwan;Turkey;United States Of America
Guselkumab dose 3
   Janssen Research & Development, LLC
      2022   Phase 3   NCT05528510   Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;China;Czechia;France;Germany;Hungary;India;Israel;Italy;Japan;Jordan;Korea, Republic of;Malaysia;Mexico;New Zealand;Poland;Portugal;Serbia;Slovakia;Spain;Sweden;Taiwan;Turkey;United States
   Numaguchi Hirotaka
      2022   Phase 3   JPRN-jRCT2031220426   Argentina;Australia;Canada;China;Czechia;France;Germany;Hungary;Israel;Italy;Japan;Malaysia;New Zealand;Poland;Portugal;Republic of Korea;Serbia;Slovakia;Spain;Sweden;Taiwan;Turkey;United States Of America
Guselkumab intravenous
   Janssen Research & Development, LLC
      2024   Phase 3   NCT06260163   Australia;Belgium;China;Denmark;France;Italy;Japan;Norway;Poland;Portugal;Spain;Turkey;United States
Guselkumab subcutaneous
   Janssen Research & Development, LLC
      2024   Phase 3   NCT06260163   Australia;Belgium;China;Denmark;France;Italy;Japan;Norway;Poland;Portugal;Spain;Turkey;United States
GUT microbial transplantation
   Spectrum Health Hospitals
      2012   Phase 1   NCT01560819   United States
GWP42003
   GW Pharma Ltd.
      2013   Phase 2   EUCTR2011-003208-19-CZ   Czech Republic;United Kingdom
      2011   Phase 2   EUCTR2011-003208-19-GB   Czech Republic;United Kingdom
   GW Research Ltd
      2012   Phase 2   NCT01562314   Czech Republic;United Kingdom
H021
   Jiangsu Carephar Pharmaceutical Co., Ltd.
      2024   Phase 1   NCT06627556   Australia
H02AB
   GETECCU (Grupo Español de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa)
      2009   -   EUCTR2007-003815-30-PT   Portugal;Spain
Haemoglobin
   GlobiFer International bvba
      2010   Phase 2   EUCTR2008-004277-17-GB   United Kingdom
HE3286
   Harbor Therapeutics
      2008   Phase 1/Phase 2   NCT00628433   United States
Hemay005 tablets
   Ganzhou Hemay Pharmaceutical Co., Ltd
      2022   Phase 2   NCT05486104   China
Hemay007
   Hemay Pharmaceutical PTY. LTD.
      2017   Phase 1   NCT02603185   Australia
   Tianjin Hemay Pharmaceutical Co., Ltd
      2019   Phase 2   NCT03977480   China
Hepatitis A vaccine
   Asan Medical Center
      2011   Phase 4   NCT01341808   Korea, Republic of
Hepatitis B vaccine
   Boston Medical Center
      2017   -   NCT03056924   United States
   Millennium Pharmaceuticals, Inc.
      2011   Phase 1   NCT01981616   United Kingdom
Hextend
   Spectrum Health Hospitals
      2007   Phase 3   NCT00467922   United States
HF2
   Sheba Medical Center
      2019   Phase 1/Phase 2   NCT03720002   Greece;Israel
HGD40
   sterna biologicals GmbH & Co. KG
      2014   Phase 2   EUCTR2013-004599-36-DE   Germany
HGS1025
   Human Genome Sciences Inc.
      2011   Phase 1   NCT01434576   -
High dose
   Hama Yoriko
      2023   Phase 2   JPRN-jRCT2071230044   Japan;Romania;Switzerland;United States
   Holy Stone Healthcare Co., Ltd
      2016   Phase 2   NCT02493712   Italy;Taiwan
   Liu W. Jerry
      2022   Phase 2-3   JPRN-jRCT2021220013   France;Japan;United States
   Shenzhen Children's Hospital
      2024   -   ChiCTR2500097769   China
   Shikamura Mitsuhiro
      2021   Phase 3   JPRN-jRCT2071210030   Australia;Belgium;Bosnia;Canada;China;Croatia;Czech Republic;Germany;Hungary;Israel;Italy;Japan;Lithuania;New Zealand;Poland;Romania;Russia;Slovakia;Spain;Ukraine;United Kingdom;United States
   Shire
      2014   Phase 3   NCT02093663   Belgium;Canada;Germany;Hungary;Israel;Netherlands;Poland;Slovakia;United Kingdom;United States
   University of Wisconsin, Madison
      2016   Phase 4   NCT02461758   United States
High dose budesonide
   Bausch Health Americas, Inc.
      2023   Phase 4   NCT04314375   United States
High dose budesonide rectal foam
   Bausch Health Americas, Inc.
      2024   Phase 4   NCT05976802   -
High dose MT-1303
   Bausch Health Americas, Inc.
      2021   Phase 2   NCT04857112   United States
High gluten diet
   University of Southern Denmark
      2024   -   NCT06249763   Denmark
High protein and LOW fiber diet
   Mayo Clinic
      2021   -   NCT04933162   United States
HIGH-dose CICR-NAM
   University Hospital Schleswig-Holstein
      2024   Phase 2/Phase 3   NCT06488625   Germany
Histology
   Hospital San Carlos, Madrid
      2019   -   NCT03773445   Spain
Hladqa1*05A>G screening
   Western University, Canada
      2020   -   NCT04109300   Canada
HM201
   Syneos Health
      2021   Phase 1   NCT05088369   Australia
HMPL-004
   Hutchison MediPharma Enterprises Limited
      2008   -   EUCTR2007-005166-12-DE   Germany
   Hutchison Medipharma Limited
      2013   Phase 3   NCT01882764   United States
   Nutrition Science Partners Limited
      2014   -   EUCTR2013-003060-31-PL   Bulgaria;Czech Republic;Hungary;Latvia;Lithuania;Poland;Ukraine;United States
      2014   -   EUCTR2013-003060-31-LV   Bulgaria;Czech Republic;Hungary;Latvia;Lithuania;Poland;Ukraine;United States
      2014   -   EUCTR2013-003060-31-LT   Bulgaria;Czech Republic;Hungary;Latvia;Lithuania;Poland;Ukraine;United States
      2014   -   EUCTR2013-003060-31-HU   Bulgaria;Czech Republic;Hungary;Latvia;Lithuania;Poland;Ukraine;United States
      2014   -   EUCTR2013-003060-31-CZ   Bulgaria;Czech Republic;Hungary;Latvia;Lithuania;Poland;Ukraine;United States
      2014   -   EUCTR2013-003060-31-BG   Bulgaria;Czech Republic;Hungary;Latvia;Lithuania;Poland;Ukraine;United States
      2013   -   EUCTR2013-002116-27-LV   Bulgaria;Czech Republic;Hungary;Korea, Republic of;Latvia;Lithuania;Poland;Ukraine;United States
      2013   -   EUCTR2013-002116-27-LT   Bulgaria;Czech Republic;Hungary;Korea, Republic of;Latvia;Lithuania;Poland;Ukraine;United States
      2013   -   EUCTR2013-002116-27-HU   Bulgaria;Czech Republic;Hungary;Korea, Republic of;Latvia;Lithuania;Poland;Ukraine;United States
      2013   Phase 3   EUCTR2013-002116-27-CZ   Bulgaria;Czech Republic;Hungary;Korea, Republic of;Latvia;Lithuania;Poland;Ukraine;United States
      2013   -   EUCTR2013-002116-27-BG   Bulgaria;Czech Republic;Hungary;Latvia;Lithuania;Poland;Ukraine;United States
HMPL-004 1800 MG/DAY
   Hutchison Medipharma Limited
      2013   Phase 3   NCT01805791   United States
HMPL-004 2400 MG/DAY
   Hutchison Medipharma Limited
      2013   Phase 3   NCT01805791   United States
HMPL-004 high dose
   Hutchison Medipharma Limited
      2008   Phase 2   NCT00659802   United States
HMPL-004 LOW dose
   Hutchison Medipharma Limited
      2008   Phase 2   NCT00659802   United States
HMPL004-6599
   Nutrition Science Partners Limited
      2018   Phase 1   NCT03597971   Australia
HRS-7085 tablets
   Atridia Pty Ltd.
      2022   Phase 1   NCT05638347   Australia
Hulio
   University Medical Center Groningen
      2021   Phase 4   EUCTR2020-001811-26-BE   Belgium;Netherlands;Spain
      2020   Phase 4   EUCTR2020-001811-26-NL   Belgium;Netherlands;Spain
HUM291
   PDL BioPharma , Inc.
      2006   -   EUCTR2005-003482-17-IT   Greece;Ireland;Italy;Spain;United Kingdom
   PDL BioPharma, Inc
      2007   -   EUCTR2005-003707-37-BE   Austria;Belgium
      2007   -   EUCTR2005-003707-37-AT   Austria;Belgium
      2006   -   EUCTR2005-004105-28-NL   France;Germany;Greece;Hungary;Ireland;Netherlands;United Kingdom
      2006   Phase 2   EUCTR2005-003481-42-IE   Austria;Czech Republic;Germany;Greece;Hungary;Ireland;Slovakia;Spain
      2006   -   EUCTR2005-003481-42-ES   Czech Republic;Germany;Greece;Hungary;Ireland;Italy;Slovakia;Spain
      2006   Phase 2;Phase 3   EUCTR2005-002063-87-SK   Austria;Belgium;Czech Republic;Germany;Hungary;Slovakia
      2006   -   EUCTR2005-002063-87-DE   Belgium;Czech Republic;Germany;Hungary
   PDL BioPharma, Inc.
      2007   -   EUCTR2005-004105-28-GR   France;Germany;Greece;Hungary;Ireland;Netherlands;United Kingdom
      2007   -   EUCTR2005-004105-28-FR   France;Germany;Greece;Hungary;Ireland;Netherlands;United Kingdom
      2007   Phase 2   EUCTR2005-003482-17-GR   Greece;Ireland;Italy;Spain;United Kingdom
      2007   -   EUCTR2005-003482-17-GB   Greece;Ireland;Italy;Spain;United Kingdom
      2007   -   EUCTR2005-003481-42-GR   Czech Republic;Germany;Greece;Hungary;Ireland;Italy;Slovakia;Spain
      2006   -   NCT00355901   Australia;Austria;Belgium;Canada;Czech Republic;France;Germany;Hungary;Ireland;Italy;Netherlands;Norway;Ukraine;United States
      2006   Phase 2   EUCTR2005-004105-28-IE   France;Germany;Greece;Hungary;Ireland;Netherlands;United Kingdom
      2006   -   EUCTR2005-004105-28-GB   France;Germany;Greece;Hungary;Ireland;Netherlands;United Kingdom
      2006   -   EUCTR2005-004105-28-DE   France;Germany;Greece;Hungary;Ireland;Netherlands;United Kingdom
      2006   Phase 2   EUCTR2005-003482-17-IE   Greece;Ireland;Italy;Spain;United Kingdom
      2006   -   EUCTR2005-003482-17-ES   Greece;Ireland;Italy;Spain;United Kingdom
      2006   -   EUCTR2005-003481-42-HU   Czech Republic;Germany;Greece;Hungary;Ireland;Italy;Slovakia;Spain
      2006   -   EUCTR2005-003481-42-DE   Czech Republic;Germany;Greece;Hungary;Ireland;Italy;Slovakia;Spain
      2006   Phase 2   EUCTR2005-003481-42-CZ   Austria;Czech Republic;Germany;Greece;Hungary;Ireland;Slovakia;Spain
      2006   Phase 2;Phase 3   EUCTR2005-002063-87-CZ   Austria;Belgium;Czech Republic;Germany;Hungary;Slovakia
   PDL BioPharma, Inc;
      2006   -   EUCTR2005-003481-42-IT   Czech Republic;Germany;Greece;Hungary;Ireland;Italy;Slovakia;Spain
   Protein Design Labs, Inc
      2006   Phase 2   EUCTR2005-003481-42-SK   Austria;Czech Republic;Germany;Greece;Hungary;Ireland;Slovakia;Spain
      2006   -   EUCTR2005-003481-42-AT   Austria;Czech Republic;Germany;Greece;Hungary;Ireland;Slovakia;Spain
   Protein Design Labs, Inc.
      2006   -   EUCTR2005-002063-87-HU   Belgium;Czech Republic;Germany;Hungary
      2006   -   EUCTR2005-002063-87-BE   Belgium;Czech Republic;Germany;Hungary
      2005   -   EUCTR2005-002063-87-AT   Austria;Belgium;Czech Republic;Germany;Hungary
Human ANTI-IP10 monoclonal antibody
   Bristol-Myers Squibb International Corporation
      2011   -   EUCTR2010-022506-41-PL   Australia;Austria;Belgium;Brazil;Canada;France;Germany;Hungary;Italy;Mexico;Netherlands;Poland;South Africa;United States
      2011   -   EUCTR2010-022506-41-IT   Australia;Austria;Brazil;Canada;Germany;Hungary;Italy;Mexico;Poland;South Africa;United States
      2011   -   EUCTR2010-022506-41-HU   Australia;Austria;Belgium;Brazil;Canada;France;Germany;Hungary;Italy;Mexico;Netherlands;Poland;South Africa;United States
      2011   -   EUCTR2010-022506-41-DE   Australia;Austria;Belgium;Brazil;Canada;France;Germany;Hungary;Italy;Mexico;Netherlands;Poland;South Africa;United States
      2011   Phase 2   EUCTR2010-022506-41-BE   Australia;Austria;Belgium;Brazil;Canada;France;Germany;Hungary;Italy;Mexico;Netherlands;Poland;South Africa;United States
      2011   -   EUCTR2010-022506-41-AT   Australia;Austria;Belgium;Brazil;Canada;France;Germany;Hungary;Italy;Mexico;Netherlands;Poland;South Africa;United States
Human ANTI-TNF IGG1 monoclonal antibody
   Centocor BV
      2010   -   EUCTR2006-003398-28-CZ   Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden
      2008   -   EUCTR2006-003399-37-LT   Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden
      2008   -   EUCTR2006-003398-28-SE   Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden
      2008   -   EUCTR2006-003398-28-NL   Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden
      2008   -   EUCTR2006-003398-28-LT   Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden
      2008   -   EUCTR2006-003398-28-DK   Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden
      2008   -   EUCTR2006-003398-28-BG   Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden
      2008   -   EUCTR2006-003397-94-SE   Austria;Belgium;Bulgaria;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden
      2008   -   EUCTR2006-003397-94-NL   Austria;Belgium;Bulgaria;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden
      2008   -   EUCTR2006-003397-94-LT   Austria;Belgium;Bulgaria;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden
      2008   -   EUCTR2006-003397-94-BG   Austria;Belgium;Bulgaria;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden
      2007   Phase 3   EUCTR2006-003399-37-FR   Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Slovakia;Sweden
      2007   Phase 2;Phase 3   EUCTR2006-003398-28-SK   Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Slovakia;Sweden
      2007   -   EUCTR2006-003398-28-LV   Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden
      2007   -   EUCTR2006-003398-28-HU   Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden
      2007   Phase 2;Phase 3   EUCTR2006-003398-28-FR   Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Slovakia;Sweden
      2007   -   EUCTR2006-003398-28-DE   Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden
      2007   -   EUCTR2006-003398-28-BE   Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden
      2007   -   EUCTR2006-003398-28-AT   Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden
      2007   Phase 2;Phase 3   EUCTR2006-003397-94-SK   Austria;Belgium;Bulgaria;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Slovakia;Sweden
      2007   -   EUCTR2006-003397-94-LV   Austria;Belgium;Bulgaria;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden
      2007   Phase 2;Phase 3   EUCTR2006-003397-94-HU   Austria;Belgium;Bulgaria;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Slovakia;Sweden
      2007   Phase 2;Phase 3   EUCTR2006-003397-94-FR   Austria;Belgium;Bulgaria;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Slovakia;Sweden
      2007   -   EUCTR2006-003397-94-DE   Austria;Belgium;Bulgaria;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden
      2007   -   EUCTR2006-003397-94-BE   Austria;Belgium;Bulgaria;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden
      2007   -   EUCTR2006-003397-94-AT   Austria;Belgium;Bulgaria;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden
   Janssen Biologics B.V.
      2010   -   EUCTR2006-003399-37-CZ   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;India;Israel;Japan;Latvia;Lithuania;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Sweden;Ukraine;United States
      2008   -   EUCTR2006-003399-37-SE   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;India;Israel;Japan;Latvia;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Sweden;Ukraine;United States
      2008   -   EUCTR2006-003399-37-DK   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;India;Israel;Japan;Latvia;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Sweden;Ukraine;United States
      2008   -   EUCTR2006-003399-37-BG   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;India;Israel;Japan;Latvia;Lithuania;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Sweden;Ukraine;United States
      2007   -   EUCTR2006-003399-37-LV   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;India;Israel;Japan;Latvia;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Sweden;Ukraine;United States
      2007   -   EUCTR2006-003399-37-HU   Australia;Austria;Belgium;Bulgaria;Czech Republic;Denmark;Finland;France;Germany;Hungary;India;Israel;Latvia;Lithuania;Netherlands;New Zealand;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Sweden;Ukraine
      2007   -   EUCTR2006-003399-37-DE   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;India;Israel;Japan;Latvia;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Sweden;Ukraine;United States
      2007   -   EUCTR2006-003399-37-BE   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;India;Israel;Japan;Latvia;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Sweden;Ukraine;United States
      2007   -   EUCTR2006-003399-37-AT   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;India;Israel;Japan;Latvia;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Sweden;Ukraine;United States
   Janssen Biologics BV
      2008   -   EUCTR2006-003399-37-NL   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;India;Israel;Japan;Latvia;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Sweden;Ukraine;United States
      2007   Phase 3   EUCTR2006-003399-37-SK   Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Slovakia;Sweden
Human ANTI-TNF-alpha monoclonal antibody
   Janssen Biologics B.V.
      2014   Phase 1   EUCTR2012-004366-18-BE   Austria;Belgium;Canada;Denmark;France;Germany;Israel;Netherlands;Poland;United States
      2013   -   EUCTR2012-004366-18-NL   Austria;Belgium;Canada;Denmark;France;Germany;Israel;Netherlands;Poland;United States
      2013   Phase 1   EUCTR2012-004366-18-DK   Austria;Belgium;Canada;Denmark;France;Germany;Israel;Netherlands;Poland;United States
      2013   Phase 1   EUCTR2012-004366-18-DE   Austria;Belgium;Canada;Denmark;France;Germany;Israel;Netherlands;Poland;United States
      2013   Phase 1   EUCTR2012-004366-18-AT   Austria;Belgium;Canada;Denmark;France;Germany;Israel;Netherlands;Poland;United States
      -   Phase 1   EUCTR2012-004366-18-FR   Austria;Belgium;Canada;Denmark;France;Germany;Israel;Netherlands;Poland;United States
Human ANTI-tnfalfa
   Centocor BV
      2010   -   EUCTR2006-003398-28-CZ   Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden
      2008   -   EUCTR2006-003399-37-LT   Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden
      2008   -   EUCTR2006-003398-28-SE   Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden
      2008   -   EUCTR2006-003398-28-NL   Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden
      2008   -   EUCTR2006-003398-28-LT   Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden
      2008   -   EUCTR2006-003398-28-DK   Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden
      2008   -   EUCTR2006-003398-28-BG   Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden
      2008   -   EUCTR2006-003397-94-SE   Austria;Belgium;Bulgaria;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden
      2008   -   EUCTR2006-003397-94-NL   Austria;Belgium;Bulgaria;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden
      2008   -   EUCTR2006-003397-94-LT   Austria;Belgium;Bulgaria;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden
      2008   -   EUCTR2006-003397-94-BG   Austria;Belgium;Bulgaria;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden
      2007   Phase 3   EUCTR2006-003399-37-FR   Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Slovakia;Sweden
      2007   Phase 2;Phase 3   EUCTR2006-003398-28-SK   Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Slovakia;Sweden
      2007   -   EUCTR2006-003398-28-LV   Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden
      2007   -   EUCTR2006-003398-28-HU   Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden
      2007   Phase 2;Phase 3   EUCTR2006-003398-28-FR   Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Slovakia;Sweden
      2007   -   EUCTR2006-003398-28-DE   Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden
      2007   -   EUCTR2006-003398-28-BE   Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden
      2007   -   EUCTR2006-003398-28-AT   Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden
      2007   Phase 2;Phase 3   EUCTR2006-003397-94-SK   Austria;Belgium;Bulgaria;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Slovakia;Sweden
      2007   -   EUCTR2006-003397-94-LV   Austria;Belgium;Bulgaria;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden
      2007   Phase 2;Phase 3   EUCTR2006-003397-94-HU   Austria;Belgium;Bulgaria;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Slovakia;Sweden
      2007   Phase 2;Phase 3   EUCTR2006-003397-94-FR   Austria;Belgium;Bulgaria;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Slovakia;Sweden
      2007   -   EUCTR2006-003397-94-DE   Austria;Belgium;Bulgaria;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden
      2007   -   EUCTR2006-003397-94-BE   Austria;Belgium;Bulgaria;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden
      2007   -   EUCTR2006-003397-94-AT   Austria;Belgium;Bulgaria;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden
   Janssen Biologics B.V.
      2010   -   EUCTR2006-003399-37-CZ   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;India;Israel;Japan;Latvia;Lithuania;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Sweden;Ukraine;United States
      2008   -   EUCTR2006-003399-37-SE   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;India;Israel;Japan;Latvia;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Sweden;Ukraine;United States
      2008   -   EUCTR2006-003399-37-DK   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;India;Israel;Japan;Latvia;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Sweden;Ukraine;United States
      2008   -   EUCTR2006-003399-37-BG   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;India;Israel;Japan;Latvia;Lithuania;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Sweden;Ukraine;United States
      2007   -   EUCTR2006-003399-37-LV   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;India;Israel;Japan;Latvia;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Sweden;Ukraine;United States
      2007   -   EUCTR2006-003399-37-HU   Australia;Austria;Belgium;Bulgaria;Czech Republic;Denmark;Finland;France;Germany;Hungary;India;Israel;Latvia;Lithuania;Netherlands;New Zealand;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Sweden;Ukraine
      2007   -   EUCTR2006-003399-37-DE   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;India;Israel;Japan;Latvia;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Sweden;Ukraine;United States
      2007   -   EUCTR2006-003399-37-BE   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;India;Israel;Japan;Latvia;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Sweden;Ukraine;United States
      2007   -   EUCTR2006-003399-37-AT   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;India;Israel;Japan;Latvia;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Sweden;Ukraine;United States
   Janssen Biologics BV
      2008   -   EUCTR2006-003399-37-NL   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;India;Israel;Japan;Latvia;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Sweden;Ukraine;United States
      2007   Phase 3   EUCTR2006-003399-37-SK   Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Slovakia;Sweden
Human papillomavirus vaccine
   Mayo Clinic
      2010   Phase 4   NCT01034358   United States
Humanized recombinant IGG4 monoclonal antibody against CD-127
   OSE Immunotherapeutics
      2023   Phase 2   EUCTR2020-001398-59-PT   Belarus;Belgium;Bulgaria;Croatia;Georgia;Hungary;Israel;Latvia;Lithuania;Poland;Portugal;Russian Federation;Serbia;South Africa;Spain;Ukraine
      2020   Phase 2   EUCTR2020-001398-59-LV   Belarus;Belgium;Bulgaria;Croatia;Georgia;Hungary;Latvia;Poland;Portugal;Russian Federation;Serbia;South Africa;Spain;Ukraine
      2020   Phase 2   EUCTR2020-001398-59-HR   Belarus;Belgium;Bulgaria;Croatia;Georgia;Hungary;Latvia;Poland;Portugal;Russian Federation;Serbia;South Africa;Spain;Ukraine
      2020   Phase 2   EUCTR2020-001398-59-BG   Belarus;Belgium;Bulgaria;Croatia;Georgia;Hungary;Latvia;Poland;Portugal;Russian Federation;Serbia;South Africa;Spain;Ukraine
      2020   Phase 2   EUCTR2020-001398-59-BE   Belarus;Belgium;Bulgaria;Croatia;Georgia;Hungary;Latvia;Lithuania;Poland;Portugal;Russian Federation;Serbia;Ukraine
Humira
   Abbott GmbH Co. KG
      2007   -   EUCTR2006-002781-20-IT   Austria;Czech Republic;Germany;Hungary;Italy;Sweden
   Applied Molecular Transport
      2021   Phase 2   NCT05372939   Georgia;Netherlands;Poland;Ukraine
   Applied Molecular Transport Inc.
      2021   Phase 2   EUCTR2020-002833-13-PL   Georgia;Netherlands;Poland;Ukraine
      2021   Phase 2   EUCTR2020-002833-13-NL   Georgia;Netherlands;Poland;Ukraine
   Erasmus MC
      2014   -   EUCTR2014-001919-39-NL   Netherlands
   F. Hoffmann-La Roche Ltd
      2019   Phase 3   EUCTR2013-004279-11-FR   Argentina;Australia;Brazil;Bulgaria;Estonia;France;Hong Kong;Mexico;Poland;Russian Federation;Serbia;Slovakia;Ukraine;United States
      2019   Phase 3   EUCTR2013-004277-27-HU   Argentina;Australia;Brazil;Bulgaria;Colombia;Croatia;Czech Republic;Greece;Hungary;Latvia;Lithuania;Malaysia;New Zealand;Poland;Russian Federation;Turkey;Ukraine;United States
      2019   Phase 3   EUCTR2013-004277-27-CZ   Argentina;Australia;Brazil;Bulgaria;Colombia;Croatia;Czech Republic;Greece;Hungary;Latvia;Lithuania;Malaysia;New Zealand;Poland;Russian Federation;Turkey;Ukraine;United States
      2015   Phase 3   EUCTR2013-004279-11-BG   Argentina;Australia;Brazil;Bulgaria;Estonia;France;Hong Kong;Mexico;Poland;Russian Federation;Serbia;Slovakia;Ukraine;United States
      2015   Phase 3   EUCTR2013-004277-27-BG   Argentina;Australia;Brazil;Bulgaria;Colombia;Croatia;Czech Republic;Greece;Hungary;Latvia;Lithuania;Malaysia;New Zealand;Poland;Russian Federation;Turkey;Ukraine;United States
      2014   Phase 3   EUCTR2013-004279-11-SK   Argentina;Australia;Brazil;Bulgaria;Estonia;France;Hong Kong;Mexico;Poland;Russian Federation;Serbia;Slovakia;Ukraine;United States
      2014   Phase 3   EUCTR2013-004279-11-EE   Argentina;Australia;Brazil;Bulgaria;Estonia;France;Hong Kong;Mexico;Poland;Russian Federation;Serbia;Slovakia;Ukraine;United States
      2014   Phase 3   EUCTR2013-004277-27-LV   Argentina;Australia;Brazil;Bulgaria;Colombia;Croatia;Czech Republic;Greece;Hungary;Latvia;Lithuania;Malaysia;New Zealand;Poland;Russian Federation;Turkey;Ukraine;United States
      2014   Phase 3   EUCTR2013-004277-27-LT   Argentina;Australia;Brazil;Bulgaria;Colombia;Croatia;Czech Republic;Greece;Hungary;Latvia;Lithuania;Malaysia;New Zealand;Poland;Russian Federation;Turkey;Ukraine;United States
      2014   Phase 3   EUCTR2013-004277-27-HR   Argentina;Australia;Brazil;Bulgaria;Colombia;Croatia;Czech Republic;Greece;Hungary;Latvia;Lithuania;Malaysia;New Zealand;Poland;Russian Federation;Turkey;Ukraine;United States
      2014   Phase 3   EUCTR2013-004277-27-GR   Argentina;Australia;Brazil;Bulgaria;Colombia;Croatia;Czech Republic;Greece;Hungary;Latvia;Lithuania;Malaysia;New Zealand;Poland;Russian Federation;Turkey;Ukraine;United States
   Fundación Publica Andaluza para la Gestión de Salud en Sevilla (FISEVI)
      2019   Phase 4   EUCTR2019-000717-37-ES   Spain
   GETAID
      2019   Phase 4   EUCTR2018-003490-10-FR   France
   Helse More og Romsdal Hospital Trust
      2016   Phase 4   EUCTR2016-001409-18-NO   Norway
   Region Örebro län
      2021   Phase 4   EUCTR2019-002942-19-NO   Denmark;Iceland;Norway
      2021   Phase 4   EUCTR2019-002942-19-IS   Denmark;Iceland
      2021   Phase 4   EUCTR2019-002942-19-DK   Denmark;Iceland
   Regionalhospital Silkeborg
      2010   Phase 4   EUCTR2009-018085-35-DK   Denmark
   Royal Liverpool University Hospital
      2012   -   EUCTR2011-006084-22-GB   United Kingdom
   Samsung Bioepis Co., Ltd.
      2014   -   EUCTR2013-005013-13-PL   Bosnia and Herzegovina;Bulgaria;Czech Republic;Korea, Republic of;Latvia;Lithuania;Mexico;Poland;Russian Federation;Ukraine;United Kingdom
      2014   -   EUCTR2013-005013-13-LT   Bosnia and Herzegovina;Bulgaria;Czech Republic;Korea, Republic of;Lithuania;Mexico;Poland;Russian Federation;Ukraine;United Kingdom
      2014   -   EUCTR2013-005013-13-CZ   Bosnia and Herzegovina;Bulgaria;Czech Republic;Korea, Republic of;Lithuania;Mexico;Poland;Russian Federation;Ukraine;United Kingdom
      2014   Phase 3   EUCTR2013-005013-13-BG   Bosnia and Herzegovina;Bulgaria;Czech Republic;Korea, Republic of;Lithuania;Mexico;Poland;Russian Federation;Ukraine;United Kingdom
   Takeda Development Centre Europe, Ltd.
      2016   Phase 3   EUCTR2015-000939-33-PT   Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000939-33-PL   Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000939-33-NL   Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000939-33-HU   Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000939-33-HR   Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000939-33-ES   Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2015   Phase 3   EUCTR2015-000939-33-SK   Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2015   Phase 3   EUCTR2015-000939-33-LV   Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2015   Phase 3   EUCTR2015-000939-33-LT   Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2015   Phase 3   EUCTR2015-000939-33-GB   Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2015   Phase 3   EUCTR2015-000939-33-EE   Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2015   Phase 3   EUCTR2015-000939-33-DK   Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2015   Phase 3   EUCTR2015-000939-33-DE   Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2015   Phase 3   EUCTR2015-000939-33-CZ   Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2015   Phase 3   EUCTR2015-000939-33-BG   Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2015   Phase 3   EUCTR2015-000939-33-BE   Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
   University Hospital Southampton NHS Foundation Trust
      2019   Phase 4   EUCTR2018-004967-30-GB   United Kingdom
   University Maastricht
      2019   Phase 4   EUCTR2017-004588-11-NL   Netherlands
   University Medical Center Groningen
      2021   Phase 4   EUCTR2020-001811-26-BE   Belgium;Netherlands;Spain
      2020   Phase 4   EUCTR2020-001811-26-NL   Belgium;Netherlands;Spain
Humira - 40 MG soluzione iniettabile USO sottocutaneo 1 siringa preriempita 0.8 ML + 1 tampone imbevuto DI alcol IN UN blister
   TAKEDA DEVELOPMENT CENTRE EUROPE LTD
      2015   Phase 3   EUCTR2015-000939-33-IT   Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
Humira 40 MG solution FOR injection IN PRE-filled syringe
   ABBOTT GMBH & Co. KG
      2012   -   EUCTR2011-002411-29-IT   Austria;Belgium;Canada;Czech Republic;Denmark;Finland;Germany;Greece;Ireland;Israel;Italy;Poland;Portugal;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom
   AbbVie Deutschland GmbH & Co. KG
      2015   Phase 3   EUCTR2015-001346-29-SK   Belgium;Canada;Czech Republic;European Union;Hungary;Israel;Japan;New Zealand;Poland;Slovakia;Spain;Sweden;United Kingdom;United States
      2013   -   EUCTR2011-002411-29-SK   Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Ireland;Israel;Italy;Norway;Poland;Portugal;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom
      2013   -   EUCTR2011-002411-29-PL   Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Ireland;Israel;Italy;Norway;Poland;Portugal;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom
      2013   -   EUCTR2011-002411-29-CZ   Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Ireland;Israel;Italy;Norway;Poland;Portugal;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom
      2012   -   EUCTR2011-002411-29-SE   Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Ireland;Israel;Italy;Norway;Poland;Portugal;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom
      2012   -   EUCTR2011-002411-29-PT   Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Ireland;Israel;Italy;Netherlands;Norway;Poland;Portugal;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom
      2012   -   EUCTR2011-002411-29-IE   Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Ireland;Israel;Italy;Norway;Poland;Portugal;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom
      2012   -   EUCTR2011-002411-29-FI   Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Ireland;Israel;Italy;Netherlands;Norway;Poland;Portugal;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom
      2012   -   EUCTR2011-002411-29-DK   Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Ireland;Israel;Italy;Norway;Poland;Portugal;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom
      2012   -   EUCTR2011-002411-29-DE   Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Ireland;Israel;Italy;Norway;Poland;Portugal;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom
      2012   -   EUCTR2011-002411-29-BE   Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Ireland;Israel;Italy;Norway;Poland;Portugal;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom
      2012   -   EUCTR2011-002411-29-AT   Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Ireland;Israel;Italy;Norway;Poland;Portugal;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom
      2009   Phase 3   EUCTR2007-004157-28-SE   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Slovakia;Spain;Sweden;Switzerland
      2008   Phase 3   EUCTR2007-004157-28-NL   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Slovakia;Spain;Sweden;Switzerland
      2008   Phase 3   EUCTR2007-004157-28-HU   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Slovakia;Spain;Sweden;Switzerland
      2008   Phase 3   EUCTR2007-004157-28-DE   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Slovakia;Spain;Sweden;Switzerland
      2008   Phase 3   EUCTR2007-004157-28-CZ   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Slovakia;Spain;Sweden;Switzerland
      2008   Phase 3   EUCTR2007-004157-28-BE   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Slovakia;Spain;Sweden;Switzerland
      2008   Phase 3   EUCTR2007-004157-28-AT   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Slovakia;Spain;Sweden;Switzerland
      -   Phase 3   EUCTR2015-001346-29-PL   Belgium;Canada;Czech Republic;European Union;Hungary;Israel;Japan;New Zealand;Poland;Slovakia;Spain;Sweden;United Kingdom;United States
   Abbott GmbH & Co. KG
      2012   -   EUCTR2011-002411-29-GR   Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Ireland;Israel;Italy;Netherlands;Norway;Poland;Portugal;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom
      2012   -   EUCTR2011-002411-29-ES   Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Ireland;Israel;Italy;Netherlands;Norway;Poland;Portugal;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom
      2009   Phase 3   EUCTR2007-004157-28-PT   Austria;Belgium;Czech Republic;France;Germany;Hungary;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden
      2008   Phase 3   EUCTR2007-004157-28-SK   Austria;Belgium;Czech Republic;France;Germany;Hungary;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden
      2008   Phase 3   EUCTR2007-004157-28-FR   Austria;Belgium;Czech Republic;France;Germany;Hungary;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden
   Abbvie Deutschland GmbH & Co. KG
      2012   -   EUCTR2011-002411-29-GB   Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Ireland;Israel;Italy;Netherlands;Norway;Poland;Portugal;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom
Humira 40 MG solution FOR injection IN PRE-filled syringes
   Odense University Hospital
      2011   Phase 3   EUCTR2011-004268-31-DK   Denmark
Humira 40 MG/0.8 ML solution FOR injection
   AbbVie Deutschland GmbH & Co. KG
      2019   Phase 3   EUCTR2013-001682-16-DK   Austria;Canada;Czech Republic;Denmark;Germany;Hungary;Israel;Italy;Japan;Netherlands;Poland;Slovakia;Spain;Switzerland;United States
      2015   Phase 3   EUCTR2013-001682-16-BE   Belgium;Canada;Germany;Hungary;Israel;Italy;Japan;Netherlands;Poland;Spain;Switzerland;United States
      2014   Phase 3   EUCTR2013-001682-16-SK   Austria;Canada;Czech Republic;Denmark;Germany;Hungary;Israel;Italy;Japan;Netherlands;Poland;Slovakia;Spain;Switzerland;United States
      2014   Phase 3   EUCTR2013-001682-16-PL   Austria;Belgium;Canada;Czech Republic;Denmark;Germany;Hungary;Israel;Italy;Japan;Netherlands;Poland;Slovakia;Spain;Switzerland;United States
      2014   Phase 3   EUCTR2013-001682-16-NL   Austria;Belgium;Canada;Czech Republic;Denmark;Germany;Hungary;Israel;Japan;Netherlands;Poland;Slovakia;Spain;Switzerland;United States
      2014   Phase 3   EUCTR2013-001682-16-IT   Austria;Belgium;Canada;Czech Republic;Denmark;Germany;Hungary;Israel;Italy;Japan;Netherlands;Poland;Slovakia;Spain;Switzerland;United States
      2014   Phase 3   EUCTR2013-001682-16-HU   Austria;Belgium;Canada;Czech Republic;Denmark;Germany;Hungary;Israel;Italy;Japan;Netherlands;Poland;Slovakia;Spain;Switzerland;United States
      2014   Phase 3   EUCTR2013-001682-16-ES   Austria;Canada;Czech Republic;Denmark;Germany;Hungary;Israel;Italy;Japan;Netherlands;Poland;Slovakia;Spain;Switzerland;United States
      2014   Phase 3   EUCTR2013-001682-16-DE   Austria;Belgium;Canada;Czech Republic;Denmark;Germany;Hungary;Israel;Italy;Japan;Netherlands;Poland;Slovakia;Spain;Switzerland;United States
      2014   Phase 3   EUCTR2013-001682-16-CZ   Austria;Belgium;Canada;Czech Republic;Denmark;Germany;Hungary;Israel;Italy;Japan;Netherlands;Poland;Slovakia;Spain;Switzerland;United States
      2014   Phase 3   EUCTR2013-001682-16-AT   Austria;Belgium;Canada;Czech Republic;Denmark;Germany;Hungary;Israel;Japan;Netherlands;Poland;Slovakia;Spain;Switzerland;United States
   AbbVie Inc.
      -   -   EUCTR2014-004559-29-Outside-EU/EEA   Japan
Humira 40 MG/0.8 ML solution FOR injection FOR paediatric USE
   AbbVie Deutschland GmbH & Co. KG
      2017   Phase 3   EUCTR2015-001346-29-CZ   Belgium;Canada;Czech Republic;European Union;Hungary;Israel;Italy;Japan;New Zealand;Poland;Slovakia;Spain;Sweden;United Kingdom;United States
      2016   Phase 3   EUCTR2015-001346-29-HU   Australia;Belgium;Canada;Czech Republic;Hungary;Israel;Italy;New Zealand;Poland;Slovakia;Spain;Sweden;United Kingdom;United States
      2016   Phase 3   EUCTR2015-001346-29-GB   Belgium;Canada;Czech Republic;European Union;Hungary;Israel;Japan;New Zealand;Spain;Sweden;United Kingdom;United States
      2016   Phase 3   EUCTR2015-001346-29-ES   Australia;Belgium;Canada;Czech Republic;Hungary;Israel;Japan;New Zealand;Poland;Slovakia;Spain;Sweden;United Kingdom;United States
      2016   Phase 3   EUCTR2015-001346-29-BE   Australia;Belgium;Canada;Czech Republic;Hungary;Israel;Japan;New Zealand;Poland;Slovakia;Spain;Sweden;United Kingdom;United States
      2015   Phase 3   EUCTR2015-001346-29-SK   Belgium;Canada;Czech Republic;European Union;Hungary;Israel;Japan;New Zealand;Poland;Slovakia;Spain;Sweden;United Kingdom;United States
      2014   Phase 3   EUCTR2013-003032-77-IT   Australia;Austria;Belgium;Canada;Czech Republic;France;Hungary;Israel;Italy;New Zealand;Poland;Slovakia;Spain;Switzerland;United Kingdom;United States
      2014   Phase 3   EUCTR2013-003032-77-HU   Australia;Austria;Belgium;Canada;Czech Republic;France;Hungary;Israel;Italy;New Zealand;Poland;Slovakia;Spain;United Kingdom;United States
      2014   Phase 3   EUCTR2013-003032-77-GB   Austria;Belgium;Canada;Czech Republic;France;Hungary;Israel;Italy;New Zealand;Poland;Slovakia;Spain;United Kingdom;United States
      -   Phase 3   EUCTR2015-001346-29-SE   Belgium;Canada;Czech Republic;European Union;Hungary;Israel;Japan;New Zealand;Spain;Sweden;United Kingdom;United States
      -   Phase 3   EUCTR2015-001346-29-PL   Belgium;Canada;Czech Republic;European Union;Hungary;Israel;Japan;New Zealand;Poland;Slovakia;Spain;Sweden;United Kingdom;United States
      -   Phase 3   EUCTR2015-001346-29-AT   Austria;Belgium;Canada;Czech Republic;European Union;Hungary;Israel;Japan;New Zealand;Spain;Sweden;United Kingdom;United States
   Abbvie Deutschland GmbH & Co. KG
      2015   Phase 3   EUCTR2013-003032-77-PL   Austria;Belgium;Canada;Czech Republic;France;Hungary;Israel;Italy;New Zealand;Poland;Slovakia;Spain;United Kingdom;United States
      2014   Phase 3   EUCTR2013-003032-77-SK   Austria;Belgium;Canada;Czech Republic;France;Hungary;Israel;Italy;New Zealand;Poland;Slovakia;Spain;United Kingdom;United States
      2014   Phase 3   EUCTR2013-003032-77-ES   Australia;Austria;Belgium;Canada;Czech Republic;France;Hungary;Israel;Italy;New Zealand;Poland;Slovakia;Spain;Switzerland;United Kingdom;United States
      2014   Phase 3   EUCTR2013-003032-77-CZ   Austria;Belgium;Canada;Czech Republic;France;Hungary;Israel;Italy;New Zealand;Poland;Slovakia;Spain;United Kingdom;United States
      2014   Phase 3   EUCTR2013-003032-77-BE   Australia;Austria;Belgium;Canada;Czech Republic;France;Hungary;Israel;Italy;New Zealand;Poland;Slovakia;Spain;Switzerland;United Kingdom;United States
      2014   Phase 3   EUCTR2013-003032-77-AT   Austria;Belgium;Canada;Czech Republic;France;Hungary;Israel;Italy;New Zealand;Poland;Slovakia;Spain;United Kingdom;United States
      -   Phase 3   EUCTR2013-003032-77-FR   Australia;Austria;Belgium;Canada;Czech Republic;France;Hungary;Israel;Italy;New Zealand;Poland;Slovakia;Spain;Switzerland;United Kingdom;United States
Humira 40MG solution FOR injection
   Fundación Pública Andaluza para la gestión de la Investigación en Sevilla
      2019   Phase 4   NCT04131322   Spain
Humira 40MG/0.4ML PRE-filled syringe
   PIBD net
      2018   Phase 4   EUCTR2016-000522-18-GB   Belgium;Canada;Czech Republic;France;Germany;Israel;Italy;Netherlands;Poland;Spain;United Kingdom
Hydrocortisone
   Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives
      2016   Phase 4   NCT02425852   France
Hydrogen
   411th Hospital of PLA
      2013   -   ChiCTR-TRC-13003530   China
   Juntendo University Hospital
      2020   -   JPRN-UMIN000042017   Japan
   The Second Affiliated Hospital of the Chinese People's Liberation Army Air Force Medical University
      2025   -   ChiCTR2500095979   China
Hydroxocobalamin with butyrate
   Joshua Korzenik
      2024   Phase 2   NCT04259060   United States
Hydroxychloroquine
   Icahn School of Medicine at Mount Sinai
      2022   Phase 1/Phase 2   NCT05119140   United States
Hyperbaric oxygen
   Dartmouth-Hitchcock Medical Center
      2013   Phase 2/Phase 3   NCT02144350   United States
Hyperbaric oxygen therapy
   Dartmouth-Hitchcock Medical Center
      2017   Phase 2   NCT03494764   United States
   Medical University of Warsaw
      2018   -   NCT03576027   Poland
IBD98-M delayed-release capsules
   Holy Stone Healthcare Co., Ltd.
      2015   Phase 2   EUCTR2015-001022-42-IT   Italy
Iberogast N
   Bayer
      2014   Phase 2   NCT02246686   Germany
   Steigerwald Arzneimittelwerk GmbH
      2014   -   EUCTR2013-000891-13-DE   Germany
Identical tacrolimus-free lipid suspension FOR enema
   Jina Pharmaceuticals Inc.
      2025   Phase 2   NCT06867042   -
Idoform®travel
   Oslo University Hospital
      2020   -   NCT04241029   Norway
IGG2 antibodies
   EA Pharma Co., Ltd.
      2019   Phase 2   EUCTR2018-002109-70-HU   Czech Republic;Hungary;Japan;Poland
      2019   Phase 2   EUCTR2018-002109-70-CZ   Czech Republic;Czechia;Hungary;Japan;Poland;Russian Federation
IM90838
   Immunic AG
      2020   Phase 2   EUCTR2017-003703-22-RO   Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Croatia;Czechia;Germany;Netherlands;North Macedonia;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
      2020   Phase 2   EUCTR2017-003703-22-PT   Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Croatia;Czechia;Germany;Netherlands;North Macedonia;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
      2020   Phase 2   EUCTR2017-003703-22-BG   Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Croatia;Czechia;Germany;Netherlands;North Macedonia;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
      2019   Phase 2   EUCTR2017-003703-22-PL   Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Croatia;Czechia;Germany;Netherlands;North Macedonia;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
      2019   Phase 2   EUCTR2017-003703-22-HR   Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Croatia;Czechia;Georgia;Germany;Netherlands;North Macedonia;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
      2018   Phase 2   EUCTR2017-003703-22-NL   Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Croatia;Czechia;Germany;Netherlands;North Macedonia;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
      2018   Phase 2   EUCTR2017-003703-22-GB   Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Croatia;Czech Republic;Germany;Macedonia, the former Yugoslav Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
      2018   Phase 2   EUCTR2017-003703-22-ES   Belgium;Czech Republic;Germany;Netherlands;Poland;Russian Federation;Serbia;Slovakia;Spain;Ukraine;United Kingdom;United States
Immunotherapy
   King's College London
      2022   Phase 1   NCT03185000   United Kingdom
Imolope
   Department of surgery, Odense University Hospital
      2014   Phase 4   EUCTR2014-004740-35-DK   Denmark
Imraldi
   University Hospital Southampton NHS Foundation Trust
      2019   Phase 4   EUCTR2018-004967-30-GB   United Kingdom
IMU-838
   Immunic AG
      2020   Phase 2   EUCTR2017-003703-22-RO   Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Croatia;Czechia;Germany;Netherlands;North Macedonia;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
      2020   Phase 2   EUCTR2017-003703-22-PT   Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Croatia;Czechia;Germany;Netherlands;North Macedonia;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
      2020   Phase 2   EUCTR2017-003703-22-BG   Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Croatia;Czechia;Germany;Netherlands;North Macedonia;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
      2019   Phase 2   EUCTR2017-003703-22-PL   Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Croatia;Czechia;Germany;Netherlands;North Macedonia;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
      2019   Phase 2   EUCTR2017-003703-22-HR   Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Croatia;Czechia;Georgia;Germany;Netherlands;North Macedonia;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
      2018   Phase 2   NCT03341962   Albania;Belarus;Bosnia and Herzegovina;Bulgaria;Croatia;Czechia;Georgia;Netherlands;North Macedonia;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 2   EUCTR2017-003703-22-NL   Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Croatia;Czechia;Germany;Netherlands;North Macedonia;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
      2018   Phase 2   EUCTR2017-003703-22-GB   Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Croatia;Czech Republic;Germany;Macedonia, the former Yugoslav Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
      2018   Phase 2   EUCTR2017-003703-22-ES   Belgium;Czech Republic;Germany;Netherlands;Poland;Russian Federation;Serbia;Slovakia;Spain;Ukraine;United Kingdom;United States
Imuran
   Amsterdam UMC location AMC
      2021   Phase 3;Phase 4   EUCTR2021-000469-33-NL   Netherlands
   SCHERING-PLOUGH
      2007   -   EUCTR2006-002670-22-IT   Belgium;Czech Republic;France;Germany;Hungary;Italy;Portugal;Spain;United Kingdom
Imurek 25MG filmtabletten
   Essex Pharma GmbH
      2009   -   EUCTR2009-010065-23-DE   Germany
Imurek 50MG filmtabletten
   Essex Pharma GmbH
      2009   -   EUCTR2009-010065-23-DE   Germany
Imurel
   Hvidovre Hospital
      2016   Phase 3   EUCTR2016-002433-30-DK   Denmark
   Marianne Kiszka-Kanowitz
      2013   Phase 3   EUCTR2013-001503-37-DK   Denmark
   Region Örebro län
      2021   Phase 4   EUCTR2019-002942-19-NO   Denmark;Iceland;Norway
      2021   Phase 4   EUCTR2019-002942-19-IS   Denmark;Iceland
      2021   Phase 4   EUCTR2019-002942-19-DK   Denmark;Iceland
   SOIBD (The Swedish Organisation for the study of Inflammatory Bowel Diseases)
      2018   Phase 4   EUCTR2016-004112-35-SE   Sweden
Inactivated influenza vaccine (IIV) AT baseline
   McGill University Health Centre/Research Institute of the McGill University Health Centre
      2024   Phase 2   NCT06599658   Canada
Inactivated influenza vaccine AT month 1
   McGill University Health Centre/Research Institute of the McGill University Health Centre
      2024   Phase 2   NCT06599658   Canada
INCB039110
   Incyte Corporation
      2020   Phase 2   EUCTR2018-004491-35-RO   Czechia;Germany;Poland;Romania;United States
      2019   Phase 2   EUCTR2018-004491-35-PL   Czech Republic;Germany;Poland;Romania;United States
Increased dietary intake OF salmon or COD
   Institute of Food Research
      2004   -   NCT00145015   Netherlands;United Kingdom
Indigo
   Kanai Takanori
      2019   Phase 3   JPRN-jRCTs031190156   -
   Keio University School of Medicine
      2017   -   JPRN-UMIN000029633   Japan
   Kitazono Takanari
      2017   Phase 2   JPRN-jRCTs071180073   -
   Osaka University, Graduate School of Medicine, Department of Gastroenterology and Hepatology
      2015   -   JPRN-UMIN000017359   Japan
   Shuguang Hospital affiliated to Shanghai University of traditional Chinese Medicine
      2020   Phase 0   ChiCTR2000037220   China
Indigo-carmine 0.2% using A spray catheter
   The Leeds Teaching Hospitals NHS Trust
      2017   -   NCT03250780   United Kingdom
Induction- PF-06480605 150 MG SC Q4W
   Hoffmann-La Roche
      2019   Phase 2   NCT04090411   Australia;Austria;Belgium;Bulgaria;Canada;Colombia;France;Germany;Hungary;India;Italy;Japan;Mexico;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Thailand;Turkey;Ukraine;United Kingdom;United States
Induction- PF-06480605 450 MG SC Q4W
   Hoffmann-La Roche
      2019   Phase 2   NCT04090411   Australia;Austria;Belgium;Bulgaria;Canada;Colombia;France;Germany;Hungary;India;Italy;Japan;Mexico;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Thailand;Turkey;Ukraine;United Kingdom;United States
Induction- PF-06480605 50 MG SC Q4W
   Hoffmann-La Roche
      2019   Phase 2   NCT04090411   Australia;Austria;Belgium;Bulgaria;Canada;Colombia;France;Germany;Hungary;India;Italy;Japan;Mexico;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Thailand;Turkey;Ukraine;United Kingdom;United States
Inflectra
   CUB- Hopital Erasme
      2016   Phase 4   EUCTR2015-004618-10-BE   Belgium
   Celltrion, Inc.
      2020   Phase 3   EUCTR2019-003849-15-PL   Austria;Belarus;Bulgaria;Croatia;Czech Republic;Czechia;France;Greece;Israel;Italy;Latvia;Mexico;Moldova, Republic of;Peru;Poland;Russian Federation;Serbia;South Africa;Spain;Turkey;Ukraine
      2020   Phase 3   EUCTR2019-003849-15-HR   Austria;Belarus;Brazil;Bulgaria;Chile;Croatia;Czechia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Latvia;Mexico;Moldova, Republic of;Peru;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Turkey;Ukraine;United States
      2020   Phase 3   EUCTR2019-003849-15-GR   Austria;Belarus;Brazil;Bulgaria;Chile;Croatia;Czech Republic;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Latvia;Mexico;Moldova, Republic of;Peru;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Turkey;Ukraine;United States
      2020   Phase 3   EUCTR2019-003849-15-FR   Austria;Belarus;Brazil;Bulgaria;Chile;Croatia;Czech Republic;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Latvia;Mexico;Moldova, Republic of;Peru;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Turkey;Ukraine;United States
      2020   Phase 3   EUCTR2019-003849-15-ES   Austria;Belarus;Brazil;Bulgaria;Chile;Croatia;Czech Republic;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Latvia;Mexico;Moldova, Republic of;Peru;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Turkey;Ukraine;United States
      2020   Phase 3   EUCTR2019-003849-15-CZ   Austria;Belarus;Bulgaria;Croatia;Czech Republic;Czechia;France;Greece;Israel;Italy;Latvia;Mexico;Moldova, Republic of;Peru;Poland;Russian Federation;Serbia;South Africa;Spain;Turkey;Ukraine
      2020   Phase 3   EUCTR2019-003849-15-BG   Austria;Belarus;Bulgaria;Croatia;Czech Republic;Czechia;France;Greece;Israel;Italy;Latvia;Mexico;Moldova, Republic of;Peru;Poland;Russian Federation;Serbia;South Africa;Spain;Turkey;Ukraine
      2020   Phase 3   EUCTR2019-003849-15-AT   Austria;Belarus;Brazil;Bulgaria;Chile;Croatia;Czech Republic;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Latvia;Mexico;Moldova, Republic of;Peru;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Turkey;Ukraine;United States
   Centre Hospitalier Universitaire de Rennes
      2018   Phase 4   EUCTR2018-002673-21-FR   France
   Erasmus Medical Center
      2019   Phase 4   EUCTR2018-004587-61-NL   Netherlands
   Helse More og Romsdal Hospital Trust
      2016   Phase 4   EUCTR2016-001409-18-NO   Norway
   Hospira UK Ltd.
      2015   Phase 4   EUCTR2014-005192-89-FI   Belgium;Czech Republic;Finland;France;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovakia;Spain;United Kingdom
   Pfizer
      2018   -   NCT03801928   Canada;United States
   UMC Amsterdam location AMC
      2021   Phase 4   EUCTR2018-003524-36-NO   France;Ireland;Netherlands;Norway;United Kingdom
      2020   Phase 4   EUCTR2018-003524-36-IE   Ireland;Netherlands;Norway
   UZ Leuven
      2021   Phase 4   EUCTR2020-004012-10-BE   Belgium
   University Medical Center Groningen
      2021   Phase 4   EUCTR2020-001811-26-BE   Belgium;Netherlands;Spain
      2020   Phase 4   EUCTR2020-001811-26-NL   Belgium;Netherlands;Spain
Inflectra 100 MG
   CHU Amiens-Picardie
      2020   Phase 4   EUCTR2020-004391-18-FR   France
Inflectra 100 MG powder FOR concentrate FOR solution FOR infusion
   Santeon
      2015   Phase 4   EUCTR2015-001954-14-NL   Netherlands
Infliximab
   Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
      2019   Phase 4   NCT03937609   Ireland;Netherlands;Norway
   Alimentiv Inc.
      2018   -   NCT03765450   Canada;United States
   Assiut University
      2022   -   NCT05406934   -
      2018   -   NCT03445624   Egypt
   Austin Health
      2016   Phase 4   NCT02770040   Australia
   Belgian Inflammatory Bowel Disease Research and Development (BIRD) VZW
      2024   Phase 4   NCT06113913   Belgium
   Beth Israel Deaconess Medical Center
      2021   Phase 4   NCT04835506   Canada;United States
   CELLTRION INC.
      2020   Phase 3   EUCTR2019-003849-15-IT   Austria;Belarus;Brazil;Bulgaria;Chile;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Latvia;Mexico;Moldova, Republic of;Peru;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Turkey;Ukraine;United States
   CENTOCOR
      2007   -   EUCTR2006-000410-20-IT   Belgium;Denmark;Italy;Netherlands
   COSMO TECHNOLOGIES LTD
      2008   -   EUCTR2007-007702-30-IT   Italy
   CUB- Hopital Erasme
      2016   Phase 4   EUCTR2015-004618-10-BE   Belgium
   Celltrion
      2020   Phase 3   NCT04205643   Poland
   Celltrion, Inc.
      2020   Phase 3   EUCTR2019-003849-15-PL   Austria;Belarus;Bulgaria;Croatia;Czech Republic;Czechia;France;Greece;Israel;Italy;Latvia;Mexico;Moldova, Republic of;Peru;Poland;Russian Federation;Serbia;South Africa;Spain;Turkey;Ukraine
      2020   Phase 3   EUCTR2019-003849-15-HR   Austria;Belarus;Brazil;Bulgaria;Chile;Croatia;Czechia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Latvia;Mexico;Moldova, Republic of;Peru;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Turkey;Ukraine;United States
      2020   Phase 3   EUCTR2019-003849-15-GR   Austria;Belarus;Brazil;Bulgaria;Chile;Croatia;Czech Republic;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Latvia;Mexico;Moldova, Republic of;Peru;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Turkey;Ukraine;United States
      2020   Phase 3   EUCTR2019-003849-15-FR   Austria;Belarus;Brazil;Bulgaria;Chile;Croatia;Czech Republic;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Latvia;Mexico;Moldova, Republic of;Peru;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Turkey;Ukraine;United States
      2020   Phase 3   EUCTR2019-003849-15-ES   Austria;Belarus;Brazil;Bulgaria;Chile;Croatia;Czech Republic;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Latvia;Mexico;Moldova, Republic of;Peru;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Turkey;Ukraine;United States
      2020   Phase 3   EUCTR2019-003849-15-CZ   Austria;Belarus;Bulgaria;Croatia;Czech Republic;Czechia;France;Greece;Israel;Italy;Latvia;Mexico;Moldova, Republic of;Peru;Poland;Russian Federation;Serbia;South Africa;Spain;Turkey;Ukraine
      2020   Phase 3   EUCTR2019-003849-15-BG   Austria;Belarus;Bulgaria;Croatia;Czech Republic;Czechia;France;Greece;Israel;Italy;Latvia;Mexico;Moldova, Republic of;Peru;Poland;Russian Federation;Serbia;South Africa;Spain;Turkey;Ukraine
      2020   Phase 3   EUCTR2019-003849-15-AT   Austria;Belarus;Brazil;Bulgaria;Chile;Croatia;Czech Republic;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Latvia;Mexico;Moldova, Republic of;Peru;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Turkey;Ukraine;United States
   Centocor BV
      2007   -   EUCTR2006-000410-20-DK   Belgium;Denmark;Italy;Netherlands
      2007   -   EUCTR2006-000410-20-BE   Belgium;Denmark;Italy;Netherlands
   Centocor, Inc.
      2006   Phase 3   NCT00336492   Belgium;Canada;Denmark;Netherlands;United States
      2002   Phase 3   NCT00096655   -
      2002   Phase 3   NCT00036439   Belgium;United States
   Centre Hospitalier Universitaire de Rennes
      2018   Phase 4   EUCTR2018-002673-21-FR   France
   Children's Hospital of Fudan University
      2021   Phase 4   NCT04999228   China
   Department of Gastroenterology and Hepatology, Kyoto University Hospital
      2011   -   JPRN-UMIN000006141   Japan
   Department of Internal Medicine, Division of Gastroenterology and Hepatology, Keio University School of Medicine
      2013   Phase 4   JPRN-UMIN000010612   Japan
   Department of Internal Medicine,Juntendo University
      2014   -   JPRN-UMIN000013033   Japan
   Erasmus Medical Center
      2019   Phase 4   EUCTR2018-004587-61-NL   Netherlands
      2013   -   NCT01971970   Netherlands
   Ernest Seidman
      2014   -   NCT02453607   Canada
   Essex Pharma GmbH
      2009   -   EUCTR2009-010065-23-DE   Germany
   F. Hoffmann-La Roche Ltd
      2015   Phase 3   EUCTR2013-004282-14-PT   Austria;Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;Norway;Philippines;Portugal;Romania;Singapore;South Africa;Spain;Sweden;Switzerland;United Kingdom;Vietnam
      2015   Phase 3   EUCTR2013-004282-14-NL   Austria;Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;Norway;Philippines;Portugal;Romania;Singapore;South Africa;Spain;Sweden;Switzerland;United Kingdom;Vietnam
      2014   Phase 3   EUCTR2013-004282-14-NO   Austria;Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;Norway;Philippines;Portugal;Romania;Singapore;South Africa;Spain;Sweden;Switzerland;United Kingdom;Vietnam
      2014   -   EUCTR2013-004282-14-IT   Austria;Belgium;Canada;Czech Republic;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;Norway;Philippines;Portugal;Romania;Singapore;South Africa;Spain;Sweden;Switzerland;United Kingdom;Vietnam
      2014   Phase 3   EUCTR2013-004282-14-HU   Austria;Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;Norway;Portugal;Romania;Singapore;South Africa;Spain;Sweden;Switzerland;United Kingdom
      2014   Phase 3   EUCTR2013-004282-14-GB   Austria;Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;Norway;Portugal;Romania;Singapore;South Africa;Spain;Sweden;Switzerland;United Kingdom
      2014   Phase 3   EUCTR2013-004282-14-FR   Austria;Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;Norway;Philippines;Portugal;Romania;Singapore;South Africa;Spain;Sweden;Switzerland;United Kingdom;Vietnam
      2014   Phase 3   EUCTR2013-004282-14-DE   Austria;Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;Norway;Portugal;Romania;Singapore;South Africa;Spain;Sweden;Switzerland;United Kingdom
      2014   Phase 3   EUCTR2013-004282-14-CZ   Austria;Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;Norway;Portugal;Romania;Singapore;South Africa;Spain;Sweden;Switzerland;United Kingdom
      2014   Phase 3   EUCTR2013-004282-14-BE   Austria;Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;Norway;Portugal;Romania;Singapore;South Africa;Spain;Sweden;Switzerland;United Kingdom
      2014   Phase 3   EUCTR2013-004282-14-AT   Austria;Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;Norway;Portugal;Romania;Singapore;South Africa;Spain;Sweden;Switzerland;United Kingdom
   Federico II University
      2023   -   NCT05931458   -
   Fukuoka University Chikushi Hospital
      2021   -   JPRN-UMIN000043165   Japan
   Fundación Española de Gastroenterología
      2021   Phase 4   EUCTR2021-002211-65-ES   Spain
   Fundación de Investigación Biomédica - Hospital Universitario de La Princesa
      2017   Phase 4   NCT02994836   Spain
   Fundación de Investigación Biomédica Hospital Universitario de la Princesa
      2016   Phase 4   EUCTR2015-001410-10-ES   Spain
   Fundación de Investigación Biomédica del Hospital Universitario de La Princesa
      2018   Phase 4   EUCTR2018-002925-47-ES   Spain
   GETAID
      2008   -   EUCTR2006-005299-42-BE   Belgium;Finland;France;Spain
      2007   -   EUCTR2006-005299-42-FR   Belgium;Finland;France;Spain
   GETECCU (Grupo Español para el estudio de la enfermedad de Crohn y la colitis ulcerosa)
      2008   -   EUCTR2006-005299-42-ES   Belgium;Finland;France;Spain
   Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives
      2016   Phase 4   NCT02425852   France
   Groupe d'Etude Thérapeutique des Affections Inflammatoires Digestives (G.E.T.A.I.D.)
      2008   -   EUCTR2006-005299-42-FI   Belgium;Finland;France;Spain
   Grupo de Estudo da Doença Inflamatória Intestinal
      2011   Phase 4   NCT01408810   Portugal
   Helse More og Romsdal Hospital Trust
      2016   Phase 4   EUCTR2016-001409-18-NO   Norway
   Helwan University
      2025   -   NCT06786507   Egypt
   Hikma Pharmaceuticals LLC
      2018   -   NCT03452501   Saudi Arabia
   Hiroshima University Hospital, Department of Endoscopy
      2014   -   JPRN-UMIN000015068   Japan
   Hoffmann-La Roche
      2014   Phase 3   NCT02136069   Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;Norway;Philippines;Portugal;Romania;Singapore;South Africa;Spain;Sweden;Switzerland;United Kingdom;Vietnam
   Hospira UK Ltd.
      2015   Phase 4   EUCTR2014-005192-89-FI   Belgium;Czech Republic;Finland;France;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovakia;Spain;United Kingdom
   Hyogo College of Medicine
      2014   Phase 1   JPRN-UMIN000014275   Japan
   Hyogo college of medicine
      2013   -   JPRN-UMIN000013371   Japan
   IRCCS Burlo Garofolo
      2022   Phase 4   NCT05280405   Italy
   IRCCS ISTITUTO CLINICO HUMANITAS
      2017   Phase 4   EUCTR2016-002707-25-IT   Italy
   IRCCS MATERNO INFANTILE BURLO GAROFOLO
      2022   Phase 4   EUCTR2021-003220-32-IT   Italy
   Inflammatory bowel disease center, Hyogo college of medicine
      2013   Phase 1   JPRN-UMIN000013370   Japan
   Istituto Clinico Humanitas
      2017   Phase 4   NCT03151525   Italy
   JAROSLAW KIERKUS
      2024   Phase 3   NCT06614387   -
   Janssen Biologics B.V.
      2019   Phase 3   EUCTR2017-004496-31-IT   Belgium;Brazil;France;Israel;Italy;Korea, Republic of;Netherlands;Poland;Spain;Taiwan;United States
      2009   -   EUCTR2008-005237-30-NL   Canada;Netherlands;Sweden;United States
   Janssen Biologics BV
      2019   Phase 3   EUCTR2017-004496-31-PL   Belgium;Brazil;France;Israel;Italy;Korea, Republic of;Netherlands;Poland;Spain;Taiwan;United States
      2019   Phase 3   EUCTR2017-004496-31-NL   Belgium;Brazil;France;Israel;Italy;Korea, Republic of;Netherlands;Poland;Spain;Taiwan;United States
      2018   Phase 3   EUCTR2017-004496-31-FR   Belgium;Brazil;France;Israel;Italy;Korea, Republic of;Netherlands;Poland;Spain;Taiwan;United States
      2018   Phase 3   EUCTR2017-004496-31-ES   Belgium;Brazil;France;Israel;Italy;Korea, Republic of;Netherlands;Poland;Spain;Taiwan;United States
      2018   Phase 3   EUCTR2017-004496-31-BE   Belgium;Brazil;France;Israel;Italy;Korea, Republic of;Netherlands;Poland;Spain;Taiwan;United States
   Janssen Korea, Ltd., Korea
      2007   -   NCT00724529   Korea, Republic of
   Janssen Research & Development, LLC
      2018   Phase 3   NCT03596645   Belgium;Brazil;France;Israel;Italy;Korea, Republic of;Netherlands;Poland;Spain;Taiwan;United States
   Janssen Scientific Affairs, LLC
      2016   Phase 4   NCT02566889   Canada;United States
      2013   Phase 4   NCT01804166   United States
   Katholieke Universiteit Leuven
      2011   Phase 4   EUCTR2011-002061-38-BE   Belgium
   Keio University Gastroenterology and Hepatology
      2016   -   JPRN-UMIN000024936   Japan
   Klinikum Westbrandenburg GmbH
      2015   -   NCT02522169   -
   Marta Maia Boscá Watts
      2019   Phase 2   EUCTR2019-000668-27-ES   Spain
   Medical University of Lodz
      2025   Phase 2   NCT06453317   Poland
   Merck Sharp & Dohme Corp.
      2009   Phase 3   NCT00984568   Germany
      2007   -   NCT00705484   Austria;Belgium;Czech Republic;Denmark;France;Germany;Greece;Ireland;Italy;Netherlands;Spain;Sweden;United Kingdom;United States
      2007   Phase 3   NCT00537316   Argentina;Belgium;Canada;Colombia;Czech Republic;France;Germany;Hungary;Italy;Poland;Portugal;Russian Federation;Spain;Sweden;Switzerland;Ukraine;United Kingdom
   Mitsubishi Tanabe Pharma Corporation
      2006   Phase 3   JPRN-jRCT2080220293   -
   Mundipharma Pharmaceuticals B.V.
      2016   Phase 4   EUCTR2014-004904-31-BE   Belgium;Netherlands
      2015   Phase 4   EUCTR2014-004904-31-NL   Netherlands
   Naganuma Makoto
      2021   -   JPRN-jRCT1031200329   -
   Nagoya University Graduate School of Medicine, Department of Gastroentrology and hepatology
      2015   -   JPRN-UMIN000018745   Japan
   National Institute of Allergy and Infectious Diseases (NIAID)
      2007   Phase 2   NCT00514982   United States
      2006   Phase 1/Phase 2   NCT00325078   United States
   Peking Union Medical College Hospital
      2020   -   NCT05386290   China
   Pfizer
      2019   -   NCT03884439   Japan
   Pontificia Universidad Catolica de Chile
      2025   -   NCT06758024   Chile
   Region Örebro län
      2021   Phase 4   EUCTR2019-002942-19-NO   Denmark;Iceland;Norway
      2021   Phase 4   EUCTR2019-002942-19-IS   Denmark;Iceland
      2021   Phase 4   EUCTR2019-002942-19-DK   Denmark;Iceland
   Rehab Werida
      2022   -   NCT05291039   Egypt
   Rennes University Hospital
      2019   Phase 4   NCT03679546   France
   Roche Farma S.A. en nombre de F. Hoffmann-La Roche Ltd
      2014   Phase 3   EUCTR2013-004282-14-ES   Austria;Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;Norway;Philippines;Portugal;Romania;Singapore;South Africa;Spain;Sweden;Switzerland;United Kingdom;Vietnam
   Royal Liverpool University Hospital
      2012   -   EUCTR2011-006084-22-GB   United Kingdom
   SCHERING-PLOUGH
      2007   -   EUCTR2006-002670-22-IT   Belgium;Czech Republic;France;Germany;Hungary;Italy;Portugal;Spain;United Kingdom
   Schering-Plough Research Institute, a division of Schering Corporation
      2008   Phase 3   EUCTR2006-002670-22-SK   Belgium;Czech Republic;France;Germany;Hungary;Italy;Portugal;Slovakia;Spain;United Kingdom
      2008   Phase 3   EUCTR2006-002670-22-GB   Belgium;Czech Republic;France;Germany;Hungary;Italy;Portugal;Slovakia;Spain;United Kingdom
      2007   -   EUCTR2006-002670-22-PT   Belgium;Czech Republic;France;Germany;Hungary;Italy;Portugal;Spain;United Kingdom
      2007   -   EUCTR2006-002670-22-HU   Belgium;Czech Republic;France;Germany;Hungary;Italy;Portugal;Spain;United Kingdom
      2007   Phase 3   EUCTR2006-002670-22-FR   Belgium;Czech Republic;France;Germany;Hungary;Italy;Portugal;Slovakia;Spain;United Kingdom
      2007   Phase 3   EUCTR2006-002670-22-ES   Belgium;Czech Republic;France;Germany;Hungary;Italy;Portugal;Slovakia;Spain;United Kingdom
      2007   -   EUCTR2006-002670-22-DE   Belgium;Czech Republic;France;Germany;Hungary;Italy;Portugal;Spain;United Kingdom
      2007   -   EUCTR2006-002670-22-CZ   Belgium;Czech Republic;France;Germany;Hungary;Italy;Portugal;Spain;United Kingdom
      2007   Phase 3   EUCTR2006-002670-22-BE   Belgium;Czech Republic;France;Germany;Hungary;Italy;Portugal;Slovakia;Spain;United Kingdom
   Schneider Children's Medical Center, Israel
      2018   -   NCT03209232   Israel
   Sixth Affiliated Hospital, Sun Yat-sen University
      2022   Phase 4   NCT05205603   China
      2021   -   NCT04879966   China
   Southern Medical University Southern Hospital
      2025   -   ChiCTR2500096107   China
   Taina Sipponen
      2016   Phase 4   EUCTR2016-001278-13-FI   Finland
   Tampere University Hospital
      2021   Phase 4   EUCTR2021-000570-28-FI   Finland
   The Affiliated Wuxi People’s Hospital, Nanjing Medical University
      2023   -   ChiCTR2400079722   China
   Tohoku University Graduate School of Medicine (Tohoku University Hospital)
      2012   -   JPRN-UMIN000007341   Japan
   UMC Amsterdam location AMC
      2020   Phase 4   EUCTR2018-003524-36-IE   Ireland;Netherlands;Norway
   UMC Utrecht
      2019   Phase 4   EUCTR2019-003068-39-NL   Netherlands
   UZ Leuven
      2021   Phase 4   EUCTR2020-004012-10-BE   Belgium
   University Hospitals Cleveland Medical Center
      2008   -   NCT00791557   United States
   University Medical Center Groningen
      2021   Phase 4   NCT04646187   Belgium;Netherlands;Spain
      2021   Phase 4   EUCTR2020-001811-26-BE   Belgium;Netherlands;Spain
      2020   Phase 4   EUCTR2020-001811-26-NL   Belgium;Netherlands;Spain
   University Southampton Hospital NHS Foundation Trust
      2018   Phase 4   EUCTR2018-001546-33-GB   United Kingdom
   University of Alberta
      2015   -   NCT02847884   Canada
   University of California, San Francisco
      2013   Phase 1   NCT01971814   United States
   University of Western Ontario, Canada
      2014   Phase 4   NCT01960426   United States
   Universitätsklinik für Innere Medizin III, Klinische Abteilung für Gastroenterologie und Hepatologie
      2013   -   EUCTR2011-001332-29-AT   Austria
   Vastra Gotaland Region
      2024   -   NCT06269185   Sweden
   Xian-Janssen Pharmaceutical Ltd.
      2012   Phase 3   NCT01551290   China
   Yokohama City University Medical Center
      2014   Phase 2   JPRN-UMIN000013716   Japan
   Zon MW
      2014   Phase 4   EUCTR2013-002651-15-NL   Netherlands
Infliximab 10 MG/KG
   Janssen Research & Development, LLC
      2004   -   NCT00207688   Argentina;Australia;Austria;Belgium;Canada;Czech Republic;Czechia;Denmark;France;Germany;Israel;Netherlands;New Zealand;Switzerland;United Kingdom;United States
Infliximab 5 MG/KG
   Janssen Research & Development, LLC
      2004   -   NCT00207688   Argentina;Australia;Austria;Belgium;Canada;Czech Republic;Czechia;Denmark;France;Germany;Israel;Netherlands;New Zealand;Switzerland;United Kingdom;United States
Infliximab adalimumab Y golimumab
   Fundación de Investigación Biomédica - Hospital Universitario de La Princesa
      2022   Phase 4   NCT05313620   Spain
Infliximab and adalimumab
   Regionshospitalet Viborg, Skive
      2009   -   NCT02322008   -
Infliximab AT weeks 0 and 8
   New York University School of Medicine
      2016   Phase 3   NCT02771457   -
Infliximab AT weeks 0,2, and 6
   New York University School of Medicine
      2016   Phase 3   NCT02771457   -
Infliximab AT weeks 0,4, and 8
   New York University School of Medicine
      2016   Phase 3   NCT02771457   -
Infliximab infusion
   Chiba University Hospital
      2012   Phase 2   JPRN-UMIN000015297   Japan
      2012   Phase 2   JPRN-UMIN000007806   Japan
Infliximab or adalimumab or golimumab or vedolizumab or ustekinumab or tofacitinib
   Fundación de Investigación Biomédica - Hospital Universitario de La Princesa
      2019   Phase 4   NCT03885713   Spain
Infliximab therapeutic drug monitoring
   Imelda GI Clinical Research Center
      2018   Phase 4   NCT04775732   Belgium
Infliximab treatment
   Xijing Hospital of Digestive Diseases
      2023   Phase 1   NCT05912712   China
Infliximab, adalimumab, certolizumab pegol
   Oslo University Hospital
      2013   -   NCT02073526   Norway
Infliximab, adalimumab, golimumab, vedolizumab, ustekinumab
   Tampere University Hospital
      2009   -   NCT05530122   -
Infliximab-biosimilar
   Onze Lieve Vrouwe Gasthuis
      2015   Phase 4   NCT02452151   -
Infliximab-innovator
   Onze Lieve Vrouwe Gasthuis
      2015   Phase 4   NCT02452151   -
Influenza vaccination
   University of Calgary
      2012   -   NCT01666535   Canada
Influenza vaccine
   Boston Medical Center
      2017   -   NCT03056924   United States
   Stony Brook University
      2017   Phase 2   NCT03277703   United States
   University of Wisconsin, Madison
      2023   -   NCT05584735   United States
      2016   Phase 4   NCT02461758   United States
Infusion OF saline
   Guangzhou First People's Hospital
      2019   Phase 2/Phase 3   NCT03804931   China
Infusion rate OF infliximab
   University Hospital, Akershus
      2025   -   NCT06839820   Norway
Injectafer
   American Regent, Inc.
      2014   Phase 4   NCT02086968   United States
   Atrium Medical Centre
      2018   Phase 4   EUCTR2012-005644-26-BE   Belgium;Netherlands
Injectafer 50 MG ijzer / ML oplossing voor injectie/infusie
   Iron Therapeutics (UK) Ltd.
      2015   Phase 3   EUCTR2015-002496-26-BE   Belgium;Germany;Hungary;Spain
Innovator infliximab
   Diakonhjemmet Hospital
      2014   Phase 4   NCT02148640   Norway
Inositol
   National Cancer Institute (NCI)
      2010   Phase 1/Phase 2   NCT01111292   United States
Intensify treatment with THE existing drug
   University of Western Ontario, Canada
      2014   Phase 4   NCT01960426   United States
Interferon BETA-1A
   Biogen
      2008   Phase 2   NCT00616434   Canada;Czech Republic;Hungary;Poland;Russian Federation;Slovakia;United States
Interferon-BETA-1A, 44 microgram
   EMD Serono
      2001   Phase 2   NCT00303381   Germany;Israel;Netherlands;Singapore;Spain;Sweden;Switzerland;United Kingdom
Interferon-BETA-1A, 66 microgram
   EMD Serono
      2001   Phase 2   NCT00303381   Germany;Israel;Netherlands;Singapore;Spain;Sweden;Switzerland;United Kingdom
Interleukin 2
   Assistance Publique - Hôpitaux de Paris
      2014   Phase 2   NCT01988506   France
Interleukin-11
   Wyeth is now a wholly owned subsidiary of Pfizer
      2002   Phase 2   NCT00040521   United States
Interleukin-2
   Scott B. Snapper, MD PHD
      2015   Phase 1   NCT02200445   United States
Intestinal flora capsule
   Third Military Medical University
      2021   -   NCT05030064   China
Intravenous (IV) infusions
   Polpharma Biologics S.A.
      2023   Phase 3   NCT05771155   Georgia
Intravenous iron
   Leiden University Medical Center
      2022   Phase 4   NCT05456932   Netherlands
Intravenous iron sucrose
   Wayne State University
      2011   Phase 2   NCT01438372   United States
Intravenous methylprednisolone
   Berinstein, Jeffrey
      2023   Phase 4   NCT05867329   United States
Inulin sachet
   McMaster University
      2024   -   NCT06541938   Canada
INV-101
   Innovo Therapeutics, Inc.
      2022   Phase 1   NCT05844592   Korea, Republic of
Iron
   Iron Therapeutics (Switzerland) AG
      2012   -   EUCTR2010-023588-16-DE   Austria;Germany;Hungary;United Kingdom
      2011   -   EUCTR2010-023588-16-HU   Austria;Germany;Hungary;United Kingdom
      2011   Phase 3   EUCTR2010-023588-16-GB   Austria;Germany;Hungary;United Kingdom
      2011   -   EUCTR2010-023588-16-AT   Austria;Germany;Hungary;United Kingdom
   Liverpool University Hospitals NHS Foundation Trust
      2023   Phase 3   NCT06321887   United Kingdom
Iron (III) hydroxide hydroxyethyl starch glucopheptonic acid complex
   SerumWerk Bernburg AG
      2013   -   EUCTR2013-001123-39-DK   Denmark
Iron dextran
   Pharmacosmos A/S
      2013   -   EUCTR2011-003121-94-NL   Denmark;Netherlands;Sweden
Iron HES complex
   SerumWerk Bernburg AG
      2013   -   EUCTR2013-001123-39-DK   Denmark
Iron isomalto-oligosaccharide complex
   Pharmacosmos A/S
      2011   -   EUCTR2009-012544-16-AT   Austria;Denmark;Hungary;United Kingdom
      2009   Phase 3   EUCTR2009-012544-16-GB   Austria;Denmark;Hungary;United Kingdom
      2009   -   EUCTR2009-012544-16-DK   Austria;Denmark;Hungary;United Kingdom
Iron isomaltoside
   Pharmacosmos A/S
      2018   Phase 4   NCT03466983   Denmark
Iron isomaltoside 1000
   Pharmacosmos A/S
      2014   -   EUCTR2014-001518-25-DE   Germany;Russian Federation;United Kingdom;United States
      2013   -   EUCTR2011-003121-94-NL   Denmark;Netherlands;Sweden
      2012   Phase 3   NCT01599702   Denmark;Sweden
      2012   Phase 1   NCT01213680   India
Iron isomaltoside complex - iron isomaltoside 1000
   Pharmacosmos A/S
      2012   Phase 3   EUCTR2011-001593-25-HU   Austria;Hungary
      2011   -   EUCTR2011-001593-25-AT   Austria;Hungary
Iron oligosaccharide complex
   Pharmacosmos A/S
      2019   Phase 4   EUCTR2017-002452-87-DE   Austria;Denmark;Germany;Sweden;United Kingdom
      2018   Phase 4   EUCTR2017-002452-87-SE   Austria;Denmark;Germany;Sweden;United Kingdom
      2018   Phase 4   EUCTR2017-002452-87-GB   Austria;Denmark;Germany;Sweden;United Kingdom
      2018   Phase 4   EUCTR2017-002452-87-AT   Austria;Denmark;Germany;Sweden;United Kingdom
      2017   Phase 4   EUCTR2017-002452-87-DK   Austria;Denmark;Germany;Sweden;United Kingdom
      2011   -   EUCTR2009-012544-16-AT   Austria;Denmark;Hungary;United Kingdom
      2009   Phase 3   EUCTR2009-012544-16-GB   Austria;Denmark;Hungary;United Kingdom
      2009   -   EUCTR2009-012544-16-DK   Austria;Denmark;Hungary;United Kingdom
Iron status testing
   VIFORFRANCE
      2019   -   NCT04123990   -
Iron sucrose
   Leiden University Medical Center
      2022   Phase 4   EUCTR2022-000894-16-NL   Netherlands
   Richard Fedorak
      2010   Phase 4   NCT01067547   Canada
   Vifor (International) Inc.
      2009   -   EUCTR2008-002333-75-SE   Austria;Denmark;Estonia;Germany;Lithuania;Spain;Sweden;United Kingdom
      2009   -   EUCTR2008-002333-75-LT   Austria;Denmark;Estonia;Germany;Lithuania;Spain;Sweden;United Kingdom
      2009   Phase 3   EUCTR2008-002333-75-GB   Austria;Denmark;Estonia;Germany;Lithuania;Spain;Sweden;United Kingdom
      2009   -   EUCTR2008-002333-75-DK   Austria;Denmark;Estonia;Germany;Lithuania;Spain;Sweden;United Kingdom
      2009   -   EUCTR2008-002333-75-AT   Austria;Denmark;Estonia;Germany;Lithuania;Spain;Sweden;United Kingdom
      2008   Phase 3   EUCTR2008-002333-75-ES   Austria;Denmark;Estonia;Germany;Lithuania;Spain;Sweden;United Kingdom
      2008   -   EUCTR2008-002333-75-EE   Austria;Denmark;Estonia;Germany;Lithuania;Spain;Sweden;United Kingdom
      -   -   EUCTR2008-002333-75-DE   Austria;Denmark;Estonia;Germany;Lithuania;Spain;Sweden;United Kingdom
   Vifor Inc.
      2008   Phase 3   NCT00810030   Austria;Russian Federation
Iron sulfate
   American University of Beirut Medical Center
      2016   Phase 4   NCT02774057   Lebanon
Iron sulphate
   Pharmacosmos A/S
      2009   Phase 3   NCT01017614   Denmark;India;United Kingdom
      2009   Phase 3   EUCTR2009-012544-16-GB   Austria;Denmark;Hungary;United Kingdom
Iron sulphate 200MG coated tablets
   Barts Health NHS Trust
      2011   Phase 4   EUCTR2010-023797-39-GB   United Kingdom
Iron supplement 300-600 MG/DAY
   University Health Network, Toronto
      2002   Phase 2   NCT00152841   Canada
Iron trivalent
   Pharmacosmos A/S
      2019   Phase 4   EUCTR2017-002452-87-DE   Austria;Denmark;Germany;Sweden;United Kingdom
      2018   Phase 4   EUCTR2017-002452-87-SE   Austria;Denmark;Germany;Sweden;United Kingdom
      2018   Phase 4   EUCTR2017-002452-87-GB   Austria;Denmark;Germany;Sweden;United Kingdom
      2018   Phase 4   EUCTR2017-002452-87-AT   Austria;Denmark;Germany;Sweden;United Kingdom
      2017   Phase 4   EUCTR2017-002452-87-DK   Austria;Denmark;Germany;Sweden;United Kingdom
Iron(III) isomaltoside 1000
   Leiden University Medical Center
      2022   Phase 4   EUCTR2022-000894-16-NL   Netherlands
   Pharmacosmos A/S
      2019   Phase 4   EUCTR2017-002452-87-DE   Austria;Denmark;Germany;Sweden;United Kingdom
      2018   Phase 4   EUCTR2017-002452-87-SE   Austria;Denmark;Germany;Sweden;United Kingdom
      2018   Phase 4   EUCTR2017-002452-87-GB   Austria;Denmark;Germany;Sweden;United Kingdom
      2018   Phase 4   EUCTR2017-002452-87-AT   Austria;Denmark;Germany;Sweden;United Kingdom
      2017   Phase 4   EUCTR2017-002452-87-DK   Austria;Denmark;Germany;Sweden;United Kingdom
Iron(III)- hydroxide dextran complex
   Barts Health NHS Trust
      2011   Phase 4   EUCTR2010-023797-39-GB   United Kingdom
Iron(III)-hydroxide dextran complex
   Leiden University Medical Center
      2022   Phase 4   EUCTR2022-000894-16-NL   Netherlands
Itacitinib
   Incyte Corporation
      2018   Phase 2   NCT03627052   United States
Itacitinib adipate
   Incyte Corporation
      2020   Phase 2   EUCTR2018-004491-35-RO   Czechia;Germany;Poland;Romania;United States
      2019   Phase 2   EUCTR2018-004491-35-PL   Czech Republic;Germany;Poland;Romania;United States
Itraconazole
   Guangzhou Women and Children's Medical Center
      2019   Phase 0   ChiCTR1900027287   China
   Theravance Biopharma
      2018   Phase 1   NCT03555617   United States
IV corticosteroid
   Connecticut Children's Medical Center
      2012   Phase 4   NCT01536535   Canada;United States
IV tulisokibart
   Merck Sharp & Dohme LLC
      2023   Phase 3   NCT06052059   Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czechia;Dominican Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
Izinova
   IPSEN PHARMA SAS
      2017   Phase 3   EUCTR2016-002265-60-IT   Czech Republic;Czechia;France;Germany;Italy;Netherlands;Poland
   Ipsen Pharma
      2017   Phase 3   EUCTR2016-002265-60-FR   Czech Republic;France;Germany;Netherlands;Poland
JAK inhibitor
   Humanitas Clinical and Research Center
      2023   -   NCT06691061   Italy
Janus kinase inhibitor
   Alimentiv Inc.
      2020   -   NCT04576000   Belgium;Canada;Italy;Netherlands;Spain;United States
      2020   Phase 4   EUCTR2019-003780-21-NL   Belgium;Canada;Italy;Netherlands;Spain;United States
JNJ-54781532 150 MG once daily
   Janssen Research & Development, LLC
      2013   Phase 2   NCT01959282   Australia;Belgium;Bulgaria;Canada;France;Germany;Hungary;Israel;Netherlands;Poland;Romania;Russian Federation;Ukraine;United States
JNJ-54781532 25 MG once daily
   Janssen Research & Development, LLC
      2013   Phase 2   NCT01959282   Australia;Belgium;Bulgaria;Canada;France;Germany;Hungary;Israel;Netherlands;Poland;Romania;Russian Federation;Ukraine;United States
JNJ-54781532 75 MG once daily
   Janssen Research & Development, LLC
      2013   Phase 2   NCT01959282   Australia;Belgium;Bulgaria;Canada;France;Germany;Hungary;Israel;Netherlands;Poland;Romania;Russian Federation;Ukraine;United States
JNJ-54781532 75 MG twice daily
   Janssen Research & Development, LLC
      2013   Phase 2   NCT01959282   Australia;Belgium;Bulgaria;Canada;France;Germany;Hungary;Israel;Netherlands;Poland;Romania;Russian Federation;Ukraine;United States
JNJ-54781532-AAD-10 MG
   Janssen-Cilag International NV
      2014   Phase 2   EUCTR2013-000263-88-RO   Belgium;Bulgaria;Canada;France;Germany;Hungary;Netherlands;Poland;Romania;Russian Federation;Ukraine;United States
      2014   -   EUCTR2013-000263-88-PL   Belgium;Bulgaria;Canada;France;Germany;Hungary;Netherlands;Poland;Romania;Russian Federation;Ukraine;United States
      2014   -   EUCTR2013-000263-88-NL   Belgium;Bulgaria;Canada;France;Germany;Hungary;Netherlands;Poland;Romania;Russian Federation;Ukraine;United States
      2014   -   EUCTR2013-000263-88-HU   Belgium;Bulgaria;Canada;France;Germany;Hungary;Netherlands;Poland;Romania;Russian Federation;Ukraine;United States
      2014   Phase 2   EUCTR2013-000263-88-DE   Belgium;Bulgaria;Canada;France;Germany;Hungary;Netherlands;Poland;Romania;Russian Federation;Ukraine;United States
      2014   Phase 2   EUCTR2013-000263-88-BG   Belgium;Bulgaria;Canada;France;Germany;Hungary;Netherlands;Poland;Romania;Russian Federation;Ukraine;United States
      2014   -   EUCTR2013-000263-88-BE   Australia;Belgium;Bulgaria;Canada;France;Germany;Hungary;Israel;Netherlands;Poland;Romania;Russian Federation;Ukraine;United States
JNJ-54781532-AAD-30 MG
   Janssen-Cilag International NV
      2014   Phase 2   EUCTR2013-000263-88-RO   Belgium;Bulgaria;Canada;France;Germany;Hungary;Netherlands;Poland;Romania;Russian Federation;Ukraine;United States
      2014   -   EUCTR2013-000263-88-PL   Belgium;Bulgaria;Canada;France;Germany;Hungary;Netherlands;Poland;Romania;Russian Federation;Ukraine;United States
      2014   -   EUCTR2013-000263-88-NL   Belgium;Bulgaria;Canada;France;Germany;Hungary;Netherlands;Poland;Romania;Russian Federation;Ukraine;United States
      2014   -   EUCTR2013-000263-88-HU   Belgium;Bulgaria;Canada;France;Germany;Hungary;Netherlands;Poland;Romania;Russian Federation;Ukraine;United States
      2014   Phase 2   EUCTR2013-000263-88-DE   Belgium;Bulgaria;Canada;France;Germany;Hungary;Netherlands;Poland;Romania;Russian Federation;Ukraine;United States
      2014   Phase 2   EUCTR2013-000263-88-BG   Belgium;Bulgaria;Canada;France;Germany;Hungary;Netherlands;Poland;Romania;Russian Federation;Ukraine;United States
      2014   -   EUCTR2013-000263-88-BE   Australia;Belgium;Bulgaria;Canada;France;Germany;Hungary;Israel;Netherlands;Poland;Romania;Russian Federation;Ukraine;United States
JNJ-54781532-AAD-5 MG
   Janssen-Cilag International NV
      2014   Phase 2   EUCTR2013-000263-88-RO   Belgium;Bulgaria;Canada;France;Germany;Hungary;Netherlands;Poland;Romania;Russian Federation;Ukraine;United States
      2014   -   EUCTR2013-000263-88-PL   Belgium;Bulgaria;Canada;France;Germany;Hungary;Netherlands;Poland;Romania;Russian Federation;Ukraine;United States
      2014   -   EUCTR2013-000263-88-NL   Belgium;Bulgaria;Canada;France;Germany;Hungary;Netherlands;Poland;Romania;Russian Federation;Ukraine;United States
      2014   -   EUCTR2013-000263-88-HU   Belgium;Bulgaria;Canada;France;Germany;Hungary;Netherlands;Poland;Romania;Russian Federation;Ukraine;United States
      2014   Phase 2   EUCTR2013-000263-88-DE   Belgium;Bulgaria;Canada;France;Germany;Hungary;Netherlands;Poland;Romania;Russian Federation;Ukraine;United States
      2014   Phase 2   EUCTR2013-000263-88-BG   Belgium;Bulgaria;Canada;France;Germany;Hungary;Netherlands;Poland;Romania;Russian Federation;Ukraine;United States
      2014   -   EUCTR2013-000263-88-BE   Australia;Belgium;Bulgaria;Canada;France;Germany;Hungary;Israel;Netherlands;Poland;Romania;Russian Federation;Ukraine;United States
JNJ-64841829
   Vedanta Biosciences, Inc.
      2023   Phase 2   EUCTR2021-001280-24-BG   Bulgaria;Czechia;Hungary;Lithuania;Netherlands;Poland;Ukraine;United Kingdom;United States
      2022   Phase 2   EUCTR2021-001280-24-NL   Bulgaria;Czechia;Hungary;Lithuania;Netherlands;Poland;Ukraine;United Kingdom;United States
      2021   Phase 2   EUCTR2021-001280-24-LT   Bulgaria;Czechia;Hungary;Lithuania;Netherlands;Poland;Ukraine;United Kingdom;United States
JNJ-64841842
   Vedanta Biosciences, Inc.
      2023   Phase 2   EUCTR2021-001280-24-BG   Bulgaria;Czechia;Hungary;Lithuania;Netherlands;Poland;Ukraine;United Kingdom;United States
      2022   Phase 2   EUCTR2021-001280-24-NL   Bulgaria;Czechia;Hungary;Lithuania;Netherlands;Poland;Ukraine;United Kingdom;United States
      2021   Phase 2   EUCTR2021-001280-24-LT   Bulgaria;Czechia;Hungary;Lithuania;Netherlands;Poland;Ukraine;United Kingdom;United States
JNJ-64841855
   Vedanta Biosciences, Inc.
      2023   Phase 2   EUCTR2021-001280-24-BG   Bulgaria;Czechia;Hungary;Lithuania;Netherlands;Poland;Ukraine;United Kingdom;United States
      2022   Phase 2   EUCTR2021-001280-24-NL   Bulgaria;Czechia;Hungary;Lithuania;Netherlands;Poland;Ukraine;United Kingdom;United States
      2021   Phase 2   EUCTR2021-001280-24-LT   Bulgaria;Czechia;Hungary;Lithuania;Netherlands;Poland;Ukraine;United Kingdom;United States
JNJ-64841894
   Vedanta Biosciences, Inc.
      2023   Phase 2   EUCTR2021-001280-24-BG   Bulgaria;Czechia;Hungary;Lithuania;Netherlands;Poland;Ukraine;United Kingdom;United States
      2022   Phase 2   EUCTR2021-001280-24-NL   Bulgaria;Czechia;Hungary;Lithuania;Netherlands;Poland;Ukraine;United Kingdom;United States
      2021   Phase 2   EUCTR2021-001280-24-LT   Bulgaria;Czechia;Hungary;Lithuania;Netherlands;Poland;Ukraine;United Kingdom;United States
JNJ-64841907
   Vedanta Biosciences, Inc.
      2023   Phase 2   EUCTR2021-001280-24-BG   Bulgaria;Czechia;Hungary;Lithuania;Netherlands;Poland;Ukraine;United Kingdom;United States
      2022   Phase 2   EUCTR2021-001280-24-NL   Bulgaria;Czechia;Hungary;Lithuania;Netherlands;Poland;Ukraine;United Kingdom;United States
      2021   Phase 2   EUCTR2021-001280-24-LT   Bulgaria;Czechia;Hungary;Lithuania;Netherlands;Poland;Ukraine;United Kingdom;United States
JNJ-64841920
   Vedanta Biosciences, Inc.
      2023   Phase 2   EUCTR2021-001280-24-BG   Bulgaria;Czechia;Hungary;Lithuania;Netherlands;Poland;Ukraine;United Kingdom;United States
      2022   Phase 2   EUCTR2021-001280-24-NL   Bulgaria;Czechia;Hungary;Lithuania;Netherlands;Poland;Ukraine;United Kingdom;United States
      2021   Phase 2   EUCTR2021-001280-24-LT   Bulgaria;Czechia;Hungary;Lithuania;Netherlands;Poland;Ukraine;United Kingdom;United States
JNJ-64841933
   Vedanta Biosciences, Inc.
      2023   Phase 2   EUCTR2021-001280-24-BG   Bulgaria;Czechia;Hungary;Lithuania;Netherlands;Poland;Ukraine;United Kingdom;United States
      2022   Phase 2   EUCTR2021-001280-24-NL   Bulgaria;Czechia;Hungary;Lithuania;Netherlands;Poland;Ukraine;United Kingdom;United States
      2021   Phase 2   EUCTR2021-001280-24-LT   Bulgaria;Czechia;Hungary;Lithuania;Netherlands;Poland;Ukraine;United Kingdom;United States
JNJ-64841946
   Vedanta Biosciences, Inc.
      2023   Phase 2   EUCTR2021-001280-24-BG   Bulgaria;Czechia;Hungary;Lithuania;Netherlands;Poland;Ukraine;United Kingdom;United States
      2022   Phase 2   EUCTR2021-001280-24-NL   Bulgaria;Czechia;Hungary;Lithuania;Netherlands;Poland;Ukraine;United Kingdom;United States
      2021   Phase 2   EUCTR2021-001280-24-LT   Bulgaria;Czechia;Hungary;Lithuania;Netherlands;Poland;Ukraine;United Kingdom;United States
JNJ-66525433
   Janssen Research & Development, LLC
      2020   Phase 1   NCT04457960   Georgia;Germany;Moldova, Republic of
JNJ-72537634
   Vedanta Biosciences, Inc.
      2021   Phase 2   EUCTR2021-001280-24-HU   Bulgaria;Czechia;Hungary;Lithuania;Netherlands;Poland;Russian Federation;Ukraine;United States
JNJ-77242113
   Janssen Research & Development, LLC
      2023   Phase 2   NCT06049017   Argentina;Australia;Belgium;Brazil;Canada;China;Czechia;France;Germany;Hungary;India;Italy;Japan;Korea, Republic of;Malaysia;Poland;Romania;Spain;Turkey;United Kingdom;United States
JNJ-78934804
   JANSSEN CILAG INTERNATIONAL NV
      2022   Phase 2   EUCTR2021-005528-39-IT   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;Finland;France;Georgia;Germany;Greece;Hong Kong;Hungary;India;Ireland;Israel;Italy;Japan;Jordan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
   Janssen Research & Development, LLC
      2022   Phase 2   NCT05242484   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czechia;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Jordan;Korea, Republic of;Lithuania;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;United Kingdom;United States
   Janssen-Cilag International NV
      2023   Phase 2   EUCTR2021-005528-39-SK   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Jordan;Korea, Republic of;Lithuania;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Switzerland;Taiwan;Türkiye;Ukraine;United Kingdom;United States
      2023   Phase 2   EUCTR2021-005528-39-SI   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Jordan;Korea, Republic of;Lithuania;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2023   Phase 2   EUCTR2021-005528-39-SE   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Jordan;Korea, Republic of;Lithuania;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2023   Phase 2   EUCTR2021-005528-39-PT   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;Finland;France;Georgia;Germany;Greece;Hong Kong;Hungary;India;Ireland;Israel;Italy;Japan;Jordan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2023   Phase 2   EUCTR2021-005528-39-NO   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Jordan;Korea, Republic of;Lithuania;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2023   Phase 2   EUCTR2021-005528-39-HR   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;Finland;France;Georgia;Germany;Greece;Hong Kong;Hungary;India;Ireland;Israel;Italy;Japan;Jordan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2023   Phase 2   EUCTR2021-005528-39-FR   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Jordan;Korea, Republic of;Lithuania;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2023   Phase 2   EUCTR2021-005528-39-DK   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Jordan;Korea, Republic of;Lithuania;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2023   Phase 2   EUCTR2021-005528-39-DE   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Jordan;Korea, Republic of;Lithuania;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2023   Phase 2   EUCTR2021-005528-39-BG   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Jordan;Korea, Republic of;Lithuania;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2023   Phase 2   EUCTR2021-005528-39-AT   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2022   Phase 2   EUCTR2021-005528-39-NL   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Jordan;Korea, Republic of;Lithuania;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2022   Phase 2   EUCTR2021-005528-39-HU   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Jordan;Korea, Republic of;Lithuania;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2022   Phase 2   EUCTR2021-005528-39-CZ   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Jordan;Korea, Republic of;Lithuania;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
   Nishikawa Kazuko
      2023   Phase 2   JPRN-jRCT2031220308   Argentina;Australia;Austria,;Belgium;Brazil;Bulgaria;Canada;Chile;Czechia;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Korea;Mexico;Netherlands;NewZealand;Norway;Poland;Portugal;Republic Of Lithuania;Serbia;Spain;Switzerland;United Kingdom Of Great Britain
Jyseleca
   GALAPAGOS NV
      2022   Phase 3   EUCTR2022-000719-30-IT   Belgium;Czech Republic;Czechia;France;Germany;Hungary;India;Italy;Korea, Republic of;Poland;South Africa;Spain;Switzerland;Taiwan;United Kingdom;United States
   Galapagos NV
      2022   Phase 3   EUCTR2022-000719-30-PL   Belgium;Czech Republic;Czechia;France;Germany;Hungary;India;Italy;Korea, Republic of;Poland;South Africa;Spain;Taiwan;United Kingdom;United States
      2022   Phase 3   EUCTR2022-000719-30-FR   Belgium;Czech Republic;Czechia;France;Germany;Hungary;India;Italy;Korea, Republic of;Poland;South Africa;Spain;Switzerland;Taiwan;United Kingdom;United States
      2022   Phase 3   EUCTR2022-000719-30-ES   Belgium;Czech Republic;Czechia;France;Germany;Hungary;India;Italy;Korea, Republic of;Poland;South Africa;Spain;Switzerland;Taiwan;United Kingdom;United States
      2022   Phase 3   EUCTR2022-000719-30-CZ   Belgium;Czech Republic;Czechia;France;Germany;Hungary;India;Italy;Korea, Republic of;Poland;South Africa;Spain;Taiwan;United Kingdom;United States
      2022   Phase 3   EUCTR2022-000719-30-BE   Belgium;Czech Republic;Czechia;France;Germany;Hungary;India;Italy;Korea, Republic of;Poland;South Africa;Spain;Taiwan;United Kingdom;United States
K(D)PT
   DR. AUGUST WOLFF GMBH & CO. KG
      2012   -   EUCTR2011-002462-20-IT   Czech Republic;Germany;Hungary;Italy;Poland;Slovakia
   Dr August Wolff GmbH & Co KG Arzneimittel
      2012   -   EUCTR2011-002462-20-SK   Czech Republic;Germany;Hungary;Italy;Poland;Slovakia
      2011   -   EUCTR2011-002462-20-PL   Czech Republic;Germany;Hungary;Italy;Poland
      2011   -   EUCTR2011-002462-20-HU   Czech Republic;Germany;Hungary;Italy;Poland
      2011   -   EUCTR2011-002462-20-DE   Czech Republic;Germany;Hungary;Italy;Poland
      2011   -   EUCTR2011-002462-20-CZ   Czech Republic;Germany;Hungary;Italy;Poland
   Dr. August Wolff GmbH & Co. KG Arzneimittel
      2011   Phase 2   EUCTR2010-023494-19-SE   Sweden
KamillenblüTEN 3ML/10ML
   Steigerwald Arzneimittelwerk GmbH
      2014   -   EUCTR2013-000891-13-DE   Germany
Kappaproct
   INDEX PHARMACEUTICALS
      2012   -   EUCTR2011-003130-14-IT   Czech Republic;Germany;Hungary;Italy;Poland;United Kingdom
   InDex Pharmaceuticals
      2011   Phase 3   NCT01493960   Czech Republic;France;Germany;Hungary;Italy;Poland;United Kingdom
   InDex Pharmaceuticals AB
      2012   -   EUCTR2011-003130-14-CZ   Czech Republic;Germany;Hungary;Italy;Poland;United Kingdom
      2011   -   EUCTR2011-003130-14-PL   Czech Republic;Germany;Hungary;Italy;Poland;United Kingdom
      2011   -   EUCTR2011-003130-14-HU   Czech Republic;Germany;Hungary;Italy;Poland;United Kingdom
      2011   Phase 3   EUCTR2011-003130-14-GB   Czech Republic;Germany;Hungary;Italy;Poland;United Kingdom
      2011   -   EUCTR2011-003130-14-DE   Czech Republic;Germany;Hungary;Italy;Poland;United Kingdom
      2006   -   EUCTR2006-001846-15-SE   Sweden
KBL697
   KoBioLabs
      2022   Phase 2   NCT04898348   Australia
Kdpt
   Dr August Wolff GmbH & Co KG Arzneimittel
      2012   -   EUCTR2011-002462-20-SK   Czech Republic;Germany;Hungary;Italy;Poland;Slovakia
      2011   -   EUCTR2011-002462-20-PL   Czech Republic;Germany;Hungary;Italy;Poland
      2011   -   EUCTR2011-002462-20-HU   Czech Republic;Germany;Hungary;Italy;Poland
      2011   -   EUCTR2011-002462-20-DE   Czech Republic;Germany;Hungary;Italy;Poland
      2011   -   EUCTR2011-002462-20-CZ   Czech Republic;Germany;Hungary;Italy;Poland
KHK4083
   Kyowa Kirin Co., Ltd.
      2016   Phase 1   NCT02985593   Japan
   Kyowa Kirin Pharmaceutical Development, Inc.
      2016   Phase 2   EUCTR2015-001555-69-PL   Czech Republic;Hungary;Poland;Romania;Russian Federation;Serbia;United States
      2016   Phase 2   EUCTR2015-001555-69-HU   Czech Republic;Hungary;Poland;Russian Federation;Serbia;United States
      2016   Phase 2   EUCTR2015-001555-69-CZ   Czech Republic;Hungary;Poland;Russian Federation;Serbia;United States
   Kyowa Kirin, Inc.
      2016   Phase 2   NCT02647866   Czech Republic;Czechia;Hungary;Poland;Puerto Rico;Romania;Russian Federation;Serbia;United States
Klean prep - polvere PER soluzione orale 4 bustine DA 69 G
   IPSEN PHARMA SAS
      2017   Phase 3   EUCTR2016-002265-60-IT   Czech Republic;Czechia;France;Germany;Italy;Netherlands;Poland
Klean-prep
   IPSEN PHARMA SAS
      2017   Phase 3   EUCTR2016-002265-60-IT   Czech Republic;Czechia;France;Germany;Italy;Netherlands;Poland
   Ipsen Pharma
      2017   Phase 3   EUCTR2016-002265-60-NL   Czech Republic;France;Germany;Italy;Netherlands;Poland
      2017   Phase 3   EUCTR2016-002265-60-FR   Czech Republic;France;Germany;Netherlands;Poland
      2017   Phase 3   EUCTR2016-002265-60-DE   Czech Republic;France;Germany;Italy;Netherlands;Poland
      2017   Phase 3   EUCTR2016-002265-60-CZ   Czech Republic;France;Germany;Italy;Netherlands;Poland
      -   Phase 3   EUCTR2016-002265-60-PL   Czech Republic;France;Germany;Italy;Netherlands;Poland
Kleanlyte
   University of Manitoba
      2024   Phase 4   NCT06298461   Canada
Kremezin®, spherical adsorptive carbon
   Ocera Therapeutics, Inc.
      2007   -   EUCTR2005-005363-28-HU   Austria;Belgium;Czech Republic;Germany;Hungary;United Kingdom
      2007   -   EUCTR2005-005363-28-AT   Austria;Belgium;Czech Republic;Germany;Hungary;United Kingdom
      2006   Phase 3   EUCTR2005-005363-28-GB   Austria;Belgium;Czech Republic;Germany;Hungary;United Kingdom
      2006   -   EUCTR2005-005363-28-DE   Austria;Belgium;Czech Republic;Germany;Hungary;United Kingdom
      2006   -   EUCTR2005-005363-28-CZ   Austria;Belgium;Czech Republic;Germany;Hungary;United Kingdom
      2006   -   EUCTR2005-005363-28-BE   Austria;Belgium;Czech Republic;Germany;Hungary;United Kingdom
KRP203
   Novartis Pharmaceuticals
      2010   Phase 2   NCT01375179   Belgium;Germany;Hungary;Sweden;Switzerland;United Kingdom
   Novartis Services AG
      2010   -   EUCTR2010-019970-33-SE   Belgium;Germany;Hungary;Sweden;United Kingdom
      2010   -   EUCTR2010-019970-33-DE   Belgium;Germany;Hungary;Sweden;United Kingdom
KRP203A
   Novartis Services AG
      2011   -   EUCTR2010-019970-33-GB   Belgium;Germany;Hungary;Sweden;United Kingdom
      2010   -   EUCTR2010-019970-33-SE   Belgium;Germany;Hungary;Sweden;United Kingdom
      2010   -   EUCTR2010-019970-33-HU   Belgium;Germany;Hungary;Sweden;United Kingdom
      2010   -   EUCTR2010-019970-33-DE   Belgium;Germany;Hungary;Sweden;United Kingdom
      2010   Phase 2   EUCTR2010-019970-33-BE   Belgium;Germany;Hungary;Sweden;United Kingdom
KSP-0243
   Kissei Pharmaceutical Co., Ltd.
      2023   Phase 2   NCT05831670   Japan
      2022   Phase 2   EUCTR2022-000942-14-RO   Georgia;Moldova, Republic of;Romania
KYO-dophilus
   University of California, Irvine
      2007   Phase 1   NCT00578799   United States
Kümmel 2ML/10ML
   Steigerwald Arzneimittelwerk GmbH
      2014   -   EUCTR2013-000891-13-DE   Germany
L-lysyl-D-prolyl-L-threonine acetate
   Dr August Wolff GmbH & Co KG Arzneimittel
      2012   -   EUCTR2011-002462-20-SK   Czech Republic;Germany;Hungary;Italy;Poland;Slovakia
      2011   -   EUCTR2011-002462-20-PL   Czech Republic;Germany;Hungary;Italy;Poland
      2011   -   EUCTR2011-002462-20-HU   Czech Republic;Germany;Hungary;Italy;Poland
      2011   -   EUCTR2011-002462-20-DE   Czech Republic;Germany;Hungary;Italy;Poland
      2011   -   EUCTR2011-002462-20-CZ   Czech Republic;Germany;Hungary;Italy;Poland
L-lysyl-D-prolyl-lthreonine acetate, lyophilisate
   DR. AUGUST WOLFF GMBH & CO. KG
      2012   -   EUCTR2011-002462-20-IT   Czech Republic;Germany;Hungary;Italy;Poland;Slovakia
Laboratory biomarker analysis
   National Cancer Institute (NCI)
      2016   Phase 1   NCT02365480   China;United States
Laboratory testing
   Oregon Health and Science University
      2021   Early Phase 1   NCT05119712   United States
Lactated ringers
   Spectrum Health Hospitals
      2007   Phase 3   NCT00467922   United States
Lactobacillus casei
   Jiangnan University
      2020   Phase 0   ChiCTR2000033953   China
Lactobacillus casei DG
   University of Padova
      2016   -   NCT03136419   Italy
Lactobacillus GG
   Children's Hospital Medical Center, Cincinnati
      2011   Phase 2   NCT00895336   United States
Lactobacillus plantarum
   Jiangnan University
      2020   Phase 0   ChiCTR2000033953   China
Lactobacillus reuteri
   BioGaia Pharma AB
      2021   Phase 1;Phase 2   EUCTR2019-004578-25-SE   Sweden
   Uppsala University
      2017   Phase 2   NCT03798210   Sweden
Lactobacillus rhamnosus GG atcc 53103
   San Giovanni Addolorata Hospital
      2019   Phase 1/Phase 2   NCT04102852   Italy
Lactobacillus salivarius UCC118
   University College Cork
      2002   Phase 2/Phase 3   NCT00510978   Ireland
Lactobacilus acidophilus & bifidobacterium animalis/lactis
   Hvidovre University Hospital
      2004   Phase 2   NCT00268164   Denmark
Lactose IN water
   University Hospitals, Leicester
      2007   -   NCT00403923   United Kingdom
Lactose sachet
   McMaster University
      2024   -   NCT06541938   Canada
Lactulose
   Department of Gastroenterology, The Second Affiliated Hospital of Wenzhou Medical University
      2023   -   ChiCTR2300071791   China
LAP TAP bupivacaine/epinephrine
   Cedars-Sinai Medical Center
      2015   -   NCT02538679   -
LC51-0255
   LG Chem
      2020   Phase 2   NCT04096573   -
LDP-02
   Millennium Pharmaceuticals, Inc.
      2009   -   EUCTR2008-002782-32-AT   Austria;Belgium;Bulgaria;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;Iceland;Ireland;Italy;Latvia;Malta;Netherlands;Portugal;Spain;United Kingdom
Lenograstim
   POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI
      2009   Phase 2   EUCTR2008-008285-12-IT   Italy
Levocarnitine
   SIGMA-TAU
      2005   -   EUCTR2005-003471-20-IT   Italy;Lithuania
Levocarnitine propyl hydrochloride
   SIGMA-TAU
      2012   -   EUCTR2011-004765-32-IT   Belgium;Czech Republic;Italy;Netherlands
   Sigma-Tau Industrie Farmaceutiche Riunite S.p.A.
      2012   -   EUCTR2011-004770-28-PL   Austria;France;Germany;Hungary;Latvia;Lithuania;Poland;Spain
      2012   -   EUCTR2011-004770-28-LV   Austria;France;Germany;Hungary;Latvia;Lithuania;Poland;Spain
      2012   -   EUCTR2011-004770-28-LT   Austria;France;Germany;Hungary;Latvia;Lithuania;Poland;Spain
      2012   -   EUCTR2011-004770-28-HU   Austria;Germany;Hungary;Latvia;Lithuania;Poland;Spain
      2012   Phase 3   EUCTR2011-004770-28-ES   Austria;France;Germany;Hungary;Latvia;Lithuania;Poland;Spain
      2012   -   EUCTR2011-004770-28-AT   Austria;Germany;Hungary;Latvia;Lithuania;Poland;Spain
      2012   Phase 3   EUCTR2011-004765-32-SK   Belgium;Czech Republic;Italy;Netherlands;Slovakia
      2012   Phase 3   EUCTR2011-004765-32-NL   Belgium;Czech Republic;Israel;Italy;Netherlands;Russian Federation;Slovakia
      2012   -   EUCTR2011-004765-32-CZ   Belgium;Czech Republic;Italy;Netherlands
      2012   Phase 3   EUCTR2011-004765-32-BE   Belgium;Czech Republic;Italy;Netherlands;Slovakia
Levotonine
   Ghent University Hospital
      2018   Phase 2   EUCTR2017-005059-10-BE   Belgium
Levovanox
   UNIVERSITÀ DEGLI STUDI MILANO BICOCCA
      2022   Phase 2   EUCTR2022-000875-37-IT   Italy
Linaclotide
   University of Virginia
      2015   Phase 4   NCT02465385   United States
Liposomal curcumin
   S.LAB (SOLOWAYS)
      2024   -   NCT06867939   Russian Federation
LIV001
   Liveome Inc.
      2025   Phase 1   NCT06749795   Poland
      2023   Phase 1   NCT05975047   Australia
Live SK08 powder
   Guangzhou Zhiyi Biotechnology Co., Ltd.
      2025   Phase 2   NCT06725017   -
Lixacol
   Palau Pharma S.A.
      2009   Phase 2   EUCTR2008-004610-27-SK   Belgium;Hungary;Slovakia;Spain
      2009   -   EUCTR2008-004610-27-HU   Belgium;Hungary;Spain
      2008   Phase 2   EUCTR2008-004610-27-ES   Belgium;Hungary;Slovakia;Spain
      2008   -   EUCTR2008-004610-27-BE   Belgium;Hungary;Spain
LMT503
   Lmito Therapeutics Inc.
      2025   Phase 1   NCT05659953   Netherlands
Loperamide
   Department of surgery, Odense University Hospital
      2014   Phase 4   EUCTR2014-004740-35-DK   Denmark
   Odense University Hospital
      2014   Phase 3   NCT02266849   Denmark
Loperamide hydrochloride
   University of Leeds
      2020   Phase 2;Phase 3   EUCTR2019-003220-21-GB   United Kingdom
Losartan
   Takeda
      2016   Phase 4   NCT02760615   United States
Lovoldyl*30CPR RIV 5MG
   AZIENDA OSPEDALIERA L. SACCO (A.O. DI RILIEVO NAZIONALE)
      2012   -   EUCTR2012-004214-34-IT   Italy
LOW dose
   Ageishi Yuji
      2022   Phase 2   JPRN-jRCT2011210030   Australia;Austria;Belgium;Bulgaria;Canada;Czechia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Poland;Puerto Rico;Romania;Russian Federation;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
   Eli Lilly Japan K.K.
      2016   Phase 2   JPRN-jRCT2080223301   Europe;Japan;North America;Oceania
   Hama Yoriko
      2023   Phase 2   JPRN-jRCT2071230044   Japan;Romania;Switzerland;United States
   Holy Stone Healthcare Co., Ltd
      2016   Phase 2   NCT02493712   Italy;Taiwan
   Liu W. Jerry
      2022   Phase 2-3   JPRN-jRCT2021220013   France;Japan;United States
   Shikamura Mitsuhiro
      2021   Phase 3   JPRN-jRCT2071210030   Australia;Belgium;Bosnia;Canada;China;Croatia;Czech Republic;Germany;Hungary;Israel;Italy;Japan;Lithuania;New Zealand;Poland;Romania;Russia;Slovakia;Spain;Ukraine;United Kingdom;United States
   Shire
      2014   Phase 3   NCT02093663   Belgium;Canada;Germany;Hungary;Israel;Netherlands;Poland;Slovakia;United Kingdom;United States
LOW dose budesonide
   Bausch Health Americas, Inc.
      2023   Phase 4   NCT04314375   United States
LOW dose budesonide rectal foam
   Bausch Health Americas, Inc.
      2024   Phase 4   NCT05976802   -
LOW dose MT-1303
   Bausch Health Americas, Inc.
      2021   Phase 2   NCT04857112   United States
LOW dose naltrexone
   Santa Barbara Cottage Hospital
      2013   Phase 2   NCT01810185   United States
LOW fodmap
   Vendsyssel Hospital
      2018   -   NCT02469220   Denmark
LOW fodmap diet
   McMaster University
      2024   -   NCT06541938   Canada
LOW protein and high fiber diet
   Mayo Clinic
      2021   -   NCT04933162   United States
LOW-dose CICR-NAM
   University Hospital Schleswig-Holstein
      2024   Phase 2/Phase 3   NCT06488625   Germany
LT-02
   Dr. Falk Pharma GmbH
      2016   Phase 3   EUCTR2013-001205-84-HU   Austria;Belgium;Germany;Hungary;Israel;Latvia;Lithuania;Netherlands;Poland;Russian Federation;Slovakia;Switzerland;Ukraine
      2016   Phase 3   EUCTR2013-001205-84-BE   Austria;Belgium;Czech Republic;Germany;Hungary;Israel;Latvia;Lithuania;Netherlands;Poland;Russian Federation;Slovakia;Switzerland;Ukraine
      2015   Phase 3   EUCTR2013-001205-84-SK   Austria;Belgium;Czech Republic;Germany;Hungary;Israel;Latvia;Lithuania;Netherlands;Poland;Russian Federation;Slovakia;Switzerland;Ukraine
      2015   Phase 3   EUCTR2013-001205-84-PL   Austria;Belgium;Czech Republic;Germany;Hungary;Israel;Latvia;Lithuania;Netherlands;Poland;Russian Federation;Slovakia;Switzerland;Ukraine
      2015   Phase 3   EUCTR2013-001205-84-LV   Austria;Belgium;Czech Republic;Germany;Hungary;Israel;Latvia;Lithuania;Netherlands;Poland;Russian Federation;Slovakia;Switzerland;Ukraine
      2015   Phase 3   EUCTR2013-001205-84-DE   Austria;Belgium;Czech Republic;Germany;Hungary;Israel;Latvia;Lithuania;Netherlands;Poland;Russian Federation;Slovakia;Switzerland;Ukraine
      2015   Phase 3   EUCTR2013-001205-84-AT   Austria;Belgium;Czech Republic;Germany;Hungary;Israel;Latvia;Lithuania;Netherlands;Poland;Russian Federation;Slovakia;Switzerland;Ukraine
      2014   Phase 3   NCT02280629   Germany
      2014   Phase 3   NCT02142725   Germany
      2014   Phase 3   EUCTR2012-003702-27-SK   Austria;Belgium;Czech Republic;Germany;Hungary;Israel;Latvia;Lithuania;Netherlands;Poland;Russian Federation;Slovakia;Switzerland;Ukraine
      2014   Phase 3   EUCTR2012-003702-27-PL   Austria;Belgium;Czech Republic;Germany;Hungary;Israel;Latvia;Lithuania;Netherlands;Poland;Russian Federation;Slovakia;Switzerland;Ukraine
      2014   Phase 3   EUCTR2012-003702-27-NL   Austria;Belgium;Czech Republic;Germany;Hungary;Israel;Latvia;Lithuania;Netherlands;Poland;Russian Federation;Slovakia;Switzerland;Ukraine
      2014   Phase 3   EUCTR2012-003702-27-LV   Austria;Belgium;Czech Republic;Germany;Hungary;Israel;Latvia;Lithuania;Netherlands;Poland;Russian Federation;Slovakia;Switzerland;Ukraine
      2014   Phase 3   EUCTR2012-003702-27-LT   Austria;Belgium;Czech Republic;Germany;Hungary;Israel;Latvia;Lithuania;Netherlands;Poland;Russian Federation;Slovakia;Switzerland;Ukraine
      2014   Phase 3   EUCTR2012-003702-27-HU   Austria;Belgium;Czech Republic;Germany;Hungary;Israel;Latvia;Lithuania;Netherlands;Poland;Russian Federation;Slovakia;Switzerland;Ukraine
      2014   Phase 3   EUCTR2012-003702-27-DE   Austria;Belgium;Czech Republic;Germany;Hungary;Israel;Latvia;Lithuania;Netherlands;Poland;Russian Federation;Slovakia;Switzerland;Ukraine
      2014   Phase 3   EUCTR2012-003702-27-CZ   Austria;Belgium;Czech Republic;Germany;Hungary;Israel;Latvia;Lithuania;Netherlands;Poland;Russian Federation;Slovakia;Switzerland;Ukraine
      2014   Phase 3   EUCTR2012-003702-27-BE   Austria;Belgium;Czech Republic;Germany;Hungary;Israel;Latvia;Lithuania;Netherlands;Poland;Russian Federation;Slovakia;Switzerland;Ukraine
      2014   Phase 3   EUCTR2012-003702-27-AT   Austria;Belgium;Czech Republic;Germany;Hungary;Israel;Latvia;Lithuania;Netherlands;Poland;Russian Federation;Slovakia;Switzerland;Ukraine
   Lipid Therapeutics GmbH
      2009   Phase 2   NCT01011322   Germany;Lithuania;Romania
      2009   -   EUCTR2008-007952-90-LT   Germany;Lithuania
      2009   -   EUCTR2008-007952-90-DE   Germany;Lithuania
   Prometheus Laboratories
      2016   Phase 3   NCT02849951   United States
Lubiprostone
   Hidetoshi Ohta
      2013   Phase 3   JPRN-jRCT1092220114   Japan
   University of South Alabama
      2008   Phase 4   NCT00746395   United States
Lumbar puncture
   Shire
      2012   Phase 1   NCT01387594   Austria;Belgium;France;Germany;Netherlands
Lusvertikimab
   OSE Immunotherapeutics
      2023   Phase 2   EUCTR2020-001398-59-PT   Belarus;Belgium;Bulgaria;Croatia;Georgia;Hungary;Israel;Latvia;Lithuania;Poland;Portugal;Russian Federation;Serbia;South Africa;Spain;Ukraine
      2020   Phase 2   EUCTR2020-001398-59-LV   Belarus;Belgium;Bulgaria;Croatia;Georgia;Hungary;Latvia;Poland;Portugal;Russian Federation;Serbia;South Africa;Spain;Ukraine
      2020   Phase 2   EUCTR2020-001398-59-HR   Belarus;Belgium;Bulgaria;Croatia;Georgia;Hungary;Latvia;Poland;Portugal;Russian Federation;Serbia;South Africa;Spain;Ukraine
      2020   Phase 2   EUCTR2020-001398-59-BG   Belarus;Belgium;Bulgaria;Croatia;Georgia;Hungary;Latvia;Poland;Portugal;Russian Federation;Serbia;South Africa;Spain;Ukraine
      2020   Phase 2   EUCTR2020-001398-59-BE   Belarus;Belgium;Bulgaria;Croatia;Georgia;Hungary;Latvia;Lithuania;Poland;Portugal;Russian Federation;Serbia;Ukraine
Lutikizumab
   AbbVie
      2024   Phase 2   NCT06257875   Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;New Zealand;Norway;Poland;Puerto Rico;Serbia;Slovenia;South Africa;Spain;Switzerland;Taiwan;United Kingdom;United States
LX1606
   Lexicon Pharmaceuticals, Inc.
      2012   -   EUCTR2011-003532-32-LT   Belgium;Lithuania;Poland;Slovakia;United States
      2011   -   EUCTR2011-003532-32-SK   Belgium;Lithuania;Poland;Slovakia;United States
LY3074828
   ELI LILLY & COMPANY, LILLY CORPORATE CENTER
      2022   Phase 3   EUCTR2020-005311-49-IT   Argentina;Australia;Austria;Belgium;Canada;Czechia;Denmark;France;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Netherlands;Norway;Poland;Portugal;Slovakia;Spain;United Kingdom;United States
      2019   Phase 3   EUCTR2017-004092-31-IT   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czechia;Denmark;France;Georgia;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Netherlands;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-003238-96-IT   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Czechia;Denmark;France;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-003229-14-IT   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Czechia;Denmark;France;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Democratic People's Republic of;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom
   Eli Lilly Cork Limited
      2018   Phase 3   EUCTR2017-003238-96-DK   Argentina;Australia;Austria;Belgium;Canada;China;Croatia;Czech Republic;Denmark;France;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-003229-14-HU   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Denmark;France;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-003229-14-DK   Argentina;Australia;Austria;Belgium;Canada;China;Croatia;Czech Republic;Denmark;France;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
   Eli Lilly Japan K.K.
      2019   Phase 3   JPRN-jRCT2080224156   Asia except Japan;Europe;Japan;North America;Oceania;South America
      2018   Phase 3   JPRN-jRCT2080224155   Asia except Japan;Europe;Japan;North America;Oceania;South America
      2018   Phase 3   JPRN-jRCT2080224003   Asia except Japan;Europe;Japan;Middle East;North America;Oceania;South America
      2016   Phase 2   JPRN-jRCT2080223301   Europe;Japan;North America;Oceania
   Eli Lilly and Company
      2021   Phase 3   EUCTR2019-001653-99-LV   Argentina;Australia;Austria;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;France;Germany;Hungary;India;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2021   Phase 3   EUCTR2019-001653-99-LT   Argentina;Australia;Austria;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;France;Germany;Hungary;India;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2021   Phase 3   EUCTR2019-001653-99-DE   Argentina;Australia;Austria;Belgium;Brazil;Canada;Croatia;Czech Republic;Czechia;Denmark;France;Germany;Hungary;India;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2021   Phase 3   EUCTR2019-001653-99-BE   Argentina;Australia;Austria;Belgium;Brazil;Canada;Croatia;Czechia;Denmark;France;Germany;Hungary;India;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2021   Phase 3   EUCTR2019-001653-99-AT   Argentina;Australia;Austria;Belgium;Brazil;Canada;Croatia;Czech Republic;Czechia;Denmark;France;Germany;Hungary;India;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2020   Phase 3   EUCTR2019-001653-99-FR   Argentina;Australia;Austria;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;France;Germany;Hungary;India;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2020   Phase 3   EUCTR2017-004092-31-RO   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czechia;Denmark;France;Georgia;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Netherlands;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2020   Phase 3   EUCTR2017-004092-31-AT   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czechia;Denmark;France;Georgia;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Netherlands;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2017-004092-31-SK   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czechia;Denmark;France;Georgia;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Netherlands;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2017-004092-31-PL   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Denmark;France;Georgia;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Netherlands;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2017-004092-31-HU   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Denmark;France;Georgia;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Netherlands;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2017-004092-31-HR   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Denmark;France;Georgia;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Netherlands;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2017-004092-31-FR   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Denmark;France;Georgia;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Netherlands;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2017-004092-31-DE   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czechia;Denmark;France;Georgia;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Netherlands;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2017-003238-96-RO   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Czechia;Denmark;France;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2017-003238-96-HR   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Denmark;France;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2017-003229-14-RO   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Czechia;Denmark;France;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2017-003229-14-HR   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Denmark;France;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004092-31-NL   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czechia;Denmark;France;Georgia;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Netherlands;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004092-31-LV   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czechia;Denmark;France;Georgia;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Netherlands;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004092-31-LT   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czechia;Denmark;France;Georgia;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Netherlands;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004092-31-GB   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Denmark;France;Georgia;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Netherlands;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004092-31-DK   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czechia;Denmark;France;Georgia;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Netherlands;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004092-31-BE   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czechia;Denmark;France;Georgia;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Netherlands;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-003238-96-SK   Argentina;Australia;Austria;Belgium;Canada;China;Croatia;Czech Republic;Denmark;France;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-003238-96-NL   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Denmark;France;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-003238-96-LV   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Denmark;France;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-003238-96-LT   Argentina;Australia;Austria;Belgium;Canada;China;Croatia;Czech Republic;Denmark;France;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-003238-96-HU   Argentina;Australia;Austria;Belgium;Canada;China;Croatia;Czech Republic;Denmark;France;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-003238-96-GB   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Denmark;France;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-003238-96-ES   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Denmark;France;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-003238-96-DE   Argentina;Australia;Austria;Belgium;Canada;China;Croatia;Czech Republic;Czechia;Denmark;France;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-003238-96-CZ   Argentina;Australia;Austria;Belgium;Canada;China;Croatia;Czech Republic;Denmark;France;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-003238-96-BE   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Denmark;France;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-003238-96-AT   Argentina;Australia;Austria;Belgium;Canada;China;Croatia;Czech Republic;Denmark;France;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-003229-14-SK   Argentina;Australia;Austria;Belgium;Canada;China;Croatia;Czech Republic;Denmark;France;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-003229-14-LV   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Denmark;France;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-003229-14-LT   Argentina;Australia;Austria;Belgium;Canada;China;Croatia;Czech Republic;Denmark;France;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-003229-14-GB   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Denmark;France;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-003229-14-ES   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Denmark;France;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-003229-14-DE   Argentina;Australia;Austria;Belgium;Canada;China;Croatia;Czech Republic;Denmark;France;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-003229-14-CZ   Argentina;Australia;Austria;Belgium;Canada;China;Croatia;Czech Republic;Denmark;France;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-003229-14-BE   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Denmark;France;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-003229-14-AT   Argentina;Australia;Austria;Belgium;Canada;China;Croatia;Czech Republic;Denmark;France;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 2   EUCTR2015-003123-57-PL   Australia;Belgium;Canada;Czech Republic;Denmark;France;Georgia;Hungary;Japan;Lithuania;Moldova, Republic of;Netherlands;Poland;Romania;Russian Federation;Ukraine;United Kingdom;United States
      2016   Phase 2   EUCTR2015-003123-57-NL   Australia;Belgium;Canada;Czech Republic;Denmark;France;Georgia;Hungary;Japan;Lithuania;Moldova, Republic of;Netherlands;Poland;Romania;Russian Federation;Ukraine;United Kingdom;United States
      2016   Phase 2   EUCTR2015-003123-57-HU   Australia;Belgium;Canada;Czech Republic;Denmark;France;Georgia;Hungary;Japan;Lithuania;Moldova, Republic of;Netherlands;Poland;Romania;Russian Federation;Ukraine;United Kingdom;United States
      2016   Phase 2   EUCTR2015-003123-57-GB   Australia;Belgium;Canada;Czech Republic;Denmark;France;Georgia;Hungary;Japan;Lithuania;Moldova, Republic of;Netherlands;Poland;Romania;Russian Federation;Ukraine;United Kingdom;United States
      2016   Phase 2   EUCTR2015-003123-57-DK   Australia;Belgium;Canada;Czech Republic;Denmark;France;Georgia;Hungary;Japan;Lithuania;Moldova, Republic of;Netherlands;Poland;Romania;Russian Federation;Ukraine;United Kingdom;United States
      2016   Phase 2   EUCTR2015-003123-57-CZ   Australia;Belgium;Canada;Czech Republic;Denmark;France;Georgia;Hungary;Japan;Lithuania;Moldova, Republic of;Netherlands;Poland;Romania;Russian Federation;Ukraine;United Kingdom;United States
      2016   Phase 2   EUCTR2015-003123-57-BE   Australia;Belgium;Canada;Czech Republic;Denmark;France;Georgia;Hungary;Japan;Lithuania;Moldova, Republic of;Netherlands;Poland;Romania;Russian Federation;Ukraine;United Kingdom;United States
      2015   Phase 2   EUCTR2015-003123-57-LT   Australia;Belgium;Canada;Czech Republic;Denmark;France;Georgia;Hungary;Japan;Lithuania;Moldova, Republic of;Netherlands;Poland;Romania;Russian Federation;Ukraine;United Kingdom;United States
      -   Phase 3   EUCTR2020-005311-49-PL   Argentina;Australia;Austria;Belgium;Canada;Czechia;Denmark;France;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Netherlands;Norway;Poland;Portugal;Slovakia;Spain;United Kingdom;United States
   Lilly S.A.
      2019   Phase 3   EUCTR2017-004092-31-ES   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Denmark;France;Georgia;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Netherlands;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
   Masaki Takeshi
      2023   Phase 3   JPRN-jRCT2031230330   Australia;Belgium;Canada;France;Germany;Italy;Japan;Poland;Portugal;United States
      2021   Phase 3   JPRN-jRCT2031210210   Japan;United States
LY3471851
   Eli Lilly and Company
      2021   Phase 2   EUCTR2020-003017-35-SK   Argentina;Australia;Belgium;Brazil;Canada;China;Czech Republic;Czechia;France;Georgia;Germany;Hungary;India;Israel;Japan;Korea, Republic of;Latvia;Poland;Romania;Russian Federation;Slovakia;Ukraine;United Kingdom;United States
      2021   Phase 2   EUCTR2020-003017-35-PL   Argentina;Australia;Belgium;Brazil;Canada;China;Czech Republic;Czechia;France;Georgia;Germany;Hungary;India;Israel;Japan;Korea, Republic of;Latvia;Poland;Romania;Russian Federation;Slovakia;Ukraine;United Kingdom;United States
      2021   Phase 2   EUCTR2020-003017-35-LV   Argentina;Australia;Belgium;Brazil;Canada;China;Czech Republic;Czechia;France;Georgia;Germany;Hungary;India;Israel;Japan;Korea, Republic of;Latvia;Poland;Romania;Russian Federation;Slovakia;Ukraine;United Kingdom;United States
      2021   Phase 2   EUCTR2020-003017-35-HU   Argentina;Australia;Belgium;Brazil;Canada;China;Czech Republic;Czechia;France;Georgia;Germany;Hungary;India;Israel;Japan;Korea, Republic of;Latvia;Poland;Romania;Russian Federation;Slovakia;Ukraine;United Kingdom;United States
      2021   Phase 2   EUCTR2020-003017-35-FR   Argentina;Australia;Belgium;Brazil;Canada;China;Czech Republic;Czechia;France;Georgia;Germany;Hungary;India;Israel;Japan;Korea, Republic of;Latvia;Poland;Romania;Russian Federation;Slovakia;Ukraine;United Kingdom;United States
      2021   Phase 2   EUCTR2020-003017-35-CZ   Argentina;Australia;Belgium;Brazil;Canada;China;Czech Republic;Czechia;France;Georgia;Germany;Hungary;India;Israel;Japan;Korea, Republic of;Latvia;Poland;Romania;Russian Federation;Slovakia;Ukraine;United Kingdom;United States
      2021   Phase 2   EUCTR2020-003017-35-BE   Argentina;Australia;Belgium;Brazil;Canada;China;Czech Republic;Czechia;France;Georgia;Germany;Hungary;India;Israel;Japan;Korea, Republic of;Latvia;Poland;Romania;Russian Federation;Slovakia;Ukraine;United Kingdom;United States
LYC-30937
   Lycera Corp.
      2016   Phase 1   NCT02818543   Hungary
LYC-30937-EC
   Lycera Corp.
      2017   Phase 2   EUCTR2016-003633-26-PL   Canada;Czech Republic;Hungary;Netherlands;Poland;Serbia;United States
      2017   Phase 2   EUCTR2016-003633-26-NL   Canada;Czech Republic;Hungary;Netherlands;Poland;Serbia;United States
      2017   Phase 2   EUCTR2016-003633-26-CZ   Canada;Czech Republic;Hungary;Netherlands;Poland;Serbia;United States
      2016   Phase 2   NCT02764229   Czechia;Hungary;Netherlands;Poland;Serbia;United States
      2016   Phase 2   NCT02762500   Canada;Czech Republic;Czechia;Hungary;Netherlands;Poland;Serbia;United States
      2016   Phase 2   EUCTR2016-003633-26-HU   Canada;Czech Republic;Hungary;Netherlands;Poland;Serbia;United States
      2016   Phase 2   EUCTR2016-000518-31-PL   Canada;Czech Republic;Hungary;Netherlands;Poland;Serbia;United States
      2016   Phase 2   EUCTR2016-000518-31-NL   Canada;Czech Republic;Hungary;Netherlands;Poland;Serbia;United States
      2016   Phase 2   EUCTR2016-000518-31-HU   Canada;Czech Republic;Hungary;Netherlands;Poland;Serbia;United States
      2016   Phase 2   EUCTR2016-000518-31-CZ   Canada;Czech Republic;Hungary;Netherlands;Poland;Serbia;United States
LYS006
   Novartis Pharma AG
      2021   Phase 2   EUCTR2019-003113-34-SK   Bulgaria;Czechia;Germany;Hungary;Norway;Poland;Russian Federation;Slovakia;United States
      2020   Phase 2   EUCTR2019-003113-34-NO   Bulgaria;Czechia;Germany;Hungary;Norway;Poland;Russian Federation;Slovakia;United States
      2020   Phase 2   EUCTR2019-003113-34-HU   Bulgaria;Czech Republic;Germany;Hungary;Norway;Poland;Russian Federation;Slovakia;United States
      2020   Phase 2   EUCTR2019-003113-34-DE   Czech Republic;Germany;Hungary;Norway;Slovakia;United States
   Novartis Pharmaceuticals
      2020   Phase 2   NCT04074590   Bulgaria;Czechia;Germany;Hungary;Norway;Poland;Russian Federation;Slovakia;United Kingdom;United States
Lysine-D-proline-threonine
   DR. AUGUST WOLFF GMBH & CO. KG
      2012   -   EUCTR2011-002462-20-IT   Czech Republic;Germany;Hungary;Italy;Poland;Slovakia
   Dr. August Wolff GmbH & Co. KG Arzneimittel
      2011   Phase 2   EUCTR2010-023494-19-SE   Sweden
Macrogol
   AZIENDA OSPEDALIERA L. SACCO (A.O. DI RILIEVO NAZIONALE)
      2012   -   EUCTR2012-004214-34-IT   Italy
   Medical University of Graz
      2017   -   NCT03395548   Austria
Macrogol 3350
   Hospital Universitario La Paz
      2019   Phase 4   EUCTR2018-001402-28-ES   Spain
   Ipsen Pharma
      2017   Phase 3   EUCTR2016-002265-60-NL   Czech Republic;France;Germany;Italy;Netherlands;Poland
      2017   Phase 3   EUCTR2016-002265-60-DE   Czech Republic;France;Germany;Italy;Netherlands;Poland
      2017   Phase 3   EUCTR2016-002265-60-CZ   Czech Republic;France;Germany;Italy;Netherlands;Poland
      -   Phase 3   EUCTR2016-002265-60-PL   Czech Republic;France;Germany;Italy;Netherlands;Poland
Magnesio solfato eptaidrato
   IPSEN PHARMA SAS
      2017   Phase 3   EUCTR2016-002265-60-IT   Czech Republic;Czechia;France;Germany;Italy;Netherlands;Poland
Magnesium citrate
   Shenzhen Hospital of Southern Medical University
      2022   Phase 0   ChiCTR2200056969   China
Magnesium sulfate heptahydrate
   Ipsen Pharma
      2017   Phase 3   EUCTR2016-002265-60-NL   Czech Republic;France;Germany;Italy;Netherlands;Poland
      2017   Phase 3   EUCTR2016-002265-60-DE   Czech Republic;France;Germany;Italy;Netherlands;Poland
      2017   Phase 3   EUCTR2016-002265-60-CZ   Czech Republic;France;Germany;Italy;Netherlands;Poland
      -   Phase 3   EUCTR2016-002265-60-PL   Czech Republic;France;Germany;Italy;Netherlands;Poland
Magnesium sulphate heptahydrate
   Ipsen Pharma
      2017   Phase 3   EUCTR2016-002265-60-NL   Czech Republic;France;Germany;Italy;Netherlands;Poland
      2017   Phase 3   EUCTR2016-002265-60-DE   Czech Republic;France;Germany;Italy;Netherlands;Poland
      2017   Phase 3   EUCTR2016-002265-60-CZ   Czech Republic;France;Germany;Italy;Netherlands;Poland
      -   Phase 3   EUCTR2016-002265-60-PL   Czech Republic;France;Germany;Italy;Netherlands;Poland
Magnesium sulphate heptaydrate
   IPSEN PHARMA SAS
      2017   Phase 3   EUCTR2016-002265-60-IT   Czech Republic;Czechia;France;Germany;Italy;Netherlands;Poland
Magnetic resonance imaging scanning
   LanZhou University
      2024   -   NCT06471894   -
Maltodextrin
   Affiliated Hospital of Qingdao University
      2024   -   ChiCTR2500102563   China
   Capital Medical University
      2020   Phase 0   ChiCTR2000032498   China
   Children's Hospital of Philadelphia
      2018   -   NCT03653481   United States
   Jiangnan University
      2020   Phase 0   ChiCTR2000033953   China
   University of Alberta
      2016   -   NCT02865707   Canada
   Wecare Probiotics Co., Ltd.
      2025   -   NCT06781827   China
Maltose
   Honda Takashi
      2018   -   JPRN-jRCTs041190010   -
Mango polyphenolics
   Texas A&M University
      2014   -   NCT02227602   United States
Mare´S milk
   University of Jena
      2000   -   NCT00940576   Germany
Matricaria flower
   REPHA GmbH
      2008   -   EUCTR2007-007928-18-DE   Germany
Matricaria recutita L. flos
   Steigerwald Arzneimittelwerk GmbH
      2014   -   EUCTR2013-000891-13-DE   Germany
Maximal oral 5ASA
   University of Aarhus
      2012   -   NCT01534312   Denmark
MB-001
   Mage Biologics
      2024   Phase 1   NCT06363383   Australia
MB310
   Microbiotica Ltd
      2024   Phase 1   NCT06582264   Austria;Bulgaria;Poland;United Kingdom
MDX-1100
   Bristol-Myers Squibb
      2008   Phase 2   NCT00656890   Canada;Czech Republic;Hungary;Latvia;Romania;Russian Federation;Ukraine;United States
      2006   Phase 1   NCT00295282   United States
   Bristol-Myers Squibb Company
      2008   -   EUCTR2007-002544-25-LV   Czech Republic;Hungary;Latvia
   Bristol-Myers Squibb International Corporation
      2011   -   EUCTR2010-022506-41-PL   Australia;Austria;Belgium;Brazil;Canada;France;Germany;Hungary;Italy;Mexico;Netherlands;Poland;South Africa;United States
      2011   -   EUCTR2010-022506-41-HU   Australia;Austria;Belgium;Brazil;Canada;France;Germany;Hungary;Italy;Mexico;Netherlands;Poland;South Africa;United States
      2011   -   EUCTR2010-022506-41-DE   Australia;Austria;Belgium;Brazil;Canada;France;Germany;Hungary;Italy;Mexico;Netherlands;Poland;South Africa;United States
      2011   Phase 2   EUCTR2010-022506-41-BE   Australia;Austria;Belgium;Brazil;Canada;France;Germany;Hungary;Italy;Mexico;Netherlands;Poland;South Africa;United States
      2011   -   EUCTR2010-022506-41-AT   Australia;Austria;Belgium;Brazil;Canada;France;Germany;Hungary;Italy;Mexico;Netherlands;Poland;South Africa;United States
      2008   -   EUCTR2007-002544-25-HU   Czech Republic;Hungary;Latvia
      2008   -   EUCTR2007-002544-25-CZ   Czech Republic;Hungary;Latvia
Mebendazole
   Tanta University
      2024   -   NCT06335160   -
MEDI2070
   ASTRAZENECA AB
      2021   Phase 2   EUCTR2021-001644-10-IT   Austria;Canada;Czechia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Poland;Russian Federation;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
   AstraZeneca AB
      2022   Phase 2   EUCTR2021-001644-10-HU   Austria;Canada;Czechia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Poland;Russian Federation;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2022   Phase 2   EUCTR2021-001644-10-DE   Austria;Canada;Czechia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Poland;Russian Federation;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2021   Phase 2   EUCTR2021-001644-10-PL   Austria;Canada;Czechia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Poland;Russian Federation;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2021   Phase 2   EUCTR2021-001644-10-ES   Austria;Canada;Czechia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Poland;Russian Federation;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2021   Phase 2   EUCTR2021-001644-10-AT   Austria;Canada;Czechia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Poland;Russian Federation;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
MEDI7183 high dose
   AstraZeneca
      2013   Phase 2   NCT01959165   Japan
MEDI7183 LOW dose
   AstraZeneca
      2013   Phase 2   NCT01959165   Japan
MEDI7183 medium dose
   AstraZeneca
      2013   Phase 2   NCT01959165   Japan
Medical cannabis
   Eli Sprecher, MD
      2019   -   NCT05578313   Israel
Mediterranean diet
   Ardahan University
      2022   -   NCT05761327   Turkey
   University of California, San Diego
      2023   -   NCT05973500   United States
   University of Miami
      2025   Phase 4   NCT06774079   United States
   Yasmin Ashraf Mahmoud Osman
      2021   -   NCT04552158   -
Medium chain triglycerides
   Imperial College London
      2008   Phase 4   NCT00672763   United Kingdom
Melatonin
   Emory University
      2009   Phase 2   NCT00790478   United States
   Peking Union Medical College Hospital, Chinese Academy of Medical Sciences
      2025   -   ChiCTR2500097177   China
Melissae folii DRY aqueous extract
   Steigerwald Arzneimittelwerk GmbH
      2014   -   EUCTR2013-000891-13-DE   Germany
Melissenblätter 15ML/10ML
   Steigerwald Arzneimittelwerk GmbH
      2014   -   EUCTR2013-000891-13-DE   Germany
Melitracen
   Guiyang 1st People's Hospital
      2018   -   ChiCTR1800016438   China
Menatetrenone
   Department of Gastroenterology, Osaka University Graduate School of Medicine
      2011   -   JPRN-UMIN000006915   Japan
Mentha × piperita L. folium
   Steigerwald Arzneimittelwerk GmbH
      2014   -   EUCTR2013-000891-13-DE   Germany
Mercaptopurine
   Academic Medical Centre
      2016   Phase 3   EUCTR2015-005260-41-NL   Netherlands
   Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
      2016   Phase 3   NCT02910245   Netherlands
   Region Örebro län
      2021   Phase 4   EUCTR2019-002942-19-DK   Denmark;Iceland
   UMC Amsterdam location AMC
      2020   Phase 4   EUCTR2018-003524-36-IE   Ireland;Netherlands;Norway
Mesalamin
   Tillotts Pharma AG
      2009   Phase 3   NCT01059344   Belarus;India;Turkey;Ukraine
Mesalamine
   AbbVie
      2024   Phase 3   NCT05316220   Puerto Rico;United States
   Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
      2016   Phase 3   NCT02910245   Netherlands
   Altheus Therapeutics, Inc.
      2009   Phase 1   NCT01020708   United States
   Beijing Friendship Hospital, Capital Medical University
      2019   -   ChiCTR1900021229   China
   Department of Gastroenterology, Jinan Central Hospital
      2018   -   ChiCTR2100043797   China
   Dr. Falk Pharma GmbH
      2014   Phase 3   NCT02280629   Germany
   EMET Pharmaceuticals, LLC
      2008   Phase 3   NCT01045018   -
      2008   -   EUCTR2007-004732-23-PL   Estonia;Latvia;Poland
   Ferring International PharmaScience Center U.S., Inc.
      2017   Phase 3   EUCTR2015-002558-11-BG   Belgium;Bulgaria;Canada;Hungary;Latvia;Mexico;Russian Federation;Serbia;Switzerland;Ukraine;United States
      2017   Phase 3   EUCTR2015-002557-35-BG   Belgium;Bulgaria;Canada;Hungary;Latvia;Mexico;Russian Federation;Serbia;Switzerland;Ukraine;United States
      2016   Phase 3   EUCTR2015-002558-11-LV   Belarus;Belgium;Bulgaria;Canada;Hungary;Ireland;Latvia;Lithuania;Mexico;Russian Federation;Serbia;Switzerland;Ukraine;United States
      2016   Phase 3   EUCTR2015-002558-11-HU   Belgium;Bulgaria;Canada;Hungary;Latvia;Mexico;Russian Federation;Serbia;Switzerland;Ukraine;United States
      2016   Phase 3   EUCTR2015-002557-35-LV   Belarus;Belgium;Bulgaria;Canada;Hungary;Ireland;Latvia;Lithuania;Mexico;Russian Federation;Serbia;Switzerland;Ukraine;United States
      2016   Phase 3   EUCTR2015-002557-35-HU   Belgium;Bulgaria;Canada;Hungary;Latvia;Mexico;Russian Federation;Serbia;Switzerland;Ukraine;United States
      2015   Phase 3   EUCTR2015-002558-11-BE   Belgium;Bulgaria;Canada;Czech Republic;Hungary;Israel;Korea, Republic of;Latvia;New Zealand;Poland;Russian Federation;Slovakia;Switzerland;Ukraine;United States
      2015   Phase 3   EUCTR2015-002557-35-BE   Belgium;Bulgaria;Canada;Czech Republic;Hungary;Israel;Latvia;Poland;Russian Federation;Slovakia;Switzerland;Ukraine;United States
   Ferring Pharmaceuticals
      2021   -   NCT04499495   Korea, Republic of
      2016   Phase 3   NCT02522780   Belgium;Bulgaria;Canada;Hungary;Latvia;Mexico;Poland;Russian Federation;Serbia;Switzerland;Ukraine;United States
      2015   Phase 3   NCT02522767   Belgium;Bulgaria;Canada;Hungary;Latvia;Mexico;Poland;Russian Federation;Serbia;Switzerland;Ukraine;United States
   Icahn School of Medicine at Mount Sinai
      2022   Phase 1/Phase 2   NCT05119140   United States
   James Lewis
      2008   Phase 4   NCT00652145   United States
   Mostafa Bahaa
      2023   Phase 2/Phase 3   NCT05988528   Egypt
      2023   Phase 2/Phase 3   NCT05986136   Egypt
   Nanjing Hospital of Traditional Chinese Medicine
      2023   -   ChiCTR2300076210   China
   National Institute of Allergy and Infectious Diseases (NIAID)
      2007   Phase 2   NCT00514982   United States
   Procter & Gamble Technical Centres Limited
      2006   -   EUCTR2006-001310-32-LV   Czech Republic;Estonia;Hungary;Latvia;Lithuania
      2006   -   EUCTR2006-001310-32-LT   Czech Republic;Estonia;Hungary;Latvia;Lithuania
      2006   -   EUCTR2006-001310-32-HU   Czech Republic;Estonia;Hungary;Latvia;Lithuania
      2006   -   EUCTR2006-001310-32-EE   Czech Republic;Estonia;Hungary;Latvia;Lithuania
      2006   -   EUCTR2006-001310-32-CZ   Czech Republic;Estonia;Hungary;Latvia;Lithuania
   Tanta University
      2025   Phase 2   NCT06213857   Egypt
      2024   Early Phase 1   NCT06525974   -
      2023   Phase 2   NCT05781698   Egypt
      2023   Phase 2/Phase 3   NCT05753267   Egypt
      2023   Phase 2   NCT05567068   Egypt
   The Second Affiliated Hospital of Guangzhou University of Chinese Medicine
      2024   Phase 1   ChiCTR2400093130   China
   University of Chicago
      2006   Phase 3   NCT00343850   United States
   University of Washington
      2003   Phase 4   NCT00194818   United States
   VSL Pharmaceuticals
      2017   -   NCT03415711   Italy
   Warner Chilcott
      2006   Phase 3   NCT00350415   Belarus;Canada;Croatia;Czech Republic;Estonia;Former Serbia and Montenegro;Hungary;Latvia;Lithuania;Poland;Puerto Rico;Romania;Russian Federation;Serbia;Ukraine;United States
      2005   Phase 1   NCT00254618   United States
      2001   Phase 3   NCT00577473   United States
      2000   Phase 3   NCT00073021   Canada;Puerto Rico;United States
   Wolfson Medical Center
      2010   Phase 4   NCT01201122   Israel
   Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai
      2020   Phase 0   ChiCTR2000037261   China
Mesalamine and alpha-lipoic acid
   Tanta University
      2023   -   NCT06067698   Egypt
Mesalamine delayed release tablets 400MG
   EMET Pharmaceuticals LLC
      2008   -   EUCTR2007-004732-23-LV   Estonia;Latvia;Poland
      2007   -   EUCTR2007-004732-23-EE   Estonia;Latvia;Poland
Mesalamine enema
   Altheus Therapeutics, Inc.
      2012   Phase 2   NCT01586533   United States
Mesalamine granules
   Bausch Health Americas, Inc.
      2005   Phase 3   NCT00326209   United States
   Dayanand Medical College and Hospital
      2018   Phase 3   NCT03716388   India
   Dr. Falk Pharma GmbH
      2005   Phase 3   NCT00746447   Germany
Mesalamine ONCE-daily
   Warner Chilcott
      2007   Phase 3   NCT00505778   Canada;Puerto Rico;United States
Mesalamine twice-daily
   Warner Chilcott
      2007   Phase 3   NCT00505778   Canada;Puerto Rico;United States
Mesalamine, 5-ASA
   Holy Stone Healthcare Co., Ltd.
      2015   Phase 2   EUCTR2015-001022-42-IT   Italy
Mesalazina
   Palau Pharma S.A.
      2008   Phase 2   EUCTR2008-004610-27-ES   Belgium;Hungary;Slovakia;Spain
Mesalazine
   Affiliated Hospital of Inner Mongolia Medical University
      2017   -   ChiCTR-IPR-17010306   China
   Affiliated Hospital of Jiangnan University
      2021   -   ChiCTR2100046446   China
   Affiliated Hospital of Nanjing University of Traditional Chinese Medicine (Jiangsu Province Traditional Chinese Medicine Hospital)
      2014   -   ChiCTR1800016668   China
   Ajinomoto Pharmaceuticals Co., Ltd.
      2010   Phase 2-3   JPRN-jRCT2080221110   -
   Anhui Provincial Hospital
      2023   Phase 0   ChiCTR2300070493   China
   BIRD vzw (Belgian IBD Research and Development)
      2022   Phase 4   EUCTR2022-001683-10-BE   Belgium
   Beijing Anorectal Hospital (Beijing Erlong Road Hospital)
      2024   Phase 0   ChiCTR2400082951   China
   Beijing Hospital of Traditional Chinese Medicine affiliated to Capital Medical University
      2020   Phase 2   ChiCTR2000028869   China
   Beijing University of Chinese Medicine
      2023   Phase 0   ChiCTR2300078272   China
   Bogomolets National Medical University
      2020   -   NCT05538026   Ukraine
   Cardiff and Vale NHS Trust
      2006   Phase 3   EUCTR2005-002784-91-GB   United Kingdom
   Cardiff and Vale University Health Board
      2006   Phase 3   NCT00708656   United Kingdom
   Charité Universitätsmedizin, Campus Charité Mitte
      2007   Phase 2   EUCTR2006-004162-13-DE   Germany
   Chengdu University of Traditional Chinese Medicine
      2020   Phase 0   ChiCTR2000039161   China
      2020   Phase 0   ChiCTR2000038888   China
   Chiba University Hospital
      2013   Phase 2   JPRN-UMIN000010906   Japan
   Children´s Hospital, University of Helsinki
      2012   Phase 4   EUCTR2012-004851-35-FI   Finland;Israel
   Chinese University of Hong Kong
      2015   -   NCT02537210   China;Hong Kong
   Connecticut Children's Medical Center
      2012   Phase 4   NCT01536535   Canada;United States
   Copenhagen University Hospital Hvidovre
      2019   Phase 4   EUCTR2019-002070-31-DK   Denmark
   Department of Gastroenterology and Hepatology, Kyoto University Hospital
      2013   -   JPRN-UMIN000010127   Japan
   Department of Medicine and Clinical Science, Graduate School of Medical Sciences, Kyushu University
      2017   -   JPRN-UMIN000026175   Japan
   Department of anorectal surgery, Dongzhimen Hospital, Beijing University of Chinese Medicine
      2014   -   ChiCTR-IOR-15006812   China
   Division of Gastroenterology and Hepatology, Department of Internal Medicine, Keio University School of Medicine
      2011   -   JPRN-UMIN000011236   Japan
   Dongfang Hospital Affiliated to Beijing University of Traditional Chinese Medicine
      2014   -   ChiCTR-OCH-14004615   China
   Dongfang Hospital of Beijing University of Chinese Medicine
      2019   Phase 0   ChiCTR1900023159   China
   Dongfang hospital, Beijing univetsity of Chinese Medicine
      2015   -   ChiCTR-IOR-15007194   China
   Dongguan Hospital of Guangzhou University of Chinese Medinine
      2022   Phase 0   ChiCTR2200059150   China
   Dr. Falk Pharma GmbH
      2021   Phase 3   EUCTR2019-003334-16-LV   Belarus;Bulgaria;Germany;Latvia;Poland;Russian Federation;Ukraine
      2021   Phase 3   EUCTR2019-003334-16-BG   Belarus;Bulgaria;Germany;Latvia;Poland;Russian Federation;Ukraine
      2020   Phase 3   EUCTR2019-003334-16-DE   Belarus;Bulgaria;Germany;Latvia;Poland;Russian Federation;Ukraine
      2016   Phase 3   EUCTR2013-001205-84-HU   Austria;Belgium;Germany;Hungary;Israel;Latvia;Lithuania;Netherlands;Poland;Russian Federation;Slovakia;Switzerland;Ukraine
      2016   Phase 3   EUCTR2013-001205-84-BE   Austria;Belgium;Czech Republic;Germany;Hungary;Israel;Latvia;Lithuania;Netherlands;Poland;Russian Federation;Slovakia;Switzerland;Ukraine
      2015   Phase 3   EUCTR2013-001205-84-SK   Austria;Belgium;Czech Republic;Germany;Hungary;Israel;Latvia;Lithuania;Netherlands;Poland;Russian Federation;Slovakia;Switzerland;Ukraine
      2015   Phase 3   EUCTR2013-001205-84-PL   Austria;Belgium;Czech Republic;Germany;Hungary;Israel;Latvia;Lithuania;Netherlands;Poland;Russian Federation;Slovakia;Switzerland;Ukraine
      2015   Phase 3   EUCTR2013-001205-84-LV   Austria;Belgium;Czech Republic;Germany;Hungary;Israel;Latvia;Lithuania;Netherlands;Poland;Russian Federation;Slovakia;Switzerland;Ukraine
      2015   Phase 3   EUCTR2013-001205-84-DE   Austria;Belgium;Czech Republic;Germany;Hungary;Israel;Latvia;Lithuania;Netherlands;Poland;Russian Federation;Slovakia;Switzerland;Ukraine
      2015   Phase 3   EUCTR2013-001205-84-AT   Austria;Belgium;Czech Republic;Germany;Hungary;Israel;Latvia;Lithuania;Netherlands;Poland;Russian Federation;Slovakia;Switzerland;Ukraine
      2007   Phase 3   NCT00747110   Germany
      2007   Phase 3   EUCTR2006-005377-22-SK   Czech Republic;Germany;Latvia;Lithuania;Poland;Slovakia;Spain
      2007   -   EUCTR2006-005377-22-LV   Czech Republic;Germany;Latvia;Lithuania;Poland;Spain
      2007   -   EUCTR2006-005377-22-LT   Czech Republic;Germany;Latvia;Lithuania;Poland;Spain
      2007   Phase 3   EUCTR2006-005377-22-ES   Czech Republic;Germany;Latvia;Lithuania;Poland;Slovakia;Spain
      2007   -   EUCTR2006-005377-22-DE   Czech Republic;Germany;Latvia;Lithuania;Poland;Spain
      2007   -   EUCTR2006-005377-22-CZ   Czech Republic;Germany;Latvia;Lithuania;Poland;Spain
      2005   Phase 3   NCT00449722   Germany
      -   Phase 3   EUCTR2006-005377-22-PL   Czech Republic;Germany;Latvia;Lithuania;Poland;Slovakia;Spain
   EMET Pharmaceuticals LLC
      2008   -   EUCTR2007-004732-23-LV   Estonia;Latvia;Poland
      2007   -   EUCTR2007-004732-23-EE   Estonia;Latvia;Poland
   EMET Pharmaceuticals, LLC
      2008   -   EUCTR2007-004732-23-PL   Estonia;Latvia;Poland
   Faes Farma, S.A.
      2024   Phase 3   NCT06176560   -
   Ferring BV
      2005   -   EUCTR2004-004565-15-SE   Czech Republic;Denmark;Finland;Germany;Norway;Sweden
      2005   -   EUCTR2004-004565-15-NO   Czech Republic;Denmark;Finland;Germany;Norway;Sweden
      2005   -   EUCTR2004-004565-15-FI   Czech Republic;Denmark;Finland;Germany;Norway;Sweden
      2005   -   EUCTR2004-004565-15-DK   Czech Republic;Denmark;Finland;Germany;Norway;Sweden
      2005   Phase 3   EUCTR2004-004565-15-CZ   Czech Republic;Denmark;Finland;Germany;Norway;Sweden
      -   -   EUCTR2004-004565-15-DE   Czech Republic;Denmark;Finland;Germany;Norway;Sweden
   Ferring International PharmaScience Center U.S., Inc.
      2017   Phase 3   EUCTR2015-002558-11-BG   Belgium;Bulgaria;Canada;Hungary;Latvia;Mexico;Russian Federation;Serbia;Switzerland;Ukraine;United States
      2017   Phase 3   EUCTR2015-002557-35-BG   Belgium;Bulgaria;Canada;Hungary;Latvia;Mexico;Russian Federation;Serbia;Switzerland;Ukraine;United States
      2016   Phase 3   EUCTR2015-002558-11-LV   Belarus;Belgium;Bulgaria;Canada;Hungary;Ireland;Latvia;Lithuania;Mexico;Russian Federation;Serbia;Switzerland;Ukraine;United States
      2016   Phase 3   EUCTR2015-002558-11-HU   Belgium;Bulgaria;Canada;Hungary;Latvia;Mexico;Russian Federation;Serbia;Switzerland;Ukraine;United States
      2016   Phase 3   EUCTR2015-002557-35-LV   Belarus;Belgium;Bulgaria;Canada;Hungary;Ireland;Latvia;Lithuania;Mexico;Russian Federation;Serbia;Switzerland;Ukraine;United States
      2016   Phase 3   EUCTR2015-002557-35-HU   Belgium;Bulgaria;Canada;Hungary;Latvia;Mexico;Russian Federation;Serbia;Switzerland;Ukraine;United States
      2015   Phase 3   EUCTR2015-002558-11-BE   Belgium;Bulgaria;Canada;Czech Republic;Hungary;Israel;Korea, Republic of;Latvia;New Zealand;Poland;Russian Federation;Slovakia;Switzerland;Ukraine;United States
      2015   Phase 3   EUCTR2015-002557-35-BE   Belgium;Bulgaria;Canada;Czech Republic;Hungary;Israel;Latvia;Poland;Russian Federation;Slovakia;Switzerland;Ukraine;United States
   Ferring Pharmaceuticals
      2018   Phase 3   NCT03412682   Japan
      2015   -   NCT02368743   France
      2015   -   NCT02261636   Netherlands
      2012   -   NCT01517607   Germany
   Ferring Pharmaceuticals Ltd.
      2009   -   EUCTR2008-000045-59-GB   Belgium;France;Netherlands;United Kingdom
   Ferring SAS
      2008   -   EUCTR2008-000045-59-NL   Belgium;France;Netherlands;United Kingdom
      2008   Phase 3   EUCTR2008-000045-59-FR   Belgium;France;Netherlands;United Kingdom
      2008   Phase 3   EUCTR2008-000045-59-BE   Belgium;France;Netherlands;United Kingdom
   Flemming Bendtsen
      2019   Phase 4   NCT04133194   Denmark
   GIULIANI
      2009   -   EUCTR2008-007292-25-IT   Italy
      2004   -   EUCTR2004-000916-25-IT   Italy
   Guangdong Provincial Hospital of Chinese Medicine
      2022   Phase 1   ChiCTR2200060570   China
   Guiyang 1st People's Hospital
      2018   -   ChiCTR1800016438   China
   Holy Stone Healthcare Co., Ltd.
      2015   Phase 2   EUCTR2015-001022-42-IT   Italy
   Jiangsu Province Hospital of Chinese Medicine
      2020   Phase 0   ChiCTR2000035099   China
      2019   Phase 4   ChiCTR1900023158   China
   Kitasato University Kitasato Institute Hospital
      2016   -   JPRN-UMIN000022954   Japan
   Kyorin Pharmaceutical Co.,LTD
      2009   Phase 3   JPRN-jRCT2080220935   -
   Longhua Hospital, Shanghai University of Traditional Chinese Medicine
      2022   Phase 0   ChiCTR2200055503   China
   MOCHIDA PHARMACEUTICAL CO., LTD
      2018   Phase 2-3   JPRN-jRCT2080223747   Japan
      2018   Phase 2-3   JPRN-jRCT2080223746   Japan
   MOCHIDA PHARMACEUTICAL CO., LTD.
      2014   Phase 3   JPRN-jRCT2080222425   -
      2011   Phase 3   JPRN-jRCT2080221344   -
      2011   Phase 3   JPRN-jRCT2080221343   -
   Medizinische Universität Wien, Universitätsklinik für Innere Medizin 3, Abteilung für Gastroenterologie und Hepatologie
      2012   Phase 2   EUCTR2012-002023-15-AT   Austria
   Mostafa Bahaa
      2024   Phase 2   NCT06201793   Egypt
   Nanjing Hospital of Chinese Medicine
      2019   Phase 3   ChiCTR1900025900   China
   Northern Jiangsu People’s Hospital
      2024   -   ChiCTR2500101494    China
   Palau Pharma S.A.
      2009   Phase 2   EUCTR2008-004610-27-SK   Belgium;Hungary;Slovakia;Spain
      2009   -   EUCTR2008-004610-27-HU   Belgium;Hungary;Spain
      2008   Phase 2   NCT00808977   Belgium;Hungary;Slovakia;Spain
      2008   Phase 2   EUCTR2008-004610-27-ES   Belgium;Hungary;Slovakia;Spain
      2008   -   EUCTR2008-004610-27-BE   Belgium;Hungary;Spain
   Peking Union Medical College Hospital
      2020   -   NCT05386290   China
   Peking University First Hospital
      2023   Phase 1   ChiCTR2300078576   China
      2019   Phase 0   ChiCTR1900024591   China
   Peking University Third Hospital
      2024   Phase 0   ChiCTR2400083224   China
   Procter & Gamble Pharmaceuticals
      2005   Phase 2   EUCTR2004-004077-29-SK   Czech Republic;Germany;Lithuania;Slovakia;United Kingdom
      2005   -   EUCTR2004-004077-29-LT   Czech Republic;Germany;Lithuania;United Kingdom
      2005   -   EUCTR2004-004077-29-DE   Czech Republic;Germany;Lithuania;United Kingdom
      2005   -   EUCTR2004-004077-29-CZ   Czech Republic;Germany;Lithuania;United Kingdom
      -   Phase 3   EUCTR2007-005702-49-PL   Poland
   Procter & Gamble Technical Centres Limited
      2006   -   EUCTR2006-001310-32-LV   Czech Republic;Estonia;Hungary;Latvia;Lithuania
      2006   -   EUCTR2006-001310-32-LT   Czech Republic;Estonia;Hungary;Latvia;Lithuania
      2006   -   EUCTR2006-001310-32-HU   Czech Republic;Estonia;Hungary;Latvia;Lithuania
      2006   -   EUCTR2006-001310-32-EE   Czech Republic;Estonia;Hungary;Latvia;Lithuania
      2006   -   EUCTR2006-001310-32-CZ   Czech Republic;Estonia;Hungary;Latvia;Lithuania
   Procter & Gamble Technical Centres Ltd
      2005   -   EUCTR2004-004077-29-GB   Czech Republic;Germany;Lithuania;United Kingdom
   REPHA GmbH
      2008   -   EUCTR2007-007928-18-DE   Germany
   Saitama Medical Center, Saitama Medical University
      2013   -   JPRN-UMIN000010340   Japan
      2012   -   JPRN-UMIN000008352   Japan
   Shanghai Traditional Chinese MedicineIntegrated Hospital
      2023   Phase 0   ChiCTR2300068348   China
   Shire
      2003   Phase 3   NCT00151944   -
   Shire Development Inc
      2012   -   EUCTR2011-000164-10-SK   Slovakia;United Kingdom;United States
   Shire Development LLC
      2018   Phase 3   EUCTR2013-001744-65-DE   Belgium;Canada;Germany;Hungary;Israel;Netherlands;Poland;Slovakia;Sweden;United Kingdom;United States
      2018   Phase 3   EUCTR2013-001744-65-BE   Belgium;Canada;Germany;Hungary;Israel;Netherlands;Poland;Slovakia;Sweden;United Kingdom;United States
      2014   Phase 3   EUCTR2013-001744-65-GB   Belgium;Canada;Germany;Hungary;Israel;Netherlands;Poland;Slovakia;Sweden;United Kingdom;United States
      2013   Phase 1   EUCTR2011-000164-10-GB   Australia;Poland;Slovakia;United Kingdom;United States
   Shire Devlopment LLC
      2015   Phase 3   EUCTR2013-001744-65-NL   Belgium;Canada;Germany;Hungary;Israel;Netherlands;Poland;Slovakia;United Kingdom;United States
      2014   Phase 3   EUCTR2013-001744-65-SK   Belgium;Canada;Germany;Hungary;Israel;Netherlands;Poland;Slovakia;Sweden;United Kingdom;United States
      2014   Phase 3   EUCTR2013-001744-65-PL   Belgium;Canada;Germany;Hungary;Israel;Netherlands;Poland;Slovakia;Sweden;United Kingdom;United States
      2014   Phase 3   EUCTR2013-001744-65-HU   Belgium;Canada;Germany;Hungary;Israel;Netherlands;Poland;Slovakia;United Kingdom;United States
   Shire Pharmaceutical Development Inc
      2004   Phase 3   EUCTR2004-000733-12-CZ   Czech Republic
   Shire Pharmaceutical Development Inc.
      2005   Phase 3   EUCTR2004-000734-36-CZ   Czech Republic
   Shire Pharmaceutical Development Ltd
      2009   -   EUCTR2004-004184-29-DK   Czech Republic;Denmark;Germany;Hungary;Netherlands;Portugal;Spain;Sweden;United Kingdom
      2008   Phase 3   EUCTR2004-004184-29-NL   Czech Republic;Denmark;Germany;Hungary;Netherlands;Portugal;Spain;Sweden;United Kingdom
      2007   -   EUCTR2004-004184-29-SE   Czech Republic;Denmark;Germany;Hungary;Netherlands;Portugal;Spain;Sweden;United Kingdom
      2007   -   EUCTR2004-004184-29-PT   Czech Republic;Denmark;Germany;Hungary;Netherlands;Portugal;Spain;Sweden;United Kingdom
      2005   Phase 3   EUCTR2004-004184-29-HU   Czech Republic;Denmark;Germany;Hungary;Netherlands;Portugal;Spain;Sweden;United Kingdom
      2005   Phase 3   EUCTR2004-004184-29-GB   Czech Republic;Denmark;Germany;Hungary;Netherlands;Portugal;Spain;Sweden;United Kingdom
      2005   -   EUCTR2004-004184-29-ES   Czech Republic;Denmark;Germany;Hungary;Netherlands;Portugal;Spain;Sweden;United Kingdom
      2005   -   EUCTR2004-004184-29-DE   Czech Republic;Denmark;Germany;Hungary;Netherlands;Portugal;Spain;Sweden;United Kingdom
      2005   -   EUCTR2004-004184-29-CZ   Czech Republic;Denmark;Germany;Hungary;Netherlands;Portugal;Spain;Sweden;United Kingdom
   Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine
      2021   Phase 0   ChiCTR2100048176   China
   Shuguang Hospital affiliated to Shanghai University of traditional Chinese Medicine
      2020   Phase 0   ChiCTR2000037220   China
      2020   Phase 0   ChiCTR2000035497   China
   Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University
      2025   -   ChiCTR2500098522   China
   Sixth Affiliated Hospital, Sun Yat-sen University
      2022   Phase 4   NCT05205603   China
   Southern Medical University, Nanfang Hospital, Department of Gastroenterology
      2015   -   ChiCTR-ICR-15007188   China
   The 900th Hospital of PLA
      2018   Phase 4   ChiCTR2000038316   China
   The Affiliated Hospital of Nanjing University of Traditional Chinese Medicine
      2006   Phase 1 study   ChiCTR-TRC-08000048   China
   The First Affiliated Hospital of Guangzhou University of Chinese Medicine
      2021   -   ChiCTR2100048502   China
      2019   -   ChiCTR1900024086   China
   The First Affiliated Hospital of Nanchang University
      2023   Phase 0   ChiCTR2300073313   China
   The First Affiliated Hospital of Nanjing Medical University
      2023   -   ChiCTR2300071576   China
   The Peoples' Hospital of Tinghu District of Yancheng City
      2022   -   ChiCTR2200065108   China
   The Second Affiliated hospital of Fujian Medical University
      2025   -   ChiCTR2500097078   China
   The Second Hospital of Nanjing Medical University
      2019   -   NCT03917095   China
   The Sixth Affiliated Hospital, Sun Yat-sen University
      2023   -   ChiCTR2300072352   China
   Tillotts Pharma AG
      2015   Phase 3   EUCTR2013-000366-11-RO   Belarus;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Hungary;Ireland;Latvia;Lithuania;Norway;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Ukraine;United Kingdom
      2014   Phase 3   EUCTR2013-000366-11-SK   Belarus;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;Hungary;Ireland;Latvia;Lithuania;Poland;Romania;Russian Federation;Slovakia;Spain;Sweden;Ukraine
      2014   Phase 3   EUCTR2013-000366-11-LV   Belarus;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Hungary;Ireland;Latvia;Lithuania;Norway;Poland;Romania;Russian Federation;Slovakia;Spain;Sweden;Ukraine;United Kingdom
      2014   Phase 3   EUCTR2013-000366-11-LT   Belarus;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Hungary;Ireland;Latvia;Lithuania;Norway;Poland;Romania;Russian Federation;Slovakia;Spain;Sweden;Ukraine;United Kingdom
      2014   Phase 3   EUCTR2013-000366-11-HU   Belarus;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Hungary;Ireland;Latvia;Lithuania;Norway;Poland;Romania;Russian Federation;Slovakia;Spain;Sweden;Ukraine;United Kingdom
      2014   Phase 3   EUCTR2013-000366-11-BG   Belarus;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Hungary;Ireland;Latvia;Lithuania;Norway;Poland;Romania;Russian Federation;Slovakia;Spain;Sweden;Ukraine;United Kingdom
      2013   Phase 3   EUCTR2013-000366-11-SE   Belarus;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Hungary;Ireland;Latvia;Lithuania;Norway;Poland;Romania;Russian Federation;Slovakia;Spain;Sweden;Ukraine;United Kingdom
      2013   Phase 3   EUCTR2013-000366-11-PL   Belarus;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;Hungary;Ireland;Latvia;Lithuania;Poland;Romania;Russian Federation;Spain;Sweden;Ukraine
      2013   Phase 3   EUCTR2013-000366-11-IE   Belarus;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Hungary;Ireland;Latvia;Lithuania;Norway;Poland;Romania;Russian Federation;Slovakia;Spain;Sweden;Ukraine;United Kingdom
      2013   Phase 3   EUCTR2013-000366-11-GB   Belarus;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Hungary;Ireland;Latvia;Lithuania;Norway;Poland;Romania;Russian Federation;Slovakia;Spain;Sweden;Ukraine;United Kingdom
      2013   Phase 3   EUCTR2013-000366-11-FI   Belarus;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Hungary;Ireland;Latvia;Lithuania;Norway;Poland;Romania;Russian Federation;Slovakia;Spain;Sweden;Ukraine;United Kingdom
      2013   -   EUCTR2013-000366-11-ES   Belarus;Belgium;Bulgaria;Canada;Denmark;Finland;Hungary;Ireland;Latvia;Lithuania;Poland;Russian Federation;Spain;Sweden;Ukraine
      2013   Phase 3   EUCTR2013-000366-11-DK   Belarus;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Hungary;Ireland;Latvia;Lithuania;Norway;Poland;Romania;Russian Federation;Slovakia;Spain;Sweden;Ukraine;United Kingdom
      2013   Phase 3   EUCTR2013-000366-11-CZ   Belarus;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Hungary;Ireland;Latvia;Lithuania;Norway;Poland;Romania;Russian Federation;Slovakia;Spain;Sweden;Ukraine;United Kingdom
      2013   Phase 3   EUCTR2013-000366-11-BE   Belarus;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Hungary;Ireland;Latvia;Lithuania;Norway;Poland;Romania;Russian Federation;Slovakia;Spain;Sweden;Ukraine;United Kingdom
      2010   Phase 3   NCT01257399   China
      2010   Phase 3   NCT01257386   China
   UMC Utrecht
      2009   -   EUCTR2009-010921-38-NL   Netherlands
   University Medical Center Groningen
      2010   -   EUCTR2010-018557-35-NL   Netherlands
   Xiangya Hospital of Central South University
      2020   -   ChiCTR2000028767   China
   Yanling Wei
      2015   Phase 2   NCT02335281   China
   Yueyang Hospital of Integrated Chinese and Western Medicine affiliated to Shanghai University of Traditional Chinese Medicine
      2023   Phase 0   ChiCTR2400082626   China
   Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine
      2024   Phase 0   ChiCTR2400082454   China
   Yueyang Hospital of Integrated Traditional Chinese and Western Medicine,Shanghai University of TCM
      2020   Phase 0   ChiCTR2000036950   China
   Zeria Pharmaceutical Co., Ltd.
      2013   Phase 3   JPRN-jRCT2080222089   -
      2012   Phase 2   JPRN-jRCT2080221898   -
   Zeria Pharmaceutical Co.,LTD.
      2005   Phase 3   JPRN-C000000289   Japan
      2005   Phase 3   JPRN-C000000288   Japan
Mesalazine - TID 1000 MG
   Dr. Falk Pharma GmbH
      2013   Phase 3   NCT01745770   Germany
Mesalazine - TID 2X 500 MG
   Dr. Falk Pharma GmbH
      2013   Phase 3   NCT01745770   Germany
Mesalazine 1000 MG gastro-resistant tablets
   Dr. Falk Pharma GmbH
      2013   -   EUCTR2012-001830-32-PL   Hungary;Latvia;Lithuania;Poland;Russian Federation;Ukraine
      2013   -   EUCTR2012-001830-32-LT   Hungary;Latvia;Lithuania;Poland;Russian Federation;Ukraine
      2013   Phase 3   EUCTR2012-001830-32-DE   Germany;Hungary;Latvia;Lithuania;Poland;Russian Federation;Ukraine
      2012   Phase 3   EUCTR2012-001830-32-LV   Germany;Hungary;Latvia;Lithuania;Poland;Russian Federation;Ukraine
      2012   Phase 3   EUCTR2012-001830-32-HU   Hungary;Latvia;Lithuania;Poland;Russian Federation;Ukraine
Mesalazine 250MG tablet and nitazoxanide 500MG oral tablet
   Research Institute of Epidemiology, Microbiology and Infectious Diseases, Uzbekistan
      2015   Phase 1/Phase 2   NCT03441893   -
Mesalazine 4G enema
   Institute for Clinical and Experimental Medicine
      2017   Phase 2   NCT03104036   Czech Republic;Czechia
Mesalazine 500 MG gastro-resistant tablets (salofa
   Dr. Falk Pharma GmbH
      2013   -   EUCTR2012-001830-32-PL   Hungary;Latvia;Lithuania;Poland;Russian Federation;Ukraine
      2013   -   EUCTR2012-001830-32-LT   Hungary;Latvia;Lithuania;Poland;Russian Federation;Ukraine
      2013   Phase 3   EUCTR2012-001830-32-DE   Germany;Hungary;Latvia;Lithuania;Poland;Russian Federation;Ukraine
      2012   Phase 3   EUCTR2012-001830-32-LV   Germany;Hungary;Latvia;Lithuania;Poland;Russian Federation;Ukraine
Mesalazine enema
   Ferring Pharmaceuticals
      2015   Phase 3   NCT02368717   China
   Huashan Hospital, Fudan University
      2015   Phase 1   ChiCTR2300073148   China
   Hyogo College of Medicine
      2018   -   JPRN-UMIN000034016   Japan
   Jiangsu Province Hospital of Chinese Medicine
      2022   Phase 1   ChiCTR2200063282   China
   University Hospitals of Leicester NHS Trust
      2006   Phase 3   EUCTR2006-002036-25-GB   United Kingdom
Mesalazine liquid enema
   Ferring Pharmaceuticals
      2008   Phase 3   NCT00737789   Belgium;France;Netherlands;United Kingdom
Mesalazine SLOW-release granules
   Ferring Pharmaceuticals
      2008   Phase 3   NCT00737789   Belgium;France;Netherlands;United Kingdom
Mesalazine suppository treatment
   Xijing Hospital of Digestive Diseases
      2023   Phase 1   NCT05912712   China
Mesalazine with hydrocortisone sodium succinate
   Xijing Hospital of Digestive Diseases
      2017   Phase 4   NCT03110198   China
Mesalazinum
   Shire Pharmaceutical Development Inc
      2004   Phase 3   EUCTR2004-000733-12-CZ   Czech Republic
   Shire Pharmaceutical Development Inc.
      2005   Phase 3   EUCTR2004-000734-36-CZ   Czech Republic
Mesenchymal cells
   Leiden University Medical Center
      2018   Phase 2   EUCTR2017-003524-75-NL   Netherlands
Mesenchymal stem cells
   The Cleveland Clinic
      2022   Phase 1   NCT05578508   United States
Mesenchymal stromal cells
   Leiden University Medical Center
      2018   Phase 2   EUCTR2017-003524-75-NL   Netherlands
   Liaocheng People's Hospital
      2018   Phase 1/Phase 2   NCT03609905   China
MET-2
   NuBiyota
      2019   Phase 1   NCT03832400   Canada
Metformin
   Tanta University
      2023   Phase 2   NCT05574387   Egypt
      2022   Phase 2   NCT05553704   Egypt
   The First Affiliated Hospital, College of Medicine, Zhejiang University
      2024   Phase 0   ChiCTR2400092548   China
Metformin 500 MG TID oral tablet
   National Hepatology & Tropical Medicine Research Institute
      2021   Phase 2   NCT04750135   Egypt
Methalazine suppository WAS given rectally once A DAY
   The Second Affiliated Hospital of Anhui University of Traditional Chinese Medicine
      2024   Phase 1/Phase 2   NCT06667934   -
Methane
   The Second Affiliated Hospital of the Chinese People's Liberation Army Air Force Medical University
      2025   -   ChiCTR2500095979   China
Methotrexate
   Centre Hospitalier Universitaire de Besancon
      2007   Phase 2   NCT00498589   Austria;Belgium;France;Israel;Italy;Netherlands
   GETAID, Jean Minjoz Hospital
      2009   -   EUCTR2006-003607-40-FI   Austria;Belgium;Finland;Netherlands
   IQVIA Services Japan K.K. jRCT Call Center
      2023   Phase 3   JPRN-jRCT2031230081   Argentina;Belgium;Bosnia;Brazil;Bulgaria;Canada;Croatia;Czech Republic;France;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Lithuania;Mexico;New Zealand;Poland;Romania;Serbia;Slovenia;Spain;Taiwan;United Kingdom;United States
   Indiana University
      2015   -   NCT02413047   United States
   National Center for Research Resources (NCRR)
      2002   -   NCT00035074   United States
   PIBD net
      2018   Phase 4   EUCTR2016-000522-18-GB   Belgium;Canada;Czech Republic;France;Germany;Israel;Italy;Netherlands;Poland;Spain;United Kingdom
   University of North Carolina, Chapel Hill
      2012   Phase 2   NCT01393405   United States
   jRCT Inquiries IQVIA Contact person
      2023   Phase 3   JPRN-jRCT2031230257   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Czech Republic;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Korea;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Serbia;Slovakia;Slovenia;Spain;Switzerland;Turkey;UK USA
Methotrexate bellon 25MG/ML
   Besancon University Hospital
      2008   -   EUCTR2006-003607-40-NL   Austria;Finland;Netherlands
      2008   Phase 2   EUCTR2006-003607-40-BE   Austria;Belgium;Finland;Netherlands
   Besancon University Hospitaö
      2008   -   EUCTR2006-003607-40-AT   Austria;Finland;Netherlands
Methotrexate disodium
   UMC Amsterdam location AMC
      2020   Phase 4   EUCTR2018-003524-36-IE   Ireland;Netherlands;Norway
Methotrexate injection
   Amsterdam UMC location AMC
      2019   Phase 4   EUCTR2018-003594-95-NL   Netherlands
Methylene blue 25MG tablets
   COSMO TECHNOLOGIES LTD
      2012   -   EUCTR2011-005693-36-IT   Italy
Methylprednisolone
   Grupo Espanol de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa
      2018   Phase 4   NCT02921555   Spain
   Stanford University
      2022   Phase 1   NCT05587673   United States
   University of Chicago
      2004   -   NCT00152620   United States
Methylprednisolone sodium hemisuccinate
   GETECCU (Grupo Español de Trabajo en Enfermedad de Crohn y Colitis ulcerosa)
      2017   Phase 4   EUCTR2016-001170-15-ES   Spain
Metoject
   UMC Amsterdam location AMC
      2021   Phase 4   EUCTR2018-003524-36-NO   France;Ireland;Netherlands;Norway;United Kingdom
      2020   Phase 4   EUCTR2018-003524-36-IE   Ireland;Netherlands;Norway
      2019   Phase 4   EUCTR2018-003524-36-NL   Ireland;Netherlands;Norway
Metotrexat
   Region Örebro län
      2021   Phase 4   EUCTR2019-002942-19-IS   Denmark;Iceland
Metronidazole
   Ari M Grinspan
      2021   Early Phase 1   NCT04968951   United States
   Benha University
      2023   -   NCT06583863   Egypt
   Division of General Medicine, Department of Internal Medicine, Nihon University School of Medicine
      2013   Phase 3   JPRN-UMIN000009811   Japan
   Hamilton Health Sciences Corporation
      2016   Phase 2   NCT02606032   Canada
   Hokkaido University Hospital
      2016   -   JPRN-UMIN000024520   Japan
   Ishikawa Dai
      2017   -   JPRN-jRCTs031180415   -
   Japan UC Antibiotics-therapy Study Group(JUCASG)
      2003   Phase 2   JPRN-C000000078   Japan
   Juntendo University
      2008   -   JPRN-UMIN000048515   Japan
   Juntendo University Graduate School of Medicine
      2002   -   JPRN-UMIN000053277   Japan
   Juntendo university school of medicine Department of gastroenterology
      2017   -   JPRN-UMIN000025846   Japan
   Juntendo university school of medicine Department of gastroenterology
      2015   -   JPRN-UMIN000018642   Japan
      2014   -   JPRN-UMIN000014152   Japan
   Nagahara Akihito
      2023   Phase 2   JPRN-jRCTs031220542   -
   National Center for Child Health and Development
      2016   -   JPRN-UMIN000026485   Japan
   Postgraduate Institute of Medical Education and Research
      2019   Phase 2   NCT03794765   India
   Shiga University of Medical Science
      2015   -   JPRN-UMIN000017844   Japan
   University of Dundee
      2006   -   NCT00355602   United Kingdom
Metronidazole capsule 50 MG
   FORMAC Pharmaceuticals NV
      2009   -   EUCTR2009-015136-14-BE   Belgium
Mezavant
   GIULIANI
      2009   -   EUCTR2008-007292-25-IT   Italy
Mezavant 1200 MG magensaftresistente retardtabletten
   Medizinische Universität Wien, Universitätsklinik für Innere Medizin 3, Abteilung für Gastroenterologie und Hepatologie
      2012   Phase 2   EUCTR2012-002023-15-AT   Austria
Mezavant gastro-resistant, prolonged release tablets
   Shire Development LLC
      2018   Phase 3   EUCTR2013-001744-65-DE   Belgium;Canada;Germany;Hungary;Israel;Netherlands;Poland;Slovakia;Sweden;United Kingdom;United States
      2018   Phase 3   EUCTR2013-001744-65-BE   Belgium;Canada;Germany;Hungary;Israel;Netherlands;Poland;Slovakia;Sweden;United Kingdom;United States
   Shire Devlopment LLC
      2014   Phase 3   EUCTR2013-001744-65-SK   Belgium;Canada;Germany;Hungary;Israel;Netherlands;Poland;Slovakia;Sweden;United Kingdom;United States
      2014   Phase 3   EUCTR2013-001744-65-PL   Belgium;Canada;Germany;Hungary;Israel;Netherlands;Poland;Slovakia;Sweden;United Kingdom;United States
Mezavant XL 1200 MG gastro-resistant prolonged release tablets
   Shire Pharmaceutical Development Ltd
      2009   -   EUCTR2004-004184-29-DK   Czech Republic;Denmark;Germany;Hungary;Netherlands;Portugal;Spain;Sweden;United Kingdom
      2008   Phase 3   EUCTR2004-004184-29-NL   Czech Republic;Denmark;Germany;Hungary;Netherlands;Portugal;Spain;Sweden;United Kingdom
      2007   -   EUCTR2004-004184-29-SE   Czech Republic;Denmark;Germany;Hungary;Netherlands;Portugal;Spain;Sweden;United Kingdom
      2007   -   EUCTR2004-004184-29-PT   Czech Republic;Denmark;Germany;Hungary;Netherlands;Portugal;Spain;Sweden;United Kingdom
      2005   Phase 3   EUCTR2004-004184-29-GB   Czech Republic;Denmark;Germany;Hungary;Netherlands;Portugal;Spain;Sweden;United Kingdom
Mezavant XL 1200 MG gastro-resistant, prolonged release tablets
   Shire Pharmaceutical Development Ltd
      2005   Phase 3   EUCTR2004-004184-29-HU   Czech Republic;Denmark;Germany;Hungary;Netherlands;Portugal;Spain;Sweden;United Kingdom
      2005   -   EUCTR2004-004184-29-CZ   Czech Republic;Denmark;Germany;Hungary;Netherlands;Portugal;Spain;Sweden;United Kingdom
Mezavant XL 1200MG gastro-resistant, prolonged release tablets
   Shire Development LLC
      2013   Phase 1   EUCTR2011-000164-10-GB   Australia;Poland;Slovakia;United Kingdom;United States
Mezavant XL gastro-resistant, prolonged release tablets
   Shire Development Inc
      2010   Phase 4   EUCTR2009-017044-13-FR   Belgium;Czech Republic;France;Germany;Hungary;Ireland;Spain;United Kingdom
      2010   -   EUCTR2009-017044-13-DE   Canada;Colombia;Czech Republic;France;Germany;Hungary;India;Ireland;Poland;Russian Federation;South Africa;Spain;United Kingdom;United States
   Shire Development Inc.
      2010   Phase 4   EUCTR2009-017044-13-ES   Belgium;Czech Republic;France;Germany;Hungary;Ireland;Spain;United Kingdom
   Shire Development LLC
      2014   Phase 3   EUCTR2013-001744-65-GB   Belgium;Canada;Germany;Hungary;Israel;Netherlands;Poland;Slovakia;Sweden;United Kingdom;United States
      2010   -   EUCTR2009-017044-13-IE   Canada;Colombia;Czech Republic;France;Germany;Hungary;India;Ireland;Poland;Russian Federation;South Africa;Spain;United Kingdom;United States
      2010   -   EUCTR2009-017044-13-HU   Canada;Colombia;Czech Republic;France;Germany;Hungary;India;Ireland;Poland;Russian Federation;South Africa;Spain;United Kingdom;United States
      2010   Phase 4   EUCTR2009-017044-13-GB   Belgium;Canada;Colombia;Czech Republic;France;Germany;Hungary;India;Ireland;Poland;Russian Federation;South Africa;Spain;United Kingdom;United States
      2010   -   EUCTR2009-017044-13-CZ   Canada;Colombia;Czech Republic;France;Germany;Hungary;India;Ireland;Poland;Russian Federation;South Africa;Spain;United Kingdom;United States
      2010   Phase 4   EUCTR2009-017044-13-BE   Belgium;Canada;Colombia;Czech Republic;France;Germany;Hungary;India;Ireland;Poland;Russian Federation;South Africa;Spain;United Kingdom;United States
   Shire Devlopment LLC
      2015   Phase 3   EUCTR2013-001744-65-NL   Belgium;Canada;Germany;Hungary;Israel;Netherlands;Poland;Slovakia;United Kingdom;United States
      2014   Phase 3   EUCTR2013-001744-65-HU   Belgium;Canada;Germany;Hungary;Israel;Netherlands;Poland;Slovakia;United Kingdom;United States
MH002
   MRM Health NV
      2021   Phase 1;Phase 2   EUCTR2020-004355-33-PL   Belgium;Czech Republic;Poland
      2021   Phase 1;Phase 2   EUCTR2020-004355-33-CZ   Belgium;Czech Republic
      2021   Phase 1;Phase 2   EUCTR2020-004355-33-BE   Belgium
Microbiome
   Connecticut Children's Medical Center
      2015   -   NCT02984059   United States
   Nagahara Akihito
      2023   Phase 2   JPRN-jRCTs031220542   -
Microbiota capsule
   Ferring Pharmaceuticals
      2024   Phase 1   NCT06260267   United States
Microbiota suspension
   Ferring Pharmaceuticals
      2024   Phase 1   NCT06260267   United States
Microbiote FéCAL
   AP-HP/DRCD
      2022   Phase 2   EUCTR2020-000311-71-FR   France
Microcrystalline cellulose
   University of Alberta
      2025   -   NCT06515210   -
Midazolam
   Copenhagen University Hospital at Herlev
      2014   Phase 4   NCT01934088   Denmark
   Sakakibara Yuko
      2020   Phase 4   JPRN-jRCTs031200018   -
   Takeda
      2016   Phase 4   NCT02760615   United States
   Takeuchi Yutaka
      2015   Phase 1   JPRN-jRCT2071230023   -
Midazolam 2 MG
   Janssen Research & Development, LLC
      2018   Phase 1   NCT03358706   Austria;Belgium;Denmark;Germany;Sweden;United Kingdom;United States
Midazolam B. braun
   Gastroenheden D, Herlev Hospital
      2013   -   EUCTR2013-002428-17-DK   Denmark
Midazolam B.braun
   Gastroenheden D, Herlev Hospital
      2013   -   EUCTR2013-002428-17-DK   Denmark
Milk
   Public Health Research foundation
      2012   -   JPRN-UMIN000007593   Japan
   Universitary Hospital Príncipe de Asturias
      2021   Phase 4   EUCTR2021-000985-14-ES   Spain
Minocycline
   Mostafa Bahaa
      2024   Phase 2   NCT06201793   Egypt
Mirikizumab
   ELI LILLY & COMPANY, LILLY CORPORATE CENTER
      2022   Phase 3   EUCTR2020-005311-49-IT   Argentina;Australia;Austria;Belgium;Canada;Czechia;Denmark;France;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Netherlands;Norway;Poland;Portugal;Slovakia;Spain;United Kingdom;United States
      2019   Phase 3   EUCTR2017-004092-31-IT   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czechia;Denmark;France;Georgia;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Netherlands;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-003238-96-IT   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Czechia;Denmark;France;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-003229-14-IT   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Czechia;Denmark;France;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Democratic People's Republic of;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom
   Eli Lilly Cork Limited
      2018   Phase 3   EUCTR2017-003238-96-DK   Argentina;Australia;Austria;Belgium;Canada;China;Croatia;Czech Republic;Denmark;France;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-003229-14-HU   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Denmark;France;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-003229-14-DK   Argentina;Australia;Austria;Belgium;Canada;China;Croatia;Czech Republic;Denmark;France;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
   Eli Lilly Japan K.K.
      2019   Phase 3   JPRN-jRCT2080224156   Asia except Japan;Europe;Japan;North America;Oceania;South America
      2018   Phase 3   JPRN-jRCT2080224155   Asia except Japan;Europe;Japan;North America;Oceania;South America
      2018   Phase 3   JPRN-jRCT2080224003   Asia except Japan;Europe;Japan;Middle East;North America;Oceania;South America
      2016   Phase 2   JPRN-jRCT2080223301   Europe;Japan;North America;Oceania
   Eli Lilly and Company
      2025   Phase 3   NCT06937086   Austria;Belgium;Brazil;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Mexico;Netherlands;Poland;Romania;Slovakia;Spain;Turkey;United Kingdom;United States
      2024   Phase 2   NCT06598943   Argentina;Belgium;Canada;Croatia;Czechia;Denmark;France;Germany;Greece;Hungary;Ireland;Italy;Japan;Korea, Republic of;Latvia;Poland;Romania;Serbia;Spain;Turkey;United States
      2023   Phase 3   NCT05767021   Austria;Belgium;Canada;Czechia;France;Germany;Hungary;Italy;Poland;Slovakia;United Kingdom;United States
      2021   Phase 3   NCT04844606   Austria;Belgium;Brazil;France;Germany;Israel;Italy;Japan;Korea, Republic of;Netherlands;Poland;Spain;United Kingdom;United States
      2021   Phase 3   EUCTR2019-001653-99-LV   Argentina;Australia;Austria;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;France;Germany;Hungary;India;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2021   Phase 3   EUCTR2019-001653-99-LT   Argentina;Australia;Austria;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;France;Germany;Hungary;India;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2021   Phase 3   EUCTR2019-001653-99-DE   Argentina;Australia;Austria;Belgium;Brazil;Canada;Croatia;Czech Republic;Czechia;Denmark;France;Germany;Hungary;India;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2021   Phase 3   EUCTR2019-001653-99-BE   Argentina;Australia;Austria;Belgium;Brazil;Canada;Croatia;Czechia;Denmark;France;Germany;Hungary;India;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2021   Phase 3   EUCTR2019-001653-99-AT   Argentina;Australia;Austria;Belgium;Brazil;Canada;Croatia;Czech Republic;Czechia;Denmark;France;Germany;Hungary;India;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2020   Phase 2   NCT04004611   Canada;Israel;Japan;Korea, Republic of;United States
      2020   Phase 3   EUCTR2019-001653-99-FR   Argentina;Australia;Austria;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;France;Germany;Hungary;India;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2020   Phase 3   EUCTR2017-004092-31-RO   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czechia;Denmark;France;Georgia;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Netherlands;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2020   Phase 3   EUCTR2017-004092-31-AT   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czechia;Denmark;France;Georgia;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Netherlands;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2017-004092-31-SK   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czechia;Denmark;France;Georgia;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Netherlands;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2017-004092-31-PL   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Denmark;France;Georgia;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Netherlands;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2017-004092-31-HU   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Denmark;France;Georgia;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Netherlands;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2017-004092-31-HR   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Denmark;France;Georgia;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Netherlands;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2017-004092-31-FR   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Denmark;France;Georgia;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Netherlands;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2017-004092-31-DE   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czechia;Denmark;France;Georgia;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Netherlands;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2017-003238-96-RO   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Czechia;Denmark;France;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2017-003238-96-HR   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Denmark;France;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2017-003229-14-RO   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Czechia;Denmark;France;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2017-003229-14-HR   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Denmark;France;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   NCT03519945   Argentina;Australia;Austria;Belgium;Canada;China;Croatia;Czechia;Denmark;France;Georgia;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Netherlands;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   NCT03518086   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czechia;Denmark;France;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004092-31-NL   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czechia;Denmark;France;Georgia;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Netherlands;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004092-31-LV   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czechia;Denmark;France;Georgia;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Netherlands;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004092-31-LT   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czechia;Denmark;France;Georgia;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Netherlands;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004092-31-GB   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Denmark;France;Georgia;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Netherlands;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004092-31-DK   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czechia;Denmark;France;Georgia;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Netherlands;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004092-31-BE   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czechia;Denmark;France;Georgia;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Netherlands;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-003238-96-SK   Argentina;Australia;Austria;Belgium;Canada;China;Croatia;Czech Republic;Denmark;France;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-003238-96-NL   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Denmark;France;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-003238-96-LV   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Denmark;France;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-003238-96-LT   Argentina;Australia;Austria;Belgium;Canada;China;Croatia;Czech Republic;Denmark;France;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-003238-96-HU   Argentina;Australia;Austria;Belgium;Canada;China;Croatia;Czech Republic;Denmark;France;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-003238-96-GB   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Denmark;France;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-003238-96-ES   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Denmark;France;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-003238-96-DE   Argentina;Australia;Austria;Belgium;Canada;China;Croatia;Czech Republic;Czechia;Denmark;France;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-003238-96-CZ   Argentina;Australia;Austria;Belgium;Canada;China;Croatia;Czech Republic;Denmark;France;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-003238-96-BE   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Denmark;France;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-003238-96-AT   Argentina;Australia;Austria;Belgium;Canada;China;Croatia;Czech Republic;Denmark;France;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-003229-14-SK   Argentina;Australia;Austria;Belgium;Canada;China;Croatia;Czech Republic;Denmark;France;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-003229-14-LV   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Denmark;France;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-003229-14-LT   Argentina;Australia;Austria;Belgium;Canada;China;Croatia;Czech Republic;Denmark;France;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-003229-14-GB   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Denmark;France;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-003229-14-ES   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Denmark;France;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-003229-14-DE   Argentina;Australia;Austria;Belgium;Canada;China;Croatia;Czech Republic;Denmark;France;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-003229-14-CZ   Argentina;Australia;Austria;Belgium;Canada;China;Croatia;Czech Republic;Denmark;France;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-003229-14-BE   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Denmark;France;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-003229-14-AT   Argentina;Australia;Austria;Belgium;Canada;China;Croatia;Czech Republic;Denmark;France;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 2   EUCTR2015-003123-57-PL   Australia;Belgium;Canada;Czech Republic;Denmark;France;Georgia;Hungary;Japan;Lithuania;Moldova, Republic of;Netherlands;Poland;Romania;Russian Federation;Ukraine;United Kingdom;United States
      2016   Phase 2   EUCTR2015-003123-57-DK   Australia;Belgium;Canada;Czech Republic;Denmark;France;Georgia;Hungary;Japan;Lithuania;Moldova, Republic of;Netherlands;Poland;Romania;Russian Federation;Ukraine;United Kingdom;United States
      2016   Phase 2   EUCTR2015-003123-57-CZ   Australia;Belgium;Canada;Czech Republic;Denmark;France;Georgia;Hungary;Japan;Lithuania;Moldova, Republic of;Netherlands;Poland;Romania;Russian Federation;Ukraine;United Kingdom;United States
      2016   Phase 2   EUCTR2015-003123-57-BE   Australia;Belgium;Canada;Czech Republic;Denmark;France;Georgia;Hungary;Japan;Lithuania;Moldova, Republic of;Netherlands;Poland;Romania;Russian Federation;Ukraine;United Kingdom;United States
      2015   Phase 2   NCT02589665   Australia;Belgium;Canada;Czech Republic;Czechia;Denmark;France;Georgia;Hungary;Japan;Lithuania;Moldova, Republic of;Netherlands;Poland;Puerto Rico;Romania;Russian Federation;Ukraine;United Kingdom;United States
      2015   Phase 2   EUCTR2015-003123-57-LT   Australia;Belgium;Canada;Czech Republic;Denmark;France;Georgia;Hungary;Japan;Lithuania;Moldova, Republic of;Netherlands;Poland;Romania;Russian Federation;Ukraine;United Kingdom;United States
      -   Phase 3   EUCTR2020-005311-49-PL   Argentina;Australia;Austria;Belgium;Canada;Czechia;Denmark;France;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Netherlands;Norway;Poland;Portugal;Slovakia;Spain;United Kingdom;United States
   Lilly S.A.
      2019   Phase 3   EUCTR2017-004092-31-ES   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Denmark;France;Georgia;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Netherlands;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
   Masaki Takeshi
      2021   Phase 3   JPRN-jRCT2031210210   Japan;United States
   Showa Inan General Hospital
      2024   Phase 4   NCT06626165   Japan
Mirikizumab IV
   Eli Lilly and Company
      2023   Phase 3   NCT05784246   Australia;Belgium;Canada;France;Germany;Israel;Italy;Japan;Korea, Republic of;Netherlands;Poland;Portugal;United Kingdom;United States
      2021   Phase 3   NCT04469062   -
      2018   Phase 3   NCT03524092   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czechia;Denmark;France;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
   Masaki Takeshi
      2023   Phase 3   JPRN-jRCT2031230330   Australia;Belgium;Canada;France;Germany;Italy;Japan;Poland;Portugal;United States
Mirikizumab SC
   Eli Lilly and Company
      2023   Phase 3   NCT05784246   Australia;Belgium;Canada;France;Germany;Israel;Italy;Japan;Korea, Republic of;Netherlands;Poland;Portugal;United Kingdom;United States
      2021   Phase 3   NCT04469062   -
      2018   Phase 3   NCT03524092   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czechia;Denmark;France;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
   Masaki Takeshi
      2023   Phase 3   JPRN-jRCT2031230330   Australia;Belgium;Canada;France;Germany;Italy;Japan;Poland;Portugal;United States
Mirtazapine
   King's College London
      2024   Phase 2   NCT06309472   United Kingdom
Mitoq
   University of Edinburgh
      2024   Phase 2   NCT05539625   United Kingdom
      2022   Phase 2   NCT04276740   United Kingdom
MK-6194
   Merck Sharp & Dohme LLC
      2021   Phase 1   NCT04924114   Georgia;Germany;Hungary;Moldova, Republic of;Poland;Ukraine;United Kingdom;United States
   Tanaka Yoshiyuki
      2022   Phase 1   JPRN-jRCT2051210183   -
MK-8259
   MSD Belgium BVBA/SPRL
      2014   Phase 4   EUCTR2014-000656-29-BE   Belgium
MLN0002
   ALIMENTIV INC.
      2021   Phase 4   EUCTR2019-002485-12-IT   Belarus;Belgium;Canada;France;Italy;Netherlands;Poland;Russian Federation;Ukraine;United Kingdom;United States
   Academic Medical Center/ Gastroenterology
      2015   Phase 4   EUCTR2014-005443-40-BE   Belgium;Hungary;Netherlands
   Alimentiv
      2021   Phase 4   EUCTR2019-002485-12-PL   Belarus;Belgium;Canada;France;Italy;Netherlands;Poland;Russian Federation;Ukraine;United Kingdom;United States
   Alimentiv Inc.
      2021   Phase 4   EUCTR2019-002485-12-NL   Belarus;Belgium;Canada;France;Italy;Netherlands;Poland;Ukraine;United Kingdom;United States
      2020   Phase 4   EUCTR2019-002485-12-BE   Belarus;Belgium;Canada;France;Italy;Netherlands;Poland;Russian Federation;Ukraine;United Kingdom;United States
   Alimentiv Inc. (formerly Robarts Clinical Trials)
      2020   Phase 4   EUCTR2019-002485-12-GB   Belarus;Belgium;Canada;France;Italy;Netherlands;Poland;Russian Federation;Ukraine;United Kingdom;United States
   MILLENNIUM PHARMACEUTICALS, INC.
      2009   Phase 3   EUCTR2008-002784-14-IT   Austria;Belgium;Bulgaria;Czech Republic;Estonia;France;Germany;Greece;Hungary;Iceland;Ireland;Italy;Latvia;Malta;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom
      2009   -   EUCTR2008-002782-32-IT   Austria;Belgium;Bulgaria;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;Iceland;Ireland;Italy;Latvia;Malta;Netherlands;Portugal;Spain;United Kingdom
   Millennium Pharmaceuticals, Inc.
      2009   Phase 3   EUCTR2008-002784-14-PT   Austria;Belgium;Bulgaria;Czech Republic;Estonia;France;Germany;Greece;Hungary;Iceland;Ireland;Italy;Latvia;Malta;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom
      2009   -   EUCTR2008-002784-14-MT   Austria;Belgium;Bulgaria;Czech Republic;Estonia;France;Germany;Greece;Hungary;Iceland;Ireland;Italy;Latvia;Malta;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom
      2009   Phase 3   EUCTR2008-002784-14-IE   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Estonia;France;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Korea, Republic of;Latvia;Malaysia;Malta;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2009   Phase 3   EUCTR2008-002784-14-GR   Austria;Belgium;Bulgaria;Czech Republic;Estonia;France;Germany;Greece;Hungary;Iceland;Ireland;Italy;Latvia;Malta;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom
      2009   Phase 3   EUCTR2008-002784-14-FR   Austria;Belgium;Bulgaria;Czech Republic;Estonia;France;Germany;Greece;Hungary;Iceland;Ireland;Italy;Latvia;Malta;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom
      2009   Phase 3   EUCTR2008-002784-14-ES   Austria;Belgium;Bulgaria;Czech Republic;Estonia;France;Germany;Greece;Hungary;Iceland;Ireland;Italy;Latvia;Malta;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom
      2009   Phase 3   EUCTR2008-002784-14-EE   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Estonia;France;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Korea, Republic of;Latvia;Malaysia;Malta;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2009   -   EUCTR2008-002783-33-MT   Austria;Belgium;Bulgaria;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;Iceland;Ireland;Italy;Latvia;Malta;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom
      2009   -   EUCTR2008-002783-33-AT   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Korea, Republic of;Latvia;Malaysia;Malta;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom
      2009   -   EUCTR2008-002782-32-PT   Austria;Belgium;Bulgaria;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;Iceland;Ireland;Italy;Latvia;Malta;Netherlands;Portugal;Spain;United Kingdom
      2009   -   EUCTR2008-002782-32-NL   Austria;Belgium;Bulgaria;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;Iceland;Ireland;Italy;Latvia;Malta;Netherlands;Portugal;Spain;United Kingdom
      2009   -   EUCTR2008-002782-32-MT   Austria;Belgium;Bulgaria;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;Iceland;Ireland;Italy;Latvia;Malta;Netherlands;Portugal;Spain;United Kingdom
      2009   Phase 3   EUCTR2008-002782-32-IS   Austria;Belgium;Bulgaria;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;Iceland;Ireland;Italy;Latvia;Malta;Netherlands;Portugal;Spain;United Kingdom
      2009   -   EUCTR2008-002782-32-IE   Austria;Belgium;Bulgaria;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;Iceland;Ireland;Italy;Latvia;Malta;Netherlands;Portugal;Spain;United Kingdom
      2009   -   EUCTR2008-002782-32-HU   Austria;Belgium;Bulgaria;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;Iceland;Ireland;Italy;Latvia;Malta;Netherlands;Portugal;Spain;United Kingdom
      2009   -   EUCTR2008-002782-32-GR   Austria;Belgium;Bulgaria;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;Iceland;Ireland;Italy;Latvia;Malta;Netherlands;Portugal;Spain;United Kingdom
      2009   Phase 3   EUCTR2008-002782-32-GB   Austria;Belgium;Bulgaria;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;Iceland;Ireland;Italy;Latvia;Malta;Netherlands;Portugal;Spain;United Kingdom
      2009   Phase 3   EUCTR2008-002782-32-FR   Austria;Belgium;Bulgaria;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;Iceland;Ireland;Italy;Latvia;Malta;Netherlands;Portugal;Spain;United Kingdom
      2009   -   EUCTR2008-002782-32-ES   Austria;Belgium;Bulgaria;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;Iceland;Ireland;Italy;Latvia;Malta;Netherlands;Portugal;Spain;United Kingdom
      2009   -   EUCTR2008-002782-32-EE   Austria;Belgium;Bulgaria;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;Iceland;Ireland;Italy;Latvia;Malta;Netherlands;Portugal;Spain;United Kingdom
      2009   -   EUCTR2008-002782-32-DK   Austria;Belgium;Bulgaria;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;Iceland;Ireland;Italy;Latvia;Malta;Netherlands;Portugal;Spain;United Kingdom
      2009   -   EUCTR2008-002782-32-DE   Australia;Austria;Belgium;Bulgaria;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Korea, Democratic People's Republic of;Latvia;Malaysia;Malta;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom
      2009   -   EUCTR2008-002782-32-CZ   Austria;Belgium;Bulgaria;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;Iceland;Ireland;Italy;Latvia;Malta;Netherlands;Portugal;Spain;United Kingdom
      2009   -   EUCTR2008-002782-32-BG   Austria;Belgium;Bulgaria;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;Iceland;Ireland;Italy;Latvia;Malta;Netherlands;Portugal;Spain;United Kingdom
      2009   Phase 3   EUCTR2008-002782-32-BE   Austria;Belgium;Bulgaria;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;Iceland;Ireland;Italy;Latvia;Malta;Netherlands;Portugal;Spain;United Kingdom
      2009   -   EUCTR2008-002782-32-AT   Austria;Belgium;Bulgaria;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;Iceland;Ireland;Italy;Latvia;Malta;Netherlands;Portugal;Spain;United Kingdom
      2008   -   EUCTR2008-002782-32-LV   Austria;Belgium;Bulgaria;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;Iceland;Ireland;Italy;Latvia;Malta;Netherlands;Portugal;Spain;United Kingdom
   Robarts Clinical Trials Inc.
      2020   Phase 4   EUCTR2019-002485-12-FR   Belarus;Belgium;Canada;France;Italy;Netherlands;Poland;Russian Federation;Ukraine;United Kingdom;United States
   Shikamura Mitsuhiro
      2023   Phase 3   JPRN-jRCT2071230036   China;Greece;Hungary;Italy;Japan;Korea;Poland
   TAKEDA DEVELOPMENT CENTER AMERICAS INC.
      2021   Phase 3   EUCTR2020-004300-34-IT   Australia;Austria;Belgium;Bosnia and Herzegovina;Canada;China;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Japan;Lithuania;New Zealand;Poland;Romania;Russian Federation;Slovakia;Spain;Ukraine;United Kingdom;United States
   TAKEDA DEVELOPMENT CENTRE EUROPE LTD
      2016   Phase 3   EUCTR2014-003942-28-IT   Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Hungary;Israel;Italy;Japan;Netherlands;Poland;Russian Federation;Spain;Sweden;Switzerland;United Kingdom;United States
      2015   Phase 3   EUCTR2015-000939-33-IT   Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
      -   Phase 4   EUCTR2016-000678-40-IT   Austria;Belgium;Bulgaria;Czech Republic;Czechia;Estonia;Hungary;Iceland;India;Italy;Korea, Democratic People's Republic of;Korea, Republic of;Latvia;Malaysia;New Zealand;Poland;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Taiwan;Turkey;Ukraine
   TAKEDA PHARMACEUTICAL COMPANY LTD.
      2014   Phase 3   JPRN-jRCT2080222353   Japan
   Takeda Development Center Americas, Inc.
      2023   Phase 3   EUCTR2021-000630-34-SK   Australia;Belgium;Canada;China;Croatia;Czech Republic;Czechia;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Poland;Slovakia;Spain;United Kingdom;United States
      2023   Phase 3   EUCTR2021-000630-34-GR   Australia;Belgium;Canada;China;Croatia;Czech Republic;Czechia;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Poland;Slovakia;Spain;United Kingdom;United States
      2023   Phase 3   EUCTR2021-000630-34-BE   Australia;Belgium;Canada;China;Croatia;Czech Republic;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Poland;Slovakia;Spain;United Kingdom;United States
      2022   Phase 3   EUCTR2021-000630-34-HU   Australia;Belgium;Canada;China;Croatia;Czech Republic;Czechia;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Poland;Russian Federation;Slovakia;Spain;Ukraine;United Kingdom;United States
      2022   Phase 3   EUCTR2021-000630-34-HR   Australia;Belgium;Canada;China;Croatia;Czech Republic;Czechia;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Poland;Russian Federation;Slovakia;Spain;Ukraine;United Kingdom;United States
      2022   Phase 3   EUCTR2020-004300-34-BE   Australia;Belgium;Canada;China;Croatia;Czech Republic;Czechia;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Poland;Slovakia;Spain;United Kingdom;United States
      2021   Phase 3   EUCTR2020-004300-34-SK   Australia;Belgium;Canada;China;Croatia;Czech Republic;Czechia;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Poland;Slovakia;Spain;United Kingdom;United States
      2021   Phase 3   EUCTR2020-004300-34-LT   Australia;Belgium;Canada;China;Croatia;Czech Republic;Czechia;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Poland;Russian Federation;Slovakia;Spain;Ukraine;United Kingdom;United States
      2021   Phase 3   EUCTR2020-004300-34-HU   Australia;Austria;Belgium;Bosnia and Herzegovina;Canada;China;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Japan;Lithuania;New Zealand;Poland;Romania;Russian Federation;Slovakia;Spain;Ukraine;United Kingdom;United States
      2021   Phase 3   EUCTR2020-004300-34-HR   Australia;Austria;Belgium;Bosnia and Herzegovina;Canada;China;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Japan;Lithuania;New Zealand;Poland;Romania;Russian Federation;Slovakia;Spain;Ukraine;United Kingdom;United States
      2021   Phase 3   EUCTR2020-004300-34-GR   Australia;Belgium;Canada;China;Croatia;Czech Republic;Czechia;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Poland;Slovakia;Spain;United Kingdom;United States
      2021   Phase 3   EUCTR2020-004300-34-ES   Australia;Austria;Belgium;Bosnia and Herzegovina;Canada;China;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Japan;Lithuania;New Zealand;Poland;Romania;Russian Federation;Slovakia;Spain;Ukraine;United Kingdom;United States
      -   Phase 3   EUCTR2021-000630-34-PL   Australia;Belgium;Canada;China;Croatia;Czech Republic;Czechia;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Poland;Slovakia;Spain;United Kingdom;United States
      -   Phase 3   EUCTR2021-000630-34-Outside-EU/EEA   Australia;Canada;China;Israel;Japan;Korea, Republic of;United Kingdom;United States
      -   Phase 3   EUCTR2021-000630-34-CZ   Australia;Belgium;Canada;China;Croatia;Czech Republic;Czechia;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Poland;Slovakia;Spain;United Kingdom;United States
      -   Phase 3   EUCTR2020-004300-34-PL   Australia;Belgium;Canada;China;Croatia;Czech Republic;Czechia;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Poland;Slovakia;Spain;United Kingdom;United States
      -   Phase 3   EUCTR2020-004300-34-Outside-EU/EEA   Australia;Belgium;Canada;China;Croatia;Czechia;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Poland;Slovakia;Spain;United Kingdom;United States
      -   Phase 3   EUCTR2020-004300-34-CZ   Australia;Belgium;Canada;China;Croatia;Czech Republic;Czechia;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Poland;Slovakia;Spain;United Kingdom;United States
   Takeda Development Centre Americas Inc.
      2018   Phase 2   EUCTR2017-002182-21-PL   Belgium;Canada;France;Germany;Hungary;Israel;Netherlands;Poland;Ukraine;United Kingdom;United States
   Takeda Development Centre Americas, Ltd.
      2017   Phase 2   EUCTR2017-002182-21-HU   Belgium;Canada;France;Germany;Hungary;Israel;Netherlands;Poland;Ukraine;United Kingdom;United States
   Takeda Development Centre Europe Limited
      2017   Phase 4   EUCTR2016-000678-40-BG   Australia;Bulgaria;Czech Republic;Estonia;Hungary;India;Italy;Korea, Republic of;Latvia;Malaysia;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Taiwan;Turkey;Ukraine
      2016   Phase 4   EUCTR2016-000678-40-LV   Australia;Bulgaria;Czech Republic;Estonia;Hungary;India;Italy;Korea, Republic of;Latvia;Malaysia;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Taiwan;Turkey;Ukraine
      2016   Phase 4   EUCTR2016-000678-40-HU   Australia;Bulgaria;Czech Republic;Czechia;Estonia;Hungary;India;Italy;Korea, Republic of;Latvia;Malaysia;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Taiwan;Turkey;Ukraine
      2016   Phase 4   EUCTR2016-000678-40-EE   Australia;Bulgaria;Czech Republic;Estonia;Hungary;India;Italy;Korea, Republic of;Latvia;Malaysia;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Taiwan;Turkey;Ukraine
      2016   Phase 4   EUCTR2016-000678-40-CZ   Australia;Bulgaria;Czech Republic;Estonia;Hungary;India;Italy;Korea, Republic of;Latvia;Malaysia;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Taiwan;Turkey;Ukraine
   Takeda Development Centre Europe Ltd
      2009   Phase 3   EUCTR2008-002784-14-IS   Austria;Belgium;Bulgaria;Czech Republic;Estonia;France;Germany;Greece;Hungary;Iceland;Ireland;Italy;Latvia;Malta;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom
   Takeda Development Centre Europe Ltd.
      2010   Phase 3   EUCTR2008-002784-14-SE   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Estonia;France;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Korea, Republic of;Latvia;Malaysia;Malta;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2010   Phase 3   EUCTR2008-002784-14-GB   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Estonia;France;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Korea, Republic of;Latvia;Malaysia;Malta;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;United Kingdom
      2009   Phase 3   EUCTR2008-002784-14-SK   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Estonia;France;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Korea, Republic of;Latvia;Malaysia;Malta;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2009   Phase 3   EUCTR2008-002784-14-NL   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Estonia;France;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Korea, Republic of;Latvia;Malaysia;Malta;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2009   Phase 3   EUCTR2008-002784-14-DE   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Estonia;France;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Korea, Republic of;Latvia;Malaysia;Malta;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2009   Phase 3   EUCTR2008-002784-14-CZ   Australia;Austria;Belgium;Bulgaria;Czech Republic;Estonia;France;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Korea, Republic of;Latvia;Malaysia;Malta;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom
      2009   Phase 3   EUCTR2008-002784-14-BG   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Estonia;France;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Korea, Republic of;Latvia;Malaysia;Malta;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2009   Phase 3   EUCTR2008-002784-14-BE   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Estonia;France;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Korea, Republic of;Latvia;Malaysia;Malta;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2009   Phase 3   EUCTR2008-002784-14-AT   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Estonia;France;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Korea, Republic of;Latvia;Malaysia;Malta;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2008   Phase 3   EUCTR2008-002784-14-LV   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Estonia;France;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Korea, Republic of;Latvia;Malaysia;Malta;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
   Takeda Development Centre Europe ltd.
      2009   Phase 3   EUCTR2008-002784-14-HU   Australia;Austria;Belgium;Bulgaria;Czech Republic;Estonia;France;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Korea, Republic of;Latvia;Malaysia;Malta;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
   Takeda Development Centre Europe, Ltd.
      2018   Phase 2   EUCTR2017-002231-41-PL   Belgium;Canada;France;Germany;Hungary;Israel;Netherlands;Poland;Ukraine;United Kingdom;United States
      2018   Phase 2   EUCTR2017-002231-41-NL   Belgium;Canada;France;Germany;Hungary;Israel;Netherlands;Poland;Ukraine;United Kingdom;United States
      2018   Phase 2   EUCTR2017-002231-41-BE   Belgium;Canada;France;Germany;Hungary;Israel;Netherlands;Poland;Ukraine;United Kingdom;United States
      2018   Phase 2   EUCTR2017-002182-21-NL   Belgium;Canada;France;Germany;Hungary;Israel;Netherlands;Poland;Ukraine;United Kingdom;United States
      2018   Phase 2   EUCTR2017-002182-21-BE   Belgium;Canada;France;Germany;Hungary;Israel;Netherlands;Poland;Ukraine;United Kingdom;United States
      2017   Phase 2   EUCTR2017-002231-41-HU   Belgium;Canada;France;Germany;Hungary;Israel;Netherlands;Poland;Ukraine;United Kingdom;United States
      2017   Phase 2   EUCTR2017-002231-41-GB   Belgium;Canada;France;Germany;Hungary;Israel;Netherlands;Poland;Ukraine;United Kingdom;United States
      2017   Phase 2   EUCTR2017-002231-41-DE   Belgium;Canada;France;Germany;Hungary;Israel;Netherlands;Poland;Ukraine;United Kingdom;United States
      2017   Phase 2   EUCTR2017-002182-21-GB   Belgium;Canada;France;Germany;Hungary;Israel;Netherlands;Poland;Ukraine;United Kingdom;United States
      2017   Phase 2   EUCTR2017-002182-21-FR   Belgium;Canada;France;Germany;Hungary;Israel;Netherlands;Poland;Ukraine;United Kingdom;United States
      2017   Phase 2   EUCTR2017-002182-21-DE   Belgium;Canada;France;Germany;Hungary;Israel;Netherlands;Poland;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000939-33-PT   Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000939-33-PL   Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000939-33-NL   Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000939-33-HU   Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000939-33-HR   Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000939-33-ES   Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2014-003942-28-SE   Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Israel;Italy;Japan;Netherlands;Poland;Russian Federation;Spain;Sweden;Switzerland;United Kingdom;United States
      2016   Phase 3   EUCTR2014-003942-28-PL   Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Israel;Italy;Japan;Netherlands;Poland;Russian Federation;Spain;Sweden;Switzerland;United Kingdom;United States
      2016   Phase 3   EUCTR2014-003942-28-HU   Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Israel;Italy;Japan;Netherlands;Poland;Russian Federation;Spain;Sweden;Switzerland;United Kingdom;United States
      2016   Phase 3   EUCTR2014-003942-28-GB   Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Israel;Italy;Japan;Netherlands;Poland;Russian Federation;Spain;Sweden;Switzerland;United Kingdom;United States
      2016   Phase 3   EUCTR2014-003942-28-FR   Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Israel;Italy;Japan;Netherlands;Poland;Russian Federation;Spain;Sweden;Switzerland;United Kingdom;United States
      2016   Phase 3   EUCTR2014-003942-28-ES   Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Israel;Italy;Japan;Netherlands;Poland;Russian Federation;Spain;Sweden;Switzerland;United Kingdom;United States
      2016   Phase 3   EUCTR2014-003942-28-DE   Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Israel;Italy;Japan;Netherlands;Poland;Russian Federation;Spain;Sweden;Switzerland;United Kingdom;United States
      2016   Phase 3   EUCTR2014-003942-28-CZ   Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Israel;Italy;Japan;Netherlands;Poland;Russian Federation;Spain;Sweden;Switzerland;United Kingdom;United States
      2016   Phase 3   EUCTR2014-003942-28-BE   Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Israel;Italy;Japan;Netherlands;Poland;Russian Federation;Spain;Sweden;Switzerland;United Kingdom;United States
      2016   Phase 3   EUCTR2014-003942-28-AT   Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Israel;Italy;Japan;Netherlands;Poland;Russian Federation;Spain;Sweden;Switzerland;United Kingdom;United States
      2015   Phase 3   EUCTR2015-000939-33-SK   Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2015   Phase 3   EUCTR2015-000939-33-LV   Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2015   Phase 3   EUCTR2015-000939-33-LT   Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2015   Phase 3   EUCTR2015-000939-33-GB   Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2015   Phase 3   EUCTR2015-000939-33-EE   Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2015   Phase 3   EUCTR2015-000939-33-DK   Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2015   Phase 3   EUCTR2015-000939-33-DE   Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2015   Phase 3   EUCTR2015-000939-33-CZ   Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2015   Phase 3   EUCTR2015-000939-33-BG   Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2015   Phase 3   EUCTR2015-000939-33-BE   Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
      -   Phase 2   EUCTR2017-002231-41-FR   Belgium;Canada;France;Germany;Hungary;Israel;Netherlands;Poland;Ukraine;United Kingdom;United States
MLN0002 SC
   TAKEDA DEVELOPMENT CENTRE EUROPE LTD
      2016   Phase 3   EUCTR2015-000482-31-IT   Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Montenegro;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000480-14-IT   Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
   Takeda Development Centre Europe, Ltd.
      2016   Phase 3   EUCTR2015-000482-31-SK   Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000482-31-SE   Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000482-31-RO   Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000482-31-NL   Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000482-31-LT   Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000482-31-HU   Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000482-31-HR   Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000482-31-GB   Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000482-31-ES   Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000482-31-DK   Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000482-31-DE   Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000482-31-CZ   Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000482-31-BG   Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000482-31-BE   Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000480-14-SK   Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000480-14-SE   Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000480-14-RO   Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000480-14-NL   Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000480-14-LT   Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000480-14-HU   Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000480-14-HR   Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000480-14-GB   Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000480-14-ES   Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000480-14-DK   Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000480-14-DE   Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000480-14-CZ   Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000480-14-BG   Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000480-14-BE   Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
MLN002
   TAKEDA DEVELOPMENT CENTRE EUROPE LTD
      -   Phase 4   EUCTR2016-000678-40-IT   Austria;Belgium;Bulgaria;Czech Republic;Czechia;Estonia;Hungary;Iceland;India;Italy;Korea, Democratic People's Republic of;Korea, Republic of;Latvia;Malaysia;New Zealand;Poland;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Taiwan;Turkey;Ukraine
   Takeda Development Centre Europe Limited
      2016   Phase 4   EUCTR2016-000678-40-CZ   Australia;Bulgaria;Czech Republic;Estonia;Hungary;India;Italy;Korea, Republic of;Latvia;Malaysia;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Taiwan;Turkey;Ukraine
MMX mesalamine
   Shire
      2010   Phase 1   NCT01130844   Australia;Poland;Slovakia;United Kingdom;United States
      2007   Phase 4   NCT00446849   United States
MMX mesalamine/ mesalazine
   Shire
      2010   Phase 4   NCT01124149   Belgium;Brazil;Canada;Colombia;Czech Republic;Czechia;France;Germany;Hungary;India;Ireland;Poland;Romania;South Africa;Spain;United Kingdom;United States
MMX mesalamine/mesalazine
   Shire
      2014   Phase 3   NCT02093663   Belgium;Canada;Germany;Hungary;Israel;Netherlands;Poland;Slovakia;United Kingdom;United States
   Shire Development Inc
      2010   Phase 4   EUCTR2009-017044-13-FR   Belgium;Czech Republic;France;Germany;Hungary;Ireland;Spain;United Kingdom
      2010   -   EUCTR2009-017044-13-DE   Canada;Colombia;Czech Republic;France;Germany;Hungary;India;Ireland;Poland;Russian Federation;South Africa;Spain;United Kingdom;United States
   Shire Development Inc.
      2010   Phase 4   EUCTR2009-017044-13-ES   Belgium;Czech Republic;France;Germany;Hungary;Ireland;Spain;United Kingdom
   Shire Development LLC
      2010   -   EUCTR2009-017044-13-IE   Canada;Colombia;Czech Republic;France;Germany;Hungary;India;Ireland;Poland;Russian Federation;South Africa;Spain;United Kingdom;United States
      2010   -   EUCTR2009-017044-13-HU   Canada;Colombia;Czech Republic;France;Germany;Hungary;India;Ireland;Poland;Russian Federation;South Africa;Spain;United Kingdom;United States
      2010   Phase 4   EUCTR2009-017044-13-GB   Belgium;Canada;Colombia;Czech Republic;France;Germany;Hungary;India;Ireland;Poland;Russian Federation;South Africa;Spain;United Kingdom;United States
      2010   -   EUCTR2009-017044-13-CZ   Canada;Colombia;Czech Republic;France;Germany;Hungary;India;Ireland;Poland;Russian Federation;South Africa;Spain;United Kingdom;United States
      2010   Phase 4   EUCTR2009-017044-13-BE   Belgium;Canada;Colombia;Czech Republic;France;Germany;Hungary;India;Ireland;Poland;Russian Federation;South Africa;Spain;United Kingdom;United States
Modified gegen qinlian decoction
   Xiyuan Hospital of China Academy of Chinese Medical Sciences
      2019   Early Phase 1   NCT04057547   China
Modified-release phosphatidylcholine
   Lipid Therapeutics GmbH
      2009   -   EUCTR2008-007952-90-LT   Germany;Lithuania
      2009   -   EUCTR2008-007952-90-DE   Germany;Lithuania
Mongersen
   Celgene Corporation
      2016   Phase 2   EUCTR2015-003364-36-SK   Bulgaria;Canada;Hungary;Poland;Slovakia;United States
      2016   Phase 2   EUCTR2015-003364-36-HU   Bulgaria;Canada;Hungary;Poland;Slovakia;United States
      2016   Phase 2   EUCTR2015-003364-36-BG   Bulgaria;Canada;Hungary;Poland;Slovakia;United States
Monoclonal antibody ANTI-IGG1
   BOEHRINGER-INGELHEIM ITALIA S.P.A.
      2018   Phase 2   EUCTR2018-000334-35-IT   Australia;Austria;Belgium;Canada;Germany;Hungary;Italy;Japan;Korea, Republic of;Netherlands;Norway;Poland;Russian Federation;Spain;United Kingdom;United States
      2018   Phase 2;Phase 3   EUCTR2017-004230-28-IT   Austria;Belgium;Canada;Czech Republic;Denmark;Germany;Greece;Hungary;Italy;Japan;Korea, Republic of;Netherlands;Poland;Russian Federation;Spain;Taiwan;United Kingdom;United States
   Boehringer Ingelheim BV Netherlands
      2017   Phase 2   EUCTR2016-004572-21-NL   Denmark;Germany;Netherlands;Norway;Spain;United Kingdom
   Boehringer Ingelheim Denmark A/S
      2019   Phase 2;Phase 3   EUCTR2017-004230-28-DK   Argentina;Australia;Austria;Belgium;Canada;China;Czech Republic;Denmark;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Norway;Poland;Russian Federation;Spain;Taiwan;United Kingdom;United States
   Boehringer Ingelheim España, S.A.
      2018   Phase 2   EUCTR2018-000334-35-ES   Austria;Belgium;Canada;Germany;Italy;Japan;Korea, Republic of;Netherlands;Poland;Russian Federation;Spain;United Kingdom;United States
      2018   Phase 2;Phase 3   EUCTR2017-004230-28-ES   Austria;Belgium;Canada;Czech Republic;Denmark;Germany;Greece;Hungary;Italy;Japan;Korea, Republic of;Netherlands;Poland;Russian Federation;Spain;Taiwan;United Kingdom;United States
      2017   Phase 2   EUCTR2016-004572-21-ES   Denmark;Germany;Netherlands;Norway;Spain;United Kingdom
   Boehringer Ingelheim International GmbH
      2019   Phase 2;Phase 3   EUCTR2017-004230-28-HU   Argentina;Australia;Austria;Belgium;Canada;China;Czech Republic;Denmark;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Norway;Poland;Russian Federation;Spain;Taiwan;United Kingdom;United States
      2019   Phase 2;Phase 3   EUCTR2017-004230-28-GR   Argentina;Australia;Austria;Belgium;Canada;China;Czech Republic;Denmark;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Norway;Poland;Russian Federation;Spain;Taiwan;United Kingdom;United States
      2019   Phase 2;Phase 3   EUCTR2017-004230-28-CZ   Argentina;Australia;Austria;Belgium;Canada;China;Czech Republic;Denmark;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Norway;Poland;Russian Federation;Spain;Taiwan;United Kingdom;United States
   Boehringer Ingelheim LImited
      2018   Phase 2   EUCTR2018-000334-35-GB   Austria;Belgium;Canada;Germany;Hungary;Italy;Japan;Korea, Republic of;Netherlands;Norway;Poland;Russian Federation;Spain;United Kingdom;United States
   Boehringer Ingelheim Limited
      2018   Phase 2;Phase 3   EUCTR2017-004230-28-GB   Argentina;Australia;Austria;Belgium;Canada;China;Czech Republic;Denmark;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Norway;Poland;Russian Federation;Spain;Taiwan;United Kingdom;United States
      2017   Phase 2   EUCTR2017-000100-20-GB   Belgium;Germany;United Kingdom
      2017   Phase 2   EUCTR2016-004572-21-GB   Denmark;Germany;Netherlands;Norway;Spain;United Kingdom
   Boehringer Ingelheim Norway KS
      2019   Phase 2   EUCTR2018-000334-35-NO   Austria;Belgium;Canada;Germany;Hungary;Italy;Japan;Korea, Republic of;Netherlands;Norway;Poland;Russian Federation;Spain;United Kingdom;United States
      2017   Phase 2   EUCTR2016-004572-21-NO   Denmark;Germany;Netherlands;Norway;Spain;United Kingdom
   Boehringer Ingelheim Pharma GmbH & Co. KG
      2018   Phase 2   EUCTR2018-000334-35-DE   Australia;Austria;Belgium;Canada;Czechia;Denmark;Germany;Greece;Hungary;Italy;Japan;Korea, Republic of;Netherlands;Norway;Poland;Russian Federation;Spain;United Kingdom;United States
      2018   Phase 2;Phase 3   EUCTR2017-004230-28-DE   Argentina;Australia;Austria;Belgium;Canada;China;Czech Republic;Denmark;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Norway;Poland;Russian Federation;Spain;Taiwan;United Kingdom;United States
      2017   Phase 2   EUCTR2017-000100-20-DE   Belgium;Germany;United Kingdom
      2017   Phase 2   EUCTR2016-004572-21-DK   Denmark;Germany;Netherlands;Norway;Spain;United Kingdom
      2017   Phase 2   EUCTR2016-004572-21-DE   Denmark;Germany;Netherlands;Norway;Spain;United Kingdom
   Boehringer Ingelheim RCV GmbH & Co KG
      2018   Phase 2;Phase 3   EUCTR2017-004230-28-AT   Argentina;Australia;Austria;Belgium;Canada;China;Czech Republic;Denmark;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Norway;Poland;Russian Federation;Spain;Taiwan;United Kingdom;United States
   Boehringer Ingelheim RCV GmbH&Co. KG
      2019   Phase 2   EUCTR2018-000334-35-PL   Australia;Austria;Belgium;Canada;Czechia;Denmark;Germany;Greece;Hungary;Italy;Japan;Korea, Republic of;Netherlands;Norway;Poland;Russian Federation;Spain;United Kingdom;United States
      2019   Phase 2   EUCTR2018-000334-35-HU   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Germany;Greece;Hungary;Italy;Japan;Korea, Republic of;Netherlands;Norway;Poland;Russian Federation;Spain;United Kingdom;United States
      2018   Phase 2   EUCTR2018-000334-35-AT   Austria;Belgium;Canada;Germany;Hungary;Italy;Japan;Korea, Republic of;Netherlands;Norway;Poland;Russian Federation;Spain;United Kingdom;United States
   Boehringer Ingelheim bv
      2018   Phase 2;Phase 3   EUCTR2017-004230-28-NL   Austria;Belgium;Canada;Czech Republic;Denmark;Germany;Greece;Hungary;Italy;Japan;Korea, Republic of;Netherlands;Poland;Russian Federation;Spain;Taiwan;United Kingdom;United States
   Boehringer Ingelheim bv Netherlands
      2019   Phase 2   EUCTR2018-000334-35-NL   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Germany;Greece;Hungary;Italy;Japan;Korea, Republic of;Netherlands;Norway;Poland;Russian Federation;Spain;United Kingdom;United States
   SCS Boehringer Ingelheim Comm. V
      2018   Phase 2   EUCTR2018-000334-35-BE   Austria;Belgium;Canada;Germany;Hungary;Italy;Japan;Korea, Republic of;Netherlands;Norway;Poland;Russian Federation;Spain;United Kingdom;United States
      2018   Phase 2;Phase 3   EUCTR2017-004230-28-BE   Argentina;Australia;Austria;Belgium;Canada;China;Czech Republic;Denmark;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Poland;Russian Federation;Spain;Taiwan;United Kingdom;United States
      2017   Phase 2   EUCTR2017-000100-20-BE   Belgium;Germany;United Kingdom
Monofer
   Leiden University Medical Center
      2022   Phase 4   EUCTR2022-000894-16-NL   Netherlands
   Pharmacosmos A/S
      2019   Phase 4   EUCTR2017-002452-87-DE   Austria;Denmark;Germany;Sweden;United Kingdom
      2018   Phase 4   EUCTR2017-002452-87-SE   Austria;Denmark;Germany;Sweden;United Kingdom
      2018   Phase 4   EUCTR2017-002452-87-AT   Austria;Denmark;Germany;Sweden;United Kingdom
      2017   Phase 4   EUCTR2017-002452-87-DK   Austria;Denmark;Germany;Sweden;United Kingdom
      2014   -   EUCTR2014-001518-25-DE   Germany;Russian Federation;United Kingdom;United States
      2013   -   EUCTR2011-003121-94-NL   Denmark;Netherlands;Sweden
      2012   Phase 1   NCT01213680   India
      2012   -   EUCTR2011-003121-94-SE   Denmark;Netherlands;Sweden
      2012   Phase 3   EUCTR2011-001593-25-HU   Austria;Hungary
      2011   Phase 3   NCT01410435   Austria;Hungary
      2011   -   EUCTR2011-003121-94-DK   Denmark;Netherlands;Sweden
      2011   -   EUCTR2011-001593-25-AT   Austria;Hungary
      2011   -   EUCTR2009-012544-16-AT   Austria;Denmark;Hungary;United Kingdom
      2009   Phase 3   NCT01017614   Denmark;India;United Kingdom
      2009   -   EUCTR2009-012544-16-DK   Austria;Denmark;Hungary;United Kingdom
Monofer 100 MG/ML
   Pharmacosmos A/S
      2011   -   EUCTR2009-012544-16-HU   Austria;Denmark;Hungary;United Kingdom
      2009   Phase 3   EUCTR2009-012544-16-GB   Austria;Denmark;Hungary;United Kingdom
Monofer 100MG/ML
   Pharmacosmos A/S
      2018   Phase 4   EUCTR2017-002452-87-GB   Austria;Denmark;Germany;Sweden;United Kingdom
Montmorency tart cherry
   University of Central Lancashire
      2023   -   NCT05486507   United Kingdom
MORF-057
   Morphic Therapeutic, Inc
      2022   Phase 2   NCT05611671   Australia;Austria;Bulgaria;Czechia;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Poland;Romania;Serbia;Slovakia;Taiwan;United States
      2022   Phase 2   NCT05291689   Poland;United States
   Morphic Therapeutic, Inc.
      2022   Phase 2   EUCTR2021-005288-31-PL   Poland;United States
Morning group
   Rush University Medical Center
      2016   Phase 4   NCT04304950   United States
Moviprep polvo para solucióN oral
   Universitary Hospital Príncipe de Asturias
      2021   Phase 4   EUCTR2021-000985-14-ES   Spain
Moviprep sabor naranja
   Hospital Universitario La Paz
      2019   Phase 4   EUCTR2018-001402-28-ES   Spain
Mrna COVD19 vaccine
   Mayo Clinic
      2021   Early Phase 1   NCT04839315   United States
MS-20 oral solution
   National Taiwan University Hospital
      2021   -   NCT04908644   Taiwan
MSC
   Leiden University Medical Center
      2018   Phase 2   EUCTR2017-003524-75-NL   Netherlands
MT-1303
   Mitsubishi Tanabe Pharma Corporation
      2012   Phase 1   NCT01666327   United Kingdom
   Salix Pharmaceuticals Inc.
      2022   Phase 2   EUCTR2020-005232-30-IT   Australia;Belarus;Bulgaria;Czech Republic;Czechia;Estonia;Georgia;Germany;Hungary;Italy;Japan;Korea, Republic of;Moldova, Republic of;Poland;Russian Federation;Serbia;Slovakia;Taiwan;Ukraine;United States
   Salix Pharmaceuticals, Inc.
      2021   Phase 2   EUCTR2020-005232-30-HU   Australia;Belarus;Belgium;Bulgaria;Czech Republic;Czechia;Estonia;Georgia;Germany;Hungary;Italy;Japan;Korea, Republic of;Moldova, Republic of;Poland;Russian Federation;Serbia;Slovakia;Taiwan;Ukraine;United States
      2021   Phase 2   EUCTR2020-005232-30-EE   Australia;Belarus;Bulgaria;Czech Republic;Czechia;Estonia;Georgia;Germany;Hungary;Italy;Japan;Korea, Republic of;Moldova, Republic of;Poland;Russian Federation;Serbia;Slovakia;Taiwan;Ukraine;United States
      2021   Phase 2   EUCTR2020-005232-30-DE   Australia;Belarus;Bulgaria;Czech Republic;Czechia;Estonia;France;Georgia;Germany;Hungary;Italy;Japan;Korea, Republic of;Moldova, Republic of;New Zealand;Poland;Russian Federation;Serbia;Slovakia;Taiwan;Ukraine;United States
      2021   Phase 2   EUCTR2020-005232-30-CZ   Australia;Belarus;Bulgaria;Czech Republic;Czechia;Estonia;Georgia;Germany;Hungary;Italy;Japan;Korea, Republic of;Moldova, Republic of;Poland;Russian Federation;Serbia;Slovakia;Taiwan;Ukraine;United States
      2021   Phase 2   EUCTR2020-005232-30-BG   Australia;Belarus;Bulgaria;Czech Republic;Czechia;Estonia;Georgia;Germany;Hungary;Italy;Japan;Korea, Republic of;Moldova, Republic of;Poland;Russian Federation;Serbia;Slovakia;Taiwan;Ukraine;United States
MTX 12.5
   University of Western Ontario, Canada
      2013   Phase 4   NCT01716039   -
MTX 25
   University of Western Ontario, Canada
      2013   Phase 4   NCT01716039   -
Multi-strain probiotics
   National University of Malaysia
      2024   -   NCT06595719   Malaysia
Multiple DOSE- group B
   Pfizer
      2005   Phase 1   NCT00928681   Belgium;Czech Republic;Denmark;Germany;Norway;Slovakia;Spain
Multiple DOSE-group B
   Pfizer
      2005   Phase 1   NCT00928681   Belgium;Czech Republic;Denmark;Germany;Norway;Slovakia;Spain
Multistem
   PFIZER LIMITED
      2012   -   EUCTR2010-022766-27-IT   Belgium;Canada;Hungary;Italy;Sweden;United States
   Pfizer Limited, Ramsgate Road, Sandwich, Kent, CT13 9NJ, UK
      2012   -   EUCTR2010-022766-27-SK   Belgium;Canada;Hungary;Italy;Poland;Slovakia;Sweden;United States
      2012   -   EUCTR2010-022766-27-SE   Belgium;Canada;Germany;Hungary;Italy;Poland;Slovakia;Sweden;United States
      2012   -   EUCTR2010-022766-27-HU   Belgium;Canada;Germany;Hungary;Italy;Poland;Slovakia;Sweden;United States
      2012   -   EUCTR2010-022766-27-BE   Belgium;Canada;Germany;Hungary;Italy;Poland;Slovakia;Sweden;United States
Multistem high dose
   Pfizer
      2011   Phase 2   NCT01240915   Belgium;Canada;Germany;Hungary;Italy;Slovakia;Sweden;United States
Multistem LOW dose
   Pfizer
      2011   Phase 2   NCT01240915   Belgium;Canada;Germany;Hungary;Italy;Slovakia;Sweden;United States
Mycodigest supplement
   Tel-Aviv Sourasky Medical Center
      2018   -   NCT04329481   Israel
Myrrh
   REPHA GmbH
      2008   -   EUCTR2007-007928-18-DE   Germany
Nabilone
   Samuel Lunenfeld Research Institute, Mount Sinai Hospital
      2023   -   NCT03422861   Canada
Naltrexone hydrochloride
   ErasmusMC
      2020   Phase 2   EUCTR2019-000852-32-NL   Netherlands
Nanocort
   Enceladus Pharmaceuticals
      2011   -   EUCTR2010-020448-37-NL   Belgium;Netherlands
      2010   Phase 2   EUCTR2010-020448-37-BE   Belgium;Netherlands
Neomycin
   University of Dundee
      2006   -   NCT00355602   United Kingdom
Neoral
   GETAID
      2008   -   EUCTR2006-005299-42-BE   Belgium;Finland;France;Spain
      2007   -   EUCTR2006-005299-42-FR   Belgium;Finland;France;Spain
Neoral soft gelatin capsules
   Swansea University
      2008   Phase 3   EUCTR2008-001968-36-GB   United Kingdom
Nestle impact immunonutrition
   University of Alabama at Birmingham
      2020   Early Phase 1   NCT03333148   -
Niclosamide
   First Wave Bio, Inc.
      2018   Phase 1/Phase 2   NCT03521232   Italy
Nicolon
   S.L.A. PHARMA (UK) LTD
      2007   -   EUCTR2006-006052-35-IT   Italy
Nicotinamide mononucleotide
   The Third Xiangya Hospital of Central South University
      2024   -   NCT06214078   China
Nicotinamide riboside chloride
   University of Pittsburgh
      2024   -   NCT05561738   United States
Nifuroxazide
   Mostafa Bahaa
      2023   Phase 2/Phase 3   NCT05988528   Egypt
Nitric oxide
   The Second Affiliated Hospital of the Chinese People's Liberation Army Air Force Medical University
      2025   -   ChiCTR2500095979   China
Nivolumab
   Alliance Foundation Trials, LLC.
      2019   Phase 1   NCT03656627   United States
   National Cancer Institute (NCI)
      2019   Phase 1   NCT03816345   Canada;United States
Nolpitantium besylate
   SANOFI-SYNTHELABO
      2005   -   EUCTR2004-001677-26-IT   Czech Republic;Estonia;Hungary;Italy;Spain;Sweden
   Sanofi
      2005   Phase 2   NCT00232258   Argentina;Belgium;Brazil;Canada;Chile;Czech Republic;Estonia;France;Hungary;Italy;Russian Federation;Singapore;South Africa;Spain;Sweden;United States
   Sanofi-Synthelabo Recherche
      2005   -   EUCTR2004-001677-26-SE   Czech Republic;Estonia;Hungary;Italy;Spain;Sweden
      2005   Phase 2   EUCTR2004-001677-26-HU   Czech Republic;Estonia;Hungary;Italy;Spain;Sweden
      2005   Phase 2   EUCTR2004-001677-26-ES   Czech Republic;Estonia;Hungary;Italy;Spain;Sweden
      2005   -   EUCTR2004-001677-26-EE   Czech Republic;Estonia;Hungary;Italy;Spain;Sweden
   sanofi-aventis recherche & developpement
      2004   -   EUCTR2004-001677-26-CZ   Czech Republic;Estonia;Hungary;Italy;Spain;Sweden
NON AS OF YET
   Lexicon Pharmaceuticals, Inc.
      2011   -   EUCTR2011-003532-32-SK   Belgium;Lithuania;Poland;Slovakia;United States
NON-exposed group
   CorEvitas
      2025   -   NCT06910553   United States
NON-genotyping
   Yonsei University
      2016   -   NCT03719118   Korea, Republic of
None given
   Shire Pharmaceutical Development Ltd
      2005   -   EUCTR2004-004184-29-DE   Czech Republic;Denmark;Germany;Hungary;Netherlands;Portugal;Spain;Sweden;United Kingdom
Norditropin simplexx
   Royal Hospital For Sick Children, Yorkhill Division
      2004   Phase 4   EUCTR2004-002507-32-GB   United Kingdom
Norditropin® simplexx® 5MG/1.5ML
   Royal Hospital For Sick Children, Yorkhill Division
      2004   Phase 4   EUCTR2004-002507-32-GB   United Kingdom
Normal diet
   Region Skane
      2024   -   NCT05743374   Sweden
Normal dietetic scheme
   Università Politecnica delle Marche
      2019   -   NCT04513015   Italy
Normal saline
   Affiliated Hospital to Academy of Military Medical Sciences
      2015   Phase 1/Phase 2   NCT02442037   China
   First Affiliated Hospital of Chengdu Medical College
      2016   Phase 1/Phase 2   NCT03016780   China
   Samuel Lunenfeld Research Institute, Mount Sinai Hospital
      2021   -   NCT06230003   Canada
Normal saline enema
   McMaster Children's Hospital
      2015   Phase 1   NCT02487238   Canada
NOT YET assigned
   Applied Molecular Transport Inc.
      2021   Phase 2   EUCTR2020-002833-13-PL   Georgia;Netherlands;Poland;Ukraine
      2021   Phase 2   EUCTR2020-002833-13-NL   Georgia;Netherlands;Poland;Ukraine
      2021   Phase 2   EUCTR2020-000047-31-PL   Belarus;Bulgaria;Canada;France;Georgia;Germany;Hungary;India;Italy;Kazakhstan;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Switzerland;Ukraine;United Kingdom;United States
      2021   Phase 2   EUCTR2020-000047-31-DE   Belarus;Belgium;Bulgaria;Canada;France;Georgia;Germany;Hungary;India;Italy;Kazakhstan;Moldova, Republic of;Netherlands;Poland;Romania;Russian Federation;Serbia;Switzerland;Ukraine;United Kingdom;United States
      2020   Phase 2   EUCTR2020-000047-31-HU   Belarus;Belgium;Bulgaria;Canada;France;Georgia;Germany;Hungary;India;Italy;Kazakhstan;Moldova, Republic of;Netherlands;Poland;Romania;Russian Federation;Serbia;Spain;Switzerland;Ukraine;United Kingdom;United States
      2020   Phase 2   EUCTR2020-000047-31-GB   Belarus;Bulgaria;Canada;France;Georgia;Germany;Hungary;India;Italy;Kazakhstan;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Spain;Switzerland;Ukraine;United Kingdom;United States
      2020   Phase 2   EUCTR2020-000047-31-FR   Belarus;Belgium;Bulgaria;Canada;Czech Republic;France;Georgia;Germany;Hungary;India;Italy;Kazakhstan;Moldova, Republic of;Netherlands;Poland;Romania;Russian Federation;Serbia;Spain;Switzerland;Ukraine;United Kingdom;United States
      2020   Phase 2   EUCTR2020-000047-31-BG   Belarus;Belgium;Bulgaria;Canada;France;Georgia;Germany;Hungary;India;Italy;Kazakhstan;Moldova, Republic of;Netherlands;Poland;Romania;Russian Federation;Serbia;Switzerland;Ukraine;United Kingdom;United States
   Prometheus Biosciences, Inc.
      2021   Phase 2   EUCTR2021-000091-11-HU   Australia;Belgium;Canada;Czech Republic;Czechia;France;Georgia;Hungary;Israel;Italy;Poland;Russian Federation;Ukraine;United Kingdom;United States
      2021   Phase 2   EUCTR2021-000091-11-FR   Australia;Belgium;Canada;Czech Republic;Czechia;France;Georgia;Hungary;Israel;Italy;Poland;Russian Federation;Ukraine;United Kingdom;United States
   Prometheus Biosciences, Inc. a subsidiary of Merck & Co., Inc.
      2021   Phase 2   EUCTR2021-000091-11-PL   Australia;Belgium;Canada;Czech Republic;Czechia;France;Georgia;Hungary;Italy;Poland;United Kingdom;United States
      2021   Phase 2   EUCTR2021-000091-11-CZ   Australia;Belgium;Canada;Czech Republic;Czechia;France;Georgia;Hungary;Italy;Poland;United Kingdom;United States
Nutrition specialist
   NYU Langone Health
      2025   -   NCT06309017   United States
Nutrition supplement
   Baptist Memorial Health Care Corporation
      2018   -   NCT03594708   United States
Nutritional dietary intervention
   Hospital Galdakao-Usansolo
      2020   -   NCT04188990   Spain
NX-13 250 MG
   Landos Biopharma Inc.
      2020   Phase 1   NCT04458805   Australia
NX-13 250MG
   AbbVie
      2023   Phase 2   NCT05785715   Belgium;Italy;Poland;United States
NX-13 250MG IR
   Landos Biopharma Inc.
      2021   Phase 1   NCT04862741   Ukraine;United States
NX-13 500MG IR
   Landos Biopharma Inc.
      2021   Phase 1   NCT04862741   Ukraine;United States
NX-13 500MG MR
   Landos Biopharma Inc.
      2021   Phase 1   NCT04862741   Ukraine;United States
NX-13 750MG
   AbbVie
      2023   Phase 2   NCT05785715   Belgium;Italy;Poland;United States
Obefazimod
   ABIVAX
      2022   Phase 2   EUCTR2021-004398-30-SI   Austria;Belgium;Canada;Czechia;France;Germany;Hungary;Italy;Poland;Serbia;Slovakia;Slovenia;Spain;Ukraine
      2022   Phase 2   EUCTR2021-004398-30-BE   Austria;Belgium;Canada;Czechia;France;Germany;Hungary;Italy;Poland;Serbia;Slovakia;Slovenia;Spain;Ukraine
      2022   Phase 2   EUCTR2021-004398-30-AT   Austria;Belgium;Canada;Czechia;France;Germany;Hungary;Italy;Poland;Serbia;Slovakia;Slovenia;Spain;Ukraine
      2021   Phase 2   EUCTR2021-004398-30-SK   Austria;Belgium;Canada;Czechia;France;Germany;Hungary;Italy;Poland;Serbia;Slovakia;Slovenia;Spain;Ukraine
      2021   Phase 2   EUCTR2021-004398-30-HU   Austria;Belgium;Canada;Czechia;France;Germany;Hungary;Italy;Poland;Serbia;Slovakia;Slovenia;Spain;Ukraine
      2020   Phase 2   EUCTR2019-000733-39-DE   Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Poland;Serbia;Slovakia;Slovenia;Spain;Ukraine;United Kingdom
      2019   Phase 2   EUCTR2019-000733-39-PL   Austria;Belgium;Canada;Czechia;France;Germany;Hungary;Italy;Poland;Serbia;Slovakia;Slovenia;Spain;Ukraine;United Kingdom
OD-07656
   Odyssey Therapeutics
      2025   Phase 2   NCT06850727   -
      2024   Phase 1   NCT06206811   Australia
Oligofructose-enriched inulin OI
   Children's Hospital of Philadelphia
      2018   -   NCT03653481   United States
Olimel parenteral nutrition
   University of Calgary
      2017   -   NCT02985489   -
Omeprazole
   Brigham and Women's Hospital
      2011   Phase 1/Phase 2   NCT01287195   United States
   Medical University of Gdansk
      2025   -   NCT06917963   Poland
   Takeda
      2016   Phase 4   NCT02760615   United States
Omeprazole 20 MG
   Janssen Research & Development, LLC
      2018   Phase 1   NCT03358706   Austria;Belgium;Denmark;Germany;Sweden;United Kingdom;United States
Ondansetron hydrochloride dihydrate
   University of Leeds
      2020   Phase 2;Phase 3   EUCTR2019-003220-21-GB   United Kingdom
Ontamalimab
   SHIRE HUMAN GENETIC THERAPIES, INC
      2018   Phase 3   EUCTR2017-000599-27-IT   Australia;Austria;Brazil;Croatia;Czech Republic;Czechia;Germany;Greece;Israel;Italy;Japan;Lithuania;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;United Kingdom;United States
      2018   Phase 3   EUCTR2017-000574-11-IT   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-000573-37-IT   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
   Shire
      2018   Phase 3   NCT03290781   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Colombia;Croatia;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   NCT03259334   Australia;Austria;Brazil;Croatia;Czechia;Germany;Israel;Italy;Japan;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;South Africa;United Kingdom;United States
      2017   Phase 3   NCT03259308   Argentina;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Colombia;Estonia;France;Greece;Hungary;Ireland;Japan;Korea, Republic of;Lebanon;Mexico;New Zealand;Portugal;Slovakia;Spain;Switzerland;Turkey;Ukraine;United States
   Shire Human Genetic Therapies, Inc.
      2018   Phase 3   EUCTR2017-000572-28-BG   Argentina;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Colombia;Estonia;France;Greece;Hungary;Ireland;Japan;Korea, Republic of;Lebanon;Mexico;Portugal;Slovakia;Spain;Switzerland;Turkey;Ukraine;United States
   Shire Human Genetic Therapies, Inc.
      2018   Phase 3   EUCTR2017-000599-27-NL   Australia;Austria;Brazil;Croatia;Czech Republic;Germany;Greece;Israel;Italy;Japan;Lithuania;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;United Kingdom;United States
      2018   Phase 3   EUCTR2017-000599-27-LT   Australia;Austria;Brazil;Croatia;Czech Republic;Czechia;Germany;Greece;Israel;Italy;Japan;Lithuania;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;United Kingdom;United States
      2018   Phase 3   EUCTR2017-000599-27-HR   Australia;Austria;Brazil;Croatia;Czech Republic;Czechia;Germany;Greece;Israel;Italy;Japan;Lithuania;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;United Kingdom;United States
      2018   Phase 3   EUCTR2017-000599-27-GB   Australia;Austria;Brazil;Croatia;Czech Republic;Germany;Greece;Israel;Italy;Japan;Lithuania;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;United Kingdom;United States
      2018   Phase 3   EUCTR2017-000599-27-DE   Australia;Austria;Brazil;Croatia;Czech Republic;Germany;Greece;Israel;Italy;Japan;Lithuania;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;United Kingdom;United States
      2018   Phase 3   EUCTR2017-000599-27-CZ   Australia;Austria;Brazil;Croatia;Czech Republic;Germany;Greece;Israel;Italy;Japan;Lithuania;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;United Kingdom;United States
      2018   Phase 3   EUCTR2017-000574-11-PT   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-000574-11-NL   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-000574-11-LT   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-000574-11-IE   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-000574-11-HU   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-000574-11-HR   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-000574-11-GB   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-000574-11-EE   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-000574-11-DE   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-000574-11-BG   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-000574-11-BE   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-000573-37-PT   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-000573-37-NL   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-000573-37-LT   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-000573-37-IE   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-000573-37-HU   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-000573-37-HR   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-000573-37-GB   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-000573-37-EE   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-000573-37-DE   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-000573-37-CZ   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-000573-37-BG   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-000572-28-PT   Argentina;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Colombia;France;Greece;Hungary;Ireland;Japan;Korea, Republic of;Lebanon;Mexico;Portugal;Slovakia;Spain;Switzerland;Turkey;Ukraine;United States
      2018   Phase 3   EUCTR2017-000572-28-HU   Argentina;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Colombia;France;Greece;Hungary;Ireland;Japan;Korea, Republic of;Lebanon;Mexico;Portugal;Slovakia;Spain;Switzerland;Turkey;Ukraine;United States
      2018   Phase 3   EUCTR2017-000572-28-BE   Argentina;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Colombia;France;Greece;Hungary;Ireland;Japan;Korea, Republic of;Mexico;Portugal;Slovakia;Spain;Switzerland;Ukraine;United States
      2017   Phase 3   EUCTR2017-000599-27-AT   Australia;Austria;Brazil;Croatia;Czech Republic;Germany;Greece;Israel;Italy;Japan;Lithuania;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;United Kingdom;United States
      2017   Phase 3   EUCTR2017-000574-11-SK   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2017-000574-11-AT   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2017-000573-37-SK   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2017-000573-37-AT   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2017-000572-28-SK   Argentina;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Colombia;Estonia;France;Greece;Hungary;Ireland;Japan;Korea, Republic of;Lebanon;Mexico;Portugal;Slovakia;Spain;Switzerland;Turkey;Ukraine;United States
      -   Phase 3   EUCTR2017-000574-11-PL   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
      -   Phase 3   EUCTR2017-000574-11-CZ   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
      -   Phase 3   EUCTR2017-000599-27-PL   Australia;Austria;Brazil;Croatia;Czech Republic;Germany;Greece;Israel;Italy;Japan;Lithuania;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;United Kingdom;United States
      -   Phase 3   EUCTR2017-000573-37-PL   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
      -   Phase 3   EUCTR2017-000572-28-IE   Argentina;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Colombia;France;Greece;Hungary;Ireland;Japan;Korea, Republic of;Lebanon;Mexico;Portugal;Slovakia;Spain;Switzerland;Turkey;Ukraine;United States
OPC-6535
   Otsuka Maryland Research Institute, Inc.
      2005   Phase 3   EUCTR2005-003724-19-HU   Czech Republic;Hungary
      2005   -   EUCTR2005-003724-19-CZ   Czech Republic;Hungary
      2004   Phase 3   EUCTR2004-000611-25-IE   Hungary;Ireland
      2004   -   EUCTR2004-000611-25-HU   Hungary;Ireland
   Otsuka Pharmaceutical Co., Ltd.
      2006   Phase 2   NCT00317356   Japan
   Otsuka Pharmaceutical Development & Commercialization, Inc.
      2004   Phase 3   NCT00092508   United States
      2003   Phase 3   NCT00064454   United States
      2003   Phase 3   NCT00064441   United States
OPEN-label
   Numaguchi Hirotaka
      2024   Phase 3   JPRN-jRCT2071230116   Australia;Belgium;Canada;China;Denmark;Finland;France;Greece;Italy;Japan;Norway;Poland;Portugal;Spain;Sweden;Turkey;United States
   TAKEDA PHARMACEUTICAL COMPANY LTD.
      2014   Phase 3   JPRN-jRCT2080222353   Japan
   Takeda Pharmaceutical Company Limited
      2015   Phase 3   JPRN-jRCT2080223167   Japan;Japan, Refer to Other section
   University Hospital Schleswig-Holstein
      2024   Phase 2/Phase 3   NCT06488625   Germany
OPRX-106
   Protalix
      2016   Phase 2   NCT02768974   Israel
OPRX-106 (plant cells expressing TNFR-FC) 2MG
   Protalix Biotherapeutics Ltd.
      2016   Phase 2   EUCTR2016-000509-35-BG   Bulgaria;Israel;Serbia
OPRX-106 (plant cells expressing TNFR-FC) 8MG
   Protalix Biotherapeutics Ltd.
      2016   Phase 2   EUCTR2016-000509-35-BG   Bulgaria;Israel;Serbia
Oral 5-ASA+/-topical 5-ASA+IV corticosteroids / PO methylprednisolone
   Sheba Medical Center
      2013   Phase 4   NCT01941589   China;France;Greece;Israel;Italy;Korea, Republic of;Serbia
Oral budesonide
   Wolfson Medical Center
      2023   -   NCT05791487   Israel;Italy;Netherlands;Switzerland
Oral cholera vaccine
   Millennium Pharmaceuticals, Inc.
      2011   Phase 1   NCT01981616   United Kingdom
Oral corticosteroids
   Connecticut Children's Medical Center
      2012   Phase 4   NCT01536535   Canada;United States
Oral ferrous sulfate
   Wayne State University
      2011   Phase 2   NCT01438372   United States
Oral iron
   American University of Beirut Medical Center
      2019   Phase 3   NCT05225545   Lebanon
Oral liposomal iron
   Federal University of Juiz de Fora
      2016   Phase 4   NCT02760940   -
Oral OKT3
   Brigham and Women's Hospital
      2011   Phase 1/Phase 2   NCT01287195   United States
Oral vancomycin
   Stanford University
      2012   Phase 3   NCT01802073   United States
   University of Milano Bicocca
      2023   Phase 2   NCT05876182   Italy
Ordinary meat diet
   Region Skane
      2024   -   NCT06696222   -
ORE1001
   Ore Pharmaceuticals, Inc.
      2009   Phase 1/Phase 2   NCT01039597   Canada;India
Orencia
   Bristol-Myers Squibb International Corporation
      2007   -   EUCTR2006-003604-19-IT   Belgium;Czech Republic;France;Germany;Ireland;Italy;Poland;United Kingdom
      2007   Phase 3   EUCTR2006-003604-19-GB   Belgium;Czech Republic;France;Germany;Ireland;Italy;Poland;United Kingdom
      2007   -   EUCTR2006-003604-19-DE   Belgium;Czech Republic;France;Germany;Ireland;Italy;Poland;United Kingdom
      2007   -   EUCTR2006-003604-19-CZ   Belgium;Czech Republic;France;Germany;Ireland;Italy;Poland;United Kingdom
      2007   -   EUCTR2006-003604-19-BE   Belgium;Czech Republic;France;Germany;Ireland;Italy;Poland;United Kingdom
Originator (legacy) drug
   McGill University Health Centre/Research Institute of the McGill University Health Centre
      2018   -   NCT03729674   Canada
OSE-127
   OSE Immunotherapeutics
      2023   Phase 2   EUCTR2020-001398-59-PT   Belarus;Belgium;Bulgaria;Croatia;Georgia;Hungary;Israel;Latvia;Lithuania;Poland;Portugal;Russian Federation;Serbia;South Africa;Spain;Ukraine
      2020   Phase 2   NCT04882007   Belarus;Belgium;Bulgaria;Croatia;Georgia;Hungary;Latvia;Poland;Russian Federation;South Africa;Ukraine
      2020   Phase 2   EUCTR2020-001398-59-LV   Belarus;Belgium;Bulgaria;Croatia;Georgia;Hungary;Latvia;Poland;Portugal;Russian Federation;Serbia;South Africa;Spain;Ukraine
      2020   Phase 2   EUCTR2020-001398-59-HR   Belarus;Belgium;Bulgaria;Croatia;Georgia;Hungary;Latvia;Poland;Portugal;Russian Federation;Serbia;South Africa;Spain;Ukraine
      2020   Phase 2   EUCTR2020-001398-59-BG   Belarus;Belgium;Bulgaria;Croatia;Georgia;Hungary;Latvia;Poland;Portugal;Russian Federation;Serbia;South Africa;Spain;Ukraine
      2020   Phase 2   EUCTR2020-001398-59-BE   Belarus;Belgium;Bulgaria;Croatia;Georgia;Hungary;Latvia;Lithuania;Poland;Portugal;Russian Federation;Serbia;Ukraine
Oseltamivir
   Xiangya Hospital of Central South University
      2020   -   ChiCTR2000028767   China
OST-122
   ONCOSTELLAE S.L.
      2020   Phase 1;Phase 2   EUCTR2019-004090-50-ES   Spain
   Oncostellae S.L
      2020   Phase 1/Phase 2   NCT04353791   Spain;Ukraine
Other biologic agents
   Takeda
      2015   -   NCT02674308   Austria;Belgium;Canada;Croatia;Denmark;Estonia;France;Germany;Greece;Ireland;Israel;Italy;Netherlands;Norway;Portugal;Slovenia;Spain;Sweden;Switzerland;United Kingdom;United States
Other biologic therapies
   Janssen Scientific Affairs, LLC
      2021   -   NCT04372108   United States
Overencapsulated azathioprine (imuran) 50 MG tablet
   Schering-Plough Research Institute, a division of Schering Corporation
      2008   Phase 3   EUCTR2006-002670-22-SK   Belgium;Czech Republic;France;Germany;Hungary;Italy;Portugal;Slovakia;Spain;United Kingdom
      2008   Phase 3   EUCTR2006-002670-22-GB   Belgium;Czech Republic;France;Germany;Hungary;Italy;Portugal;Slovakia;Spain;United Kingdom
      2007   -   EUCTR2006-002670-22-PT   Belgium;Czech Republic;France;Germany;Hungary;Italy;Portugal;Spain;United Kingdom
      2007   -   EUCTR2006-002670-22-HU   Belgium;Czech Republic;France;Germany;Hungary;Italy;Portugal;Spain;United Kingdom
      2007   Phase 3   EUCTR2006-002670-22-ES   Belgium;Czech Republic;France;Germany;Hungary;Italy;Portugal;Slovakia;Spain;United Kingdom
      2007   -   EUCTR2006-002670-22-DE   Belgium;Czech Republic;France;Germany;Hungary;Italy;Portugal;Spain;United Kingdom
      2007   -   EUCTR2006-002670-22-CZ   Belgium;Czech Republic;France;Germany;Hungary;Italy;Portugal;Spain;United Kingdom
      2007   Phase 3   EUCTR2006-002670-22-BE   Belgium;Czech Republic;France;Germany;Hungary;Italy;Portugal;Slovakia;Spain;United Kingdom
Overencapsulated mesalazine tablets
   GlaxoSmithKline Research and Development Ltd
      2009   -   EUCTR2009-011608-51-SE   Germany;Sweden
      2009   Phase 2   EUCTR2009-011608-51-BE   Belgium;Germany;Sweden
   GlaxoSmithKline Research and Development Ltd.
      2009   -   EUCTR2009-011608-51-DE   Germany;Sweden
Oxitriptan
   Ghent University Hospital
      2018   Phase 2   EUCTR2017-005059-10-BE   Belgium
Oxygen GAS FOR inhalation
   Ottawa Hospital Research Institute
      2024   Phase 1/Phase 2   NCT06109961   -
Oxygen medicinal GAS SOL 100% V/V medicinal GAS, compressed
   Amsterdam UMC
      2022   Phase 4   EUCTR2021-003913-21-NL   Netherlands
Ozanimod
   Beth Israel Deaconess Medical Center
      2023   -   NCT05809583   United States
   Bristol-Myers Squibb
      2024   -   NCT06126835   United States
      2024   -   NCT06073873   Korea, Republic of
      2022   Phase 3   NCT05644665   China;Taiwan
      2022   Phase 4   NCT05369832   France;Germany;Puerto Rico;Spain;United Kingdom;United States
      2022   Phase 2/Phase 3   NCT05076175   Australia;Belgium;Canada;France;Germany;Israel;Japan;Poland;Russian Federation;Spain;United Kingdom;United States
   CELGENE INTERNATIONAL II SàRL
      2016   Phase 3   EUCTR2015-001600-64-IT   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Germany;Greece;Hungary;Israel;Italy;Korea, Democratic People's Republic of;Korea, Republic of;Latvia;Mexico;Netherlands;New Zealand;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
      2015   Phase 3   EUCTR2015-000319-41-IT   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
   Celgene
      2019   Phase 3   NCT03915769   Japan
      2012   Phase 2   NCT01647516   Australia;Belgium;Bulgaria;Canada;Greece;Hungary;Israel;Korea, Republic of;Netherlands;New Zealand;Poland;Russian Federation;Slovakia;Ukraine;United States
   Celgene International II Sàrl
      2018   Phase 3   EUCTR2015-001600-64-RO   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2015-001600-64-LV   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2015-001600-64-GR   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2015-001600-64-ES   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2015-001600-64-AT   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2015-001600-64-HR   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-001600-64-NL   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-001600-64-BG   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
      2015   Phase 3   EUCTR2015-001600-64-SK   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Djibouti;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
      2015   Phase 3   EUCTR2015-001600-64-GB   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
      2015   Phase 3   EUCTR2015-001600-64-CZ   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
      2015   Phase 3   EUCTR2015-001600-64-BE   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
      2015   Phase 3   EUCTR2015-000319-41-GB   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
   Celgene International II Sàrl (CIS II)
      2018   Phase 3   EUCTR2015-000319-41-LV   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2015-000319-41-GR   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2015-000319-41-ES   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2015-000319-41-AT   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2015-000319-41-HR   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000319-41-NL   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
      2015   Phase 3   EUCTR2015-001600-64-DE   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
      2015   Phase 3   EUCTR2015-000319-41-SK   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
      2015   Phase 3   EUCTR2015-000319-41-DE   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
      2015   Phase 3   EUCTR2015-000319-41-CZ   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
      2015   Phase 3   EUCTR2015-000319-41-BE   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
      -   Phase 3   EUCTR2015-001600-64-PL   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Ukraine;United Kingdom;United States
      -   Phase 3   EUCTR2015-000319-41-PL   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Ukraine;United Kingdom;United States
      -   Phase 3   EUCTR2015-000319-41-BG   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
   Celgene International II Sárl (CIS II)
      2015   Phase 3   EUCTR2015-001600-64-HU   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
      2015   Phase 3   EUCTR2015-000319-41-HU   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Mexico;Netherlands;New Zealand;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
   Insel Gruppe AG, University Hospital Bern
      2023   -   NCT05702879   Switzerland
   Liu W. Jerry
      2022   Phase 2-3   JPRN-jRCT2021220013   France;Japan;United States
Ozanimod HCL
   Celgene International II Sàrl
      2023   Phase 2;Phase 3   EUCTR2021-002308-11-BE   Belgium;Canada;France;Germany;Israel;Japan;Netherlands;Poland;Russian Federation;Spain;United Kingdom;United States
      2022   Phase 2;Phase 3   EUCTR2021-002308-11-ES   Belgium;Canada;France;Germany;Israel;Japan;Netherlands;Poland;Russian Federation;Spain;United Kingdom;United States
      2022   Phase 2;Phase 3   EUCTR2021-002308-11-DE   Belgium;Canada;France;Germany;Israel;Japan;Netherlands;Poland;Spain;United Kingdom;United States
      2021   Phase 2;Phase 3   EUCTR2021-002308-11-FR   Belgium;Canada;France;Germany;Israel;Japan;Netherlands;Poland;Russian Federation;Spain;United Kingdom;United States
      -   Phase 2;Phase 3   EUCTR2021-002308-11-PL   Belgium;Canada;France;Germany;Israel;Japan;Netherlands;Poland;Russian Federation;Spain;United Kingdom;United States
Ozanimod hydrochloride
   Celgene International II Sàrl
      2016   Phase 1   EUCTR2016-003073-18-GB   United Kingdom
Ozanimod oral capsule
   Geert D'Haens
      2024   Phase 4   NCT06188637   -
Pain questionnaires
   Connecticut Children's Medical Center
      2015   -   NCT02984059   United States
PALI-2108
   Palisade Bio
      2024   Phase 1   NCT06663605   Canada
Palmitoleic acid
   National Institute of Medical Sciences and Nutrition, Salvador Zubiran
      2013   Phase 0   NCT01771224   Mexico
Pancrelipase
   Department of Gastroenterology Osaka City University Graduate School of Medicine
      2014   -   JPRN-UMIN000014205   Japan
Parnaparin sodium
   Cosmo Technologies Ltd
      2006   -   EUCTR2006-001782-42-HU   Hungary;Italy;United Kingdom
      2006   Phase 2   EUCTR2006-001782-42-GB   Hungary;Italy;United Kingdom
Partial enteral nutrition
   The First Affiliated Hospital of Shantou University Medical College
      2022   -   ChiCTR2200058055   China
   Wolfson Medical Center
      2023   -   NCT05791487   Israel;Italy;Netherlands;Switzerland
PBF-677
   PaloBiofarma S.L.
      2018   Phase 2   EUCTR2017-003228-54-ES   Spain
   Palobiofarma SL
      2018   Phase 2   NCT03773952   Spain
PCR-rflp
   Assiut University
      2020   -   NCT04284878   -
PEG
   Department of Gastroenterology, The Second Affiliated Hospital of Wenzhou Medical University
      2023   -   ChiCTR2300071791   China
   Shenzhen Hospital of Southern Medical University
      2022   Phase 0   ChiCTR2200056969   China
PEG LOW volume with bisacodyl
   Catholic University of the Sacred Heart
      2010   -   NCT01533090   Italy
PEG-liposomal prednisolone sodium phosphate
   Enceladus Pharmaceuticals
      2011   -   EUCTR2010-020448-37-NL   Belgium;Netherlands
      2010   Phase 2   EUCTR2010-020448-37-BE   Belgium;Netherlands
Pending
   Reistone Biopharma Company Limited
      2019   Phase 2   EUCTR2018-003364-31-PL   China;Poland;Ukraine;United States
Pentasa
   Children´s Hospital, University of Helsinki
      2012   Phase 4   EUCTR2012-004851-35-FI   Finland;Israel
   Ferring Pharmaceuticals
      2021   -   NCT04499495   Korea, Republic of
      2005   Phase 3   NCT00209300   Belgium;Czech Republic;Denmark;Finland;Germany;Netherlands;Norway;Sweden
   Ferring Pharmaceuticals Ltd.
      2009   -   EUCTR2008-000045-59-GB   Belgium;France;Netherlands;United Kingdom
   Ferring SAS
      2008   -   EUCTR2008-000045-59-NL   Belgium;France;Netherlands;United Kingdom
      2008   Phase 3   EUCTR2008-000045-59-FR   Belgium;France;Netherlands;United Kingdom
      2008   Phase 3   EUCTR2008-000045-59-BE   Belgium;France;Netherlands;United Kingdom
   VU University Medical Center
      2005   Phase 4   NCT00167882   Netherlands
   Zeria Pharmaceutical Co.,LTD.
      2005   Phase 3   JPRN-C000000289   Japan
      2005   Phase 3   JPRN-C000000288   Japan
Pentasa 500 MG retardtabletten
   Essex Pharma GmbH
      2009   -   EUCTR2009-010065-23-DE   Germany
Pentasa compact 2G, granulate with prolonged release
   Ferring International PharmaScience Center U.S., Inc.
      2017   Phase 3   EUCTR2015-002558-11-BG   Belgium;Bulgaria;Canada;Hungary;Latvia;Mexico;Russian Federation;Serbia;Switzerland;Ukraine;United States
      2016   Phase 3   EUCTR2015-002558-11-LV   Belarus;Belgium;Bulgaria;Canada;Hungary;Ireland;Latvia;Lithuania;Mexico;Russian Federation;Serbia;Switzerland;Ukraine;United States
      2016   Phase 3   EUCTR2015-002558-11-HU   Belgium;Bulgaria;Canada;Hungary;Latvia;Mexico;Russian Federation;Serbia;Switzerland;Ukraine;United States
      2015   Phase 3   EUCTR2015-002558-11-BE   Belgium;Bulgaria;Canada;Czech Republic;Hungary;Israel;Korea, Republic of;Latvia;New Zealand;Poland;Russian Federation;Slovakia;Switzerland;Ukraine;United States
Pentasa compact 4G, granulate with prolonged release
   Ferring International PharmaScience Center U.S., Inc.
      2017   Phase 3   EUCTR2015-002557-35-BG   Belgium;Bulgaria;Canada;Hungary;Latvia;Mexico;Russian Federation;Serbia;Switzerland;Ukraine;United States
      2016   Phase 3   EUCTR2015-002557-35-LV   Belarus;Belgium;Bulgaria;Canada;Hungary;Ireland;Latvia;Lithuania;Mexico;Russian Federation;Serbia;Switzerland;Ukraine;United States
      2016   Phase 3   EUCTR2015-002557-35-HU   Belgium;Bulgaria;Canada;Hungary;Latvia;Mexico;Russian Federation;Serbia;Switzerland;Ukraine;United States
      2015   Phase 3   EUCTR2015-002557-35-BE   Belgium;Bulgaria;Canada;Czech Republic;Hungary;Israel;Latvia;Poland;Russian Federation;Slovakia;Switzerland;Ukraine;United States
Pentasa enema
   University Hospitals of Leicester NHS Trust
      2006   Phase 3   EUCTR2006-002036-25-GB   United Kingdom
Pentasa prolonged release granules 2G
   Ferring BV
      2005   -   EUCTR2004-004565-15-NO   Czech Republic;Denmark;Finland;Germany;Norway;Sweden
      2005   -   EUCTR2004-004565-15-FI   Czech Republic;Denmark;Finland;Germany;Norway;Sweden
      2005   Phase 3   EUCTR2004-004565-15-CZ   Czech Republic;Denmark;Finland;Germany;Norway;Sweden
      -   -   EUCTR2004-004565-15-DE   Czech Republic;Denmark;Finland;Germany;Norway;Sweden
Pentasa sachet
   Ferring BV
      2005   -   EUCTR2004-004565-15-DK   Czech Republic;Denmark;Finland;Germany;Norway;Sweden
Pentasa sachet 1 G
   Ferring BV
      2005   -   EUCTR2004-004565-15-SE   Czech Republic;Denmark;Finland;Germany;Norway;Sweden
Pentasa sachet 1G
   Ferring BV
      2005   -   EUCTR2004-004565-15-SE   Czech Republic;Denmark;Finland;Germany;Norway;Sweden
      2005   -   EUCTR2004-004565-15-NO   Czech Republic;Denmark;Finland;Germany;Norway;Sweden
      2005   Phase 3   EUCTR2004-004565-15-CZ   Czech Republic;Denmark;Finland;Germany;Norway;Sweden
Pentasa sachet 2 G
   Ferring BV
      2005   -   EUCTR2004-004565-15-SE   Czech Republic;Denmark;Finland;Germany;Norway;Sweden
Pentoxifylline
   University of Miami
      2017   Early Phase 1   NCT02953275   United States
Pentoxifylline 400 MG
   Tanta University
      2023   Phase 2   NCT05575505   Egypt
      2022   Phase 2   NCT05558761   Egypt
Period 1 IBI112 dose 1
   Innovent Biologics (Suzhou) Co. Ltd.
      2022   Phase 2   NCT05377580   China
Period 1 IBI112 dose 2
   Innovent Biologics (Suzhou) Co. Ltd.
      2022   Phase 2   NCT05377580   China
Period 2 IBI112 dose 3
   Innovent Biologics (Suzhou) Co. Ltd.
      2022   Phase 2   NCT05377580   China
Period 2 IBI112 dose 4
   Innovent Biologics (Suzhou) Co. Ltd.
      2022   Phase 2   NCT05377580   China
Personalized B-fructan diet
   University of Manitoba
      2023   -   NCT05615779   Canada
Personalized pectin diet
   University of Manitoba
      2023   -   NCT05615779   Canada
Pethidine
   Sakakibara Yuko
      2020   Phase 4   JPRN-jRCTs031200018   -
PF 06687234
   Pfizer
      2020   Phase 1   NCT03414788   United States
PF-00547659
   Pfizer Inc, 235 East 42nd Street, New York, NY10017, United States
      2014   -   EUCTR2012-002030-37-HR   Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Norway;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;United Kingdom;United States
      2013   Phase 2   EUCTR2012-002031-28-SE   Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Norway;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;United Kingdom;United States
      2013   Phase 2   EUCTR2012-002031-28-IT   Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Norway;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;United Kingdom;United States
      2013   Phase 2   EUCTR2012-002031-28-HU   Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Norway;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;United Kingdom;United States
      2013   Phase 2   EUCTR2012-002031-28-ES   Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Norway;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;United Kingdom;United States
      2013   -   EUCTR2012-002030-37-SK   Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Norway;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;United Kingdom;United States
      2013   -   EUCTR2012-002030-37-SE   Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Norway;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;United Kingdom;United States
      2013   -   EUCTR2012-002030-37-PL   Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Norway;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;United Kingdom;United States
      2013   -   EUCTR2012-002030-37-NL   Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Norway;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;United Kingdom;United States
      2013   -   EUCTR2012-002030-37-IT   Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Norway;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;United Kingdom;United States
      2013   -   EUCTR2012-002030-37-HU   Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Norway;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;United Kingdom;United States
      2013   -   EUCTR2012-002030-37-ES   Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Norway;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;United Kingdom;United States
      2013   Phase 2   EUCTR2012-002030-37-DE   Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Norway;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;United Kingdom;United States
      2013   Phase 2   EUCTR2012-002030-37-CZ   Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Norway;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;United Kingdom;United States
      2013   Phase 2   EUCTR2012-002030-37-BG   Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Norway;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;United Kingdom;United States
      2013   Phase 2   EUCTR2012-002030-37-AT   Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Norway;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;United Kingdom;United States
   Pfizer Inc.
      2013   Phase 2   EUCTR2012-002030-37-BE   Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;United Kingdom
   Shire
      2013   Phase 2   NCT01771809   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;United States
   Shire Human Genetic Therapie, Inc.
      2013   Phase 2   EUCTR2012-002031-28-BG   Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Norway;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;United Kingdom;United States
   Shire Human Genetic Therapies, Inc.
      2013   Phase 2   EUCTR2012-002031-28-SK   Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Norway;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;United Kingdom;United States
      2013   Phase 2   EUCTR2012-002031-28-PL   Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Norway;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;United Kingdom;United States
      2013   Phase 2   EUCTR2012-002031-28-NL   Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Norway;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;United Kingdom;United States
      2013   Phase 2   EUCTR2012-002031-28-DE   Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Norway;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;United Kingdom;United States
      2013   Phase 2   EUCTR2012-002031-28-CZ   Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Norway;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;United Kingdom;United States
      2013   Phase 2   EUCTR2012-002031-28-BE   Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Norway;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;United Kingdom;United States
      2013   Phase 2   EUCTR2012-002031-28-AT   Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Norway;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;United Kingdom;United States
PF-00547659 SC injection
   Shire
      2012   Phase 2   NCT01620255   Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Norway;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;United Kingdom;United States
PF-05230917
   Pfizer Inc., 235 East 42nd Street, New York, NY 10017
      2012   -   EUCTR2010-023762-49-PL   Austria;Belgium;Bulgaria;Canada;France;Germany;Hungary;Netherlands;Poland;Romania;Spain;United States
      2012   Phase 2   EUCTR2010-023762-49-BE   Austria;Belgium;Bulgaria;Canada;France;Germany;Hungary;Netherlands;Poland;Romania;Spain;United States
      2011   -   EUCTR2010-023762-49-HU   Austria;Belgium;Bulgaria;Canada;France;Germany;Hungary;Netherlands;Poland;Romania;Spain;United States
      2011   -   EUCTR2010-023762-49-BG   Austria;Belgium;Bulgaria;Canada;France;Germany;Hungary;Netherlands;Poland;Romania;Spain;United States
      2011   -   EUCTR2010-023762-49-AT   Austria;Belgium;Bulgaria;Canada;France;Germany;Hungary;Netherlands;Poland;Romania;Spain;United States
   Pfizer Inc., 235 East 42nd Street, New York, NY 10017, USA
      2011   -   EUCTR2010-023762-49-DE   Austria;Belgium;Bulgaria;Canada;France;Germany;Hungary;Netherlands;Poland;Romania;Spain;United States
   Pfizer, S.L.U.
      2011   -   EUCTR2010-023762-49-ES   Belgium;Bulgaria;Germany;Hungary;Poland;Spain
PF-05285401
   PFIZER LIMITED
      2012   -   EUCTR2010-022766-27-IT   Belgium;Canada;Hungary;Italy;Sweden;United States
   Pfizer Limited, Ramsgate Road, Sandwich, Kent, CT13 9NJ, UK
      2012   -   EUCTR2010-022766-27-SK   Belgium;Canada;Hungary;Italy;Poland;Slovakia;Sweden;United States
      2012   -   EUCTR2010-022766-27-SE   Belgium;Canada;Germany;Hungary;Italy;Poland;Slovakia;Sweden;United States
      2012   -   EUCTR2010-022766-27-HU   Belgium;Canada;Germany;Hungary;Italy;Poland;Slovakia;Sweden;United States
      2012   -   EUCTR2010-022766-27-BE   Belgium;Canada;Germany;Hungary;Italy;Poland;Slovakia;Sweden;United States
PF-06480605
   PFIZER INC
      2020   Phase 2   EUCTR2019-002698-74-IT   Australia;Belgium;Bulgaria;Canada;China;Czechia;France;Germany;Hungary;India;Israel;Italy;Japan;Mexico;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 2   EUCTR2016-001158-16-IT   Belgium;France;Italy;Korea, Republic of;Netherlands;Poland;United States
   Pfizer Inc
      2021   Phase 2   EUCTR2019-002698-74-RO   Australia;Austria;Belgium;Bulgaria;Canada;China;France;Germany;Hungary;India;Italy;Japan;Mexico;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Turkey;Ukraine;United Kingdom;United States
      2020   Phase 2   EUCTR2019-002698-74-PL   Australia;Austria;Belgium;Bulgaria;Canada;China;Colombia;France;Germany;Hungary;India;Italy;Japan;Mexico;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Thailand;Turkey;Ukraine;United Kingdom;United States
      2020   Phase 2   EUCTR2019-002698-74-HU   Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;France;Germany;Hungary;India;Israel;Italy;Japan;Mexico;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United States
      2020   Phase 2   EUCTR2019-002698-74-GB   Australia;Austria;Belgium;Bulgaria;Canada;China;France;Germany;Hungary;India;Italy;Japan;Mexico;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Turkey;Ukraine;United Kingdom;United States
      2020   Phase 2   EUCTR2019-002698-74-FR   Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;France;Germany;Hungary;India;Israel;Italy;Japan;Mexico;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States
      2020   Phase 2   EUCTR2019-002698-74-ES   Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;France;Germany;Hungary;India;Israel;Italy;Japan;Mexico;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States
      2020   Phase 2   EUCTR2019-002698-74-DE   Australia;Austria;Belgium;Bulgaria;Canada;China;Colombia;France;Germany;Hungary;India;Italy;Japan;Mexico;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Thailand;Turkey;Ukraine;United Kingdom;United States
      2020   Phase 2   EUCTR2019-002698-74-BG   Australia;Austria;Belgium;Bulgaria;Canada;China;France;Germany;Hungary;India;Italy;Japan;Mexico;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Turkey;Ukraine;United Kingdom;United States
      2020   Phase 2   EUCTR2019-002698-74-BE   Australia;Austria;Belgium;Bulgaria;Canada;China;France;Germany;Hungary;India;Italy;Japan;Mexico;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Turkey;Ukraine;United Kingdom;United States
      2020   Phase 2   EUCTR2019-002698-74-AT   Australia;Austria;Belgium;Bulgaria;Canada;China;France;Germany;Hungary;India;Italy;Japan;Mexico;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Turkey;Ukraine;United Kingdom;United States
   Pfizer Inc. 235 East 42nd Street, New York, NY 10017
      2017   Phase 2   EUCTR2016-001158-16-NL   Belgium;France;Italy;Korea, Republic of;Netherlands;Poland;United States
      2016   Phase 2   EUCTR2016-001158-16-PL   Belgium;France;Italy;Korea, Republic of;Netherlands;Poland;United States
      2016   Phase 2   EUCTR2016-001158-16-BE   Belgium;France;Italy;Korea, Republic of;Netherlands;Poland;United States
   Telavant, Inc.
      2016   Phase 2   NCT02840721   Belgium;France;Italy;Korea, Republic of;Netherlands;Poland;United States
PF-06480605 100 MG/ML
   Pfizer Inc
      2020   Phase 2   EUCTR2019-002698-74-SK   Australia;Austria;Belgium;Bulgaria;Canada;China;Colombia;France;Germany;Hungary;India;Italy;Japan;Mexico;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Thailand;Turkey;Ukraine;United Kingdom;United States
PF-06651600
   Pfizer Inc.
      2022   Phase 3   EUCTR2021-003702-42-ES   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Czechia;Denmark;France;Germany;Greece;India;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Norway;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
PF-06651600 10 MG
   PFIZER INC
      2017   Phase 2   EUCTR2016-003708-29-IT   Austria;Bulgaria;Canada;Czechia;Denmark;Georgia;Germany;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United States
   Pfizer Inc.
      2017   Phase 2   EUCTR2016-003708-29-SK   Austria;Bulgaria;Canada;Denmark;Georgia;Germany;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United States
   Pfizer Inc., 235 East 42nd Street, New York, NY 10017
      2018   Phase 2   EUCTR2016-003708-29-BG   Austria;Bulgaria;Canada;Czechia;Denmark;Georgia;Germany;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United States
      2017   Phase 2   EUCTR2016-003708-29-PL   Austria;Bulgaria;Canada;Czechia;Denmark;Georgia;Germany;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United States
      2017   Phase 2   EUCTR2016-003708-29-NL   Austria;Bulgaria;Canada;Czech Republic;Denmark;Georgia;Germany;Hungary;Ireland;Israel;Italy;Korea, Republic of;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United States
      2017   Phase 2   EUCTR2016-003708-29-LT   Austria;Bulgaria;Canada;Czech Republic;Denmark;Georgia;Germany;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United States
      2017   Phase 2   EUCTR2016-003708-29-HU   Austria;Bulgaria;Canada;Czech Republic;Denmark;Georgia;Germany;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United States
      2017   Phase 2   EUCTR2016-003708-29-ES   Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Netherlands;Norway;Philippines;Poland;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States
      2017   Phase 2   EUCTR2016-003708-29-DK   Austria;Bulgaria;Canada;Czechia;Denmark;Georgia;Germany;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United States
      2017   Phase 2   EUCTR2016-003708-29-DE   Austria;Bulgaria;Canada;Czechia;Denmark;Georgia;Germany;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United States
      2017   Phase 2   EUCTR2016-003708-29-AT   Austria;Bulgaria;Canada;Czech Republic;Denmark;Georgia;Germany;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United States
PF-06651600 50 MG
   PFIZER INC
      2017   Phase 2   EUCTR2016-003708-29-IT   Austria;Bulgaria;Canada;Czechia;Denmark;Georgia;Germany;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United States
   Pfizer Inc.
      2017   Phase 2   EUCTR2016-003708-29-SK   Austria;Bulgaria;Canada;Denmark;Georgia;Germany;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United States
   Pfizer Inc., 235 East 42nd Street, New York, NY 10017
      2018   Phase 2   EUCTR2016-003708-29-BG   Austria;Bulgaria;Canada;Czechia;Denmark;Georgia;Germany;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United States
      2017   Phase 2   EUCTR2016-003708-29-PL   Austria;Bulgaria;Canada;Czechia;Denmark;Georgia;Germany;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United States
      2017   Phase 2   EUCTR2016-003708-29-NL   Austria;Bulgaria;Canada;Czech Republic;Denmark;Georgia;Germany;Hungary;Ireland;Israel;Italy;Korea, Republic of;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United States
      2017   Phase 2   EUCTR2016-003708-29-LT   Austria;Bulgaria;Canada;Czech Republic;Denmark;Georgia;Germany;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United States
      2017   Phase 2   EUCTR2016-003708-29-HU   Austria;Bulgaria;Canada;Czech Republic;Denmark;Georgia;Germany;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United States
      2017   Phase 2   EUCTR2016-003708-29-ES   Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Netherlands;Norway;Philippines;Poland;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States
      2017   Phase 2   EUCTR2016-003708-29-DK   Austria;Bulgaria;Canada;Czechia;Denmark;Georgia;Germany;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United States
      2017   Phase 2   EUCTR2016-003708-29-DE   Austria;Bulgaria;Canada;Czechia;Denmark;Georgia;Germany;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United States
      2017   Phase 2   EUCTR2016-003708-29-AT   Austria;Bulgaria;Canada;Czech Republic;Denmark;Georgia;Germany;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United States
PF-06651600-15
   PFIZER INC
      2017   Phase 2   EUCTR2016-003708-29-IT   Austria;Bulgaria;Canada;Czechia;Denmark;Georgia;Germany;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United States
   Pfizer Inc.
      2017   Phase 2   EUCTR2016-003708-29-SK   Austria;Bulgaria;Canada;Denmark;Georgia;Germany;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United States
   Pfizer Inc., 235 East 42nd Street, New York, NY 10017
      2018   Phase 2   EUCTR2016-003708-29-BG   Austria;Bulgaria;Canada;Czechia;Denmark;Georgia;Germany;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United States
      2017   Phase 2   EUCTR2016-003708-29-PL   Austria;Bulgaria;Canada;Czechia;Denmark;Georgia;Germany;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United States
      2017   Phase 2   EUCTR2016-003708-29-NL   Austria;Bulgaria;Canada;Czech Republic;Denmark;Georgia;Germany;Hungary;Ireland;Israel;Italy;Korea, Republic of;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United States
      2017   Phase 2   EUCTR2016-003708-29-LT   Austria;Bulgaria;Canada;Czech Republic;Denmark;Georgia;Germany;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United States
      2017   Phase 2   EUCTR2016-003708-29-HU   Austria;Bulgaria;Canada;Czech Republic;Denmark;Georgia;Germany;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United States
      2017   Phase 2   EUCTR2016-003708-29-ES   Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Netherlands;Norway;Philippines;Poland;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States
      2017   Phase 2   EUCTR2016-003708-29-DK   Austria;Bulgaria;Canada;Czechia;Denmark;Georgia;Germany;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United States
      2017   Phase 2   EUCTR2016-003708-29-DE   Austria;Bulgaria;Canada;Czechia;Denmark;Georgia;Germany;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United States
      2017   Phase 2   EUCTR2016-003708-29-AT   Austria;Bulgaria;Canada;Czech Republic;Denmark;Georgia;Germany;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United States
PF-06687234
   PFIZER INC
      2018   Phase 2   EUCTR2017-002108-28-IT   Australia;Belgium;Germany;Israel;Italy;Korea, Democratic People's Republic of;Saudi Arabia;Serbia;Spain;United States
   Pfizer
      2017   Phase 2   NCT03269695   Australia;Belgium;Germany;Israel;Italy;Korea, Republic of;Saudi Arabia;Serbia;Spain;Turkey;United States
   Pfizer Inc, 235 East 42nd Street, New York, New York 10017
      2018   Phase 2   EUCTR2017-002108-28-ES   Australia;Belgium;Germany;Israel;Italy;Korea, Republic of;Saudi Arabia;Serbia;Spain;United States
      2018   Phase 2   EUCTR2017-002108-28-DE   Australia;Belgium;Germany;Israel;Italy;Korea, Republic of;Saudi Arabia;Serbia;Spain;United States
      2018   Phase 2   EUCTR2017-002108-28-BE   Australia;Belgium;Germany;Israel;Italy;Korea, Republic of;Saudi Arabia;Serbia;Spain;United States
PF-06700841 25 MG
   PFIZER INC
      2017   Phase 2   EUCTR2016-003708-29-IT   Austria;Bulgaria;Canada;Czechia;Denmark;Georgia;Germany;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United States
   Pfizer Inc.
      2017   Phase 2   EUCTR2016-003708-29-SK   Austria;Bulgaria;Canada;Denmark;Georgia;Germany;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United States
   Pfizer Inc., 235 East 42nd Street, New York, NY 10017
      2018   Phase 2   EUCTR2016-003708-29-BG   Austria;Bulgaria;Canada;Czechia;Denmark;Georgia;Germany;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United States
      2017   Phase 2   EUCTR2016-003708-29-PL   Austria;Bulgaria;Canada;Czechia;Denmark;Georgia;Germany;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United States
      2017   Phase 2   EUCTR2016-003708-29-NL   Austria;Bulgaria;Canada;Czech Republic;Denmark;Georgia;Germany;Hungary;Ireland;Israel;Italy;Korea, Republic of;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United States
      2017   Phase 2   EUCTR2016-003708-29-LT   Austria;Bulgaria;Canada;Czech Republic;Denmark;Georgia;Germany;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United States
      2017   Phase 2   EUCTR2016-003708-29-HU   Austria;Bulgaria;Canada;Czech Republic;Denmark;Georgia;Germany;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United States
      2017   Phase 2   EUCTR2016-003708-29-ES   Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Netherlands;Norway;Philippines;Poland;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States
      2017   Phase 2   EUCTR2016-003708-29-DK   Austria;Bulgaria;Canada;Czechia;Denmark;Georgia;Germany;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United States
      2017   Phase 2   EUCTR2016-003708-29-DE   Austria;Bulgaria;Canada;Czechia;Denmark;Georgia;Germany;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United States
      2017   Phase 2   EUCTR2016-003708-29-AT   Austria;Bulgaria;Canada;Czech Republic;Denmark;Georgia;Germany;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United States
PF-06700841 5 MG
   PFIZER INC
      2017   Phase 2   EUCTR2016-003708-29-IT   Austria;Bulgaria;Canada;Czechia;Denmark;Georgia;Germany;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United States
   Pfizer Inc.
      2017   Phase 2   EUCTR2016-003708-29-SK   Austria;Bulgaria;Canada;Denmark;Georgia;Germany;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United States
   Pfizer Inc., 235 East 42nd Street, New York, NY 10017
      2018   Phase 2   EUCTR2016-003708-29-BG   Austria;Bulgaria;Canada;Czechia;Denmark;Georgia;Germany;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United States
      2017   Phase 2   EUCTR2016-003708-29-PL   Austria;Bulgaria;Canada;Czechia;Denmark;Georgia;Germany;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United States
      2017   Phase 2   EUCTR2016-003708-29-NL   Austria;Bulgaria;Canada;Czech Republic;Denmark;Georgia;Germany;Hungary;Ireland;Israel;Italy;Korea, Republic of;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United States
      2017   Phase 2   EUCTR2016-003708-29-LT   Austria;Bulgaria;Canada;Czech Republic;Denmark;Georgia;Germany;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United States
      2017   Phase 2   EUCTR2016-003708-29-HU   Austria;Bulgaria;Canada;Czech Republic;Denmark;Georgia;Germany;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United States
      2017   Phase 2   EUCTR2016-003708-29-ES   Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Netherlands;Norway;Philippines;Poland;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States
      2017   Phase 2   EUCTR2016-003708-29-DK   Austria;Bulgaria;Canada;Czechia;Denmark;Georgia;Germany;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United States
      2017   Phase 2   EUCTR2016-003708-29-DE   Austria;Bulgaria;Canada;Czechia;Denmark;Georgia;Germany;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United States
      2017   Phase 2   EUCTR2016-003708-29-AT   Austria;Bulgaria;Canada;Czech Republic;Denmark;Georgia;Germany;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United States
PF-06700841-15
   PFIZER INC
      2017   Phase 2   EUCTR2016-003708-29-IT   Austria;Bulgaria;Canada;Czechia;Denmark;Georgia;Germany;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United States
   Pfizer Inc.
      2017   Phase 2   EUCTR2016-003708-29-SK   Austria;Bulgaria;Canada;Denmark;Georgia;Germany;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United States
   Pfizer Inc., 235 East 42nd Street, New York, NY 10017
      2018   Phase 2   EUCTR2016-003708-29-BG   Austria;Bulgaria;Canada;Czechia;Denmark;Georgia;Germany;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United States
      2017   Phase 2   EUCTR2016-003708-29-PL   Austria;Bulgaria;Canada;Czechia;Denmark;Georgia;Germany;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United States
      2017   Phase 2   EUCTR2016-003708-29-NL   Austria;Bulgaria;Canada;Czech Republic;Denmark;Georgia;Germany;Hungary;Ireland;Israel;Italy;Korea, Republic of;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United States
      2017   Phase 2   EUCTR2016-003708-29-LT   Austria;Bulgaria;Canada;Czech Republic;Denmark;Georgia;Germany;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United States
      2017   Phase 2   EUCTR2016-003708-29-HU   Austria;Bulgaria;Canada;Czech Republic;Denmark;Georgia;Germany;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United States
      2017   Phase 2   EUCTR2016-003708-29-ES   Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Netherlands;Norway;Philippines;Poland;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States
      2017   Phase 2   EUCTR2016-003708-29-DK   Austria;Bulgaria;Canada;Czechia;Denmark;Georgia;Germany;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United States
      2017   Phase 2   EUCTR2016-003708-29-DE   Austria;Bulgaria;Canada;Czechia;Denmark;Georgia;Germany;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United States
      2017   Phase 2   EUCTR2016-003708-29-AT   Austria;Bulgaria;Canada;Czech Republic;Denmark;Georgia;Germany;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United States
PF-06826647
   Pfizer Inc., 235 East 42nd Street, New York, NY 10017
      2020   Phase 2   EUCTR2019-003999-39-NO   Armenia;Australia;Belgium;Bosnia and Herzegovina;Brazil;China;Croatia;Czech Republic;France;Georgia;Germany;Hong Kong;India;Ireland;Italy;Jordan;Lebanon;Macedonia, the former Yugoslav Republic of;Malaysia;Mexico;Morocco;Norway;Oman;Poland;Puerto Rico;Qatar;Romania;Russian Federation;Saudi Arabia;Slovakia;Spain;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States
PF-06826647 100 MG QD
   Pfizer
      2020   Phase 2   NCT04209556   United States
PF-06826647 300 MG QD
   Pfizer
      2020   Phase 2   NCT04209556   United States
PF-06826647 600 MG QD
   Pfizer
      2020   Phase 2   NCT04209556   United States
PF-07054894
   Pfizer
      2022   Phase 1   NCT05549323   Germany;Poland;United States
PF-6826647 400 MG QD
   Pfizer
      2020   Phase 2   NCT04209556   United States
Pfefferminzblätter 1ML/10ML
   Steigerwald Arzneimittelwerk GmbH
      2014   -   EUCTR2013-000891-13-DE   Germany
Pfizer comirnaty vaccine
   Italian Group for the study of Inflammatory Bowel Disease (IG-IBD)
      2021   -   NCT04769258   -
PGX-guided POST-operative pain management
   The Cleveland Clinic
      2018   -   NCT03455751   United States
Phentermine-topiramate
   University of California, San Diego
      2020   Phase 2   NCT04721873   United States
Physician-prescribed exercise programme
   Royal College of Surgeons, Ireland
      2022   -   NCT05174754   Ireland
Picosulfate
   Shenzhen Hospital of Southern Medical University
      2022   Phase 0   ChiCTR2200056969   China
PK-model TO decide when TO dose vedolizumab and ustekinumab
   Odense University Hospital
      2025   Phase 4   NCT06788340   Denmark
PL8177
   Palatin Technologies, Inc
      2022   Phase 2   NCT05466890   United States
PN-10884A
   Protagonist Therapeutics, Inc
      2017   Phase 2   EUCTR2016-003452-75-PL   Belgium;Bosnia and Herzegovina;Croatia;Czech Republic;Germany;Greece;Hungary;Latvia;Netherlands;Poland;Russian Federation;Serbia;Slovenia;Ukraine;United Kingdom;United States
      2017   Phase 2   EUCTR2016-003452-75-NL   Belgium;Bosnia and Herzegovina;Croatia;Czech Republic;Germany;Greece;Hungary;Latvia;Netherlands;Poland;Russian Federation;Serbia;Slovenia;Ukraine;United Kingdom;United States
      2017   Phase 2   EUCTR2016-003452-75-LV   Belgium;Bosnia and Herzegovina;Croatia;Czech Republic;Germany;Greece;Hungary;Latvia;Netherlands;Poland;Russian Federation;Serbia;Slovenia;Ukraine;United Kingdom;United States
      2017   Phase 2   EUCTR2016-003452-75-HU   Belgium;Bosnia and Herzegovina;Croatia;Czech Republic;Germany;Greece;Hungary;Latvia;Netherlands;Poland;Russian Federation;Serbia;Slovenia;Ukraine;United Kingdom;United States
      2017   Phase 2   EUCTR2016-003452-75-HR   Belgium;Bosnia and Herzegovina;Croatia;Czech Republic;Germany;Greece;Hungary;Latvia;Netherlands;Poland;Russian Federation;Serbia;Slovenia;Ukraine;United Kingdom;United States
      2017   Phase 2   EUCTR2016-003452-75-CZ   Belgium;Bosnia and Herzegovina;Croatia;Czech Republic;Germany;Greece;Hungary;Latvia;Netherlands;Poland;Russian Federation;Serbia;Slovenia;Ukraine;United Kingdom;United States
      2017   Phase 2   EUCTR2016-003452-75-BE   Belgium;Bosnia and Herzegovina;Croatia;Czech Republic;Germany;Greece;Hungary;Latvia;Netherlands;Poland;Russian Federation;Serbia;Slovenia;Ukraine;United Kingdom;United States
PN-943
   Protagonist Therapeutics, Inc
      2020   Phase 2   EUCTR2019-004469-41-HU   Australia;Austria;Bulgaria;Canada;Georgia;Germany;Hungary;Italy;Korea, Republic of;Poland;Russian Federation;Serbia;Ukraine;United States
      2020   Phase 2   EUCTR2019-004469-41-DE   Austria;Bulgaria;Canada;Georgia;Germany;Hungary;Italy;Korea, Republic of;Poland;Russian Federation;Serbia;Ukraine;United States
      2020   Phase 2   EUCTR2019-004469-41-BG   Austria;Bulgaria;Canada;Georgia;Germany;Hungary;Italy;Korea, Republic of;Poland;Russian Federation;Serbia;Ukraine;United States
      2020   Phase 2   EUCTR2019-004469-41-AT   Austria;Bulgaria;Canada;Georgia;Germany;Hungary;Italy;Korea, Republic of;Poland;Russian Federation;Serbia;Ukraine;United States
   Protagonist Therapeutics, Inc.
      2020   Phase 2   NCT04504383   Austria;Bulgaria;Canada;Georgia;Germany;Hungary;Italy;Korea, Republic of;Poland;Russian Federation;Serbia;Ukraine;United States
      2020   Phase 2   EUCTR2019-004469-41-IT   Austria;Bulgaria;Canada;Georgia;Germany;Hungary;Italy;Korea, Republic of;Netherlands;Poland;Russian Federation;Serbia;Ukraine;United States
Pneumo 23
   Centre Hospitalier Universitaire de Saint Etienne
      2015   Phase 2   NCT02255227   France
Pneumococcal pneumonia vaccine
   Boston Medical Center
      2017   -   NCT03056924   United States
Pneumovax
   Cedars-Sinai Medical Center
      2005   -   NCT00829595   United States
Polaprezinc
   The Jikei University School of Medicine Division of Gastroenterology and Hepatology
      2009   -   JPRN-UMIN000008967   Japan
Polietilenglicole
   IPSEN PHARMA SAS
      2017   Phase 3   EUCTR2016-002265-60-IT   Czech Republic;Czechia;France;Germany;Italy;Netherlands;Poland
Polyethylene glycol
   Catholic University of the Sacred Heart
      2010   -   NCT01533090   Italy
   Kyungpook National University
      2013   -   NCT01929668   Korea, Republic of
   Shenzhen Children's Hospital
      2024   -   ChiCTR2500097769   China
Polyethylene glycols
   Peking Union Medical College Hospital
      2022   -   NCT05485103   China
Polyphenon E
   University of Louisville
      2008   Phase 2   NCT00718094   United States
Potassio solfato
   IPSEN PHARMA SAS
      2017   Phase 3   EUCTR2016-002265-60-IT   Czech Republic;Czechia;France;Germany;Italy;Netherlands;Poland
Potassium chloride
   Hospital Universitario La Paz
      2019   Phase 4   EUCTR2018-001402-28-ES   Spain
   Ipsen Pharma
      2017   Phase 3   EUCTR2016-002265-60-NL   Czech Republic;France;Germany;Italy;Netherlands;Poland
      2017   Phase 3   EUCTR2016-002265-60-DE   Czech Republic;France;Germany;Italy;Netherlands;Poland
      2017   Phase 3   EUCTR2016-002265-60-CZ   Czech Republic;France;Germany;Italy;Netherlands;Poland
      -   Phase 3   EUCTR2016-002265-60-PL   Czech Republic;France;Germany;Italy;Netherlands;Poland
Potassium sulphate
   IPSEN PHARMA SAS
      2017   Phase 3   EUCTR2016-002265-60-IT   Czech Republic;Czechia;France;Germany;Italy;Netherlands;Poland
   Ipsen Pharma
      2017   Phase 3   EUCTR2016-002265-60-NL   Czech Republic;France;Germany;Italy;Netherlands;Poland
      2017   Phase 3   EUCTR2016-002265-60-DE   Czech Republic;France;Germany;Italy;Netherlands;Poland
      2017   Phase 3   EUCTR2016-002265-60-CZ   Czech Republic;France;Germany;Italy;Netherlands;Poland
      -   Phase 3   EUCTR2016-002265-60-PL   Czech Republic;France;Germany;Italy;Netherlands;Poland
PRA023
   Prometheus Biosciences Inc.
      2021   Phase 2   EUCTR2021-000091-11-IT   Australia;Belarus;Belgium;Bulgaria;Canada;Czech Republic;Czechia;France;Georgia;Hungary;Israel;Italy;Poland;Russian Federation;Ukraine;United Kingdom;United States
   Prometheus Biosciences, Inc.
      2021   Phase 2   EUCTR2021-000091-11-HU   Australia;Belgium;Canada;Czech Republic;Czechia;France;Georgia;Hungary;Israel;Italy;Poland;Russian Federation;Ukraine;United Kingdom;United States
      2021   Phase 2   EUCTR2021-000091-11-FR   Australia;Belgium;Canada;Czech Republic;Czechia;France;Georgia;Hungary;Israel;Italy;Poland;Russian Federation;Ukraine;United Kingdom;United States
   Prometheus Biosciences, Inc. a subsidiary of Merck & Co., Inc.
      2021   Phase 2   EUCTR2021-000091-11-PL   Australia;Belgium;Canada;Czech Republic;Czechia;France;Georgia;Hungary;Italy;Poland;United Kingdom;United States
      2021   Phase 2   EUCTR2021-000091-11-CZ   Australia;Belgium;Canada;Czech Republic;Czechia;France;Georgia;Hungary;Italy;Poland;United Kingdom;United States
PRD5973697
   CHU Nantes
      2018   Phase 3   EUCTR2017-004967-11-FR   France
PRE-filled syringe
   ALIMENTIV INC.
      2021   Phase 4   EUCTR2019-002485-12-IT   Belarus;Belgium;Canada;France;Italy;Netherlands;Poland;Russian Federation;Ukraine;United Kingdom;United States
   ASTRAZENECA AB
      2021   Phase 2   EUCTR2021-001644-10-IT   Austria;Canada;Czechia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Poland;Russian Federation;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
   AZIENDA SOCIO SANITARIA TERRITORIALE DEI SETTE LAGHI
      2022   Phase 2   EUCTR2021-001984-25-IT   Italy
   AbbVie Deutschland GmbH & Co. KG
      2021   Phase 2;Phase 3   EUCTR2016-004677-40-FR   Argentina;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czechia;Denmark;Egypt;France;Germany;Greece;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2021   Phase 3   EUCTR2016-004676-22-FR   Argentina;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czechia;Denmark;Egypt;France;Germany;Greece;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 2;Phase 3   EUCTR2016-004677-40-SI   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czechia;Denmark;Egypt;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 2;Phase 3   EUCTR2016-004677-40-HR   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 2;Phase 3   EUCTR2016-004677-40-BG   Argentina;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czechia;Denmark;Egypt;France;Germany;Greece;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2016-004676-22-SI   Argentina;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czechia;Denmark;Egypt;France;Germany;Greece;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Türkiye;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2016-004676-22-RO   Argentina;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czechia;Denmark;Egypt;France;Germany;Greece;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Türkiye;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2016-004676-22-HR   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2016-004676-22-DE   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czechia;Denmark;Egypt;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Türkiye;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2016-004676-22-BG   Argentina;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czechia;Denmark;Egypt;France;Germany;Greece;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2016-004676-22-BE   Argentina;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czechia;Denmark;Egypt;France;Germany;Greece;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 2;Phase 3   EUCTR2016-004677-40-SK   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czechia;Denmark;Egypt;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 2;Phase 3   EUCTR2016-004677-40-SE   Argentina;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czechia;Denmark;Egypt;France;Germany;Greece;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 2;Phase 3   EUCTR2016-004677-40-PT   Argentina;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czechia;Denmark;Egypt;France;Germany;Greece;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 2;Phase 3   EUCTR2016-004677-40-NL   Argentina;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;France;Germany;Greece;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 2;Phase 3   EUCTR2016-004677-40-LV   Argentina;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czechia;Denmark;Egypt;France;Germany;Greece;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 2;Phase 3   EUCTR2016-004677-40-LT   Argentina;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czechia;Denmark;Egypt;France;Germany;Greece;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 2;Phase 3   EUCTR2016-004677-40-GR   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 2;Phase 3   EUCTR2016-004677-40-ES   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 2;Phase 3   EUCTR2016-004677-40-DK   Argentina;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czechia;Denmark;Egypt;France;Germany;Greece;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 2;Phase 3   EUCTR2016-004677-40-DE   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czechia;Denmark;Egypt;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 2;Phase 3   EUCTR2016-004677-40-BE   Argentina;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;France;Germany;Greece;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 2;Phase 3   EUCTR2016-004677-40-AT   Argentina;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czechia;Denmark;Egypt;France;Germany;Greece;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2016-004676-22-SK   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czechia;Denmark;Egypt;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Türkiye;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2016-004676-22-SE   Argentina;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czechia;Denmark;Egypt;France;Germany;Greece;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2016-004676-22-PT   Argentina;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czechia;Denmark;Egypt;France;Germany;Greece;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2016-004676-22-NL   Argentina;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czechia;Denmark;Egypt;France;Germany;Greece;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Türkiye;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2016-004676-22-LV   Argentina;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czechia;Denmark;Egypt;France;Germany;Greece;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2016-004676-22-GR   Argentina;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czechia;Denmark;Egypt;France;Germany;Greece;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2016-004676-22-GB   Argentina;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czechia;Denmark;Egypt;France;Germany;Greece;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2016-004676-22-ES   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2016-004676-22-DK   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2016-004676-22-AT   Argentina;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czechia;Denmark;Egypt;France;Germany;Greece;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Türkiye;Ukraine;United Kingdom;United States
      -   Phase 2;Phase 3   EUCTR2016-004677-40-PL   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      -   Phase 2;Phase 3   EUCTR2016-004677-40-GB   Argentina;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czechia;Denmark;Egypt;France;Germany;Greece;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      -   Phase 2;Phase 3   EUCTR2016-004677-40-CZ   Argentina;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;France;Germany;Greece;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      -   Phase 3   EUCTR2016-004676-22-PL   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czechia;Denmark;Egypt;France;Germany;Greece;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Türkiye;Ukraine;United Kingdom;United States
      -   Phase 3   EUCTR2016-004676-22-CZ   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
   Alimentiv
      2021   Phase 4   EUCTR2019-002485-12-PL   Belarus;Belgium;Canada;France;Italy;Netherlands;Poland;Russian Federation;Ukraine;United Kingdom;United States
   Alimentiv Inc.
      2021   Phase 4   EUCTR2019-002485-12-NL   Belarus;Belgium;Canada;France;Italy;Netherlands;Poland;Ukraine;United Kingdom;United States
      2020   Phase 4   EUCTR2019-002485-12-BE   Belarus;Belgium;Canada;France;Italy;Netherlands;Poland;Russian Federation;Ukraine;United Kingdom;United States
   Alimentiv Inc. (formerly Robarts Clinical Trials)
      2020   Phase 4   EUCTR2019-002485-12-GB   Belarus;Belgium;Canada;France;Italy;Netherlands;Poland;Russian Federation;Ukraine;United Kingdom;United States
   Amsterdam UMC location AMC
      2021   Phase 3;Phase 4   EUCTR2021-000469-33-NL   Netherlands
   AstraZeneca AB
      2022   Phase 2   EUCTR2021-001644-10-HU   Austria;Canada;Czechia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Poland;Russian Federation;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2022   Phase 2   EUCTR2021-001644-10-DE   Austria;Canada;Czechia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Poland;Russian Federation;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2022   Phase 2   EUCTR2018-001605-93-FR   Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2021   Phase 2   EUCTR2021-001644-10-PL   Austria;Canada;Czechia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Poland;Russian Federation;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2021   Phase 2   EUCTR2021-001644-10-ES   Austria;Canada;Czechia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Poland;Russian Federation;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2021   Phase 2   EUCTR2021-001644-10-AT   Austria;Canada;Czechia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Poland;Russian Federation;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2021   Phase 2   EUCTR2018-001605-93-HU   Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Poland;Romania;Russian Federation;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2020   Phase 2   EUCTR2018-001605-93-DE   Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Poland;Romania;Russian Federation;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2020   Phase 2   EUCTR2018-001605-93-AT   Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Poland;Romania;Russian Federation;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2019   Phase 2   EUCTR2018-001605-93-CZ   Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Poland;Romania;Russian Federation;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
   Boehringer Ingelheim LImited
      2018   Phase 2   EUCTR2018-000334-35-GB   Austria;Belgium;Canada;Germany;Hungary;Italy;Japan;Korea, Republic of;Netherlands;Norway;Poland;Russian Federation;Spain;United Kingdom;United States
   Boehringer Ingelheim Norway KS
      2019   Phase 2   EUCTR2018-000334-35-NO   Austria;Belgium;Canada;Germany;Hungary;Italy;Japan;Korea, Republic of;Netherlands;Norway;Poland;Russian Federation;Spain;United Kingdom;United States
   Boehringer Ingelheim Pharma GmbH & Co. KG
      2018   Phase 2   EUCTR2018-000334-35-DE   Australia;Austria;Belgium;Canada;Czechia;Denmark;Germany;Greece;Hungary;Italy;Japan;Korea, Republic of;Netherlands;Norway;Poland;Russian Federation;Spain;United Kingdom;United States
   Boehringer Ingelheim RCV GmbH&Co. KG
      2019   Phase 2   EUCTR2018-000334-35-PL   Australia;Austria;Belgium;Canada;Czechia;Denmark;Germany;Greece;Hungary;Italy;Japan;Korea, Republic of;Netherlands;Norway;Poland;Russian Federation;Spain;United Kingdom;United States
      2018   Phase 2   EUCTR2018-000334-35-AT   Austria;Belgium;Canada;Germany;Hungary;Italy;Japan;Korea, Republic of;Netherlands;Norway;Poland;Russian Federation;Spain;United Kingdom;United States
   CHU Amiens-Picardie
      2020   Phase 4   EUCTR2020-004391-18-FR   France
   Cambridge University Hospitals NHS Foundation Trust & University of Cambridge
      2017   Phase 2   EUCTR2017-001389-10-GB   United Kingdom
   Celltrion, Inc.
      2020   Phase 3   EUCTR2019-003849-15-PL   Austria;Belarus;Bulgaria;Croatia;Czech Republic;Czechia;France;Greece;Israel;Italy;Latvia;Mexico;Moldova, Republic of;Peru;Poland;Russian Federation;Serbia;South Africa;Spain;Turkey;Ukraine
      2020   Phase 3   EUCTR2019-003849-15-HR   Austria;Belarus;Brazil;Bulgaria;Chile;Croatia;Czechia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Latvia;Mexico;Moldova, Republic of;Peru;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Turkey;Ukraine;United States
      2020   Phase 3   EUCTR2019-003849-15-GR   Austria;Belarus;Brazil;Bulgaria;Chile;Croatia;Czech Republic;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Latvia;Mexico;Moldova, Republic of;Peru;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Turkey;Ukraine;United States
      2020   Phase 3   EUCTR2019-003849-15-FR   Austria;Belarus;Brazil;Bulgaria;Chile;Croatia;Czech Republic;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Latvia;Mexico;Moldova, Republic of;Peru;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Turkey;Ukraine;United States
      2020   Phase 3   EUCTR2019-003849-15-ES   Austria;Belarus;Brazil;Bulgaria;Chile;Croatia;Czech Republic;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Latvia;Mexico;Moldova, Republic of;Peru;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Turkey;Ukraine;United States
      2020   Phase 3   EUCTR2019-003849-15-CZ   Austria;Belarus;Bulgaria;Croatia;Czech Republic;Czechia;France;Greece;Israel;Italy;Latvia;Mexico;Moldova, Republic of;Peru;Poland;Russian Federation;Serbia;South Africa;Spain;Turkey;Ukraine
      2020   Phase 3   EUCTR2019-003849-15-BG   Austria;Belarus;Bulgaria;Croatia;Czech Republic;Czechia;France;Greece;Israel;Italy;Latvia;Mexico;Moldova, Republic of;Peru;Poland;Russian Federation;Serbia;South Africa;Spain;Turkey;Ukraine
      2020   Phase 3   EUCTR2019-003849-15-AT   Austria;Belarus;Brazil;Bulgaria;Chile;Croatia;Czech Republic;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Latvia;Mexico;Moldova, Republic of;Peru;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Turkey;Ukraine;United States
   F. Hoffmann-La Roche Ltd
      2019   Phase 3   EUCTR2013-004279-11-FR   Argentina;Australia;Brazil;Bulgaria;Estonia;France;Hong Kong;Mexico;Poland;Russian Federation;Serbia;Slovakia;Ukraine;United States
      2019   Phase 3   EUCTR2013-004277-27-HU   Argentina;Australia;Brazil;Bulgaria;Colombia;Croatia;Czech Republic;Greece;Hungary;Latvia;Lithuania;Malaysia;New Zealand;Poland;Russian Federation;Turkey;Ukraine;United States
      2019   Phase 3   EUCTR2013-004277-27-CZ   Argentina;Australia;Brazil;Bulgaria;Colombia;Croatia;Czech Republic;Greece;Hungary;Latvia;Lithuania;Malaysia;New Zealand;Poland;Russian Federation;Turkey;Ukraine;United States
      2017   Phase 3   EUCTR2013-004278-88-PL   Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Spain;Switzerland;United Kingdom;United States
      2016   Phase 3   EUCTR2013-004280-31-SK   Brazil;Canada;Czech Republic;Denmark;Germany;Hungary;Israel;Italy;Mexico;Poland;Slovakia;South Africa;Ukraine;United States
      2016   Phase 3   EUCTR2013-004280-31-PL   Brazil;Canada;Czech Republic;Denmark;Germany;Hungary;Israel;Italy;Mexico;Poland;Slovakia;South Africa;Ukraine;United States
      2015   Phase 3   EUCTR2013-004435-72-PT   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Philippines;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States;Vietnam
      2015   Phase 3   EUCTR2013-004435-72-NL   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Germany;Greece;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Philippines;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States;Viet Nam
      2015   Phase 3   EUCTR2013-004435-72-IT   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Philippines;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States;Vietnam
      2015   Phase 3   EUCTR2013-004435-72-DE   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Germany;Greece;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Philippines;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States;Viet Nam
      2015   Phase 3   EUCTR2013-004435-72-BG   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Germany;Greece;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Philippines;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States;Vietnam
      2015   Phase 3   EUCTR2013-004282-14-PT   Austria;Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;Norway;Philippines;Portugal;Romania;Singapore;South Africa;Spain;Sweden;Switzerland;United Kingdom;Vietnam
      2015   Phase 3   EUCTR2013-004282-14-NL   Austria;Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;Norway;Philippines;Portugal;Romania;Singapore;South Africa;Spain;Sweden;Switzerland;United Kingdom;Vietnam
      2015   Phase 3   EUCTR2013-004279-11-BG   Argentina;Australia;Brazil;Bulgaria;Estonia;France;Hong Kong;Mexico;Poland;Russian Federation;Serbia;Slovakia;Ukraine;United States
      2015   Phase 3   EUCTR2013-004277-27-BG   Argentina;Australia;Brazil;Bulgaria;Colombia;Croatia;Czech Republic;Greece;Hungary;Latvia;Lithuania;Malaysia;New Zealand;Poland;Russian Federation;Turkey;Ukraine;United States
      2014   Phase 3   EUCTR2013-004435-72-SK   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Germany;Greece;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Philippines;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States;Vietnam
      2014   Phase 3   EUCTR2013-004435-72-SE   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Philippines;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States;Vietnam
      2014   Phase 3   EUCTR2013-004435-72-NO   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Philippines;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States;Vietnam
      2014   Phase 3   EUCTR2013-004435-72-LV   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Philippines;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States;Vietnam
      2014   Phase 3   EUCTR2013-004435-72-LT   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Philippines;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States;Vietnam
      2014   Phase 3   EUCTR2013-004435-72-HU   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Philippines;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States;Vietnam
      2014   Phase 3   EUCTR2013-004435-72-HR   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Philippines;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States;Vietnam
      2014   Phase 3   EUCTR2013-004435-72-GR   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Philippines;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States;Vietnam
      2014   Phase 3   EUCTR2013-004435-72-GB   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Philippines;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States;Vietnam
      2014   Phase 3   EUCTR2013-004435-72-FR   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Philippines;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States;Vietnam
      2014   Phase 3   EUCTR2013-004435-72-EE   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Philippines;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States;Vietnam
      2014   Phase 3   EUCTR2013-004435-72-DK   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Germany;Greece;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Philippines;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States;Vietnam
      2014   Phase 3   EUCTR2013-004435-72-CZ   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Germany;Greece;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Philippines;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States;Viet Nam
      2014   Phase 3   EUCTR2013-004435-72-BE   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Philippines;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States;Vietnam
      2014   Phase 3   EUCTR2013-004435-72-AT   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Philippines;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States;Vietnam
      2014   Phase 3   EUCTR2013-004282-14-NO   Austria;Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;Norway;Philippines;Portugal;Romania;Singapore;South Africa;Spain;Sweden;Switzerland;United Kingdom;Vietnam
      2014   -   EUCTR2013-004282-14-IT   Austria;Belgium;Canada;Czech Republic;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;Norway;Philippines;Portugal;Romania;Singapore;South Africa;Spain;Sweden;Switzerland;United Kingdom;Vietnam
      2014   Phase 3   EUCTR2013-004282-14-HU   Austria;Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;Norway;Portugal;Romania;Singapore;South Africa;Spain;Sweden;Switzerland;United Kingdom
      2014   Phase 3   EUCTR2013-004282-14-GB   Austria;Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;Norway;Portugal;Romania;Singapore;South Africa;Spain;Sweden;Switzerland;United Kingdom
      2014   Phase 3   EUCTR2013-004282-14-FR   Austria;Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;Norway;Philippines;Portugal;Romania;Singapore;South Africa;Spain;Sweden;Switzerland;United Kingdom;Vietnam
      2014   Phase 3   EUCTR2013-004282-14-DE   Austria;Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;Norway;Portugal;Romania;Singapore;South Africa;Spain;Sweden;Switzerland;United Kingdom
      2014   Phase 3   EUCTR2013-004282-14-CZ   Austria;Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;Norway;Portugal;Romania;Singapore;South Africa;Spain;Sweden;Switzerland;United Kingdom
      2014   Phase 3   EUCTR2013-004282-14-BE   Austria;Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;Norway;Portugal;Romania;Singapore;South Africa;Spain;Sweden;Switzerland;United Kingdom
      2014   Phase 3   EUCTR2013-004282-14-AT   Austria;Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;Norway;Portugal;Romania;Singapore;South Africa;Spain;Sweden;Switzerland;United Kingdom
      2014   Phase 3   EUCTR2013-004280-31-HU   Brazil;Canada;Czech Republic;Denmark;Germany;Hungary;Israel;Italy;Mexico;Poland;Slovakia;South Africa;Ukraine;United States
      2014   Phase 3   EUCTR2013-004280-31-DK   Canada;Czech Republic;Denmark;Germany;Hungary;Israel;Poland;Slovakia;South Africa;United States
      2014   Phase 3   EUCTR2013-004280-31-DE   Brazil;Canada;Czech Republic;Denmark;Germany;Hungary;Israel;Italy;Mexico;Poland;Slovakia;South Africa;Ukraine;United States
      2014   Phase 3   EUCTR2013-004280-31-CZ   Brazil;Canada;Czech Republic;Denmark;Germany;Hungary;Israel;Italy;Mexico;Poland;Slovakia;South Africa;Ukraine;United States
      2014   Phase 3   EUCTR2013-004279-11-SK   Argentina;Australia;Brazil;Bulgaria;Estonia;France;Hong Kong;Mexico;Poland;Russian Federation;Serbia;Slovakia;Ukraine;United States
      2014   Phase 3   EUCTR2013-004279-11-EE   Argentina;Australia;Brazil;Bulgaria;Estonia;France;Hong Kong;Mexico;Poland;Russian Federation;Serbia;Slovakia;Ukraine;United States
      2014   Phase 3   EUCTR2013-004278-88-NL   Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Spain;Switzerland;United Kingdom;United States
      2014   Phase 3   EUCTR2013-004278-88-LT   Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Spain;Switzerland;United Kingdom;United States
      2014   Phase 3   EUCTR2013-004278-88-IT   Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Spain;Switzerland;United Kingdom;United States
      2014   Phase 3   EUCTR2013-004278-88-HU   Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Spain;Switzerland;United Kingdom;United States
      2014   Phase 3   EUCTR2013-004278-88-GR   Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Spain;Switzerland;United Kingdom;United States
      2014   Phase 3   EUCTR2013-004278-88-FR   Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Spain;Switzerland;United Kingdom;United States
      2014   Phase 3   EUCTR2013-004278-88-DK   Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Spain;Switzerland;United Kingdom;United States
      2014   Phase 3   EUCTR2013-004278-88-DE   Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Spain;Switzerland;United Kingdom;United States
      2014   Phase 3   EUCTR2013-004278-88-CZ   Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Spain;Switzerland;United Kingdom;United States
      2014   Phase 3   EUCTR2013-004278-88-BE   Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Spain;Switzerland;United Kingdom;United States
      2014   Phase 3   EUCTR2013-004278-88-AT   Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Spain;Switzerland;United Kingdom;United States
      2014   Phase 3   EUCTR2013-004277-27-LV   Argentina;Australia;Brazil;Bulgaria;Colombia;Croatia;Czech Republic;Greece;Hungary;Latvia;Lithuania;Malaysia;New Zealand;Poland;Russian Federation;Turkey;Ukraine;United States
      2014   Phase 3   EUCTR2013-004277-27-LT   Argentina;Australia;Brazil;Bulgaria;Colombia;Croatia;Czech Republic;Greece;Hungary;Latvia;Lithuania;Malaysia;New Zealand;Poland;Russian Federation;Turkey;Ukraine;United States
      2014   Phase 3   EUCTR2013-004277-27-HR   Argentina;Australia;Brazil;Bulgaria;Colombia;Croatia;Czech Republic;Greece;Hungary;Latvia;Lithuania;Malaysia;New Zealand;Poland;Russian Federation;Turkey;Ukraine;United States
      2014   Phase 3   EUCTR2013-004277-27-GR   Argentina;Australia;Brazil;Bulgaria;Colombia;Croatia;Czech Republic;Greece;Hungary;Latvia;Lithuania;Malaysia;New Zealand;Poland;Russian Federation;Turkey;Ukraine;United States
   Gilead Sciences, Inc
      2016   Phase 2;Phase 3   EUCTR2014-005217-24-SE   Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Germany;Hong Kong;Hungary;Iceland;India;Iran, Islamic Republic of;Ireland;Israel;Korea, Republic of;Latvia;Malaysia;Mexico;Moldova, Republic of;Netherlands;New Zealand;Philippines;Romania;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;Vietnam
      2016   Phase 2;Phase 3   EUCTR2014-005217-24-IS   Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Germany;Hong Kong;Hungary;Iceland;India;Iran, Islamic Republic of;Ireland;Israel;Korea, Republic of;Latvia;Malaysia;Mexico;Moldova, Republic of;Netherlands;New Zealand;Philippines;Romania;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;Vietnam
      2016   Phase 2;Phase 3   EUCTR2014-005217-24-HR   Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Germany;Hong Kong;Hungary;Iceland;India;Iran, Islamic Republic of;Ireland;Israel;Korea, Republic of;Latvia;Malaysia;Mexico;Moldova, Republic of;Netherlands;New Zealand;Philippines;Romania;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;Vietnam
      2016   Phase 2;Phase 3   EUCTR2014-005217-24-ES   Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Germany;Hong Kong;Hungary;Iceland;India;Iran, Islamic Republic of;Ireland;Israel;Korea, Republic of;Latvia;Malaysia;Mexico;Moldova, Republic of;Netherlands;New Zealand;Philippines;Romania;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;Vietnam
      2016   Phase 2;Phase 3   EUCTR2014-005217-24-DE   Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Germany;Hong Kong;Hungary;Iceland;India;Iran, Islamic Republic of;Ireland;Israel;Korea, Republic of;Latvia;Malaysia;Mexico;Moldova, Republic of;Netherlands;New Zealand;Philippines;Romania;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;Vietnam
      2016   Phase 2;Phase 3   EUCTR2014-005217-24-BG   Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Germany;Hong Kong;Hungary;Iceland;India;Iran, Islamic Republic of;Ireland;Israel;Korea, Republic of;Latvia;Malaysia;Mexico;Moldova, Republic of;Netherlands;New Zealand;Philippines;Romania;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;Vietnam
      2016   Phase 2;Phase 3   EUCTR2014-005217-24-BE   Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Germany;Hong Kong;Hungary;Iceland;India;Iran, Islamic Republic of;Ireland;Israel;Korea, Republic of;Latvia;Malaysia;Mexico;Moldova, Republic of;Netherlands;New Zealand;Philippines;Romania;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;Vietnam
      2015   Phase 2;Phase 3   EUCTR2014-005217-24-SK   Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Germany;Hong Kong;Hungary;Iceland;India;Iran, Islamic Republic of;Ireland;Israel;Korea, Republic of;Latvia;Malaysia;Mexico;Moldova, Republic of;Netherlands;New Zealand;Philippines;Romania;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;Vietnam
      2015   Phase 2;Phase 3   EUCTR2014-005217-24-NL   Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Germany;Hong Kong;Hungary;Iceland;India;Iran, Islamic Republic of;Ireland;Israel;Korea, Republic of;Latvia;Malaysia;Mexico;Moldova, Republic of;Netherlands;New Zealand;Philippines;Romania;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;Vietnam
      2015   Phase 2;Phase 3   EUCTR2014-005217-24-LV   Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Germany;Hong Kong;Hungary;Iceland;India;Iran, Islamic Republic of;Ireland;Israel;Korea, Republic of;Latvia;Malaysia;Mexico;Moldova, Republic of;Netherlands;New Zealand;Philippines;Romania;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;Vietnam
      2015   Phase 2;Phase 3   EUCTR2014-005217-24-IE   Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Germany;Hong Kong;Hungary;Iceland;India;Iran, Islamic Republic of;Ireland;Israel;Korea, Republic of;Latvia;Malaysia;Mexico;Moldova, Republic of;Netherlands;New Zealand;Philippines;Romania;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;Vietnam
      2015   Phase 2;Phase 3   EUCTR2014-005217-24-HU   Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Germany;Hong Kong;Hungary;Iceland;India;Iran, Islamic Republic of;Ireland;Israel;Korea, Republic of;Latvia;Malaysia;Mexico;Moldova, Republic of;Netherlands;New Zealand;Philippines;Romania;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;Vietnam
      2015   Phase 2;Phase 3   EUCTR2014-005217-24-GB   Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Germany;Hong Kong;Hungary;Iceland;India;Iran, Islamic Republic of;Ireland;Israel;Korea, Republic of;Latvia;Malaysia;Mexico;Moldova, Republic of;Netherlands;New Zealand;Philippines;Romania;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;Vietnam
      2015   Phase 2;Phase 3   EUCTR2014-005217-24-CZ   Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Germany;Hong Kong;Hungary;Iceland;India;Iran, Islamic Republic of;Ireland;Israel;Korea, Republic of;Latvia;Malaysia;Mexico;Moldova, Republic of;Netherlands;New Zealand;Philippines;Romania;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;Vietnam
      2015   Phase 2;Phase 3   EUCTR2014-005217-24-AT   Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Germany;Hong Kong;Hungary;Iceland;India;Iran, Islamic Republic of;Ireland;Israel;Korea, Republic of;Latvia;Malaysia;Mexico;Moldova, Republic of;Netherlands;New Zealand;Philippines;Romania;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;Vietnam
   IRCCS ISTITUTO CLINICO HUMANITAS
      2021   Phase 4   EUCTR2020-003420-16-IT   Austria;Belgium;France;Germany;Italy;Portugal;Spain;Sweden;Switzerland;United Kingdom
   Instituto Clinico Humanitas
      2021   Phase 4   EUCTR2020-003420-16-ES   Austria;Belgium;France;Germany;Italy;Portugal;Spain;Sweden;Switzerland;United Kingdom
      2021   Phase 4   EUCTR2020-003420-16-BE   Austria;Belgium;France;Germany;Italy;Portugal;Spain;Sweden;Switzerland;United Kingdom
   JANSSEN CILAG INTERNATIONAL NV
      2022   Phase 2   EUCTR2021-005528-39-IT   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;Finland;France;Georgia;Germany;Greece;Hong Kong;Hungary;India;Ireland;Israel;Italy;Japan;Jordan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2018-004002-25-IT   Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czechia;France;Germany;Hong Kong;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Malaysia;Netherlands;Poland;Portugal;Russian Federation;Slovakia;Spain;Sweden;Taiwan;Turkey;Ukraine;United Kingdom;United States
   Janssen Biologics B.V.
      2015   Phase 2   EUCTR2013-002042-36-FR   Belgium;Bulgaria;Canada;Czech Republic;France;Germany;Hungary;Israel;Netherlands;Poland;Russian Federation;Ukraine;United States
      2014   Phase 2   EUCTR2013-002042-36-PL   Belgium;Bulgaria;Canada;Czech Republic;France;Germany;Hungary;Israel;Netherlands;Poland;Russian Federation;Ukraine;United States
      2014   -   EUCTR2013-002042-36-NL   Belgium;Bulgaria;Canada;Czech Republic;France;Germany;Hungary;Israel;Netherlands;Poland;Russian Federation;Ukraine;United States
      2014   -   EUCTR2013-002042-36-HU   Belgium;Bulgaria;Canada;Czech Republic;France;Germany;Hungary;Israel;Netherlands;Poland;Russian Federation;Ukraine;United States
      2014   -   EUCTR2013-002042-36-DE   Belgium;Bulgaria;Canada;Czech Republic;France;Germany;Hungary;Israel;Netherlands;Poland;Russian Federation;Ukraine;United States
      2014   -   EUCTR2013-002042-36-CZ   Belgium;Bulgaria;Canada;Czech Republic;France;Germany;Hungary;Israel;Netherlands;Poland;Russian Federation;Ukraine;United States
      2014   Phase 2   EUCTR2013-002042-36-BG   Belgium;Bulgaria;Canada;Czech Republic;France;Germany;Hungary;Israel;Netherlands;Poland;Russian Federation;Ukraine;United States
      2014   -   EUCTR2013-002042-36-BE   Belgium;Bulgaria;Canada;Czech Republic;France;Germany;Hungary;Israel;Netherlands;Poland;Russian Federation;Ukraine;United States
   Janssen Biologics BV
      2019   Phase 3   EUCTR2017-004496-31-PL   Belgium;Brazil;France;Israel;Italy;Korea, Republic of;Netherlands;Poland;Spain;Taiwan;United States
      2019   Phase 3   EUCTR2017-004496-31-NL   Belgium;Brazil;France;Israel;Italy;Korea, Republic of;Netherlands;Poland;Spain;Taiwan;United States
      2018   Phase 3   EUCTR2017-004496-31-FR   Belgium;Brazil;France;Israel;Italy;Korea, Republic of;Netherlands;Poland;Spain;Taiwan;United States
      2018   Phase 3   EUCTR2017-004496-31-ES   Belgium;Brazil;France;Israel;Italy;Korea, Republic of;Netherlands;Poland;Spain;Taiwan;United States
      2018   Phase 3   EUCTR2017-004496-31-BE   Belgium;Brazil;France;Israel;Italy;Korea, Republic of;Netherlands;Poland;Spain;Taiwan;United States
   Janssen-Cilag International N.V.
      2020   Phase 3   EUCTR2018-002629-51-GB   Austria;France;Germany;Italy;Netherlands;Spain;Sweden;United Kingdom;United States
      2019   Phase 3   EUCTR2018-002629-51-SE   Austria;Czech Republic;Czechia;France;Germany;Italy;Korea, Republic of;Netherlands;Russian Federation;Spain;Sweden;United Kingdom;United States
      2019   Phase 3   EUCTR2018-002629-51-FR   Austria;Czech Republic;France;Germany;Italy;Netherlands;Spain;Sweden;United Kingdom;United States
      2018   Phase 3   EUCTR2018-002629-51-ES   France;Germany;Netherlands;Spain;Sweden;United States
   Janssen-Cilag International NV
      2023   Phase 3   EUCTR2022-000365-41-PL   Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;China;Czech Republic;Czechia;France;Germany;Hungary;India;Israel;Italy;Japan;Jordan;Korea, Republic of;Malaysia;Mexico;New Zealand;Poland;Portugal;Serbia;Slovakia;Spain;Sweden;Taiwan;Türkiye;United States
      2023   Phase 3   EUCTR2022-000365-41-HU   Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;China;Czech Republic;Czechia;France;Germany;Hungary;India;Israel;Italy;Japan;Jordan;Korea, Republic of;Malaysia;Mexico;New Zealand;Poland;Portugal;Serbia;Slovakia;Spain;Sweden;Taiwan;Turkey;United States
      2023   Phase 3   EUCTR2022-000365-41-FR   Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;China;Czech Republic;Czechia;France;Germany;Hungary;India;Israel;Italy;Japan;Jordan;Korea, Republic of;Malaysia;Mexico;New Zealand;Poland;Portugal;Serbia;Slovakia;Spain;Sweden;Taiwan;Turkey;United States
      2023   Phase 3   EUCTR2022-000365-41-DE   Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;China;Czech Republic;Czechia;France;Germany;Hungary;India;Israel;Italy;Japan;Jordan;Korea, Republic of;Malaysia;Mexico;New Zealand;Poland;Portugal;Serbia;Slovakia;Spain;Sweden;Taiwan;Turkey;United States
      2023   Phase 3   EUCTR2022-000365-41-CZ   Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;China;Czech Republic;Czechia;France;Germany;Hungary;India;Israel;Italy;Japan;Jordan;Korea, Republic of;Malaysia;Mexico;New Zealand;Poland;Portugal;Serbia;Slovakia;Spain;Sweden;Taiwan;Turkey;United States
      2023   Phase 3   EUCTR2022-000365-41-BG   Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;China;Czech Republic;Czechia;France;Germany;Hungary;India;Israel;Italy;Japan;Jordan;Korea, Republic of;Malaysia;Mexico;New Zealand;Poland;Portugal;Serbia;Slovakia;Spain;Sweden;Taiwan;Türkiye;United States
      2023   Phase 2   EUCTR2021-005528-39-SK   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Jordan;Korea, Republic of;Lithuania;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Switzerland;Taiwan;Türkiye;Ukraine;United Kingdom;United States
      2023   Phase 2   EUCTR2021-005528-39-SI   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Jordan;Korea, Republic of;Lithuania;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2023   Phase 2   EUCTR2021-005528-39-SE   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Jordan;Korea, Republic of;Lithuania;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2023   Phase 2   EUCTR2021-005528-39-PT   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;Finland;France;Georgia;Germany;Greece;Hong Kong;Hungary;India;Ireland;Israel;Italy;Japan;Jordan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2023   Phase 2   EUCTR2021-005528-39-NO   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Jordan;Korea, Republic of;Lithuania;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2023   Phase 2   EUCTR2021-005528-39-HR   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;Finland;France;Georgia;Germany;Greece;Hong Kong;Hungary;India;Ireland;Israel;Italy;Japan;Jordan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2023   Phase 2   EUCTR2021-005528-39-FR   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Jordan;Korea, Republic of;Lithuania;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2023   Phase 2   EUCTR2021-005528-39-DK   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Jordan;Korea, Republic of;Lithuania;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2023   Phase 2   EUCTR2021-005528-39-DE   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Jordan;Korea, Republic of;Lithuania;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2023   Phase 2   EUCTR2021-005528-39-BG   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Jordan;Korea, Republic of;Lithuania;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2023   Phase 2   EUCTR2021-005528-39-AT   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2022   Phase 2   EUCTR2021-005528-39-NL   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Jordan;Korea, Republic of;Lithuania;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2022   Phase 2   EUCTR2021-005528-39-HU   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Jordan;Korea, Republic of;Lithuania;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2022   Phase 2   EUCTR2021-005528-39-CZ   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Jordan;Korea, Republic of;Lithuania;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2022   Phase 3   EUCTR2020-004457-76-HU   Argentina;Belgium;France;Germany;Hungary;Italy;Japan;Poland;Russian Federation;Spain;Turkey;United Kingdom;United States
      2022   Phase 3   EUCTR2020-004457-76-DE   Argentina;Belgium;France;Germany;Hungary;Italy;Japan;Poland;Russian Federation;Spain;Turkey;United Kingdom;United States
      2022   Phase 3   EUCTR2020-004457-76-BE   Argentina;Belgium;France;Germany;Hungary;Italy;Japan;Poland;Russian Federation;Spain;Turkey;United Kingdom;United States
      2021   Phase 3   EUCTR2020-004457-76-PL   Argentina;Belgium;France;Germany;Hungary;Japan;Poland;Russian Federation;Turkey;United States
      2021   Phase 3   EUCTR2019-004224-38-DE   Belgium;Germany;Hungary;Japan;Poland;United Kingdom;United States
      2021   Phase 3   EUCTR2019-004224-38-BE   Belgium;Germany;Hungary;Japan;Poland;Russian Federation;United Kingdom;United States
      2021   Phase 2;Phase 3   EUCTR2018-004002-25-SK   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Czechia;France;Germany;Hungary;Ireland;Israel;Italy;Japan;Jordan;Korea, Republic of;Latvia;Malaysia;Netherlands;New Zealand;Poland;Portugal;Russian Federation;Serbia;Slovakia;Spain;Sweden;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2021   Phase 2;Phase 3   EUCTR2018-004002-25-LV   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Czechia;France;Germany;Hungary;Ireland;Israel;Italy;Japan;Jordan;Korea, Republic of;Latvia;Netherlands;Poland;Portugal;Russian Federation;Serbia;Slovakia;Spain;Sweden;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2021   Phase 2;Phase 3   EUCTR2018-004002-25-AT   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Czechia;France;Germany;Hungary;Ireland;Israel;Italy;Japan;Jordan;Korea, Republic of;Latvia;Malaysia;Netherlands;New Zealand;Poland;Portugal;Russian Federation;Serbia;Slovakia;Spain;Sweden;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2021   Phase 3   EUCTR2018-002629-51-CZ   Austria;Czech Republic;Czechia;France;Germany;Italy;Korea, Republic of;Netherlands;Russian Federation;Spain;Sweden;United Kingdom;United States
      2020   Phase 3   EUCTR2019-004224-38-HU   Belgium;Germany;Hungary;Japan;Poland;Russian Federation;United Kingdom;United States
      2020   Phase 2;Phase 3   EUCTR2018-004002-25-PT   Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czechia;France;Germany;Hong Kong;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Malaysia;Netherlands;Poland;Portugal;Russian Federation;Slovakia;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
      2020   Phase 2;Phase 3   EUCTR2018-004002-25-NL   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Czechia;France;Germany;Hungary;Ireland;Israel;Italy;Japan;Jordan;Korea, Republic of;Latvia;Malaysia;Netherlands;New Zealand;Poland;Portugal;Russian Federation;Serbia;Slovakia;Spain;Sweden;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2020   Phase 2;Phase 3   EUCTR2018-004002-25-ES   Argentina;Australia;Belgium;Bulgaria;Canada;China;Czech Republic;France;Germany;Hong Kong;Hungary;Israel;Italy;Japan;Korea, Republic of;Malaysia;Netherlands;Poland;Portugal;Russian Federation;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
      2020   Phase 2;Phase 3   EUCTR2018-004002-25-DE   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Czechia;France;Germany;Hong Kong;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Malaysia;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2020   Phase 2;Phase 3   EUCTR2018-004002-25-BG   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Czechia;France;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Malaysia;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Taiwan;Türkiye;Ukraine;United Kingdom;United States
      2019   Phase 2;Phase 3   EUCTR2018-004002-25-SE   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Czechia;France;Germany;Hong Kong;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Malaysia;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 2;Phase 3   EUCTR2018-004002-25-PL   Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czechia;France;Germany;Hong Kong;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Malaysia;Netherlands;Poland;Portugal;Russian Federation;Slovakia;Spain;Sweden;Taiwan;Thailand;Türkiye;Ukraine;United Kingdom;United States
      2019   Phase 2;Phase 3   EUCTR2018-004002-25-HU   Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;France;Germany;Hong Kong;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Malaysia;Netherlands;Poland;Portugal;Russian Federation;Slovakia;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 2;Phase 3   EUCTR2018-004002-25-GB   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Czech Republic;France;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 2;Phase 3   EUCTR2018-004002-25-FR   Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;France;Germany;Hong Kong;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Malaysia;Netherlands;Poland;Portugal;Russian Federation;Slovakia;Spain;Sweden;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 2;Phase 3   EUCTR2018-004002-25-BE   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Czechia;France;Germany;Hungary;Ireland;Israel;Italy;Japan;Jordan;Korea, Republic of;Latvia;Malaysia;Netherlands;New Zealand;Poland;Portugal;Russian Federation;Serbia;Slovakia;Spain;Sweden;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2018-002629-51-NL   Austria;Czech Republic;Czechia;France;Germany;Italy;Korea, Republic of;Netherlands;Russian Federation;Spain;Sweden;United Kingdom;United States
      2019   Phase 3   EUCTR2018-002629-51-AT   Austria;Czech Republic;Czechia;France;Germany;Italy;Korea, Republic of;Netherlands;Russian Federation;Spain;Sweden;United Kingdom;United States
      2019   Phase 2   EUCTR2018-001510-15-PL   Argentina;Australia;Brazil;Germany;Mexico;Poland;Russian Federation;Ukraine;United States
      2019   Phase 2   EUCTR2018-001510-15-DE   Argentina;Australia;Brazil;Germany;Mexico;Poland;Russian Federation;Ukraine;United States
      2016   Phase 3   EUCTR2014-005606-38-PL   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;United Kingdom;United States
      2015   Phase 3   EUCTR2014-005606-38-SK   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;United Kingdom;United States
      2015   Phase 3   EUCTR2014-005606-38-NL   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;United Kingdom;United States
      2015   Phase 3   EUCTR2014-005606-38-HU   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;United Kingdom;United States
      2015   Phase 3   EUCTR2014-005606-38-DK   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;United Kingdom;United States
      2015   Phase 3   EUCTR2014-005606-38-DE   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;United Kingdom;United States
      2015   Phase 3   EUCTR2014-005606-38-CZ   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;United Kingdom;United States
      2015   Phase 3   EUCTR2014-005606-38-BG   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;United Kingdom;United States
      2015   Phase 3   EUCTR2014-005606-38-BE   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;United Kingdom;United States
      2015   Phase 3   EUCTR2014-005606-38-AT   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;United Kingdom;United States
      -   Phase 3   EUCTR2019-004224-38-PL   Belgium;Germany;Hungary;Japan;Poland;Russian Federation;United Kingdom;United States
      -   Phase 3   EUCTR2019-004224-38-Outside-EU/EEA   Belgium;Germany;Hungary;Japan;Poland;Russian Federation;United Kingdom;United States
      -   Phase 3   EUCTR2019-004224-38-GB   Belgium;Germany;Hungary;Japan;Poland;Russian Federation;United Kingdom;United States
   Leiden University Medical Center
      2018   Phase 2   EUCTR2017-003524-75-NL   Netherlands
   MSD
      2014   Phase 4   EUCTR2013-004583-56-GB   United Kingdom
   MSD Belgium BVBA/SPRL
      2014   Phase 4   EUCTR2014-000656-29-BE   Belgium
   Region Örebro län
      2021   Phase 4   EUCTR2019-002942-19-IS   Denmark;Iceland
   Robarts Clinical Trials Inc.
      2020   Phase 4   EUCTR2019-002485-12-FR   Belarus;Belgium;Canada;France;Italy;Netherlands;Poland;Russian Federation;Ukraine;United Kingdom;United States
   Roche Farma S.A en nombre de F. Hoffmann-La Roche Ltd
      2014   Phase 3   EUCTR2013-004278-88-ES   Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Spain;Switzerland;United Kingdom;United States
   Roche Farma S.A. en nombre de F. Hoffmann-La Roche Ltd
      2014   Phase 3   EUCTR2013-004435-72-ES   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Philippines;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States;Vietnam
      2014   Phase 3   EUCTR2013-004282-14-ES   Austria;Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;Norway;Philippines;Portugal;Romania;Singapore;South Africa;Spain;Sweden;Switzerland;United Kingdom;Vietnam
   Royal Liverpool University Hospital
      2012   -   EUCTR2011-006084-22-GB   United Kingdom
   SCS Boehringer Ingelheim Comm. V
      2018   Phase 2   EUCTR2018-000334-35-BE   Austria;Belgium;Canada;Germany;Hungary;Italy;Japan;Korea, Republic of;Netherlands;Norway;Poland;Russian Federation;Spain;United Kingdom;United States
   Samsung Bioepis Co., Ltd
      2015   -   EUCTR2014-004887-39-PL   Poland
   Samsung Bioepis Co., Ltd.
      2014   -   EUCTR2013-005013-13-PL   Bosnia and Herzegovina;Bulgaria;Czech Republic;Korea, Republic of;Latvia;Lithuania;Mexico;Poland;Russian Federation;Ukraine;United Kingdom
      2014   -   EUCTR2013-005013-13-LT   Bosnia and Herzegovina;Bulgaria;Czech Republic;Korea, Republic of;Lithuania;Mexico;Poland;Russian Federation;Ukraine;United Kingdom
      2014   -   EUCTR2013-005013-13-CZ   Bosnia and Herzegovina;Bulgaria;Czech Republic;Korea, Republic of;Lithuania;Mexico;Poland;Russian Federation;Ukraine;United Kingdom
      2014   Phase 3   EUCTR2013-005013-13-BG   Bosnia and Herzegovina;Bulgaria;Czech Republic;Korea, Republic of;Lithuania;Mexico;Poland;Russian Federation;Ukraine;United Kingdom
   Takeda Development Centre Europe, Ltd.
      2016   Phase 3   EUCTR2015-000939-33-PT   Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000939-33-PL   Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000939-33-NL   Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000939-33-HU   Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000939-33-HR   Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000939-33-ES   Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000482-31-SK   Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000482-31-SE   Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000482-31-RO   Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000482-31-NL   Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000482-31-LT   Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000482-31-HU   Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000482-31-HR   Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000482-31-GB   Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000482-31-ES   Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000482-31-DK   Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000482-31-DE   Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000482-31-CZ   Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000482-31-BG   Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000482-31-BE   Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000480-14-SK   Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000480-14-SE   Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000480-14-RO   Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000480-14-NL   Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000480-14-LT   Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000480-14-HU   Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000480-14-HR   Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000480-14-GB   Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000480-14-ES   Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000480-14-DK   Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000480-14-DE   Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000480-14-CZ   Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000480-14-BG   Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000480-14-BE   Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
      2015   Phase 3   EUCTR2015-000939-33-SK   Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2015   Phase 3   EUCTR2015-000939-33-LV   Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2015   Phase 3   EUCTR2015-000939-33-LT   Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2015   Phase 3   EUCTR2015-000939-33-GB   Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2015   Phase 3   EUCTR2015-000939-33-EE   Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2015   Phase 3   EUCTR2015-000939-33-DK   Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2015   Phase 3   EUCTR2015-000939-33-DE   Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2015   Phase 3   EUCTR2015-000939-33-CZ   Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2015   Phase 3   EUCTR2015-000939-33-BG   Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2015   Phase 3   EUCTR2015-000939-33-BE   Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
   Universitätsklinikum Erlangen
      2019   Phase 4   EUCTR2019-003662-40-DE   Germany
PRE-genotype NUDT15 and optimize azathioprine dosage
   Sixth Affiliated Hospital, Sun Yat-sen University
      2016   -   NCT02929706   China
Prebiotic
   University of California, Los Angeles
      2024   -   NCT06495658   United States
Prebiotics
   Capital Medical University
      2020   Phase 0   ChiCTR2000032498   China
   Wageningen University
      2023   -   NCT05579483   Netherlands
Precision dosing infliximab
   Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
      2015   Phase 4   NCT02453776   Netherlands
Prednisolon jenapharm
   4SC AG
      2010   -   EUCTR2008-005903-25-BG   Bulgaria;Germany
      2009   -   EUCTR2008-005903-25-DE   Bulgaria;Germany
Prednisolone
   ALIZYME
      2006   -   EUCTR2004-005032-35-IT   Belgium;Czech Republic;Denmark;Hungary;Italy;Spain;Sweden;United Kingdom
   Alizyme
      2006   Phase 3   NCT00299013   Australia;Belgium;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Poland;Russian Federation;South Africa;Spain;Sweden;United Kingdom
   Assiut University
      2022   Phase 2/Phase 3   NCT05341401   -
   Department of Inflammatory Bowel Disease Hyogo College of Medicine
      2018   Phase 1   JPRN-UMIN000030000   Japan
   Essex Pharma GmbH
      2009   -   EUCTR2009-010065-23-DE   Germany
   Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives
      2016   Phase 4   NCT02425852   France
   Lower Gastroenterology, Hyogo College of Medicine
      2011   Phase 2,3   JPRN-UMIN000005358   Japan
   Merck Sharp & Dohme Corp.
      2009   Phase 3   NCT00984568   Germany
   Takeuchi Yutaka
      2015   Phase 1   JPRN-jRCT2071230023   -
Prednisolone sodium metasulphobenzoate
   Alizyme Therapeutics Limited
      2007   -   EUCTR2004-005032-35-BE   Belgium;Czech Republic;Denmark;Hungary;Italy;Spain;Sweden;United Kingdom
      2005   -   EUCTR2004-005032-35-SE   Belgium;Czech Republic;Denmark;Hungary;Italy;Spain;Sweden;United Kingdom
      2005   -   EUCTR2004-005032-35-HU   Belgium;Czech Republic;Denmark;Hungary;Italy;Spain;Sweden;United Kingdom
      2005   Phase 3   EUCTR2004-005032-35-GB   Belgium;Czech Republic;Denmark;Hungary;Italy;Spain;Sweden;United Kingdom
      2005   -   EUCTR2004-005032-35-DK   Belgium;Czech Republic;Denmark;Hungary;Italy;Spain;Sweden;United Kingdom
      2005   -   EUCTR2004-005032-35-CZ   Belgium;Czech Republic;Denmark;Hungary;Italy;Spain;Sweden;United Kingdom
Prednisolone tablets B.P. 5MG
   Alizyme Therapeutics Limited
      2005   Phase 3   EUCTR2004-005032-35-GB   Belgium;Czech Republic;Denmark;Hungary;Italy;Spain;Sweden;United Kingdom
Prednisone
   Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
      2016   Phase 3   NCT02910245   Netherlands
   CHIESI
      2007   -   EUCTR2006-004230-32-IT   Belgium;Italy;Poland;Spain
   CHIESI Farmaceutici S.p.A.
      2007   -   EUCTR2006-004230-32-BE   Belgium;Italy;Poland;Spain
   Chiesi Farmaceutici SpA
      2007   Phase 3   EUCTR2006-004230-32-PL   Belgium;Italy;Poland;Spain
      2007   Phase 3   EUCTR2006-004230-32-ES   Belgium;Italy;Poland;Spain
   GETECCU (Grupo Español de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa)
      2009   -   EUCTR2007-003815-30-PT   Portugal;Spain
      2007   -   EUCTR2007-003815-30-ES   Portugal;Spain
   Grupo Espanol de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa
      2018   Phase 4   NCT02921555   Spain
   IRCCS ISTITUTO CLINICO HUMANITAS
      2021   Phase 4   EUCTR2020-003420-16-IT   Austria;Belgium;France;Germany;Italy;Portugal;Spain;Sweden;Switzerland;United Kingdom
   McMaster Children's Hospital
      2015   -   NCT02521064   Canada
   Peking University First Hospital
      2019   Phase 0   ChiCTR1900024591   China
   Shandong Qilu Stem Cells Engineering Co., Ltd.
      2021   -   NCT04882683   China
   Southern Medical University, Nanfang Hospital, Department of Gastroenterology
      2015   -   ChiCTR-ICR-15007188   China
   The Second Affiliated Hospital of Shandong University of Traditional Chinese Medicine
      2021   Phase 0   ChiCTR2100046284   China
   University of British Columbia
      2013   Phase 4   NCT01981889   Canada
Prednisone oral product
   Berinstein, Jeffrey
      2023   Phase 4   NCT05867329   United States
Prefilled syringe delivery OF golimumab
   Merck Sharp & Dohme Corp.
      2014   Phase 4   NCT02155335   Belgium
Pretreatment antibiotics
   Najwa Elnachef
      2017   Phase 1   NCT03006809   United States
Prevenar 13
   Centre Hospitalier Universitaire de Saint Etienne
      2015   Phase 2   NCT02255227   France
Previously referred TO AS MEDI2070 and AMG 139
   ALLERGAN LIMITED
      2019   Phase 2   EUCTR2018-001605-93-IT   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Colombia;Czech Republic;Czechia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Poland;Romania;Russian Federation;Singapore;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States
   Allergan Ltd.
      2019   Phase 2   EUCTR2018-001605-93-RO   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Colombia;Czech Republic;Czechia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Poland;Romania;Russian Federation;Singapore;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States
      2019   Phase 2   EUCTR2018-001605-93-ES   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Colombia;Czech Republic;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Poland;Romania;Russian Federation;Singapore;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States
      2019   Phase 2   EUCTR2018-001605-93-BG   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Colombia;Czech Republic;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Poland;Romania;Russian Federation;Singapore;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States
   AstraZeneca AB
      2019   Phase 2   EUCTR2018-001605-93-GB   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Colombia;Czech Republic;Czechia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Poland;Romania;Russian Federation;Singapore;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States
      2019   Phase 2   EUCTR2018-001605-93-BE   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Colombia;Czech Republic;Czechia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Poland;Romania;Russian Federation;Singapore;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States
PRIM-DJ2727
   The University of Texas Health Science Center, Houston
      2020   Phase 2   NCT04373473   United States
PRIM-DJ2727 - capsules
   The University of Texas Health Science Center, Houston
      2023   Phase 1   NCT05786404   United States
PRIM-DJ2727 - frozen
   The University of Texas Health Science Center, Houston
      2023   Phase 1   NCT05786404   United States
PRO145223
   Genentech, Inc.
      2012   Phase 2   EUCTR2011-003409-36-DE   Australia;Belgium;Canada;Czech Republic;Germany;Hungary;Israel;New Zealand;Spain;United Kingdom;United States
      2012   Phase 2   EUCTR2011-003409-36-CZ   Australia;Belgium;Canada;Czech Republic;Germany;Hungary;Israel;New Zealand;Spain;United Kingdom;United States
      2011   Phase 2   EUCTR2011-003409-36-GB   Australia;Belgium;Canada;Czech Republic;Germany;Hungary;Israel;New Zealand;Spain;United Kingdom;United States
      2011   Phase 2   EUCTR2011-003409-36-ES   Australia;Belgium;Canada;Czech Republic;Germany;Hungary;Israel;New Zealand;Spain;United Kingdom;United States
      2011   Phase 2   EUCTR2011-003409-36-BE   Australia;Belgium;Canada;Czech Republic;Germany;Hungary;Israel;New Zealand;Spain;United Kingdom;United States
      2011   -   EUCTR2011-000897-80-HU   Australia;Canada;Czech Republic;Germany;Hungary;Israel;New Zealand;Spain;United Kingdom;United States
      2011   -   EUCTR2011-000897-80-GB   Australia;Canada;Czech Republic;Germany;Hungary;Israel;New Zealand;Spain;United Kingdom;United States
      2011   -   EUCTR2011-000897-80-ES   Australia;Canada;Czech Republic;Germany;Hungary;Israel;New Zealand;Spain;United Kingdom;United States
      2011   -   EUCTR2011-000897-80-DE   Australia;Canada;Czech Republic;Germany;Hungary;Israel;New Zealand;Spain;United Kingdom;United States
      2011   -   EUCTR2011-000897-80-CZ   Australia;Canada;Czech Republic;Germany;Hungary;Israel;New Zealand;Spain;United Kingdom;United States
      2011   Phase 2   EUCTR2011-000897-80-BE   Australia;Belgium;Canada;Czech Republic;Germany;Hungary;Israel;New Zealand;Spain;United Kingdom;United States
Probiotic
   2nd Affiliated Hospital, Zhejiang University School of Medicine
      2024   -   ChiCTR2400089904   China
   Odense University Hospital
      2003   -   NCT00374725   Denmark
   Postgraduate Institute of Medical Education and Research
      2011   Phase 4   NCT01479660   India
   The Baruch Padeh Medical Center, Poriya
      2013   Phase 4   NCT01765998   Israel
   The First Affiliated Hospital of Nanchang University
      2023   Phase 0   ChiCTR2300073313   China
   The Second Affiliated hospital of Fujian Medical University
      2025   -   ChiCTR2500097078   China
   University College Dublin
      2023   -   NCT05906043   Ireland
   Wecare Probiotics Co., Ltd.
      2025   -   NCT06781827   China
   Xijing Hospital of Digestive Diseases
      2019   -   NCT04006977   China
Probiotic - VSL#3
   University of Alberta
      2003   Phase 3   NCT00175292   Canada
Probiotic formula capsule
   University of Jordan
      2020   Phase 2/Phase 3   NCT04223479   Jordan
Probiotic mixture
   Massachusetts General Hospital
      2017   -   NCT03266484   United States
Probiotics
   Affiliated Hospital of Inner Mongolia Medical University
      2017   -   ChiCTR-IPR-17010306   China
   Capital Medical University
      2020   Phase 0   ChiCTR2000032498   China
   The Baruch Padeh Medical Center, Poriya
      2012   Phase 4   NCT01078935   -
   The First Affiliated Hospital of Nanchang University
      2023   Phase 0   ChiCTR2300073313   China
   The First Affiliated Hospital of Xinxiang Medical College
      2022   -   NCT05652621   China
   The Second Affiliated hospital of Fujian Medical University
      2025   -   ChiCTR2500097078   China
   Tianjin Medical University General Hospital
      2019   Phase 0   ChiCTR1900022243   China
   UMC Utrecht
      2005   Phase 3   NCT00161148   Netherlands
Products containing aminosalicylate
   University of Nottingham
      2005   Phase 4   EUCTR2005-000695-40-GB   United Kingdom
Products containing azathioprine or 6-mercaptopurine
   University of Nottingham
      2005   Phase 4   EUCTR2005-000695-40-GB   United Kingdom
Prolife
   University of Padova
      2024   -   NCT06642883   Italy
Promiten
   PFIZER LIMITED
      2012   -   EUCTR2010-022766-27-IT   Belgium;Canada;Hungary;Italy;Sweden;United States
   Pfizer Limited, Ramsgate Road, Sandwich, Kent, CT13 9NJ, UK
      2012   -   EUCTR2010-022766-27-SK   Belgium;Canada;Hungary;Italy;Poland;Slovakia;Sweden;United States
      2012   -   EUCTR2010-022766-27-SE   Belgium;Canada;Germany;Hungary;Italy;Poland;Slovakia;Sweden;United States
      2012   -   EUCTR2010-022766-27-HU   Belgium;Canada;Germany;Hungary;Italy;Poland;Slovakia;Sweden;United States
      2012   -   EUCTR2010-022766-27-BE   Belgium;Canada;Germany;Hungary;Italy;Poland;Slovakia;Sweden;United States
Propionate
   The First Affiliated Hospital, College of Medicine, Zhejiang University
      2024   Phase 0   ChiCTR2400094060   China
Propionyl L-carnitine
   SIGMA-TAU
      2012   -   EUCTR2011-004765-32-IT   Belgium;Czech Republic;Italy;Netherlands
   Sigma-Tau Industrie Farmaceutiche Riunite S.p.A.
      2012   -   EUCTR2011-004770-28-PL   Austria;France;Germany;Hungary;Latvia;Lithuania;Poland;Spain
      2012   -   EUCTR2011-004770-28-LV   Austria;France;Germany;Hungary;Latvia;Lithuania;Poland;Spain
      2012   -   EUCTR2011-004770-28-LT   Austria;France;Germany;Hungary;Latvia;Lithuania;Poland;Spain
      2012   -   EUCTR2011-004770-28-HU   Austria;Germany;Hungary;Latvia;Lithuania;Poland;Spain
      2012   Phase 3   EUCTR2011-004770-28-ES   Austria;France;Germany;Hungary;Latvia;Lithuania;Poland;Spain
      2012   -   EUCTR2011-004770-28-DE   Austria;Germany;Hungary;Latvia;Lithuania;Poland;Spain
      2012   -   EUCTR2011-004770-28-AT   Austria;Germany;Hungary;Latvia;Lithuania;Poland;Spain
      2012   Phase 3   EUCTR2011-004765-32-SK   Belgium;Czech Republic;Italy;Netherlands;Slovakia
      2012   -   EUCTR2011-004765-32-CZ   Belgium;Czech Republic;Italy;Netherlands
      2012   Phase 3   EUCTR2011-004765-32-BE   Belgium;Czech Republic;Italy;Netherlands;Slovakia
Propionyl L-carnitine hydrochloride
   Sigma-Tau Industrie Farmaceutiche Riunite S.p.A.
      2012   Phase 3   EUCTR2011-004765-32-NL   Belgium;Czech Republic;Israel;Italy;Netherlands;Russian Federation;Slovakia
Propionyl-L-carnitine
   SIGMA-TAU
      2012   -   EUCTR2011-004765-32-IT   Belgium;Czech Republic;Italy;Netherlands
      2008   -   EUCTR2005-003471-20-LT   Italy;Lithuania
      2005   -   EUCTR2005-003471-20-IT   Italy;Lithuania
   Sigma-Tau Industrie Farmaceutiche Riunite S.p.A.
      2012   -   EUCTR2011-004770-28-PL   Austria;France;Germany;Hungary;Latvia;Lithuania;Poland;Spain
      2012   -   EUCTR2011-004770-28-LV   Austria;France;Germany;Hungary;Latvia;Lithuania;Poland;Spain
      2012   -   EUCTR2011-004770-28-LT   Austria;France;Germany;Hungary;Latvia;Lithuania;Poland;Spain
      2012   -   EUCTR2011-004770-28-HU   Austria;Germany;Hungary;Latvia;Lithuania;Poland;Spain
      2012   Phase 3   EUCTR2011-004770-28-ES   Austria;France;Germany;Hungary;Latvia;Lithuania;Poland;Spain
      2012   -   EUCTR2011-004770-28-DE   Austria;Germany;Hungary;Latvia;Lithuania;Poland;Spain
      2012   -   EUCTR2011-004770-28-AT   Austria;Germany;Hungary;Latvia;Lithuania;Poland;Spain
      2012   Phase 3   EUCTR2011-004765-32-SK   Belgium;Czech Republic;Italy;Netherlands;Slovakia
      2012   Phase 3   EUCTR2011-004765-32-NL   Belgium;Czech Republic;Israel;Italy;Netherlands;Russian Federation;Slovakia
      2012   -   EUCTR2011-004765-32-CZ   Belgium;Czech Republic;Italy;Netherlands
      2012   Phase 3   EUCTR2011-004765-32-BE   Belgium;Czech Republic;Italy;Netherlands;Slovakia
   sigma-tau i.f.r. S.p.A.
      2012   Phase 3   NCT01567956   Austria;France;Germany;Hungary;Latvia;Lithuania;Poland;Spain
      2012   Phase 3   NCT01538251   Belgium;Czech Republic;Israel;Italy;Netherlands;Romania;Russian Federation;Slovakia
      2006   Phase 2   NCT01026857   Italy;Lithuania;Poland;Russian Federation
Propionylcarnitinhydrochlorid
   Sigma-Tau Industrie Farmaceutiche Riunite S.p.A.
      2012   -   EUCTR2011-004770-28-DE   Austria;Germany;Hungary;Latvia;Lithuania;Poland;Spain
Propofol
   Copenhagen University Hospital at Herlev
      2014   Phase 4   NCT01934088   Denmark
Propofol B. braun
   Gastroenheden D, Herlev Hospital
      2013   -   EUCTR2013-002428-17-DK   Denmark
Protein hydrolysate
   Stanford University
      2023   Phase 1   NCT06116643   United States
PRV-300
   Provention Bio, Inc.
      2018   Phase 1   NCT03849599   Georgia;Moldova, Republic of;Ukraine
Psyllium husk powder
   Weill Medical College of Cornell University
      2020   Phase 2   NCT03998488   United States
PTG-100
   Protagonist Therapeutics, Inc
      2017   Phase 2   EUCTR2016-003452-75-PL   Belgium;Bosnia and Herzegovina;Croatia;Czech Republic;Germany;Greece;Hungary;Latvia;Netherlands;Poland;Russian Federation;Serbia;Slovenia;Ukraine;United Kingdom;United States
      2017   Phase 2   EUCTR2016-003452-75-NL   Belgium;Bosnia and Herzegovina;Croatia;Czech Republic;Germany;Greece;Hungary;Latvia;Netherlands;Poland;Russian Federation;Serbia;Slovenia;Ukraine;United Kingdom;United States
      2017   Phase 2   EUCTR2016-003452-75-LV   Belgium;Bosnia and Herzegovina;Croatia;Czech Republic;Germany;Greece;Hungary;Latvia;Netherlands;Poland;Russian Federation;Serbia;Slovenia;Ukraine;United Kingdom;United States
      2017   Phase 2   EUCTR2016-003452-75-HU   Belgium;Bosnia and Herzegovina;Croatia;Czech Republic;Germany;Greece;Hungary;Latvia;Netherlands;Poland;Russian Federation;Serbia;Slovenia;Ukraine;United Kingdom;United States
      2017   Phase 2   EUCTR2016-003452-75-HR   Belgium;Bosnia and Herzegovina;Croatia;Czech Republic;Germany;Greece;Hungary;Latvia;Netherlands;Poland;Russian Federation;Serbia;Slovenia;Ukraine;United Kingdom;United States
      2017   Phase 2   EUCTR2016-003452-75-CZ   Belgium;Bosnia and Herzegovina;Croatia;Czech Republic;Germany;Greece;Hungary;Latvia;Netherlands;Poland;Russian Federation;Serbia;Slovenia;Ukraine;United Kingdom;United States
      2017   Phase 2   EUCTR2016-003452-75-BE   Belgium;Bosnia and Herzegovina;Croatia;Czech Republic;Germany;Greece;Hungary;Latvia;Netherlands;Poland;Russian Federation;Serbia;Slovenia;Ukraine;United Kingdom;United States
   Protagonist Therapeutics, Inc.
      2016   Phase 2   NCT02895100   Australia;Belgium;Bosnia and Herzegovina;Canada;Croatia;Czechia;Germany;Hungary;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Russian Federation;Serbia;Ukraine;United States
PUR 0110
   PurGenesis Techonologies Inc.
      2010   -   EUCTR2009-017839-18-DE   Germany
PUR 0110 rectal enema
   PurGenesis Technologies Inc.
      2009   Phase 1   NCT01149694   Germany
PUR 0110 rectal enema 1000 MG
   PurGenesis Technologies Inc.
      2010   Phase 2   NCT01149707   Germany
PUR 0110 rectal enema 250 MG
   PurGenesis Technologies Inc.
      2010   Phase 2   NCT01149707   Germany
PUR 0110 rectal enema 500 MG
   PurGenesis Technologies Inc.
      2010   Phase 2   NCT01149707   Germany
Pure give pectin 20G/D FOR five days
   Jinling Hospital, China
      2013   -   NCT02016469   China
Puri nethol
   Amsterdam UMC location AMC
      2021   Phase 3;Phase 4   EUCTR2021-000469-33-NL   Netherlands
PURI-nethol
   Academic Medical Centre
      2016   Phase 3   EUCTR2015-005260-41-NL   Netherlands
   Region Örebro län
      2021   Phase 4   EUCTR2019-002942-19-NO   Denmark;Iceland;Norway
      2021   Phase 4   EUCTR2019-002942-19-IS   Denmark;Iceland
      2021   Phase 4   EUCTR2019-002942-19-DK   Denmark;Iceland
   UMC Amsterdam location AMC
      2021   Phase 4   EUCTR2018-003524-36-NO   France;Ireland;Netherlands;Norway;United Kingdom
      2020   Phase 4   EUCTR2018-003524-36-IE   Ireland;Netherlands;Norway
      2019   Phase 4   EUCTR2018-003524-36-NL   Ireland;Netherlands;Norway
Qbeco
   Qu Biologics Inc.
      2013   Phase 1/Phase 2   NCT01809275   Canada
Qbeco SSI
   Qu Biologics Inc.
      2015   Phase 2   NCT02426372   Canada
Quadrivalent HPV vaccine
   The University of New South Wales
      2007   Phase 3   NCT02263703   Australia
Questionnaire administration
   Northwestern University
      2021   Phase 2   NCT04767984   United States
R-3750
   Rise Therapeutics LLC
      2023   Phase 1   NCT05666960   United States
Ramosetron
   Hyogo College of Medicine
      2016   -   JPRN-UMIN000023399   Japan
Randomized B-fructan diet
   University of Manitoba
      2023   -   NCT05615779   Canada
Ranolazine
   Vanderbilt University Medical Center
      2022   Phase 2   NCT04456517   United States
Ravagalimab
   ABBVIE DEUTSCHLAND GMBH & CO. KG
      2019   Phase 2   EUCTR2018-000930-37-IT   Canada;France;Germany;Hungary;Italy;Korea, Republic of;Netherlands;Spain;United Kingdom;United States
   AbbVie Deutschland GmbH & Co. KG
      2020   Phase 2   EUCTR2018-000930-37-HU   Canada;France;Germany;Hungary;Italy;Korea, Republic of;Netherlands;Spain;United Kingdom;United States
      2019   Phase 2   EUCTR2018-000930-37-GB   Canada;France;Germany;Hungary;Italy;Korea, Republic of;Netherlands;Spain;United Kingdom;United States
      2019   Phase 2   EUCTR2018-000930-37-ES   Canada;France;Germany;Hungary;Italy;Netherlands;Spain;United Kingdom;United States
      2019   Phase 2   EUCTR2018-000930-37-DE   Canada;France;Germany;Hungary;Italy;Korea, Republic of;Netherlands;Spain;United Kingdom;United States
      2018   Phase 2   EUCTR2018-000930-37-NL   Canada;France;Germany;Hungary;Italy;Korea, Republic of;Netherlands;Spain;United Kingdom;United States
RCTB-401
   SBL Vaccin AB
      2005   -   EUCTR2005-002048-25-SE   Sweden
RDP58
   Procter & Gamble Pharmaceuticals
      2005   Phase 2   EUCTR2004-004077-29-SK   Czech Republic;Germany;Lithuania;Slovakia;United Kingdom
      2005   -   EUCTR2004-004077-29-LT   Czech Republic;Germany;Lithuania;United Kingdom
      2005   -   EUCTR2004-004077-29-DE   Czech Republic;Germany;Lithuania;United Kingdom
      2005   -   EUCTR2004-004077-29-CZ   Czech Republic;Germany;Lithuania;United Kingdom
   Procter & Gamble Technical Centres Ltd
      2005   -   EUCTR2004-004077-29-GB   Czech Republic;Germany;Lithuania;United Kingdom
Rebamipide
   Otsuka Pharmaceutical Co., Ltd.
      2007   Phase 2   NCT00463151   Japan
      2007   Phase 2   JPRN-jRCT2080220390   Japan
Rectal dialysis
   NorthShore University HealthSystem
      2012   Phase 2   NCT04032652   -
Rectal tacrolimus
   The University of Western Australia
      2012   Phase 4   NCT01418131   Australia
Rectosigmoidoscopy
   Centre Hospitalier Universitaire de Saint Etienne
      2017   Phase 2   NCT03182166   France
      2017   -   NCT03172195   France
Regular treatment
   Xijing Hospital of Digestive Diseases
      2016   Phase 4   NCT02962245   -
Regulatory T cells
   University of Erlangen-Nürnberg Medical School
      2021   Phase 1   NCT04691232   Germany
Remestemcel-L
   The Cleveland Clinic
      2020   Phase 1/Phase 2   NCT04543994   United States
Remicade
   CENTOCOR
      2007   -   EUCTR2006-000410-20-IT   Belgium;Denmark;Italy;Netherlands
   COSMO TECHNOLOGIES LTD
      2008   -   EUCTR2007-007702-30-IT   Italy
   CUB- Hopital Erasme
      2016   Phase 4   EUCTR2015-004618-10-BE   Belgium
   Centocor BV
      2007   -   EUCTR2006-000410-20-NL   Belgium;Denmark;Italy;Netherlands
      2007   -   EUCTR2006-000410-20-DK   Belgium;Denmark;Italy;Netherlands
      2007   -   EUCTR2006-000410-20-BE   Belgium;Denmark;Italy;Netherlands
   Centre Hospitalier Universitaire de Rennes
      2018   Phase 4   EUCTR2018-002673-21-FR   France
   Essex Pharma GmbH
      2009   -   EUCTR2009-010065-23-DE   Germany
   F. Hoffmann-La Roche Ltd
      2015   Phase 3   EUCTR2013-004282-14-PT   Austria;Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;Norway;Philippines;Portugal;Romania;Singapore;South Africa;Spain;Sweden;Switzerland;United Kingdom;Vietnam
      2015   Phase 3   EUCTR2013-004282-14-NL   Austria;Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;Norway;Philippines;Portugal;Romania;Singapore;South Africa;Spain;Sweden;Switzerland;United Kingdom;Vietnam
      2014   Phase 3   EUCTR2013-004282-14-NO   Austria;Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;Norway;Philippines;Portugal;Romania;Singapore;South Africa;Spain;Sweden;Switzerland;United Kingdom;Vietnam
      2014   -   EUCTR2013-004282-14-IT   Austria;Belgium;Canada;Czech Republic;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;Norway;Philippines;Portugal;Romania;Singapore;South Africa;Spain;Sweden;Switzerland;United Kingdom;Vietnam
      2014   Phase 3   EUCTR2013-004282-14-HU   Austria;Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;Norway;Portugal;Romania;Singapore;South Africa;Spain;Sweden;Switzerland;United Kingdom
      2014   Phase 3   EUCTR2013-004282-14-GB   Austria;Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;Norway;Portugal;Romania;Singapore;South Africa;Spain;Sweden;Switzerland;United Kingdom
      2014   Phase 3   EUCTR2013-004282-14-FR   Austria;Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;Norway;Philippines;Portugal;Romania;Singapore;South Africa;Spain;Sweden;Switzerland;United Kingdom;Vietnam
      2014   Phase 3   EUCTR2013-004282-14-DE   Austria;Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;Norway;Portugal;Romania;Singapore;South Africa;Spain;Sweden;Switzerland;United Kingdom
      2014   Phase 3   EUCTR2013-004282-14-CZ   Austria;Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;Norway;Portugal;Romania;Singapore;South Africa;Spain;Sweden;Switzerland;United Kingdom
      2014   Phase 3   EUCTR2013-004282-14-BE   Austria;Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;Norway;Portugal;Romania;Singapore;South Africa;Spain;Sweden;Switzerland;United Kingdom
      2014   Phase 3   EUCTR2013-004282-14-AT   Austria;Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;Norway;Portugal;Romania;Singapore;South Africa;Spain;Sweden;Switzerland;United Kingdom
   GEDII - Grupo de Estudo da Doença inflamatória Intestinal
      2010   -   EUCTR2009-013890-16-PT   Portugal
   GETAID
      2008   -   EUCTR2006-005299-42-BE   Belgium;Finland;France;Spain
      2007   -   EUCTR2006-005299-42-FR   Belgium;Finland;France;Spain
   GETECCU (Grupo Español para el estudio de la enfermedad de Crohn y la colitis ulcerosa)
      2008   -   EUCTR2006-005299-42-ES   Belgium;Finland;France;Spain
   Hospira UK Ltd.
      2015   Phase 4   EUCTR2014-005192-89-FI   Belgium;Czech Republic;Finland;France;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovakia;Spain;United Kingdom
   Janssen Biologics B.V.
      2019   Phase 3   EUCTR2017-004496-31-IT   Belgium;Brazil;France;Israel;Italy;Korea, Republic of;Netherlands;Poland;Spain;Taiwan;United States
      2009   -   EUCTR2008-005237-30-NL   Canada;Netherlands;Sweden;United States
   Janssen Biologics BV
      2019   Phase 3   EUCTR2017-004496-31-PL   Belgium;Brazil;France;Israel;Italy;Korea, Republic of;Netherlands;Poland;Spain;Taiwan;United States
      2019   Phase 3   EUCTR2017-004496-31-NL   Belgium;Brazil;France;Israel;Italy;Korea, Republic of;Netherlands;Poland;Spain;Taiwan;United States
      2018   Phase 3   EUCTR2017-004496-31-FR   Belgium;Brazil;France;Israel;Italy;Korea, Republic of;Netherlands;Poland;Spain;Taiwan;United States
      2018   Phase 3   EUCTR2017-004496-31-ES   Belgium;Brazil;France;Israel;Italy;Korea, Republic of;Netherlands;Poland;Spain;Taiwan;United States
      2018   Phase 3   EUCTR2017-004496-31-BE   Belgium;Brazil;France;Israel;Italy;Korea, Republic of;Netherlands;Poland;Spain;Taiwan;United States
   Katholieke Universiteit Leuven
      2011   Phase 4   EUCTR2011-002061-38-BE   Belgium
   Pfizer
      2015   -   NCT02539368   Belgium;Czech Republic;Czechia;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;United Kingdom
   Region Örebro län
      2021   Phase 4   EUCTR2019-002942-19-NO   Denmark;Iceland;Norway
      2021   Phase 4   EUCTR2019-002942-19-IS   Denmark;Iceland
      2021   Phase 4   EUCTR2019-002942-19-DK   Denmark;Iceland
   Roche Farma S.A. en nombre de F. Hoffmann-La Roche Ltd
      2014   Phase 3   EUCTR2013-004282-14-ES   Austria;Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;Norway;Philippines;Portugal;Romania;Singapore;South Africa;Spain;Sweden;Switzerland;United Kingdom;Vietnam
   Royal Liverpool University Hospital
      2012   -   EUCTR2011-006084-22-GB   United Kingdom
   SCHERING-PLOUGH
      2007   -   EUCTR2006-002670-22-IT   Belgium;Czech Republic;France;Germany;Hungary;Italy;Portugal;Spain;United Kingdom
   Schering-Plough Research Institute, a division of Schering Corporation
      2008   Phase 3   EUCTR2006-002670-22-SK   Belgium;Czech Republic;France;Germany;Hungary;Italy;Portugal;Slovakia;Spain;United Kingdom
      2008   Phase 3   EUCTR2006-002670-22-GB   Belgium;Czech Republic;France;Germany;Hungary;Italy;Portugal;Slovakia;Spain;United Kingdom
      2007   -   EUCTR2006-002670-22-PT   Belgium;Czech Republic;France;Germany;Hungary;Italy;Portugal;Spain;United Kingdom
      2007   -   EUCTR2006-002670-22-HU   Belgium;Czech Republic;France;Germany;Hungary;Italy;Portugal;Spain;United Kingdom
      2007   Phase 3   EUCTR2006-002670-22-FR   Belgium;Czech Republic;France;Germany;Hungary;Italy;Portugal;Slovakia;Spain;United Kingdom
      2007   Phase 3   EUCTR2006-002670-22-ES   Belgium;Czech Republic;France;Germany;Hungary;Italy;Portugal;Slovakia;Spain;United Kingdom
      2007   -   EUCTR2006-002670-22-DE   Belgium;Czech Republic;France;Germany;Hungary;Italy;Portugal;Spain;United Kingdom
      2007   -   EUCTR2006-002670-22-CZ   Belgium;Czech Republic;France;Germany;Hungary;Italy;Portugal;Spain;United Kingdom
      2007   Phase 3   EUCTR2006-002670-22-BE   Belgium;Czech Republic;France;Germany;Hungary;Italy;Portugal;Slovakia;Spain;United Kingdom
   Swansea University
      2008   Phase 3   EUCTR2008-001968-36-GB   United Kingdom
   UMC Amsterdam location AMC
      2021   Phase 4   EUCTR2018-003524-36-NO   France;Ireland;Netherlands;Norway;United Kingdom
      2020   Phase 4   EUCTR2018-003524-36-IE   Ireland;Netherlands;Norway
      2019   Phase 4   EUCTR2018-003524-36-NL   Ireland;Netherlands;Norway
   University Medical Center Groningen
      2021   Phase 4   EUCTR2020-001811-26-BE   Belgium;Netherlands;Spain
      2020   Phase 4   EUCTR2020-001811-26-NL   Belgium;Netherlands;Spain
   University of Leuven Hospitals, Division of Gastroenterology
      2009   Phase 4   EUCTR2008-007519-34-SE   Sweden
   Universitätsklinik für Innere Medizin III, Klinische Abteilung für Gastroenterologie und Hepatologie
      2013   -   EUCTR2011-001332-29-AT   Austria
   Zon MW
      2014   Phase 4   EUCTR2013-002651-15-NL   Netherlands
Remicade 100 MG
   Santeon
      2015   Phase 4   EUCTR2015-001954-14-NL   Netherlands
Remicade 100 MG infuusiokuiva-aine, konsentraattiliuosta varten
   Groupe d'Etude Thérapeutique des Affections Inflammatoires Digestives (G.E.T.A.I.D.)
      2008   -   EUCTR2006-005299-42-FI   Belgium;Finland;France;Spain
Remicade 100 MG pulver TIL konsentrat TIL infusjonsvæSKE, oppløsning
   Diakonhjemmet Hospital AS
      2014   Phase 4   EUCTR2014-002056-40-NO   Norway
Remsima
   Amsterdam UMC location AMC
      2021   Phase 3;Phase 4   EUCTR2021-000469-33-NL   Netherlands
   CELLTRION INC.
      2020   Phase 3   EUCTR2019-003849-15-IT   Austria;Belarus;Brazil;Bulgaria;Chile;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Latvia;Mexico;Moldova, Republic of;Peru;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Turkey;Ukraine;United States
   CUB- Hopital Erasme
      2016   Phase 4   EUCTR2015-004618-10-BE   Belgium
   Celltrion, Inc.
      2020   Phase 3   EUCTR2019-003849-15-PL   Austria;Belarus;Bulgaria;Croatia;Czech Republic;Czechia;France;Greece;Israel;Italy;Latvia;Mexico;Moldova, Republic of;Peru;Poland;Russian Federation;Serbia;South Africa;Spain;Turkey;Ukraine
      2020   Phase 3   EUCTR2019-003849-15-HR   Austria;Belarus;Brazil;Bulgaria;Chile;Croatia;Czechia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Latvia;Mexico;Moldova, Republic of;Peru;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Turkey;Ukraine;United States
      2020   Phase 3   EUCTR2019-003849-15-GR   Austria;Belarus;Brazil;Bulgaria;Chile;Croatia;Czech Republic;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Latvia;Mexico;Moldova, Republic of;Peru;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Turkey;Ukraine;United States
      2020   Phase 3   EUCTR2019-003849-15-FR   Austria;Belarus;Brazil;Bulgaria;Chile;Croatia;Czech Republic;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Latvia;Mexico;Moldova, Republic of;Peru;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Turkey;Ukraine;United States
      2020   Phase 3   EUCTR2019-003849-15-ES   Austria;Belarus;Brazil;Bulgaria;Chile;Croatia;Czech Republic;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Latvia;Mexico;Moldova, Republic of;Peru;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Turkey;Ukraine;United States
      2020   Phase 3   EUCTR2019-003849-15-CZ   Austria;Belarus;Bulgaria;Croatia;Czech Republic;Czechia;France;Greece;Israel;Italy;Latvia;Mexico;Moldova, Republic of;Peru;Poland;Russian Federation;Serbia;South Africa;Spain;Turkey;Ukraine
      2020   Phase 3   EUCTR2019-003849-15-BG   Austria;Belarus;Bulgaria;Croatia;Czech Republic;Czechia;France;Greece;Israel;Italy;Latvia;Mexico;Moldova, Republic of;Peru;Poland;Russian Federation;Serbia;South Africa;Spain;Turkey;Ukraine
      2020   Phase 3   EUCTR2019-003849-15-AT   Austria;Belarus;Brazil;Bulgaria;Chile;Croatia;Czech Republic;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Latvia;Mexico;Moldova, Republic of;Peru;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Turkey;Ukraine;United States
   Centre Hospitalier Universitaire de Rennes
      2018   Phase 4   EUCTR2018-002673-21-FR   France
   Helse More og Romsdal Hospital Trust
      2016   Phase 4   EUCTR2016-001409-18-NO   Norway
   IRCCS ISTITUTO CLINICO HUMANITAS
      2017   Phase 4   EUCTR2016-002707-25-IT   Italy
   Marta Maia Boscá Watts
      2019   Phase 2   EUCTR2019-000668-27-ES   Spain
   Mundipharma Pharmaceuticals B.V.
      2016   Phase 4   EUCTR2014-004904-31-BE   Belgium;Netherlands
      2015   Phase 4   EUCTR2014-004904-31-NL   Netherlands
   Taina Sipponen
      2016   Phase 4   EUCTR2016-001278-13-FI   Finland
   UMC Amsterdam location AMC
      2021   Phase 4   EUCTR2018-003524-36-NO   France;Ireland;Netherlands;Norway;United Kingdom
      2020   Phase 4   EUCTR2018-003524-36-IE   Ireland;Netherlands;Norway
   UNIVERSITÀ CATTOLICA DEL SACRO CUORE- POLICLINICO A. GEMELLI
      2016   Phase 4   EUCTR2016-002061-54-IT   Italy
   University Medical Center Groningen
      2021   Phase 4   EUCTR2020-001811-26-BE   Belgium;Netherlands;Spain
      2020   Phase 4   EUCTR2020-001811-26-NL   Belgium;Netherlands;Spain
Remsima 100 MG pulver TIL konsentrat TIL infusjonsvæSKE, oppløsning
   Diakonhjemmet Hospital AS
      2014   Phase 4   EUCTR2014-002056-40-NO   Norway
Remsima and inflectra
   Janssen Biologics B.V.
      2009   -   EUCTR2008-005237-30-NL   Canada;Netherlands;Sweden;United States
Resveratrol supplementation
   Ardahan University
      2022   -   NCT05761327   Turkey
Retarded release phosphatidylcholine
   Heidelberg University
      2003   Phase 2/Phase 3   NCT00259571   Germany
      2003   Phase 2   NCT00259558   Germany
      2003   Phase 2   NCT00259545   Germany
      2000   -   NCT00463619   Germany
RHIL-11
   Wyeth is now a wholly owned subsidiary of Pfizer
      2002   Phase 2   NCT00040521   United States
      1994   Phase 1   NCT00038922   United States
Rhumab BETA7
   F. Hoffmann-La Roche Ltd
      2020   Phase 3   EUCTR2019-004652-11-SI   Argentina;Austria;Belgium;Brazil;Canada;Czech Republic;France;Germany;Hungary;Ireland;Israel;Italy;Latvia;Netherlands;Poland;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
   Genentech, Inc.
      2012   Phase 2   EUCTR2011-003409-36-DE   Australia;Belgium;Canada;Czech Republic;Germany;Hungary;Israel;New Zealand;Spain;United Kingdom;United States
      2012   Phase 2   EUCTR2011-003409-36-CZ   Australia;Belgium;Canada;Czech Republic;Germany;Hungary;Israel;New Zealand;Spain;United Kingdom;United States
      2011   Phase 2   NCT01336465   Australia;Belgium;Canada;Czech Republic;Germany;Hungary;Israel;New Zealand;Spain;United Kingdom;United States
      2011   Phase 2   EUCTR2011-003409-36-GB   Australia;Belgium;Canada;Czech Republic;Germany;Hungary;Israel;New Zealand;Spain;United Kingdom;United States
      2011   Phase 2   EUCTR2011-003409-36-ES   Australia;Belgium;Canada;Czech Republic;Germany;Hungary;Israel;New Zealand;Spain;United Kingdom;United States
      2011   Phase 2   EUCTR2011-003409-36-BE   Australia;Belgium;Canada;Czech Republic;Germany;Hungary;Israel;New Zealand;Spain;United Kingdom;United States
      2011   -   EUCTR2011-000897-80-HU   Australia;Canada;Czech Republic;Germany;Hungary;Israel;New Zealand;Spain;United Kingdom;United States
      2011   -   EUCTR2011-000897-80-GB   Australia;Canada;Czech Republic;Germany;Hungary;Israel;New Zealand;Spain;United Kingdom;United States
      2011   -   EUCTR2011-000897-80-ES   Australia;Canada;Czech Republic;Germany;Hungary;Israel;New Zealand;Spain;United Kingdom;United States
      2011   -   EUCTR2011-000897-80-DE   Australia;Canada;Czech Republic;Germany;Hungary;Israel;New Zealand;Spain;United Kingdom;United States
      2011   -   EUCTR2011-000897-80-CZ   Australia;Canada;Czech Republic;Germany;Hungary;Israel;New Zealand;Spain;United Kingdom;United States
      2011   Phase 2   EUCTR2011-000897-80-BE   Australia;Belgium;Canada;Czech Republic;Germany;Hungary;Israel;New Zealand;Spain;United Kingdom;United States
      2008   Phase 1   NCT00694980   Belgium;Canada;Germany;Netherlands;United Kingdom;United States
Rhumab BETA7, anti beta 7, PRO145223
   F. Hoffmann-La Roche Ltd
      2014   Phase 3   EUCTR2013-004278-88-NL   Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Spain;Switzerland;United Kingdom;United States
Rhumab BETA7, anti BETA7, PRO145223
   F. Hoffmann-La Roche Ltd
      2017   Phase 3   EUCTR2013-004278-88-PL   Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Spain;Switzerland;United Kingdom;United States
      2015   Phase 3   EUCTR2013-004435-72-BG   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Germany;Greece;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Philippines;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States;Vietnam
      2014   Phase 3   EUCTR2013-004435-72-SK   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Germany;Greece;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Philippines;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States;Vietnam
      2014   Phase 3   EUCTR2013-004435-72-NO   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Philippines;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States;Vietnam
      2014   Phase 3   EUCTR2013-004435-72-LV   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Philippines;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States;Vietnam
      2014   Phase 3   EUCTR2013-004435-72-LT   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Philippines;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States;Vietnam
      2014   Phase 3   EUCTR2013-004435-72-HU   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Philippines;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States;Vietnam
      2014   Phase 3   EUCTR2013-004435-72-GB   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Philippines;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States;Vietnam
      2014   Phase 3   EUCTR2013-004435-72-DK   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Germany;Greece;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Philippines;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States;Vietnam
      2014   Phase 3   EUCTR2013-004435-72-CZ   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Germany;Greece;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Philippines;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States;Viet Nam
      2014   Phase 3   EUCTR2013-004435-72-BE   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Philippines;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States;Vietnam
      2014   Phase 3   EUCTR2013-004278-88-LT   Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Spain;Switzerland;United Kingdom;United States
      2014   Phase 3   EUCTR2013-004278-88-HU   Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Spain;Switzerland;United Kingdom;United States
      2014   Phase 3   EUCTR2013-004278-88-DK   Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Spain;Switzerland;United Kingdom;United States
      2014   Phase 3   EUCTR2013-004278-88-DE   Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Spain;Switzerland;United Kingdom;United States
      2014   Phase 3   EUCTR2013-004278-88-CZ   Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Spain;Switzerland;United Kingdom;United States
      2014   Phase 3   EUCTR2013-004278-88-BE   Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Spain;Switzerland;United Kingdom;United States
      2014   Phase 3   EUCTR2013-004278-88-AT   Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Spain;Switzerland;United Kingdom;United States
Riboflavin
   Novartis Pharma Services AG
      2007   Phase 2   EUCTR2007-002542-38-DK   Denmark;Germany
      2007   -   EUCTR2007-002542-38-DE   Denmark;Germany
Rifampicin
   Takeuchi Yutaka
      2017   Phase 1   JPRN-jRCT2071230024   -
Rifaximin
   University of Dundee
      2006   -   NCT00355602   United Kingdom
Risankizumab
   ABBVIE DEUTSCHLAND GMBH & CO. KG
      2018   Phase 3   EUCTR2016-004676-22-IT   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czechia;Denmark;Egypt;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      -   Phase 2;Phase 3   EUCTR2016-004677-40-IT   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czechia;Denmark;Egypt;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
   AbbVie
      2025   Phase 3   NCT06880744   -
      2024   Phase 4   NCT06346288   Israel;United States
      2020   Phase 1   NCT04254783   Germany;Israel;United States
      2019   -   NCT03914261   Belgium;Israel;Spain;Switzerland;United States
      2018   Phase 3   NCT03398135   American Samoa;Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czechia;Denmark;Egypt;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
   AbbVie Deutschland GmbH & Co. KG
      2021   Phase 2;Phase 3   EUCTR2016-004677-40-FR   Argentina;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czechia;Denmark;Egypt;France;Germany;Greece;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2021   Phase 3   EUCTR2016-004676-22-FR   Argentina;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czechia;Denmark;Egypt;France;Germany;Greece;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 2;Phase 3   EUCTR2016-004677-40-SI   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czechia;Denmark;Egypt;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 2;Phase 3   EUCTR2016-004677-40-HR   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 2;Phase 3   EUCTR2016-004677-40-BG   Argentina;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czechia;Denmark;Egypt;France;Germany;Greece;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2016-004676-22-SI   Argentina;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czechia;Denmark;Egypt;France;Germany;Greece;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Türkiye;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2016-004676-22-RO   Argentina;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czechia;Denmark;Egypt;France;Germany;Greece;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Türkiye;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2016-004676-22-HR   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2016-004676-22-DE   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czechia;Denmark;Egypt;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Türkiye;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2016-004676-22-BG   Argentina;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czechia;Denmark;Egypt;France;Germany;Greece;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2016-004676-22-BE   Argentina;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czechia;Denmark;Egypt;France;Germany;Greece;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 2;Phase 3   EUCTR2016-004677-40-SK   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czechia;Denmark;Egypt;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 2;Phase 3   EUCTR2016-004677-40-SE   Argentina;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czechia;Denmark;Egypt;France;Germany;Greece;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 2;Phase 3   EUCTR2016-004677-40-PT   Argentina;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czechia;Denmark;Egypt;France;Germany;Greece;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 2;Phase 3   EUCTR2016-004677-40-NL   Argentina;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;France;Germany;Greece;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 2;Phase 3   EUCTR2016-004677-40-LV   Argentina;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czechia;Denmark;Egypt;France;Germany;Greece;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 2;Phase 3   EUCTR2016-004677-40-LT   Argentina;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czechia;Denmark;Egypt;France;Germany;Greece;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 2;Phase 3   EUCTR2016-004677-40-GR   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 2;Phase 3   EUCTR2016-004677-40-ES   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 2;Phase 3   EUCTR2016-004677-40-DK   Argentina;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czechia;Denmark;Egypt;France;Germany;Greece;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 2;Phase 3   EUCTR2016-004677-40-DE   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czechia;Denmark;Egypt;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 2;Phase 3   EUCTR2016-004677-40-BE   Argentina;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;France;Germany;Greece;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 2;Phase 3   EUCTR2016-004677-40-AT   Argentina;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czechia;Denmark;Egypt;France;Germany;Greece;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2016-004676-22-SK   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czechia;Denmark;Egypt;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Türkiye;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2016-004676-22-SE   Argentina;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czechia;Denmark;Egypt;France;Germany;Greece;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2016-004676-22-PT   Argentina;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czechia;Denmark;Egypt;France;Germany;Greece;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2016-004676-22-NL   Argentina;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czechia;Denmark;Egypt;France;Germany;Greece;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Türkiye;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2016-004676-22-LV   Argentina;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czechia;Denmark;Egypt;France;Germany;Greece;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2016-004676-22-GR   Argentina;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czechia;Denmark;Egypt;France;Germany;Greece;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2016-004676-22-GB   Argentina;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czechia;Denmark;Egypt;France;Germany;Greece;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2016-004676-22-ES   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2016-004676-22-DK   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2016-004676-22-AT   Argentina;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czechia;Denmark;Egypt;France;Germany;Greece;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Türkiye;Ukraine;United Kingdom;United States
      -   Phase 2;Phase 3   EUCTR2016-004677-40-PL   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      -   Phase 2;Phase 3   EUCTR2016-004677-40-GB   Argentina;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czechia;Denmark;Egypt;France;Germany;Greece;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      -   Phase 2;Phase 3   EUCTR2016-004677-40-CZ   Argentina;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;France;Germany;Greece;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      -   Phase 3   EUCTR2016-004676-22-PL   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czechia;Denmark;Egypt;France;Germany;Greece;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Türkiye;Ukraine;United Kingdom;United States
      -   Phase 3   EUCTR2016-004676-22-CZ   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
   AbbVie GK
      2018   Phase 3   JPRN-jRCT2080223951   Africa;Asia except Japan;Europe;Japan;North America;Oceania;South America
      2018   Phase 2-3   JPRN-jRCT2080223940   Africa;Asia except Japan;Europe;Japan;North America;Oceania;South America
Risankizumab IV
   AbbVie
      2018   Phase 2/Phase 3   NCT03398148   American Samoa;Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czechia;Denmark;Egypt;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
Risankizumab SC
   AbbVie
      2018   Phase 2/Phase 3   NCT03398148   American Samoa;Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czechia;Denmark;Egypt;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
Risankizumab-800CW 15 MG
   University Medical Center Groningen
      2024   Phase 1/Phase 2   NCT06606808   Netherlands
Risankizumab-800CW 25 MG
   University Medical Center Groningen
      2024   Phase 1/Phase 2   NCT06606808   Netherlands
Risankizumab-800CW 4.5 MG
   University Medical Center Groningen
      2024   Phase 1/Phase 2   NCT06606808   Netherlands
Risankizumab-800CW optimal dose
   University Medical Center Groningen
      2024   Phase 1/Phase 2   NCT06606808   Netherlands
Ritlecitinib
   Pfizer Inc.
      2022   Phase 3   EUCTR2021-003702-42-ES   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Czechia;Denmark;France;Germany;Greece;India;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Norway;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
Ritlecitinib 10 MG
   Pfizer Inc.
      2017   Phase 2   EUCTR2016-003708-29-SK   Austria;Bulgaria;Canada;Denmark;Georgia;Germany;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United States
   Pfizer Inc., 235 East 42nd Street, New York, NY 10017
      2018   Phase 2   EUCTR2016-003708-29-BG   Austria;Bulgaria;Canada;Czechia;Denmark;Georgia;Germany;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United States
      2017   Phase 2   EUCTR2016-003708-29-PL   Austria;Bulgaria;Canada;Czechia;Denmark;Georgia;Germany;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United States
      2017   Phase 2   EUCTR2016-003708-29-DK   Austria;Bulgaria;Canada;Czechia;Denmark;Georgia;Germany;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United States
      2017   Phase 2   EUCTR2016-003708-29-DE   Austria;Bulgaria;Canada;Czechia;Denmark;Georgia;Germany;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United States
Ritlecitinib 5 MG
   Pfizer Inc., 235 East 42nd Street, New York, NY 10017
      2018   Phase 2   EUCTR2016-003708-29-BG   Austria;Bulgaria;Canada;Czechia;Denmark;Georgia;Germany;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United States
Ritlecitinib 50 MG
   Pfizer Inc.
      2017   Phase 2   EUCTR2016-003708-29-SK   Austria;Bulgaria;Canada;Denmark;Georgia;Germany;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United States
   Pfizer Inc., 235 East 42nd Street, New York, NY 10017
      2018   Phase 2   EUCTR2016-003708-29-BG   Austria;Bulgaria;Canada;Czechia;Denmark;Georgia;Germany;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United States
      2017   Phase 2   EUCTR2016-003708-29-PL   Austria;Bulgaria;Canada;Czechia;Denmark;Georgia;Germany;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United States
      2017   Phase 2   EUCTR2016-003708-29-DK   Austria;Bulgaria;Canada;Czechia;Denmark;Georgia;Germany;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United States
      2017   Phase 2   EUCTR2016-003708-29-DE   Austria;Bulgaria;Canada;Czechia;Denmark;Georgia;Germany;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United States
Rituximab
   Royal Liverpool University Hospital
      2004   Phase 2/Phase 3   NCT00261118   United Kingdom
Rivenprost
   Kyoto University, Graduate School of Medicine
      2006   Phase 2   NCT00296556   Japan
RNA analysis
   Connecticut Children's Medical Center
      2015   -   NCT02984059   United States
RO 549-0261/F04
   F. Hoffmann-La Roche Ltd
      2019   Phase 3   EUCTR2013-004279-11-FR   Argentina;Australia;Brazil;Bulgaria;Estonia;France;Hong Kong;Mexico;Poland;Russian Federation;Serbia;Slovakia;Ukraine;United States
      2019   Phase 3   EUCTR2013-004277-27-HU   Argentina;Australia;Brazil;Bulgaria;Colombia;Croatia;Czech Republic;Greece;Hungary;Latvia;Lithuania;Malaysia;New Zealand;Poland;Russian Federation;Turkey;Ukraine;United States
      2019   Phase 3   EUCTR2013-004277-27-CZ   Argentina;Australia;Brazil;Bulgaria;Colombia;Croatia;Czech Republic;Greece;Hungary;Latvia;Lithuania;Malaysia;New Zealand;Poland;Russian Federation;Turkey;Ukraine;United States
      2017   Phase 3   EUCTR2013-004278-88-PL   Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Spain;Switzerland;United Kingdom;United States
      2016   Phase 3   EUCTR2013-004280-31-SK   Brazil;Canada;Czech Republic;Denmark;Germany;Hungary;Israel;Italy;Mexico;Poland;Slovakia;South Africa;Ukraine;United States
      2016   Phase 3   EUCTR2013-004280-31-PL   Brazil;Canada;Czech Republic;Denmark;Germany;Hungary;Israel;Italy;Mexico;Poland;Slovakia;South Africa;Ukraine;United States
      2015   Phase 3   EUCTR2013-004435-72-PT   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Philippines;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States;Vietnam
      2015   Phase 3   EUCTR2013-004435-72-NL   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Germany;Greece;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Philippines;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States;Viet Nam
      2015   Phase 3   EUCTR2013-004435-72-IT   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Philippines;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States;Vietnam
      2015   Phase 3   EUCTR2013-004435-72-DE   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Germany;Greece;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Philippines;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States;Viet Nam
      2015   Phase 3   EUCTR2013-004435-72-BG   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Germany;Greece;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Philippines;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States;Vietnam
      2015   Phase 3   EUCTR2013-004282-14-PT   Austria;Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;Norway;Philippines;Portugal;Romania;Singapore;South Africa;Spain;Sweden;Switzerland;United Kingdom;Vietnam
      2015   Phase 3   EUCTR2013-004282-14-NL   Austria;Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;Norway;Philippines;Portugal;Romania;Singapore;South Africa;Spain;Sweden;Switzerland;United Kingdom;Vietnam
      2015   Phase 3   EUCTR2013-004279-11-BG   Argentina;Australia;Brazil;Bulgaria;Estonia;France;Hong Kong;Mexico;Poland;Russian Federation;Serbia;Slovakia;Ukraine;United States
      2015   Phase 3   EUCTR2013-004277-27-BG   Argentina;Australia;Brazil;Bulgaria;Colombia;Croatia;Czech Republic;Greece;Hungary;Latvia;Lithuania;Malaysia;New Zealand;Poland;Russian Federation;Turkey;Ukraine;United States
      2014   Phase 3   EUCTR2013-004435-72-SK   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Germany;Greece;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Philippines;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States;Vietnam
      2014   Phase 3   EUCTR2013-004435-72-SE   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Philippines;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States;Vietnam
      2014   Phase 3   EUCTR2013-004435-72-NO   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Philippines;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States;Vietnam
      2014   Phase 3   EUCTR2013-004435-72-LV   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Philippines;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States;Vietnam
      2014   Phase 3   EUCTR2013-004435-72-LT   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Philippines;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States;Vietnam
      2014   Phase 3   EUCTR2013-004435-72-HU   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Philippines;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States;Vietnam
      2014   Phase 3   EUCTR2013-004435-72-HR   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Philippines;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States;Vietnam
      2014   Phase 3   EUCTR2013-004435-72-GR   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Philippines;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States;Vietnam
      2014   Phase 3   EUCTR2013-004435-72-GB   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Philippines;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States;Vietnam
      2014   Phase 3   EUCTR2013-004435-72-FR   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Philippines;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States;Vietnam
      2014   Phase 3   EUCTR2013-004435-72-EE   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Philippines;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States;Vietnam
      2014   Phase 3   EUCTR2013-004435-72-DK   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Germany;Greece;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Philippines;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States;Vietnam
      2014   Phase 3   EUCTR2013-004435-72-CZ   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Germany;Greece;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Philippines;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States;Viet Nam
      2014   Phase 3   EUCTR2013-004435-72-BE   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Philippines;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States;Vietnam
      2014   Phase 3   EUCTR2013-004435-72-AT   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Philippines;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States;Vietnam
      2014   Phase 3   EUCTR2013-004282-14-NO   Austria;Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;Norway;Philippines;Portugal;Romania;Singapore;South Africa;Spain;Sweden;Switzerland;United Kingdom;Vietnam
      2014   -   EUCTR2013-004282-14-IT   Austria;Belgium;Canada;Czech Republic;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;Norway;Philippines;Portugal;Romania;Singapore;South Africa;Spain;Sweden;Switzerland;United Kingdom;Vietnam
      2014   Phase 3   EUCTR2013-004282-14-HU   Austria;Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;Norway;Portugal;Romania;Singapore;South Africa;Spain;Sweden;Switzerland;United Kingdom
      2014   Phase 3   EUCTR2013-004282-14-GB   Austria;Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;Norway;Portugal;Romania;Singapore;South Africa;Spain;Sweden;Switzerland;United Kingdom
      2014   Phase 3   EUCTR2013-004282-14-FR   Austria;Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;Norway;Philippines;Portugal;Romania;Singapore;South Africa;Spain;Sweden;Switzerland;United Kingdom;Vietnam
      2014   Phase 3   EUCTR2013-004282-14-DE   Austria;Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;Norway;Portugal;Romania;Singapore;South Africa;Spain;Sweden;Switzerland;United Kingdom
      2014   Phase 3   EUCTR2013-004282-14-CZ   Austria;Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;Norway;Portugal;Romania;Singapore;South Africa;Spain;Sweden;Switzerland;United Kingdom
      2014   Phase 3   EUCTR2013-004282-14-BE   Austria;Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;Norway;Portugal;Romania;Singapore;South Africa;Spain;Sweden;Switzerland;United Kingdom
      2014   Phase 3   EUCTR2013-004282-14-AT   Austria;Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;Norway;Portugal;Romania;Singapore;South Africa;Spain;Sweden;Switzerland;United Kingdom
      2014   Phase 3   EUCTR2013-004280-31-HU   Brazil;Canada;Czech Republic;Denmark;Germany;Hungary;Israel;Italy;Mexico;Poland;Slovakia;South Africa;Ukraine;United States
      2014   Phase 3   EUCTR2013-004280-31-DK   Canada;Czech Republic;Denmark;Germany;Hungary;Israel;Poland;Slovakia;South Africa;United States
      2014   Phase 3   EUCTR2013-004280-31-DE   Brazil;Canada;Czech Republic;Denmark;Germany;Hungary;Israel;Italy;Mexico;Poland;Slovakia;South Africa;Ukraine;United States
      2014   Phase 3   EUCTR2013-004280-31-CZ   Brazil;Canada;Czech Republic;Denmark;Germany;Hungary;Israel;Italy;Mexico;Poland;Slovakia;South Africa;Ukraine;United States
      2014   Phase 3   EUCTR2013-004279-11-SK   Argentina;Australia;Brazil;Bulgaria;Estonia;France;Hong Kong;Mexico;Poland;Russian Federation;Serbia;Slovakia;Ukraine;United States
      2014   Phase 3   EUCTR2013-004279-11-EE   Argentina;Australia;Brazil;Bulgaria;Estonia;France;Hong Kong;Mexico;Poland;Russian Federation;Serbia;Slovakia;Ukraine;United States
      2014   Phase 3   EUCTR2013-004278-88-NL   Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Spain;Switzerland;United Kingdom;United States
      2014   Phase 3   EUCTR2013-004278-88-LT   Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Spain;Switzerland;United Kingdom;United States
      2014   Phase 3   EUCTR2013-004278-88-IT   Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Spain;Switzerland;United Kingdom;United States
      2014   Phase 3   EUCTR2013-004278-88-HU   Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Spain;Switzerland;United Kingdom;United States
      2014   Phase 3   EUCTR2013-004278-88-GR   Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Spain;Switzerland;United Kingdom;United States
      2014   Phase 3   EUCTR2013-004278-88-FR   Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Spain;Switzerland;United Kingdom;United States
      2014   Phase 3   EUCTR2013-004278-88-DK   Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Spain;Switzerland;United Kingdom;United States
      2014   Phase 3   EUCTR2013-004278-88-DE   Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Spain;Switzerland;United Kingdom;United States
      2014   Phase 3   EUCTR2013-004278-88-CZ   Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Spain;Switzerland;United Kingdom;United States
      2014   Phase 3   EUCTR2013-004278-88-BE   Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Spain;Switzerland;United Kingdom;United States
      2014   Phase 3   EUCTR2013-004278-88-AT   Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Spain;Switzerland;United Kingdom;United States
      2014   Phase 3   EUCTR2013-004277-27-LV   Argentina;Australia;Brazil;Bulgaria;Colombia;Croatia;Czech Republic;Greece;Hungary;Latvia;Lithuania;Malaysia;New Zealand;Poland;Russian Federation;Turkey;Ukraine;United States
      2014   Phase 3   EUCTR2013-004277-27-LT   Argentina;Australia;Brazil;Bulgaria;Colombia;Croatia;Czech Republic;Greece;Hungary;Latvia;Lithuania;Malaysia;New Zealand;Poland;Russian Federation;Turkey;Ukraine;United States
      2014   Phase 3   EUCTR2013-004277-27-HR   Argentina;Australia;Brazil;Bulgaria;Colombia;Croatia;Czech Republic;Greece;Hungary;Latvia;Lithuania;Malaysia;New Zealand;Poland;Russian Federation;Turkey;Ukraine;United States
      2014   Phase 3   EUCTR2013-004277-27-GR   Argentina;Australia;Brazil;Bulgaria;Colombia;Croatia;Czech Republic;Greece;Hungary;Latvia;Lithuania;Malaysia;New Zealand;Poland;Russian Federation;Turkey;Ukraine;United States
   Roche Farma S.A en nombre de F. Hoffmann-La Roche Ltd
      2014   Phase 3   EUCTR2013-004278-88-ES   Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Spain;Switzerland;United Kingdom;United States
   Roche Farma S.A. en nombre de F. Hoffmann-La Roche Ltd
      2014   Phase 3   EUCTR2013-004435-72-ES   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Philippines;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States;Vietnam
      2014   Phase 3   EUCTR2013-004282-14-ES   Austria;Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;Norway;Philippines;Portugal;Romania;Singapore;South Africa;Spain;Sweden;Switzerland;United Kingdom;Vietnam
RO5490261 / F02
   Genentech, Inc.
      2011   Phase 2   EUCTR2011-003409-36-GB   Australia;Belgium;Canada;Czech Republic;Germany;Hungary;Israel;New Zealand;Spain;United Kingdom;United States
RO5490261/F02
   F. Hoffmann-La Roche Ltd
      2018   Phase 1   EUCTR2017-003649-10-GB   Belgium;Germany;Poland;Spain;United Kingdom
      2018   Phase 1   EUCTR2017-003649-10-DE   Belgium;Germany;Poland;Spain;United Kingdom;United States
      2018   Phase 1   EUCTR2017-003649-10-BE   Belgium;Germany;Poland;Spain;United Kingdom
      -   Phase 1   EUCTR2017-003649-10-PL   Belgium;Germany;Poland;Spain;United Kingdom
   Genentech, Inc.
      2012   Phase 2   EUCTR2011-003409-36-CZ   Australia;Belgium;Canada;Czech Republic;Germany;Hungary;Israel;New Zealand;Spain;United Kingdom;United States
   Roche Farma S.A. (Soc unipersonal) que realiza el ensayo en España y que actúa como represntante de FHoffmann-La Roche
      2018   Phase 1   EUCTR2017-003649-10-ES   Belgium;Germany;Poland;Spain;United Kingdom;United States
RO7049665
   Hoffmann-La Roche
      2019   Phase 1   NCT03943550   Georgia;Hungary;Moldova, Republic of;Ukraine;United States
RO7246311
   GENENTECH, INC.
      2018   Phase 2   EUCTR2017-002350-36-IT   Bulgaria;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
   Genentech, Inc.
      2018   Phase 2   EUCTR2017-002350-36-NL   Bulgaria;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
      2018   Phase 2   EUCTR2017-002350-36-IE   Bulgaria;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
      2018   Phase 2   EUCTR2017-002350-36-HU   Bulgaria;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
      2018   Phase 2   EUCTR2017-002350-36-GR   Bulgaria;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
      2018   Phase 2   EUCTR2017-002350-36-GB   Bulgaria;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
      2018   Phase 2   EUCTR2017-002350-36-DE   Bulgaria;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
      2018   Phase 2   EUCTR2017-002350-36-BG   Bulgaria;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
   Roche Farma, S.A por delegación de Genentech, Inc.
      2018   Phase 2   EUCTR2017-002350-36-ES   Bulgaria;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
RO7790121
   Hoffmann-La Roche
      2024   Phase 3   NCT06589986   Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Chile;China;Croatia;Czechia;Denmark;France;Germany;Hungary;Italy;Japan;Netherlands;Poland;Portugal;Romania;Serbia;Slovakia;Spain;Thailand;United Kingdom;United States
      2024   Phase 3   NCT06588855   Argentina;Australia;Austria;Belgium;Canada;Chile;China;Croatia;Czechia;Denmark;France;Germany;Hungary;Italy;Mexico;Netherlands;Poland;Portugal;Spain;Thailand;United Kingdom;United States
RO7837195
   Genentech, Inc.
      2025   Phase 2   NCT06979336   -
Roflumilast
   Tanta University
      2023   Phase 4   NCT05684484   Egypt
Ropivacaine
   Samuel Lunenfeld Research Institute, Mount Sinai Hospital
      2021   -   NCT06230003   Canada
Rosiglitazone
   Herlev Hospital
      2005   Phase 1/Phase 2   NCT00309660   Denmark
   James Lewis
      2007   Phase 4   NCT00567593   United States
      2002   Phase 2   NCT00065065   United States
Rosnilimab
   AnaptysBio, Inc.
      2023   Phase 2   NCT06127043   Austria;Bulgaria;Canada;Croatia;France;Georgia;Germany;Italy;Netherlands;Poland;Romania;Serbia;Spain;United Kingdom;United States
Rosuvastatin 10MG
   Universitaire Ziekenhuizen KU Leuven
      2020   Phase 2/Phase 3   NCT04883840   Belgium
Rosuvastatin calcium
   UZ Leuven
      2020   Phase 3   EUCTR2019-004208-37-BE   Belgium
Rosuvastatine EG
   UZ Leuven
      2020   Phase 3   EUCTR2019-004208-37-BE   Belgium
RPC1063
   CELGENE INTERNATIONAL II SàRL
      2015   Phase 3   EUCTR2015-000319-41-IT   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
   Celgene
      2015   Phase 3   NCT02531126   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
      2015   Phase 3   NCT02435992   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
   Celgene International II Sàrl
      2023   Phase 2;Phase 3   EUCTR2021-002308-11-BE   Belgium;Canada;France;Germany;Israel;Japan;Netherlands;Poland;Russian Federation;Spain;United Kingdom;United States
      2022   Phase 2;Phase 3   EUCTR2021-002308-11-ES   Belgium;Canada;France;Germany;Israel;Japan;Netherlands;Poland;Russian Federation;Spain;United Kingdom;United States
      2022   Phase 2;Phase 3   EUCTR2021-002308-11-DE   Belgium;Canada;France;Germany;Israel;Japan;Netherlands;Poland;Spain;United Kingdom;United States
      2021   Phase 2;Phase 3   EUCTR2021-002308-11-FR   Belgium;Canada;France;Germany;Israel;Japan;Netherlands;Poland;Russian Federation;Spain;United Kingdom;United States
      2016   Phase 1   EUCTR2016-003073-18-GB   United Kingdom
      2015   Phase 3   EUCTR2015-000319-41-GB   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
      -   Phase 2;Phase 3   EUCTR2021-002308-11-PL   Belgium;Canada;France;Germany;Israel;Japan;Netherlands;Poland;Russian Federation;Spain;United Kingdom;United States
   Celgene International II Sàrl (CIS II)
      2018   Phase 3   EUCTR2015-000319-41-LV   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2015-000319-41-AT   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2015-000319-41-HR   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000319-41-NL   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
      2015   Phase 3   EUCTR2015-000319-41-SK   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
      2015   Phase 3   EUCTR2015-000319-41-DE   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
      2015   Phase 3   EUCTR2015-000319-41-CZ   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
      2015   Phase 3   EUCTR2015-000319-41-BE   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
      -   Phase 3   EUCTR2015-000319-41-PL   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Ukraine;United Kingdom;United States
      -   Phase 3   EUCTR2015-000319-41-BG   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
   Celgene International II Sárl (CIS II)
      2015   Phase 3   EUCTR2015-000319-41-HU   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Mexico;Netherlands;New Zealand;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
RTNV148B IGG
   Centocor BV
      2010   -   EUCTR2006-003398-28-CZ   Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden
      2008   -   EUCTR2006-003399-37-LT   Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden
      2008   -   EUCTR2006-003398-28-SE   Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden
      2008   -   EUCTR2006-003398-28-NL   Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden
      2008   -   EUCTR2006-003398-28-LT   Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden
      2008   -   EUCTR2006-003398-28-DK   Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden
      2008   -   EUCTR2006-003398-28-BG   Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden
      2008   -   EUCTR2006-003397-94-SE   Austria;Belgium;Bulgaria;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden
      2008   -   EUCTR2006-003397-94-NL   Austria;Belgium;Bulgaria;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden
      2008   -   EUCTR2006-003397-94-LT   Austria;Belgium;Bulgaria;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden
      2008   -   EUCTR2006-003397-94-BG   Austria;Belgium;Bulgaria;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden
      2007   Phase 3   EUCTR2006-003399-37-FR   Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Slovakia;Sweden
      2007   Phase 2;Phase 3   EUCTR2006-003398-28-SK   Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Slovakia;Sweden
      2007   -   EUCTR2006-003398-28-LV   Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden
      2007   -   EUCTR2006-003398-28-HU   Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden
      2007   Phase 2;Phase 3   EUCTR2006-003398-28-FR   Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Slovakia;Sweden
      2007   -   EUCTR2006-003398-28-DE   Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden
      2007   -   EUCTR2006-003398-28-BE   Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden
      2007   -   EUCTR2006-003398-28-AT   Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden
      2007   Phase 2;Phase 3   EUCTR2006-003397-94-SK   Austria;Belgium;Bulgaria;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Slovakia;Sweden
      2007   -   EUCTR2006-003397-94-LV   Austria;Belgium;Bulgaria;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden
      2007   Phase 2;Phase 3   EUCTR2006-003397-94-HU   Austria;Belgium;Bulgaria;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Slovakia;Sweden
      2007   Phase 2;Phase 3   EUCTR2006-003397-94-FR   Austria;Belgium;Bulgaria;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Slovakia;Sweden
      2007   -   EUCTR2006-003397-94-DE   Austria;Belgium;Bulgaria;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden
      2007   -   EUCTR2006-003397-94-BE   Austria;Belgium;Bulgaria;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden
      2007   -   EUCTR2006-003397-94-AT   Austria;Belgium;Bulgaria;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden
   Janssen Biologics B.V.
      2010   -   EUCTR2006-003399-37-CZ   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;India;Israel;Japan;Latvia;Lithuania;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Sweden;Ukraine;United States
      2008   -   EUCTR2006-003399-37-SE   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;India;Israel;Japan;Latvia;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Sweden;Ukraine;United States
      2008   -   EUCTR2006-003399-37-DK   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;India;Israel;Japan;Latvia;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Sweden;Ukraine;United States
      2008   -   EUCTR2006-003399-37-BG   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;India;Israel;Japan;Latvia;Lithuania;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Sweden;Ukraine;United States
      2007   -   EUCTR2006-003399-37-LV   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;India;Israel;Japan;Latvia;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Sweden;Ukraine;United States
      2007   -   EUCTR2006-003399-37-HU   Australia;Austria;Belgium;Bulgaria;Czech Republic;Denmark;Finland;France;Germany;Hungary;India;Israel;Latvia;Lithuania;Netherlands;New Zealand;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Sweden;Ukraine
      2007   -   EUCTR2006-003399-37-DE   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;India;Israel;Japan;Latvia;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Sweden;Ukraine;United States
      2007   -   EUCTR2006-003399-37-BE   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;India;Israel;Japan;Latvia;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Sweden;Ukraine;United States
      2007   -   EUCTR2006-003399-37-AT   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;India;Israel;Japan;Latvia;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Sweden;Ukraine;United States
   Janssen Biologics BV
      2008   -   EUCTR2006-003399-37-NL   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;India;Israel;Japan;Latvia;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Sweden;Ukraine;United States
      2007   Phase 3   EUCTR2006-003399-37-SK   Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Slovakia;Sweden
RVG 114681
   Amsterdam UMC location AMC
      2021   Phase 3;Phase 4   EUCTR2021-000469-33-NL   Netherlands
RVG 116648
   Amsterdam UMC location AMC
      2021   Phase 3;Phase 4   EUCTR2021-000469-33-NL   Netherlands
RVG00859
   Amsterdam UMC location AMC
      2021   Phase 3;Phase 4   EUCTR2021-000469-33-NL   Netherlands
RYAH-medtech inhaler
   OMNI Medical Services, LLC
      2018   Phase 2   NCT03944447   United States
Saffron
   Minia University
      2023   Phase 4   NCT05715099   Egypt
Saffron 100
   Shiraz University of Medical Sciences
      2023   Phase 2   NCT05117749   -
Saffron 50
   Shiraz University of Medical Sciences
      2023   Phase 2   NCT05117749   -
Saffron supplement FOR IBD
   Howard University
      2020   -   NCT04749576   United States
Saline
   Aarhus University Hospital
      2015   -   NCT02084550   Denmark
   Ishikawa Dai
      2020   -   JPRN-jRCTs031200103   -
      2017   -   JPRN-jRCTs031180415   -
   The First Affiliated Hospital, College of Medicine, Zhejiang University
      2024   Phase 0   ChiCTR2400092548   China
   The Second Hospital of Nanjing Medical University
      2016   Phase 4   NCT02998112   China
Saline +5% albumin
   Shanghai East Hospital
      2025   Early Phase 1   NCT06853522   China
Salmon
   Children's Hospital Boston
      2004   -   NCT00114803   United States
Salofalk
   Dongfang Hospital of Beijing University of Chinese Medicine
      2019   Phase 0   ChiCTR1900023159   China
   Dr. Falk Pharma GmbH
      2005   Phase 3   EUCTR2004-001216-31-SK   Czech Republic;Estonia;Germany;Hungary;Latvia;Lithuania;Slovakia;Slovenia
      2005   -   EUCTR2004-001216-31-SI   Czech Republic;Estonia;Germany;Hungary;Latvia;Lithuania;Slovenia
      2005   -   EUCTR2004-001216-31-LV   Czech Republic;Estonia;Germany;Hungary;Latvia;Lithuania
      2005   -   EUCTR2004-001216-31-LT   Czech Republic;Estonia;Germany;Hungary;Latvia;Lithuania
      2005   -   EUCTR2004-001216-31-HU   Czech Republic;Estonia;Germany;Hungary;Latvia;Lithuania
      2005   -   EUCTR2004-001216-31-EE   Czech Republic;Estonia;Germany;Hungary;Latvia;Lithuania
      2005   -   EUCTR2004-001216-31-DE   Czech Republic;Estonia;Germany;Hungary;Latvia;Lithuania
      2005   -   EUCTR2004-001216-31-CZ   Czech Republic;Estonia;Germany;Hungary;Latvia;Lithuania
   Jiangsu Province Hospital of Chinese Medicine
      2019   Phase 4   ChiCTR1900023158   China
   Peking University First Hospital
      2019   Phase 0   ChiCTR1900024591   China
   UMC Utrecht
      2009   -   EUCTR2009-010921-38-NL   Netherlands
   University Medical Center Groningen
      2010   -   EUCTR2010-018557-35-NL   Netherlands
Salofalk 1000MG granu-stix
   Dr. Falk Pharma GmbH
      2007   Phase 3   EUCTR2006-005377-22-SK   Czech Republic;Germany;Latvia;Lithuania;Poland;Slovakia;Spain
      2007   -   EUCTR2006-005377-22-LV   Czech Republic;Germany;Latvia;Lithuania;Poland;Spain
      2007   -   EUCTR2006-005377-22-LT   Czech Republic;Germany;Latvia;Lithuania;Poland;Spain
      2007   Phase 3   EUCTR2006-005377-22-ES   Czech Republic;Germany;Latvia;Lithuania;Poland;Slovakia;Spain
      2007   -   EUCTR2006-005377-22-DE   Czech Republic;Germany;Latvia;Lithuania;Poland;Spain
      2007   -   EUCTR2006-005377-22-CZ   Czech Republic;Germany;Latvia;Lithuania;Poland;Spain
      -   Phase 3   EUCTR2006-005377-22-PL   Czech Republic;Germany;Latvia;Lithuania;Poland;Slovakia;Spain
Salofalk 3G gastro-resistant prolonged-release granules
   Dr. Falk Pharma GmbH
      2021   Phase 3   EUCTR2019-003334-16-LV   Belarus;Bulgaria;Germany;Latvia;Poland;Russian Federation;Ukraine
      2021   Phase 3   EUCTR2019-003334-16-BG   Belarus;Bulgaria;Germany;Latvia;Poland;Russian Federation;Ukraine
      2020   Phase 3   EUCTR2019-003334-16-DE   Belarus;Bulgaria;Germany;Latvia;Poland;Russian Federation;Ukraine
Salofalk 4G/60ML klysma
   Charité Universitätsmedizin, Campus Charité Mitte
      2007   Phase 2   EUCTR2006-004162-13-DE   Germany
Salofalk granu-stix 500 MG
   Dr. Falk Pharma GmbH
      2016   Phase 3   EUCTR2013-001205-84-HU   Austria;Belgium;Germany;Hungary;Israel;Latvia;Lithuania;Netherlands;Poland;Russian Federation;Slovakia;Switzerland;Ukraine
      2016   Phase 3   EUCTR2013-001205-84-BE   Austria;Belgium;Czech Republic;Germany;Hungary;Israel;Latvia;Lithuania;Netherlands;Poland;Russian Federation;Slovakia;Switzerland;Ukraine
      2015   Phase 3   EUCTR2013-001205-84-SK   Austria;Belgium;Czech Republic;Germany;Hungary;Israel;Latvia;Lithuania;Netherlands;Poland;Russian Federation;Slovakia;Switzerland;Ukraine
      2015   Phase 3   EUCTR2013-001205-84-PL   Austria;Belgium;Czech Republic;Germany;Hungary;Israel;Latvia;Lithuania;Netherlands;Poland;Russian Federation;Slovakia;Switzerland;Ukraine
      2015   Phase 3   EUCTR2013-001205-84-LV   Austria;Belgium;Czech Republic;Germany;Hungary;Israel;Latvia;Lithuania;Netherlands;Poland;Russian Federation;Slovakia;Switzerland;Ukraine
      2015   Phase 3   EUCTR2013-001205-84-DE   Austria;Belgium;Czech Republic;Germany;Hungary;Israel;Latvia;Lithuania;Netherlands;Poland;Russian Federation;Slovakia;Switzerland;Ukraine
      2015   Phase 3   EUCTR2013-001205-84-AT   Austria;Belgium;Czech Republic;Germany;Hungary;Israel;Latvia;Lithuania;Netherlands;Poland;Russian Federation;Slovakia;Switzerland;Ukraine
Salofalk® 500 MG gastro-resistant tablet
   Dr. Falk Pharma GmbH
      2013   -   EUCTR2012-001830-32-PL   Hungary;Latvia;Lithuania;Poland;Russian Federation;Ukraine
      2013   -   EUCTR2012-001830-32-LT   Hungary;Latvia;Lithuania;Poland;Russian Federation;Ukraine
      2013   Phase 3   EUCTR2012-001830-32-DE   Germany;Hungary;Latvia;Lithuania;Poland;Russian Federation;Ukraine
      2012   Phase 3   EUCTR2012-001830-32-LV   Germany;Hungary;Latvia;Lithuania;Poland;Russian Federation;Ukraine
      2012   Phase 3   EUCTR2012-001830-32-HU   Hungary;Latvia;Lithuania;Poland;Russian Federation;Ukraine
Salofalk® 500 MG tablets
   Dr. Falk Pharma GmbH
      2012   Phase 3   EUCTR2012-001830-32-HU   Hungary;Latvia;Lithuania;Poland;Russian Federation;Ukraine
Salofalk® 500MG
   Dr. Falk Pharma GmbH
      2005   Phase 3   EUCTR2004-001218-15-SK   Estonia;Germany;Hungary;Latvia;Lithuania;Slovakia;Slovenia
      2005   -   EUCTR2004-001218-15-SI   Estonia;Germany;Hungary;Latvia;Lithuania;Slovenia
      2005   -   EUCTR2004-001218-15-LV   Estonia;Germany;Hungary;Latvia;Lithuania
      2005   -   EUCTR2004-001218-15-LT   Estonia;Germany;Hungary;Latvia;Lithuania
      2005   -   EUCTR2004-001218-15-HU   Estonia;Germany;Hungary;Latvia;Lithuania
      2005   -   EUCTR2004-001218-15-EE   Estonia;Germany;Hungary;Latvia;Lithuania
   REPHA GmbH
      2008   -   EUCTR2007-007928-18-DE   Germany
Sampling
   Assistance Publique - Hôpitaux de Paris
      2016   -   NCT02693340   France
Sandimmum
   GETECCU (Grupo Español para el estudio de la enfermedad de Crohn y la colitis ulcerosa)
      2008   -   EUCTR2006-005299-42-ES   Belgium;Finland;France;Spain
Sandimmun
   Swansea University
      2008   Phase 3   EUCTR2008-001968-36-GB   United Kingdom
Sandimmun 50 MG/ML, infuusiokonsentraatti
   Groupe d'Etude Thérapeutique des Affections Inflammatoires Digestives (G.E.T.A.I.D.)
      2008   -   EUCTR2006-005299-42-FI   Belgium;Finland;France;Spain
Sandimmun neoral
   Groupe d'Etude Thérapeutique des Affections Inflammatoires Digestives (G.E.T.A.I.D.)
      2008   -   EUCTR2006-005299-42-FI   Belgium;Finland;France;Spain
Sandinum
   GETAID
      2008   -   EUCTR2006-005299-42-BE   Belgium;Finland;France;Spain
      2007   -   EUCTR2006-005299-42-FR   Belgium;Finland;France;Spain
SAR339658
   Sanofi
      2013   Phase 2   NCT01861249   Canada;United States
      2012   Phase 2   NCT01659138   Austria;Belgium;Canada;France;Germany;Italy;Poland;United States
   Sanofi aventis Recherche&Développement
      2013   -   EUCTR2012-002013-19-PL   Austria;Belgium;Canada;France;Germany;Italy;Poland;United States
      2013   -   EUCTR2012-002013-19-IT   Austria;Belgium;Canada;France;Germany;Italy;Poland;United States
      2013   -   EUCTR2012-002013-19-DE   Austria;Belgium;Canada;France;Germany;Italy;Poland;United States
      2013   Phase 2   EUCTR2012-002013-19-BE   Austria;Belgium;Canada;France;Germany;Italy;Poland;United States
      2013   -   EUCTR2012-002013-19-AT   Austria;Belgium;Canada;France;Germany;Italy;Poland;United States
   Sanofi-aventis recherche & développement
      2014   -   EUCTR2013-001012-30-DE   Austria;Belgium;Canada;Germany;Italy;Poland;United States
      2013   -   EUCTR2013-001012-30-PL   Austria;Canada;Germany;Italy;Poland;United States
      2013   -   EUCTR2013-001012-30-IT   Austria;Canada;Germany;Italy;Poland;United States
      2013   Phase 2   EUCTR2013-001012-30-BE   Austria;Belgium;Canada;Germany;Italy;Poland;United States
      2013   -   EUCTR2013-001012-30-AT   Austria;Canada;Germany;Italy;Poland;United States
SAR441566
   Sanofi
      2025   Phase 2   NCT06867094   Canada;United States
SAR442970
   Sanofi
      2025   Phase 2   NCT06975722   -
SAR443122
   Sanofi
      2022   Phase 2   NCT05588843   Argentina;Chile;China;Czechia;France;Georgia;Germany;Hungary;India;Italy;Japan;Mexico;Netherlands;Poland;Slovakia;Spain;United Kingdom;United States
   Tanaka Tomoyuki
      2023   Phase 2   JPRN-jRCT2031230203   Argentina;Chile;Japan;United Kingdom;United States
SB-656933
   GlaxoSmithKline
      2009   Phase 2   NCT00748410   Netherlands
SB-656933 tablets
   GlaxoSmithKline R&D Ltd
      2008   -   EUCTR2007-005520-32-NL   Netherlands
SB012
   Sterna Biologicals GmbH & Co. KG
      2014   Phase 1/Phase 2   NCT02129439   Germany
   sterna biologicals GmbH & Co. KG
      2014   Phase 2   EUCTR2013-004599-36-DE   Germany
SB5
   Samsung Bioepis Co., Ltd
      2015   -   EUCTR2014-004887-39-PL   Poland
   Samsung Bioepis Co., Ltd.
      2014   -   EUCTR2013-005013-13-PL   Bosnia and Herzegovina;Bulgaria;Czech Republic;Korea, Republic of;Latvia;Lithuania;Mexico;Poland;Russian Federation;Ukraine;United Kingdom
      2014   -   EUCTR2013-005013-13-LT   Bosnia and Herzegovina;Bulgaria;Czech Republic;Korea, Republic of;Lithuania;Mexico;Poland;Russian Federation;Ukraine;United Kingdom
      2014   -   EUCTR2013-005013-13-CZ   Bosnia and Herzegovina;Bulgaria;Czech Republic;Korea, Republic of;Lithuania;Mexico;Poland;Russian Federation;Ukraine;United Kingdom
      2014   Phase 3   EUCTR2013-005013-13-BG   Bosnia and Herzegovina;Bulgaria;Czech Republic;Korea, Republic of;Lithuania;Mexico;Poland;Russian Federation;Ukraine;United Kingdom
SC tulisokibart
   Merck Sharp & Dohme LLC
      2023   Phase 3   NCT06052059   Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czechia;Dominican Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
SC12267
   4SC AG
      2010   -   EUCTR2008-005903-25-BG   Bulgaria;Germany
      2009   Phase 2   NCT00820365   Bulgaria;Germany;Romania
      2009   -   EUCTR2008-005903-25-DE   Bulgaria;Germany
SCH 900050
   SCHERING-PLOUGH
      2007   -   EUCTR2006-002670-22-IT   Belgium;Czech Republic;France;Germany;Hungary;Italy;Portugal;Spain;United Kingdom
   Schering-Plough Research Institute, a division of Schering Corporation
      2008   Phase 3   EUCTR2006-002670-22-SK   Belgium;Czech Republic;France;Germany;Hungary;Italy;Portugal;Slovakia;Spain;United Kingdom
      2008   Phase 3   EUCTR2006-002670-22-GB   Belgium;Czech Republic;France;Germany;Hungary;Italy;Portugal;Slovakia;Spain;United Kingdom
      2007   -   EUCTR2006-002670-22-PT   Belgium;Czech Republic;France;Germany;Hungary;Italy;Portugal;Spain;United Kingdom
      2007   -   EUCTR2006-002670-22-HU   Belgium;Czech Republic;France;Germany;Hungary;Italy;Portugal;Spain;United Kingdom
      2007   Phase 3   EUCTR2006-002670-22-FR   Belgium;Czech Republic;France;Germany;Hungary;Italy;Portugal;Slovakia;Spain;United Kingdom
      2007   Phase 3   EUCTR2006-002670-22-ES   Belgium;Czech Republic;France;Germany;Hungary;Italy;Portugal;Slovakia;Spain;United Kingdom
      2007   -   EUCTR2006-002670-22-DE   Belgium;Czech Republic;France;Germany;Hungary;Italy;Portugal;Spain;United Kingdom
      2007   -   EUCTR2006-002670-22-CZ   Belgium;Czech Republic;France;Germany;Hungary;Italy;Portugal;Spain;United Kingdom
      2007   Phase 3   EUCTR2006-002670-22-BE   Belgium;Czech Republic;France;Germany;Hungary;Italy;Portugal;Slovakia;Spain;United Kingdom
SCI-B-VAC
   Soroka University Medical Center
      2012   -   NCT01531075   Israel
Selg*OS polv 4bust 70G 1LT
   AZIENDA OSPEDALIERA L. SACCO (A.O. DI RILIEVO NAZIONALE)
      2012   -   EUCTR2012-004214-34-IT   Italy
SEMI-vegetarian diet
   Mayo Clinic
      2017   Early Phase 1   NCT03309865   United States
Sequential FMT
   Fondazione Policlinico Universitario Agostino Gemelli IRCCS
      2023   Phase 1/Phase 2   NCT06071312   Italy
SER-287
   Seres Therapeutics, Inc.
      2018   Phase 2   NCT03759041   Canada;United States
      2016   Phase 1   NCT02618187   United States
Serum albumin level
   Assiut University
      2018   -   NCT03496246   Egypt
Serum calcium level
   Assiut University
      2018   -   NCT03496246   Egypt
Serum creatinine
   Assiut University
      2018   -   NCT03496246   Egypt
Serum leucine-rich alpha-2 glycoprotein (LRG) levels
   Showa Inan General Hospital
      2020   -   NCT04535882   Japan
Serum phosphurus level
   Assiut University
      2018   -   NCT03496246   Egypt
Serum potassium level
   Assiut University
      2018   -   NCT03496246   Egypt
Serum total 25 hydroxycholecalciferol 25(OH) vitamin D
   Assiut University
      2018   -   NCT03496246   Egypt
Seum alanine aminotransferase
   Assiut University
      2018   -   NCT03496246   Egypt
SF257 C59
   Procter & Gamble Pharmaceuticals
      2005   Phase 2   EUCTR2004-004077-29-SK   Czech Republic;Germany;Lithuania;Slovakia;United Kingdom
      2005   -   EUCTR2004-004077-29-LT   Czech Republic;Germany;Lithuania;United Kingdom
      2005   -   EUCTR2004-004077-29-DE   Czech Republic;Germany;Lithuania;United Kingdom
      2005   -   EUCTR2004-004077-29-CZ   Czech Republic;Germany;Lithuania;United Kingdom
   Procter & Gamble Technical Centres Ltd
      2005   -   EUCTR2004-004077-29-GB   Czech Republic;Germany;Lithuania;United Kingdom
Sham hyperbaric AIR
   Dartmouth-Hitchcock Medical Center
      2013   Phase 2/Phase 3   NCT02144350   United States
Shingrix
   Boston Medical Center
      2019   Phase 4   NCT03591770   United States
   University of Wisconsin, Madison
      2019   Phase 4   NCT03798691   United States
SHP647
   Baxalta Innovations GmbH
      2018   Phase 3   EUCTR2017-000573-37-BE   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Ukraine;United Kingdom;United States
   SHIRE HUMAN GENETIC THERAPIES, INC
      2018   Phase 3   EUCTR2017-000599-27-IT   Australia;Austria;Brazil;Croatia;Czech Republic;Czechia;Germany;Greece;Israel;Italy;Japan;Lithuania;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;United Kingdom;United States
      2018   Phase 3   EUCTR2017-000574-11-IT   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-000573-37-IT   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
   Shire
      2013   Phase 2   NCT01771809   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;United States
   Shire Human Genetic Therapies, Inc.
      2018   Phase 3   EUCTR2017-000572-28-BG   Argentina;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Colombia;Estonia;France;Greece;Hungary;Ireland;Japan;Korea, Republic of;Lebanon;Mexico;Portugal;Slovakia;Spain;Switzerland;Turkey;Ukraine;United States
   Shire Human Genetic Therapies, Inc.
      2019   Phase 3   EUCTR2017-000574-11-RO   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2017-000574-11-GR   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-000599-27-NL   Australia;Austria;Brazil;Croatia;Czech Republic;Germany;Greece;Israel;Italy;Japan;Lithuania;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;United Kingdom;United States
      2018   Phase 3   EUCTR2017-000599-27-LT   Australia;Austria;Brazil;Croatia;Czech Republic;Czechia;Germany;Greece;Israel;Italy;Japan;Lithuania;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;United Kingdom;United States
      2018   Phase 3   EUCTR2017-000599-27-HR   Australia;Austria;Brazil;Croatia;Czech Republic;Czechia;Germany;Greece;Israel;Italy;Japan;Lithuania;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;United Kingdom;United States
      2018   Phase 3   EUCTR2017-000599-27-GB   Australia;Austria;Brazil;Croatia;Czech Republic;Germany;Greece;Israel;Italy;Japan;Lithuania;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;United Kingdom;United States
      2018   Phase 3   EUCTR2017-000599-27-DE   Australia;Austria;Brazil;Croatia;Czech Republic;Germany;Greece;Israel;Italy;Japan;Lithuania;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;United Kingdom;United States
      2018   Phase 3   EUCTR2017-000599-27-CZ   Australia;Austria;Brazil;Croatia;Czech Republic;Germany;Greece;Israel;Italy;Japan;Lithuania;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;United Kingdom;United States
      2018   Phase 3   EUCTR2017-000574-11-PT   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-000574-11-NL   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-000574-11-LT   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-000574-11-IE   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-000574-11-HU   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-000574-11-HR   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-000574-11-GB   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-000574-11-ES   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-000574-11-EE   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-000574-11-DE   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-000574-11-BG   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-000574-11-BE   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-000573-37-PT   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-000573-37-NL   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-000573-37-LT   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-000573-37-IE   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-000573-37-HU   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-000573-37-HR   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-000573-37-GB   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-000573-37-ES   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-000573-37-EE   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-000573-37-DE   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-000573-37-CZ   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-000573-37-BG   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-000572-28-PT   Argentina;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Colombia;France;Greece;Hungary;Ireland;Japan;Korea, Republic of;Lebanon;Mexico;Portugal;Slovakia;Spain;Switzerland;Turkey;Ukraine;United States
      2018   Phase 3   EUCTR2017-000572-28-HU   Argentina;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Colombia;France;Greece;Hungary;Ireland;Japan;Korea, Republic of;Lebanon;Mexico;Portugal;Slovakia;Spain;Switzerland;Turkey;Ukraine;United States
      2018   Phase 3   EUCTR2017-000572-28-FR   Argentina;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Colombia;France;Greece;Hungary;Ireland;Japan;Korea, Republic of;Mexico;Portugal;Slovakia;Spain;Switzerland;Ukraine;United States
      2018   Phase 3   EUCTR2017-000572-28-ES   Argentina;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Colombia;France;Greece;Hungary;Ireland;Japan;Korea, Republic of;Mexico;Portugal;Slovakia;Spain;Switzerland;Ukraine;United States
      2018   Phase 3   EUCTR2017-000572-28-BE   Argentina;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Colombia;France;Greece;Hungary;Ireland;Japan;Korea, Republic of;Mexico;Portugal;Slovakia;Spain;Switzerland;Ukraine;United States
      2017   Phase 3   EUCTR2017-000599-27-AT   Australia;Austria;Brazil;Croatia;Czech Republic;Germany;Greece;Israel;Italy;Japan;Lithuania;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;United Kingdom;United States
      2017   Phase 3   EUCTR2017-000574-11-SK   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2017-000574-11-AT   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2017-000573-37-SK   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2017-000573-37-GR   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2017-000573-37-AT   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2017-000572-28-SK   Argentina;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Colombia;Estonia;France;Greece;Hungary;Ireland;Japan;Korea, Republic of;Lebanon;Mexico;Portugal;Slovakia;Spain;Switzerland;Turkey;Ukraine;United States
      2017   Phase 3   EUCTR2017-000572-28-GR   Argentina;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Colombia;France;Greece;Hungary;Ireland;Japan;Korea, Republic of;Mexico;Portugal;Slovakia;Spain;Switzerland;Ukraine;United States
      -   Phase 3   EUCTR2017-000599-27-PL   Australia;Austria;Brazil;Croatia;Czech Republic;Germany;Greece;Israel;Italy;Japan;Lithuania;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;United Kingdom;United States
      -   Phase 3   EUCTR2017-000574-11-PL   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
      -   Phase 3   EUCTR2017-000574-11-CZ   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
      -   Phase 3   EUCTR2017-000573-37-PL   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
      -   Phase 3   EUCTR2017-000572-28-IE   Argentina;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Colombia;France;Greece;Hungary;Ireland;Japan;Korea, Republic of;Lebanon;Mexico;Portugal;Slovakia;Spain;Switzerland;Turkey;Ukraine;United States
SHR0302
   Reistone Biopharma Company Limited
      2021   Phase 3   NCT05181137   China;Georgia;Poland;Ukraine;United States
      2019   Phase 2   NCT03675477   China;Poland;Puerto Rico;Ukraine;United States
      2019   Phase 2   EUCTR2018-003364-31-PL   China;Poland;Ukraine;United States
SHR0302 tablets
   Reistone Biopharma Company Limited
      2021   Phase 3   EUCTR2021-001940-86-PL   China;Georgia;Poland;Ukraine;United States
Sigmoidoscopy
   Virginia O. Shaffer
      2014   Phase 2   NCT02049502   United States
Silymarin
   Tanta University
      2025   Phase 2   NCT06213857   Egypt
Simponi
   CHU Amiens-Picardie
      2020   Phase 4   EUCTR2020-004391-18-FR   France
   Guy's and St Thomas' NHS Foundation Trust
      2017   Phase 4   EUCTR2017-001374-42-GB   United Kingdom
   Helse More og Romsdal Hospital Trust
      2016   Phase 4   EUCTR2016-001409-18-NO   Norway
   Istituto Clinico Humanitas
      2015   Phase 4   EUCTR2014-002579-27-IT   Italy
   Janssen Biologics B.V.
      2019   Phase 3   EUCTR2017-004496-31-IT   Belgium;Brazil;France;Israel;Italy;Korea, Republic of;Netherlands;Poland;Spain;Taiwan;United States
      2015   Phase 2   EUCTR2013-002042-36-FR   Belgium;Bulgaria;Canada;Czech Republic;France;Germany;Hungary;Israel;Netherlands;Poland;Russian Federation;Ukraine;United States
      2014   Phase 2   EUCTR2013-002042-36-PL   Belgium;Bulgaria;Canada;Czech Republic;France;Germany;Hungary;Israel;Netherlands;Poland;Russian Federation;Ukraine;United States
      2014   -   EUCTR2013-002042-36-NL   Belgium;Bulgaria;Canada;Czech Republic;France;Germany;Hungary;Israel;Netherlands;Poland;Russian Federation;Ukraine;United States
      2014   -   EUCTR2013-002042-36-HU   Belgium;Bulgaria;Canada;Czech Republic;France;Germany;Hungary;Israel;Netherlands;Poland;Russian Federation;Ukraine;United States
      2014   -   EUCTR2013-002042-36-DE   Belgium;Bulgaria;Canada;Czech Republic;France;Germany;Hungary;Israel;Netherlands;Poland;Russian Federation;Ukraine;United States
      2014   -   EUCTR2013-002042-36-CZ   Belgium;Bulgaria;Canada;Czech Republic;France;Germany;Hungary;Israel;Netherlands;Poland;Russian Federation;Ukraine;United States
      2014   Phase 2   EUCTR2013-002042-36-BG   Belgium;Bulgaria;Canada;Czech Republic;France;Germany;Hungary;Israel;Netherlands;Poland;Russian Federation;Ukraine;United States
      2014   -   EUCTR2013-002042-36-BE   Belgium;Bulgaria;Canada;Czech Republic;France;Germany;Hungary;Israel;Netherlands;Poland;Russian Federation;Ukraine;United States
   Janssen Biologics BV
      2019   Phase 3   EUCTR2017-004496-31-PL   Belgium;Brazil;France;Israel;Italy;Korea, Republic of;Netherlands;Poland;Spain;Taiwan;United States
      2019   Phase 3   EUCTR2017-004496-31-NL   Belgium;Brazil;France;Israel;Italy;Korea, Republic of;Netherlands;Poland;Spain;Taiwan;United States
      2018   Phase 3   EUCTR2017-004496-31-FR   Belgium;Brazil;France;Israel;Italy;Korea, Republic of;Netherlands;Poland;Spain;Taiwan;United States
      2018   Phase 3   EUCTR2017-004496-31-ES   Belgium;Brazil;France;Israel;Italy;Korea, Republic of;Netherlands;Poland;Spain;Taiwan;United States
      2018   Phase 3   EUCTR2017-004496-31-BE   Belgium;Brazil;France;Israel;Italy;Korea, Republic of;Netherlands;Poland;Spain;Taiwan;United States
   Janssen-Cilag International NV
      2023   Phase 2   EUCTR2021-005528-39-FR   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Jordan;Korea, Republic of;Lithuania;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 2   EUCTR2018-001510-15-PL   Argentina;Australia;Brazil;Germany;Mexico;Poland;Russian Federation;Ukraine;United States
      2019   Phase 2   EUCTR2018-001510-15-DE   Argentina;Australia;Brazil;Germany;Mexico;Poland;Russian Federation;Ukraine;United States
   MSD
      2014   Phase 4   EUCTR2013-004583-56-GB   United Kingdom
   MSD Belgium BVBA/SPRL
      2014   Phase 4   EUCTR2014-000656-29-BE   Belgium
   Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc.
      2014   Phase 4   EUCTR2014-003262-25-PT   Portugal
   UCD
      2015   Phase 4   EUCTR2015-004724-62-IE   Ireland
   University Medical Centre Ljubljana, Department of gastroenterology
      2020   Phase 4   EUCTR2019-003987-37-SI   Slovenia
Simponi 100 MG
   GETAID
      2019   Phase 4   EUCTR2016-000152-96-BE   Belgium
Simponi 50 MG
   GETAID
      2019   Phase 4   EUCTR2016-000152-96-BE   Belgium
Simulect
   Cerimon Pharmaceuticals, Inc.
      2007   Phase 2   EUCTR2006-006319-54-SK   Belgium;Czech Republic;Slovakia;United Kingdom
      2007   Phase 2   EUCTR2006-006319-54-GB   Belgium;Czech Republic;Slovakia;United Kingdom
      2007   Phase 2   EUCTR2006-006319-54-CZ   Belgium;Czech Republic;United Kingdom
      2007   -   EUCTR2006-006319-54-BE   Belgium;United Kingdom
      2007   Phase 2   EUCTR2006-004303-19-SK   Belgium;Czech Republic;Slovakia;United Kingdom
      2007   Phase 2   EUCTR2006-004303-19-GB   Belgium;Czech Republic;Slovakia;United Kingdom
      2007   -   EUCTR2006-004303-19-CZ   Belgium;Czech Republic;United Kingdom
      2007   -   EUCTR2006-004303-19-BE   Belgium;Czech Republic;United Kingdom
Single DOSE-group A
   Pfizer
      2005   Phase 1   NCT00928681   Belgium;Czech Republic;Denmark;Germany;Norway;Slovakia;Spain
Single fecal microbiota transplantation
   Jinling Hospital, China
      2013   -   NCT02016469   China
Single FMT
   Fondazione Policlinico Universitario Agostino Gemelli IRCCS
      2023   Phase 1/Phase 2   NCT06071312   Italy
Sirolimus
   Children's Hospital of Philadelphia
      2006   Phase 1/Phase 2   NCT00392951   United States
Smartject device delivery OF golimumab
   Merck Sharp & Dohme Corp.
      2014   Phase 4   NCT02155335   Belgium
Smoking cigarettes
   Meir Medical Center
      2010   Phase 1/Phase 2   NCT01040910   Israel
Smoking OF cannabis
   Meir Medical Center
      2010   Phase 1/Phase 2   NCT01040910   Israel
Sodio solfato anidro
   IPSEN PHARMA SAS
      2017   Phase 3   EUCTR2016-002265-60-IT   Czech Republic;Czechia;France;Germany;Italy;Netherlands;Poland
Sodium
   Shenzhen Hospital of Southern Medical University
      2022   Phase 0   ChiCTR2200056969   China
   The First Affiliated Hospital, College of Medicine, Zhejiang University
      2024   Phase 0   ChiCTR2400094060   China
Sodium (S)-3-(4-hydroxyphenyl)-2-(2-((S)-1-((S)-1-palmitoylpyrrolidine-2-carbonyl)pyrrolidine-2-carboxamido)acetamido)propanoate
   Bridge Biotherapeutics, Inc.
      2021   Phase 2   EUCTR2020-003556-33-PL   Korea, Republic of;New Zealand;Poland;Ukraine;United States
Sodium ascorbate
   Hospital Universitario La Paz
      2019   Phase 4   EUCTR2018-001402-28-ES   Spain
Sodium bicarbonate
   IPSEN PHARMA SAS
      2017   Phase 3   EUCTR2016-002265-60-IT   Czech Republic;Czechia;France;Germany;Italy;Netherlands;Poland
Sodium bicarbonate BP
   Ipsen Pharma
      2017   Phase 3   EUCTR2016-002265-60-NL   Czech Republic;France;Germany;Italy;Netherlands;Poland
      2017   Phase 3   EUCTR2016-002265-60-DE   Czech Republic;France;Germany;Italy;Netherlands;Poland
      2017   Phase 3   EUCTR2016-002265-60-CZ   Czech Republic;France;Germany;Italy;Netherlands;Poland
      -   Phase 3   EUCTR2016-002265-60-PL   Czech Republic;France;Germany;Italy;Netherlands;Poland
Sodium chloride
   Hospital Universitario La Paz
      2019   Phase 4   EUCTR2018-001402-28-ES   Spain
   IPSEN PHARMA SAS
      2017   Phase 3   EUCTR2016-002265-60-IT   Czech Republic;Czechia;France;Germany;Italy;Netherlands;Poland
   Ipsen Pharma
      2017   Phase 3   EUCTR2016-002265-60-NL   Czech Republic;France;Germany;Italy;Netherlands;Poland
      2017   Phase 3   EUCTR2016-002265-60-DE   Czech Republic;France;Germany;Italy;Netherlands;Poland
      2017   Phase 3   EUCTR2016-002265-60-CZ   Czech Republic;France;Germany;Italy;Netherlands;Poland
      -   Phase 3   EUCTR2016-002265-60-PL   Czech Republic;France;Germany;Italy;Netherlands;Poland
Sodium hyaluronate
   Holy Stone Healthcare Co., Ltd.
      2015   Phase 2   EUCTR2015-001022-42-IT   Italy
Sodium picosulfate/magnesium citrate laxative
   American University of Beirut Medical Center
      2018   Phase 4   NCT03581149   Lebanon
Sodium sulfate anhydrous
   Hospital Universitario La Paz
      2019   Phase 4   EUCTR2018-001402-28-ES   Spain
   Ipsen Pharma
      2017   Phase 3   EUCTR2016-002265-60-NL   Czech Republic;France;Germany;Italy;Netherlands;Poland
      2017   Phase 3   EUCTR2016-002265-60-DE   Czech Republic;France;Germany;Italy;Netherlands;Poland
      2017   Phase 3   EUCTR2016-002265-60-CZ   Czech Republic;France;Germany;Italy;Netherlands;Poland
      -   Phase 3   EUCTR2016-002265-60-PL   Czech Republic;France;Germany;Italy;Netherlands;Poland
Sodium sulphate anhydrous
   IPSEN PHARMA SAS
      2017   Phase 3   EUCTR2016-002265-60-IT   Czech Republic;Czechia;France;Germany;Italy;Netherlands;Poland
   Ipsen Pharma
      2017   Phase 3   EUCTR2016-002265-60-NL   Czech Republic;France;Germany;Italy;Netherlands;Poland
      2017   Phase 3   EUCTR2016-002265-60-DE   Czech Republic;France;Germany;Italy;Netherlands;Poland
      2017   Phase 3   EUCTR2016-002265-60-CZ   Czech Republic;France;Germany;Italy;Netherlands;Poland
      -   Phase 3   EUCTR2016-002265-60-PL   Czech Republic;France;Germany;Italy;Netherlands;Poland
Solfato DI sodio anidro
   IPSEN PHARMA SAS
      2017   Phase 3   EUCTR2016-002265-60-IT   Czech Republic;Czechia;France;Germany;Italy;Netherlands;Poland
SOLU-medrol
   Copenhagen University Hospital at Herlev
      2019   -   NCT03942861   Denmark
Somatropin
   Royal Hospital For Sick Children, Yorkhill Division
      2004   Phase 4   EUCTR2004-002507-32-GB   United Kingdom
Sonovue
   Gastroenterology MIDT
      2012   Phase 2   EUCTR2011-005846-36-DK   Denmark
   Medical University of Vienna (MUW)
      -   -   EUCTR2015-002882-41-AT   Austria
SOR102
   Sorriso Pharmaceuticals, Inc.
      2023   Phase 1   NCT06080048   Georgia;Ukraine;United Kingdom
Sorbitol sachet
   McMaster University
      2024   -   NCT06541938   Canada
Sotrastaurin (INN) acetate
   Novartis Pharma Services AG
      2007   Phase 2   EUCTR2007-002542-38-DK   Denmark;Germany
Soybean phosphatidylcholine
   Dr. Falk Pharma GmbH
      2016   Phase 3   EUCTR2013-001205-84-HU   Austria;Belgium;Germany;Hungary;Israel;Latvia;Lithuania;Netherlands;Poland;Russian Federation;Slovakia;Switzerland;Ukraine
      2016   Phase 3   EUCTR2013-001205-84-BE   Austria;Belgium;Czech Republic;Germany;Hungary;Israel;Latvia;Lithuania;Netherlands;Poland;Russian Federation;Slovakia;Switzerland;Ukraine
      2015   Phase 3   EUCTR2013-001205-84-SK   Austria;Belgium;Czech Republic;Germany;Hungary;Israel;Latvia;Lithuania;Netherlands;Poland;Russian Federation;Slovakia;Switzerland;Ukraine
      2015   Phase 3   EUCTR2013-001205-84-PL   Austria;Belgium;Czech Republic;Germany;Hungary;Israel;Latvia;Lithuania;Netherlands;Poland;Russian Federation;Slovakia;Switzerland;Ukraine
      2015   Phase 3   EUCTR2013-001205-84-LV   Austria;Belgium;Czech Republic;Germany;Hungary;Israel;Latvia;Lithuania;Netherlands;Poland;Russian Federation;Slovakia;Switzerland;Ukraine
      2015   Phase 3   EUCTR2013-001205-84-DE   Austria;Belgium;Czech Republic;Germany;Hungary;Israel;Latvia;Lithuania;Netherlands;Poland;Russian Federation;Slovakia;Switzerland;Ukraine
      2015   Phase 3   EUCTR2013-001205-84-AT   Austria;Belgium;Czech Republic;Germany;Hungary;Israel;Latvia;Lithuania;Netherlands;Poland;Russian Federation;Slovakia;Switzerland;Ukraine
      2014   Phase 3   EUCTR2012-003702-27-SK   Austria;Belgium;Czech Republic;Germany;Hungary;Israel;Latvia;Lithuania;Netherlands;Poland;Russian Federation;Slovakia;Switzerland;Ukraine
      2014   Phase 3   EUCTR2012-003702-27-PL   Austria;Belgium;Czech Republic;Germany;Hungary;Israel;Latvia;Lithuania;Netherlands;Poland;Russian Federation;Slovakia;Switzerland;Ukraine
      2014   Phase 3   EUCTR2012-003702-27-NL   Austria;Belgium;Czech Republic;Germany;Hungary;Israel;Latvia;Lithuania;Netherlands;Poland;Russian Federation;Slovakia;Switzerland;Ukraine
      2014   Phase 3   EUCTR2012-003702-27-LV   Austria;Belgium;Czech Republic;Germany;Hungary;Israel;Latvia;Lithuania;Netherlands;Poland;Russian Federation;Slovakia;Switzerland;Ukraine
      2014   Phase 3   EUCTR2012-003702-27-LT   Austria;Belgium;Czech Republic;Germany;Hungary;Israel;Latvia;Lithuania;Netherlands;Poland;Russian Federation;Slovakia;Switzerland;Ukraine
      2014   Phase 3   EUCTR2012-003702-27-HU   Austria;Belgium;Czech Republic;Germany;Hungary;Israel;Latvia;Lithuania;Netherlands;Poland;Russian Federation;Slovakia;Switzerland;Ukraine
      2014   Phase 3   EUCTR2012-003702-27-DE   Austria;Belgium;Czech Republic;Germany;Hungary;Israel;Latvia;Lithuania;Netherlands;Poland;Russian Federation;Slovakia;Switzerland;Ukraine
      2014   Phase 3   EUCTR2012-003702-27-CZ   Austria;Belgium;Czech Republic;Germany;Hungary;Israel;Latvia;Lithuania;Netherlands;Poland;Russian Federation;Slovakia;Switzerland;Ukraine
      2014   Phase 3   EUCTR2012-003702-27-BE   Austria;Belgium;Czech Republic;Germany;Hungary;Israel;Latvia;Lithuania;Netherlands;Poland;Russian Federation;Slovakia;Switzerland;Ukraine
      2014   Phase 3   EUCTR2012-003702-27-AT   Austria;Belgium;Czech Republic;Germany;Hungary;Israel;Latvia;Lithuania;Netherlands;Poland;Russian Federation;Slovakia;Switzerland;Ukraine
SPD476
   Shire
      2005   Phase 3   NCT00151892   Argentina;Australia;Belgium;Brazil;Canada;Chile;Czech Republic;Czechia;Denmark;France;Germany;Hungary;India;Korea, Republic of;Mexico;Netherlands;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Singapore;South Africa;Spain;Sweden;Taiwan;United Kingdom;United States
      2003   Phase 3   NCT00151944   -
   Shire Development Inc
      2012   -   EUCTR2011-000164-10-SK   Slovakia;United Kingdom;United States
      2010   Phase 4   EUCTR2009-017044-13-FR   Belgium;Czech Republic;France;Germany;Hungary;Ireland;Spain;United Kingdom
      2010   -   EUCTR2009-017044-13-DE   Canada;Colombia;Czech Republic;France;Germany;Hungary;India;Ireland;Poland;Russian Federation;South Africa;Spain;United Kingdom;United States
   Shire Development Inc.
      2010   Phase 4   EUCTR2009-017044-13-ES   Belgium;Czech Republic;France;Germany;Hungary;Ireland;Spain;United Kingdom
   Shire Development LLC
      2018   Phase 3   EUCTR2013-001744-65-DE   Belgium;Canada;Germany;Hungary;Israel;Netherlands;Poland;Slovakia;Sweden;United Kingdom;United States
      2018   Phase 3   EUCTR2013-001744-65-BE   Belgium;Canada;Germany;Hungary;Israel;Netherlands;Poland;Slovakia;Sweden;United Kingdom;United States
      2014   Phase 3   EUCTR2013-001744-65-GB   Belgium;Canada;Germany;Hungary;Israel;Netherlands;Poland;Slovakia;Sweden;United Kingdom;United States
      2013   Phase 1   EUCTR2011-000164-10-GB   Australia;Poland;Slovakia;United Kingdom;United States
      2010   -   EUCTR2009-017044-13-IE   Canada;Colombia;Czech Republic;France;Germany;Hungary;India;Ireland;Poland;Russian Federation;South Africa;Spain;United Kingdom;United States
      2010   -   EUCTR2009-017044-13-HU   Canada;Colombia;Czech Republic;France;Germany;Hungary;India;Ireland;Poland;Russian Federation;South Africa;Spain;United Kingdom;United States
      2010   Phase 4   EUCTR2009-017044-13-GB   Belgium;Canada;Colombia;Czech Republic;France;Germany;Hungary;India;Ireland;Poland;Russian Federation;South Africa;Spain;United Kingdom;United States
      2010   -   EUCTR2009-017044-13-CZ   Canada;Colombia;Czech Republic;France;Germany;Hungary;India;Ireland;Poland;Russian Federation;South Africa;Spain;United Kingdom;United States
      2010   Phase 4   EUCTR2009-017044-13-BE   Belgium;Canada;Colombia;Czech Republic;France;Germany;Hungary;India;Ireland;Poland;Russian Federation;South Africa;Spain;United Kingdom;United States
   Shire Devlopment LLC
      2015   Phase 3   EUCTR2013-001744-65-NL   Belgium;Canada;Germany;Hungary;Israel;Netherlands;Poland;Slovakia;United Kingdom;United States
      2014   Phase 3   EUCTR2013-001744-65-SK   Belgium;Canada;Germany;Hungary;Israel;Netherlands;Poland;Slovakia;Sweden;United Kingdom;United States
      2014   Phase 3   EUCTR2013-001744-65-PL   Belgium;Canada;Germany;Hungary;Israel;Netherlands;Poland;Slovakia;Sweden;United Kingdom;United States
      2014   Phase 3   EUCTR2013-001744-65-HU   Belgium;Canada;Germany;Hungary;Israel;Netherlands;Poland;Slovakia;United Kingdom;United States
   Shire Pharmaceutical Development Inc
      2004   Phase 3   EUCTR2004-000733-12-CZ   Czech Republic
   Shire Pharmaceutical Development Inc.
      2005   Phase 3   EUCTR2004-000734-36-CZ   Czech Republic
   Shire Pharmaceutical Development Ltd
      2009   -   EUCTR2004-004184-29-DK   Czech Republic;Denmark;Germany;Hungary;Netherlands;Portugal;Spain;Sweden;United Kingdom
      2008   Phase 3   EUCTR2004-004184-29-NL   Czech Republic;Denmark;Germany;Hungary;Netherlands;Portugal;Spain;Sweden;United Kingdom
      2007   -   EUCTR2004-004184-29-SE   Czech Republic;Denmark;Germany;Hungary;Netherlands;Portugal;Spain;Sweden;United Kingdom
      2007   -   EUCTR2004-004184-29-PT   Czech Republic;Denmark;Germany;Hungary;Netherlands;Portugal;Spain;Sweden;United Kingdom
      2005   Phase 3   EUCTR2004-004184-29-HU   Czech Republic;Denmark;Germany;Hungary;Netherlands;Portugal;Spain;Sweden;United Kingdom
      2005   Phase 3   EUCTR2004-004184-29-GB   Czech Republic;Denmark;Germany;Hungary;Netherlands;Portugal;Spain;Sweden;United Kingdom
      2005   -   EUCTR2004-004184-29-ES   Czech Republic;Denmark;Germany;Hungary;Netherlands;Portugal;Spain;Sweden;United Kingdom
      2005   -   EUCTR2004-004184-29-DE   Czech Republic;Denmark;Germany;Hungary;Netherlands;Portugal;Spain;Sweden;United Kingdom
      2005   -   EUCTR2004-004184-29-CZ   Czech Republic;Denmark;Germany;Hungary;Netherlands;Portugal;Spain;Sweden;United Kingdom
SPD476 IS A polymeric matrix formulation that displays both delayed- and extended-release OF mesalazine
   Shire
      2003   Phase 3   NCT00548574   Belgium
      2003   Phase 2   NCT00545389   Belgium
Spesolimab
   BOEHRINGER-INGELHEIM ITALIA S.P.A.
      2018   Phase 2   EUCTR2018-000334-35-IT   Australia;Austria;Belgium;Canada;Germany;Hungary;Italy;Japan;Korea, Republic of;Netherlands;Norway;Poland;Russian Federation;Spain;United Kingdom;United States
   Boehringer Ingelheim
      2018   Phase 2/Phase 3   NCT03482635   Australia;Austria;Belgium;Canada;Czechia;Denmark;Germany;Greece;Hungary;Italy;Japan;Korea, Republic of;Netherlands;Norway;Poland;Russian Federation;Spain;United Kingdom;United States
      2018   Phase 2   JPRN-jRCT2080224139   Asia except Japan;Europe;Japan;North America;Oceania
      2018   Phase 2-3   JPRN-jRCT2080223993   Asia except Japan;Europe;Japan;North America;Oceania
      2017   Phase 2   NCT03123120   Denmark;Germany;Ireland;Netherlands;Norway;Spain;United Kingdom
      2017   Phase 2   NCT03100864   Belgium;Germany;United Kingdom
   Boehringer Ingelheim Denmark A/S
      2019   Phase 2;Phase 3   EUCTR2017-004230-28-DK   Argentina;Australia;Austria;Belgium;Canada;China;Czech Republic;Denmark;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Norway;Poland;Russian Federation;Spain;Taiwan;United Kingdom;United States
   Boehringer Ingelheim International GmbH
      2019   Phase 2;Phase 3   EUCTR2017-004230-28-HU   Argentina;Australia;Austria;Belgium;Canada;China;Czech Republic;Denmark;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Norway;Poland;Russian Federation;Spain;Taiwan;United Kingdom;United States
   Boehringer Ingelheim LImited
      2018   Phase 2   EUCTR2018-000334-35-GB   Austria;Belgium;Canada;Germany;Hungary;Italy;Japan;Korea, Republic of;Netherlands;Norway;Poland;Russian Federation;Spain;United Kingdom;United States
   Boehringer Ingelheim Limited
      2018   Phase 2;Phase 3   EUCTR2017-004230-28-GB   Argentina;Australia;Austria;Belgium;Canada;China;Czech Republic;Denmark;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Norway;Poland;Russian Federation;Spain;Taiwan;United Kingdom;United States
   Boehringer Ingelheim Norway KS
      2019   Phase 2   EUCTR2018-000334-35-NO   Austria;Belgium;Canada;Germany;Hungary;Italy;Japan;Korea, Republic of;Netherlands;Norway;Poland;Russian Federation;Spain;United Kingdom;United States
   Boehringer Ingelheim Pharma GmbH & Co. KG
      2018   Phase 2   EUCTR2018-000334-35-DE   Australia;Austria;Belgium;Canada;Czechia;Denmark;Germany;Greece;Hungary;Italy;Japan;Korea, Republic of;Netherlands;Norway;Poland;Russian Federation;Spain;United Kingdom;United States
      2018   Phase 2;Phase 3   EUCTR2017-004230-28-DE   Argentina;Australia;Austria;Belgium;Canada;China;Czech Republic;Denmark;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Norway;Poland;Russian Federation;Spain;Taiwan;United Kingdom;United States
   Boehringer Ingelheim RCV GmbH & Co KG
      2018   Phase 2;Phase 3   EUCTR2017-004230-28-AT   Argentina;Australia;Austria;Belgium;Canada;China;Czech Republic;Denmark;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Norway;Poland;Russian Federation;Spain;Taiwan;United Kingdom;United States
   Boehringer Ingelheim RCV GmbH&Co. KG
      2019   Phase 2   EUCTR2018-000334-35-PL   Australia;Austria;Belgium;Canada;Czechia;Denmark;Germany;Greece;Hungary;Italy;Japan;Korea, Republic of;Netherlands;Norway;Poland;Russian Federation;Spain;United Kingdom;United States
      2018   Phase 2   EUCTR2018-000334-35-AT   Austria;Belgium;Canada;Germany;Hungary;Italy;Japan;Korea, Republic of;Netherlands;Norway;Poland;Russian Federation;Spain;United Kingdom;United States
   SCS Boehringer Ingelheim Comm. V
      2018   Phase 2   EUCTR2018-000334-35-BE   Austria;Belgium;Canada;Germany;Hungary;Italy;Japan;Korea, Republic of;Netherlands;Norway;Poland;Russian Federation;Spain;United Kingdom;United States
Spesolimab IV infusion
   Boehringer Ingelheim
      2018   Phase 2   NCT03648541   Austria;Belgium;Canada;Germany;Italy;Japan;Korea, Republic of;Poland;Russian Federation;Spain;United Kingdom;United States
Spesolimab SC solution FOR injection
   Boehringer Ingelheim
      2018   Phase 2   NCT03648541   Austria;Belgium;Canada;Germany;Italy;Japan;Korea, Republic of;Poland;Russian Federation;Spain;United Kingdom;United States
SPH3127
   Shanghai Pharma Biotherapeutics USA Inc.
      2022   Phase 2   NCT05019742   United States
SPH3127 tablets with dose A
   Shanghai Pharmaceuticals Holding Co., Ltd
      2023   Phase 2   NCT05770609   China
SPH3127 tablets with dose B
   Shanghai Pharmaceuticals Holding Co., Ltd
      2023   Phase 2   NCT05770609   China
SPH7854
   Shanghai Pharmaceuticals Holding Co., Ltd
      2024   Early Phase 1   NCT06483373   China
SR140333B
   SANOFI-SYNTHELABO
      2005   -   EUCTR2004-001677-26-IT   Czech Republic;Estonia;Hungary;Italy;Spain;Sweden
   Sanofi-Synthelabo Recherche
      2005   -   EUCTR2004-001677-26-SE   Czech Republic;Estonia;Hungary;Italy;Spain;Sweden
      2005   Phase 2   EUCTR2004-001677-26-HU   Czech Republic;Estonia;Hungary;Italy;Spain;Sweden
      2005   Phase 2   EUCTR2004-001677-26-ES   Czech Republic;Estonia;Hungary;Italy;Spain;Sweden
      2005   -   EUCTR2004-001677-26-EE   Czech Republic;Estonia;Hungary;Italy;Spain;Sweden
   sanofi-aventis recherche & developpement
      2004   -   EUCTR2004-001677-26-CZ   Czech Republic;Estonia;Hungary;Italy;Spain;Sweden
SRT2104
   Sirtris, a GSK Company
      2012   Phase 1   NCT01453491   United States
ST 261
   SIGMA-TAU
      2012   -   EUCTR2011-004765-32-IT   Belgium;Czech Republic;Italy;Netherlands
   Sigma-Tau Industrie Farmaceutiche Riunite S.p.A.
      2012   -   EUCTR2011-004770-28-PL   Austria;France;Germany;Hungary;Latvia;Lithuania;Poland;Spain
      2012   -   EUCTR2011-004770-28-LV   Austria;France;Germany;Hungary;Latvia;Lithuania;Poland;Spain
      2012   -   EUCTR2011-004770-28-LT   Austria;France;Germany;Hungary;Latvia;Lithuania;Poland;Spain
      2012   -   EUCTR2011-004770-28-HU   Austria;Germany;Hungary;Latvia;Lithuania;Poland;Spain
      2012   Phase 3   EUCTR2011-004770-28-ES   Austria;France;Germany;Hungary;Latvia;Lithuania;Poland;Spain
      2012   -   EUCTR2011-004770-28-DE   Austria;Germany;Hungary;Latvia;Lithuania;Poland;Spain
      2012   -   EUCTR2011-004770-28-AT   Austria;Germany;Hungary;Latvia;Lithuania;Poland;Spain
      2012   Phase 3   EUCTR2011-004765-32-SK   Belgium;Czech Republic;Italy;Netherlands;Slovakia
      2012   Phase 3   EUCTR2011-004765-32-NL   Belgium;Czech Republic;Israel;Italy;Netherlands;Russian Federation;Slovakia
      2012   -   EUCTR2011-004765-32-CZ   Belgium;Czech Republic;Italy;Netherlands
      2012   Phase 3   EUCTR2011-004765-32-BE   Belgium;Czech Republic;Italy;Netherlands;Slovakia
ST-0529
   Sublimity Therapeutics (Hold Co) Ltd.
      2019   Phase 2   EUCTR2018-003349-41-RO   Belarus;Bulgaria;Canada;France;Germany;Hungary;Israel;Italy;Poland;Romania;Russian Federation;Serbia;Ukraine;United Kingdom;United States
      2019   Phase 2   EUCTR2018-003349-41-PL   Belarus;Bulgaria;Canada;France;Germany;Hungary;Israel;Italy;Poland;Russian Federation;Serbia;Ukraine;United Kingdom;United States
      2019   Phase 2   EUCTR2018-003349-41-HU   Belarus;Belgium;Bulgaria;Canada;France;Germany;Hungary;Ireland;Israel;Poland;Romania;Russian Federation;Serbia;Spain;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 2   EUCTR2018-003349-41-GB   Belarus;Bulgaria;Canada;France;Germany;Hungary;Ireland;Israel;Italy;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
      2019   Phase 2   EUCTR2018-003349-41-FR   Belarus;Bulgaria;Canada;France;Germany;Hungary;Ireland;Israel;Italy;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
      2019   Phase 2   EUCTR2018-003349-41-DE   Belarus;Bulgaria;Canada;France;Germany;Hungary;Israel;Poland;Russian Federation;Serbia;Ukraine;United Kingdom;United States
      2019   Phase 2   EUCTR2018-003349-41-BG   Belarus;Bulgaria;Canada;France;Germany;Hungary;Ireland;Israel;Italy;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
   Sublimity Therapeutics HoldCo Limited
      2019   Phase 2   EUCTR2018-003349-41-IT   Belarus;Bulgaria;Canada;France;Germany;Hungary;Ireland;Israel;Italy;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
   Sublimity Therapeutics Holdco Limited
      2019   Phase 2   NCT03844932   Belarus;Bulgaria;Canada;France;Germany;Hungary;Ireland;Israel;Italy;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
ST10
   Shield Therapeutics
      2011   Phase 3   NCT01352221   Austria;United Kingdom
ST10-021
   Iron Therapeutics (Switzerland) AG
      2012   -   EUCTR2010-023588-16-DE   Austria;Germany;Hungary;United Kingdom
      2011   -   EUCTR2010-023588-16-HU   Austria;Germany;Hungary;United Kingdom
      2011   Phase 3   EUCTR2010-023588-16-GB   Austria;Germany;Hungary;United Kingdom
      2011   -   EUCTR2010-023588-16-AT   Austria;Germany;Hungary;United Kingdom
   Iron Therapeutics (UK) Ltd.
      2016   Phase 3   EUCTR2015-002496-26-ES   Belgium;Germany;Hungary;Spain
      2015   Phase 3   EUCTR2015-002496-26-BE   Belgium;Germany;Hungary;Spain
   Shield TX (UK) Ltd.
      2017   Phase 3   EUCTR2015-002496-26-HU   Belgium;France;Germany;Hungary;Spain;United States
      2015   Phase 3   EUCTR2015-002496-26-DE   Belgium;France;Germany;Hungary;Spain;United States
   Shield Therapeutics
      2011   Phase 3   NCT01340872   Austria;United Kingdom
ST261
   SIGMA-TAU
      2012   -   EUCTR2011-004765-32-IT   Belgium;Czech Republic;Italy;Netherlands
      2008   -   EUCTR2005-003471-20-LT   Italy;Lithuania
      2005   -   EUCTR2005-003471-20-IT   Italy;Lithuania
   Sigma-Tau Industrie Farmaceutiche Riunite S.p.A.
      2012   -   EUCTR2011-004770-28-PL   Austria;France;Germany;Hungary;Latvia;Lithuania;Poland;Spain
      2012   -   EUCTR2011-004770-28-LV   Austria;France;Germany;Hungary;Latvia;Lithuania;Poland;Spain
      2012   -   EUCTR2011-004770-28-LT   Austria;France;Germany;Hungary;Latvia;Lithuania;Poland;Spain
      2012   -   EUCTR2011-004770-28-HU   Austria;Germany;Hungary;Latvia;Lithuania;Poland;Spain
      2012   Phase 3   EUCTR2011-004770-28-ES   Austria;France;Germany;Hungary;Latvia;Lithuania;Poland;Spain
      2012   -   EUCTR2011-004770-28-DE   Austria;Germany;Hungary;Latvia;Lithuania;Poland;Spain
      2012   -   EUCTR2011-004770-28-AT   Austria;Germany;Hungary;Latvia;Lithuania;Poland;Spain
      2012   Phase 3   EUCTR2011-004765-32-SK   Belgium;Czech Republic;Italy;Netherlands;Slovakia
      2012   Phase 3   EUCTR2011-004765-32-NL   Belgium;Czech Republic;Israel;Italy;Netherlands;Russian Federation;Slovakia
      2012   -   EUCTR2011-004765-32-CZ   Belgium;Czech Republic;Italy;Netherlands
      2012   Phase 3   EUCTR2011-004765-32-BE   Belgium;Czech Republic;Italy;Netherlands;Slovakia
Standard 2 hours-infusion
   Asan Medical Center
      2011   Phase 4   NCT01346826   Korea, Republic of
Standard hepatitis B vaccine
   Assiut University
      2023   -   NCT05967650   -
Standard therapy
   Merck Sharp & Dohme Corp.
      2007   -   NCT00705484   Austria;Belgium;Czech Republic;Denmark;France;Germany;Greece;Ireland;Italy;Netherlands;Spain;Sweden;United Kingdom;United States
Standardized anthocyanin-rich extract
   University of Zurich
      2019   Phase 2   NCT04000139   Switzerland
Standardized FMT
   The Second Hospital of Nanjing Medical University
      2013   Phase 2/Phase 3   NCT01790061   China
Standardized fodmap
   Vendsyssel Hospital
      2018   -   NCT02469220   Denmark
Stelara
   Janssen-Cilag International N.V.
      2020   Phase 3   EUCTR2018-002629-51-GB   Austria;France;Germany;Italy;Netherlands;Spain;Sweden;United Kingdom;United States
      2019   Phase 3   EUCTR2018-002629-51-SE   Austria;Czech Republic;Czechia;France;Germany;Italy;Korea, Republic of;Netherlands;Russian Federation;Spain;Sweden;United Kingdom;United States
      2019   Phase 3   EUCTR2018-002629-51-FR   Austria;Czech Republic;France;Germany;Italy;Netherlands;Spain;Sweden;United Kingdom;United States
      2018   Phase 3   EUCTR2018-002629-51-ES   France;Germany;Netherlands;Spain;Sweden;United States
   Janssen-Cilag International NV
      2022   Phase 3   EUCTR2020-004457-76-HU   Argentina;Belgium;France;Germany;Hungary;Italy;Japan;Poland;Russian Federation;Spain;Turkey;United Kingdom;United States
      2022   Phase 3   EUCTR2020-004457-76-DE   Argentina;Belgium;France;Germany;Hungary;Italy;Japan;Poland;Russian Federation;Spain;Turkey;United Kingdom;United States
      2022   Phase 3   EUCTR2020-004457-76-BE   Argentina;Belgium;France;Germany;Hungary;Italy;Japan;Poland;Russian Federation;Spain;Turkey;United Kingdom;United States
      2021   Phase 3   EUCTR2020-004457-76-PL   Argentina;Belgium;France;Germany;Hungary;Japan;Poland;Russian Federation;Turkey;United States
      2021   Phase 3   EUCTR2019-004224-38-DE   Belgium;Germany;Hungary;Japan;Poland;United Kingdom;United States
      2021   Phase 3   EUCTR2019-004224-38-BE   Belgium;Germany;Hungary;Japan;Poland;Russian Federation;United Kingdom;United States
      2021   Phase 3   EUCTR2018-002629-51-CZ   Austria;Czech Republic;Czechia;France;Germany;Italy;Korea, Republic of;Netherlands;Russian Federation;Spain;Sweden;United Kingdom;United States
      2020   Phase 3   EUCTR2019-004224-38-HU   Belgium;Germany;Hungary;Japan;Poland;Russian Federation;United Kingdom;United States
      2019   Phase 3   EUCTR2018-002629-51-NL   Austria;Czech Republic;Czechia;France;Germany;Italy;Korea, Republic of;Netherlands;Russian Federation;Spain;Sweden;United Kingdom;United States
      2019   Phase 3   EUCTR2018-002629-51-AT   Austria;Czech Republic;Czechia;France;Germany;Italy;Korea, Republic of;Netherlands;Russian Federation;Spain;Sweden;United Kingdom;United States
      2016   Phase 3   EUCTR2014-005606-38-PL   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;United Kingdom;United States
      2015   Phase 3   EUCTR2014-005606-38-SK   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;United Kingdom;United States
      2015   Phase 3   EUCTR2014-005606-38-NL   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;United Kingdom;United States
      2015   Phase 3   EUCTR2014-005606-38-HU   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;United Kingdom;United States
      2015   Phase 3   EUCTR2014-005606-38-DK   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;United Kingdom;United States
      2015   Phase 3   EUCTR2014-005606-38-DE   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;United Kingdom;United States
      2015   Phase 3   EUCTR2014-005606-38-CZ   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;United Kingdom;United States
      2015   Phase 3   EUCTR2014-005606-38-BG   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;United Kingdom;United States
      2015   Phase 3   EUCTR2014-005606-38-BE   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;United Kingdom;United States
      2015   Phase 3   EUCTR2014-005606-38-AT   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;United Kingdom;United States
      -   Phase 3   EUCTR2019-004224-38-PL   Belgium;Germany;Hungary;Japan;Poland;Russian Federation;United Kingdom;United States
      -   Phase 3   EUCTR2019-004224-38-Outside-EU/EEA   Belgium;Germany;Hungary;Japan;Poland;Russian Federation;United Kingdom;United States
      -   Phase 3   EUCTR2019-004224-38-GB   Belgium;Germany;Hungary;Japan;Poland;Russian Federation;United Kingdom;United States
Stelara - 45 MG soluzione iniettabile - USO sottocutaneo - flaconcino (vetro) 0.5 ML (90 MG/ML) 1 flaconcino
   JANSSEN CILAG INTERNATIONAL NV
      2019   Phase 3   EUCTR2018-002629-51-IT   Austria;Czech Republic;France;Germany;Italy;Netherlands;Spain;Sweden;United Kingdom;United States
Stelara - 90 MG - soluzione iniettabile IN siringhe preriempite - USO sottocutaneo - siringa preriempita(vetro) 1 ML(90MG/ML) 1 siringa preriempita DA 1 ML
   AZIENDA SOCIO SANITARIA TERRITORIALE DEI SETTE LAGHI
      2022   Phase 2   EUCTR2021-001984-25-IT   Italy
Stelara - 90 MG soluzione iniettabile - USO sottocutaneo - flaconcino (vetro) 1.0 ML (90 MG/ML) 1 flaconcino
   JANSSEN CILAG INTERNATIONAL NV
      2019   Phase 3   EUCTR2018-002629-51-IT   Austria;Czech Republic;France;Germany;Italy;Netherlands;Spain;Sweden;United Kingdom;United States
      2015   Phase 3   EUCTR2014-005606-38-IT   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;United Kingdom;United States
Stelara®
   Janssen-Cilag International NV
      2021   Phase 3   EUCTR2020-004457-76-FR   Argentina;Belgium;France;Germany;Hungary;Italy;Japan;Poland;Russian Federation;Spain;Turkey;United Kingdom;United States
Sterile saline FOR injection
   Bristol-Myers Squibb
      2008   Phase 2   NCT00656890   Canada;Czech Republic;Hungary;Latvia;Romania;Russian Federation;Ukraine;United States
Steroids
   Insel Gruppe AG, University Hospital Bern
      2023   -   NCT05702879   Switzerland
   Medical University of Graz
      2018   -   NCT03460847   Austria
   Southern Medical University, Nanfang Hospital, Department of Gastroenterology
      2015   -   ChiCTR-ICR-15007188   China
STNM01 1.84 MG
   STELIC INSTITUTE & CO.
      2013   Phase 2   EUCTR2012-004768-23-DE   Germany
Stool samples
   University Hospital, Bordeaux
      2020   -   NCT04272307   France
STW5-II
   Bayer
      2014   Phase 2   NCT02246686   Germany
   Steigerwald Arzneimittelwerk GmbH
      2014   -   EUCTR2013-000891-13-DE   Germany
SUB20016
   PIBD net
      2018   Phase 4   EUCTR2016-000522-18-GB   Belgium;Canada;Czech Republic;France;Germany;Israel;Italy;Netherlands;Poland;Spain;United Kingdom
Sucrosomial iron
   American University of Beirut Medical Center
      2019   Phase 3   NCT05225545   Lebanon
   IRCCS Policlinico S. Matteo
      2020   Phase 3   NCT04587141   Italy
Sugar extract
   Oslo University Hospital
      2011   Phase 2/Phase 3   NCT01496053   Norway
Sulfur hexafluoride
   Gastroenterology MIDT
      2012   Phase 2   EUCTR2011-005846-36-DK   Denmark
   Medical University of Vienna (MUW)
      -   -   EUCTR2015-002882-41-AT   Austria
Sulphsalazine, pentasa, asacol, colazide, depentum
   University of Nottingham
      2005   Phase 4   EUCTR2005-000695-40-GB   United Kingdom
Sulphur hexafluoride
   Gastroenterology MIDT
      2012   Phase 2   EUCTR2011-005846-36-DK   Denmark
   Medical University of Vienna (MUW)
      -   -   EUCTR2015-002882-41-AT   Austria
Suspension containing 7500 embryonated viable trichuris suis OVA/15ML
   ParaTech A/S
      2018   Phase 2   EUCTR2017-004772-65-DK   Denmark
Suspension DE microbiote FéCAL
   CHU Nantes
      2018   Phase 3   EUCTR2017-004967-11-FR   France
Suspension OF adipose derived autologous adult stem cells
   CELLERIX, S.L.
      2008   -   EUCTR2006-003370-95-NL   Germany;Netherlands;Spain
      2008   -   EUCTR2006-003370-95-DE   Germany;Netherlands;Spain
      2007   Phase 3   EUCTR2006-003370-95-ES   Germany;Netherlands;Spain
Synergy-1
   University of Alberta
      2016   -   NCT02865707   Canada
Synergy1
   University of Alberta
      2007   -   NCT02093767   Canada
Süßholzwurzel 1ML/10ML
   Steigerwald Arzneimittelwerk GmbH
      2014   -   EUCTR2013-000891-13-DE   Germany
TA-650
   Mitsubishi Tanabe Pharma Corporation
      2012   Phase 3   NCT01585155   Japan
      2006   Phase 3   JPRN-jRCT2080220293   -
Tacrolimus
   Astellas Pharma Inc
      2006   Phase 3   NCT00643071   Japan
      2006   Phase 3   NCT00347048   Japan
   Chiba University Hospital
      2013   -   JPRN-UMIN000010776   Japan
   Department of Internal Medicine, Division of Gastroenterology and Hepatology, Keio University School of Medicine
      2013   Phase 4   JPRN-UMIN000010612   Japan
   Department of Internal medicine, Division of Lower Gastroenterology, Hyogo College of Medicine
      2010   Phase 3   JPRN-UMIN000003785   Japan
   Department of lower gastroenterology, Hyogo College of Medicine
      2010   Phase 4   JPRN-UMIN000003952   Japan
   Juntendo University
      2011   -   JPRN-UMIN000005824   Japan
   Keio University Gastroenterology and Hepatology
      2016   -   JPRN-UMIN000024936   Japan
   Kitasato University Kitasato Institute Hospital
      2014   -   JPRN-UMIN000013694   Japan
   Medical College of Wisconsin
      2017   Phase 3   NCT02954159   United States
   National Institute of Allergy and Infectious Diseases (NIAID)
      2007   Phase 2   NCT00514982   United States
   Osaka City University, Graduate School of Medicine,Department of Gastroenterology
      2013   -   JPRN-UMIN000004201   Japan
   Osaka Medical College
      2014   -   JPRN-UMIN000015912   Japan
   Saitama Medical Center, Saitama Medical University
      2011   -   JPRN-UMIN000005033   Japan
   Yokohama City University Medical Center
      2014   Phase 2   JPRN-UMIN000013716   Japan
Tacrolimus lipid suspension FOR enema
   Jina Pharmaceuticals Inc.
      2025   Phase 2   NCT06867042   -
TAK-279
   Takeda
      2024   Phase 2   NCT06254950   Australia;Belgium;Bulgaria;Canada;China;Czechia;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Netherlands;Norway;Poland;Romania;Slovakia;Spain;Switzerland;Taiwan;United Kingdom;United States
Tauroursoursodeoxycholic acid, brand name tudcabil
   Washington University School of Medicine
      2019   Phase 1   NCT04114292   United States
TD-1473
   Theravance Biopharma
      2018   Phase 1   NCT03555617   United States
      2016   Phase 1   NCT02818686   Georgia;Moldova, Republic of;Romania;United States
   Theravance Biopharma Ireland Limited
      2021   Phase 3   EUCTR2018-002135-19-FR   Australia;Bulgaria;Canada;Croatia;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Democratic People's Republic of;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2020   Phase 2;Phase 3   EUCTR2018-002136-24-RO   Australia;Bulgaria;Canada;Croatia;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2020   Phase 2;Phase 3   EUCTR2018-002136-24-IT   Australia;Bulgaria;Canada;Croatia;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2020   Phase 3   EUCTR2018-002135-19-RO   Australia;Bulgaria;Canada;Croatia;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2020   Phase 3   EUCTR2018-002135-19-IT   Australia;Bulgaria;Canada;Croatia;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2019   Phase 2;Phase 3   EUCTR2018-002136-24-SK   Australia;Bulgaria;Canada;Croatia;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2019   Phase 2;Phase 3   EUCTR2018-002136-24-PT   Australia;Bulgaria;Canada;Croatia;France;Georgia;Germany;Greece;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2019   Phase 2;Phase 3   EUCTR2018-002136-24-PL   Australia;Bulgaria;Canada;Croatia;France;Georgia;Germany;Greece;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2019   Phase 2;Phase 3   EUCTR2018-002136-24-HU   Australia;Bulgaria;Canada;Croatia;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2019   Phase 2;Phase 3   EUCTR2018-002136-24-GR   Australia;Bulgaria;Canada;Croatia;France;Georgia;Germany;Greece;Hungary;India;Israel;Italy;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2019   Phase 2;Phase 3   EUCTR2018-002136-24-FR   Australia;Bulgaria;Canada;Croatia;France;Georgia;Germany;Greece;Hungary;India;Israel;Italy;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2019   Phase 2;Phase 3   EUCTR2018-002136-24-ES   Australia;Bulgaria;Canada;Croatia;France;Georgia;Germany;Greece;Hungary;India;Israel;Italy;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2019   Phase 2;Phase 3   EUCTR2018-002136-24-DE   Australia;Bulgaria;Canada;Croatia;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2019   Phase 2;Phase 3   EUCTR2018-002136-24-BG   Australia;Bulgaria;Canada;Croatia;France;Georgia;Germany;Greece;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2018-002135-19-SK   Australia;Bulgaria;Canada;Croatia;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2018-002135-19-PT   Australia;Bulgaria;Canada;Croatia;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2018-002135-19-PL   Australia;Bulgaria;Canada;Croatia;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2018-002135-19-HU   Australia;Bulgaria;Canada;Croatia;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2018-002135-19-GR   Australia;Bulgaria;Canada;Croatia;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2018-002135-19-ES   Australia;Bulgaria;Canada;Croatia;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2018-002135-19-DE   Australia;Bulgaria;Canada;Croatia;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2018-002135-19-BG   Australia;Bulgaria;Canada;Croatia;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
TD-1473 dose A
   Theravance Biopharma
      2020   Phase 2/Phase 3   NCT03920254   Australia;Bulgaria;Canada;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Poland;Portugal;Romania;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United States
      2019   Phase 2/Phase 3   NCT03758443   Australia;Bulgaria;Canada;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Poland;Portugal;Romania;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United States
TD-1473 dose B
   Theravance Biopharma
      2020   Phase 2/Phase 3   NCT03920254   Australia;Bulgaria;Canada;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Poland;Portugal;Romania;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United States
      2019   Phase 2/Phase 3   NCT03758443   Australia;Bulgaria;Canada;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Poland;Portugal;Romania;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United States
TD-1473 dose C
   Theravance Biopharma
      2020   Phase 2/Phase 3   NCT03920254   Australia;Bulgaria;Canada;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Poland;Portugal;Romania;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United States
      2019   Phase 2/Phase 3   NCT03758443   Australia;Bulgaria;Canada;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Poland;Portugal;Romania;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United States
TD-3504
   Theravance Biopharma
      2017   Phase 1   NCT03103412   United States
Telotristat etiprate
   Lexicon Pharmaceuticals
      2012   Phase 2   NCT01456052   Lithuania;Poland;Slovakia;United States
   Lexicon Pharmaceuticals, Inc.
      2012   -   EUCTR2011-003532-32-LT   Belgium;Lithuania;Poland;Slovakia;United States
      2011   -   EUCTR2011-003532-32-SK   Belgium;Lithuania;Poland;Slovakia;United States
Terbinafine
   Hamilton Health Sciences Corporation
      2016   Phase 2   NCT02606032   Canada
Terbinafine tablets
   Oregon Health and Science University
      2021   Early Phase 1   NCT05119712   United States
Tetomilast
   Otsuka Pharmaceutical Co., Ltd.
      2006   Phase 2   NCT00317356   Japan
Tetracycline
   Division of General Medicine, Department of Internal Medicine, Nihon University School of Medicine
      2013   Phase 3   JPRN-UMIN000009811   Japan
   Hokkaido University Hospital
      2016   -   JPRN-UMIN000024520   Japan
   Japan UC Antibiotics-therapy Study Group(JUCASG)
      2003   Phase 2   JPRN-C000000078   Japan
   Juntendo University
      2008   -   JPRN-UMIN000048515   Japan
   Juntendo University Graduate School of Medicine
      2002   -   JPRN-UMIN000053277   Japan
   Shiga University of Medical Science
      2015   -   JPRN-UMIN000017844   Japan
TEV-48574
   TEVA BRANDED PHARMACEUTICAL PRODUCTS R&D, INC
      2023   Phase 2   EUCTR2022-002593-89-IT   Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Hungary;Israel;Italy;Norway;Poland;Slovakia;Spain;United Kingdom;United States
   Teva Branded Pharmaceutical Products R&D, Inc.
      2023   Phase 2   EUCTR2022-002593-89-HU   Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Hungary;Israel;Italy;Norway;Poland;Slovakia;Spain;United Kingdom;United States
      2023   Phase 2   EUCTR2022-002593-89-FR   Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Hungary;Israel;Italy;Norway;Poland;Slovakia;Spain;United Kingdom;United States
      2023   Phase 2   EUCTR2022-002593-89-CZ   Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;France;Georgia;Germany;Hungary;Israel;Italy;Japan;Moldova, Republic of;Norway;Poland;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
      2023   Phase 2   EUCTR2022-002593-89-BG   Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;France;Georgia;Germany;Hungary;Israel;Italy;Japan;Moldova, Republic of;Norway;Poland;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
      2023   Phase 2   EUCTR2022-002593-89-AT   Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;France;Georgia;Germany;Hungary;Israel;Italy;Moldova, Republic of;Norway;Poland;Serbia;Slovakia;South Africa;Spain;United Kingdom;United States
      2023   Phase 2   EUCTR2021-006881-19-SK   Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;France;Georgia;Germany;Hungary;Israel;Italy;Japan;Moldova, Republic of;Norway;Poland;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
      2023   Phase 2   EUCTR2021-006881-19-PL   Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;France;Georgia;Germany;Hungary;Israel;Italy;Japan;Moldova, Republic of;Norway;Poland;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
      2023   Phase 2   EUCTR2021-006881-19-FR   Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Hungary;Israel;Italy;Japan;Norway;Poland;Slovakia;Spain;United Kingdom;United States
      2023   Phase 2   EUCTR2021-006881-19-DE   Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;France;Georgia;Germany;Hungary;Israel;Italy;Japan;Moldova, Republic of;Norway;Poland;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
      2023   Phase 2   EUCTR2021-006881-19-CZ   Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;France;Georgia;Germany;Hungary;Israel;Italy;Japan;Moldova, Republic of;Norway;Poland;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
      2023   Phase 2   EUCTR2021-006881-19-BG   Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;France;Georgia;Germany;Hungary;Israel;Italy;Japan;Moldova, Republic of;Norway;Poland;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
      2023   Phase 2   EUCTR2021-006881-19-AT   Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;France;Georgia;Germany;Hungary;Israel;Italy;Japan;Moldova, Republic of;Norway;Poland;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
      2022   Phase 2   NCT05499130   Austria;Belgium;Bulgaria;Canada;Czechia;France;Georgia;Germany;Hungary;Israel;Italy;Japan;Moldova, Republic of;Norway;Poland;Serbia;Slovakia;Spain;Ukraine;United Kingdom;United States
      2022   Phase 2   EUCTR2021-006881-19-HU   Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Hungary;Israel;Italy;Japan;Norway;Poland;Serbia;Slovakia;Spain;Sweden;United Kingdom;United States
TEV-48574 dose regimen A
   Teva Branded Pharmaceutical Products R&D, Inc.
      2023   Phase 2   NCT05668013   Austria;Belgium;Bulgaria;Czechia;France;Georgia;Germany;Hungary;Israel;Italy;Japan;Norway;Poland;Slovakia;Spain;Ukraine;United Kingdom;United States
TEV-48574 dose regiment B
   Teva Branded Pharmaceutical Products R&D, Inc.
      2023   Phase 2   NCT05668013   Austria;Belgium;Bulgaria;Czechia;France;Georgia;Germany;Hungary;Israel;Italy;Japan;Norway;Poland;Slovakia;Spain;Ukraine;United Kingdom;United States
Thalidomide
   Children's Hospital of Fudan University
      2024   -   NCT06382519   China
   IRCCS Burlo Garofolo
      2008   Phase 3   NCT00720538   Italy
   Kawai Toshinao
      2017   Phase 2-3   JPRN-jRCT2031200236   -
Thalidomide pharmion
   ISTITUTO PER L INFANZIA BURLO GAROFOLO
      2006   -   EUCTR2005-005414-20-IT   Italy
Therapy education
   Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives
      2020   Phase 4   NCT04183608   France
Thiamin
   Aarhus University Hospital
      2018   Phase 4   EUCTR2018-002324-17-DK   Denmark
Thiopurine
   Ernest Seidman
      2014   -   NCT02453607   Canada
Thiosix
   Amsterdam UMC location AMC
      2021   Phase 3;Phase 4   EUCTR2021-000469-33-NL   Netherlands
Threonine
   Nestlé
      2015   -   NCT02423460   Canada
THRX-139060
   Theravance Biopharma Ireland Limited
      2021   Phase 3   EUCTR2018-002135-19-FR   Australia;Bulgaria;Canada;Croatia;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Democratic People's Republic of;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2020   Phase 2;Phase 3   EUCTR2018-002136-24-RO   Australia;Bulgaria;Canada;Croatia;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2020   Phase 3   EUCTR2018-002135-19-RO   Australia;Bulgaria;Canada;Croatia;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2019   Phase 2;Phase 3   EUCTR2018-002136-24-SK   Australia;Bulgaria;Canada;Croatia;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2019   Phase 2;Phase 3   EUCTR2018-002136-24-PT   Australia;Bulgaria;Canada;Croatia;France;Georgia;Germany;Greece;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2019   Phase 2;Phase 3   EUCTR2018-002136-24-PL   Australia;Bulgaria;Canada;Croatia;France;Georgia;Germany;Greece;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2019   Phase 2;Phase 3   EUCTR2018-002136-24-HU   Australia;Bulgaria;Canada;Croatia;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2019   Phase 2;Phase 3   EUCTR2018-002136-24-GR   Australia;Bulgaria;Canada;Croatia;France;Georgia;Germany;Greece;Hungary;India;Israel;Italy;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2019   Phase 2;Phase 3   EUCTR2018-002136-24-FR   Australia;Bulgaria;Canada;Croatia;France;Georgia;Germany;Greece;Hungary;India;Israel;Italy;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2019   Phase 2;Phase 3   EUCTR2018-002136-24-ES   Australia;Bulgaria;Canada;Croatia;France;Georgia;Germany;Greece;Hungary;India;Israel;Italy;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2019   Phase 2;Phase 3   EUCTR2018-002136-24-DE   Australia;Bulgaria;Canada;Croatia;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2019   Phase 2;Phase 3   EUCTR2018-002136-24-BG   Australia;Bulgaria;Canada;Croatia;France;Georgia;Germany;Greece;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2018-002135-19-SK   Australia;Bulgaria;Canada;Croatia;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2018-002135-19-PT   Australia;Bulgaria;Canada;Croatia;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2018-002135-19-PL   Australia;Bulgaria;Canada;Croatia;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2018-002135-19-HU   Australia;Bulgaria;Canada;Croatia;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2018-002135-19-GR   Australia;Bulgaria;Canada;Croatia;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2018-002135-19-ES   Australia;Bulgaria;Canada;Croatia;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2018-002135-19-DE   Australia;Bulgaria;Canada;Croatia;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2018-002135-19-BG   Australia;Bulgaria;Canada;Croatia;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
Tiamin DAK
   Aarhus University Hospital
      2018   Phase 4   EUCTR2018-002324-17-DK   Denmark
Tiamin SAD
   Aarhus University Hospital
      2018   Phase 4   EUCTR2018-002324-17-DK   Denmark
Tilpisertib
   Gilead Sciences
      2019   Phase 2   NCT04130919   Australia;Austria;Canada;France;Germany;Italy;Poland;Switzerland;United States
Tilpisertib fosmecarbil
   Gilead Sciences
      2023   Phase 2   NCT06029972   Australia;Austria;Belgium;Canada;France;Germany;Hungary;Italy;Japan;Korea, Republic of;Poland;Switzerland;United Kingdom;United States
Time and attention + active fructooligosaccharide supplementation
   Rush University Medical Center
      2006   Phase 1/Phase 2   NCT00343642   United States
Tirzepatide
   Eli Lilly and Company
      2025   Phase 3   NCT06937086   Austria;Belgium;Brazil;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Mexico;Netherlands;Poland;Romania;Slovakia;Spain;Turkey;United Kingdom;United States
   University of Miami
      2025   Phase 4   NCT06774079   United States
Tissucol DUO (5.0ML) fibrin tissue adhesive
   CELLERIX, S.L.
      2008   -   EUCTR2006-003370-95-NL   Germany;Netherlands;Spain
      2008   -   EUCTR2006-003370-95-DE   Germany;Netherlands;Spain
      2007   Phase 3   EUCTR2006-003370-95-ES   Germany;Netherlands;Spain
TJ301 300MG
   I-Mab Biopharma HongKong Limited
      2018   Phase 2   NCT03235752   Australia;China;Korea, Republic of;Taiwan
TJ301 600MG
   I-Mab Biopharma HongKong Limited
      2018   Phase 2   NCT03235752   Australia;China;Korea, Republic of;Taiwan
TLL018
   TLL Pharmaceutical, LLC
      2022   Phase 2   NCT05121402   United States
TNF inhibitor
   Insel Gruppe AG, University Hospital Bern
      2023   -   NCT05702879   Switzerland
TNF inhibitors
   IQVIA Services Japan K.K. jRCT Call Center
      2023   Phase 3   JPRN-jRCT2031230081   Argentina;Belgium;Bosnia;Brazil;Bulgaria;Canada;Croatia;Czech Republic;France;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Lithuania;Mexico;New Zealand;Poland;Romania;Serbia;Slovenia;Spain;Taiwan;United Kingdom;United States
   Mohamed Nasr
      2024   -   NCT06601595   -
   jRCT Inquiries IQVIA Contact person
      2023   Phase 3   JPRN-jRCT2031230257   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Czech Republic;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Korea;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Serbia;Slovakia;Slovenia;Spain;Switzerland;Turkey;UK USA
TNF-A antagonists, NON-tnfs, dmard NON-biologics
   Biologics & Biosimilars Collective Intelligence Consortium
      2012   -   NCT02922192   -
TO BE confirmed
   Gilead Sciences, Inc.
      2020   Phase 2   EUCTR2019-001430-33-GB   Australia;Austria;Belgium;Canada;Czechia;France;Germany;Italy;Poland;Russian Federation;Switzerland;United Kingdom;United States
TO BE requested
   Landos Biopharma Inc.
      2020   Phase 2   EUCTR2018-005086-39-BG   Belarus;Bosnia and Herzegovina;Bulgaria;Croatia;Georgia;Hungary;Moldova, Republic of;Poland;Russian Federation;Serbia;Ukraine;United States
      2019   Phase 2   EUCTR2018-005086-39-PL   Belarus;Bosnia and Herzegovina;Bulgaria;Croatia;Georgia;Hungary;Moldova, Republic of;Poland;Russian Federation;Serbia;Ukraine;United States
      2019   Phase 2   EUCTR2018-005086-39-HU   Belarus;Bosnia and Herzegovina;Bulgaria;Croatia;Georgia;Hungary;Moldova, Republic of;Poland;Russian Federation;Serbia;Ukraine;United States
      2019   Phase 2   EUCTR2018-005086-39-HR   Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Georgia;Hungary;Moldova, Republic of;Poland;Russian Federation;Serbia;Ukraine;United States
Tofacinitib
   FONDAZIONE POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI IRCCS UNIVERSITA' CATTOLICA DEL SACRO CUORE
      2021   Phase 4   EUCTR2020-003006-31-IT   Italy
Tofacitinib
   Erasmus Medical Center
      2019   Phase 4   EUCTR2018-004587-61-NL   Netherlands
   Fundación Española de Gastroenterología
      2021   Phase 4   EUCTR2021-002211-65-ES   Spain
   Fundación de Investigación Biomédica - Hospital Universitario de La Princesa
      2022   Phase 4   NCT05313620   Spain
   IRCCS San Raffaele
      2022   -   NCT05728008   Italy
   Kawai Norisuke
      2021   Phase 3   JPRN-jRCT2071210075   Australia;Canada;Japan;United States
   McMaster University
      2021   Phase 2   NCT04925973   Canada
   PFIZER INC.
      2013   -   EUCTR2011-004578-27-IT   Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Democratic People's Republic of;Korea, Republic of;Latvia;Netherlands;Poland;Russian Federation;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
   PFIZER LIMITED
      2013   -   EUCTR2011-004581-14-IT   Australia;Austria;Brazil;Canada;Colombia;Czech Republic;Denmark;Estonia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;Russian Federation;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2013   Phase 3   EUCTR2011-004580-79-IT   Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;New Zealand;Poland;Russian Federation;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
   Pfizer
      2021   Phase 3   NCT04624230   Australia;Belgium;Canada;Finland;France;Germany;Hungary;Israel;Italy;Japan;Netherlands;Poland;Slovakia;Spain;Sweden;United Kingdom;United States
      2020   -   NCT04424303   France
      2020   -   NCT04338204   Sweden
      2012   Phase 3   NCT01465763   Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;Israel;Italy;Japan;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
      2012   Phase 3   NCT01458951   Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;Israel;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
   Pfizer Inc
      2012   Phase 3   EUCTR2011-004580-79-CZ   Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
   Pfizer Inc, 235 East 42nd Street, New York, New York 10017
      2013   Phase 3   EUCTR2011-004581-14-HR   Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2013   Phase 3   EUCTR2011-004580-79-HR   Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2013   -   EUCTR2011-004579-35-HR   Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2013   -   EUCTR2011-004578-27-NL   Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2013   -   EUCTR2011-004578-27-HR   Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2012   Phase 3   EUCTR2011-004581-14-LV   Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2012   Phase 3   EUCTR2011-004581-14-ES   Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2012   Phase 3   EUCTR2011-004580-79-SK   Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2012   Phase 3   EUCTR2011-004580-79-PL   Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2012   Phase 3   EUCTR2011-004580-79-LV   Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2012   Phase 3   EUCTR2011-004580-79-HU   Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2012   Phase 3   EUCTR2011-004580-79-GB   Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2012   Phase 3   EUCTR2011-004580-79-ES   Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2012   Phase 3   EUCTR2011-004580-79-EE   Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2012   Phase 3   EUCTR2011-004580-79-DK   Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2012   Phase 3   EUCTR2011-004580-79-BE   Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2012   Phase 3   EUCTR2011-004580-79-AT   Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2012   -   EUCTR2011-004579-35-SK   Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2012   -   EUCTR2011-004579-35-PL   Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2012   -   EUCTR2011-004579-35-NL   Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2012   -   EUCTR2011-004579-35-LV   Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2012   -   EUCTR2011-004579-35-HU   Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2012   -   EUCTR2011-004579-35-GB   Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2012   -   EUCTR2011-004579-35-ES   Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2012   -   EUCTR2011-004579-35-EE   Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2012   Phase 3   EUCTR2011-004579-35-DK   Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2012   -   EUCTR2011-004579-35-BE   Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2012   -   EUCTR2011-004579-35-AT   Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2012   -   EUCTR2011-004578-27-SK   Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2012   -   EUCTR2011-004578-27-PL   Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2012   -   EUCTR2011-004578-27-LV   Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2012   -   EUCTR2011-004578-27-HU   Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2012   -   EUCTR2011-004578-27-GB   Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2012   -   EUCTR2011-004578-27-ES   Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2012   -   EUCTR2011-004578-27-EE   Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2012   Phase 3   EUCTR2011-004578-27-DK   Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2012   -   EUCTR2011-004578-27-BE   Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2012   -   EUCTR2011-004578-27-AT   Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
   Pfizer Inc, 235 East 42nd Street, New York, New York 10017, USA
      2012   Phase 3   EUCTR2011-004580-79-DE   Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2012   Phase 3   EUCTR2011-004579-35-DE   Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2012   Phase 3   EUCTR2011-004578-27-DE   Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
   Postgraduate Institute of Medical Education and Research
      2023   -   NCT05112263   -
   Takeda
      2024   Phase 4   NCT06095128   Canada;United States
Tofacitinib citrate
   PFIZER INC
      2022   Phase 3   EUCTR2018-002378-30-IT   Australia;Belgium;Canada;Finland;France;Germany;Hungary;Israel;Italy;Japan;Netherlands;Poland;Slovakia;Spain;Sweden;United Kingdom;United States
      2018   Phase 3;Phase 4   EUCTR2017-002274-39-IT   Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Japan;Korea, Republic of;Netherlands;New Zealand;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
   Pfizer Inc, 235 East 42nd Street, New York, New York 10017
      2018   Phase 3;Phase 4   EUCTR2017-002274-39-NL   Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Japan;Korea, Republic of;Netherlands;New Zealand;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
      2018   Phase 3;Phase 4   EUCTR2017-002274-39-GB   Austria;Belgium;Canada;Czech Republic;France;Germany;Hungary;Italy;Japan;Korea, Republic of;Netherlands;New Zealand;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
      2018   Phase 3;Phase 4   EUCTR2017-002274-39-CZ   Austria;Belgium;Canada;Czech Republic;Czechia;Germany;Hungary;Italy;Japan;Korea, Republic of;Netherlands;New Zealand;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
      2018   Phase 3;Phase 4   EUCTR2017-002274-39-BE   Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Japan;Korea, Republic of;Netherlands;New Zealand;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-002274-39-AT   Austria;Belgium;Canada;Czech Republic;France;Germany;Hungary;Italy;Japan;Korea, Republic of;Netherlands;New Zealand;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
      2017   Phase 3;Phase 4   EUCTR2017-002274-39-HU   Austria;Belgium;Canada;Czech Republic;France;Germany;Hungary;Italy;Japan;Korea, Republic of;Netherlands;New Zealand;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2017-002274-39-ES   Austria;Belgium;Canada;Czech Republic;France;Germany;Hungary;Italy;Japan;Korea, Republic of;Netherlands;New Zealand;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
      2012   Phase 3   EUCTR2011-004581-14-NL   Australia;Austria;Belgium;Canada;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
      2012   Phase 3   EUCTR2011-004581-14-HU   Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2012   Phase 3   EUCTR2011-004581-14-GB   Australia;Austria;Belgium;Canada;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
      2012   Phase 3   EUCTR2011-004581-14-EE   Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2012   Phase 3   EUCTR2011-004581-14-DK   Australia;Austria;Belgium;Canada;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
      2012   Phase 3   EUCTR2011-004581-14-BE   Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2012   Phase 3   EUCTR2011-004581-14-AT   Australia;Austria;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
   Pfizer Inc, 235 East 42nd Street, New York, New York 10017, USA
      2012   Phase 3   EUCTR2011-004581-14-DE   Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
   Pfizer Inc.
      2022   Phase 3   EUCTR2018-002378-30-SK   Australia;Belgium;Canada;Finland;France;Germany;Hungary;Israel;Italy;Japan;Netherlands;Poland;Slovakia;Spain;Sweden;United Kingdom;United States
      2022   Phase 3   EUCTR2018-002378-30-NL   Australia;Belgium;Canada;Finland;France;Germany;Hungary;Israel;Italy;Japan;Netherlands;Poland;Slovakia;Spain;Sweden;United Kingdom;United States
      2022   Phase 3   EUCTR2018-002378-30-HU   Australia;Belgium;Canada;Finland;France;Germany;Hungary;Israel;Italy;Japan;Netherlands;Poland;Slovakia;Spain;Sweden;United Kingdom;United States
      2022   Phase 3   EUCTR2018-002378-30-FR   Australia;Belgium;Canada;Finland;France;Germany;Hungary;Israel;Italy;Japan;Netherlands;Poland;Slovakia;Spain;Sweden;United Kingdom;United States
      2022   Phase 3   EUCTR2018-002378-30-DE   Australia;Belgium;Canada;Finland;France;Germany;Hungary;Israel;Italy;Japan;Netherlands;Poland;Slovakia;Spain;Sweden;United Kingdom;United States
      2021   Phase 3   EUCTR2018-002378-30-FI   Australia;Belgium;Canada;Finland;France;Germany;Hungary;Israel;Italy;Japan;Netherlands;Poland;Slovakia;Spain;Sweden;United Kingdom;United States
      2017   Phase 3;Phase 4   EUCTR2017-002274-39-SK   Austria;Belgium;Canada;Czech Republic;Czechia;Germany;Hungary;Italy;Japan;Korea, Republic of;Netherlands;New Zealand;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
      2012   Phase 3   EUCTR2011-004581-14-SK   Australia;Austria;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2012   Phase 3   EUCTR2011-004581-14-CZ   Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      -   Phase 3   EUCTR2018-002378-30-SE   Australia;Belgium;Canada;Finland;France;Germany;Hungary;Israel;Italy;Japan;Netherlands;Poland;Slovakia;Spain;Sweden;United Kingdom;United States
      -   Phase 3   EUCTR2018-002378-30-PL   Australia;Belgium;Canada;Finland;France;Germany;Hungary;Israel;Italy;Japan;Netherlands;Poland;Slovakia;Spain;Sweden;United Kingdom;United States
      -   Phase 3   EUCTR2018-002378-30-BE   Australia;Belgium;Canada;Finland;France;Germany;Hungary;Israel;Italy;Japan;Netherlands;Poland;Slovakia;Spain;Sweden;United Kingdom;United States
   Pfizer Inc., 235 East 42nd Street, New York, New York 10017, United States
      2012   Phase 3   EUCTR2011-004581-14-PL   Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
Tofacitinib plus mesalamine
   Post Graduate Institute of Medical Education and Research, Chandigarh
      2024   Phase 4   NCT06625450   -
TOP down treatment IF patient AT high risk
   Region Örebro County
      2022   Phase 4   NCT05180175   Denmark;Iceland;Norway;Sweden
TOP1288
   Topivert Pharma Ltd
      2017   Phase 1   NCT03071081   United Kingdom
      2016   Phase 2   NCT02888379   Bulgaria;Czech Republic;Czechia;Hungary;Latvia;Lithuania;Poland;Ukraine;United Kingdom
      2015   Phase 1   NCT02463045   United Kingdom
TOP1288 rectal solution
   TOPIVERT Pharma Limited
      2016   Phase 2   EUCTR2016-000390-20-PL   Bulgaria;Czech Republic;Hungary;Latvia;Lithuania;Poland;Ukraine;United Kingdom
      2016   Phase 2   EUCTR2016-000390-20-LV   Bulgaria;Czech Republic;Hungary;Latvia;Lithuania;Poland;Ukraine;United Kingdom
      2016   Phase 2   EUCTR2016-000390-20-LT   Bulgaria;Czech Republic;Hungary;Latvia;Lithuania;Poland;Ukraine;United Kingdom
      2016   Phase 2   EUCTR2016-000390-20-HU   Bulgaria;Czech Republic;Hungary;Latvia;Lithuania;Poland;Ukraine;United Kingdom
      2016   Phase 2   EUCTR2016-000390-20-GB   Bulgaria;Czech Republic;Hungary;Latvia;Lithuania;Poland;Ukraine;United Kingdom
      2016   Phase 2   EUCTR2016-000390-20-CZ   Bulgaria;Czech Republic;Hungary;Latvia;Lithuania;Poland;Ukraine;United Kingdom
      2016   Phase 2   EUCTR2016-000390-20-BG   Bulgaria;Czech Republic;Hungary;Latvia;Lithuania;Poland;Ukraine;United Kingdom
TP05
   Tillotts Pharma AG
      2015   Phase 3   EUCTR2013-000366-11-RO   Belarus;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Hungary;Ireland;Latvia;Lithuania;Norway;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Ukraine;United Kingdom
      2014   Phase 3   EUCTR2013-000366-11-SK   Belarus;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;Hungary;Ireland;Latvia;Lithuania;Poland;Romania;Russian Federation;Slovakia;Spain;Sweden;Ukraine
      2014   Phase 3   EUCTR2013-000366-11-LV   Belarus;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Hungary;Ireland;Latvia;Lithuania;Norway;Poland;Romania;Russian Federation;Slovakia;Spain;Sweden;Ukraine;United Kingdom
      2014   Phase 3   EUCTR2013-000366-11-LT   Belarus;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Hungary;Ireland;Latvia;Lithuania;Norway;Poland;Romania;Russian Federation;Slovakia;Spain;Sweden;Ukraine;United Kingdom
      2014   Phase 3   EUCTR2013-000366-11-HU   Belarus;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Hungary;Ireland;Latvia;Lithuania;Norway;Poland;Romania;Russian Federation;Slovakia;Spain;Sweden;Ukraine;United Kingdom
      2014   Phase 3   EUCTR2013-000366-11-BG   Belarus;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Hungary;Ireland;Latvia;Lithuania;Norway;Poland;Romania;Russian Federation;Slovakia;Spain;Sweden;Ukraine;United Kingdom
      2013   Phase 1   NCT02306798   -
      2013   Phase 3   NCT01903252   Netherlands;Switzerland
      2013   Phase 3   EUCTR2013-000366-11-SE   Belarus;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Hungary;Ireland;Latvia;Lithuania;Norway;Poland;Romania;Russian Federation;Slovakia;Spain;Sweden;Ukraine;United Kingdom
      2013   Phase 3   EUCTR2013-000366-11-PL   Belarus;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;Hungary;Ireland;Latvia;Lithuania;Poland;Romania;Russian Federation;Spain;Sweden;Ukraine
      2013   Phase 3   EUCTR2013-000366-11-IE   Belarus;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Hungary;Ireland;Latvia;Lithuania;Norway;Poland;Romania;Russian Federation;Slovakia;Spain;Sweden;Ukraine;United Kingdom
      2013   Phase 3   EUCTR2013-000366-11-GB   Belarus;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Hungary;Ireland;Latvia;Lithuania;Norway;Poland;Romania;Russian Federation;Slovakia;Spain;Sweden;Ukraine;United Kingdom
      2013   Phase 3   EUCTR2013-000366-11-FI   Belarus;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Hungary;Ireland;Latvia;Lithuania;Norway;Poland;Romania;Russian Federation;Slovakia;Spain;Sweden;Ukraine;United Kingdom
      2013   -   EUCTR2013-000366-11-ES   Belarus;Belgium;Bulgaria;Canada;Denmark;Finland;Hungary;Ireland;Latvia;Lithuania;Poland;Russian Federation;Spain;Sweden;Ukraine
      2013   Phase 3   EUCTR2013-000366-11-DK   Belarus;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Hungary;Ireland;Latvia;Lithuania;Norway;Poland;Romania;Russian Federation;Slovakia;Spain;Sweden;Ukraine;United Kingdom
      2013   Phase 3   EUCTR2013-000366-11-CZ   Belarus;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Hungary;Ireland;Latvia;Lithuania;Norway;Poland;Romania;Russian Federation;Slovakia;Spain;Sweden;Ukraine;United Kingdom
      2013   Phase 3   EUCTR2013-000366-11-BE   Belarus;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Hungary;Ireland;Latvia;Lithuania;Norway;Poland;Romania;Russian Federation;Slovakia;Spain;Sweden;Ukraine;United Kingdom
TP05 coating A
   Tillotts Pharma AG
      2011   Phase 1   NCT02306772   -
TP05 coating B
   Tillotts Pharma AG
      2011   Phase 1   NCT02306772   -
TP05 coating D
   Tillotts Pharma AG
      2012   Phase 1   NCT02306785   -
TP05 coating E
   Tillotts Pharma AG
      2012   Phase 1   NCT02306785   -
TP05 coating H
   Tillotts Pharma AG
      2012   Phase 1   NCT02306785   -
Tpmt genotyping
   ZonMw: The Netherlands Organisation for Health Research and Development
      2007   -   NCT00521950   Netherlands
TQH3906 capsules
   Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.
      2025   Phase 1   NCT06754891   China
Traditional treatments
   The Second Hospital of Nanjing Medical University
      2013   Phase 2/Phase 3   NCT01790061   China
Tralokinumab
   ASTRAZENECA
      2011   -   EUCTR2011-004812-40-IT   Czech Republic;Germany;Italy;Netherlands;United Kingdom
   AstraZeneca
      2012   Phase 2   NCT01482884   Czech Republic;France;Germany;Italy;Netherlands;Poland;United Kingdom
   AstraZeneca AB
      2012   -   EUCTR2011-004812-40-NL   Czech Republic;Italy;Netherlands;United Kingdom
      2012   Phase 2   EUCTR2011-004812-40-GB   Czech Republic;Germany;Italy;Netherlands;United Kingdom
      2012   -   EUCTR2011-004812-40-DE   Czech Republic;Germany;Italy;Netherlands;United Kingdom
      2012   -   EUCTR2011-004812-40-CZ   Czech Republic;Italy;Netherlands;United Kingdom
Transcriptomic analysis
   Central Hospital, Nancy, France
      2010   -   NCT05060770   -
   Guangdong Provincial Hospital of Chinese Medicine
      2024   -   ChiCTR2400080701   China
Treatment algorithm A
   Alimentiv Inc.
      2020   Phase 4   NCT04259138   Belarus;Belgium;Canada;France;Italy;Netherlands;Poland;Ukraine;United Kingdom;United States
Treatment algorithm B
   Alimentiv Inc.
      2020   Phase 4   NCT04259138   Belarus;Belgium;Canada;France;Italy;Netherlands;Poland;Ukraine;United Kingdom;United States
Treatment algorithm C
   Alimentiv Inc.
      2020   Phase 4   NCT04259138   Belarus;Belgium;Canada;France;Italy;Netherlands;Poland;Ukraine;United Kingdom;United States
Treatment group: rectal instillation OF qhqyp
   Beijing Hospital of Traditional Chinese Medicine
      2023   -   NCT05780723   China
Treatment VS control bread
   Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta
      2019   -   NCT05656391   Spain
Trexan INJ 25 MG/ML
   GETAID, Jean Minjoz Hospital
      2009   -   EUCTR2006-003607-40-FI   Austria;Belgium;Finland;Netherlands
Trichuris suis eggs
   University of Aarhus
      2012   -   NCT03079700   -
Trichuris suis OVA
   National Institute of Allergy and Infectious Diseases (NIAID)
      2013   Phase 2   NCT01953354   United States
   New York University School of Medicine
      2012   -   NCT01433471   United States
   ParaTech A/S
      2018   Phase 2   NCT03565939   Denmark
Trilac
   Lebanese University
      2024   -   NCT06392061   Lebanon
Tris
   Iron Therapeutics (Switzerland) AG
      2012   -   EUCTR2010-023588-16-DE   Austria;Germany;Hungary;United Kingdom
      2011   -   EUCTR2010-023588-16-HU   Austria;Germany;Hungary;United Kingdom
      2011   Phase 3   EUCTR2010-023588-16-GB   Austria;Germany;Hungary;United Kingdom
      2011   -   EUCTR2010-023588-16-AT   Austria;Germany;Hungary;United Kingdom
TSO
   National Institute of Allergy and Infectious Diseases (NIAID)
      2013   Phase 2   NCT01953354   United States
   ParaTech A/S
      2018   Phase 2   EUCTR2017-004772-65-DK   Denmark
Tulisokibart
   Merck Sharp & Dohme LLC
      2024   Phase 3   NCT06651281   Poland;United States
   Prometheus Biosciences, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
      2021   Phase 2   NCT04996797   Australia;Belgium;Canada;Czechia;France;Georgia;Hungary;Israel;Italy;Poland;United Kingdom;United States
Tumor necrosis factor (TNF)-alpha inhibitors
   Hospital del Río Hortega
      2023   -   NCT05986903   Spain
Twice daily 90 MG hydrocortisone acetate suppository administered with sephure applicator
   Cristcot LLC
      2020   Phase 3   NCT04469686   Bulgaria;Denmark;France;Georgia;Germany;Hong Kong;India;Italy;Jordan;Lebanon;Moldova, Republic of;Philippines;Poland;Romania;Russian Federation;Saudi Arabia;South Africa;Spain;Turkey;Ukraine;United States;Vietnam
TYK2 inhibitor
   Bristol-Myers Squibb International Corporation
      2022   Phase 2   EUCTR2019-004878-26-PL   Australia;Canada;Germany;Netherlands;Poland;United Kingdom;United States
      2021   Phase 2   EUCTR2019-004878-26-NL   Australia;Canada;Germany;Netherlands;Poland;United Kingdom;United States
      2021   Phase 2   EUCTR2019-004878-26-DE   Australia;Canada;Germany;Netherlands;Poland;United Kingdom;United States
UCB4940
   UCB Biopharma SPRL
      2017   Phase 2   EUCTR2016-000420-26-PL   Bulgaria;Czech Republic;France;Georgia;Italy;Moldova, Republic of;Poland;Romania;South Africa;Spain;United Kingdom
      2017   Phase 2   EUCTR2016-000420-26-BG   Bulgaria;Czech Republic;Georgia;Italy;Moldova, Republic of;Poland;Romania;South Africa;Spain;United Kingdom
      2016   Phase 2   EUCTR2016-000420-26-ES   Bulgaria;Czech Republic;France;Georgia;Italy;Moldova, Republic of;Poland;Romania;South Africa;Spain;United Kingdom
      2016   Phase 2   EUCTR2016-000420-26-CZ   Bulgaria;Czech Republic;France;Georgia;Italy;Moldova, Republic of;Poland;Romania;South Africa;Spain;United Kingdom
Ucmsc group
   Affiliated Hospital to Academy of Military Medical Sciences
      2015   Phase 1/Phase 2   NCT02442037   China
Udca
   Stanford University
      2019   Phase 2/Phase 3   NCT03724175   United States
Ulcerative colitis diet
   Prof. Arie Levine
      2015   Phase 4   NCT02345733   Canada;Israel;United States
      2014   -   NCT02217722   Israel
Ulcerative colitis exclusion diet
   Wolfson Medical Center
      2023   -   NCT05791487   Israel;Italy;Netherlands;Switzerland
Umbilical cord blood mononuclear cells
   Shandong Qilu Stem Cells Engineering Co., Ltd.
      2021   -   NCT04882683   China
   The Second Affiliated Hospital of Shandong University of Traditional Chinese Medicine
      2021   Phase 0   ChiCTR2100046284   China
Umbilical cord mesenchymal stem cells
   Qingdao University
      2010   Phase 1/Phase 2   NCT01221428   China
Undetermined
   EA Pharma Co., Ltd.
      2019   Phase 2   EUCTR2018-002109-70-HU   Czech Republic;Hungary;Japan;Poland
      2019   Phase 2   EUCTR2018-002109-70-CZ   Czech Republic;Czechia;Hungary;Japan;Poland;Russian Federation
Unknown
   F. Hoffmann-La Roche Ltd
      2015   Phase 3   EUCTR2013-004435-72-NL   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Germany;Greece;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Philippines;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States;Viet Nam
Upadacitinib
   ABBVIE DEUTSCHLAND GMBH & CO. KG
      2019   Phase 3   EUCTR2016-000642-62-IT   Argentina;Australia;Austria;Belarus;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2016-000674-38-IT   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;Finland;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 2;Phase 3   EUCTR2016-000641-31-IT   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Kazakhstan;Korea, Democratic People's Republic of;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
   AbbVie
      2023   Phase 3   NCT05782907   Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;New Zealand;Poland;Puerto Rico;Spain;Taiwan;Turkey;United Kingdom;United States
      2018   Phase 3   NCT03653026   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czechia;Egypt;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2017   Phase 3   NCT03006068   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czechia;Egypt;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
   AbbVie Deutschland GmbH & Co. KG
      2020   Phase 3   EUCTR2016-000642-62-SE   Argentina;Australia;Austria;Belarus;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2020   Phase 3   EUCTR2016-000642-62-FR   Argentina;Australia;Austria;Belarus;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2016-000642-62-SK   Argentina;Australia;Austria;Belarus;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2016-000642-62-PT   Argentina;Australia;Austria;Belarus;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2016-000642-62-PL   Argentina;Australia;Austria;Belarus;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2016-000642-62-NL   Argentina;Australia;Austria;Belarus;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2016-000642-62-LT   Argentina;Australia;Austria;Belarus;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2016-000642-62-IE   Argentina;Australia;Austria;Belarus;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2016-000642-62-HR   Argentina;Australia;Austria;Belarus;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2016-000642-62-GR   Argentina;Australia;Austria;Belarus;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2016-000642-62-GB   Argentina;Australia;Austria;Belarus;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2016-000642-62-ES   Argentina;Australia;Austria;Belarus;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2016-000642-62-DE   Argentina;Australia;Austria;Belarus;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2016-000642-62-CZ   Argentina;Australia;Austria;Belarus;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2016-000642-62-BE   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2016-000642-62-AT   Argentina;Australia;Austria;Belarus;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2016-000642-62-NO   Argentina;Australia;Austria;Belarus;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2016-000642-62-LV   Argentina;Australia;Austria;Belarus;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2016-000642-62-HU   Argentina;Australia;Austria;Belarus;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2016-000642-62-FI   Argentina;Australia;Austria;Belarus;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 2;Phase 3   EUCTR2016-000641-31-BE   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Japan;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-000674-38-SE   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;Germany;Greece;Hungary;Ireland;Israel;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-000674-38-PT   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-000674-38-LT   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-000674-38-IE   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-000674-38-HR   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-000674-38-FI   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-000674-38-CZ   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-000674-38-BE   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2017   Phase 2;Phase 3   EUCTR2016-000641-31-SE   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Japan;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2017   Phase 2;Phase 3   EUCTR2016-000641-31-PT   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Japan;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2017   Phase 2;Phase 3   EUCTR2016-000641-31-LT   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Japan;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2017   Phase 2;Phase 3   EUCTR2016-000641-31-HR   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Japan;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2017   Phase 2;Phase 3   EUCTR2016-000641-31-FI   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Japan;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2017   Phase 2;Phase 3   EUCTR2016-000641-31-CZ   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Japan;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2016-000674-38-SK   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2016-000674-38-PL   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2016-000674-38-NL   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2016-000674-38-GR   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2016-000674-38-GB   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;Germany;Greece;Hungary;Ireland;Israel;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2016-000674-38-EE   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2016-000674-38-AT   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 2;Phase 3   EUCTR2016-000641-31-SK   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Japan;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2016   Phase 2;Phase 3   EUCTR2016-000641-31-PL   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Japan;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2016   Phase 2;Phase 3   EUCTR2016-000641-31-NL   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Japan;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2016   Phase 2;Phase 3   EUCTR2016-000641-31-IE   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Japan;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2016   Phase 2;Phase 3   EUCTR2016-000641-31-HU   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Japan;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2016   Phase 2;Phase 3   EUCTR2016-000641-31-GB   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Japan;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2016   Phase 2;Phase 3   EUCTR2016-000641-31-EE   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Japan;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2016   Phase 2;Phase 3   EUCTR2016-000641-31-AT   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Japan;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      -   Phase 3   EUCTR2016-000674-38-NO   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      -   Phase 2;Phase 3   EUCTR2016-000641-31-NO   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Japan;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      -   Phase 2;Phase 3   EUCTR2016-000641-31-DE   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Japan;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
   AbbVie GK
      2018   Phase 3   JPRN-jRCT2080224070   -;Africa;Asia except Japan;Europe;Japan;North America;Oceania;South America
   Peking University First Hospital
      2023   Phase 1   ChiCTR2300078576   China
   Sixth Affiliated Hospital, Sun Yat-sen University
      2023   -   NCT06922331   China
      2023   -   NCT06095596   China
      2021   -   NCT06274996   China
   Xiang Gao
      2024   -   NCT06780683   China
   Yamazaki Hayato
      2023   Phase 3   JPRN-jRCT2011230031   Argentina;Belgium;Brazil;Bulgaria;Canada;Czechia;France;Germany;Greece;Hungary;Italy;Japan;Korea;Mexico;Netherlands;Poland;Spain;Taiwan;Turkey;United Kingdom;United States
Upadacitinib - direct compression-yellow
   AbbVie Deutschland GmbH & Co. KG
      2017   Phase 3   EUCTR2016-000674-38-DE   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
Upadacitinib - WET granulation-yellow
   AbbVie Deutschland GmbH & Co. KG
      2017   Phase 3   EUCTR2016-000674-38-DE   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
Upadacitinib -direct compression-yellow
   AbbVie Deutschland GmbH & Co. KG
      2017   Phase 3   EUCTR2016-000674-38-DE   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
Upadacitinib extended release oral tablet
   Berinstein, Jeffrey
      2023   Phase 4   NCT05867329   United States
Upadacitinib oral product
   McMaster University
      2025   Phase 3   NCT06660693   -
UR-12746-S
   Palau Pharma S.A.
      2009   Phase 2   EUCTR2008-004610-27-SK   Belgium;Hungary;Slovakia;Spain
      2009   -   EUCTR2008-004610-27-HU   Belgium;Hungary;Spain
      2008   Phase 2   EUCTR2008-004610-27-ES   Belgium;Hungary;Slovakia;Spain
      2008   -   EUCTR2008-004610-27-BE   Belgium;Hungary;Spain
Urbason
   GETECCU (Grupo Español de Trabajo en Enfermedad de Crohn y Colitis ulcerosa)
      2017   Phase 4   EUCTR2016-001170-15-ES   Spain
Ursodeoxycholic acid
   Stanford University
      2019   Phase 2/Phase 3   NCT03724175   United States
   The 900th Hospital of PLA
      2018   Phase 4   ChiCTR2000038316   China
   UMC Utrecht
      2009   -   EUCTR2009-010921-38-NL   Netherlands
Ursodiol
   Stanford University
      2019   Phase 2/Phase 3   NCT03724175   United States
Ursofalk
   Sahlgrenska Academy
      2015   Phase 3   EUCTR2015-003310-24-SE   Sweden
   UMC Utrecht
      2009   -   EUCTR2009-010921-38-NL   Netherlands
US TAP bupivacaine/epinephrine
   Cedars-Sinai Medical Center
      2015   -   NCT02538679   -
Ustekinumab
   AZIENDA SOCIO SANITARIA TERRITORIALE DEI SETTE LAGHI
      2022   Phase 2   EUCTR2021-001984-25-IT   Italy
   Evangelismos Hospital
      2022   -   NCT05896943   Greece
   Fundación de Investigación Biomédica del Hospital Universitario de La Princesa
      2018   Phase 4   EUCTR2018-002925-47-ES   Spain
   IRCCS San Raffaele
      2022   -   NCT05728008   Italy
   Insel Gruppe AG, University Hospital Bern
      2023   -   NCT05702879   Switzerland
   JANSSEN CILAG INTERNATIONAL NV
      2019   Phase 3   EUCTR2018-002629-51-IT   Austria;Czech Republic;France;Germany;Italy;Netherlands;Spain;Sweden;United Kingdom;United States
      2015   Phase 3   EUCTR2014-005606-38-IT   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;United Kingdom;United States
   JUNTENDO UNIVERSITY NERIMA HOSPITAL
      2020   -   JPRN-UMIN000046650   Japan
   Janssen Cilag S.A.S.
      2018   -   NCT03606499   France
   Janssen Pharmaceutical K.K.
      2021   -   NCT04963725   Japan
   Janssen Scientific Affairs, LLC
      2021   -   NCT04372108   United States
   Janssen-Cilag International N.V.
      2020   Phase 3   EUCTR2018-002629-51-GB   Austria;France;Germany;Italy;Netherlands;Spain;Sweden;United Kingdom;United States
      2019   Phase 3   EUCTR2018-002629-51-SE   Austria;Czech Republic;Czechia;France;Germany;Italy;Korea, Republic of;Netherlands;Russian Federation;Spain;Sweden;United Kingdom;United States
      2019   Phase 3   EUCTR2018-002629-51-FR   Austria;Czech Republic;France;Germany;Italy;Netherlands;Spain;Sweden;United Kingdom;United States
      2018   Phase 3   EUCTR2018-002629-51-ES   France;Germany;Netherlands;Spain;Sweden;United States
   Janssen-Cilag International NV
      2022   Phase 3   EUCTR2020-004457-76-HU   Argentina;Belgium;France;Germany;Hungary;Italy;Japan;Poland;Russian Federation;Spain;Turkey;United Kingdom;United States
      2022   Phase 3   EUCTR2020-004457-76-DE   Argentina;Belgium;France;Germany;Hungary;Italy;Japan;Poland;Russian Federation;Spain;Turkey;United Kingdom;United States
      2022   Phase 3   EUCTR2020-004457-76-BE   Argentina;Belgium;France;Germany;Hungary;Italy;Japan;Poland;Russian Federation;Spain;Turkey;United Kingdom;United States
      2021   Phase 3   EUCTR2020-004457-76-PL   Argentina;Belgium;France;Germany;Hungary;Japan;Poland;Russian Federation;Turkey;United States
      2021   Phase 3   EUCTR2019-004224-38-DE   Belgium;Germany;Hungary;Japan;Poland;United Kingdom;United States
      2021   Phase 3   EUCTR2019-004224-38-BE   Belgium;Germany;Hungary;Japan;Poland;Russian Federation;United Kingdom;United States
      2021   Phase 3   EUCTR2018-002629-51-CZ   Austria;Czech Republic;Czechia;France;Germany;Italy;Korea, Republic of;Netherlands;Russian Federation;Spain;Sweden;United Kingdom;United States
      2020   Phase 3   EUCTR2019-004224-38-HU   Belgium;Germany;Hungary;Japan;Poland;Russian Federation;United Kingdom;United States
      2019   Phase 3   EUCTR2018-002629-51-NL   Austria;Czech Republic;Czechia;France;Germany;Italy;Korea, Republic of;Netherlands;Russian Federation;Spain;Sweden;United Kingdom;United States
      2019   Phase 3   EUCTR2018-002629-51-AT   Austria;Czech Republic;Czechia;France;Germany;Italy;Korea, Republic of;Netherlands;Russian Federation;Spain;Sweden;United Kingdom;United States
      2016   Phase 3   EUCTR2014-005606-38-PL   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;United Kingdom;United States
      2015   Phase 3   EUCTR2014-005606-38-SK   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;United Kingdom;United States
      2015   Phase 3   EUCTR2014-005606-38-NL   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;United Kingdom;United States
      2015   Phase 3   EUCTR2014-005606-38-HU   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;United Kingdom;United States
      2015   Phase 3   EUCTR2014-005606-38-DK   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;United Kingdom;United States
      2015   Phase 3   EUCTR2014-005606-38-DE   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;United Kingdom;United States
      2015   Phase 3   EUCTR2014-005606-38-CZ   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;United Kingdom;United States
      2015   Phase 3   EUCTR2014-005606-38-BG   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;United Kingdom;United States
      2015   Phase 3   EUCTR2014-005606-38-BE   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;United Kingdom;United States
      2015   Phase 3   EUCTR2014-005606-38-AT   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;United Kingdom;United States
      -   Phase 3   EUCTR2019-004224-38-PL   Belgium;Germany;Hungary;Japan;Poland;Russian Federation;United Kingdom;United States
      -   Phase 3   EUCTR2019-004224-38-Outside-EU/EEA   Belgium;Germany;Hungary;Japan;Poland;Russian Federation;United Kingdom;United States
      -   Phase 3   EUCTR2019-004224-38-GB   Belgium;Germany;Hungary;Japan;Poland;Russian Federation;United Kingdom;United States
   Medical University of Lodz
      2025   Phase 2   NCT06453317   Poland
   Naganuma Makoto
      2021   -   JPRN-jRCT1031200329   -
   Nishikawa Kazuko
      2022   Phase 3   JPRN-jRCT2031220186   Belgium;France;Germany;Hungary;Japan;Poland;United States Of America
   Peking Union Medical College Hospital
      2020   -   NCT05386290   China
   Shenzhen Hospital of Southern Medical University
      2024   Phase 0   ChiCTR2400093919   China
   Shimodaira Yosuke
      2022   Phase 4   JPRN-jRCTs021210073   -
Ustekinumab - standard dosage
   Humanitas Clinical and Research Center
      2023   -   NCT06691061   Italy
Ustekinumab 130 MG IV
   Janssen Research & Development, LLC
      2011   Phase 3   NCT01369355   Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Denmark;France;Germany;Hungary;Iceland;Ireland;Israel;Japan;Korea, Republic of;Netherlands;New Zealand;Poland;Russian Federation;Serbia;South Africa;Spain;United Kingdom;United States
Ustekinumab 90 MG
   Helwan University
      2025   -   NCT06786507   Egypt
Ustekinumab 90 MG SC Q12W
   Janssen Research & Development, LLC
      2011   Phase 3   NCT01369355   Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Denmark;France;Germany;Hungary;Iceland;Ireland;Israel;Japan;Korea, Republic of;Netherlands;New Zealand;Poland;Russian Federation;Serbia;South Africa;Spain;United Kingdom;United States
Ustekinumab 90 MG SC Q8W
   Janssen Research & Development, LLC
      2011   Phase 3   NCT01369355   Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Denmark;France;Germany;Hungary;Iceland;Ireland;Israel;Japan;Korea, Republic of;Netherlands;New Zealand;Poland;Russian Federation;Serbia;South Africa;Spain;United Kingdom;United States
Ustekinumab dose based ON BSA and body weight
   Janssen Research & Development, LLC
      2021   Phase 3   NCT04630028   Belgium;Germany;Hungary;Israel;Japan;Poland;Russian Federation;United Kingdom;United States
   Nishikawa Kazuko
      2021   Phase 3   JPRN-jRCT2041200098   Belgium;Germany;Hungary;Japan;Poland;Russian Federation;United Kingdom Of Great Britain And Northern Irela;United States Of America
Ustekinumab IV
   Janssen Research & Development, LLC
      2015   Phase 3   NCT02407236   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;France;Germany;Hungary;Israel;Japan;Korea, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Ukraine;United Kingdom;United States
Ustekinumab IV infusion
   Janssen Research & Development, LLC
      2018   Phase 1   NCT03358706   Austria;Belgium;Denmark;Germany;Sweden;United Kingdom;United States
Ustekinumab SC
   Janssen Research & Development, LLC
      2015   Phase 3   NCT02407236   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;France;Germany;Hungary;Israel;Japan;Korea, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Ukraine;United Kingdom;United States
Ustekinumab SC injection
   Janssen Research & Development, LLC
      2018   Phase 1   NCT03358706   Austria;Belgium;Denmark;Germany;Sweden;United Kingdom;United States
Usual current care
   Hospital Galdakao-Usansolo
      2020   -   NCT04188990   Spain
UTTR1147A
   GENENTECH, INC.
      2019   Phase 2   EUCTR2017-004997-32-IT   Bulgaria;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
      2018   Phase 2   EUCTR2017-002350-36-IT   Bulgaria;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
   Genentech, Inc.
      2019   Phase 2   NCT03650413   Bulgaria;China;France;Georgia;Germany;Greece;Hungary;Ireland;Israel;Italy;Moldova, Republic of;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
      2018   Phase 2   NCT03558152   Bulgaria;China;France;Georgia;Germany;Greece;Hungary;Ireland;Israel;Italy;Moldova, Republic of;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
      2016   Phase 1   NCT02749630   Canada;Germany;United Kingdom
UTTR1147A, IL22-FC, IL-22FC
   Genentech, Inc.
      2019   Phase 2   EUCTR2017-004997-32-NL   Bulgaria;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
      2019   Phase 2   EUCTR2017-004997-32-HU   Bulgaria;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
      2019   Phase 2   EUCTR2017-004997-32-GB   Bulgaria;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
      2019   Phase 2   EUCTR2017-004997-32-DE   Bulgaria;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
      2018   Phase 2   EUCTR2017-004997-32-IE   Bulgaria;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
      2018   Phase 2   EUCTR2017-002350-36-NL   Bulgaria;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
      2018   Phase 2   EUCTR2017-002350-36-IE   Bulgaria;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
      2018   Phase 2   EUCTR2017-002350-36-HU   Bulgaria;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
      2018   Phase 2   EUCTR2017-002350-36-GR   Bulgaria;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
      2018   Phase 2   EUCTR2017-002350-36-GB   Bulgaria;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
      2018   Phase 2   EUCTR2017-002350-36-DE   Bulgaria;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
      2018   Phase 2   EUCTR2017-002350-36-BG   Bulgaria;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
   Roche Farma, S.A por delegación de Genentech, Inc.
      2018   Phase 2   EUCTR2017-004997-32-ES   Bulgaria;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
      2018   Phase 2   EUCTR2017-002350-36-ES   Bulgaria;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
V565
   VHsquared Ltd.
      2017   Phase 1   NCT03705117   United Kingdom
Vaccination against cholera
   Medical University of Warsaw
      2017   -   NCT03998449   Poland
Vaccine
   Klara M. Pósfay Barbe
      2014   Phase 4   NCT01908283   Switzerland
   Soroka University Medical Center
      2012   -   NCT01531075   Israel
   University of Wisconsin, Madison
      2024   Phase 4   NCT06224270   United States
Vaccine ANTI-H1n1
   Assistance Publique - Hôpitaux de Paris
      2009   Phase 3   NCT01022749   France
Vaccine vivotif + vaccine dukoral + oats
   Haukeland University Hospital
      2008   Phase 2   NCT00751933   Norway
Valganciclovir
   CHU de Saint Etienne
      2019   Phase 4   EUCTR2019-001032-54-FR   France
   Centre Hospitalier Universitaire de Saint Etienne
      2021   Phase 3   NCT04064697   France
Vaminolac
   Aarhus University Hospital
      2015   -   NCT02084550   Denmark
   Department of Medicine and Endocrinology
      2015   Phase 3   EUCTR2014-000784-41-DK   Denmark
Vamorolone 4% suspension FOR oral dosing
   ReveraGen BioPharma, Inc.
      2020   Phase 1/Phase 2   NCT04348890   -
Vancomicina cloridrato
   UNIVERSITÀ DEGLI STUDI MILANO BICOCCA
      2022   Phase 2   EUCTR2022-000875-37-IT   Italy
Vancomycin
   Ari M Grinspan
      2021   Early Phase 1   NCT04968951   United States
   Brigham and Women's Hospital
      2025   Phase 4   NCT06794944   United States
   Karolinska Institutet
      2013   -   EUCTR2009-018034-11-SE   Sweden
   Microbiotica Ltd
      2024   Phase 1   NCT06582264   Austria;Bulgaria;Poland;United Kingdom
   University of Dundee
      2006   -   NCT00355602   United Kingdom
   University of Minnesota
      2015   Phase 1   NCT02464020   United States
Vancomycin oral capsule
   Vedanta Biosciences, Inc.
      2023   Phase 2   NCT05370885   Australia;Bulgaria;Czech Republic;Czechia;Hungary;Lithuania;Netherlands;Poland;Ukraine;United Kingdom;United States
Vancomycin PRE-treat
   Seres Therapeutics, Inc.
      2016   Phase 1   NCT02618187   United States
Vancomycin PRE-treatment
   Seres Therapeutics, Inc.
      2018   Phase 2   NCT03759041   Canada;United States
Vancomycin, mupirocin ointment
   Chikara Tashiro
      2009   -   NCT01918813   Japan
Vatelizumab
   Sanofi aventis Recherche&Développement
      2013   -   EUCTR2012-002013-19-PL   Austria;Belgium;Canada;France;Germany;Italy;Poland;United States
      2013   -   EUCTR2012-002013-19-IT   Austria;Belgium;Canada;France;Germany;Italy;Poland;United States
      2013   -   EUCTR2012-002013-19-DE   Austria;Belgium;Canada;France;Germany;Italy;Poland;United States
      2013   Phase 2   EUCTR2012-002013-19-BE   Austria;Belgium;Canada;France;Germany;Italy;Poland;United States
      2013   -   EUCTR2012-002013-19-AT   Austria;Belgium;Canada;France;Germany;Italy;Poland;United States
   Sanofi-aventis recherche & développement
      2014   -   EUCTR2013-001012-30-DE   Austria;Belgium;Canada;Germany;Italy;Poland;United States
      2013   -   EUCTR2013-001012-30-PL   Austria;Canada;Germany;Italy;Poland;United States
      2013   -   EUCTR2013-001012-30-IT   Austria;Canada;Germany;Italy;Poland;United States
      2013   Phase 2   EUCTR2013-001012-30-BE   Austria;Belgium;Canada;Germany;Italy;Poland;United States
      2013   -   EUCTR2013-001012-30-AT   Austria;Canada;Germany;Italy;Poland;United States
VB-201
   Vascular Biogenics Ltd.
      2013   -   EUCTR2012-003974-18-BG   Bulgaria;Hungary
      2012   -   EUCTR2012-003974-18-HU   Bulgaria;Hungary
VB-201 160MG
   Vascular Biogenics Ltd. operating as VBL Therapeutics
      2013   Phase 2   NCT01839214   Bulgaria;Hungary;Poland
VE202
   Vedanta Biosciences, Inc.
      2023   Phase 2   NCT05370885   Australia;Bulgaria;Czech Republic;Czechia;Hungary;Lithuania;Netherlands;Poland;Ukraine;United Kingdom;United States
      2023   Phase 2   EUCTR2021-001280-24-BG   Bulgaria;Czechia;Hungary;Lithuania;Netherlands;Poland;Ukraine;United Kingdom;United States
      2022   Phase 2   EUCTR2021-001280-24-NL   Bulgaria;Czechia;Hungary;Lithuania;Netherlands;Poland;Ukraine;United Kingdom;United States
      2021   Phase 2   EUCTR2021-001280-24-LT   Bulgaria;Czechia;Hungary;Lithuania;Netherlands;Poland;Ukraine;United Kingdom;United States
      2021   Phase 2   EUCTR2021-001280-24-HU   Bulgaria;Czechia;Hungary;Lithuania;Netherlands;Poland;Russian Federation;Ukraine;United States
Vedolizumab
   2nd Affiliated Hospital, Zhejiang University School of Medicine
      2024   -   ChiCTR2400089904   China
   ALIMENTIV INC.
      2021   Phase 4   EUCTR2019-002485-12-IT   Belarus;Belgium;Canada;France;Italy;Netherlands;Poland;Russian Federation;Ukraine;United Kingdom;United States
   AbbVie
      2025   Phase 3   NCT06880744   -
   Alimentiv
      2021   Phase 4   EUCTR2019-002485-12-PL   Belarus;Belgium;Canada;France;Italy;Netherlands;Poland;Russian Federation;Ukraine;United Kingdom;United States
   Alimentiv Inc.
      2021   Phase 4   EUCTR2019-002485-12-NL   Belarus;Belgium;Canada;France;Italy;Netherlands;Poland;Ukraine;United Kingdom;United States
      2020   Phase 4   EUCTR2019-002485-12-BE   Belarus;Belgium;Canada;France;Italy;Netherlands;Poland;Russian Federation;Ukraine;United Kingdom;United States
   Alimentiv Inc. (formerly Robarts Clinical Trials)
      2020   Phase 4   EUCTR2019-002485-12-GB   Belarus;Belgium;Canada;France;Italy;Netherlands;Poland;Russian Federation;Ukraine;United Kingdom;United States
   Allergan Ltd.
      2019   Phase 2   EUCTR2018-001605-93-RO   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Colombia;Czech Republic;Czechia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Poland;Romania;Russian Federation;Singapore;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States
      2019   Phase 2   EUCTR2018-001605-93-ES   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Colombia;Czech Republic;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Poland;Romania;Russian Federation;Singapore;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States
      2019   Phase 2   EUCTR2018-001605-93-BG   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Colombia;Czech Republic;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Poland;Romania;Russian Federation;Singapore;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States
   Alvotech Swiss AG
      2024   Phase 3   NCT06570772   Argentina;Bulgaria;Croatia;Georgia;Latvia;Poland;Romania;Serbia;Slovakia;Sri Lanka;Ukraine
   AstraZeneca
      2018   Phase 2   NCT04718818   Canada;India;Korea, Republic of;Puerto Rico;Romania;Taiwan;United States
   AstraZeneca AB
      2019   Phase 2   EUCTR2018-001605-93-GB   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Colombia;Czech Republic;Czechia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Poland;Romania;Russian Federation;Singapore;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States
      2019   Phase 2   EUCTR2018-001605-93-BE   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Colombia;Czech Republic;Czechia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Poland;Romania;Russian Federation;Singapore;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States
   CHU de Saint Etienne
      2019   Phase 4   EUCTR2019-001032-54-FR   France
   Ced Service GmbH
      2017   -   NCT03375424   Germany
   Centre Hospitalier Universitaire de Rennes
      2018   Phase 4   EUCTR2018-002673-21-FR   France
   Eli Lilly and Company
      2021   Phase 3   EUCTR2019-001653-99-LV   Argentina;Australia;Austria;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;France;Germany;Hungary;India;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2021   Phase 3   EUCTR2019-001653-99-LT   Argentina;Australia;Austria;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;France;Germany;Hungary;India;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2021   Phase 3   EUCTR2019-001653-99-DE   Argentina;Australia;Austria;Belgium;Brazil;Canada;Croatia;Czech Republic;Czechia;Denmark;France;Germany;Hungary;India;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2021   Phase 3   EUCTR2019-001653-99-BE   Argentina;Australia;Austria;Belgium;Brazil;Canada;Croatia;Czechia;Denmark;France;Germany;Hungary;India;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2021   Phase 3   EUCTR2019-001653-99-AT   Argentina;Australia;Austria;Belgium;Brazil;Canada;Croatia;Czech Republic;Czechia;Denmark;France;Germany;Hungary;India;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2020   Phase 3   EUCTR2019-001653-99-FR   Argentina;Australia;Austria;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;France;Germany;Hungary;India;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
   FONDAZIONE IRCCS CA' GRANDA OSPEDALE MAGGIORE POLICLINICO
      2016   Phase 4   EUCTR2015-003270-32-IT   Italy
   Fundación de Investigación Biomédica del Hospital Universitario de La Princesa
      2018   Phase 4   EUCTR2018-002925-47-ES   Spain
   GENENTECH, INC.
      2018   Phase 2   EUCTR2017-002350-36-IT   Bulgaria;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
   Genentech, Inc.
      2018   Phase 2   NCT03558152   Bulgaria;China;France;Georgia;Germany;Greece;Hungary;Ireland;Israel;Italy;Moldova, Republic of;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
      2018   Phase 2   EUCTR2017-002350-36-NL   Bulgaria;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
      2018   Phase 2   EUCTR2017-002350-36-IE   Bulgaria;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
      2018   Phase 2   EUCTR2017-002350-36-HU   Bulgaria;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
      2018   Phase 2   EUCTR2017-002350-36-GR   Bulgaria;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
      2018   Phase 2   EUCTR2017-002350-36-GB   Bulgaria;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
      2018   Phase 2   EUCTR2017-002350-36-DE   Bulgaria;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
      2018   Phase 2   EUCTR2017-002350-36-BG   Bulgaria;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
   Guy's & St Thomas NHS Foundation Trust
      2018   Phase 4   EUCTR2018-002794-21-GB   United Kingdom
   Guy's and St Thomas' NHS Foundation Trust
      2019   Phase 4   NCT04006080   United Kingdom
   Humanitas Clinical and Research Center
      2023   -   NCT06691061   Italy
   Insel Gruppe AG, University Hospital Bern
      2023   -   NCT05702879   Switzerland
   MILLENNIUM PHARMACEUTICALS, INC.
      2009   Phase 3   EUCTR2008-002784-14-IT   Austria;Belgium;Bulgaria;Czech Republic;Estonia;France;Germany;Greece;Hungary;Iceland;Ireland;Italy;Latvia;Malta;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom
      2009   -   EUCTR2008-002782-32-IT   Austria;Belgium;Bulgaria;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;Iceland;Ireland;Italy;Latvia;Malta;Netherlands;Portugal;Spain;United Kingdom
   Medical College of Wisconsin
      2017   Phase 3   NCT02954159   United States
   Millennium Pharmaceuticals, Inc.
      2011   Phase 1   NCT01981616   United Kingdom
      2009   Phase 3   NCT00783718   Canada;Puerto Rico;United States
      2009   Phase 3   EUCTR2008-002784-14-PT   Austria;Belgium;Bulgaria;Czech Republic;Estonia;France;Germany;Greece;Hungary;Iceland;Ireland;Italy;Latvia;Malta;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom
      2009   -   EUCTR2008-002784-14-MT   Austria;Belgium;Bulgaria;Czech Republic;Estonia;France;Germany;Greece;Hungary;Iceland;Ireland;Italy;Latvia;Malta;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom
      2009   Phase 3   EUCTR2008-002784-14-IE   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Estonia;France;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Korea, Republic of;Latvia;Malaysia;Malta;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2009   Phase 3   EUCTR2008-002784-14-GR   Austria;Belgium;Bulgaria;Czech Republic;Estonia;France;Germany;Greece;Hungary;Iceland;Ireland;Italy;Latvia;Malta;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom
      2009   Phase 3   EUCTR2008-002784-14-FR   Austria;Belgium;Bulgaria;Czech Republic;Estonia;France;Germany;Greece;Hungary;Iceland;Ireland;Italy;Latvia;Malta;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom
      2009   Phase 3   EUCTR2008-002784-14-ES   Austria;Belgium;Bulgaria;Czech Republic;Estonia;France;Germany;Greece;Hungary;Iceland;Ireland;Italy;Latvia;Malta;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom
      2009   Phase 3   EUCTR2008-002784-14-EE   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Estonia;France;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Korea, Republic of;Latvia;Malaysia;Malta;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2009   -   EUCTR2008-002783-33-MT   Austria;Belgium;Bulgaria;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;Iceland;Ireland;Italy;Latvia;Malta;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom
      2009   -   EUCTR2008-002783-33-AT   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Korea, Republic of;Latvia;Malaysia;Malta;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom
      2009   -   EUCTR2008-002782-32-PT   Austria;Belgium;Bulgaria;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;Iceland;Ireland;Italy;Latvia;Malta;Netherlands;Portugal;Spain;United Kingdom
      2009   -   EUCTR2008-002782-32-NL   Austria;Belgium;Bulgaria;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;Iceland;Ireland;Italy;Latvia;Malta;Netherlands;Portugal;Spain;United Kingdom
      2009   -   EUCTR2008-002782-32-MT   Austria;Belgium;Bulgaria;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;Iceland;Ireland;Italy;Latvia;Malta;Netherlands;Portugal;Spain;United Kingdom
      2009   Phase 3   EUCTR2008-002782-32-IS   Austria;Belgium;Bulgaria;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;Iceland;Ireland;Italy;Latvia;Malta;Netherlands;Portugal;Spain;United Kingdom
      2009   -   EUCTR2008-002782-32-IE   Austria;Belgium;Bulgaria;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;Iceland;Ireland;Italy;Latvia;Malta;Netherlands;Portugal;Spain;United Kingdom
      2009   -   EUCTR2008-002782-32-HU   Austria;Belgium;Bulgaria;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;Iceland;Ireland;Italy;Latvia;Malta;Netherlands;Portugal;Spain;United Kingdom
      2009   -   EUCTR2008-002782-32-GR   Austria;Belgium;Bulgaria;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;Iceland;Ireland;Italy;Latvia;Malta;Netherlands;Portugal;Spain;United Kingdom
      2009   Phase 3   EUCTR2008-002782-32-GB   Austria;Belgium;Bulgaria;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;Iceland;Ireland;Italy;Latvia;Malta;Netherlands;Portugal;Spain;United Kingdom
      2009   Phase 3   EUCTR2008-002782-32-FR   Austria;Belgium;Bulgaria;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;Iceland;Ireland;Italy;Latvia;Malta;Netherlands;Portugal;Spain;United Kingdom
      2009   -   EUCTR2008-002782-32-ES   Austria;Belgium;Bulgaria;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;Iceland;Ireland;Italy;Latvia;Malta;Netherlands;Portugal;Spain;United Kingdom
      2009   -   EUCTR2008-002782-32-EE   Austria;Belgium;Bulgaria;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;Iceland;Ireland;Italy;Latvia;Malta;Netherlands;Portugal;Spain;United Kingdom
      2009   -   EUCTR2008-002782-32-DK   Austria;Belgium;Bulgaria;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;Iceland;Ireland;Italy;Latvia;Malta;Netherlands;Portugal;Spain;United Kingdom
      2009   -   EUCTR2008-002782-32-DE   Australia;Austria;Belgium;Bulgaria;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Korea, Democratic People's Republic of;Latvia;Malaysia;Malta;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom
      2009   -   EUCTR2008-002782-32-CZ   Austria;Belgium;Bulgaria;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;Iceland;Ireland;Italy;Latvia;Malta;Netherlands;Portugal;Spain;United Kingdom
      2009   -   EUCTR2008-002782-32-BG   Austria;Belgium;Bulgaria;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;Iceland;Ireland;Italy;Latvia;Malta;Netherlands;Portugal;Spain;United Kingdom
      2009   Phase 3   EUCTR2008-002782-32-BE   Austria;Belgium;Bulgaria;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;Iceland;Ireland;Italy;Latvia;Malta;Netherlands;Portugal;Spain;United Kingdom
      2009   -   EUCTR2008-002782-32-AT   Austria;Belgium;Bulgaria;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;Iceland;Ireland;Italy;Latvia;Malta;Netherlands;Portugal;Spain;United Kingdom
      2008   -   EUCTR2008-002782-32-LV   Austria;Belgium;Bulgaria;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;Iceland;Ireland;Italy;Latvia;Malta;Netherlands;Portugal;Spain;United Kingdom
      2007   Phase 2   NCT01177228   -
      2007   Phase 2   NCT00619489   Canada
   Nantes University Hospital
      2017   -   NCT02878083   France
   Odyssey Therapeutics
      2025   Phase 2   NCT06850727   -
   Parc de Salut Mar
      2017   -   NCT02712866   Spain
   Peking Union Medical College Hospital
      2020   -   NCT05386290   China
   Robarts Clinical Trials Inc.
      2020   Phase 4   EUCTR2019-002485-12-FR   Belarus;Belgium;Canada;France;Italy;Netherlands;Poland;Russian Federation;Ukraine;United Kingdom;United States
   Roche Farma, S.A por delegación de Genentech, Inc.
      2018   Phase 2   EUCTR2017-002350-36-ES   Bulgaria;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
   Second Affiliated Hospital of Wenzhou Medical University
      2020   -   NCT06873711   China
      2019   -   NCT06961435   China
   Second Affiliated Hospital, School of Medicine, Zhejiang University
      2024   Phase 4   NCT06609447   China
   Shaare Zedek Medical Center
      2017   -   NCT02862132   Denmark;Finland;Ireland;Israel;Slovenia;United Kingdom;United States
   Shenzhen Hospital of Southern Medical University
      2024   Phase 0   ChiCTR2400093919   China
   Showa Inan General Hospital
      2024   Phase 4   NCT06626165   Japan
   Sixth Affiliated Hospital, Sun Yat-sen University
      2023   -   NCT06095596   China
      2022   Phase 4   NCT05205603   China
   Stanford University
      2020   -   NCT03802214   Canada;United States
   TAKEDA DEVELOPMENT CENTER AMERICAS INC.
      2021   Phase 3   EUCTR2020-004300-34-IT   Australia;Austria;Belgium;Bosnia and Herzegovina;Canada;China;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Japan;Lithuania;New Zealand;Poland;Romania;Russian Federation;Slovakia;Spain;Ukraine;United Kingdom;United States
   Takeda
      2024   Phase 4   NCT06095128   Canada;United States
      2022   Phase 3   NCT04779307   Australia;Belgium;Canada;China;Croatia;Czechia;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Poland;Russian Federation;Slovakia;Spain;Ukraine;United Kingdom;United States
      2021   Phase 3   NCT04738942   Japan
      2019   -   NCT03824561   Japan
      2018   Phase 2   NCT03196427   Belgium;Canada;France;Hungary;Israel;Netherlands;Poland;Ukraine;United Kingdom;United States
      2017   Phase 2   NCT03138655   Belgium;Canada;France;Germany;Hungary;Israel;Netherlands;Poland;Ukraine;United Kingdom;United States
      2017   Phase 3   NCT03035058   -
      2017   Phase 4   NCT02559713   United States
      2016   Phase 4   NCT02760615   United States
      2016   Phase 4   NCT02743806   Australia;Bulgaria;Czech Republic;Czechia;Estonia;Hungary;India;Italy;Korea, Republic of;Latvia;Malaysia;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Taiwan;Turkey;Ukraine
      2015   -   NCT02674308   Austria;Belgium;Canada;Croatia;Denmark;Estonia;France;Germany;Greece;Ireland;Israel;Italy;Netherlands;Norway;Portugal;Slovenia;Spain;Sweden;Switzerland;United Kingdom;United States
      2015   Phase 3   NCT02497469   Argentina;Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2014   Phase 3   NCT02039505   Japan
      2009   Phase 3   NCT00790933   Australia;Belgium;Canada;Czech Republic;Czechia;Germany;Hungary;Israel;Korea, Republic of;Malaysia;United States
   Takeda Development Center Americas, Inc.
      2023   Phase 3   EUCTR2021-000630-34-SK   Australia;Belgium;Canada;China;Croatia;Czech Republic;Czechia;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Poland;Slovakia;Spain;United Kingdom;United States
      2023   Phase 3   EUCTR2021-000630-34-GR   Australia;Belgium;Canada;China;Croatia;Czech Republic;Czechia;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Poland;Slovakia;Spain;United Kingdom;United States
      2023   Phase 3   EUCTR2021-000630-34-BE   Australia;Belgium;Canada;China;Croatia;Czech Republic;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Poland;Slovakia;Spain;United Kingdom;United States
      2022   Phase 3   EUCTR2021-000630-34-HU   Australia;Belgium;Canada;China;Croatia;Czech Republic;Czechia;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Poland;Russian Federation;Slovakia;Spain;Ukraine;United Kingdom;United States
      2022   Phase 3   EUCTR2021-000630-34-HR   Australia;Belgium;Canada;China;Croatia;Czech Republic;Czechia;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Poland;Russian Federation;Slovakia;Spain;Ukraine;United Kingdom;United States
      2022   Phase 3   EUCTR2020-004300-34-BE   Australia;Belgium;Canada;China;Croatia;Czech Republic;Czechia;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Poland;Slovakia;Spain;United Kingdom;United States
      2021   Phase 3   EUCTR2020-004300-34-SK   Australia;Belgium;Canada;China;Croatia;Czech Republic;Czechia;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Poland;Slovakia;Spain;United Kingdom;United States
      2021   Phase 3   EUCTR2020-004300-34-LT   Australia;Belgium;Canada;China;Croatia;Czech Republic;Czechia;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Poland;Russian Federation;Slovakia;Spain;Ukraine;United Kingdom;United States
      2021   Phase 3   EUCTR2020-004300-34-HU   Australia;Austria;Belgium;Bosnia and Herzegovina;Canada;China;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Japan;Lithuania;New Zealand;Poland;Romania;Russian Federation;Slovakia;Spain;Ukraine;United Kingdom;United States
      2021   Phase 3   EUCTR2020-004300-34-HR   Australia;Austria;Belgium;Bosnia and Herzegovina;Canada;China;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Japan;Lithuania;New Zealand;Poland;Romania;Russian Federation;Slovakia;Spain;Ukraine;United Kingdom;United States
      2021   Phase 3   EUCTR2020-004300-34-GR   Australia;Belgium;Canada;China;Croatia;Czech Republic;Czechia;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Poland;Slovakia;Spain;United Kingdom;United States
      2021   Phase 3   EUCTR2020-004300-34-ES   Australia;Austria;Belgium;Bosnia and Herzegovina;Canada;China;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Japan;Lithuania;New Zealand;Poland;Romania;Russian Federation;Slovakia;Spain;Ukraine;United Kingdom;United States
      -   Phase 3   EUCTR2021-000630-34-PL   Australia;Belgium;Canada;China;Croatia;Czech Republic;Czechia;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Poland;Slovakia;Spain;United Kingdom;United States
      -   Phase 3   EUCTR2021-000630-34-Outside-EU/EEA   Australia;Canada;China;Israel;Japan;Korea, Republic of;United Kingdom;United States
      -   Phase 3   EUCTR2021-000630-34-CZ   Australia;Belgium;Canada;China;Croatia;Czech Republic;Czechia;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Poland;Slovakia;Spain;United Kingdom;United States
      -   Phase 3   EUCTR2020-004300-34-PL   Australia;Belgium;Canada;China;Croatia;Czech Republic;Czechia;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Poland;Slovakia;Spain;United Kingdom;United States
      -   Phase 3   EUCTR2020-004300-34-Outside-EU/EEA   Australia;Belgium;Canada;China;Croatia;Czechia;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Poland;Slovakia;Spain;United Kingdom;United States
      -   Phase 3   EUCTR2020-004300-34-CZ   Australia;Belgium;Canada;China;Croatia;Czech Republic;Czechia;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Poland;Slovakia;Spain;United Kingdom;United States
   Takeda Development Centre Americas Inc.
      2018   Phase 2   EUCTR2017-002182-21-PL   Belgium;Canada;France;Germany;Hungary;Israel;Netherlands;Poland;Ukraine;United Kingdom;United States
   Takeda Development Centre Americas, Ltd.
      2017   Phase 2   EUCTR2017-002182-21-HU   Belgium;Canada;France;Germany;Hungary;Israel;Netherlands;Poland;Ukraine;United Kingdom;United States
   Takeda Development Centre Europe Limited
      2017   Phase 4   EUCTR2016-000678-40-BG   Australia;Bulgaria;Czech Republic;Estonia;Hungary;India;Italy;Korea, Republic of;Latvia;Malaysia;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Taiwan;Turkey;Ukraine
      2016   Phase 4   EUCTR2016-000678-40-LV   Australia;Bulgaria;Czech Republic;Estonia;Hungary;India;Italy;Korea, Republic of;Latvia;Malaysia;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Taiwan;Turkey;Ukraine
      2016   Phase 4   EUCTR2016-000678-40-HU   Australia;Bulgaria;Czech Republic;Czechia;Estonia;Hungary;India;Italy;Korea, Republic of;Latvia;Malaysia;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Taiwan;Turkey;Ukraine
      2016   Phase 4   EUCTR2016-000678-40-EE   Australia;Bulgaria;Czech Republic;Estonia;Hungary;India;Italy;Korea, Republic of;Latvia;Malaysia;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Taiwan;Turkey;Ukraine
   Takeda Development Centre Europe Ltd
      2009   Phase 3   EUCTR2008-002784-14-IS   Austria;Belgium;Bulgaria;Czech Republic;Estonia;France;Germany;Greece;Hungary;Iceland;Ireland;Italy;Latvia;Malta;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom
   Takeda Development Centre Europe Ltd.
      2010   Phase 3   EUCTR2008-002784-14-SE   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Estonia;France;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Korea, Republic of;Latvia;Malaysia;Malta;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2010   Phase 3   EUCTR2008-002784-14-GB   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Estonia;France;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Korea, Republic of;Latvia;Malaysia;Malta;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;United Kingdom
      2009   Phase 3   EUCTR2008-002784-14-SK   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Estonia;France;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Korea, Republic of;Latvia;Malaysia;Malta;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2009   Phase 3   EUCTR2008-002784-14-NL   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Estonia;France;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Korea, Republic of;Latvia;Malaysia;Malta;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2009   Phase 3   EUCTR2008-002784-14-DE   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Estonia;France;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Korea, Republic of;Latvia;Malaysia;Malta;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2009   Phase 3   EUCTR2008-002784-14-CZ   Australia;Austria;Belgium;Bulgaria;Czech Republic;Estonia;France;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Korea, Republic of;Latvia;Malaysia;Malta;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom
      2009   Phase 3   EUCTR2008-002784-14-BG   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Estonia;France;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Korea, Republic of;Latvia;Malaysia;Malta;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2009   Phase 3   EUCTR2008-002784-14-BE   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Estonia;France;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Korea, Republic of;Latvia;Malaysia;Malta;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2009   Phase 3   EUCTR2008-002784-14-AT   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Estonia;France;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Korea, Republic of;Latvia;Malaysia;Malta;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2008   Phase 3   EUCTR2008-002784-14-LV   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Estonia;France;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Korea, Republic of;Latvia;Malaysia;Malta;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
   Takeda Development Centre Europe ltd.
      2009   Phase 3   EUCTR2008-002784-14-HU   Australia;Austria;Belgium;Bulgaria;Czech Republic;Estonia;France;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Korea, Republic of;Latvia;Malaysia;Malta;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
   Takeda Development Centre Europe, Ltd.
      2018   Phase 2   EUCTR2017-002182-21-NL   Belgium;Canada;France;Germany;Hungary;Israel;Netherlands;Poland;Ukraine;United Kingdom;United States
      2018   Phase 2   EUCTR2017-002182-21-BE   Belgium;Canada;France;Germany;Hungary;Israel;Netherlands;Poland;Ukraine;United Kingdom;United States
      2017   Phase 2   EUCTR2017-002182-21-GB   Belgium;Canada;France;Germany;Hungary;Israel;Netherlands;Poland;Ukraine;United Kingdom;United States
      2017   Phase 2   EUCTR2017-002182-21-FR   Belgium;Canada;France;Germany;Hungary;Israel;Netherlands;Poland;Ukraine;United Kingdom;United States
      2017   Phase 2   EUCTR2017-002182-21-DE   Belgium;Canada;France;Germany;Hungary;Israel;Netherlands;Poland;Ukraine;United Kingdom;United States
   Takeda Pharmaceutical Company Limited
      2020   -   JPRN-jRCT1080225363   Japan
      2019   -   JPRN-jRCT1080224534   Japan
   The Second Affiliated Hospital of Guangzhou University of Chinese Medicine
      2024   Phase 1   ChiCTR2400089333   China
   University of Miami
      2017   Early Phase 1   NCT02953275   United States
   University of Pennsylvania
      2017   Phase 4   NCT03237260   United States
   Yonsei University
      2021   Phase 3   NCT04919252   Korea, Republic of
   ooi makoto
      2022   Phase 3   JPRN-jRCT1051210145   -
Vedolizumab 108 MG SC
   Takeda
      2015   Phase 3   NCT02611830   Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
   Takeda Pharmaceutical Company Limited
      2015   Phase 3   JPRN-jRCT2080223167   Japan;Japan, Refer to Other section
Vedolizumab 300 MG
   Fujiya Mikihiro
      2021   Phase 4   JPRN-jRCTs011200009   -
   Geert D'Haens
      2015   Phase 4   NCT02646657   Belgium;Hungary;Netherlands
   Naganuma Makoto
      2021   -   JPRN-jRCT1031200329   -
   Shikamura Mitsuhiro
      2023   Phase 3   JPRN-jRCT2071230036   China;Greece;Hungary;Italy;Japan;Korea;Poland
      2021   Phase 3   JPRN-jRCT2071210030   Australia;Belgium;Bosnia;Canada;China;Croatia;Czech Republic;Germany;Hungary;Israel;Italy;Japan;Lithuania;New Zealand;Poland;Romania;Russia;Slovakia;Spain;Ukraine;United Kingdom;United States
      2021   Phase 3   JPRN-jRCT2031200371   -
   TAKEDA PHARMACEUTICAL COMPANY LTD.
      2014   Phase 3   JPRN-jRCT2080222353   Japan
Vedolizumab 300 MG IV
   Takeda
      2015   Phase 3   NCT02611830   Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
   Takeda Pharmaceutical Company Limited
      2015   Phase 3   JPRN-jRCT2080223167   Japan;Japan, Refer to Other section
Vedolizumab injection
   Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
      2023   Phase 4   NCT06584162   Netherlands
   Mayo Clinic
      2017   Early Phase 1   NCT03309865   United States
   Rennes University Hospital
      2019   Phase 4   NCT03679546   France
Vedolizumab intravenous injection
   Takeda
      2014   Phase 2   NCT02913508   -
Vedolizumab IV
   Academic Medical Center/ Gastroenterology
      2015   Phase 4   EUCTR2014-005443-40-BE   Belgium;Hungary;Netherlands
   Eli Lilly and Company
      2021   Phase 3   NCT04469062   -
   Shikamura Mitsuhiro
      2021   Phase 3   JPRN-jRCT2031200371   -
   TAKEDA DEVELOPMENT CENTRE EUROPE LTD
      2016   Phase 3   EUCTR2015-000480-14-IT   Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
      2015   Phase 3   EUCTR2015-000939-33-IT   Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
      -   Phase 4   EUCTR2016-000678-40-IT   Austria;Belgium;Bulgaria;Czech Republic;Czechia;Estonia;Hungary;Iceland;India;Italy;Korea, Democratic People's Republic of;Korea, Republic of;Latvia;Malaysia;New Zealand;Poland;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Taiwan;Turkey;Ukraine
   Takeda
      2025   -   NCT06856135   United States
      2025   Phase 4   NCT06581328   United States
      2025   Phase 3   NCT06100289   Belgium;Bulgaria;Denmark;Ireland;Italy;Japan;Korea, Republic of;Netherlands;Poland;Portugal;Romania;Serbia;Spain;Switzerland;Taiwan;Turkey;United States
      2023   Phase 3   NCT05442567   Australia;Belgium;Canada;China;Croatia;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Poland;Slovakia;United Kingdom;United States
      2021   Phase 4   NCT04804540   India
      2017   Phase 3   NCT03221036   China
      2017   Phase 4   NCT03029143   Canada;United States
   Takeda Development Centre Europe Limited
      2016   Phase 4   EUCTR2016-000678-40-CZ   Australia;Bulgaria;Czech Republic;Estonia;Hungary;India;Italy;Korea, Republic of;Latvia;Malaysia;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Taiwan;Turkey;Ukraine
   Takeda Development Centre Europe, Ltd.
      2018   Phase 2   EUCTR2017-002231-41-PL   Belgium;Canada;France;Germany;Hungary;Israel;Netherlands;Poland;Ukraine;United Kingdom;United States
      2018   Phase 2   EUCTR2017-002231-41-NL   Belgium;Canada;France;Germany;Hungary;Israel;Netherlands;Poland;Ukraine;United Kingdom;United States
      2018   Phase 2   EUCTR2017-002231-41-BE   Belgium;Canada;France;Germany;Hungary;Israel;Netherlands;Poland;Ukraine;United Kingdom;United States
      2017   Phase 2   EUCTR2017-002231-41-HU   Belgium;Canada;France;Germany;Hungary;Israel;Netherlands;Poland;Ukraine;United Kingdom;United States
      2017   Phase 2   EUCTR2017-002231-41-GB   Belgium;Canada;France;Germany;Hungary;Israel;Netherlands;Poland;Ukraine;United Kingdom;United States
      2017   Phase 2   EUCTR2017-002231-41-DE   Belgium;Canada;France;Germany;Hungary;Israel;Netherlands;Poland;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000939-33-PT   Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000939-33-PL   Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000939-33-NL   Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000939-33-HU   Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000939-33-HR   Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000939-33-ES   Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000480-14-SK   Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000480-14-SE   Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000480-14-RO   Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000480-14-NL   Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000480-14-LT   Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000480-14-HU   Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000480-14-HR   Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000480-14-GB   Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000480-14-ES   Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000480-14-DK   Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000480-14-DE   Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000480-14-CZ   Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000480-14-BG   Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000480-14-BE   Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2014-003942-28-SE   Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Israel;Italy;Japan;Netherlands;Poland;Russian Federation;Spain;Sweden;Switzerland;United Kingdom;United States
      2016   Phase 3   EUCTR2014-003942-28-PL   Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Israel;Italy;Japan;Netherlands;Poland;Russian Federation;Spain;Sweden;Switzerland;United Kingdom;United States
      2016   Phase 3   EUCTR2014-003942-28-HU   Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Israel;Italy;Japan;Netherlands;Poland;Russian Federation;Spain;Sweden;Switzerland;United Kingdom;United States
      2016   Phase 3   EUCTR2014-003942-28-GB   Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Israel;Italy;Japan;Netherlands;Poland;Russian Federation;Spain;Sweden;Switzerland;United Kingdom;United States
      2016   Phase 3   EUCTR2014-003942-28-FR   Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Israel;Italy;Japan;Netherlands;Poland;Russian Federation;Spain;Sweden;Switzerland;United Kingdom;United States
      2016   Phase 3   EUCTR2014-003942-28-ES   Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Israel;Italy;Japan;Netherlands;Poland;Russian Federation;Spain;Sweden;Switzerland;United Kingdom;United States
      2016   Phase 3   EUCTR2014-003942-28-DE   Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Israel;Italy;Japan;Netherlands;Poland;Russian Federation;Spain;Sweden;Switzerland;United Kingdom;United States
      2016   Phase 3   EUCTR2014-003942-28-CZ   Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Israel;Italy;Japan;Netherlands;Poland;Russian Federation;Spain;Sweden;Switzerland;United Kingdom;United States
      2016   Phase 3   EUCTR2014-003942-28-BE   Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Israel;Italy;Japan;Netherlands;Poland;Russian Federation;Spain;Sweden;Switzerland;United Kingdom;United States
      2016   Phase 3   EUCTR2014-003942-28-AT   Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Israel;Italy;Japan;Netherlands;Poland;Russian Federation;Spain;Sweden;Switzerland;United Kingdom;United States
      2015   Phase 3   EUCTR2015-000939-33-SK   Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2015   Phase 3   EUCTR2015-000939-33-LV   Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2015   Phase 3   EUCTR2015-000939-33-LT   Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2015   Phase 3   EUCTR2015-000939-33-GB   Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2015   Phase 3   EUCTR2015-000939-33-EE   Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2015   Phase 3   EUCTR2015-000939-33-DK   Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2015   Phase 3   EUCTR2015-000939-33-DE   Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2015   Phase 3   EUCTR2015-000939-33-CZ   Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2015   Phase 3   EUCTR2015-000939-33-BG   Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2015   Phase 3   EUCTR2015-000939-33-BE   Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
      -   Phase 2   EUCTR2017-002231-41-FR   Belgium;Canada;France;Germany;Hungary;Israel;Netherlands;Poland;Ukraine;United Kingdom;United States
   Takeda Pharmaceutical Company Limited
      2016   Phase 3   JPRN-jRCT2080223165   Japan;Refer to Othersection
      2015   Phase 3   JPRN-jRCT2080223167   Japan;Japan, Refer to Other section
Vedolizumab SC
   TAKEDA DEVELOPMENT CENTRE EUROPE LTD
      2016   Phase 3   EUCTR2015-000482-31-IT   Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Montenegro;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000480-14-IT   Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
   Takeda
      2025   Phase 4   NCT06581328   United States
      2025   Phase 3   NCT06405087   -
      2025   Phase 3   NCT06100289   Belgium;Bulgaria;Denmark;Ireland;Italy;Japan;Korea, Republic of;Netherlands;Poland;Portugal;Romania;Serbia;Spain;Switzerland;Taiwan;Turkey;United States
      2016   Phase 3   NCT02620046   Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Taiwan;Turkey;Ukraine;United Kingdom;United States
   Takeda Development Centre Europe, Ltd.
      2016   Phase 3   EUCTR2015-000482-31-SK   Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000482-31-SE   Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000482-31-RO   Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000482-31-NL   Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000482-31-LT   Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000482-31-HU   Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000482-31-HR   Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000482-31-GB   Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000482-31-ES   Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000482-31-DK   Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000482-31-DE   Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000482-31-CZ   Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000482-31-BG   Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000482-31-BE   Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000480-14-SK   Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000480-14-SE   Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000480-14-RO   Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000480-14-NL   Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000480-14-LT   Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000480-14-HU   Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000480-14-HR   Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000480-14-GB   Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000480-14-ES   Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000480-14-DK   Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000480-14-DE   Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000480-14-CZ   Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000480-14-BG   Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000480-14-BE   Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
   Takeda Pharmaceutical Company Limited
      2015   Phase 3   JPRN-jRCT2080223167   Japan;Japan, Refer to Other section
Vedolizumab SC 108 MG
   Takeda Pharmaceutical Company Limited
      2016   Phase 3   JPRN-jRCT2080223165   Japan;Refer to Othersection
Vedolizumab subcutaneous injection
   Takeda
      2014   Phase 2   NCT02913508   -
Vedolizumab, entyvio
   Amsterdam UMC
      2022   Phase 4   EUCTR2022-000837-17-NL   Netherlands
Vedolizumab, ustekinumab, or tofacitinib
   Asan Medical Center
      2022   -   NCT05186623   Korea, Republic of
Vedulizumab
   ALIMENTIV INC.
      2021   Phase 4   EUCTR2019-002485-12-IT   Belarus;Belgium;Canada;France;Italy;Netherlands;Poland;Russian Federation;Ukraine;United Kingdom;United States
Vegan drink
   Per Bendix Jeppesen
      2020   -   NCT04297852   Denmark
Vegetarian meat alternative
   Region Skane
      2024   -   NCT06696222   -
Vegetarian yogurt
   Region Skane
      2024   -   NCT06696222   -
Venlafaxine
   West China Hospital, Sichuan University
      2019   Phase 4   ChiCTR1900021496   China
Venofer
   Leiden University Medical Center
      2022   Phase 4   EUCTR2022-000894-16-NL   Netherlands
Venofer solution FOR injection, 100 MG iron
   Vifor (International) Inc.
      2009   -   EUCTR2008-002333-75-AT   Austria;Denmark;Estonia;Germany;Lithuania;Spain;Sweden;United Kingdom
Venofer solution FOR injection, 20 MG iron/ML
   Vifor (International) Inc.
      2009   -   EUCTR2008-002333-75-SE   Austria;Denmark;Estonia;Germany;Lithuania;Spain;Sweden;United Kingdom
      2009   -   EUCTR2008-002333-75-LT   Austria;Denmark;Estonia;Germany;Lithuania;Spain;Sweden;United Kingdom
      2009   Phase 3   EUCTR2008-002333-75-GB   Austria;Denmark;Estonia;Germany;Lithuania;Spain;Sweden;United Kingdom
      2009   -   EUCTR2008-002333-75-DK   Austria;Denmark;Estonia;Germany;Lithuania;Spain;Sweden;United Kingdom
      2008   Phase 3   EUCTR2008-002333-75-ES   Austria;Denmark;Estonia;Germany;Lithuania;Spain;Sweden;United Kingdom
      2008   -   EUCTR2008-002333-75-EE   Austria;Denmark;Estonia;Germany;Lithuania;Spain;Sweden;United Kingdom
Venofer solution FOR injection, 20 MG/ML iron
   Vifor (International) Inc.
      -   -   EUCTR2008-002333-75-DE   Austria;Denmark;Estonia;Germany;Lithuania;Spain;Sweden;United Kingdom
Vidofludimus calcium
   Immunic AG
      2020   Phase 2   EUCTR2017-003703-22-RO   Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Croatia;Czechia;Germany;Netherlands;North Macedonia;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
      2020   Phase 2   EUCTR2017-003703-22-PT   Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Croatia;Czechia;Germany;Netherlands;North Macedonia;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
      2020   Phase 2   EUCTR2017-003703-22-BG   Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Croatia;Czechia;Germany;Netherlands;North Macedonia;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
      2019   Phase 2   EUCTR2017-003703-22-PL   Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Croatia;Czechia;Germany;Netherlands;North Macedonia;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
      2019   Phase 2   EUCTR2017-003703-22-HR   Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Croatia;Czechia;Georgia;Germany;Netherlands;North Macedonia;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
      2018   Phase 2   EUCTR2017-003703-22-NL   Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Croatia;Czechia;Germany;Netherlands;North Macedonia;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
      2018   Phase 2   EUCTR2017-003703-22-ES   Belgium;Czech Republic;Germany;Netherlands;Poland;Russian Federation;Serbia;Slovakia;Spain;Ukraine;United Kingdom;United States
Vidofludimus calcium dihydrate
   Immunic AG
      2018   Phase 2   EUCTR2017-003703-22-GB   Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Croatia;Czech Republic;Germany;Macedonia, the former Yugoslav Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
Vigantol OEL TM
   Imperial College London
      2008   -   EUCTR2008-001467-10-GB   United Kingdom
      2008   Phase 4   EUCTR2007-006692-37-GB   United Kingdom
Visilizumab
   Abbott
      2006   Phase 2   NCT00307827   Canada;Croatia;Ireland;Italy;Poland;Russian Federation;Serbia;Spain;Switzerland;United States
   Facet Biotech
      2006   Phase 2/Phase 3   NCT00279435   Australia;Austria;Belgium;Canada;Croatia;Czech Republic;France;Germany;Hungary;Israel;Italy;Netherlands;Norway;Ukraine;United States
      2006   Phase 2/Phase 3   NCT00279422   Australia;Austria;Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Netherlands;Norway;Slovakia;Ukraine;United States
      2004   Phase 1/Phase 2   NCT00267306   United States
      2002   Phase 2/Phase 3   NCT00032305   United States
   PDL BioPharma , Inc.
      2006   -   EUCTR2005-003482-17-IT   Greece;Ireland;Italy;Spain;United Kingdom
   PDL BioPharma, Inc
      2007   -   EUCTR2005-003707-37-BE   Austria;Belgium
      2007   -   EUCTR2005-003707-37-AT   Austria;Belgium
      2006   -   EUCTR2005-004105-28-NL   France;Germany;Greece;Hungary;Ireland;Netherlands;United Kingdom
      2006   Phase 2   EUCTR2005-003481-42-IE   Austria;Czech Republic;Germany;Greece;Hungary;Ireland;Slovakia;Spain
      2006   -   EUCTR2005-003481-42-ES   Czech Republic;Germany;Greece;Hungary;Ireland;Italy;Slovakia;Spain
      2006   Phase 2;Phase 3   EUCTR2005-002063-87-SK   Austria;Belgium;Czech Republic;Germany;Hungary;Slovakia
      2006   -   EUCTR2005-002063-87-DE   Belgium;Czech Republic;Germany;Hungary
   PDL BioPharma, Inc.
      2007   -   EUCTR2005-004105-28-GR   France;Germany;Greece;Hungary;Ireland;Netherlands;United Kingdom
      2007   -   EUCTR2005-004105-28-FR   France;Germany;Greece;Hungary;Ireland;Netherlands;United Kingdom
      2007   Phase 2   EUCTR2005-003482-17-GR   Greece;Ireland;Italy;Spain;United Kingdom
      2007   -   EUCTR2005-003482-17-GB   Greece;Ireland;Italy;Spain;United Kingdom
      2007   -   EUCTR2005-003481-42-GR   Czech Republic;Germany;Greece;Hungary;Ireland;Italy;Slovakia;Spain
      2006   -   NCT00355901   Australia;Austria;Belgium;Canada;Czech Republic;France;Germany;Hungary;Ireland;Italy;Netherlands;Norway;Ukraine;United States
      2006   Phase 2   EUCTR2005-004105-28-IE   France;Germany;Greece;Hungary;Ireland;Netherlands;United Kingdom
      2006   -   EUCTR2005-004105-28-GB   France;Germany;Greece;Hungary;Ireland;Netherlands;United Kingdom
      2006   -   EUCTR2005-004105-28-DE   France;Germany;Greece;Hungary;Ireland;Netherlands;United Kingdom
      2006   Phase 2   EUCTR2005-003482-17-IE   Greece;Ireland;Italy;Spain;United Kingdom
      2006   -   EUCTR2005-003482-17-ES   Greece;Ireland;Italy;Spain;United Kingdom
      2006   -   EUCTR2005-003481-42-HU   Czech Republic;Germany;Greece;Hungary;Ireland;Italy;Slovakia;Spain
      2006   -   EUCTR2005-003481-42-DE   Czech Republic;Germany;Greece;Hungary;Ireland;Italy;Slovakia;Spain
      2006   Phase 2   EUCTR2005-003481-42-CZ   Austria;Czech Republic;Germany;Greece;Hungary;Ireland;Slovakia;Spain
      2006   Phase 2;Phase 3   EUCTR2005-002063-87-CZ   Austria;Belgium;Czech Republic;Germany;Hungary;Slovakia
   PDL BioPharma, Inc;
      2006   -   EUCTR2005-003481-42-IT   Czech Republic;Germany;Greece;Hungary;Ireland;Italy;Slovakia;Spain
   Protein Design Labs, Inc
      2006   Phase 2   EUCTR2005-003481-42-SK   Austria;Czech Republic;Germany;Greece;Hungary;Ireland;Slovakia;Spain
      2006   -   EUCTR2005-003481-42-AT   Austria;Czech Republic;Germany;Greece;Hungary;Ireland;Slovakia;Spain
   Protein Design Labs, Inc.
      2006   -   EUCTR2005-002063-87-HU   Belgium;Czech Republic;Germany;Hungary
      2006   -   EUCTR2005-002063-87-BE   Belgium;Czech Republic;Germany;Hungary
      2005   -   EUCTR2005-002063-87-AT   Austria;Belgium;Czech Republic;Germany;Hungary
Visilizumab (HUM291
   Facet Biotech
      2007   Phase 3   NCT00502294   -
VIT-45
   Vifor (International) Inc.
      2009   -   EUCTR2008-003591-22-SE   Austria;Denmark;Estonia;Germany;Lithuania;Spain;Sweden;United Kingdom
      2009   -   EUCTR2008-003591-22-LT   Austria;Denmark;Estonia;Germany;Lithuania;Spain;Sweden;United Kingdom
      2009   -   EUCTR2008-003591-22-GB   Austria;Denmark;Estonia;Germany;Lithuania;Spain;Sweden;United Kingdom
      2009   -   EUCTR2008-003591-22-DK   Austria;Denmark;Estonia;Germany;Lithuania;Spain;Sweden;United Kingdom
      2009   -   EUCTR2008-003591-22-AT   Austria;Denmark;Estonia;Germany;Lithuania;Spain;Sweden;United Kingdom
      2009   -   EUCTR2008-002333-75-SE   Austria;Denmark;Estonia;Germany;Lithuania;Spain;Sweden;United Kingdom
      2009   -   EUCTR2008-002333-75-LT   Austria;Denmark;Estonia;Germany;Lithuania;Spain;Sweden;United Kingdom
      2009   Phase 3   EUCTR2008-002333-75-GB   Austria;Denmark;Estonia;Germany;Lithuania;Spain;Sweden;United Kingdom
      2009   -   EUCTR2008-002333-75-DK   Austria;Denmark;Estonia;Germany;Lithuania;Spain;Sweden;United Kingdom
      2009   -   EUCTR2008-002333-75-AT   Austria;Denmark;Estonia;Germany;Lithuania;Spain;Sweden;United Kingdom
      2008   Phase 3   EUCTR2008-003591-22-ES   Austria;Denmark;Estonia;Germany;Lithuania;Spain;Sweden;United Kingdom
      2008   -   EUCTR2008-003591-22-EE   Austria;Denmark;Estonia;Germany;Lithuania;Spain;Sweden;United Kingdom
      2008   -   EUCTR2008-003591-22-DE   Austria;Denmark;Estonia;Germany;Lithuania;Spain;Sweden;United Kingdom
      2008   Phase 3   EUCTR2008-002333-75-ES   Austria;Denmark;Estonia;Germany;Lithuania;Spain;Sweden;United Kingdom
      2008   -   EUCTR2008-002333-75-EE   Austria;Denmark;Estonia;Germany;Lithuania;Spain;Sweden;United Kingdom
      -   -   EUCTR2008-002333-75-DE   Austria;Denmark;Estonia;Germany;Lithuania;Spain;Sweden;United Kingdom
   Vifor Int.
      2006   -   EUCTR2006-003328-12-AT   Austria
Vitamin B2
   Novartis Pharma Services AG
      2007   Phase 2   EUCTR2007-002542-38-DK   Denmark;Germany
Vitamin B5 tablets
   Changhai Hospital
      2023   -   NCT05701501   China
Vitamin B6 tablets
   Changhai Hospital
      2024   -   NCT06512441   China
Vitamin D
   Penn State University
      2009   Phase 1   NCT00742781   United States
   Stanford University
      2021   Phase 1   NCT04828031   United States
   Tomas Bata Hospital, Czech Republic
      2022   Phase 4   NCT05733117   Czechia
   University Hospital of North Norway
      2013   Phase 1/Phase 2   NCT01846026   Norway
Vitamin D drops
   Second Affiliated Hospital of Wenzhou Medical University
      2020   Early Phase 1   NCT04309058   China
Vitamin D enriched milk
   Hillel Yaffe Medical Center
      2010   -   NCT01121796   Israel
Vitamin D-3
   Nemours Children's Clinic
      2013   -   NCT02256605   United States
Vitamin D3
   Boston Children's Hospital
      2020   -   NCT04331639   United States
      2017   Phase 3   NCT03162432   United States
   Emory University
      2013   Phase 1/Phase 2   NCT02076750   United States
   Massachusetts General Hospital
      2020   -   NCT04225819   United States
   University Hospital, Basel, Switzerland
      2022   Phase 3   NCT04991324   Switzerland
   University of California, San Francisco
      2012   -   NCT01877577   United States
   University of Chicago
      2012   -   NCT01640496   United States
Vitamin E 800IU
   University Health Network, Toronto
      2002   Phase 2   NCT00152841   Canada
Vitamin K
   Department of Gastroenterology, Osaka University Graduate School of Medicine
      2011   -   JPRN-UMIN000006915   Japan
Vitamin K 10 MG
   Janssen Research & Development, LLC
      2018   Phase 1   NCT03358706   Austria;Belgium;Denmark;Germany;Sweden;United Kingdom;United States
Vixarelimab
   Genentech, Inc.
      2025   Phase 1/Phase 2   NCT06693908   Germany
      2024   Phase 2   NCT06137183   Belgium;Brazil;China;Czechia;France;Germany;Greece;Israel;Italy;Korea, Republic of;Mexico;Poland;Serbia;Taiwan;United Kingdom;United States
Vonoprazan
   Shanghai Tenth People's Hospital
      2021   Phase 4   ChiCTR2100047119   China
VSL#3
   2nd Affiliated Hospital, Zhejiang University School of Medicine
      2024   -   ChiCTR2400089904   China
   Charles University, Czech Republic
      2014   -   NCT01765439   Czech Republic;Czechia
   Second Affiliated Hospital, School of Medicine, Zhejiang University
      2024   Phase 4   NCT06609447   China
   VSL Pharmaceuticals
      2017   -   NCT03415711   Italy
      2006   -   NCT00951548   Italy
VTX002
   Oppilan Pharma Ltd
      2021   Phase 2   NCT05156125   Bulgaria;Czechia;France;Georgia;Germany;Hungary;India;Italy;Korea, Republic of;Lithuania;Poland;Serbia;Slovakia;Ukraine;United States
   Oppilan Pharma Ltd.
      2022   Phase 2   EUCTR2021-003050-23-PL   Belgium;Bulgaria;Czech Republic;Czechia;France;Georgia;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Lithuania;Poland;Serbia;Slovakia;Sweden;Ukraine;United States
      2021   Phase 2   EUCTR2021-003050-23-HU   Belarus;Belgium;Bulgaria;Czech Republic;Czechia;France;Georgia;Germany;Hungary;Israel;Italy;Lithuania;Poland;Russian Federation;Slovakia;Ukraine;United States
   Oppilan Pharma Ltd., wholy owned subsidiary of Ventyx Biosciences Inc.
      2023   Phase 2   EUCTR2021-003050-23-BG   Belgium;Bulgaria;Czech Republic;Czechia;France;Georgia;Germany;Hungary;India;Italy;Korea, Republic of;Lithuania;Poland;Serbia;Slovakia;Ukraine;United States
   Oppilan Pharma limited
      2022   Phase 2   EUCTR2021-003050-23-IT   Belarus;Belgium;Bulgaria;Czech Republic;Czechia;France;Georgia;Germany;Hungary;Israel;Italy;Lithuania;Poland;Russian Federation;Slovakia;Ukraine;United States
VTX002 IS NOT biologic
   Oppilan Pharma Ltd., wholy owned subsidiary of Ventyx Biosciences Inc.
      2023   Phase 2   EUCTR2021-003050-23-BE   Belgium;Bulgaria;Czech Republic;Czechia;France;Georgia;Germany;Hungary;India;Italy;Korea, Republic of;Lithuania;Poland;Serbia;Slovakia;Sweden;Ukraine;United States
      2022   Phase 2   EUCTR2021-003050-23-SK   Belgium;Bulgaria;Czech Republic;Czechia;France;Georgia;Germany;Hungary;India;Italy;Korea, Republic of;Lithuania;Poland;Serbia;Slovakia;Ukraine;United States
      2022   Phase 2   EUCTR2021-003050-23-LT   Belgium;Bulgaria;Czech Republic;Czechia;France;Georgia;Germany;Hungary;India;Italy;Korea, Republic of;Lithuania;Poland;Serbia;Slovakia;Sweden;Ukraine;United States
      2022   Phase 2   EUCTR2021-003050-23-FR   Australia;Belarus;Belgium;Bulgaria;Czech Republic;Czechia;France;Georgia;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Lithuania;Poland;Russian Federation;Serbia;Slovakia;Sweden;Ukraine;United States
      2021   Phase 2   EUCTR2021-003050-23-CZ   Belgium;Bulgaria;Czech Republic;Czechia;France;Georgia;Germany;Hungary;India;Italy;Korea, Republic of;Lithuania;Poland;Slovakia;Ukraine;United States
Warfarin 10 MG
   Janssen Research & Development, LLC
      2018   Phase 1   NCT03358706   Austria;Belgium;Denmark;Germany;Sweden;United Kingdom;United States
Water
   411th Hospital of PLA
      2013   -   ChiCTR-TRC-13003530   China
   Beijing University of Chinese Medicine
      2023   Phase 0   ChiCTR2300078272   China
   Nakamura Shiro
      2022   -   JPRN-jRCTs052210199   -
   National Institute of Medical Sciences and Nutrition, Salvador Zubiran
      2012   Phase 0   NCT01783119   Mexico
   The First Affiliated Hospital of Guangzhou University of Chinese Medicine
      2024   -   ChiCTR2400084743   China
   The Jikei University School of Medicine Division of Gastroenterology and Hepatology
      2009   -   JPRN-UMIN000008967   Japan
   Tsurumi University School of Dental Medicine, Department of Translational Research
      2018   -   JPRN-UMIN000032052   Japan
   Universitary Hospital Príncipe de Asturias
      2021   Phase 4   EUCTR2021-000985-14-ES   Spain
   Watanabe Hsopital
      2019   -   JPRN-UMIN000037537   Japan
Water immersion
   The Second Affiliated Hospital of Xi'an Jiaotong University
      2018   Phase 0   ChiCTR2200055616   China
   Vitkovice Hospital
      2013   -   NCT01933867   Czech Republic
Water or milk
   Hillel Yaffe Medical Center
      2010   -   NCT01121796   Israel
Wharton jelly mesenchymal stem cells
   Hanan Jafar
      2017   Phase 1/Phase 2   NCT03299413   Jordan
Whey
   Huadong Hospital Affiliated to Fudan University
      2021   -   ChiCTR2100051843   China
Whey protein MILK-derived exosomes
   Exosomm Ltd.
      2025   -   NCT06755021   -
Xeljanz
   Alimentiv Inc.
      2020   Phase 4   EUCTR2019-003780-21-NL   Belgium;Canada;Italy;Netherlands;Spain;United States
   CHU Amiens-Picardie
      2020   Phase 4   EUCTR2020-004391-18-FR   France
   DIP. MEDICINA DEI SISTEMI UNIVERSITà DEGLI STUDI DI ROMA TOR VERGATA
      2019   Phase 4   EUCTR2018-004890-28-IT   Italy
   Erasmus Medical Center
      2019   Phase 4   EUCTR2018-004587-61-NL   Netherlands
   McMaster University
      2021   Phase 2   NCT04925973   Canada
   PFIZER INC
      2022   Phase 3   EUCTR2018-002378-30-IT   Australia;Belgium;Canada;Finland;France;Germany;Hungary;Israel;Italy;Japan;Netherlands;Poland;Slovakia;Spain;Sweden;United Kingdom;United States
      2018   Phase 3;Phase 4   EUCTR2017-002274-39-IT   Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Japan;Korea, Republic of;Netherlands;New Zealand;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
   Pfizer Inc, 235 East 42nd Street, New York, New York 10017
      2018   Phase 3;Phase 4   EUCTR2017-002274-39-NL   Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Japan;Korea, Republic of;Netherlands;New Zealand;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
      2018   Phase 3;Phase 4   EUCTR2017-002274-39-GB   Austria;Belgium;Canada;Czech Republic;France;Germany;Hungary;Italy;Japan;Korea, Republic of;Netherlands;New Zealand;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
      2018   Phase 3;Phase 4   EUCTR2017-002274-39-CZ   Austria;Belgium;Canada;Czech Republic;Czechia;Germany;Hungary;Italy;Japan;Korea, Republic of;Netherlands;New Zealand;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
      2018   Phase 3;Phase 4   EUCTR2017-002274-39-BE   Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Japan;Korea, Republic of;Netherlands;New Zealand;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-002274-39-AT   Austria;Belgium;Canada;Czech Republic;France;Germany;Hungary;Italy;Japan;Korea, Republic of;Netherlands;New Zealand;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
      2017   Phase 3;Phase 4   EUCTR2017-002274-39-HU   Austria;Belgium;Canada;Czech Republic;France;Germany;Hungary;Italy;Japan;Korea, Republic of;Netherlands;New Zealand;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2017-002274-39-ES   Austria;Belgium;Canada;Czech Republic;France;Germany;Hungary;Italy;Japan;Korea, Republic of;Netherlands;New Zealand;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
   Pfizer Inc.
      2022   Phase 3   EUCTR2018-002378-30-SK   Australia;Belgium;Canada;Finland;France;Germany;Hungary;Israel;Italy;Japan;Netherlands;Poland;Slovakia;Spain;Sweden;United Kingdom;United States
      2022   Phase 3   EUCTR2018-002378-30-NL   Australia;Belgium;Canada;Finland;France;Germany;Hungary;Israel;Italy;Japan;Netherlands;Poland;Slovakia;Spain;Sweden;United Kingdom;United States
      2022   Phase 3   EUCTR2018-002378-30-HU   Australia;Belgium;Canada;Finland;France;Germany;Hungary;Israel;Italy;Japan;Netherlands;Poland;Slovakia;Spain;Sweden;United Kingdom;United States
      2022   Phase 3   EUCTR2018-002378-30-FR   Australia;Belgium;Canada;Finland;France;Germany;Hungary;Israel;Italy;Japan;Netherlands;Poland;Slovakia;Spain;Sweden;United Kingdom;United States
      2022   Phase 3   EUCTR2018-002378-30-DE   Australia;Belgium;Canada;Finland;France;Germany;Hungary;Israel;Italy;Japan;Netherlands;Poland;Slovakia;Spain;Sweden;United Kingdom;United States
      2021   Phase 3   EUCTR2018-002378-30-FI   Australia;Belgium;Canada;Finland;France;Germany;Hungary;Israel;Italy;Japan;Netherlands;Poland;Slovakia;Spain;Sweden;United Kingdom;United States
      2017   Phase 3;Phase 4   EUCTR2017-002274-39-SK   Austria;Belgium;Canada;Czech Republic;Czechia;Germany;Hungary;Italy;Japan;Korea, Republic of;Netherlands;New Zealand;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
      -   Phase 3   EUCTR2018-002378-30-SE   Australia;Belgium;Canada;Finland;France;Germany;Hungary;Israel;Italy;Japan;Netherlands;Poland;Slovakia;Spain;Sweden;United Kingdom;United States
      -   Phase 3   EUCTR2018-002378-30-PL   Australia;Belgium;Canada;Finland;France;Germany;Hungary;Israel;Italy;Japan;Netherlands;Poland;Slovakia;Spain;Sweden;United Kingdom;United States
      -   Phase 3   EUCTR2018-002378-30-BE   Australia;Belgium;Canada;Finland;France;Germany;Hungary;Israel;Italy;Japan;Netherlands;Poland;Slovakia;Spain;Sweden;United Kingdom;United States
Xeljanz 5 MG FILM-coated tablets
   Academic Medical Center
      2017   Phase 3   EUCTR2016-002691-27-NL   Netherlands
Xeljanz 5MG FILM-coated tablets
   Amsterdam UMC, location AMC
      2020   Phase 2   EUCTR2020-002695-12-NL   Netherlands
XMAB942
   GALE Therapeutics Inc.
      2024   Phase 1/Phase 2   NCT06619990   Australia
Xylitol
   Brigham and Women's Hospital
      2025   Early Phase 1   NCT06799039   United States
      2025   Phase 1   NCT05852587   United States
Zasocitinib
   Takeda
      2025   Phase 2   NCT06764615   -
Zeposia® indicated FOR THE treatment OF: relapsing forms OF multiple sclerosis, and active ulcerative colitis IN adults
   Corium Innovations, Inc.
      2025   -   NCT06528665   Malaysia
Zessly
   University Medical Center Groningen
      2021   Phase 4   EUCTR2020-001811-26-BE   Belgium;Netherlands;Spain
      2020   Phase 4   EUCTR2020-001811-26-NL   Belgium;Netherlands;Spain
Zessly, remsima, remicade
   Tampere University Hospital
      2021   Phase 4   EUCTR2021-000570-28-FI   Finland
ZL-82 100MG
   Chengdu Zenitar Biomedical Technology Co., Ltd
      2023   Phase 1   NCT06055023   China
ZL-82 12.5MG
   Chengdu Zenitar Biomedical Technology Co., Ltd
      2023   Phase 1   NCT06055023   China
ZL-82 200MG
   Chengdu Zenitar Biomedical Technology Co., Ltd
      2023   Phase 1   NCT06055023   China
ZL-82 25MG
   Chengdu Zenitar Biomedical Technology Co., Ltd
      2023   Phase 1   NCT06055023   China
ZL-82 300MG
   Chengdu Zenitar Biomedical Technology Co., Ltd
      2023   Phase 1   NCT06055023   China
ZL-82 450MG
   Chengdu Zenitar Biomedical Technology Co., Ltd
      2023   Phase 1   NCT06055023   China
ZL-82 50MG
   Chengdu Zenitar Biomedical Technology Co., Ltd
      2023   Phase 1   NCT06055023   China
ZL-82 600MG
   Chengdu Zenitar Biomedical Technology Co., Ltd
      2023   Phase 1   NCT06055023   China
Zoenasa-1:4
   Altheus Therapeutics, Inc.
      2012   Phase 2   NCT01586533   United States
ZOL446
   Novartis Pharma Services AG
      -   -   EUCTR2008-001252-52-Outside-EU/EEA   Australia;Canada;New Zealand
Zoledronic acid
   Novartis Pharma Services AG
      -   -   EUCTR2008-001252-52-Outside-EU/EEA   Australia;Canada;New Zealand
Zuoqing powder WAS dissolved IN 100ML normal saline, retained enema, once A night
   The Second Affiliated Hospital of Anhui University of Traditional Chinese Medicine
      2024   Phase 1/Phase 2   NCT06667934   -